PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bernhardt, J; Langhorne, P; Lindley, RI; Thrift, AG; Ellery, F; Collier, J; Churilov, L; Moodie, M; Dewey, H; Donnan, G				Bernhardt, Julie; Langhorne, Peter; Lindley, Richard I.; Thrift, Amanda G.; Ellery, Fiona; Collier, Janice; Churilov, Leonid; Moodie, Marjory; Dewey, Helen; Donnan, Geoffrey		AVERT Trial Collaboration Grp	Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial	LANCET			English	Article							EARLY REHABILITATION TRIAL; PHASE-II; ASSUMPTION-FREE; UNIT; COMPLICATIONS; METAANALYSIS; RECOVERY; EXERCISE; WALKING; CARE	Background Early mobilisation after stroke is thought to contribute to the effects of stroke-unit care; however, the intervention is poorly defined and not underpinned by strong evidence. We aimed to compare the effectiveness of frequent, higher dose, very early mobilisation with usual care after stroke. Methods We did this parallel-group, single-blind, randomised controlled trial at 56 acute stroke units in five countries. Patients (aged >= 18 years) with ischaemic or haemorrhagic stroke, first or recurrent, who met physiological criteria were randomly assigned (1: 1), via a web-based computer generated block randomisation procedure (block size of six), to receive usual stroke-unit care alone or very early mobilisation in addition to usual care. Treatment with recombinant tissue plasminogen activator was allowed. Randomisation was stratified by study site and stroke severity. Patients, outcome assessors, and investigators involved in trial and data management were masked to treatment allocation. The primary outcome was a favourable outcome 3 months after stroke, defined as a modified Rankin Scale score of 0-2. We did analysis on an intention-to-treat basis. The trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12606000185561. Findings Between July 18, 2006, and Oct 16, 2014, we randomly assigned 2104 patients to receive either very early mobilisation (n=1054) or usual care (n=1050); 2083 (99%) patients were included in the 3 month follow-up assessment. 965 (92%) patients were mobilised within 24 h in the very early mobilisation group compared with 623 (59%) patients in the usual care group. Fewer patients in the very early mobilisation group had a favourable outcome than those in the usual care group (n=480 [46%] vs n=525 [50%]; adjusted odds ratio [OR] 0.73, 95% CI 0.59-0.90; p=0.004). 88 (8%) patients died in the very early mobilisation group compared with 72 (7%) patients in the usual care group (OR 1.34, 95% CI 0.93-1.93, p=0.113). 201 (19%) patients in the very early mobilisation group and 208 (20%) of those in the usual care group had a non-fatal serious adverse event, with no reduction in immobility-related complications with very early mobilisation. Interpretation First mobilisation took place within 24 h for most patients in this trial. The higher dose, very early mobilisation protocol was associated with a reduction in the odds of a favourable outcome at 3 months. Early mobilisation after stroke is recommended in many clinical practice guidelines worldwide, and our findings should affect clinical practice by refining present guidelines; however, clinical recommendations should be informed by future analyses of dose-response associations.	[Bernhardt, Julie; Ellery, Fiona; Collier, Janice; Churilov, Leonid; Dewey, Helen; Donnan, Geoffrey] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Bernhardt, Julie] La Trobe Univ, Dept Rehabil Nutr & Sport, Bundoora, Vic, Australia; [Langhorne, Peter] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Lindley, Richard I.] Univ Sydney, Westmead Hosp, Sch Clin, Sydney Med Sch, Sydney, NSW 2006, Australia; [Thrift, Amanda G.] Monash Univ, Monash Hlth, Sch Clin Sci, Stroke & Ageing Res Grp,Dept Med, Clayton, Vic 3800, Australia; [Moodie, Marjory] Deakin Univ, Fac Hlth, Deakin Hlth Econ, Melbourne, Vic, Australia; [Dewey, Helen] Monash Univ, Fac Med Nursing & Hlth Sci, Australia & Eastern Clin Sch, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; La Trobe University; University of Glasgow; George Institute for Global Health; University of Sydney; University of Sydney; Monash University; Deakin University; Monash University	Bernhardt, J (corresponding author), Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic 3084, Australia.	julie.bernhardt@florey.edu.au	Hankey, Graeme J/H-4968-2014; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Collier, Janice/S-6179-2019; Thrift, Amanda/I-6251-2012; Macleod, Malcolm Robert/B-2052-2010; Lindley, Richard/B-8148-2013; Collier, Janice M/K-4563-2015; Bernhardt, Julie/F-9538-2015	Hankey, Graeme J/0000-0002-6044-7328; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Thrift, Amanda/0000-0001-8533-4170; Macleod, Malcolm Robert/0000-0001-9187-9839; Lindley, Richard/0000-0002-0104-5679; Collier, Janice M/0000-0003-2950-4870; Ellery, Fiona/0000-0002-7302-1895; Nicol, Marcus/0000-0002-5706-4684; Kwan, Joseph/0000-0003-4635-3322; Lennon, Sheila/0000-0001-5434-0893; Bernhardt, Julie/0000-0002-2787-8484; Kramer, Sharon/0000-0003-2795-6259	National Health and Medical Research Council; Singapore Health; Chest Heart and Stroke Scotland; Northern Ireland Chest Heart and Stroke; UK Stroke Association; National Institute of Health Research; National Institute for Health Research [12/01/16] Funding Source: researchfish; Stroke Association [TSA2009/09] Funding Source: researchfish; Chest Heart and Stroke Scotland [Res08/A114] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Singapore Health; Chest Heart and Stroke Scotland; Northern Ireland Chest Heart and Stroke; UK Stroke Association; National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association; Chest Heart and Stroke Scotland	National Health and Medical Research Council, Singapore Health, Chest Heart and Stroke Scotland, Northern Ireland Chest Heart and Stroke, UK Stroke Association, National Institute of Health Research.	Allen C, 1999, LANCET, V354, P1229, DOI 10.1016/S0140-6736(98)10063-6; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2015, STROKE, V46, P1141, DOI 10.1161/STROKEAHA.114.007434; Bernhardt J, 2015, INT J STROKE, V10, P23, DOI 10.1111/ijs.12423; Bernhardt J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006187.pub2; Briggs DE, 2001, STROKE, V32, P871, DOI 10.1161/01.STR.32.4.871; Churilov L, 2014, INT J STROKE, V9, P999, DOI 10.1111/ijs.12364; Craig LE, 2010, STROKE, V41, P2632, DOI 10.1161/STROKEAHA.110.588244; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; Egan KJ, 2014, NEUROREHAB NEURAL RE, V28, P800, DOI 10.1177/1545968314521694; Govan L, 2007, STROKE, V38, P2536, DOI 10.1161/STROKEAHA.106.478842; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Olavarria VV, 2014, CEREBROVASC DIS, V37, P401, DOI 10.1159/000362533; Saver JL, 2014, JAMA-J AM MED ASSOC, V311, P469, DOI 10.1001/jama.2013.282544; Skarin M, 2011, INT J STROKE, V6, P10, DOI 10.1111/j.1747-4949.2010.00534.x; Sundseth A, 2012, STROKE, V43, P2389, DOI 10.1161/STROKEAHA.111.646687; Tay-Teo K, 2008, CEREBROVASC DIS, V26, P475, DOI 10.1159/000155984; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	25	394	405	2	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					46	55		10.1016/S0140-6736(15)60690-0	http://dx.doi.org/10.1016/S0140-6736(15)60690-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25892679	Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000357519400027
J	Tinto, H; D'Alessandro, U; Sorgho, H; Valea, I; Tahita, MC; Kabore, W; Kiemde, F; Lompo, P; Ouedraogo, S; Derra, K; Ouedraogo, F; Ouedraogo, JB; Ballou, WR; Cohen, J; Guerra, Y; Heerwegh, D; Jongert, E; Lapierre, D; Leach, A; Lievens, M; Ofori-Anyinam, O; Olivier, A; Vekemans, J; Agnandji, ST; Lell, B; Fernandes, JF; Abossolo, BP; Kabwende, AL; Adegnika, AA; Mordmuller, B; Issifou, S; Kremsner, PG; Loembe, MM; Bache, E; Alabi, A; Owusu-Agyei, S; Asante, KP; Boahen, O; Dosoo, D; Asante, I; Yidana, Z; Anim, J; Adeniji, E; Yawson, AK; Kayan, K; Chandramohan, D; Greenwood, B; Ansong, D; Agbenyega, T; Adjei, S; Boateng, HO; Rettig, T; Sylverken, J; Sambian, D; Badu-Prepah, A; Kotey, A; Buabeng, P; Paintsil, V; Enimil, A; Hamel, MJ; Kariuki, S; Oneko, M; Odero, C; Otieno, K; Awino, N; Muturi-Kioi, V; Omoto, J; Sang, T; Odhiambo, S; Laserson, KF; Slutsker, L; Otieno, W; Otieno, L; Otsyula, N; Gondi, S; Ochola, J; Okoth, G; Mabunde, DC; Wangwe, A; Otieno, A; Oyieko, J; Cowden, J; Ogutu, B; Njuguna, P; Marsh, K; Akoo, P; Kerubo, C; Maingi, C; Bejon, P; Olotu, A; Chilengi, R; Tsofa, B; Lang, T; Gitaka, J; Awuondo, K; Martinson, F; Hoffman, I; Mvalo, T; Kamthunzi, P; Nkomo, R; Tembo, T; Tegha, G; Chawinga, C; Banda, T; Khan, S; Mwambakulu, S; Mzembe, E; Sacarlal, J; Aide, P; Madrid, L; Mandjate, S; Aponte, JJ; Bulo, H; Massora, S; Varela, E; Macete, E; Alonso, P; Lusingu, J; Gesase, S; Malabeja, A; Abdul, O; Mahende, C; Liheluka, E; Lemnge, M; Theander, TG; Drakeley, C; Mbwana, J; Olomi, R; Mmbando, B; Abdulla, S; Salim, N; Mtoro, A; Ahmed, S; Hamad, A; Kafuruki, S; Minja, R; Tanner, M; Maganga, M; Mdemu, A; Gwandu, C; Mohammed, A; Kaslow, D; Leboulleux, D; Savarese, B; Schellenberg, D				Tinto, H.; D'Alessandro, U.; Sorgho, H.; Valea, I.; Tahita, M. C.; Kabore, W.; Kiemde, F.; Lompo, P.; Ouedraogo, S.; Derra, K.; Ouedraogo, F.; Ouedraogo, J. B.; Ballou, W. R.; Cohen, J.; Guerra, Y.; Heerwegh, D.; Jongert, E.; Lapierre, D.; Leach, A.; Lievens, M.; Ofori-Anyinam, O.; Olivier, A.; Vekemans, J.; Agnandji, S. T.; Lell, B.; Fernandes, J. F.; Abossolo, B. P.; Kabwende, A. L.; Adegnika, A. A.; Mordmueller, B.; Issifou, S.; Kremsner, P. G.; Loembe, M. M.; Bache, E.; Alabi, A.; Owusu-Agyei, S.; Asante, K. P.; Boahen, O.; Dosoo, D.; Asante, I.; Yidana, Z.; Anim, J.; Adeniji, E.; Yawson, A. K.; Kayan, K.; Chandramohan, D.; Greenwood, B.; Ansong, D.; Agbenyega, T.; Adjei, S.; Boateng, H. O.; Rettig, T.; Sylverken, J.; Sambian, D.; Badu-Prepah, A.; Kotey, A.; Buabeng, P.; Paintsil, V.; Enimil, A.; Hamel, M. J.; Kariuki, S.; Oneko, M.; Odero, C.; Otieno, K.; Awino, N.; Muturi-Kioi, V.; Omoto, J.; Sang, T.; Odhiambo, S.; Laserson, K. F.; Slutsker, L.; Otieno, W.; Otieno, L.; Otsyula, N.; Gondi, S.; Ochola, J.; Okoth, G.; Mabunde, D. C.; Wangwe, A.; Otieno, A.; Oyieko, J.; Cowden, J.; Ogutu, B.; Njuguna, P.; Marsh, K.; Akoo, P.; Kerubo, C.; Maingi, C.; Bejon, P.; Olotu, A.; Chilengi, R.; Tsofa, B.; Lang, T.; Gitaka, J.; Awuondo, K.; Martinson, F.; Hoffman, I.; Mvalo, T.; Kamthunzi, P.; Nkomo, R.; Tembo, T.; Tegha, G.; Chawinga, C.; Banda, T.; Khan, S.; Mwambakulu, S.; Mzembe, E.; Sacarlal, J.; Aide, P.; Madrid, L.; Mandjate, S.; Aponte, J. J.; Bulo, H.; Massora, S.; Varela, E.; Macete, E.; Alonso, P.; Lusingu, J.; Gesase, S.; Malabeja, A.; Abdul, O.; Mahende, C.; Liheluka, E.; Lemnge, M.; Theander, T. G.; Drakeley, C.; Mbwana, J.; Olomi, R.; Mmbando, B.; Abdulla, S.; Salim, N.; Mtoro, A.; Ahmed, S.; Hamad, A.; Kafuruki, S.; Minja, R.; Tanner, M.; Maganga, M.; Mdemu, A.; Gwandu, C.; Mohammed, A.; Kaslow, D.; Leboulleux, D.; Savarese, B.; Schellenberg, D.		RTS S Clinical Trials Partnership	Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial	LANCET			English	Article							CIRCUMSPOROZOITE-PROTEIN; FALCIPARUM-MALARIA; IMMUNOGENICITY; REGION	Background The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. Herein, we report the final results from the same trial, including the efficacy of a booster dose. Methods From March 27, 2009, until Jan 31, 2011, children (age 5-17 months) and young infants (age 6-12 weeks) were enrolled at 11 centres in seven countries in sub-Saharan Africa. Participants were randomly assigned (1: 1: 1) at first vaccination by block randomisation with minimisation by centre to receive three doses of RTS, S/AS01 at months 0, 1, and 2 and a booster dose at month 20 (R3R group); three doses of RTS, S/AS01 and a dose of comparator vaccine at month 20 (R3C group); or a comparator vaccine at months 0, 1, 2, and 20 (C3C [control group]). Participants were followed up until Jan 31, 2014. Cases of clinical and severe malaria were captured through passive case detection. Serious adverse events (SAEs) were recorded. Analyses were by modified intention to treat and per protocol. The coprimary endpoints were the occurrence of malaria over 12 months after dose 3 in each age category. In this final analysis, we present data for the efficacy of the booster on the occurrence of malaria. Vaccine efficacy (VE) against clinical malaria was analysed by negative binomial regression and against severe malaria by relative risk reduction. This trial is registered with ClinicalTrials.gov, number NCT00866619. Findings 8922 children and 6537 young infants were included in the modified intention-to-treat analyses. Children were followed up for a median of 48 months (IQR 39-50) and young infants for 38 months (34-41) after dose 1. From month 0 until study end, compared with 9585 episodes of clinical malaria that met the primary case definition in children in the C3C group, 6616 episodes occurred in the R3R group (VE 36.3%, 95% CI 31.8-40.5) and 7396 occurred in the R3C group (28.3%, 23.3-32.9); compared with 171 children who experienced at least one episode of severe malaria in the C3C group, 116 children experienced at least one episode of severe malaria in the R3R group (32.2%, 13.7 to 46.9) and 169 in the R3C group (1.1%, -23.0 to 20.5). In young infants, compared with 6170 episodes of clinical malaria that met the primary case definition in the C3C group, 4993 episodes occurred in the R3R group (VE 25.9%, 95% CI 19.9-31.5) and 5444 occurred in the R3C group (18.3%, 11.7-24.4); and compared with 116 infants who experienced at least one episode of severe malaria in the C3C group, 96 infants experienced at least one episode of severe malaria in the R3R group (17.3%, 95% CI -9.4 to 37.5) and 104 in the R3C group (10.3%, -17.9 to 31.8). In children, 1774 cases of clinical malaria were averted per 1000 children (95% CI 1387-2186) in the R3R group and 1363 per 1000 children (995-1797) in the R3C group. The numbers of cases averted per 1000 young infants were 983 (95% CI 592-1337) in the R3R group and 558 (158-926) in the R3C group. The frequency of SAEs overall was balanced between groups. However, meningitis was reported as a SAE in 22 children: 11 in the R3R group, ten in the R3C group, and one in the C3C group. The incidence of generalised convulsive seizures within 7 days of RTS, S/AS01 booster was 2.2 per 1000 doses in young infants and 2.5 per 1000 doses in children. Interpretation RTS, S/AS01 prevented a substantial number of cases of clinical malaria over a 3-4 year period in young infants and children when administered with or without a booster dose. Efficacy was enhanced by the administration of a booster dose in both age categories. Thus, the vaccine has the potential to make a substantial contribution to malaria control when used in combination with other effective control measures, especially in areas of high transmission.	[Tinto, H.; D'Alessandro, U.; Sorgho, H.; Valea, I.; Tahita, M. C.; Kabore, W.; Kiemde, F.; Lompo, P.; Ouedraogo, S.; Derra, K.; Ouedraogo, F.; Ouedraogo, J. B.] Inst Rech Sci Sante, Nanoro, Burkina Faso; [Tinto, H.; D'Alessandro, U.; Sorgho, H.; Valea, I.; Tahita, M. C.; Kabore, W.; Kiemde, F.; Lompo, P.; Ouedraogo, S.; Derra, K.; Ouedraogo, F.; Ouedraogo, J. B.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ballou, W. R.; Cohen, J.; Guerra, Y.; Heerwegh, D.; Jongert, E.; Lapierre, D.; Leach, A.; Lievens, M.; Ofori-Anyinam, O.; Olivier, A.; Vekemans, J.] GlaxoSmithKline Vaccines, Wavre, Belgium; [Agnandji, S. T.; Lell, B.; Fernandes, J. F.; Abossolo, B. P.; Kabwende, A. L.; Adegnika, A. A.; Mordmueller, B.; Issifou, S.; Kremsner, P. G.; Loembe, M. M.; Bache, E.; Alabi, A.] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, S. T.; Lell, B.; Fernandes, J. F.; Abossolo, B. P.; Kabwende, A. L.; Adegnika, A. A.; Mordmueller, B.; Issifou, S.; Kremsner, P. G.; Loembe, M. M.; Bache, E.; Alabi, A.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Owusu-Agyei, S.; Asante, K. P.; Boahen, O.; Dosoo, D.; Asante, I.; Yidana, Z.; Anim, J.; Adeniji, E.; Yawson, A. K.; Kayan, K.; Chandramohan, D.; Greenwood, B.] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Owusu-Agyei, S.; Asante, K. P.; Boahen, O.; Dosoo, D.; Asante, I.; Yidana, Z.; Anim, J.; Adeniji, E.; Yawson, A. K.; Kayan, K.; Chandramohan, D.; Greenwood, B.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Ansong, D.; Agbenyega, T.; Adjei, S.; Boateng, H. O.; Rettig, T.; Sylverken, J.; Sambian, D.; Badu-Prepah, A.; Kotey, A.; Buabeng, P.; Paintsil, V.; Enimil, A.] Sch Med Sci, Kumasi, Ghana; [Hamel, M. J.; Kariuki, S.; Oneko, M.; Odero, C.; Otieno, K.; Awino, N.; Muturi-Kioi, V.; Omoto, J.; Sang, T.; Odhiambo, S.; Laserson, K. F.; Slutsker, L.] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Hamel, M. J.; Kariuki, S.; Oneko, M.; Odero, C.; Otieno, K.; Awino, N.; Muturi-Kioi, V.; Omoto, J.; Sang, T.; Odhiambo, S.; Laserson, K. F.; Slutsker, L.] KEMRI CDC Res & Publ Hlth Collaborat, Atlanta, GA USA; [Otieno, W.; Otieno, L.; Otsyula, N.; Gondi, S.; Ochola, J.; Okoth, G.; Mabunde, D. C.; Wangwe, A.; Otieno, A.; Oyieko, J.; Cowden, J.; Ogutu, B.] KEMRI Walter Reed Project, Kombewa, Kenya; [Otieno, W.; Otieno, L.; Otsyula, N.; Gondi, S.; Ochola, J.; Okoth, G.; Mabunde, D. C.; Wangwe, A.; Otieno, A.; Oyieko, J.; Cowden, J.; Ogutu, B.] KEMRI Walter Reed Project, Silver Spring, MD USA; [Njuguna, P.; Marsh, K.; Akoo, P.; Kerubo, C.; Maingi, C.; Bejon, P.; Olotu, A.; Chilengi, R.; Tsofa, B.; Lang, T.; Gitaka, J.; Awuondo, K.] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Martinson, F.; Hoffman, I.; Mvalo, T.; Kamthunzi, P.; Nkomo, R.; Tembo, T.; Tegha, G.; Chawinga, C.; Banda, T.; Khan, S.; Mwambakulu, S.; Mzembe, E.] Univ North Carolina Project, Lilongwe, Malawi; [Martinson, F.; Hoffman, I.; Mvalo, T.; Kamthunzi, P.; Nkomo, R.; Tembo, T.; Tegha, G.; Chawinga, C.; Banda, T.; Khan, S.; Mwambakulu, S.; Mzembe, E.] Univ North Carolina Project, Chapel Hill, NC USA; [Sacarlal, J.; Aide, P.; Madrid, L.; Mandjate, S.; Aponte, J. J.; Bulo, H.; Massora, S.; Varela, E.; Macete, E.; Alonso, P.] Ctr Invest Saude Manhica, Manhica, Mozambique; [Sacarlal, J.; Aide, P.; Madrid, L.; Mandjate, S.; Aponte, J. J.; Bulo, H.; Massora, S.; Varela, E.; Macete, E.; Alonso, P.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Lusingu, J.; Gesase, S.; Malabeja, A.; Abdul, O.; Mahende, C.; Liheluka, E.; Lemnge, M.; Theander, T. G.; Drakeley, C.; Mbwana, J.; Olomi, R.; Mmbando, B.] Natl Inst Med Res, Korogwe, Tanzania; [Lusingu, J.; Gesase, S.; Malabeja, A.; Abdul, O.; Mahende, C.; Liheluka, E.; Lemnge, M.; Theander, T. G.; Drakeley, C.; Mbwana, J.; Olomi, R.; Mmbando, B.] Univ Copenhagen, Copenhagen, Denmark; [Abdulla, S.; Salim, N.; Mtoro, A.; Ahmed, S.; Hamad, A.; Kafuruki, S.; Minja, R.; Tanner, M.; Maganga, M.; Mdemu, A.; Gwandu, C.; Mohammed, A.] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Abdulla, S.; Salim, N.; Mtoro, A.; Ahmed, S.; Hamad, A.; Kafuruki, S.; Minja, R.; Tanner, M.; Maganga, M.; Mdemu, A.; Gwandu, C.; Mohammed, A.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Kaslow, D.; Leboulleux, D.; Savarese, B.; Schellenberg, D.] PATH MVI, Washington, DC USA	Institute of Tropical Medicine (ITM); GlaxoSmithKline; Eberhard Karls University of Tubingen; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Copenhagen; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk	Kariuki, Simon/AFT-6596-2022; Tahita, Marc/AAG-6549-2019; Alabi, Abraham/AAD-9316-2020; Odero, Christopher/AAW-2752-2020; Alonso, Pedro L/AAZ-3645-2020; Enimil, Anthony/AAV-2595-2021; Lusingu, John P. A./GSJ-3228-2022; Mordmüller, Benjamin/A-5749-2010; Derra, Karim/AAC-1323-2022; Leach, Amanda/AAS-1120-2020; Theander, Thor/F-6714-2015; ADEGNIKA, Ayola Akim/AAK-7307-2020; Sacarlal, Jahit/R-3172-2016	Tahita, Marc/0000-0003-2158-0182; Odero, Christopher/0000-0003-2317-9405; Alonso, Pedro L/0000-0003-3292-3443; Mordmüller, Benjamin/0000-0001-9101-2768; Derra, Karim/0000-0002-2090-9698; Leach, Amanda/0000-0002-7114-9967; Theander, Thor/0000-0002-3509-7514; Liheluka, Edwin/0000-0001-9043-7529; Gitaka, Jesse/0000-0001-7516-522X; Sacarlal, Jahit/0000-0003-1059-217X; Muturi-Kioi, Vincent/0000-0003-1620-3999; Schellenberg, David/0000-0001-8222-0186; Madrid, Lola/0000-0003-4034-6033	GlaxoSmithKline Biologicals SA; PATH Malaria Vaccine Initiative; Medical Research Council [G1002624] Funding Source: researchfish	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); PATH Malaria Vaccine Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GlaxoSmithKline Biologicals SA and the PATH Malaria Vaccine Initiative.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Efron B., 1994, MONOGRAPHS STAT APPL; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; ICH, 2013, MEDDRA TERM SEL POIN; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MOLYNEUX ME, 1989, Q J MED, V71, P441; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; The Good Clinical Practice, 1996, INT C HARM TECHN REQ; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, WHO IN VACC RES GLOB	18	749	750	5	129	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					31	45		10.1016/S0140-6736(15)60721-8	http://dx.doi.org/10.1016/S0140-6736(15)60721-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25913272	Green Accepted, Green Submitted			2022-12-28	WOS:000357519400026
J	Lamb, SE				Lamb, Sarah E.			The case for stepped-wedge studies: a trial of falls prevention	LANCET			English	Editorial Material									Univ Oxford, Rehabil Res Ctr, Botnar Res Ctr, Oxford OX3 7LD, England	University of Oxford	Lamb, SE (corresponding author), Univ Oxford, Rehabil Res Ctr, Botnar Res Ctr, Oxford OX3 7LD, England.	sarah.lamb@ndorms.ox.ac.uk		Lamb, Sarah/0000-0003-4349-7195				Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Haines T, 2008, J GERONTOL A-BIOL, V63, P523, DOI 10.1093/gerona/63.5.523; Haines TP, 2011, ARCH INTERN MED, V171, P516, DOI 10.1001/archinternmed.2010.444; Hayes RJ, 2009, CHAPMAN HALL CRC INT, P136; Hill AM, 2015, LANCET; Peak EL, 2005, J BONE JOINT SURG AM, V87A, P247, DOI 10.2106/JBJS.C.01513; Taraldsen K, 2014, J GERONTOL A-BIOL, V69, P338, DOI 10.1093/gerona/glt097; Zijlstra GAR, 2009, J AM GERIATR SOC, V57, P2020, DOI 10.1111/j.1532-5415.2009.02489.x	8	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2556	2557		10.1016/S0140-6736(14)62288-1	http://dx.doi.org/10.1016/S0140-6736(14)62288-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25865866				2022-12-28	WOS:000356930000008
J	Rosenbaum, S; Westmoreland, T				Rosenbaum, Sara; Westmoreland, Timothy			Restructuring Medicaid as Block Grants - Unconstitutional Coercion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA; [Westmoreland, Timothy] Georgetown Univ, Ctr Law, Washington, DC USA	George Washington University; Georgetown University	Rosenbaum, S (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.							Holahan J, 2012, NEW ENGL J MED, V367, P393, DOI 10.1056/NEJMp1204899; Lambrew JM, 2005, MILBANK Q, V83, P41, DOI 10.1111/j.0887-378X.2005.00335.x; Park E., 2015, PROPOSED MED BLOCK G	3	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1785	1787		10.1056/NEJMp1503455	http://dx.doi.org/10.1056/NEJMp1503455			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25902383				2022-12-28	WOS:000353974700002
J	Bass, JIF; Sahni, N; Shrestha, S; Garcia-Gonzalez, A; Mori, A; Bhat, N; Yi, S; Hill, DE; Vidal, M; Walhout, AJM				Bass, Juan I. Fuxman; Sahni, Nidhi; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Yi, Song; Hill, David E.; Vidal, Marc; Walhout, Albertha J. M.			Human Gene-Centered Transcription Factor Networks for Enhancers and Disease Variants	CELL			English	Article							ONE-HYBRID ASSAYS; REGULATORY NETWORK; PROTEIN-DNA; LHX4 GENE; MUTATIONS; PROMOTER; BINDING; MOUSE	Gene regulatory networks (GRNs) comprising interactions between transcription factors (TFs) and regulatory loci control development and physiology. Numerous disease-associated mutations have been identified, the vast majority residing in non-coding regions of the genome. As current GRN mapping methods test one TF at a time and require the use of cells harboring the mutation(s) of interest, they are not suitable to identify TFs that bind to wildtype and mutant loci. Here, we use gene-centered yeast one-hybrid (eY1H) assays to interrogate binding of 1,086 human TFs to 246 enhancers, as well as to 109 non-coding disease mutations. We detect both loss and gain of TF interactions with mutant loci that are concordant with target gene expression changes. This work establishes eY1H assays as a powerful addition to the toolkit of mapping human GRNs and for the high-throughput characterization of genomic variants that are rapidly being identified by genome-wide association studies.	[Bass, Juan I. Fuxman; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Bass, Juan I. Fuxman; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sahni, Nidhi; Yi, Song; Hill, David E.; Vidal, Marc; Walhout, Albertha J. M.] Dana Farber Canc Inst, Dept Canc Biol, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	walhout@umassmed.edu	Yi, Song/ABG-6526-2020	Yi, Song/0000-0003-0047-8103; Walhout, Marian/0000-0001-5587-3608; Sahni, Nidhi/0000-0002-9155-5882; Garcia Gonzalez, Aurian P./0000-0003-4120-4408	US NIH [GM082971, HG004233, HG006066]; Pew Latin American Fellows Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC4HG006066, P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000, R01GM082971] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Latin American Fellows Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the A.J.M.W. laboratory, R. McCord, N. Kaplan, and J. Dekker for discussions and critical reading of the manuscript. We thank J. Gibcus for the pGL4 plasmid and expression vectors and advice on the luciferase assays. We thank N. Beittel and B. Parmentier for technical assistance. This work was supported by US NIH grants GM082971 to A.J.M.W., HG004233 to M.V., and HG006066 to M.V. and D.E.H. J.I.F.B. was partially supported by a postdoctoral fellowship from the Pew Latin American Fellows Program.	Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bass JIF, 2014, NUCLEIC ACIDS RES, V42, P153, DOI 10.1093/nar/gkt858; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo W, 1996, J BIOL CHEM, V271, P23445, DOI 10.1074/jbc.271.38.23445; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Reece-Hoyes JS, 2013, MOL CELL, V51, P116, DOI 10.1016/j.molcel.2013.05.018; Reece-Hoyes JS, 2012, METHODS MOL BIOL, V812, P189, DOI 10.1007/978-1-61779-455-1_11; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sharpe J, 1999, CURR BIOL, V9, P97, DOI 10.1016/S0960-9822(99)80022-0; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009	39	65	65	4	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					661	673		10.1016/j.cell.2015.03.003	http://dx.doi.org/10.1016/j.cell.2015.03.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910213	Green Accepted, Bronze			2022-12-28	WOS:000353553600023
J	Goldzweig, CL; Orshansky, G; Paige, NM; Miake-Lye, IM; Beroes, JM; Ewing, BA; Shekelle, PG				Goldzweig, Caroline Lubick; Orshansky, Greg; Paige, Neil M.; Miake-Lye, Isomi M.; Beroes, Jessica M.; Ewing, Brett A.; Shekelle, Paul G.			Electronic Health Record-Based Interventions for Improving Appropriate Diagnostic Imaging A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL DECISION-SUPPORT; COMPUTERIZED ORDER ENTRY; INFORMATION-TECHNOLOGY; IMPACT; QUALITY; YIELD; CT; GUIDELINES; EFFICIENCY; RADIOLOGY	Background: One driver of increasing health care costs is the use of radiologic imaging procedures. More appropriate use could improve quality and reduce costs. Purpose: To review interventions that use the computerized clinical decision-support (CCDS) capabilities of electronic health records to improve appropriate use of diagnostic radiologic test ordering. Data Sources: English-language articles in PubMed from 1995 to September 2014 and searches in Web of Science and PubMed of citations related to key articles. Study Selection: 23 studies, including 3 randomized trials, 7 time-series studies, and 13 pre-post studies that assessed the effect of CCDS on diagnostic radiologic test ordering in adults. Data Extraction: 2 independent reviewers extracted data on functionality, study outcomes, and context and assessed the quality of included studies. Data Synthesis: Thirteen studies provided moderate-level evidence that CCDS improves appropriateness (effect size, -0.49 [95% CI, -0.71 to -0.26]) and reduces use (effect size, -0.13 [CI, -0.23 to -0.04]). Interventions with a "hard stop" that prevents a clinician from overriding the CCDS without outside consultation, as well as interventions in integrated care delivery systems, may be more effective. Harms have rarely been assessed but include decreased ordering of appropriate tests and physician dissatisfaction. Limitation: Potential for publication bias, insufficient reporting of harms, and poor description of context and implementation. Conclusion: Computerized clinical decision support integrated with the electronic health record can improve appropriate use of diagnostic radiology by a moderate amount and decrease use by a small amount. Before widespread adoption can be recommended, more data are needed on potential harms.	West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Ewing, Brett A.] RAND Corp, Southern Calif Evidence Based Practice Ctr, Santa Monica, CA 90401 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; RAND Corporation	Goldzweig, CL (corresponding author), Vet Affairs West Los Angeles Healthcare Ctr, 11301 Wilshire Blvd,111-G, Los Angeles, CA 90073 USA.	caroline.goldzweig@va.gov			U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs. (PROSPERO registration number: CRD42014007469)	Bates DW, 1997, ARCH INTERN MED, V157, P2501, DOI 10.1001/archinte.157.21.2501; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; Borenstein M, 2011, INTRO METAANALYSIS, P45; Bowen S, 2011, J AM COLL RADIOL, V8, P251, DOI 10.1016/j.jacr.2010.11.020; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Carton M, 2002, CLIN RADIOL, V57, P123, DOI 10.1053/crad.2001.0827; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Chin HL, 1999, P AM MED INF ASS ANN; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Curry L, 2011, J AM MED INFORM ASSN, V18, P267, DOI 10.1136/amiajnl-2011-000049; Day F, 1995, Proc Annu Symp Comput Appl Med Care, P576; Drescher FS, 2011, ANN EMERG MED, V57, P613, DOI 10.1016/j.annemergmed.2010.09.018; Durand DJ, 2013, J AM COLL RADIOL, V10, P108, DOI 10.1016/j.jacr.2012.06.020; Fillmore CL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-135; Flamm M, 2013, J AM MED INFORM ASSN, V20, pE91, DOI 10.1136/amiajnl-2012-001178; Georgiou A, 2011, J AM MED INFORM ASSN, V18, P335, DOI 10.1136/amiajnl-2010-000043; Goldzweig CL, 2013, ANN INTERN MED, V159, P677, DOI 10.7326/0003-4819-159-10-201311190-00006; Gupta A, 2014, J AM MED INFORM ASSN, V21, pE347, DOI 10.1136/amiajnl-2013-002536; Harpole LH, 1997, J AM MED INFORM ASSN, V4, P511, DOI 10.1136/jamia.1997.0040511; Hoo GWS, 2011, AM J ROENTGENOL, V196, P1059, DOI 10.2214/AJR.10.4200; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Ip IK, 2014, AM J MED, V127, P512, DOI 10.1016/j.amjmed.2014.01.024; Ip IK, 2013, AM J MED, V126, P687, DOI 10.1016/j.amjmed.2012.11.034; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Raja AS, 2014, ACAD RADIOL, V21, P378, DOI 10.1016/j.acra.2013.10.017; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Rosenthal Daniel I, 2006, J Am Coll Radiol, V3, P799, DOI 10.1016/j.jacr.2006.05.006; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Sanders DL, 2001, J AM MED INFORM ASSN, P583; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Solberg LI, 2010, AM J MANAG CARE, V16, P102; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; TIERNEY WM, 1988, JAMA-J AM MED ASSOC, V259, P1194, DOI 10.1001/jama.259.8.1194; TIERNEY WM, 1990, NEW ENGL J MED, V322, P1499, DOI 10.1056/NEJM199005243222105; Vartanians VM, 2010, RADIOLOGY, V255, P842, DOI 10.1148/radiol.10091228	40	57	57	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					557	+		10.7326/M14-2600	http://dx.doi.org/10.7326/M14-2600			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4GT	25894025				2022-12-28	WOS:000353244300016
J	Mons, U; Muezzinler, A; Gellert, C; Schottker, B; Abnet, CC; Bobak, M; de Groot, L; Freedman, ND; Jansen, E; Kee, F; Kromhout, D; Kuulasmaa, K; Laatikainen, T; O'Doherty, MG; Bueno-de-Mesquita, B; Orfanos, P; Peters, A; van der Schouw, YT; Wilsgaard, T; Wolk, A; Trichopoulou, A; Boffetta, P; Brenner, H				Mons, Ute; Mueezzinler, Aysel; Gellert, Carolin; Schoettker, Ben; Abnet, Christian C.; Bobak, Martin; de Groot, Lisette; Freedman, Neal D.; Jansen, Eugene; Kee, Frank; Kromhout, Daan; Kuulasmaa, Kari; Laatikainen, Tiina; O'Doherty, Mark G.; Bueno-de-Mesquita, Bas; Orfanos, Philippos; Peters, Annette; van der Schouw, Yvonne T.; Wilsgaard, Tom; Wolk, Alicja; Trichopoulou, Antonia; Boffetta, Paolo; Brenner, Hermann		CHANCES Consortium	Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RATE ADVANCEMENT PERIODS; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; RISK-FACTORS; DISEASE; HEALTH; STROKE; WOMEN; MEN; HETEROGENEITY	OBJECTIVE To investigate the impact of smoking and smoking cessation on cardiovascular mortality, acute coronary events, and stroke events in people aged 60 and older, and to calculate and report risk advancement periods for cardiovascular mortality in addition to traditional epidemiological relative risk measures. DESIGN Individual participant meta-analysis using data from 25 cohorts participating in the CHANCES consortium. Data were harmonised, analysed separately employing Cox proportional hazard regression models, and combined by meta-analysis. RESULTS Overall, 503 905 participants aged 60 and older were included in this study, of whom 37 952 died from cardiovascular disease. Random effects meta-analysis of the association of smoking status with cardiovascular mortality yielded a summary hazard ratio of 2.07 (95% CI 1.82 to 2.36) for current smokers and 1.37 (1.25 to 1.49) for former smokers compared with never smokers. Corresponding summary estimates for risk advancement periods were 5.50 years (4.25 to 6.75) for current smokers and 2.16 years (1.38 to 2.39) for former smokers. The excess risk in smokers increased with cigarette consumption in a dose-response manner, and decreased continuously with time since smoking cessation in former smokers. Relative risk estimates for acute coronary events and for stroke events were somewhat lower than for cardiovascular mortality, but patterns were similar. CONCLUSIONS Our study corroborates and expands evidence from previous studies in showing that smoking is a strong independent risk factor of cardiovascular events and mortality even at older age, advancing cardiovascular mortality by more than five years, and demonstrating that smoking cessation in these age groups is still beneficial in reducing the excess risk.	[Mons, Ute; Mueezzinler, Aysel; Gellert, Carolin; Schoettker, Ben; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Mueezzinler, Aysel] Heidelberg Univ, NAR, Heidelberg, Germany; [Abnet, Christian C.; Freedman, Neal D.] NCI, Bethesda, MD 20892 USA; [Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England; [de Groot, Lisette; Kromhout, Daan] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Jansen, Eugene] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Kee, Frank; O'Doherty, Mark G.] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Kuulasmaa, Kari; Laatikainen, Tiina] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Laatikainen, Tiina] Hosp Dist North Karelia, Joensuu, Finland; [Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands; [Bueno-de-Mesquita, Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, Bas] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Bueno-de-Mesquita, Bas] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Orfanos, Philippos; Trichopoulou, Antonia; Boffetta, Paolo] Hellen Hlth Fdn, Athens, Greece; [Orfanos, Philippos; Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany; [van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Wilsgaard, Tom] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; University College London; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Queens University Belfast; Finland National Institute for Health & Welfare; University of Eastern Finland; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Imperial College London; Universiti Malaya; Athens Medical School; National & Kapodistrian University of Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mons, U (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	u.mons@dkfz.de	Laatikainen, Tiina/ABD-6622-2021; Freedman, Neal David/B-9741-2015; Boffetta, Paolo/AAI-7767-2021; Peters, Annette/A-6117-2011; van der Schouw, Yvonne T./F-8327-2014; Brenner, Hermann/ABE-6383-2020; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Abnet, Christian C/C-4111-2015; Schöttker, Ben/F-8183-2014; Malyutina, Sofia/J-1651-2018; Baceviciene, Migle/AAG-1246-2020; Orfanos, Philippos/AAL-2606-2021; Mons, Ute/AAO-4337-2021; Brenner, Hermann/B-4627-2017; SANCHEZ-PEREZ, MARIA JOSE/D-1087-2011; Veronesi, Giovanni/E-3859-2010	Laatikainen, Tiina/0000-0002-6614-4782; Freedman, Neal David/0000-0003-0074-1098; Boffetta, Paolo/0000-0002-3811-2791; Peters, Annette/0000-0001-6645-0985; van der Schouw, Yvonne T./0000-0002-4605-435X; Brenner, Hermann/0000-0002-6129-1572; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Abnet, Christian C/0000-0002-3008-7843; Schöttker, Ben/0000-0002-1217-4521; Malyutina, Sofia/0000-0001-6539-0466; Baceviciene, Migle/0000-0002-9819-2316; Mons, Ute/0000-0003-1764-6783; Brenner, Hermann/0000-0002-6129-1572; Pisinger, Charlotta/0000-0002-7970-3168; Feskens, Edith/0000-0001-5819-2488; de Groot, Lisette/0000-0003-2778-2789; Orfanos, Philippos/0000-0002-9949-3137; Lochen, Maja-Lisa/0000-0002-8532-6573; Bobak, Martin/0000-0002-2633-6851; Michaelsson, Karl/0000-0003-2815-1217; Kontto, Jukka/0000-0003-3899-9852; Orsini, Nicola/0000-0002-2210-5634; SANCHEZ-PEREZ, MARIA JOSE/0000-0003-4817-0757; Kuulasmaa, Kari/0000-0003-2165-1411; Veronesi, Giovanni/0000-0002-4119-6615; Pikhart, Hynek/0000-0001-5277-4049	European Commission [HEALTH-F3-2010-242244, QLK6-CT-2001-00360, RII-CT-2006-062193, CIT5-CT-2005-028857, CIT4-CT-2006-028812, 211909, 227822, 261982]; National Institute of Aging in the United States; ELSA; Hellenic Health Foundation; European Commission (DG SANCO); Dutch Ministry of Public Health, Welfare and Sports (VWS); National Institute for Public Health and the Environment; Dutch Cancer Society, the Netherlands Organisation for Health Research and Development (ZONMW); World Cancer Research Fund (WCRF); Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer [Rd06/0020/0091, Rd12/0036/0018]; Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra, Instituto de Salud Carlos III, Redes de Investigacion Cooperativa [RD06/0020]; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane; Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany); Federal Ministry of Education and Research (Berlin, Germany); Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany); Wellcome Trust [064947, 081081]; US National Institute on Aging [R01 AG23522-01, U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, OGHA 04-064]; Mac Arthur Foundation; European Union [HEALTH-F4-2007-201413, 278913]; Intramural Research Program of the National Cancer Institute (NCI), NIH; German Ministry of Education and Research; Swedish Research Council; Karolinska Institutet; UiT The Arctic University of Norway; National Screening Service; Research Council of Norway; Netherlands Prevention Foundation; Klaus Tschira Foundation; MRC [G0601463] Funding Source: UKRI; Medical Research Council [G0601463, MC_CF023241] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P30AG012815, R01AG023522, R21AG025169, P01AG005842, P01AG008291, U01AG009740] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ELSA; Hellenic Health Foundation; European Commission (DG SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Public Health, Welfare and Sports (VWS); National Institute for Public Health and the Environment; Dutch Cancer Society, the Netherlands Organisation for Health Research and Development (ZONMW); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer; Regional Governments of Andalucia, Asturias, Basque Country, Murcia(Principality of Asturias); Navarra, Instituto de Salud Carlos III, Redes de Investigacion Cooperativa; Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane; Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany); Federal Ministry of Education and Research (Berlin, Germany)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany); Wellcome Trust(Wellcome Trust); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mac Arthur Foundation; European Union(European Commission); Intramural Research Program of the National Cancer Institute (NCI), NIH; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); UiT The Arctic University of Norway; National Screening Service; Research Council of Norway(Research Council of Norway); Netherlands Prevention Foundation; Klaus Tschira Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data used throughout the present study are derived from the CHANCES project. The project is coordinated by the Hellenic Health Foundation, Greece. The project received funding by the FP7 framework programme of DG-RESEARCH in the European Commission (grant agreement no. HEALTH-F3-2010-242244). ELSA: The data of the ELSA cohort were made available through the UK Data Archive (UKDA). ELSA was developed by a team of researchers based at the NatCen Social Research, University College London and the Institute for Fiscal Studies. The data were collected by NatCen Social Research. The funding is provided by the National Institute of Aging in the United States, and a consortium of UK government departments coordinated by the Office for National Statistics. The developers and funders of ELSA and the archive do not bear any responsibility for the analyses or interpretations presented here. EPIC Greece: funded by the Hellenic Health Foundation. EPIC Netherlands: funded by European Commission (DG SANCO); Dutch Ministry of Public Health, Welfare and Sports (VWS); The National Institute for Public Health and the Environment; the Dutch Cancer Society, the Netherlands Organisation for Health Research and Development (ZONMW); World Cancer Research Fund (WCRF). EPIC Spain: supported by Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer (grant numbers: Rd06/0020/0091 and Rd12/0036/0018), Regional Governments of Andalucia, Asturias, Basque Country, Murcia (project 6236), and Navarra, Instituto de Salud Carlos III, Redes de Investigacion Cooperativa (RD06/0020). EPIC Sweden: funded by the Swedish Cancer Society, the Swedish Scientific Council and the Regional Government of Skane. ESTHER: funded by the Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany), the Federal Ministry of Education and Research (Berlin, Germany), and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany). HAPIEE: funded by the Wellcome Trust (064947 and 081081), the US National Institute on Aging (R01 AG23522-01) and a grant from Mac Arthur Foundation. MORGAM: MORGAM Project has received additional funding from European Union FP 7 projects ENGAGE (HEALTH-F4-2007-201413) and BiomarCaRE (278913). This has supported central coordination, workshops and part of the activities of the MORGAM Data Centre, at THL in Helsinki, Finland. MORGAM Participating Centres are funded by regional and national governments, research councils, charities, and other local sources. NIH-AARP: support for the National Institutes of Health (NIH)-AARP Diet and Health Study was provided by the Intramural Research Program of the National Cancer Institute (NCI), NIH. NHANES: The study is conducted by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention. The findings and conclusions in this paper are those of the authors and not necessarily those of the agency. SENECA: SENECA is a Concerted Action within the EURONUT programme of the European Union. SHARE: SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5-CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982).; Additional funding from the US National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, and OGHA 04-064) and the German Ministry of Education and Research as well as from various national sources is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). SMC: funded by the Swedish Research Council and Strategic Funds from Karolinska Institutet. Tromso: funded by: UiT The Arctic University of Norway, the National Screening Service, and the Research Council of Norway. Zutphen Elderly Study: funded by the Netherlands Prevention Foundation. The work of Aysel Muezzinler was supported by a scholarship from the Klaus Tschira Foundation.	Beer C, 2011, STROKE, V42, P952, DOI 10.1161/STROKEAHA.110.603480; Boffetta P, 2014, EUR J EPIDEMIOL, V29, P929, DOI 10.1007/s10654-014-9977-1; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Buckland A, 2005, AGE AGEING, V34, P639, DOI 10.1093/ageing/afi199; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Doolan Daniel M, 2008, Prog Cardiovasc Nurs, V23, P119, DOI 10.1111/j.1751-7117.2008.00001.x; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gellert C, 2013, EUR J EPIDEMIOL, V28, P649, DOI 10.1007/s10654-013-9776-0; Gellert C, 2013, TOB CONTROL, V22, P227, DOI 10.1136/tobaccocontrol-2012-050572; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; He Y, 2014, AM J EPIDEMIOL, V179, P1060, DOI 10.1093/aje/kwu011; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Iso H, 2005, AM J EPIDEMIOL, V161, P170, DOI 10.1093/aje/kwi027; Kelly TN, 2008, STROKE, V39, P1688, DOI 10.1161/STROKEAHA.107.505305; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; Kriekard P, 2009, CLIN GERIATR MED, V25, P745, DOI 10.1016/j.cger.2009.07.008; Liese AD, 2000, AM J EPIDEMIOL, V152, P884, DOI 10.1093/aje/152.9.884; Maguire CP, 2000, AGE AGEING, V29, P264, DOI 10.1093/ageing/29.3.264; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Myint PK, 2008, EUR J CARDIOV PREV R, V15, P663, DOI 10.1097/HJR.0b013e32830fe465; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Peters SAE, 2013, STROKE, V44, P2821, DOI 10.1161/STROKEAHA.113.002342; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Schwarzer G, 2013, META META ANALYSIS W; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Tournier M, 2008, J POPUL THER CLIN PH, V15, pE22; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; U.S. Department of Health and Human Services, 2014, HLTH CONSEQUENCES SM; US Department of Health Education and Welfare, 1964, SMOKING AND HEALTH R; World Cancer Research Fund, 2007, NUTRITION PHYSICAL A	35	252	272	4	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2015	350								h1551	10.1136/bmj.h1551	http://dx.doi.org/10.1136/bmj.h1551			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8PY	25896935	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000353572900001
J	Schechter, MT				Schechter, Martin T.			PERSONAL VIEW Drug users should be able to get heroin from the health system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; OPIOID DEPENDENCE; PRESCRIBED HEROIN; ORAL METHADONE; ADDICTS; DIACETYLMORPHINE; TRIAL		Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia	Schechter, MT (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	martin.schechter@ubc.ca		Schechter, Martin/0000-0001-6063-2155				Byford S, 2013, BRIT J PSYCHIAT, V203, P341, DOI 10.1192/bjp.bp.112.111583; Dijkgraaf MGW, 2005, BMJ-BRIT MED J, V330, P1297, DOI 10.1136/bmj.330.7503.1297; Ferri M, 2011, COCHRANE DB SYST REV, V8; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Nosyk B, 2012, CAN MED ASSOC J, V184, pE317, DOI 10.1503/cmaj.110669; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Perneger TV, 1998, BMJ-BRIT MED J, V317, P13, DOI 10.1136/bmj.317.7150.13; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310	11	1	1	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1753	10.1136/bmj.h1753	http://dx.doi.org/10.1136/bmj.h1753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG5JL	25873413				2022-12-28	WOS:000353327500002
J	Clarkson, MO; Kasemann, SA; Wood, RA; Lenton, TM; Daines, SJ; Richoz, S; Ohnemueller, F; Meixner, A; Poulton, SW; Tipper, ET				Clarkson, M. O.; Kasemann, S. A.; Wood, R. A.; Lenton, T. M.; Daines, S. J.; Richoz, S.; Ohnemueller, F.; Meixner, A.; Poulton, S. W.; Tipper, E. T.			Ocean acidification and the Permo-Triassic mass extinction	SCIENCE			English	Article							SHALLOW-MARINE CARBONATES; EROSIONAL TRUNCATION; BOUNDARY; GEOCHEMISTRY; SULFUR; FACIES; RECORD	Ocean acidification triggered by Siberian Trap volcanism was a possible kill mechanism for the Permo-Triassic Boundary mass extinction, but direct evidence for an acidification event is lacking. We present a high-resolution seawater pH record across this interval, using boron isotope data combined with a quantitative modeling approach. In the latest Permian, increased ocean alkalinity primed the Earth system with a low level of atmospheric CO2 and a high ocean buffering capacity. The first phase of extinction was coincident with a slow injection of carbon into the atmosphere, and ocean pH remained stable. During the second extinction pulse, however, a rapid and large injection of carbon caused an abrupt acidification event that drove the preferential loss of heavily calcified marine biota.	[Clarkson, M. O.; Wood, R. A.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FE, Midlothian, Scotland; [Kasemann, S. A.; Ohnemueller, F.; Meixner, A.] Univ Bremen, Fac Geosci, D-28334 Bremen, Germany; [Kasemann, S. A.; Ohnemueller, F.; Meixner, A.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Lenton, T. M.; Daines, S. J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QE, Devon, England; [Richoz, S.] Graz Univ, NAWI Graz, Inst Earth Sci, A-8010 Graz, Austria; [Poulton, S. W.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Tipper, E. T.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Edinburgh; University of Bremen; University of Bremen; University of Exeter; University of Graz; University of Leeds; University of Cambridge	Clarkson, MO (corresponding author), Univ Otago, Dept Chem, Union St,POB 56, Dunedin 9016, New Zealand.	matthew.clarkson@otago.ac.nz	Lenton, Tim M/X-1893-2018; Richoz, Sylvain/D-4079-2009; /AAL-3738-2021	Lenton, Tim M/0000-0002-6725-7498; Richoz, Sylvain/0000-0001-5424-3540; Clarkson, Matthew/0000-0002-2527-4556; Tipper, Edward/0000-0003-3540-3558; Poulton, Simon/0000-0001-7621-189X; Kasemann, Simone Antonia/0000-0002-6913-7748	Edinburgh University Principal's Career Development Scholarship; International Centre for Carbonate Reservoirs; Marsden Fund [U001314]; Natural Environment Research Council [NE/I005978]; Leverhulme Trust [RPG-2013-106]; German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST [144/307-1]; Austrian National Committee (Austrian Academy of Sciences); NERC [NE/I005978/2, NE/I005978/1, NE/I005935/1, NE/K000705/2, NE/I005862/2] Funding Source: UKRI; Natural Environment Research Council [NE/I005862/2, NE/I005978/2, NE/I005978/1, NE/K000705/2, NE/I005935/1] Funding Source: researchfish	Edinburgh University Principal's Career Development Scholarship; International Centre for Carbonate Reservoirs; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST(German Research Foundation (DFG)); Austrian National Committee (Austrian Academy of Sciences); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M.O.C. acknowledges funding from the Edinburgh University Principal's Career Development Scholarship, the International Centre for Carbonate Reservoirs, and The Marsden Fund (U001314). R.A.W., T.M.L., and S.W.P. acknowledge support from the Natural Environment Research Council through the "Co-evolution of Life and the Planet" scheme (NE/I005978). T.M.L. and S.J.D. were supported by the Leverhulme Trust (RPG-2013-106). S.A.K. and A.M. acknowledge support from the German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST 144/307-1. This is a contribution to IGCP 572, with S.R. sponsored for fieldwork by the Austrian National Committee (Austrian Academy of Sciences) for the International Geoscience Programme (IGCP). We are grateful to R. Newton and A. Thomas for helpful discussions, L. Krystyn for field assistance, F. Maurer for discussions on stratigraphy and providing photomicrographs, and B. Mills for assisting with model studies. Data are available online in the supplementary materials and at www.pangaea.de.	Algeo TJ, 2011, PALAEOGEOGR PALAEOCL, V308, P1, DOI 10.1016/j.palaeo.2011.01.011; Baud A, 2007, GLOBAL PLANET CHANGE, V55, P81, DOI 10.1016/j.gloplacha.2006.06.008; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Black BA, 2014, GEOLOGY, V42, P67, DOI 10.1130/G34875.1; Black BA, 2012, EARTH PLANET SC LETT, V317, P363, DOI 10.1016/j.epsl.2011.12.001; Blattler CL, 2011, EARTH PLANET SC LETT, V309, P77, DOI 10.1016/j.epsl.2011.06.029; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Clarkson MO, 2013, GONDWANA RES, V24, P233, DOI 10.1016/j.gr.2012.10.002; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Joachimski MM, 2005, GEOCHIM COSMOCHIM AC, V69, P4035, DOI 10.1016/j.gca.2004.11.017; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Koehrer B, 2010, GEOARABIA, V15, P91; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; Korte C, 2010, J ASIAN EARTH SCI, V39, P215, DOI 10.1016/j.jseaes.2010.01.005; Korte C, 2010, J ASIAN EARTH SCI, V37, P293, DOI 10.1016/j.jseaes.2009.08.012; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Maurer F, 2009, GEOARABIA, V14, P125; Payne JL, 2007, GEOL SOC AM BULL, V119, P771, DOI 10.1130/B26091.1; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; Rampino MR, 2005, TERRA NOVA, V17, P554, DOI 10.1111/j.1365-3121.2005.00648.x; Richoz S, 2010, J ASIAN EARTH SCI, V39, P236, DOI 10.1016/j.jseaes.2009.12.014; Shen SZ, 2013, EARTH PLANET SC LETT, V375, P156, DOI 10.1016/j.epsl.2013.05.020; Song HJ, 2013, NAT GEOSCI, V6, P52, DOI [10.1038/NGEO1649, 10.1038/ngeo1649]; Stampfli GM, 2002, EARTH PLANET SC LETT, V196, P17, DOI 10.1016/S0012-821X(01)00588-X; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Wignall PB, 2009, GEOL SOC AM BULL, V121, P954, DOI 10.1130/B26424.1; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Woods AD, 2014, EARTH-SCI REV, V137, P6, DOI 10.1016/j.earscirev.2013.08.015; Yin HF, 2014, EARTH-SCI REV, V137, P19, DOI 10.1016/j.earscirev.2013.06.003	35	221	232	20	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					229	232		10.1126/science.aaa0193	http://dx.doi.org/10.1126/science.aaa0193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859043	Green Accepted, Green Submitted			2022-12-28	WOS:000352613700044
J	Montes, C; Cardona, A; Jaramillo, C; Pardo, A; Silva, JC; Valencia, V; Ayala, C; Perez-Angel, LC; Rodriguez-Parra, LA; Ramirez, V; Nino, H				Montes, C.; Cardona, A.; Jaramillo, C.; Pardo, A.; Silva, J. C.; Valencia, V.; Ayala, C.; Perez-Angel, L. C.; Rodriguez-Parra, L. A.; Ramirez, V.; Nino, H.			Middle Miocene closure of the Central American Seaway	SCIENCE			English	Article							MAGDALENA VALLEY BASIN; PANAMA IMPLICATIONS; TECTONIC EVOLUTION; COLOMBIAN ANDES; SOUTH-AMERICA; HISTORY; ARC; GEOCHRONOLOGY; MAGMATISM; COLLISION	Uranium-lead geochronology in detrital zircons and provenance analyses in eight boreholes and two surface stratigraphic sections in the northern Andes provide insight into the time of closure of the Central American Seaway. The timing of this closure has been correlated with Plio-Pleistocene global oceanographic, atmospheric, and biotic events. We found that a uniquely Panamanian Eocene detrital zircon fingerprint is pronounced in middle Miocene fluvial and shallow marine strata cropping out in the northern Andes but is absent in underlying lower Miocene and Oligocene strata. We contend that this fingerprint demonstrates a fluvial connection, and therefore the absence of an intervening seaway, between the Panama arc and South America in middle Miocene times; the Central American Seaway had vanished by that time.	[Montes, C.; Perez-Angel, L. C.; Rodriguez-Parra, L. A.] Univ Los Andes, Bogota, Colombia; [Cardona, A.] Univ Nacl Colombia, Medellin, Colombia; [Jaramillo, C.] Smithsonian Trop Res Inst, Panama City, Panama; [Pardo, A.] Univ Caldas, Manizales, Colombia; [Silva, J. C.] Univ Houston, Houston, TX 77004 USA; [Valencia, V.] Washington State Univ, Pullman, WA 99164 USA; [Ayala, C.] Corp Geol Ares, Bogota, Colombia; [Ramirez, V.; Nino, H.] Ecopetrol, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad Nacional de Colombia; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad de Caldas; University of Houston System; University of Houston; Washington State University; Ecopetrol	Montes, C (corresponding author), Univ Los Andes, Bogota, Colombia.	cmontes@uniandes.edu.co		Montes, Camilo/0000-0002-3553-0787; jaramillo, carlos/0000-0002-2616-5079	Ecopetrol-ICP "Cronologia de la Deformacion en las Cuencas Subandinas"; Smithsonian Institution, Uniandes [P12. 160422.002/001]; Autoridad del Canal de Panama (ACP); Mark Tupper Fellowship; Ricardo Perez S.A.; NSF [EAR 0824299, OISE, EAR, DRL 0966884]; National Geographic Society	Ecopetrol-ICP "Cronologia de la Deformacion en las Cuencas Subandinas"; Smithsonian Institution, Uniandes; Autoridad del Canal de Panama (ACP); Mark Tupper Fellowship; Ricardo Perez S.A.; NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	Supported by Ecopetrol-ICP "Cronologia de la Deformacion en las Cuencas Subandinas," Smithsonian Institution, Uniandes P12. 160422.002/001, Autoridad del Canal de Panama (ACP), the Mark Tupper Fellowship, Ricardo Perez S.A.; NSF grant EAR 0824299 and OISE, EAR, DRL 0966884, Colciencias, and the National Geographic Society. We thank N. Hoyos, D. Villagomez, A. O'Dea, C. Bustamante, O. Montenegro, and C. Ojeda. All the data reported in this manuscript are presented in the main paper and in the supplementary materials.	ASPDEN JA, 1987, J GEOL SOC LONDON, V144, P893, DOI 10.1144/gsjgs.144.6.0893; Bayona G., 2012, EARTH PLANET SC LETT, V331-332, P97; Cardona A, 2010, J S AM EARTH SCI, V29, P772, DOI 10.1016/j.jsames.2009.12.005; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Cordani UG, 2005, GEOL SOC SPEC PUBL, V246, P329, DOI 10.1144/GSL.SP.2005.246.01.13; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; Farris DW, 2011, GEOLOGY, V39, P1007, DOI 10.1130/G32237.1; Grosse E., 1926, ESTUDIO GEOLOGICO TE; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Hidalgo PJ, 2011, CONTRIB MINERAL PETR, V162, P1115, DOI 10.1007/s00410-011-0643-2; Kerr AC, 2005, GEOLOGY, V33, P269, DOI 10.1130/G21109.1; Kirby MX, 2005, PALAEOGEOGR PALAEOCL, V228, P193, DOI 10.1016/j.palaeo.2005.06.002; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; Mestas-Nunez AM, 2014, PALEOCEANOGRAPHY, V29, P508, DOI 10.1002/2013PA002515; Molnar P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001574; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Montes C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008959; Nie JS, 2012, EARTH-SCI REV, V110, P111, DOI 10.1016/j.earscirev.2011.11.002; Nie JS, 2010, GEOLOGY, V38, P451, DOI 10.1130/G30775.1; Osborne AH, 2014, PALEOCEANOGRAPHY, V29, P715, DOI 10.1002/2014PA002676; RestrepoPace PA, 1997, EARTH PLANET SC LETT, V150, P427, DOI 10.1016/S0012-821X(97)00091-5; Rodriguez G, 2014, B GEOLOGIA, V36, P85; Sepulchre P, 2014, PALEOCEANOGRAPHY, V29, P176, DOI 10.1002/2013PA002501; Tamayo JCS, 2008, J S AM EARTH SCI, V26, P369, DOI 10.1016/j.jsames.2008.02.001; Van der Hammen T., 1958, B GEOLOGIA, V6, P1; Vinasco CJ, 2006, J S AM EARTH SCI, V21, P355, DOI 10.1016/j.jsames.2006.07.007; Wegner W, 2011, GEOL SOC AM BULL, V123, P703, DOI 10.1130/B30109.1; Westbrook G. K., 1990, GEOLOGY N AM, VH; Whattam SA, 2012, LITHOS, V142, P226, DOI 10.1016/j.lithos.2012.02.017; Woodring W. P., 1957, 306A US GEOL SURV, V306-A, P145	30	389	406	6	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					226	229		10.1126/science.aaa2815	http://dx.doi.org/10.1126/science.aaa2815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859042				2022-12-28	WOS:000352613700043
J	Chu, BB; Liao, YC; Qi, W; Xie, C; Du, XM; Wang, J; Yang, HY; Miao, HH; Li, BL; Song, BL				Chu, Bei-Bei; Liao, Ya-Cheng; Qi, Wei; Xie, Chang; Du, Ximing; Wang, Jiang; Yang, Hongyuan; Miao, Hong-Hua; Li, Bo-Liang; Song, Bao-Liang			Cholesterol Transport through Lysosome-Peroxisome Membrane Contacts	CELL			English	Article							SYNAPTOTAGMIN-VII; BILE-ACID; ADRENOLEUKODYSTROPHY; CELLS; GENE; MICE; HOMEOSTASIS; ENDOCYTOSIS; EXOCYTOSIS; PATHWAY	Cholesterol is dynamically transported among organelles, which is essential for multiple cellular functions. However, the mechanism underlying intracellular cholesterol transport has remained largely unknown. We established an amphotericin B-based assay enabling a genome-wide shRNA screen for delayed LDL-cholesterol transport and identified 341 hits with particular enrichment of peroxisome genes, suggesting a previously unappreciated pathway for cholesterol transport. We show dynamic membrane contacts between peroxisome and lysosome, which are mediated by lysosomal Synaptotagmin VII binding to the lipid PI(4,5)P-2 on peroxisomal membrane. LDL-cholesterol enhances such contacts, and cholesterol is transported from lysosome to peroxisome. Disruption of critical peroxisome genes leads to cholesterol accumulation in lysosome. Together, these findings reveal an unexpected role of peroxisome in intracellular cholesterol transport. We further demonstrate massive cholesterol accumulation in human patient cells and mouse model of peroxisomal disorders, suggesting a contribution of abnormal cholesterol accumulation to these diseases.	[Chu, Bei-Bei; Liao, Ya-Cheng; Xie, Chang; Miao, Hong-Hua; Li, Bo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Chu, Bei-Bei; Song, Bao-Liang] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Wuhan 430072, Peoples R China; [Chu, Bei-Bei; Wang, Jiang] Henan Agr Univ, Col Anim Sci & Vet Med, Zhengzhou 4500026, Henan Province, Peoples R China; [Du, Ximing; Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wuhan University; Henan Agricultural University; University of New South Wales Sydney	Song, BL (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Wuhan 430072, Peoples R China.	blsong@whu.edu.cn	Yang, Hongyuan/AAR-1326-2020; Chu, Beibei/ABD-9819-2021; Xie, Chang/O-8270-2016; Xie, Chang/V-7099-2019	Yang, Hongyuan/0000-0002-8482-6031; Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935; Qi, Wei/0000-0003-0813-5316	National Natural Science Foundation (NNSF) of China [31430044, 31230020, 91413112]; Ministry of Science and Technology (MOST) of China [2011CB910900, 2012CB524900]; Shanghai Science and Technology Committee [13XD1404100]; 10,000 Talents Plan; National Health and Medical Research Council (NHMRC), Australia [APP1041301]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); 10,000 Talents Plan; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Yu-Xiu Qu, Jie Xu, and Jie Qin for technical assistance. We thank Dr. Dawei Zhang (University of Alberta) for measuring ABCD1 activity, Dr. Fei Sun (Institute of Biophysics, Chinese Academy of Sciences) for helping with EM, Dr. TY Chang (Dartmouth Medical School) for CT43 cells, and Dr. Xiangdong Fu (Wuhan University) for helpful discussion and critical reading the manuscript. This work was supported by the grants from the National Natural Science Foundation (NNSF) of China (31430044, 31230020, and 91413112), the Ministry of Science and Technology (MOST) of China (2011CB910900 and 2012CB524900), Shanghai Science and Technology Committee (13XD1404100) and the 10,000 Talents Plan. X.D. and H.Y. were supported by grant APP1041301 from the National Health and Medical Research Council (NHMRC), Australia. H.Y. is a Senior Research Fellow of the NHMRC.	ANDREOLI TE, 1973, KIDNEY INT, V4, P337, DOI 10.1038/ki.1973.126; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HARDEMAN D, 1990, BIOCHIM BIOPHYS ACTA, V1027, P149, DOI 10.1016/0005-2736(90)90078-3; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lange Y, 1999, J LIPID RES, V40, P2264; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Moser HW, 2005, JAMA-J AM MED ASSOC, V294, P3131, DOI 10.1001/jama.294.24.3131; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Woudenberg J, 2010, HEPATOLOGY, V52, P623, DOI 10.1002/hep.23684	29	216	228	6	132	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					291	306		10.1016/j.cell.2015.02.019	http://dx.doi.org/10.1016/j.cell.2015.02.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860611	Bronze			2022-12-28	WOS:000352708300022
J	Raiborg, C; Wenzel, EM; Pedersen, NM; Olsvik, H; Schink, KO; Schultz, SW; Vietri, M; Nisi, V; Bucci, C; Brech, A; Johansen, T; Stenmark, H				Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Olsvik, Hallvard; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Nisi, Veronica; Bucci, Cecilia; Brech, Andreas; Johansen, Terje; Stenmark, Harald			Repeated ER-endosome contacts promote endosome translocation and neurite outgrowth	NATURE			English	Article							ENDOPLASMIC-RETICULUM; RAB7 EFFECTOR; PROTEINS; PROTRUDIN; LOCALIZATION; TRANSPORT; SITES; BINDS; PHOSPHOINOSITIDES; CHOLESTEROL	The main organelles of the secretory and endocytic pathways-the endoplasmic reticulum(ER) and endosomes, respectively-are connected through contact sites whose numbers increase as endosomes mature(1-3). One function of such sites is to enable dephosphorylation of the cytosolic tails of endosomal signalling receptors by an ER-associated phosphatase(4), whereas others serve to negatively control the association of endosomes with the minus-end-directed microtubule motor dynein(5) or mediate endosome fission(6). Cholesterol transfer and Ca2+ exchange have been proposed as additional functions of such sites(2,3). However, the compositions, activities and regulations of ER-endosome contact sites remain incompletely understood. Here we show in human and rat cell lines that protrudin, an ER protein that promotes protrusion and neurite outgrowth(7), forms contact sites with late endosomes (LEs) via coincident detection of the small GTPase RAB7 and phosphatidylinositol 3-phosphate (PtdIns(3)P). These contact sites mediate transfer of the microtubule motor kinesin 1 fromprotrudin to the motor adaptor FYCO1 on LEs. Repeated LE-ER contacts promote microtubule-dependent translocation of LEs to the cell periphery and subsequent synaptotagmin-VII-dependent fusion with the plasma membrane. Such fusion induces outgrowth of protrusions and neurites, which requires the abilities of protrudin and FYCO1 to interact with LEs and kinesin 1. Thus, protrudin-containing ER-LE contact sites are platforms for kinesin-1 loading onto LEs, and kinesin-1-mediated translocation of LEs to the plasma membrane, fuelled by repeated ER contacts, promotes protrusion and neurite outgrowth.	[Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Brech, Andreas; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway; [Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Brech, Andreas; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Olsvik, Hallvard; Johansen, Terje] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; [Nisi, Veronica; Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Salento	Raiborg, C (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway.	camilla.raiborg@rr-research.no; stenmark@ulrik.uio.no	Bucci, Cecilia/F-6699-2012; Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015; Stenmark, Harald/B-8868-2008	Bucci, Cecilia/0000-0002-6232-6183; Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Brech, Andreas/0000-0002-9803-1774; Olsvik, Hallvard/0000-0003-3489-7461; Schink, Kay Oliver/0000-0002-5903-4059; Vietri, Marina/0000-0002-5859-322X; Wenzel, Eva Maria/0000-0002-5561-3344	Associazione Italiana per la Ricerca sul Cancro [14709]; Telethon-Italy [GGP09145]; MIUR (PRIN); Norwegian Research Council [196898]; Norwegian Cancer Society [71043-PR-2006-0320]; European Research Council; Research Council of Norway through its Centres of Excellence funding scheme [179571]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway through its Centres of Excellence funding scheme	We thank A. Sagona and K.-W. Tan for assistance with plasmid constructs, E. Ronning for yeast two-hybrid analyses and protein purifications, Y. Zhen for advice on RAB7 knockdowns, and A. Engen for expert help with cell cultures. We are grateful to W. Do Heo for providing mCitrine-protrudin and the protrudin(FYVE4A) mutant. The Core Facilities for Advanced Light Microscopy and Electron Microscopy at Oslo University Hospital are acknowledged for providing access to relevant microscopes. C.R. and E.M.W. are senior research fellows of the Norwegian Cancer Society and South-Eastern Norway Regional Health Authority, respectively. C.B. was supported by the Associazione Italiana per la Ricerca sul Cancro (Investigator Grant 14709), Telethon-Italy (grant GGP09145) and MIUR (PRIN2010-2011). T.J. was supported by grant 196898 from the Norwegian Research Council and grant 71043-PR-2006-0320 from the Norwegian Cancer Society. H.S. was supported by grants from the Norwegian Cancer Society and an Advanced Grant from the European Research Council. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Catimel B, 2013, J PROTEOMICS, V82, P35, DOI 10.1016/j.jprot.2013.01.031; Chang J, 2013, P NATL ACAD SCI USA, V110, P14954, DOI 10.1073/pnas.1307391110; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Gil JE, 2012, J BIOL CHEM, V287, P41268, DOI 10.1074/jbc.M112.419127; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Honscher C, 2014, CRIT REV BIOCHEM MOL, V49, P262, DOI 10.3109/10409238.2013.875512; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pantakani DVK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029584; Pedersen NM, 2012, TRAFFIC, V13, P1547, DOI 10.1111/j.1600-0854.2012.01400.x; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CL, 2012, J CELL BIOCHEM, V113, P2296, DOI 10.1002/jcb.24100	40	255	256	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					234	+		10.1038/nature14359	http://dx.doi.org/10.1038/nature14359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855459				2022-12-28	WOS:000352454600042
J	Hill, AM; McPhail, SM; Waldron, N; Etherton-Beer, C; Ingram, K; Flicker, L; Bulsara, M; Haines, TP				Hill, Anne-Marie; McPhail, Steven M.; Waldron, Nicholas; Etherton-Beer, Christopher; Ingram, Katharine; Flicker, Leon; Bulsara, Max; Haines, Terry P.			Fall rates in hospital rehabilitation units after individualised patient and staff education programmes: a pragmatic, stepped-wedge, cluster-randomised controlled trial	LANCET			English	Article							PREVENT FALLS; MULTIFACTORIAL INTERVENTION; INPATIENT FALLS; INJURIES; EVENTS	Background Falls are the most frequent adverse events that are reported in hospitals. We examined the effectiveness of individualised falls-prevention education for patients, supported by training and feedback for staff, delivered as a ward-level programme. Methods Eight rehabilitation units in general hospitals in Australia participated in this stepped-wedge, cluster-randomised study, undertaken during a 50 week period. Units were randomly assigned to intervention or control groups by use of computer-generated, random allocation sequences. We included patients admitted to the unit during the study with a Mini-Mental State Examination (MMSE) score of more than 23/30 to receive individualised education that was based on principles of changes in health behaviour from a trained health professional, in addition to usual care. We provided information about patients' goals, feedback about the ward environment, and perceived barriers to engagement in falls-prevention strategies to staff who were trained to support the uptake of strategies by patients. The coprimary outcome measures were patient rate of falls per 1000 patient-days and the proportion of patients who were fallers. All analyses were by intention to treat. This trial is registered with the Australian New Zealand Clinical Trials registry, number ACTRN12612000877886). Findings Between Jan 13, and Dec 27, 2013, 3606 patients were admitted to the eight units (n=1983 control period; n=1623 intervention period). There were fewer falls (n=196, 7.80/1000 patient-days vs n=380, 13.78/1000 patient-days, adjusted rate ratio 0.60 [robust 95% CI 0.42-0.94], p=0.003), injurious falls (n=66, 2.63/1000 patient-days vs 131, 4.75/1000 patient-days, 0.65 [robust 95% CI 0.42-0.88], p=0.006), and fallers (n=136 [8.38%] vs n=248 [12.51%] adjusted odds ratio 0.55 [robust 95% CI 0.38 to 0.81], p=0.003) in the intervention compared with the control group. There was no significant difference in length of stay (intervention median 11 days [IQR 7-19], control 10 days [6-18]). Interpretation Individualised patient education programmes combined with training and feedback to staff added to usual care reduces the rates of falls and injurious falls in older patients in rehabilitation hospital-units.	[Hill, Anne-Marie] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA 6959, Australia; [Hill, Anne-Marie; Bulsara, Max] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA 6959, Australia; [McPhail, Steven M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [McPhail, Steven M.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [McPhail, Steven M.] Metro South Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Waldron, Nicholas] Armadale Kelmscott Mem Hosp, Dept Rehabil & Aged Care, Perth, WA, Australia; [Waldron, Nicholas] Govt Western Australia, Hlth Strategy & Networks, Strateg Syst Policy & Planning, Dept Hlth, Perth, WA, Australia; [Etherton-Beer, Christopher; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, WA Ctr Hlth & Ageing, Perth, WA 6009, Australia; [Etherton-Beer, Christopher; Flicker, Leon] Govt Western Australia, Royal Perth Hosp, Dept Hlth, Perth, WA, Australia; [Ingram, Katharine] Govt Western Australia, Dept Rehabil & Aged Care, Sir Charles Gairdner Hosp, Dept Hlth, East Perth, WA, Australia; [Haines, Terry P.] Monash Univ, Physiotherapy Dept, Frankston, Vic, Australia; [Haines, Terry P.] Monash Hlth, Allied Hlth Res Unit, Clayton, Vic, Australia	University of Notre Dame Australia; University of Notre Dame Australia; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Western Australia; Royal Perth Hospital; Monash University	Hill, AM (corresponding author), Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA 6959, Australia.	anne-marie.hill@nd.edu.au	Etherton-Beer, Christopher/B-2714-2014; Flicker, Leon/AAE-1530-2022; Haines, Terrence/E-9372-2015	Etherton-Beer, Christopher/0000-0001-5148-0188; Flicker, Leon/0000-0002-3650-0475; Haines, Terrence/0000-0003-3150-6154; McPhail, Steven/0000-0002-1463-662X; Hill, Anne-Marie/0000-0003-1411-6752	State Health Research Advisory Council, Department of Health, Government of Western Australia; National Health and Medical Research Council (of Australia); WA Health Falls Prevention Community of Practice	State Health Research Advisory Council, Department of Health, Government of Western Australia; National Health and Medical Research Council (of Australia)(National Health and Medical Research Council (NHMRC) of Australia); WA Health Falls Prevention Community of Practice	State Health Research Advisory Council, Department of Health, Government of Western Australia.; A-MH, SMMcP, and TPH receive salary support through career fellowships from the National Health and Medical Research Council (of Australia). We thank the WA Health Falls Prevention Community of Practice for their support of our study.	Ang E, 2011, J ADV NURS, V67, P1984, DOI 10.1111/j.1365-2648.2011.05646.x; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Brogan G, 2012, NATL NURSE       NOV; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Haines T, 2008, J GERONTOL A-BIOL, V63, P523, DOI 10.1093/gerona/63.5.523; Haines TP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-135; Haines TP, 2011, ARCH INTERN MED, V171, P516, DOI 10.1001/archinternmed.2010.444; Haines TP, 2011, J CLIN EPIDEMIOL, V64, P154, DOI 10.1016/j.jclinepi.2010.04.024; Haines TP, 2010, J AM GERIATR SOC, V58, P435, DOI 10.1111/j.1532-5415.2010.02735.x; Haines TP, 2004, BMJ-BRIT MED J, V328, P676, DOI 10.1136/bmj.328.7441.676; Healey F, 2004, AGE AGEING, V33, P390, DOI 10.1093/ageing/afh130; Healey F, 2008, QUAL SAF HEALTH CARE, V17, P424, DOI 10.1136/qshc.2007.024695; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill AM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004195; Hill AM, 2010, J AM GERIATR SOC, V58, P1347, DOI 10.1111/j.1532-5415.2010.02856.x; Hill AM, 2009, J AM GERIATR SOC, V57, P1458, DOI 10.1111/j.1532-5415.2009.02346.x; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Merriam S. B., 2007, LEARNING ADULTHOOD C; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Orji Rita, 2012, Online J Public Health Inform, V4, DOI 10.5210/ojphi.v4i3.4321; Sahota O, 2014, AGE AGEING, V43, P247, DOI 10.1093/ageing/aft155; Schwendimann R, 2008, GERONTOLOGY, V54, P342, DOI 10.1159/000129954; Shorr RI, 2008, J AM GERIATR SOC, V56, P701, DOI 10.1111/j.1532-5415.2007.01605.x; Shorr RI, 2012, ANN INTERN MED, V157, P692, DOI 10.7326/0003-4819-157-10-201211200-00005; Staggs VS, 2014, JT COMM J QUAL PATIE, V40, P3586; Stenvall M, 2007, OSTEOPOROSIS INT, V18, P167, DOI 10.1007/s00198-006-0226-7; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, VIOL INJ PREV	37	118	123	3	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2592	2599		10.1016/S0140-6736(14)61945-0	http://dx.doi.org/10.1016/S0140-6736(14)61945-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL4NQ	25865864	Green Submitted			2022-12-28	WOS:000356930000026
J	Novas, FE; Salgado, L; Suarez, M; Agnolin, FL; Ezcurra, MD; Chimento, NR; de la Cruz, R; Isasi, MP; Vargas, AO; Rubilar-Rogers, D				Novas, Fernando E.; Salgado, Leonardo; Suarez, Manuel; Agnolin, Federico L.; Ezcurra, Martin D.; Chimento, Nicolas R.; de la Cruz, Rita; Isasi, Marcelo P.; Vargas, Alexander O.; Rubilar-Rogers, David			An enigmatic plant-eating theropod from the Late Jurassic period of Chile	NATURE			English	Article							DINOSAUR; EVOLUTION; ANATOMY; OSTEOLOGY; TETANURAE	Theropod dinosaurs were the dominant predators inmost Mesozoic era terrestrial ecosystems(1). Early theropod evolution is currently interpreted as the diversification of various carnivorous and cursorial taxa, whereas the acquisition of herbivorism, together with the secondary loss of cursorial adaptations, occurred much later among advanced coelurosaurian theropods(1,2). A new, bizarre herbivorous basal tetanuran from the Upper Jurassic of Chile challenges this conception. The new dinosaur was discovered at Aysen, a fossil locality in the Upper Jurassic Toqui Formation of southern Chile (General Carrera Lake)(3,4). The site yielded abundant and exquisitely preserved three-dimensional skeletons of small archosaurs. Several articulated individuals of Chilesaurus at different ontogenetic stages have been collected, as well as less abundant basal crocodyliforms, and fragmentary remains of sauropod dinosaurs (diplodocids and titanosaurians).	[Novas, Fernando E.; Salgado, Leonardo; Isasi, Marcelo P.] Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Buenos Aires, DF, Argentina; [Novas, Fernando E.; Agnolin, Federico L.; Chimento, Nicolas R.; Isasi, Marcelo P.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Salgado, Leonardo] Univ Nacl Rio Negro, Inst Invest Paleobiol & Geol, CONICET, RA-8332 Gen Roca, Rio Negro, Argentina; [Salgado, Leonardo] Univ Nacl Rio Negro, Inst Invest Paleobiol & Geol, RA-8332 Gen Roca, Rio Negro, Argentina; [Suarez, Manuel] Univ Andres Bello, Geol, Fac Ingn, Santiago, Chile; [Suarez, Manuel] Univ Maimonides, Fdn Hist Nat Felix de Azara, Buenos Aires, DF, Argentina; [Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [de la Cruz, Rita] Serv Nacl Geol & Mineria, Santiago 8330177, Chile; [Vargas, Alexander O.; Rubilar-Rogers, David] Univ Chile, Dept Biol, Lab Ontogenia & Filogenia, Red Paleontol U Chile, Santiago 7800003, Chile; [Rubilar-Rogers, David] Museo Nacl Hist Nat Chile, Area Paleontol, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Andres Bello; University of Birmingham; Universidad de Chile	Novas, FE (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Ave Angel Gallardo 470 C1405DJR, Buenos Aires, DF, Argentina.	fernovas@yahoo.com.ar	Vargas, Alexander O/L-3788-2017	Vargas, Alexander/0000-0002-2009-7116; Chimento, Nicolas/0000-0002-6340-4358	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-066]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1121140, 1030162]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	We thank P. Barrett, A. Milner and R. Butler for comments on early versions of this manuscript. We are grateful to C. Alsina, M. Milani, R. Stoll and M. Aranciaga for field assistance and technical preparation of Chilesaurus specimens. G. Lio executed the silhouette of Chilesaurus in Fig. 1. C. Burke offered support to conduct fieldwork and technical preparation of the specimens. We are indebted to the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-066 to F.E.N.) and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (no. 1121140 and 1030162 to M.S.) for continuing financial assistance.	Barrett PM, 2014, ANNU REV EARTH PL SC, V42, P207, DOI 10.1146/annurev-earth-042711-105515; Barrett PM, 2005, PALAEONTOLOGY, V48, P347, DOI 10.1111/j.1475-4983.2005.00448.x; Bonaparte J.F., 1991, Historical Biology, V5, P1; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Lautenschlager S., 2014, P ROY SOC LOND B BIO, V281, P1471; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Novas Fernando E., 1996, Memoirs of the Queensland Museum, V39, P675; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Paul GS., 1984, J VERTEBR PALEONTOL, V4, P507, DOI DOI 10.1080/02724634.1984.10012026; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Sadleir Rudyard W., 2008, Monograph of the Palaeontographical Society, P1; Salgado L, 2008, J VERTEBR PALEONTOL, V28, P529, DOI 10.1671/0272-4634(2008)28[529:FLJDBF]2.0.CO;2; Smith ND, 2008, P ROY SOC B-BIOL SCI, V275, P2085, DOI 10.1098/rspb.2008.0504; Weishampel DB., 2004, DINOSAURIA; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029	27	51	51	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					331	+		10.1038/nature14307	http://dx.doi.org/10.1038/nature14307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25915021				2022-12-28	WOS:000356425400051
J	Venkatesh, HS; Johung, TB; Caretti, V; Noll, A; Tang, YJ; Nagaraja, S; Gibson, EM; Mount, CW; Polepalli, J; Mitra, SS; Woo, PJ; Malenka, RC; Vogel, H; Bredel, M; Mallick, P; Monje, M				Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Polepalli, Jai; Mitra, Siddhartha S.; Woo, Pamelyn J.; Malenka, Robert C.; Vogel, Hannes; Bredel, Markus; Mallick, Parag; Monje, Michelle			Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion	CELL			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; OLIGODENDROCYTE PRECURSOR CELLS; MALIGNANT GLIOMA; C-FOS; HUMAN GLIOBLASTOMA; TRANSGENIC MICE; HISTONE H3.3; BRAIN; ACTIVATION; EXPRESSION	Active neurons exert a mitogenic effect on normal neural precursor and oligodendroglial precursor cells, the putative cellular origins of high-grade glioma (HGG). By using optogenetic control of cortical neuronal activity in a patient-derived pediatric glioblastoma xenograft model, we demonstrate that active neurons similarly promote HGG proliferation and growth in vivo. Conditioned medium from opto-genetically stimulated cortical slices promoted proliferation of pediatric and adult patient-derived HGG cultures, indicating secretion of activity-regulated mitogen(s). The synaptic protein neuroligin-3 (NLGN3) was identified as the leading candidate mitogen, and soluble NLGN3 was sufficient and necessary to promote robust HGG cell proliferation. NLGN3 induced PI3K-mTOR pathway activity and feedforward expression of NLGN3 in glioma cells. NLGN3 expression levels in human HGG negatively correlated with patient overall survival. These findings indicate the important role of active neurons in the brain tumor microenvironment and identify secreted NLGN3 as an unexpected mechanism promoting neuronal activity-regulated cancer growth.	[Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Mitra, Siddhartha S.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Polepalli, Jai; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Bredel, Markus] Univ Alabama Birmingham, Sch Med, Dept Radiat Oncol, Birmingham, AL 35233 USA; [Mallick, Parag] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Alabama System; University of Alabama Birmingham; Stanford University	Monje, M (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	mmonje@stanford.edu		Monje, Michelle/0000-0002-3547-237X; Venkatesh, Humsa/0000-0003-1194-3015; Vogel, Otto Hannes/0000-0002-0960-3508; Mount, Christopher/0000-0003-1635-2492; Gibson, Erin/0000-0001-9749-3814; Polepalli, Jai/0000-0003-2004-2163	Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; National Institute of Neurological Disorders and Stroke (NINDS) [K08NS070926]; McKenna Claire Foundation; National Science Foundation Graduate Research Fellowship Program; California Institute for Regenerative Medicine [CIRM RB4-06093, RN3-06510]; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund, virginia; D.K. Ludwig Fund for Cancer Research; Bear Necessities Pediatric Cancer Foundation; Lucile Packard Foundation for Children's Health; Stanford University School of Medicine Dean's Fellowship; Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; National Cancer Institute [PSOC-MCSTART U54CA143907]; Canary Foundation; Ben and Catherine Ivy Foundation; Sujal and Meera Patel Foundation; Dylan Jewett Memorial Fund, Virginia; Connor Johnson Memorial Fund, Virginia; Zoey Ganesh Memorial Fund, Virginia; Dylan Frick Memorial Fund, Virginia; Abigail Jensen Memorial Fund, Virginia; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKenna Claire Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund, virginia; D.K. Ludwig Fund for Cancer Research; Bear Necessities Pediatric Cancer Foundation; Lucile Packard Foundation for Children's Health; Stanford University School of Medicine Dean's Fellowship; Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; Ben and Catherine Ivy Foundation; Sujal and Meera Patel Foundation; Dylan Jewett Memorial Fund, Virginia; Connor Johnson Memorial Fund, Virginia; Zoey Ganesh Memorial Fund, Virginia; Dylan Frick Memorial Fund, Virginia; Abigail Jensen Memorial Fund, Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge support from the Matthew Larson Foundation, Godfrey Family Fund in Memory of Fiona Penelope, National Institute of Neurological Disorders and Stroke (NINDS K08NS070926), McKenna Claire Foundation, National Science Foundation Graduate Research Fellowship Program, California Institute for Regenerative Medicine (CIRM RB4-06093 and RN3-06510), Alex's Lemonade Stand Foundation, The Cure Starts Now Foundation, Lyla Nsouli Foundation, Unravel Pediatric Cancer, the Wayland Villars DIPG Foundation, the Dylan Jewett, Connor Johnson, Zoey Ganesh, Dylan Frick, Abigail Jensen, and Jennifer Kranz Memorial Funds, Virginia and D.K. Ludwig Fund for Cancer Research, the Bear Necessities Pediatric Cancer Foundation, Lucile Packard Foundation for Children's Health, Stanford University School of Medicine Dean's Fellowship, Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases, National Cancer Institute (PSOC-MCSTART U54CA143907), Canary Foundation, Ben and Catherine Ivy Foundation, and the Sujal and Meera Patel Foundation. Special thanks to Sarah Chen for illustrations, to Elizabeth Hoyte for assistance with figures, to Eric Raabe for use of the JHH-DIPGI cell line, and to Tom Sudhof for helpful discussions.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Campbell SL, 2012, EPILEPSIA, V53, P1360, DOI 10.1111/j.1528-1167.2012.03557.x; Chen DB, 2003, MOL CELL ENDOCRINOL, V200, P141, DOI 10.1016/S0303-7207(02)00379-9; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Galvao RP, 2014, P NATL ACAD SCI USA, V111, pE4214, DOI 10.1073/pnas.1414389111; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Gjorlund MD, 2012, FASEB J, V26, P4174, DOI 10.1096/fj.11-202242; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Glasgow SM, 2014, NAT NEUROSCI, V17, P1322, DOI 10.1038/nn.3790; Gonzales M, 2002, ONCOGENE, V21, P2721, DOI 10.1038/sj.onc.1205366; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Samarelli AV, 2014, J BIOL CHEM, V289, P19466, DOI 10.1074/jbc.M113.530972; Scherer H., 1938, AM J CANC, V34, P333, DOI [DOI 10.1158/AJC.1938.333, 10.1158/ajc.1938.333]; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seifert S, 2014, J PHYSIOL-LONDON, V592, P5109, DOI 10.1113/jphysiol.2014.274498; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Stopczynski RE, 2014, CANCER RES, V74, P1718, DOI 10.1158/0008-5472.CAN-13-2050; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Synowitz M, 2001, EUR J NEUROSCI, V14, P1294, DOI 10.1046/j.0953-816x.2001.01764.x; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	57	324	336	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					803	816		10.1016/j.cell.2015.04.012	http://dx.doi.org/10.1016/j.cell.2015.04.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913192	Bronze, Green Accepted			2022-12-28	WOS:000354175200014
J	Kreiter, S; Vormehr, M; van de Roemer, N; Diken, M; Lower, M; Diekmann, J; Boegel, S; Schrors, B; Vascotto, F; Castle, JC; Tadmor, AD; Schoenberger, SP; Huber, C; Tureci, O; Sahin, U				Kreiter, Sebastian; Vormehr, Mathias; van de Roemer, Niels; Diken, Mustafa; Loewer, Martin; Diekmann, Jan; Boegel, Sebastian; Schroers, Barbara; Vascotto, Fulvia; Castle, John C.; Tadmor, Arbel D.; Schoenberger, Stephen P.; Huber, Christoph; Tuereci, Oezlem; Sahin, Ugur			Mutant MHC class II epitopes drive therapeutic immune responses to cancer	NATURE			English	Article							EXOME ANALYSIS REVEALS; CD4(+) T-CELLS; PD-1 BLOCKADE; ANTIGENS; LYMPHOCYTES; EFFICIENCY; LANDSCAPE; STABILITY; PATIENT	Tumour-specific mutations are ideal targets for cancer immunotherapy as they lack expression in healthy tissues and can potentially be recognized as neo-antigens by the mature T-cell repertoire. Their systematic targeting by vaccine approaches, however, has been hampered by the fact that every patient's tumour possesses a unique set of mutations (the mutanome') that must first be identified. Recently, we proposed a personalized immunotherapy approach to target the full spectrum of a patient's individual tumour-specific mutationsl. Here we show in three independent murine tumour models that a considerable fraction of non-synonymous cancer mutations is immunogenic and that, unexpectedly, the majority of the immunogenic mutanome is recognized by Cal+ T cells. Vaccination with such Cal+ immunogenic mutations confers strong antitumour activity. Encouraged by these findings, we established a process by which mutations identified by exome sequencing could be selected as vaccine targets solely through bioinformatic prioritization on the basis of their expression levels and major histocompatibility complex (MHC) class II-binding capacity for rapid production as synthetic poly-neo-epitope messenger RNA vaccines. We show that vaccination with such polytope mRNA vaccines induces potent tumour control and complete rejection of established aggressively growing tumours in mice. Moreover, we demonstrate that Cal+ T cell neo-epitope vaccination reshapes the tumour microenvironment and induces cytotoxic T lymphocyte responses against an independent immunodominant antigen in mice, indicating orchestration of antigen spread. Finally, we demonstrate an abundance of mutations predicted to bind to MHC class II in human cancers as well by employing the same predictive algorithm on corresponding human cancer types. Thus, the tailored immunotherapy approach introduced here may be regarded as a universally applicable blueprint for comprehensive exploitation of the substantial neo-epitope target repertoire of cancers, enabling the effective targeting of every patient's tumour with vaccines produced 'just in time'.	[Kreiter, Sebastian; Diken, Mustafa; Loewer, Martin; Diekmann, Jan; Boegel, Sebastian; Schroers, Barbara; Vascotto, Fulvia; Castle, John C.; Tadmor, Arbel D.; Tuereci, Oezlem; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, D-55131 Mainz, Germany; [Vormehr, Mathias; van de Roemer, Niels; Huber, Christoph; Sahin, Ugur] Res Ctr Immunotherapy FZI, D-55131 Mainz, Germany; [Diekmann, Jan; Sahin, Ugur] Biopharmaceut New Technol BioNTech Corp, D-55131 Mainz, Germany; [Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Johannes Gutenberg University of Mainz; BioNTech SE; La Jolla Institute for Immunology	Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Freiligrathstr 12, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017; Boegel, Sebastian/AAH-8171-2019; Vormehr, Mathias/AAJ-7808-2021	Sahin, Ugur/0000-0003-0363-1564; Vormehr, Mathias/0000-0001-7788-3380; Vascotto, Fulvia/0000-0002-9839-3484; Roth, Rene/0000-0002-4333-695X; Boegel, Sebastian/0000-0001-5425-8304; Schrors, Barbara/0000-0001-9758-250X	CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107010] Funding Source: NIH RePORTER	CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Holzmann, A. Konig, U. Schmitt, R. Roth, C. Worm and N. Krause for technical assistance; L. Ralla, J. Gross, A. Spruss, M. Erdeljan, S. Woll and C. Rohde for immunohistochemical staining and analysis; C. Paret for sequence validation of mutations; M. Brkic for immunofluorescence staining; S. Witzel and Bodo Tillmann, S. Wurzel and Z. Yildiz for cloning of constructs; S. Kind, M. Mechler, F. Wille, B. Otte and S. Petri for RNA production as well as L. Kranz and colleagues involved in RNA formulation development. We are grateful to B. Kloke, S. Heesch, A. Kuhn, J. Buck, C. Britten and H. Haas for conceptual and technical discussions. Moreover, we would like to thank V. Bukur, J. de Graf and C. Albrecht who supported the next-generation sequencing of samples. Furthermore we like to acknowledge A. Kong for critical reading and A. Orlandini for help with graphic design. The results shown here are in part based on data generated by the TCGA Research Network http://cancergenome.nih.gov/. The study was supported by the CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF).	Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Boegel S, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.954893; Britten CM, 2013, NAT BIOTECHNOL, V31, P880, DOI 10.1038/nbt.2708; Castle JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04743; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2010, CANCER RES, V70, P9031, DOI 10.1158/0008-5472.CAN-10-0699; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Shen ZH, 1997, J IMMUNOL, V158, P2723; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	30	716	788	9	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					692	U269		10.1038/nature14426	http://dx.doi.org/10.1038/nature14426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901682	Green Accepted			2022-12-28	WOS:000353689700053
J	Le Gal, G; Righini, M; Wells, PS				Le Gal, Gregoire; Righini, Marc; Wells, Philip S.			D-Dimer for Pulmonary Embolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROBABILITY; PREDICTION; RULE; AGE		[Le Gal, Gregoire; Wells, Philip S.] Univ Ottawa, Thrombosis Program, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Univ Ottawa, Div Hematol, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Le Gal, Gregoire; Wells, Philip S.] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; [Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Geneva	Wells, PS (corresponding author), Ottawa Gen Hosp, Gen Campus,501 Smyth Rd,POB 206, Ottawa, ON K1H 8L6, Canada.	pwells@toh.on.ca	Righini, Marc/AAX-8731-2020					Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Andro M, 2013, EXPERT REV CARDIOVAS, V11, P751, DOI [10.1586/erc.13.51, 10.1586/ERC.13.51]; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Center for Medicare and Medicaid Services, 2020, CLIN LAB FEE SCHED; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	10	19	20	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1668	1669		10.1001/jama.2015.3703	http://dx.doi.org/10.1001/jama.2015.3703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919531				2022-12-28	WOS:000353595200018
J	Iacobucci, G				Iacobucci, Gareth			Promises, promises-and common ground: question time for health spokespeople	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2009	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2165	10.1136/bmj.h2165	http://dx.doi.org/10.1136/bmj.h2165			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25903549				2022-12-28	WOS:000353576700013
J	Owen, C; Grace, S; Woolfson, R				Owen, Ceris; Grace, Sarah; Woolfson, Robin			A 77 year old man with asthma and renal impairment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; EOSINOPHILIC GRANULOMATOSIS; POLYARTERITIS-NODOSA; POLYANGIITIS; INVOLVEMENT; VASCULITIS; CLASSIFICATION; INTERLEUKIN-5; RITUXIMAB	Ceris Owen core medical trainee, Sarah Grace Clark foundation year 1 trainee, Robin Woolfson consultant nephrologist	[Owen, Ceris; Grace, Sarah; Woolfson, Robin] Royal Free Hosp, Dept Nephrol, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Owen, C (corresponding author), Royal Free Hosp, Dept Nephrol, Pond St, London NW3 2QG, England.	ceris.owen@nhs.net						Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Bourgarit A, 2005, MEDICINE, V84, P323, DOI 10.1097/01.md.0000180793.80212.17; CHURG J, 1951, AM J PATHOL, V27, P277; CLUTTERBUCK EJ, 1990, NEPHROL DIAL TRANSPL, V5, P161, DOI 10.1093/ndt/5.3.161; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Eustace JA, 1999, J AM SOC NEPHROL, V10, P2048; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Guillevin L, 1995, ARTHRITIS RHEUM, V38, P2180; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Healy B, 2013, J ALLERGY CLIN IMMUN, V131, P571, DOI 10.1016/j.jaci.2012.05.058; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kikuchi Y, 2001, CLIN NEPHROL, V55, P429; Kim S, 2010, J ALLERGY CLIN IMMUN, V125, P1336, DOI 10.1016/j.jaci.2010.03.028; Mahr A, 2014, CURR OPIN RHEUMATOL, V26, P16, DOI 10.1097/BOR.0000000000000015; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Mohammad AJ, 2016, ANN RHEUM DIS, V75, P396, DOI 10.1136/annrheumdis-2014-206095; Moosig F, 2013, ANN RHEUM DIS, V72, P1011, DOI 10.1136/annrheumdis-2012-201531; Neumann T, 2009, MEDICINE, V88, P236, DOI 10.1097/MD.0b013e3181af35a5; Pagnoux C, 2007, CURR OPIN RHEUMATOL, V19, P25, DOI 10.1097/BOR.0b013e3280119854; Pepper RJ, 2008, RHEUMATOLOGY, V47, P1104, DOI 10.1093/rheumatology/ken175; Ribi C, 2008, ARTHRITIS RHEUM-US, V58, P586, DOI 10.1002/art.23198; Sable-Fourtassou G, 2005, ANN INTERN MED, V143, P632, DOI 10.7326/0003-4819-143-9-200511010-00006; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Sinico RA, 2006, AM J KIDNEY DIS, V47, P770, DOI 10.1053/j.ajkd.2006.01.026; Sinico RA, 2005, ARTHRITIS RHEUM, V52, P2926, DOI 10.1002/art.21250; Thiel J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4313; Vaglio A, 2013, ALLERGY, V68, P261, DOI 10.1111/all.12088; Walters GD, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-12	29	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2021	10.1136/bmj.h2021	http://dx.doi.org/10.1136/bmj.h2021			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25903671				2022-12-28	WOS:000353576700006
J	Hawkins, JM				Hawkins, Joel M.			Streamlining drug synthesis	NATURE			English	News Item							FLOW; HYDROGENATION; MILD	Drug manufacture can benefit from flow synthesis, in which raw materials are fed into a sequence of reactors, producing the drug as a continuous output. A flow strategy that capitalizes on solid catalysts has now been realized.	Pfizer Worldwide Res & Dev, Chem Res & Dev, Groton, CT 06340 USA	Pfizer	Hawkins, JM (corresponding author), Pfizer Worldwide Res & Dev, Chem Res & Dev, Groton, CT 06340 USA.	joel.m.hawkins@pfizer.com						Battilocchio C, 2014, ORG LETT, V16, P1060, DOI 10.1021/ol403591c; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Baxendale IR, 2015, J PHARM SCI-US, V104, P781, DOI 10.1002/jps.24252; Chorghade R, 2013, ORG LETT, V15, P5698, DOI 10.1021/ol4027107; Hopkin MD, 2010, CHEM COMMUN, V46, P2450, DOI 10.1039/c001550d; Markarian J., 2014, PHARM TECHNOL, V38, P52; Ouchi T, 2014, ORG PROCESS RES DEV, V18, P1560, DOI 10.1021/op500208j; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Snead DR, 2015, ANGEW CHEM INT EDIT, V54, P983, DOI 10.1002/anie.201409093; Truppo M. D., 2014, US patent application US, Patent No. [20140106413 A1, 20140106413]; Tsubogo T, 2015, NATURE, V520, P329, DOI 10.1038/nature14343	11	15	15	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					302	303		10.1038/520302a	http://dx.doi.org/10.1038/520302a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877199				2022-12-28	WOS:000352974200026
J	Holcombe, C				Holcombe, Chris			Ask every job candidate about care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Liverpool Univ Hosp, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Holcombe, C (corresponding author), Royal Liverpool Univ Hosp, Liverpool, Merseyside, England.	chris@theholcombes.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1759	10.1136/bmj.h1759	http://dx.doi.org/10.1136/bmj.h1759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25882615				2022-12-28	WOS:000353328700006
J	Schmidt-Hansen, M; Baldwin, DR; Zamora, J				Schmidt-Hansen, Mia; Baldwin, David Raymond; Zamora, Javier			FDG-PET/CT Imaging for Mediastinal Staging in Patients With Potentially Resectable Non-Small Cell Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schmidt-Hansen, Mia] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Baldwin, David Raymond] Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Resp Med, City Hosp Nottingham, Nottingham, England; [Zamora, Javier] Queen Mary Univ, London, England; [Zamora, Javier] Cochrane Collaborating Ctr, Clin Biostat Unit, Inst Ramon & Cajal Hlth Res, Madrid, Spain; [Zamora, Javier] Cochrane Collaborating Ctr, Biomed Res Networking Ctr, Madrid, Spain	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; Queen Mary University London	Schmidt-Hansen, M (corresponding author), Natl Collaborating Ctr Canc, Pk House,Greyfriars Rd, Cardiff CF10 3AF, S Glam, Wales.	mia.schmidt-hansen@wales.nhs.uk	Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022	Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X				De Leyn P, 2014, EUR J CARDIO-THORAC, V45, P787, DOI 10.1093/ejcts/ezu028; National Institute for Health and Care Excellence (NICE), DIAGN TREATM LUNG CA; Schmidt-Hansen M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009519.pub2; Scottish Intercollegiate Guidelines Network (SIGN), MAN LUNG CANC; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355	5	20	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1465	1466		10.1001/jama.2015.2365	http://dx.doi.org/10.1001/jama.2015.2365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871673	Green Submitted			2022-12-28	WOS:000352821200023
J	van Herwaarden, N; van der Maas, A; Minten, MJM; van den Hoogen, FHJ; Kievit, W; van Vollenhoven, RF; Bijlsma, JWJ; van den Bemt, BJF; den Broeder, AA				van Herwaarden, Noortje; van der Maas, Aatke; Minten, Michiel J. M.; van den Hoogen, Frank H. J.; Kievit, Wietske; van Vollenhoven, Ronald F.; Bijlsma, Johannes W. J.; van den Bemt, Bart J. F.; den Broeder, Alfons A.			Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALLY IMPORTANT DIFFERENCE; RADIOGRAPHIC PROGRESSION; JOINT DAMAGE; METAANALYSIS; THERAPY; PATIENT; RISK; METHOTREXATE; MALIGNANCIES; SHARP/VAN	OBJECTIVE To evaluate whether a disease activity guided strategy of dose reduction of two tumour necrosis factor (TNF) inhibitors, adalimumab or etanercept, is non-inferior in maintaining disease control in patients with rheumatoid arthritis compared with usual care. DESIGN Randomised controlled, open label, non-inferiority strategy trial. SETTING Two rheumatology outpatient clinics in the Netherlands, from December 2011 to May 2014. PARTICIPANTS 180 patients with rheumatoid arthritis and low disease activity using adalimumab or etanercept; 121 allocated to the dose reduction strategy, 59 to usual care. INTERVENTIONS Disease activity guided dose reduction (advice to stepwise increase the injection interval every three months, until flare of disease activity or discontinuation) or usual care (no dose reduction advice). Flare was defined as increase in DAS28-CRP (a composite score measuring disease activity) greater than 1.2, or increase greater than 0.6 and current score of at least 3.2. In the case of flare, TNF inhibitor use was restarted or escalated. MAIN OUTCOME MEASURES Difference in proportions of patients with major flare (DAS28-CRP based flare longer than three months) between the two groups at 18 months, compared against a non-inferiority margin of 20%. Secondary outcomes included TNF inhibitor use at study end, functioning, quality of life, radiographic progression, and adverse events. RESULTS Dose reduction of adalimumab or etanercept was non-inferior to usual care (proportion of patients with major flare at 18 months, 12% v 10%; difference 2%, 95% confidence interval -12% to 12%). In the dose reduction group, TNF inhibitor use could successfully be stopped in 20% (95% confidence interval 13% to 28%), the injection interval successfully increased in 43% (34% to 53%), but no dose reduction was possible in 37% (28% to 46%). Functional status, quality of life, relevant radiographic progression, and adverse events did not differ between the groups, although short lived flares (73% v 27%) and minimal radiographic progression (32% v 15%) were more frequent in dose reduction than usual care. CONCLUSIONS A disease activity guided, dose reduction strategy of adalimumab or etanercept to treat rheumatoid arthritis is non-inferior to usual care with regard to major flaring, while resulting in the successful dose reduction or stopping in two thirds of patients.	[van Herwaarden, Noortje; van der Maas, Aatke; Minten, Michiel J. M.; van den Hoogen, Frank H. J.; den Broeder, Alfons A.] Sint Maartensklin, Dept Rheumatol, NL-6500 GM Nijmegen, Netherlands; [van den Hoogen, Frank H. J.] Radboud Univ Nijmegen, Med Ctr UMC, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Kievit, Wietske] Radboud UMC, Dept Hlth Evidence, Nijmegen, Netherlands; [van Vollenhoven, Ronald F.] Karolinska Inst, ClinTRID, Stockholm, Sweden; [Bijlsma, Johannes W. J.] Utrecht UMC, Dept Rheumatol & Immunol, Utrecht, Netherlands; [van den Bemt, Bart J. F.] Sint Maartensklin, Dept Pharm, NL-6500 GM Nijmegen, Netherlands; [van den Bemt, Bart J. F.] Radboud UMC, Dept Pharm, Nijmegen, Netherlands	Sint Maartens Clinic; Radboud University Nijmegen; Radboud University Nijmegen; Karolinska Institutet; Utrecht University; Utrecht University Medical Center; Sint Maartens Clinic; Radboud University Nijmegen	van Herwaarden, N (corresponding author), Sint Maartensklin, Dept Rheumatol, POB 9011, NL-6500 GM Nijmegen, Netherlands.	n.vanherwaarden@maartenskliniek.nl	van Vollenhoven, Ronald/ABE-1244-2021; van den Hoogen, Frank/I-7829-2018; Broeder, Alfons A den/H-4861-2016; Van den Bemt, Bart/Q-2740-2015; van Herwaarden, Noortje/U-3778-2019; Kievit, Wietske/A-5666-2015	van den Hoogen, Frank/0000-0003-1044-015X; Broeder, Alfons A den/0000-0002-9012-4079; Van den Bemt, Bart/0000-0002-8560-9514; 	Pfizer; AbbVie; Roche; Bristol Myers Squibb; Union Chimique Belge; BMS; GlaxoSmithKline (GSK); UCB; Biotest; GSK; Janssen; Lilly; Merck; Vertex	Pfizer(Pfizer); AbbVie(AbbVie); Roche(Roche Holding); Bristol Myers Squibb(Bristol-Myers Squibb); Union Chimique Belge; BMS(Bristol-Myers Squibb); GlaxoSmithKline (GSK)(GlaxoSmithKline); UCB(UCB Pharma SA); Biotest; GSK(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); Merck(Merck & Company); Vertex(Vertex Pharmaceuticals)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: JB received grants and personal fees from Pfizer and AbbVie, during the conduct of the study; and grants and personal fees from Roche, Bristol Myers Squibb, Union Chimique Belge, outside the submitted work. RvV received grants from AbbVie, BMS, GlaxoSmithKline (GSK), Pfizer, Roche, and UCB, and personal fees from AbbVie, Biotest, BMS, GSK, Janssen, Lilly, Merck, Pfizer, Roche, UCB, and Vertex, outside the submitted work. The other authors declare no conflicts of interest.	Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bartlett SJ, 2012, ANN RHEUM DIS, V71, P1855, DOI 10.1136/annrheumdis-2011-201201; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; den Broeder AA, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-299; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Huggett B, 2013, NAT BIOTECHNOL, V31, P697, DOI 10.1038/nbt.2653; Hulscher ME, 2011, ARTHRITIS RHEUMATOL, V50, P1729; Kiely PDW, 2009, RHEUMATOLOGY, V48, P765, DOI 10.1093/rheumatology/kep073; King S., 2014, FIRSTWORD LISTS PHAR; Navarro-Compan V, 2014, ANN RHEUM DIS, V73, P1067, DOI 10.1136/annrheumdis-2012-202939; Schipper LG, 2012, ANN RHEUM DIS, V71, P845, DOI 10.1136/annrheumdis-2011-200274; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2013, LANCET, V381, P918, DOI 10.1016/S0140-6736(12)61811-X; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Maas A, 2013, ANN RHEUM DIS, V72, P1800, DOI 10.1136/annrheumdis-2012-202281; Van Herwaarden N, 2014, COCHRANE DB SYST REV, V29; Welsing PMJ, 2004, ARTHRITIS RHEUM-US, V50, P2082, DOI 10.1002/art.20350; Welsing PNJ, 2006, J RHEUMATOL, V33, P501; Yoshida K, 2014, ANN RHEUM DIS, V73, P595, DOI 10.1136/annrheumdis-2013-203302	22	90	94	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1389	10.1136/bmj.h1389	http://dx.doi.org/10.1136/bmj.h1389			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858265	hybrid, Green Published			2022-12-28	WOS:000352914700004
J	Kuyken, W; Hayes, R; Barrett, B; Byng, R; Dalgleish, T; Kessler, D; Lewis, G; Watkins, E; Brejcha, C; Cardy, J; Causley, A; Cowderoy, S; Evans, A; Gradinger, F; Kaur, S; Lanham, P; Morant, N; Richards, J; Shah, P; Sutton, H; Vicary, R; Weaver, A; Wilks, J; Williams, M; Taylor, RS; Byford, S				Kuyken, Willem; Hayes, Rachel; Barrett, Barbara; Byng, Richard; Dalgleish, Tim; Kessler, David; Lewis, Glyn; Watkins, Edward; Brejcha, Claire; Cardy, Jessica; Causley, Aaron; Cowderoy, Suzanne; Evans, Alison; Gradinger, Felix; Kaur, Surinder; Lanham, Paul; Morant, Nicola; Richards, Jonathan; Shah, Pooja; Sutton, Harry; Vicary, Rachael; Weaver, Alice; Wilks, Jenny; Williams, Matthew; Taylor, Rod S.; Byford, Sarah			Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial	LANCET			English	Article							RELAPSE/RECURRENCE; PROTOCOL; HEALTH; GUIDE	Background Individuals with a history of recurrent depression have a high risk of repeated depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to medication. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk of relapse or recurrence compared with usual care, but has not yet been compared with maintenance antidepressant treatment in a definitive trial. We aimed to see whether MBCT with support to taper or discontinue antidepressant treatment (MBCT-TS) was superior to maintenance antidepressants for prevention of depressive relapse or recurrence over 24 months. Methods In this single-blind, parallel, group randomised controlled trial (PREVENT), we recruited adult patients with three or more previous major depressive episodes and on a therapeutic dose of maintenance antidepressants, from primary care general practices in urban and rural settings in the UK. Participants were randomly assigned to either MBCT-TS or maintenance antidepressants (in a 1:1 ratio) with a computer-generated random number sequence with stratification by centre and symptomatic status. Participants were aware of treatment allocation and research assessors were masked to treatment allocation. The primary outcome was time to relapse or recurrence of depression, with patients followed up at five separate intervals during the 24-month study period. The primary analysis was based on the principle of intention to treat. The trial is registered with Current Controlled Trials, ISRCTN26666654. Findings Between March 23, 2010, and Oct 21, 2011, we assessed 2188 participants for eligibility and recruited 424 patients from 95 general practices. 212 patients were randomly assigned to MBCT-TS and 212 to maintenance antidepressants. The time to relapse or recurrence of depression did not differ between MBCT-TS and maintenance antidepressants over 24 months (hazard ratio 0.89, 95% CI 0.67-1.18; p=0.43), nor did the number of serious adverse events. Five adverse events were reported, including two deaths, in each of the MBCT-TS and maintenance antidepressants groups. No adverse events were attributable to the interventions or the trial. Interpretation We found no evidence that MBCT-TS is superior to maintenance antidepressant treatment for the prevention of depressive relapse in individuals at risk for depressive relapse or recurrence. Both treatments were associated with enduring positive outcomes in terms of relapse or recurrence, residual depressive symptoms, and quality of life.	[Kuyken, Willem] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Kuyken, Willem; Hayes, Rachel; Watkins, Edward; Brejcha, Claire; Cardy, Jessica; Causley, Aaron; Cowderoy, Suzanne; Evans, Alison; Gradinger, Felix; Richards, Jonathan; Shah, Pooja; Vicary, Rachael; Weaver, Alice; Wilks, Jenny; Williams, Matthew] Univ Exeter, Mood Disorders Ctr, Psychol, Exeter, Devon, England; [Barrett, Barbara; Byford, Sarah] Kings Coll London, Ctr Econ Mental & Phys Hlth, London WC2R 2LS, England; [Byng, Richard] Univ Plymouth, Peninsula Sch Med, Primary Care Grp, Plymouth PL4 8AA, Devon, England; [Byng, Richard] Univ Plymouth, Peninsula Sch Dent, Primary Care Grp, Plymouth PL4 8AA, Devon, England; [Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Kessler, David; Kaur, Surinder] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Lewis, Glyn] UCL, Div Psychiat, London, England; [Morant, Nicola] Univ Cambridge, Dept Psychol, Cambridge, England; [Taylor, Rod S.] Univ Exeter, Exeter Med Sch, Exeter, Devon, England	University of Oxford; University of Exeter; University of London; King's College London; University of Plymouth; University of Plymouth; University of Bristol; University of London; University College London; University of Cambridge; University of Exeter	Kuyken, W (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	willem.kuyken@psych.ox.ac.uk	Mantzios, Michail/Y-6405-2019; Byford, Sarah/D-1699-2010; Kuyken, Willem/ABC-5152-2021; Taylor, Rod/R-9581-2019; Kessler, david/ABB-6489-2021; Hayes, Rachel/H-1450-2018; Hutz, Claudio S/L-7499-2013; Barrett, Barbara M/F-7606-2010; Lewis, Glyn/E-9944-2012; Dalgleish, Tim/E-8341-2010	Mantzios, Michail/0000-0002-7476-3559; Byford, Sarah/0000-0001-7084-1495; Taylor, Rod/0000-0002-3043-6011; Hayes, Rachel/0000-0001-7525-322X; Hutz, Claudio S/0000-0002-3252-7339; Barrett, Barbara M/0000-0002-0270-6256; Lewis, Glyn/0000-0001-5205-8245; Dalgleish, Tim/0000-0002-7304-2231; Byng, Richard/0000-0001-7411-9467; Watkins, Edward/0000-0002-2432-5577; Richards, Jonathan/0000-0002-3394-6391; Morant, Nicola/0000-0003-4022-8133; Kuyken, Willem/0000-0002-8596-5252; Hertenstein, Elisabeth/0000-0001-6467-0933; Shah, Pooja/0000-0001-5101-8129; Gradinger, Felix/0000-0001-8335-4047	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme; NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula; Medical Research Council [MC_U105579215] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10155] Funding Source: researchfish	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme, and NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula.	Beck A.T., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; British Medical Association Royal Pharmaceutical Society of Great Britain, 2006, BRIT NATL FORMULARY, V48; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Crane RS, 2013, ASSESSMENT, V20, P681, DOI 10.1177/1073191113490790; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; First M.B., 2016, STRUCTURED CLIN INTE; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; King's Fund London UK, 2008, PAYING PRIC COST MEN; Koopmanschap MA, 1996, PHARMACOECONOMICS, V10, P460, DOI 10.2165/00019053-199610050-00003; KUPFER DJ, 1992, ARCH GEN PSYCHIAT, V49, P769; Kuyken W, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-217; Kuyken W, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7194; Kuyken W, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-99; Kuyken W, 2008, J CONSULT CLIN PSYCH, V76, P966, DOI 10.1037/a0013786; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; Miniati M, 2010, J PSYCHIATR RES, V44, P302, DOI 10.1016/j.jpsychires.2009.09.008; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; Parker G, 1997, PSYCHOL MED, V27, P1193, DOI 10.1017/S003329179700545X; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Richards D, 2011, CLIN PSYCHOL REV, V31, P1117, DOI 10.1016/j.cpr.2011.07.004; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Segal Z.V., 2013, MINDFULNESS BASED CO, V2nd ed.; Segal ZV, 2010, ARCH GEN PSYCHIAT, V67, P1256, DOI 10.1001/archgenpsychiatry.2010.168; Segal ZV, 2002, CLIN PSYCHOL PSYCHOT, V9, P131, DOI 10.1002/cpp.320; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Stangier U, 2013, AM J PSYCHIAT, V170, P624, DOI 10.1176/appi.ajp.2013.12060734; StataCorp, 2013, STATA STAT SOFTW REL; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Williams JMG, 2014, J CONSULT CLIN PSYCH, V82, P275, DOI 10.1037/a0035036; Williams JBW, 2008, INT CLIN PSYCHOPHARM, V23, P120, DOI 10.1097/YIC.0b013e3282f948f5; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Williams JMG, 2012, BRIT J PSYCHIAT, V200, P2	41	260	266	4	149	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					63	73		10.1016/S0140-6736(14)62222-4	http://dx.doi.org/10.1016/S0140-6736(14)62222-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM2OA	25907157	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000357519400029
J	Vickers, AJ; Kent, DM				Vickers, Andrew J.; Kent, David M.			The Lake Wobegon Effect: Why Most Patients Are at Below-Average Risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INDIVIDUAL PATIENTS; PRIMARY ANGIOPLASTY; STRATIFICATION; BENEFITS; TRIALS		[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10017 USA; [Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Memorial Sloan Kettering Cancer Center; Tufts Medical Center	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, 307 East 63rd St,2nd Floor, New York, NY 10065 USA.	vickersa@mskcc.org		Vickers, Andrew/0000-0003-1525-6503	NATIONAL CANCER INSTITUTE [P30CA008748, P50CA092629] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001064] Funding Source: Medline; NCI NIH HHS [P30-CA008748, P50 CA092629, P30 CA008748, P50-CA92629] Funding Source: Medline; NINDS NIH HHS [U01 NS086294] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Carlsson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2296; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2002, J GEN INTERN MED, V17, P887, DOI 10.1046/j.1525-1497.2002.11232.x; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Thune JJ, 2005, CIRCULATION, V112, P2017, DOI 10.1161/CIRCULATIONAHA.105.558676; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521	7	14	14	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					866	+		10.7326/M14-2767	http://dx.doi.org/10.7326/M14-2767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	25867499	Green Accepted			2022-12-28	WOS:000356516300022
J	Shalapour, S; Font-Burgada, J; Di Caro, G; Zhong, ZY; Sanchez-Lopez, E; Dhar, D; Willimsky, G; Ammirante, M; Strasner, A; Hansel, DE; Jamieson, C; Kane, CJ; Klatte, T; Birner, P; Kenner, L; Karin, M				Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Willimsky, Gerald; Ammirante, Massimo; Strasner, Amy; Hansel, Donna E.; Jamieson, Christina; Kane, Christopher J.; Klatte, Tobias; Birner, Peter; Kenner, Lukas; Karin, Michael			Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy	NATURE			English	Article							GENE-EXPRESSION ANALYSIS; INFILTRATING B-CELLS; PROSTATE-CANCER; TARGETED DELETION; MICE; AUTOIMMUNITY; METASTASIS; MECHANISMS; IMMUNITY; THERAPY	Cancer-associated genetic alterations induce expression of tumour antigens that can activate CD8(+) cytotoxic T cells (CTLs), but the microenvironment of established tumours promotes immune tolerance through poorly understood mechanisms(1,2). Recently developed therapeutics that overcome tolerogenic mechanisms activate tumour-directed CTLs and are effective in some human cancers(1). Immune mechanisms also affect treatment outcome, and certain chemotherapeutic drugs stimulate cancer-specific immune responses by inducing immunogenic cell death and other effector mechanisms(3,4). Our previous studies revealed that B cells recruited by the chemokine CXCL13 into prostate cancer tumours promote the progression of castrate-resistant prostate cancer by producing lymphotoxin, which activates an IkB kinase a (IKK alpha)-BMI1 module in prostate cancer stem cells(5,6). Because castrate-resistant prostate cancer is refractory to most therapies, we examined B cell involvement in the acquisition of chemotherapy resistance. Here we focus on oxaliplatin, an immunogenic chemotherapeutic agent(3,4) that is effective in aggressive prostate cancer(7). We show that mouse B cells modulate the response to low-dose oxaliplatin, which promotes tumour-directed CTL activation by inducing immunogenic cell death. Three different mouse prostate cancer models were refractory to oxaliplatin unless genetically or pharmacologically depleted of B cells. The crucial immunosuppressive B cells are plasmocytes that express IgA, interleukin (IL)-10 and programmed death ligand 1 (PD-L1), the appearance of which depends on TGF beta receptor signalling. Elimination of these cells, which also infiltrate human-therapy-resistant prostate cancer, allows CTL-dependent eradication of oxaliplatin-treated tumours.	[Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Ammirante, Massimo; Strasner, Amy; Karin, Michael] UCSD, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Ammirante, Massimo; Strasner, Amy; Hansel, Donna E.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Willimsky, Gerald] Charite Campus Buch, Inst Immunol, D-13125 Berlin, Germany; [Jamieson, Christina; Kane, Christopher J.] Univ Calif San Diego, Div Urol, Dept Surg, San Diego, CA 92093 USA; [Klatte, Tobias] Med Univ Vienna, Dept Urol, A-1090 Vienna, Austria; [Birner, Peter; Kenner, Lukas] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna, Med Univ Vienna, Ludwig Boltzmann Inst Canc Res, Clin Inst Pathol,UPLA, A-1210 Vienna, Austria	University of California System; University of California San Diego; University of California System; University of California San Diego; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; University of Veterinary Medicine Vienna	Karin, M (corresponding author), UCSD, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Sanchez-Lopez, Elsa/A-7131-2017; Zhong, Zhenyu/A-8339-2017; Willimsky, Gerald/AAA-2445-2021; Dhar, Debanjan/P-3072-2015	Sanchez-Lopez, Elsa/0000-0002-4236-1985; Willimsky, Gerald/0000-0002-9693-948X; Shalapour, Shabnam/0000-0002-4743-3706; Zhong, Zhenyu/0000-0002-9441-7645; Kenner, Lukas/0000-0003-2184-1338	National Institutes of Health (NIH) [CA127923, AI043477]; DFG; German Cancer Consortium [TR36, DKTK]; Genome Research-Austria project 'Inflammobiota' (FWF) [P26011]; Cure Search Foundation; German Research Foundation (DFG) [SH721/1-1]; Irvington-CRI; CIRM [TG2-01154]; FIRC/AIRC; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); German Cancer Consortium; Genome Research-Austria project 'Inflammobiota' (FWF); Cure Search Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Irvington-CRI; CIRM(California Institute for Regenerative Medicine); FIRC/AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Bastian, K. Wang, A. Umemura, M. K. Kim, M. Susani, E. Gurnhofer and F. Grizzi for discussions and research materials. Antibodies and MACS-beads were gifts from eBioscience, Biolegends and Miltenyi Biotec. Anti-PD-L1 and Pdl1/2<SUP>-/-</SUP> mice were from I. Mellman (Genentech). Research was supported by the National Institutes of Health (NIH) (CA127923 and AI043477), DFG and German Cancer Consortium (TR36, DKTK to G.W.), the Genome Research-Austria project 'Inflammobiota' (FWF and P26011 to L.K.), the Cure Search Foundation (to D.D.) and postdoctoral research fellowships from the German Research Foundation (DFG, SH721/1-1 to S.S.); Irvington-CRI (to S.S. and Z.Z.); CIRM (TG2-01154 to J.F.-B.) and FIRC/AIRC (to G.D.C.). M.K. is an ACS Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Ammirante M, 2013, GENE DEV, V27, P1435, DOI 10.1101/gad.220202.113; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Czeh M, 2010, ONCOGENE, V29, P6591, DOI 10.1038/onc.2010.388; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Doi T, 2012, BIOCHEM BIOPH RES CO, V425, P918, DOI 10.1016/j.bbrc.2012.08.010; Feng T, 2011, INT IMMUNOPHARMACOL, V11, P589, DOI 10.1016/j.intimp.2010.11.016; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Foster BA, 1997, CANCER RES, V57, P3325; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Gingrich JR, 1996, CANCER RES, V56, P4096; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harriman GR, 1999, J IMMUNOL, V162, P2521; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee JL, 2014, BRIT J CANCER, V110, P2472, DOI 10.1038/bjc.2014.204; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Magee JA, 2001, CANCER RES, V61, P5692; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schumacher TN, 2015, CANCER CELL, V27, P12, DOI 10.1016/j.ccell.2014.12.004; SHAH N, 1976, Urology, V8, P270, DOI 10.1016/0090-4295(76)90384-8; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Welsh JB, 2001, CANCER RES, V61, P5974; Woo JR, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-30; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	57	329	362	10	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					94	U235		10.1038/nature14395	http://dx.doi.org/10.1038/nature14395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924065	Green Accepted, Green Submitted			2022-12-28	WOS:000354040900040
J	Dardiotis, E; Ralli, S				Dardiotis, Efthimios; Ralli, Styliani			Paraneoplastic Neuromyotonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dardiotis, Efthimios; Ralli, Styliani] Univ Hosp Larissa, Larisa, Greece	General University Hospital of Larissa	Dardiotis, E (corresponding author), Univ Hosp Larissa, Larisa, Greece.	edar@med.uth.gr		Dardiotis, Efthimios/0000-0003-2957-641X					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					E24	E24		10.1056/NEJMicm1402098	http://dx.doi.org/10.1056/NEJMicm1402098			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923574				2022-12-28	WOS:000353655000010
J	Khatter, H; Myasnikov, AG; Natchiar, SK; Klaholz, BP				Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.			Structure of the human 80S ribosome	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; TRANSFER-RNA BINDING; O HYDROGEN-BONDS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EUKARYOTIC RIBOSOME; TRANSLATION INITIATION; BACTERIAL RIBOSOME; MESSENGER-RNA; L1 STALK	Ribosomes are translational machineries that catalyse protein synthesis. Ribosome structures from various species are known at the atomic level, but obtaining the structure of the human ribosome has remained a challenge; efforts to address this would be highly relevant with regard to human diseases. Here we report the near-atomic structure of the human ribosome derived from high-resolution single-particle cryo-eiecfron microscopy and atomic model, building. The structure has an average resolution of 3.6 angstrom, reaching 2.9 angstrom resolution in the most stable regions. It provides unprecedented insights into ribosomal RNA entities and amino acid side chains, notably of the transfer RNA binding sites and specific molecular interactions with the exit site tRINA. It reveals atomic details of the subunit interface, which is seen to remodel strongly upon rotational movements of the ribosomal submits. Furthermore, the structure paves the way for analysing antibiotic side effects and diseases associated with deregulated protein synthesis.	[Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, Ctr Integrat Biol CBI, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] CNRS, UMR 7104, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] INSERM, U964, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] Univ Strasbourg, F-67081 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Klaholz, BP (corresponding author), IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, Ctr Integrat Biol CBI, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	klaholz@igbmc.fr	Myasnikov, Alexander/T-4654-2018; Khatter, Heena/U-3668-2017		Equipex Equip@Meso project; CNRS; European Research Council (ERC) [N_243296]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI)	Equipex Equip@Meso project; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council (ERC)(European Research Council (ERC)European Commission); French Infrastructure for Integrated Structural Biology (FRISBI); Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI)	We thank A. Urzhumtsev and P. Afonine for discussions on FEM maps; R. Fritz and J. Michalon for IT support; R. Druifor constant high-quality engineers support; J.-F. Menetret for technical support; H. Stark for discussions on Cs-correction; D. Moras and J.-C. Thierry for continuous encouragement in pushing structural biology frontiers; the IGBMC cell culture facilities for HeLa cell production; and the High Performance Computing Center of the University of Strasbourg funded by the Equipex Equip@Meso project. This long-term project (since 2003) was supported by the CNRS and the European Research Council (ERC Starting Grant N_243296 TRANSLATION MACHINERY), and the electron microscope facility was supported by the Alsace Region, the FRM, the I BiSA platform program, INSERM, CNRS and the Association pour la Recherche sur le Cancer (ARC) and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01, and Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI).	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Budkevich TV, 2014, CELL, V158, P121, DOI 10.1016/j.cell.2014.04.044; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Delano W.L, 2002, PYMOL USERS MANUAL; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Khatter H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1404; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu AZ, 2008, J AM CHEM SOC, V130, P2428, DOI 10.1021/ja710114r; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOORE MN, 1985, BIOCHEMISTRY-US, V24, P191, DOI 10.1021/bi00322a027; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; SPERRAZZA JM, 1980, BIOCHEMISTRY-US, V19, P1053, DOI 10.1021/bi00547a001; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Yamamoto H, 2014, NAT STRUCT MOL BIOL, V21, P721, DOI 10.1038/nsmb.2859; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	59	272	288	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					640	U338		10.1038/nature14427	http://dx.doi.org/10.1038/nature14427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901680				2022-12-28	WOS:000353689700042
J	Porter, ME; Lee, TH				Porter, Michael E.; Lee, Thomas H.			Why Strategy Matters Now	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Porter, Michael E.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Boston, MA USA; [Lee, Thomas H.] Press Ganey, Wakefield, MA USA	Harvard University; Harvard University; Harvard Medical School	Porter, ME (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.								0	53	54	4	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1681	1684		10.1056/NEJMp1502419	http://dx.doi.org/10.1056/NEJMp1502419			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG9RF	25923546				2022-12-28	WOS:000353655000001
J	Manupriya				Manupriya			PAEDIATRICS Will new Indian growth charts help stem the rise in childhood obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN					manupriya9@gmail.com						Bhatia V, 2012, INDIAN J PEDIATR, V79, P943, DOI 10.1007/s12098-012-0745-5; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2009, INDIAN PEDIATR, V46, P463; Kar Sitanshu Sekhar, 2015, J Nat Sci Biol Med, V6, P12, DOI 10.4103/0976-9668.149071; Khadilkar V, 2015, INDIAN PEDIATR, V52, P47, DOI 10.1007/s13312-015-0566-5; Khadilkar Vaman, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS166, DOI 10.4103/2230-8210.84854	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h2013	10.1136/bmj.h2013	http://dx.doi.org/10.1136/bmj.h2013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918353				2022-12-28	WOS:000353954800003
J	Kim, SJ; Yoon, JS; Shishido, H; Yang, ZY; Rooney, LA; Barral, JM; Skach, WR				Kim, Soo Jung; Yoon, Jae Seok; Shishido, Hideki; Yang, Zhongying; Rooney, LeeAnn A.; Barral, Jose M.; Skach, William R.			Translational tuning optimizes nascent protein folding in cells	SCIENCE			English	Article							CYSTIC-FIBROSIS; NMR-SPECTROSCOPY; DELTA-F508 CFTR; IN-VIVO; RIBOSOME; REVEALS; NBD1	In cells, biosynthetic machinery coordinates protein synthesis and folding to optimize efficiency and minimize off-pathway outcomes. However, it has been difficult to delineate experimentally the mechanisms responsible. Using fluorescence resonance energy transfer, we studied cotranslational folding of the first nucleotide-binding domain from the cystic fibrosis transmembrane conductance regulator. During synthesis, folding occurred discretely via sequential compaction of N-terminal, alpha-helical, and alpha/beta-core subdomains. Moreover, the timing of these events was critical; premature alpha-subdomain folding prevented subsequent core formation. This process was facilitated by modulating intrinsic folding propensity in three distinct ways: delaying alpha-subdomain compaction, facilitating b-strand intercalation, and optimizing translation kinetics via codon usage. Thus, de novo folding is translationally tuned by an integrated cellular response that shapes the cotranslational folding landscape at critical stages of synthesis.	[Kim, Soo Jung; Yoon, Jae Seok; Shishido, Hideki; Yang, Zhongying; Rooney, LeeAnn A.; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Skach, William R.] Cyst Fibrosis Fdn Therapeut, Bethesda, MD 20814 USA	Oregon Health & Science University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Cystic Fibrosis Foundation	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu		Shishido, Hideki/0000-0002-2622-0664	NIH [R01GM53457, R01DK51818]; Cystic Fibrosis Foundation [KIM10F0, SKACH05X0];  [P30EYE010572];  [P30CA069533];  [S10OD012246];  [S10RR025571]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012246] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. David, B. Conti, and members of the Skach laboratory for helpful discussions; CFTR Folding Consortium for providing 3G11 CFTR antibody. This research was funded by NIH grants R01GM53457 and R01DK51818 (to W.R.S.) and Cystic Fibrosis Foundation Therapeutics grants KIM10F0 (to S.J.K.) and SKACH05X0 (to W.R.S.). Mass spectrometric analysis was performed by the OHSU Proteomics Shared Resource with support from P30EYE010572, P30CA069533, S10OD012246, and S10RR025571. U.S. patent application 13/664,252 covers the methodology to assess and redesign the NBD1 coding sequences, claiming priority to provisional application 61/553,861, filed on 31 October 2011. No other counterpart applications have been filed.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Chartier M, 2012, BIOINFORMATICS, V28, P1438, DOI 10.1093/bioinformatics/bts149; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Hingorani KS, 2014, CURR OPIN STRUC BIOL, V24, P81, DOI 10.1016/j.sbi.2013.11.007; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	32	136	138	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					444	448		10.1126/science.aaa3974	http://dx.doi.org/10.1126/science.aaa3974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908822				2022-12-28	WOS:000353338000037
J	Cheng, YF				Cheng, Yifan			Single-Particle Cryo-EM at Crystallographic Resolution	CELL			English	Review							MAXIMUM-LIKELIHOOD METHODS; X-RAY CRYSTALLOGRAPHY; BEAM-INDUCED MOTION; ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; ATOMIC-RESOLUTION; MOLECULAR ARCHITECTURE; PROTEIN CRYSTALS; RADIATION-DAMAGE; 26S PROTEASOME	Until only a few years ago, single-particle electron cryo-microscopy (cryo-EM) was usually not the first choice for many structural biologists due to its limited resolution in the range of nanometer to subnanometer. Now, this method rivals X-ray crystallography in terms of resolution and can be used to determine atomic structures of macromolecules that are either refractory to crystallization or difficult to crystallize in specific functional states. In this review, I discuss the recent breakthroughs in both hardware and software that transformed cryo-microscopy, enabling understanding of complex biomolecules and their functions at atomic level.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94158 USA.	ycheng@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369	NIH [R01GM098672, R01GM082893, S10RR026814, P50GM082250]; NSF [DBI-0960271]; University of California San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, R01GM098672, R01GM082893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of California San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank T. Walz, T. Gonen, A. Frost, and members of my laboratory for critical reading of the manuscript. Cryo-EM work in the Cheng laboratory is supported by grants from the NIH (R01GM098672, R01GM082893 and S10RR026814 to Y.C. and P50GM082250 to A. Frankel), the NSF (DBI-0960271 to D.A.A and Y.C.), which in part funded the development of the K2 camera in association with Gatan and P. Denes at Lawrence Berkeley Laboratory, and the University of California San Francisco Program for Breakthrough Biomedical Research (to Y.C.). Note that the goal of this review is to introduce single-particle cryo-EM to a broad audience by comparing it with the well-established method of X-ray crystallography; it is not meant to be a comprehensive review of single-particle cryo-EM, nor of the history of its methodological developments. I apologize to the many colleagues whose important contributions I was unable to cite due to space limitations.	Agard D, 2014, ADV IMAG ELECT PHYS, V185, P113, DOI 10.1016/B978-0-12-800144-8.00002-1; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Baker LA, 2010, METHOD ENZYMOL, V481, P371, DOI 10.1016/S0076-6879(10)81015-8; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Booth CR, 2006, J STRUCT BIOL, V156, P556, DOI 10.1016/j.jsb.2006.08.019; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Cramer P, 2014, CELL, V159, P985, DOI 10.1016/j.cell.2014.10.047; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; FRANK J, 1978, ULTRAMICROSCOPY, V3, P283, DOI 10.1016/S0304-3991(78)80038-2; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Glaeser RM, 2011, J STRUCT BIOL, V174, P1, DOI 10.1016/j.jsb.2010.12.005; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Jones N, 2014, NATURE, V505, P602, DOI 10.1038/505602a; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1411, DOI 10.1016/j.ultramic.2009.07.004; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1144, DOI 10.1016/j.ultramic.2009.05.005; Meyer RR, 2000, ULTRAMICROSCOPY, V85, P9, DOI 10.1016/S0304-3991(00)00046-2; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Mooney P, 2007, METHOD CELL BIOL, V79, P661, DOI 10.1016/S0091-679X(06)79027-6; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Sigworth FJ, 1998, J STRUCT BIOL, V122, P328, DOI 10.1006/jsbi.1998.4014; Sigworth FJ, 2010, METHOD ENZYMOL, V482, P263, DOI 10.1016/S0076-6879(10)82011-7; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Stark H, 1996, ULTRAMICROSCOPY, V63, P75, DOI 10.1016/0304-3991(96)00045-9; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Typke D, 2004, MICROSC MICROANAL, V10, P21, DOI 10.1017/S1431927604040164; Urban KW, 2011, NAT MATER, V10, P165, DOI 10.1038/nmat2964; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162; Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877; ZHOU ZH, 1993, ULTRAMICROSCOPY, V49, P407, DOI 10.1016/0304-3991(93)90246-T	74	331	336	5	187	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					450	457		10.1016/j.cell.2015.03.049	http://dx.doi.org/10.1016/j.cell.2015.03.049			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910205	Green Accepted, Bronze			2022-12-28	WOS:000353553600007
J	Hawkes, N				Hawkes, Nigel			UK research paper of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2015	350								h2125	10.1136/bmj.h2125	http://dx.doi.org/10.1136/bmj.h2125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RA	25908619				2022-12-28	WOS:000353576800006
J	Hyle, EP; Alame, D				Hyle, Emily P.; Alame, Diana			Case 13-2015: A 27-Year-Old Woman with Arthralgias and a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENGUE CASE CLASSIFICATION; CLINICAL PRESENTATION; CHIKUNGUNYA FEVER; LABORATORY FEATURES; UNITED-STATES; OUTBREAK; INFECTION; ARTHRITIS; DISEASE; VIRUS		[Hyle, Emily P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Alame, Diana] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hyle, Emily P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Alame, Diana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hyle, EP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							[Anonymous], 2014, MANSONS TROPICAL DIS; [Anonymous], 2014, MMWR MORB MORTAL WKL, V63, P500; Bandyopadhyay D, 2008, INT J DERMATOL, V47, P1148, DOI 10.1111/j.1365-4632.2008.03817.x; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Brunette G.W., 2014, CDC HLTH INFORM INT; Burke RJ, 2014, AUTOIMMUN REV, V13, P503, DOI 10.1016/j.autrev.2014.01.036; Centers for Disease Control and Prevention, CHIK VIR US; Craig AS, 2007, AM J MED SCI, V334, P180, DOI 10.1097/MAJ.0b013e3181425411; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Elliott SP, 2007, CLIN MICROBIOL REV, V20, P13, DOI 10.1128/CMR.00016-06; Gerfaud-Valentin M, 2014, AUTOIMMUN REV, V13, P708, DOI 10.1016/j.autrev.2014.01.058; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Halsey ES, 2013, AM J TROP MED HYG, V89, P99, DOI 10.4269/ajtmh.13-0103; Horstick O, 2012, PATHOG GLOB HEALTH, V106, P94, DOI 10.1179/2047773212Y.0000000017; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Hyde TB, 2006, CLIN INFECT DIS, V43, pS146, DOI 10.1086/505947; Jaureguiberry S, 2005, CLIN MICROBIOL INFEC, V11, P391, DOI 10.1111/j.1469-0691.2005.01148.x; Kasper D. L., 2004, HARRISONS PRINCIPLES; Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746; Lau C, 2010, TRAVEL MED INFECT DI, V8, P33, DOI 10.1016/j.tmaid.2009.12.002; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Neil KP, 2012, CLIN INFECT DIS, V54, P1091, DOI 10.1093/cid/cis025; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003; Puius YA, 2008, INFECT DIS CLIN N AM, V22, P289, DOI 10.1016/j.idc.2007.12.014; Rice PA, 2005, INFECT DIS CLIN N AM, V19, P853, DOI 10.1016/j.idc.2005.07.003; Richey LE, 2013, AM J MED SCI, V345, P136, DOI 10.1097/MAJ.0b013e31825d4b88; Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032; Sabroe RA, 2014, IMMUNOL ALLERGY CLIN, V34, P11, DOI 10.1016/j.iac.2013.07.010; Servey JT, 2007, AM FAM PHYSICIAN, V75, P373; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SMITH CA, 1987, RHEUM DIS CLIN N AM, V13, P265; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; Yu C, 2014, J AUTOIMMUN, V48-49, P10, DOI 10.1016/j.jaut.2014.01.004	35	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1657	1664		10.1056/NEJMcpc1415172	http://dx.doi.org/10.1056/NEJMcpc1415172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901430				2022-12-28	WOS:000353294000013
J	Janvier, P				Janvier, Philippe			Facts and fancies about early fossil chordates and vertebrates	NATURE			English	Review							EARLY EVOLUTION; CAMBRIAN VERTEBRATE; CONODONT AFFINITY; ORDOVICIAN FISH; ANATOMY; LAMPREY; ORIGIN; HISTOLOGY; DECAY; HAGFISH	The interrelationships between major living vertebrate, and even chordate, groups are now reasonably well resolved thanks to a large amount of generally congruent data derived from molecular sequences, anatomy and physiology. But fossils provide unexpected combinations of characters that help us to understand how the anatomy of modern groups was progressively shaped over millions of years. The dawn of vertebrates is documented by fossils that are preserved as either soft-tissue imprints, or minute skeletal fragments, and it is sometimes difficult for palaeontologists to tell which of them are reliable vertebrate remains and which merely reflect our idea of an ancestral vertebrate.	Univ Paris 04, UPMC, Museum Natl Hist Nat, CNRS,UMR7207, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Janvier, P (corresponding author), Univ Paris 04, UPMC, Museum Natl Hist Nat, CNRS,UMR7207, 8 Rue Buffon, F-75231 Paris, France.	janvier@mnhn.fr	Janvier, Philippe/Q-5268-2019					ALDRIDGE RJ, 1993, PHILOS T R SOC B, V340, P405, DOI 10.1098/rstb.1993.0082; Aldridge RJ, 1998, BIOLOGY OF HAGFISHES, P15; BARDACK D, 1977, Fieldiana Geology, V33, P489; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; BARDACK D, 1968, SCIENCE, V162, P1265, DOI 10.1126/science.162.3859.1265; Bardack D, 1998, BIOLOGY OF HAGFISHES, P3; Blom H, 2012, PALAEONTOLOGY, V55, P641, DOI 10.1111/j.1475-4983.2012.01142.x; BOCKELIE T, 1976, NATURE, V260, P36, DOI 10.1038/260036a0; BRIGGS DEG, 1983, LETHAIA, V16, P1, DOI 10.1111/j.1502-3931.1983.tb01139.x; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; BRIGGS DEG, 1987, LETHAIA, V20, P107, DOI 10.1111/j.1502-3931.1987.tb00767.x; Caron JB, 2005, T ROY SOC EDIN-EARTH, V96, P95, DOI 10.1017/S0263593300001255; Chang MM, 2006, NATURE, V441, P972, DOI 10.1038/nature04730; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; DENISON ROBERT H., 1967, FIELDIANA GEOL, V16, P131; Donoghue PCJ, 1998, PHILOS T R SOC B, V353, P633, DOI 10.1098/rstb.1998.0231; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Donoghue PCJ, 2001, T ROY SOC EDIN-EARTH, V92, P15, DOI 10.1017/S026359330000002X; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dzik J, 2009, LETHAIA, V42, P31, DOI 10.1111/j.1502-3931.2008.00102.x; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gagnier Pierre-Yves, 1993, Annales de Paleontologie, V79, P19; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gee H, 2001, NATURE, V414, P407, DOI 10.1038/35106680; Gee H., 1996, BACKBONE VIEWS ORIGI; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Goudemand N, 2011, P NATL ACAD SCI USA, V108, P8720, DOI 10.1073/pnas.1101754108; Gould S. J., 1990, WONDERFUL LIFE BURGE; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Hou X. G., 2007, CAMBRIAN FOSSILS CHE; Janvier P, 2006, NATURE, V440, P1183, DOI 10.1038/nature04471; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P773, DOI 10.1671/0272-4634(2004)024[0773:CCITPF]2.0.CO;2; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; JANVIER P, 1983, Journal of Vertebrate Paleontology, V2, P407; Janvier P., 1996, EARLY VERTEBRATES; Janvier P., 2004, RECENT ADV ORIGIN EA, P29; Janvier P, 2007, GEODIVERSITAS, V29, P143; Janvier P, 2006, NATURE, V443, P921, DOI 10.1038/443921a; Janvier P, 2011, CURR BIOL, V21, pR661, DOI 10.1016/j.cub.2011.07.014; Janvier P, 2008, ZOOL SCI, V25, P1045, DOI 10.2108/zsj.25.1045; Jefferies R. P. S., 1996, ANCESTRY VERTEBRATES; Johanson Z, 2010, SEMIN CELL DEV BIOL, V21, P414, DOI 10.1016/j.semcdb.2009.10.011; Karatajute-Talimaa Valentina, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P21; KREJSA RJ, 1990, LETHAIA, V23, P359, DOI 10.1111/j.1502-3931.1990.tb01369.x; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Marss T, 2008, J VERTEBR PALEONTOL, V28, P601, DOI 10.1671/0272-4634(2008)28[601:BDOPEP]2.0.CO;2; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Mallatt J, 2003, SCIENCE, V300; Morris SC, 2014, NATURE, V512, P419, DOI 10.1038/nature13414; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; MOY-THOMAS J. A., 1940, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P391, DOI 10.1098/rstb.1940.0004; Murdock DJE, 2013, NATURE, V502, P546, DOI 10.1038/nature12645; Oisi Y, 2013, ZOOL SCI, V30, P944, DOI 10.2108/zsj.30.944; PATTERSON C, 1981, ANNU REV ECOL SYST, V12, P195, DOI 10.1146/annurev.es.12.110181.001211; Poplin C, 2001, CR ACAD SCI II A, V332, P345, DOI 10.1016/S1251-8050(01)01537-3; Pradel A, 2007, BIOL LETTERS, V3, P72, DOI 10.1098/rsbl.2006.0557; Purnell MA, 2002, P ROY SOC B-BIOL SCI, V269, P83, DOI 10.1098/rspb.2001.1826; PURNELL MA, 1995, LETHAIA, V28, P187, DOI 10.1111/j.1502-3931.1995.tb01612.x; REPETSKI JE, 1978, SCIENCE, V200, P529, DOI 10.1126/science.200.4341.529-a; RITCHIE A, 1985, ALCHERINGA, V9, P115; Ritchie A, 1977, ALCHERINGA, V1, P351, DOI 10.1080/03115517708527770; Royal Ontario Museum, 2011, BURG SHAL; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Sansom IJ, 1997, PALAEONTOLOGY, V40, P625; Sansom IJ, 2005, BIOL LETT-UK, V1, P446, DOI 10.1098/rsbl.2005.0349; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Sansom IJ, 2013, J VERTEBR PALEONTOL, V33, P764, DOI 10.1080/02724634.2013.751920; Sansom RS, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0002; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Sansom RS, 2011, P ROY SOC B-BIOL SCI, V278, P1150, DOI 10.1098/rspb.2010.1641; Sansom RS, 2010, PALAEONTOLOGY, V53, P1393, DOI 10.1111/j.1475-4983.2010.01019.x; Sansom RS, 2010, NATURE, V463, P797, DOI 10.1038/nature08745; Shu D., 2003, SCIENCE, V300, P1372, DOI DOI 10.1126/SCIENCE.1085573; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2003, SCIENCE, V299, P1380, DOI 10.1126/science.1079846; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; Smith MM, 1997, PALAEONTOLOGY, V40, P645; Smith MP, 1996, NATURE, V380, P702, DOI 10.1038/380702a0; Smith MP, 2001, SYST ASSOC SPEC VOL, V61, P67; Sollas WJ, 1904, PHILOS T R SOC LON B, V196, P265; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Turner S., 2004, ADV ORIGIN EARLY RAD, P67; Turner S, 2010, GEODIVERSITAS, V32, P545, DOI 10.5252/g2010n4a1; vanderBrugghen W, 1997, NATURE, V385, P589, DOI 10.1038/385589a0; Wang NZ, 2005, J VERTEBR PALEONTOL, V25, P745, DOI 10.1671/0272-4634(2005)025[0745:HOTGDA]2.0.CO;2; White Errol Ivor, 1946, GEOL MAG, V83, P89; Young GC, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10010948; Young GC, 1996, NATURE, V383, P810, DOI 10.1038/383810a0; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; [No title captured]	100	49	50	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					483	489		10.1038/nature14437	http://dx.doi.org/10.1038/nature14437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903630				2022-12-28	WOS:000353334500032
J	Lave, J				Lave, Jerome			EARTH SCIENCE Landscape inversion by stream piracy	NATURE			English	Editorial Material							UPLIFT	A model suggests that active deformation in mountains causes river networks to constantly reorganize, providing an explanation for the paradoxical formation of almost flat surfaces high in craggy mountain ranges.	CNRS, Ctr Rech Petrog & Grochim, F-54501 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Lave, J (corresponding author), CNRS, Ctr Rech Petrog & Grochim, F-54501 Vandoeuvre Les Nancy, France.	jlave@crpg.cnrs-nancy.fr						Clark MK, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000294; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Davis WM, 1911, ANN ASSOC AM GEOGR, V1, P21, DOI 10.2307/2560844; GUBBELS TL, 1993, GEOLOGY, V21, P695, DOI 10.1130/0091-7613(1993)021<0695:HLSPUA>2.3.CO;2; Gunnell Y, 2009, EARTH PLANET SC LETT, V278, P208, DOI 10.1016/j.epsl.2008.12.004; Hallet B, 2001, J GEOPHYS RES-SOL EA, V106, P13697, DOI 10.1029/2000JB900335; Hoke GD, 2014, EARTH PLANET SC LETT, V394, P270, DOI 10.1016/j.epsl.2014.03.007; Kohn MJ, 2007, PALEOALTIMETRY GEOCH; Liu-Zeng J, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000897; Niemann JD, 2001, EARTH SURF PROC LAND, V26, P1317, DOI 10.1002/esp.272; Perron JT, 2013, EARTH SURF PROC LAND, V38, P570, DOI 10.1002/esp.3302; Shen ZK, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003421; Willett SD, 2014, SCIENCE, V343, P1117, DOI 10.1126/science.1248765; Yang R, 2015, NATURE, V520, P526, DOI 10.1038/nature14354	14	11	12	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					442	444		10.1038/520442a	http://dx.doi.org/10.1038/520442a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903621				2022-12-28	WOS:000353334500024
J	Sahni, N; Yi, S; Taipale, M; Bass, JIF; Coulombe-Huntington, J; Yang, F; Peng, J; Weile, J; Karras, GI; Wang, Y; Kovacs, IA; Kamburov, A; Krykbaeva, I; Lam, MH; Tucker, G; Khurana, V; Sharma, A; Liu, YY; Yachie, N; Zhong, Q; Shen, Y; Palagi, A; San-Miguel, A; Fan, CY; Balcha, D; Dricot, A; Jordan, DM; Walsh, JM; Shah, AA; Yang, XP; Stoyanova, AK; Leighton, A; Calderwood, MA; Jacob, Y; Cusick, ME; Salehi-Ashtiani, K; Whitesell, LJ; Sunyaev, S; Berger, B; Barabasi, AL; Charloteaux, B; Hill, DE; Hao, T; Roth, FP; Xia, Y; Walhout, AJM; Lindquist, S; Vidal, M				Sahni, Nidhi; Yi, Song; Taipale, Mikko; Bass, Juan I. Fuxman; Coulombe-Huntington, Jasmin; Yang, Fan; Peng, Jian; Weile, Jochen; Karras, Georgios I.; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Krykbaeva, Irina; Lam, Mandy H.; Tucker, George; Khurana, Vikram; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Jordan, Daniel M.; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Leighton, Alex; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Whitesell, Luke J.; Sunyaev, Shamil; Berger, Bonnie; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Lindquist, Susan; Vidal, Marc			Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders	CELL			English	Article							ONE-HYBRID ASSAYS; SEQUENCE VARIATION; PROTEIN COMPLEXES; HUMAN-DISEASE; MUTATIONS; NETWORK; CANCER; EXPRESSION; CHAPERONE; GENOME	How disease-associated mutations impair protein activities in the context of biological networks remains mostly undetermined. Although a few renowned alleles are well characterized, functional information is missing for over 100,000 disease-associated variants. Here we functionally profile several thousand missense mutations across a spectrum of Mendelian disorders using various interaction assays. The majority of disease-associated alleles exhibit wild-type chaperone binding profiles, suggesting they preserve protein folding or stability. While common variants from healthy individuals rarely affect interactions, two-thirds of disease-associated alleles perturb protein-protein interactions, with half corresponding to "edgetic" alleles affecting only a subset of interactions while leaving most other interactions unperturbed. With transcription factors, many alleles that leave protein-protein interactions intact affect DNA binding. Different mutations in the same gene leading to different interaction profiles often result in distinct disease phenotypes. Thus disease-associated alleles that perturb distinct protein activities rather than grossly affecting folding and stability are relatively widespread.	[Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Sharma, Amitabh; Yachie, Nozomu; Shen, Yun; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Calderwood, Michael A.; Cusick, Michael E.; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Genom Anal Network, Perturbat Ctr Excellence Genom Sci CEGS, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Wang, Yang; Kamburov, Atanas; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Taipale, Mikko; Karras, Georgios I.; Krykbaeva, Irina; Khurana, Vikram; Whitesell, Luke J.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bass, Juan I. Fuxman; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Program Syst Biol, Worcester, MA 01605 USA; [Coulombe-Huntington, Jasmin; Xia, Yu] McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Lam, Mandy H.; Walhout, Albertha J. M.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Peng, Jian; Tucker, George; Leighton, Alex; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res CCNR, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Jordan, Daniel M.; Sunyaev, Shamil] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Jordan, Daniel M.] Harvard Univ, Program Biophys, Cambridge, MA 02139 USA; [Jacob, Yves] CNRS, Dept Virol, Unite Genet Mol Virus ARN GMVR, Inst Pasteur,UMR3569, Paris, France; [Jacob, Yves] Univ Paris Diderot, Paris, France; [Whitesell, Luke J.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Whitesell, Luke J.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Sunyaev, Shamil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Berger, Bonnie] MIT, Dept Math & Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Massachusetts System; University of Massachusetts Worcester; McGill University; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); Northeastern University; Northeastern University; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Canadian Institute for Advanced Research (CIFAR); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lindquist@wi.mit.edu; marc_vidal@dfci.harvard.edu	Yang, Fan/V-6555-2019; Yi, Song/ABG-6526-2020; Wang, Yang/AAN-7740-2020; Calderwood, Mike/B-2475-2014; zhong, quan/AAE-8893-2021; Roth, Frederick P/H-6308-2011; Xia, Yu/W-6150-2019; Kovacs, Istvan/A-8447-2013; Barabasi, Albert-Laszlo/S-6474-2017; Jordan, Daniel/M-6842-2019; San Miguel, Adriana/C-3937-2017; Yang, Xinping/HGA-6104-2022; Liu, Yang-Yu/G-8885-2011	Yang, Fan/0000-0003-4821-6583; Yi, Song/0000-0003-0047-8103; Calderwood, Mike/0000-0001-6475-1418; Xia, Yu/0000-0002-5596-5518; Kovacs, Istvan/0000-0002-6890-6277; Jordan, Daniel/0000-0002-5318-8225; San Miguel, Adriana/0000-0003-0172-2163; Liu, Yang-Yu/0000-0003-2728-4907; Zhong, Quan/0000-0003-2910-5597; Krykbaeva, Irina/0000-0003-1380-7607; Weile, Jochen/0000-0003-1628-9390; Karras, Georgios/0000-0003-2933-1535; Khurana, Vikram/0000-0002-4018-5527; Walhout, Marian/0000-0001-5587-3608; Taipale, Mikko/0000-0003-3811-1761; Kamburov, Atanas/0000-0002-0580-0619; Jacob, Yves/0000-0001-9125-2374; Peng, Jian/0000-0002-1736-2978; Yang, Xinping/0000-0003-4086-4180; Sahni, Nidhi/0000-0002-9155-5882; Roth, Frederick/0000-0002-6628-649X; Stoyanova, Ani/0000-0002-0804-7837; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Barabasi, Albert/0000-0002-4028-3522	NHGRI [P50HG004233, RC4HG006066, R01HG001715]; NIGMS [GM082971]; NSF [CCF-1219007]; NSERC [RGPIN-2014-03892]; Krembil Foundation; Canada Excellence Research Chair; Ontario Research Fund-Research Excellence Award; Pew Latin American Fellowship; EMBO Long-Term Fellowship; Division of Computing and Communication Foundations [1219007] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233, RC4HG006066, R01HG001715, U41HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871, R01GM082971] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Krembil Foundation; Canada Excellence Research Chair; Ontario Research Fund-Research Excellence Award; Pew Latin American Fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the DFCI Center for Cancer Systems Biology (CCSB) for valuable discussions and acknowledge A.A. Chen, M. Koeva, and E. Guney for helpful suggestions. This work was supported by NHGRI (P50HG004233 to M.V., F.P.R. and A.-L.B.; RC4HG006066 to M.V., T.H., D.E.H., K.S.-A., L.J.W., and S.L.; and R01HG001715 to M.V., D.E.H., and F.P.R.), NIGMS (GM082971 to A.J.M.W.), NSF (CCF-1219007 to Y.X.), NSERC (RGPIN-2014-03892 to Y.X.), and the Krembil Foundation, a Canada Excellence Research Chair, an Ontario Research Fund-Research Excellence Award awarded to F.P.R. J.I.F.B. is supported by a Pew Latin American Fellowship. A.K. is supported by an EMBO Long-Term Fellowship. S.L. is an investigator of the Howard Hughes Medical Institute. M.V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Balasubramanian S, 2005, NUCLEIC ACIDS RES, V33, P1710, DOI 10.1093/nar/gki311; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; De Nooy W., 2005, EXPLORATORY SOCIAL N; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; GUNNING P, 1990, DEV BIOL, V138, P443, DOI 10.1016/0012-1606(90)90210-A; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Sorgjerd K, 2006, J MOL BIOL, V356, P469, DOI 10.1016/j.jmb.2005.11.051; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Sunyaev SR, 2012, HUM MOL GENET, V21, pR10, DOI 10.1093/hmg/dds385; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tervaniemi MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049920; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	47	317	317	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					647	660		10.1016/j.cell.2015.04.013	http://dx.doi.org/10.1016/j.cell.2015.04.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910212	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000353553600022
J	Shyer, AE; Huycke, TR; Lee, CH; Mahadevan, L; Tabin, CJ				Shyer, Amy E.; Huycke, Tyler R.; Lee, ChangHee; Mahadevan, L.; Tabin, Clifford J.			Bending Gradients: How the Intestinal Stem Cell Gets Its Home	CELL			English	Article							SONIC-HEDGEHOG; BMP; MUCOSA; GROWTH; VILLI; MORPHOGENESIS; MORPHOLOGY; RENEWAL; SIGNALS; LIMB	We address the mechanism by which adult intestinal stem cells (ISCs) become localized to the base of each villus during embryonic development. We find that, early in gut development, proliferating progenitors expressing ISC markers are evenly distributed throughout the epithelium, in both the chick and mouse. However, as the villi form, the putative stem cells become restricted to the base of the villi. This shift in the localization is driven by mechanically influenced reciprocal signaling between the epithelium and underlying mesenchyme. Buckling forces physically distort the shape of the morphogenic field, causing local maxima of epithelial signals, in particular Shh, at the tip of each villus. This induces a suite of high-threshold response genes in the underlying mesenchyme to form a signaling center called the "villus cluster.'' Villus cluster signals, notably Bmp4, feed back on the overlying epithelium to ultimately restrict the stem cells to the base of each villus.	[Shyer, Amy E.; Huycke, Tyler R.; Lee, ChangHee; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Lee, ChangHee/0000-0002-9994-3142; Huycke, Tyler/0000-0001-8328-5061	NIH [HD047360]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK103563] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Rodrigues and Sandy Klemm for assistance with single-molecule FISH probe design and experiments, Jessica Lehoczky for help with mice, Maxwell Heiman for the use of his microscope, and Jinhyun Choo for help with the simulation. We also thank D. Gumucio and K. Walton for discussions and for sharing data prior to publication. This work was supported by grants from the NIH (HD047360) to C.J.T. and the MacArthur Foundation to L.M.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; COULOMBRE AJ, 1958, J EMBRYOL EXP MORPH, V6, P403; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Durdu S, 2014, NATURE, V515, P120, DOI 10.1038/nature13852; FERRI S, 1976, J ANAT, V121, P291; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fukuda K, 1998, DEVELOPMENT, V125, P3535; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hilton WA, 1902, AM J ANAT, V1, P459, DOI 10.1002/aja.1000010406; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Knezevic V, 1997, DEVELOPMENT, V124, P4523; KOTZE SH, 1995, J MORPHOL, V225, P169, DOI 10.1002/jmor.1052250203; KRAUSE WJ, 1975, ANAT RECORD, V181, P251, DOI 10.1002/ar.1091810207; LACROIX B, 1984, GUT, V25, P925, DOI 10.1136/gut.25.9.925; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; MCAVOY JW, 1978, J ANAT, V125, P155; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Salazar-Ciudad I, 2012, CURR OPIN GENET DEV, V22, P585, DOI 10.1016/j.gde.2012.10.006; SBARBATI R, 1982, J ANAT, V135, P477; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tian Q, 2005, CELL CYCLE, V4, P215; Walker RL, 2004, CAN J PHYSIOL PHARM, V82, P951, DOI [10.1139/y04-103, 10.1139/Y04-103]; Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109; Winkler F, 1998, ANAT HISTOL EMBRYOL, V27, P335, DOI 10.1111/j.1439-0264.1998.tb00204.x	38	164	170	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					569	580		10.1016/j.cell.2015.03.041	http://dx.doi.org/10.1016/j.cell.2015.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865482	Green Accepted, Bronze			2022-12-28	WOS:000353553600016
J	Rewers, A; Dong, F; Slover, RH; Klingensmith, GJ; Rewers, M				Rewers, Arleta; Dong, Fran; Slover, Robert H.; Klingensmith, Georgeanna J.; Rewers, Marian			Incidence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Youth, 1998-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHILDREN		[Rewers, Arleta] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Dong, Fran; Slover, Robert H.; Klingensmith, Georgeanna J.; Rewers, Marian] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rewers, A (corresponding author), Univ Colorado, Sch Med, Dept Pediat, 13123 E 16th Ave, Aurora, CO 80045 USA.	arleta.rewers@childrenscolorado.org	Rewers, Arleta/AAE-2484-2019		NIDDK NIH HHS [P30 DK57156] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; Limenis Elizaveta, 2012, Diabetes Care, V35, pe5, DOI 10.2337/dc11-1980; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x	4	45	45	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1570	1572		10.1001/jama.2015.1414	http://dx.doi.org/10.1001/jama.2015.1414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898057	Bronze			2022-12-28	WOS:000353198700024
J	Arrieta, JM; Mayol, E; Hansman, RL; Herndl, GJ; Dittmar, T; Duarte, CM				Arrieta, Jesus M.; Mayol, Eva; Hansman, Roberta L.; Herndl, Gerhard J.; Dittmar, Thorsten; Duarte, Carlos M.			Dilution limits dissolved organic carbon utilization in the deep ocean	SCIENCE			English	Article							MATTER; GROWTH; DEGRADATION; BACTERIA; ATLANTIC; SEAWATER; IMPACT; SEA; DOM	Oceanic dissolved organic carbon (DOC) is the second largest reservoir of organic carbon in the biosphere. About 72% of the global DOC inventory is stored in deep oceanic layers for years to centuries, supporting the current view that it consists of materials resistant to microbial degradation. An alternative hypothesis is that deep-water DOC consists of many different, intrinsically labile compounds at concentrations too low to compensate for the metabolic costs associated to their utilization. Here, we present experimental evidence showing that low concentrations rather than recalcitrance preclude consumption of a substantial fraction of DOC, leading to slow microbial growth in the deep ocean. These findings demonstrate an alternative mechanism for the long-term storage of labile DOC in the deep ocean, which has been hitherto largely ignored.	[Arrieta, Jesus M.; Mayol, Eva; Duarte, Carlos M.] UIB, CSIC, Inst Mediterrani Estudis Avancats IMEDEA, Dept Global Change Res, Esporles 07190, Spain; [Arrieta, Jesus M.; Duarte, Carlos M.] KAUST, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Hansman, Roberta L.; Herndl, Gerhard J.] Univ Vienna, Div Biooceanog, Dept Limnol & Biooceanog, A-1090 Vienna, Austria; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Res Grp Marine Geochem, ICBM MPI Bridging Grp, Inst Chem & Biol Marine Environm ICBM, Bremen, Germany; [Dittmar, Thorsten] Max Planck Inst Marine Microbiol MPI, Bremen, Germany; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; King Abdullah University of Science & Technology; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Carl von Ossietzky Universitat Oldenburg; University of Western Australia	Arrieta, JM (corresponding author), UIB, CSIC, Inst Mediterrani Estudis Avancats IMEDEA, Dept Global Change Res, Esporles 07190, Spain.	txetxu@mail.com	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Herndl, Gerhard J./B-1513-2013; Arrieta, Jesus M/B-1226-2008; Duarte, Carlos M/A-7670-2013; Herndl, Gerhard J./S-3011-2019; Dittmar, Thorsten/L-7796-2013	Herndl, Gerhard J./0000-0002-2223-2852; Arrieta, Jesus M/0000-0002-0190-6950; Duarte, Carlos M/0000-0002-1213-1361; Herndl, Gerhard J./0000-0002-2223-2852; Dittmar, Thorsten/0000-0002-3462-0107; Hansman, Roberta/0000-0003-1525-8509	Spanish Ministry of Economy and Competitiveness [CSD2008-00077]; Junta para la Ampliacion de Estudios program of CSIC; Austrian Science Fund (FWF) [I486-B09, P23234-B11]; European Research Council (ERC) under the European Community [268595]; Austrian Science Fund (FWF) [Z 194] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta para la Ampliacion de Estudios program of CSIC; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC) under the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This is a contribution to the Malaspina 2010 Expedition project, funded by the CONSOLIDER-Ingenio 2010 program of the from the Spanish Ministry of Economy and Competitiveness (Ref. CSD2008-00077). J. M. A. was supported by a "Ramon y Cajal" research fellowship from the Spanish Ministry of Economy and Competitiveness. E.M. was supported by a fellowship from the Junta para la Ampliacion de Estudios program of CSIC. G.J.H. and R.L.H. were supported by the Austrian Science Fund (FWF) projects I486-B09 and P23234-B11 and by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 268595 (MEDEA project). We thank A. Dorsett for assistance with DOC analyses, participants in the Malaspina Expedition and the crews of the BIO Hesperides, and RV Pelagia and the personnel of the Marine Technology Unit of CSIC for their invaluable support. Original data sets are available online at http://digital.csic.es/handle/10261/111563. J. M. A. designed the experimental setup, carried out part of the experiments, measured prokaryotic abundance, analyzed the data, and wrote the manuscript. E.M. carried out part of the experiments and data analysis. C.M.D. designed the Malaspina 2010 Expedition, was responsible for DOC analyses, and together with G.J.H. contributed to the design of the experiments and discussion of results. R.L.H. and T.D. analyzed the FT-ICR-MS samples. All authors discussed the results and contributed to the manuscript.	BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Bauer JE., 2002, BIOGEOCHEMISTRY MARI, P405, DOI [10.1016/B978-012323841-2/50010-5, DOI 10.1016/B978-012323841-2/50010-5]; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Copley SD, 2000, TRENDS BIOCHEM SCI, V25, P261, DOI 10.1016/S0968-0004(00)01562-0; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Follett CL, 2014, P NATL ACAD SCI USA, V111, P16706, DOI 10.1073/pnas.1407445111; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; JANNASCH HW, 1994, GLOBAL PLANET CHANGE, V9, P289, DOI 10.1016/0921-8181(94)90022-1; JANNASCH HW, 1967, LIMNOL OCEANOGR, V12, P264, DOI 10.4319/lo.1967.12.2.0264; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kattner G, 2011, MICROBIAL CARBON PUM, P60, DOI DOI 10.1126/SCIENCE.OPMS.SB0001; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Konopka A, 2000, CURR OPIN MICROBIOL, V3, P244, DOI 10.1016/S1369-5274(00)00083-7; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lechtenfeld OJ, 2014, GEOCHIM COSMOCHIM AC, V126, P321, DOI 10.1016/j.gca.2013.11.009; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Sharp JH, 2009, ESTUAR COAST, V32, P1023, DOI 10.1007/s12237-009-9210-8; Stone R, 2010, SCIENCE, V328, P1476, DOI 10.1126/science.328.5985.1476; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0; Zubkov M, 2007, J PLANKTON RES, V29, P79	26	171	180	19	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					331	333		10.1126/science.1258955	http://dx.doi.org/10.1126/science.1258955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883355				2022-12-28	WOS:000352999000043
J	Singh, AP; Frohnhofer, HG; Irion, U; Nusslein-Volhard, C				Singh, Ajeet Pratap; Frohnhoefer, Hans-Georg; Irion, Uwe; Nuesslein-Volhard, Christiane			Response to Comment on "Local reorganization of xanthophores fine-tunes and colors the striped pattern of zebrafish"	SCIENCE			English	Editorial Material							ADULT PIGMENT PATTERN; CELL-INTERACTIONS; IRIDOPHORES	Watanabe and Kondo question our conclusion that the current Turing-type model of color patterning in zebrafish requires modification. In addition to xanthophores and melanophores, iridophores are essential for stripe formation in the body, although not in the fins. A model of predictive value should accommodate the in vivo dynamics and interactions of all three chromatophore types in body stripe formation.	[Singh, Ajeet Pratap; Frohnhoefer, Hans-Georg; Irion, Uwe; Nuesslein-Volhard, Christiane] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Max Planck Society	Singh, AP (corresponding author), Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany.	ajeet.singh@tuebingen.mpg.de; christiane.nuesslein-volhard@tuebingen.mpg.de	Irion, Uwe/ABC-8635-2020	Irion, Uwe/0000-0003-2823-5840				Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Irion U, 2014, ELIFE, V3, DOI 10.7554/eLife.05125; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Mahalwar P, 2014, SCIENCE, V345, P1362, DOI 10.1126/science.1254837; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Patterson LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6299; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Singh AP, 2015, CURR BIOL, V25, pR81, DOI 10.1016/j.cub.2014.11.013; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Watanabe M, 2015, SCIENCE, V348, DOI 10.1126/science.1261947; Watanabe M, 2012, PIGM CELL MELANOMA R, V25, P326, DOI 10.1111/j.1755-148X.2012.00984.x; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	16	16	16	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232								10.1126/science.aaa2804	http://dx.doi.org/10.1126/science.aaa2804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883351				2022-12-28	WOS:000352999000032
J	Attenello, FJ; Wen, T; Cen, SY; Ng, A; Kim-Tenser, M; Sanossian, N; Amar, AP; Mack, WJ				Attenello, Frank J.; Wen, Timothy; Cen, Steven Y.; Ng, Alvin; Kim-Tenser, May; Sanossian, Nerses; Amar, Arun P.; Mack, William J.			Incidence of "never events" among weekend admissions versus weekday admissions to US hospitals: national analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LENGTH-OF-STAY; INPATIENT SAMPLE DATABASE; PATIENT SAFETY; MORTALITY; CARE; IMPACT; COMPLICATIONS; PERFORMANCE; SERVICES; MEDICARE	OBJECTIVE To evaluate the association between weekend admission to hospital and 14 hospital acquired conditions recently considered by the Centers for Medicare and Medicaid as "never events," serious, costly, and preventable medical errors, for which resulting healthcare costs are not reimbursed. DESIGN National analysis. SETTING US Nationwide Inpatient Sample discharge database. PARTICIPANTS 351 million patients discharged from US hospitals, 2002-10. MAIN OUTCOME MEASURES Univariate rates and multivariable likelihood of hospital acquired conditions among patients admitted on weekdays versus weekends, as well as the impacts of these events on prolonged length of stay and total inpatient charges. RESULTS From 2002 to 2010, 351 170 803 patients were admitted to hospital, with 19% admitted on a weekend. Hospital acquired conditions occurred at an overall frequency of 4.1% (5.7% among weekend admissions versus 3.7% among weekday admissions). Adjusting for patient and hospital cofactors the probability of having one or more hospital acquired conditions was more than 20% higher in weekend admissions compared with weekday admissions (odds ratio 1.25, 95% confidence interval 1.24 to 1.26, P < 0.01). Hospital acquired conditions have a negative impact on both hospital charges and length of stay. At least one hospital acquired condition was associated with an 83% (1.83, 1.77 to 1.90, P < 0.01) likelihood of increased charges and 38% likelihood of prolonged length of stay (1.38, 1.36 to 1.41, P < 0.01). CONCLUSION Weekend admission to hospital is associated with an increased likelihood of hospital acquired condition, cost, and length of stay. Future protocols and staffing regulations must be tailored to the requirements of this high risk subgroup.	[Attenello, Frank J.; Amar, Arun P.; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Wen, Timothy] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA; [Cen, Steven Y.; Kim-Tenser, May; Sanossian, Nerses] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Cen, Steven Y.] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90089 USA; [Ng, Alvin] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wen, T (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.	wentimot@usc.edu						Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; Allareddy V, 2013, OR SURG OR MED OR PA, V115, P710, DOI 10.1016/j.oooo.2012.09.004; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Attenello FJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.053; Aujesky D, 2009, CIRCULATION, V119, P962, DOI 10.1161/CIRCULATIONAHA.108.824292; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Bejanyan N, 2010, CANCER-AM CANCER SOC, V116, P3614, DOI 10.1002/cncr.25086; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Blegen MA, 1998, NURS ECON, V16, P196; Brown Sarah B, 2008, Hosp Health Netw, V82, P72; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Champaneria MC, 2013, ANN PLASTIC SURG; CMS, 2014, HOSP ACQ COND HAC AC; CMS, 2014, EFF IMPR PAT SAF RES; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Czaplinski C, 1998, MED CARE, V36, P1626, DOI 10.1097/00005650-199812000-00002; Dasenbrock HH, 2012, NEUROSURGERY, V70, P586, DOI 10.1227/NEU.0b013e318232d1ee; Fakih MG, 2013, INFECT CONT HOSP EP, V34, P1048, DOI 10.1086/673149; Fargen KM, 2013, J NEUROSURG, V119, P966, DOI 10.3171/2013.5.JNS122378; Gosbee J, 2002, QUAL SAF HEALTH CARE, V11, P352, DOI 10.1136/qhc.11.4.352; Hanks N, 2014, WEST J EMERG MED, V15, P499, DOI 10.5811/westjem.2014.2.20388; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hennessey P, 2012, LARYNGOSCOPE, V122, P2199, DOI 10.1002/lary.23459; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Horst MA, 2012, AM J MED QUAL, V27, P16, DOI 10.1177/1062860611409199; Houchens R, 2001, 20032 HCUP; Joice GA, 2013, UROLOGY, V81, P527, DOI 10.1016/j.urology.2012.09.050; Kaiman J., 2014, GUARDIAN; Karsh BT, 2006, QUAL SAF HEALTH CARE, V15, pI59, DOI 10.1136/qshc.2005.015974; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Lee MK, 2013, OR SURG OR MED OR PA, V116, P147, DOI 10.1016/j.oooo.2013.02.006; Mehtsun WT, 2013, SURGERY, V153, P465, DOI 10.1016/j.surg.2012.10.005; Milstein A, 2009, NEW ENGL J MED, V360, P2388, DOI 10.1056/NEJMp0809125; Morse BC, 2010, AM SURGEON, V76, P841; Naessens JM, 2012, AM J MED QUAL, V27, P48, DOI 10.1177/1062860611413456; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Panaich SS, 2014, AM J CARDIOL, V114, P1390, DOI 10.1016/j.amjcard.2014.07.075; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; SAS, 2010, SAS GLOB FOR P; Shaheen AAM, 2009, CLIN GASTROENTEROL H, V7, P303, DOI 10.1016/j.cgh.2008.08.033; Sharp AL, 2013, AM J EMERG MED, V31, P835, DOI 10.1016/j.ajem.2013.01.006; Teufack SG, 2010, J NEUROSURG, V112, P249, DOI 10.3171/2009.7.JNS09753; Turin TC, 2009, EUR J EPIDEMIOL, V24, P93, DOI 10.1007/s10654-008-9308-5; Wen T, 2014, J NEUROSURG, V121, P580, DOI 10.3171/2014.4.JNS131253; Wen T, 2014, NEUROSURGERY, V75, P43, DOI 10.1227/NEU.0000000000000352; Wen T, 2014, J ENDOUROL, V28, P660, DOI 10.1089/end.2013.0623; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	60	61	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1460	10.1136/bmj.h1460	http://dx.doi.org/10.1136/bmj.h1460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25876878	Green Published, hybrid			2022-12-28	WOS:000353328000001
J	Xiang, AH; Wang, XH; Martinez, MP; Walthall, JC; Curry, ES; Page, K; Buchanan, TA; Coleman, KJ; Getahun, D				Xiang, Anny H.; Wang, Xinhui; Martinez, Maya P.; Walthall, Johanna C.; Curry, Edward S.; Page, Kathleen; Buchanan, Thomas A.; Coleman, Karen J.; Getahun, Darios			Association of Maternal Diabetes With Autism in Offspring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPECTRUM DISORDERS; ETHNIC DISPARITIES; GLUCOSE-TOLERANCE; RISK-FACTORS; PREGNANCY; OBESITY; ADIPOSITY; MELLITUS	IMPORTANCE Information about the association of maternal diabetes and autism spectrum disorders (ASDs) in offspring is limited, with no report on the importance of timing of exposure during gestation. OBJECTIVE To assess ASD risk associated with intrauterine exposure to preexisting type 2 diabetes and gestational diabetes mellitus (GDM) by gestational age at GDM diagnosis. DESIGN, SETTING, AND PATIENTS Retrospective longitudinal cohort study including 322 323 singleton children born in 1995-2009 at Kaiser Permanente Southern California (KPSC) hospitals. Children were tracked from birth until the first of the following: date of clinical diagnosis of ASD, last date of continuous KPSC health plan membership, death due to any cause, or December 31, 2012. Relative risks of ASD were estimated by hazard ratios (HRs) using Cox regression models adjusted for birth year. EXPOSURES Maternal preexisting type 2 diabetes (n = 6496), GDM diagnosed at 26 weeks' gestation or earlier (n = 7456) or after 26 weeks' gestation (n = 17 579), or no diabetes (n = 290 792) during the index pregnancy. MAIN OUTCOMES AND MEASURES Clinical diagnosis of ASD in offspring. RESULTS During follow-up, 3388 children were diagnosed as having ASD (115 exposed to preexisting type 2 diabetes, 130 exposed to GDM at <= 26 weeks, 180 exposed to GDM at >26 weeks, and 2963 unexposed). Unadjusted annual ASD incidences were 3.26, 3.02, 1.77, and 1.77 per 1000 among children of mothers with preexisting type 2 diabetes, GDM diagnosed at 26 weeks or earlier, GDM diagnosed after 26 weeks, and no diabetes, respectively. The birth year-adjusted HRs were 1.59(95% Cl, 1.29-1.95) for preexisting type 2 diabetes, 1.63(95% Cl, 1.35-1.97) for GDM diagnosed at 26 weeks or earlier, and 0.98 (95% Cl, 0.84-1.15) for GDM diagnosed after 26 weeks relative to no exposure. After adjustment for maternal age, parity, education, household income, race/ethnicity, history of comorbidity, and sex of the child, maternal preexisting type 2 diabetes was not significantly associated with risk of ASD in offspring (HR, 1.21; 95% Cl, 0.97-1.52), but GDM diagnosed at 26 weeks or earlier remained so (HR, 1.42; 95% Cl, 1.15-1.74). Antidiabetic medication exposure was not independently associated with ASD risk. Adjustment for a mother or older sibling with ASD in the full cohort and for maternal smoking, prepregnancy body mass index, and gestational weight gain in the subset with available data (n = 68 512) did not affect the results. CONCLUSIONS AND RELEVANCE In this large, multiethnic clinical cohort of singleton children born at 28 to 44 weeks' gestation, exposure to maternal GDM diagnosed by 26 weeks' gestation was associated with risk of ASD in offspring.	[Xiang, Anny H.; Wang, Xinhui; Martinez, Maya P.; Coleman, Karen J.; Getahun, Darios] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Walthall, Johanna C.] Kaiser Permanente So Calif, Dept Psychiat, Pasadena, CA 91101 USA; [Curry, Edward S.] Kaiser Permanente So Calif, Dept Pediat, Pasadena, CA 91101 USA; [Page, Kathleen; Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol & Diabet, Los Angeles, CA 90033 USA; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Getahun, Darios] Rutgers Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; University of Southern California; University of Southern California; Rutgers State University New Brunswick; Rutgers State University Medical Center	Xiang, AH (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Los Robles Ave,Fifth Floor, Pasadena, CA 91101 USA.	anny.h.xiang@kp.org		Xiang, Anny/0000-0003-2786-1268; Martinez, Mayra/0000-0002-6134-606X	Kaiser Permanente Southern California Direct Community Benefit Funds	Kaiser Permanente Southern California Direct Community Benefit Funds	This work was supported by Kaiser Permanente Southern California Direct Community Benefit Funds.	American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baron-Cohen S, 2000, J ROY SOC MED, V93, P521, DOI 10.1177/014107680009301007; Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10-1445; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Burstyn I, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-2; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Coleman KJ, 2015, J AUTISM DEV DISORD, V45, P1989, DOI 10.1007/s10803-015-2358-0; Committee on Practice Bulletins-obstetrics, 2013, OBSTET GYNECOL, V131, P49, DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Crume TL, 2011, J PEDIATR-US, V158, P941, DOI 10.1016/j.jpeds.2010.12.007; Davenport MH, 2013, OBSTET GYNECOL, V122, P255, DOI 10.1097/AOG.0b013e31829a3b86; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Koebnick Corinna, 2012, Perm J, V16, P37; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Page KA, 2014, J PEDIATR-US, V164, P807, DOI 10.1016/j.jpeds.2013.11.063; Reynolds LC, 2014, J PERINATOL, V34, P688, DOI 10.1038/jp.2014.80; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Suren P, 2014, PEDIATRICS, V133, pE1128, DOI 10.1542/peds.2013-3664; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; von Ehrenstein OS, 2014, EPIDEMIOLOGY, V25, P851, DOI 10.1097/EDE.0000000000000150; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Xiang AH, 2011, DIABETOLOGIA, V54, P3016, DOI 10.1007/s00125-011-2330-2; Xiang AH, 2015, DIABETOLOGIA, V58, P272, DOI 10.1007/s00125-014-3420-8; Xu GF, 2014, J AUTISM DEV DISORD, V44, P766, DOI 10.1007/s10803-013-1928-2; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161	32	200	211	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1425	1434		10.1001/jama.2015.2707	http://dx.doi.org/10.1001/jama.2015.2707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871668	Bronze			2022-12-28	WOS:000352821200017
J	Kravtsova-Ivantsiv, Y; Shomer, I; Cohen-Kaplan, V; Snijder, B; Superti-Furga, G; Gonen, H; Sommer, T; Ziv, T; Admon, A; Naroditsky, I; Jbara, M; Brik, A; Pikarsky, E; Kwon, YT; Doweck, I; Ciechanover, A				Kravtsova-Ivantsiv, Yelena; Shomer, Inna; Cohen-Kaplan, Victoria; Snijder, Berend; Superti-Furga, Giulio; Gonen, Hedva; Sommer, Thomas; Ziv, Tamar; Admon, Arie; Naroditsky, Inna; Jbara, Muhammad; Brik, Ashraf; Pikarsky, Eli; Kwon, Yong Tae; Doweck, Ilana; Ciechanover, Aaron			KPC1-Mediated Ubiquitination and Proteasomal Processing of NF-kappa B1 p105 to p50 Restricts Tumor Growth	CELL			English	Article							NF-KAPPA-B; ACTIVATION; PROTEIN; PHOSPHORYLATION; DEGRADATION; SUBUNIT; PATHWAY; GLIOBLASTOMA; SUPPRESSOR; EXPRESSION	NF-kappa B is a key transcriptional regulator involved in inflammation and cell proliferation, survival, and transformation. Several key steps in its activation are mediated by the ubiquitin (Ub) system. One uncharacterized step is limited proteasomal processing of the NF-kappa B1 precursor p105 to the p50 active subunit. Here, we identify KPC1 as the Ub ligase (E3) that binds to the ankyrin repeats domain of p105, ubiquitinates it, and mediates its processing both under basal conditions and following signaling. Overexpression of KPC1 inhibits tumor growth likely mediated via excessive generation of p50. Also, overabundance of p50 downregulates p65, suggesting that a p50-p50 homodimer may modulate transcription in place of the tumorigenic p50-p65. Transcript analysis reveals increased expression of genes associated with tumor-suppressive signals. Overall, KPC1 regulation of NF-kappa B1 processing appears to constitute an important balancing step among the stimulatory and inhibitory activities of the transcription factor in cell growth control.	[Kravtsova-Ivantsiv, Yelena; Shomer, Inna; Cohen-Kaplan, Victoria; Gonen, Hedva; Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, David & Janet Polak Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Snijder, Berend; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Ziv, Tamar; Admon, Arie] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel; [Naroditsky, Inna] Rambam Hlth Care Campus, Dept Pathol, IL-31096 Haifa, Israel; [Jbara, Muhammad; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Brik, Ashraf] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91120 Jerusalem, Israel; [Kwon, Yong Tae; Ciechanover, Aaron] Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul 110799, South Korea; [Kwon, Yong Tae; Ciechanover, Aaron] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34367 Haifa, Israel	Technion Israel Institute of Technology; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Ben Gurion University; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Seoul National University (SNU); Seoul National University (SNU); Clalit Health Services; Carmel Medical Center	Ciechanover, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, David & Janet Polak Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel.	aaroncie@tx.technion.ac.il	Ciechanover, Aaron J/C-9166-2017; Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019; Superti-Furga, Giulio/AAE-5681-2019; pikarsky, eli/GXV-7099-2022	Snijder, Berend/0000-0003-3386-6583; Doweck, Ilana/0000-0002-1065-0299; Jbara, Muhammad/0000-0002-4206-5908; pikarsky, eli/0000-0003-4186-7105; Admon, Arie/0000-0003-0504-3950; Ziv, Tamar/0000-0003-4299-7454	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF); I-CORE Program of the Planning and Budgeting Committee; ISF [1775/12]; EU Treat PolyQ Network; Nobel Laureates Invitation Program of Seoul National University; Deutsch-Israelische Projektkooperation (DIP); Program for Targeting Cancer by Modulating Protein Dynamics - Albert Sweet (Malibu, CA); Swiss National Science Foundation; Basic Science Research Programs of the National Research Foundation of Korea [NRF-2013R1A2A2A01014170]	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; ISF(Israel Science Foundation); EU Treat PolyQ Network; Nobel Laureates Invitation Program of Seoul National University; Deutsch-Israelische Projektkooperation (DIP); Program for Targeting Cancer by Modulating Protein Dynamics - Albert Sweet (Malibu, CA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Basic Science Research Programs of the National Research Foundation of Korea(National Research Foundation of Korea)	Research in the laboratory of A.C. is supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), the Israel Science Foundation (ISF), the I-CORE Program of the Planning and Budgeting Committee and the ISF (Grant1775/12), the EU Treat PolyQ Network, the Nobel Laureates Invitation Program of Seoul National University, the Deutsch-Israelische Projektkooperation (DIP), and the Program for Targeting Cancer by Modulating Protein Dynamics supported by Albert Sweet (Malibu, CA). We thank Dr. Kazuhiro Iwai (Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan) for providing us with some cDNAs. RNA-seq and mapping to the human genome was done by the Technion Genome Center. B.S. is supported by a fellowship from the Swiss National Science Foundation. Y.T.K. is supported by The Basic Science Research Programs of the National Research Foundation of Korea (NRF-2013R1A2A2A01014170). A.C. is an Israel Cancer Research Fund (ICRF) USA Professor.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Betts JC, 1996, MOL CELL BIOL, V16, P6363; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; Cohen S, 2006, BIOCHEM BIOPH RES CO, V345, P7, DOI 10.1016/j.bbrc.2006.04.036; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gao J, 2009, GLIA, V57, P989, DOI 10.1002/glia.20823; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Ivanov VN, 1997, ONCOGENE, V14, P2455, DOI 10.1038/sj.onc.1201088; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacKichan ML, 1996, J BIOL CHEM, V271, P6084, DOI 10.1074/jbc.271.11.6084; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voce D. J., 2014, ONCOGENE; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	44	72	77	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					333	347		10.1016/j.cell.2015.03.001	http://dx.doi.org/10.1016/j.cell.2015.03.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860612	Bronze			2022-12-28	WOS:000352708300025
J	Mold, A				Mold, Alex			Making British patients into consumers	LANCET			English	Editorial Material									London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Mold, A (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Hist Publ Hlth, London WC1H 9SH, England.	alex.mold@lshtm.ac.uk		Mold, Alex/0000-0001-9674-9953					0	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1286	1287		10.1016/S0140-6736(15)60672-9	http://dx.doi.org/10.1016/S0140-6736(15)60672-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25890904				2022-12-28	WOS:000352272400023
J	Sekine, Y; Zyryanova, A; Crespillo-Casado, A; Fischer, PM; Harding, HP; Ron, D				Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Fischer, Peter M.; Harding, Heather P.; Ron, David			Mutations in a translation initiation factor identify the target of a memory-enhancing compound	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; GUANINE-NUCLEOTIDE EXCHANGE; EIF2-ALPHA KINASE; PHOSPHORYLATION; GCN2; METABOLISM; INHIBITOR; INSIGHTS; EIF2B; PERK	The integrated stress response (ISR) modulates messenger RNA translation to regulate the mammalian unfolded protein response (UPR), immunity, and memory formation. A chemical ISR inhibitor, ISRIB, enhances cognitive function and modulates the UPR in vivo. To explore mechanisms involved in ISRIB action, we screened cultured mammalian cells for somatic mutations that reversed its effect on the ISR. Clustered missense mutations were found at the amino-terminal portion of the delta subunit of guanine nucleotide exchange factor (GEF) eIF2B. When reintroduced by CRISPR-Cas9 gene editing of wild-type cells, these mutations reversed both ISRIB-mediated inhibition of the ISR and its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro. Thus, ISRIB targets an interaction between eIF2 and eIF2B that lies at the core of the ISR.	[Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res CIMR, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0XY, England; [Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Harding, Heather P.; Ron, David] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0XY, England; [Fischer, Peter M.] Univ Nottingham, Div Med Chem & Struct Biol, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Cambridge; University of Cambridge; University of Nottingham	Sekine, Y (corresponding author), Univ Cambridge, Cambridge Inst Med Res CIMR, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0XY, England.	ys412@cam.ac.uk; dr360@medschl.cam.ac.uk	Sekine, Yusuke/AHI-8340-2022; Fischer, Peter/E-5657-2010	Fischer, Peter/0000-0002-5866-9271; Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Sekine, Yusuke/0000-0003-0345-1416	Wellcome Trust [084812/Z/08/Z, 100140]; Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science	Wellcome Trust(Wellcome TrustEuropean Commission); Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. Walter and C. Sidrauski (University of California, San Francisco) for their gift of ISRIB (used to confirm their observations), R. Schulte from the flow cytometery core, and R. Antrobus from the mass spectrometry core at the CIMR for their technical assistance. Supported by grants from the Wellcome Trust (Wellcome 084812/Z/08/Z and a strategic award Wellcome 100140), and by fellowships to Y.S. from the Daiichi Sankyo Foundation of Life Science and the Japan Society for the Promotion of Science for research abroad. D.R. is a Wellcome Trust Principal Research Fellow.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bogorad AM, 2014, BIOCHEMISTRY-US, V53, P3432, DOI 10.1021/bi500346u; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; DEHARO C, 1979, P NATL ACAD SCI USA, V76, P1741, DOI 10.1073/pnas.76.4.1741; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; KIMBALL SR, 1989, AM J PHYSIOL, V256, pC28, DOI 10.1152/ajpcell.1989.256.1.C28; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; RANU RS, 1979, P NATL ACAD SCI USA, V76, P1079, DOI 10.1073/pnas.76.3.1079; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Wortham NC, 2014, FASEB J, V28, P2225, DOI 10.1096/fj.13-243329; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	20	146	150	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1027	1030		10.1126/science.aaa6986	http://dx.doi.org/10.1126/science.aaa6986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25858979	Green Accepted			2022-12-28	WOS:000355276600047
J	Aaron, HJ				Aaron, Henry J.			Three Cheers for Logrolling - The Demise of the SGR	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							House Committees on Energy & Commerce and Ways & Means, 2015, SGR REP MED PROV PAY; McClellan M, 2015, MED PHYS PAYMENT REF; Park E, 2015, HATCH UPTON CHIP PRO; Riffkin Rebecca, 2014, 2014 US APPR C REM N	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					1977	1979		10.1056/NEJMp1504076	http://dx.doi.org/10.1056/NEJMp1504076			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25902381				2022-12-28	WOS:000354809300001
J	Tang, YL; Zhu, YL; Ma, XL; Borisevich, AY; Morozovska, AN; Eliseev, EA; Wang, WY; Wang, YJ; Xu, YB; Zhang, ZD; Pennycook, SJ				Tang, Y. L.; Zhu, Y. L.; Ma, X. L.; Borisevich, A. Y.; Morozovska, A. N.; Eliseev, E. A.; Wang, W. Y.; Wang, Y. J.; Xu, Y. B.; Zhang, Z. D.; Pennycook, S. J.			Observation of a periodic array of flux-closure quadrants in strained ferroelectric PbTiO3 films	SCIENCE			English	Article							ELASTIC PROPERTIES; POLARIZATION; DOMAINS; CRYSTALS; ROTATION	Nanoscale ferroelectrics are expected to exhibit various exotic domain configurations, such as the full flux-closure pattern that is well known in ferromagnetic materials. Here we observe not only the atomic morphology of the flux-closure quadrant but also a periodic array of flux closures in ferroelectric PbTiO3 films, mediated by tensile strain on a GdScO3 substrate. Using aberration-corrected scanning transmission electron microscopy, we directly visualize an alternating array of clockwise and counterclockwise flux closures, whose periodicity depends on the PbTiO3 film thickness. In the vicinity of the core, the strain is sufficient to rupture the lattice, with strain gradients up to 10(9) per meter. Engineering strain at the nanoscale may facilitate the development of nanoscale ferroelectric devices.	[Tang, Y. L.; Zhu, Y. L.; Ma, X. L.; Wang, W. Y.; Wang, Y. J.; Xu, Y. B.; Zhang, Z. D.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci SYNL, Shenyang 110016, Peoples R China; [Borisevich, A. Y.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Morozovska, A. N.] Natl Acad Sci Ukraine, Inst Phys, UA-03028 Kiev, Ukraine; [Eliseev, E. A.] Natl Acad Sci Ukraine, Inst Problems Mat Sci, UA-03142 Kiev, Ukraine; [Pennycook, S. J.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Pennycook, S. J.] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117576, Singapore	Chinese Academy of Sciences; Institute of Metal Research, CAS; United States Department of Energy (DOE); Oak Ridge National Laboratory; National Academy of Sciences Ukraine; Institute of Physics of the National Academy of Sciences of Ukraine; National Academy of Sciences Ukraine; G.S. Pisarenko Institute for Problems of Strength, National Academy of Sciences of Ukraine; University of Tennessee System; University of Tennessee Knoxville; National University of Singapore	Ma, XL (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci SYNL, Wenhua Rd 72, Shenyang 110016, Peoples R China.	xlma@imr.ac.cn	Morozovska, Anna/W-8385-2018; Xu, Yao-bin/N-5641-2016; Borisevich, Albina Y/B-1624-2009; Eliseev, Eugene A./X-3013-2018; Pennycook, Stephen/AAA-1112-2019	Morozovska, Anna/0000-0002-8505-458X; Xu, Yao-bin/0000-0002-9945-3514; Borisevich, Albina Y/0000-0002-3953-8460; Eliseev, Eugene A./0000-0001-8124-8857; Pennycook, Stephen/0000-0002-3210-6323	National Natural Science Foundation of China [51231007, 51171190]; National Basic Research Program of China [2014CB921002, 2009CB623705]; National Academy of Science of the Ukraine; U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Academy of Science of the Ukraine; U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	This work is supported by the National Natural Science Foundation of China (grants 51231007 and 51171190) and the National Basic Research Program of China (grants 2014CB921002 and 2009CB623705). A.N.M. and E.A.E. acknowledge financial support from the National Academy of Science of the Ukraine; A.Y.B. and S.J.P. thank the U.S. Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division for financial support. The authors at SYNL are grateful to B. Wu and L. X. Yang of this laboratory for their technical support on the Titan platform of the aberration-corrected scanning transmission electron microscope. Author contributions: Y.L.Z. and X.L.M. conceived the project of interfacial characterization in oxides by using aberration-corrected STEM; Y.L.T. performed the thin-film growth and TEM observations; W.Y.W. provided some of the TEM images used in the supplementary materials; Y.J.W. carried out digital analysis of the STEM data; Y.B.X. and Z.D.Z. contributed to the thin-film growth; A.N.M. and E.A.E. participated in the ferroelectric theoretical analysis based on the LGD framework; and A.Y.B. and S.J.P. contributed to STEM-HAADF imaging data analysis, particularly to the calculation of the strain-gradient components near the vertex core. All authors participated in discussion and interpretation of the data. Correspondence and requests for materials should be addressed to X.L.M.	Aguado-Puente P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177601; Anthony SM, 2009, LANGMUIR, V25, P8152, DOI 10.1021/la900393v; Balke N, 2009, NAT NANOTECHNOL, V4, P868, DOI [10.1038/nnano.2009.293, 10.1038/NNANO.2009.293]; Balke N, 2012, NAT PHYS, V8, P81, DOI 10.1038/nphys2132; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Catalan G, 2011, NAT MATER, V10, P963, DOI [10.1038/NMAT3141, 10.1038/nmat3141]; Chang LW, 2013, NANO LETT, V13, P2553, DOI 10.1021/nl400629m; Chen WJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00796; Costa GCC, 2012, J AM CERAM SOC, V95, P3254, DOI 10.1111/j.1551-2916.2012.05373.x; Gao P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3791; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Jia CL, 2011, SCIENCE, V331, P1420, DOI 10.1126/science.1200605; Kalinichev AG, 1997, J MATER RES, V12, P2623, DOI 10.1557/JMR.1997.0349; KITTEL C, 1949, REV MOD PHYS, V21, P541, DOI 10.1103/RevModPhys.21.541; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; Kornev I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196104; Lai BK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.137602; Liu Y, 2008, MAT SCI ENG A-STRUCT, V472, P269, DOI 10.1016/j.msea.2007.03.028; McGilly LJ, 2011, NANO LETT, V11, P4490, DOI 10.1021/nl2031103; McGilly LJ, 2010, NANO LETT, V10, P4200, DOI 10.1021/nl102566y; McQuaid RGP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1413; McQuaid RGP, 2014, NANO LETT, V14, P4230, DOI 10.1021/nl5006788; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Naumov I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077603; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; PERTSEV NA, 1995, J APPL PHYS, V78, P6170, DOI 10.1063/1.360561; ROITBURD AL, 1976, PHYS STATUS SOLIDI A, V37, P329, DOI 10.1002/pssa.2210370141; Romming N, 2013, SCIENCE, V341, P636, DOI 10.1126/science.1240573; Schilling A, 2009, NANO LETT, V9, P3359, DOI 10.1021/nl901661a; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Shinjo T, 2000, SCIENCE, V289, P930, DOI 10.1126/science.289.5481.930; SROLOVITZ DJ, 1986, PHYS REV B, V34, P1815, DOI 10.1103/PhysRevB.34.1815; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; TAGANTSEV AK, 1991, PHASE TRANSIT, V35, P119, DOI 10.1080/01411599108213201; Tagantsev AK, 2010, DOMAINS IN FERROIC CRYSTALS AND THIN FILMS, P1, DOI 10.1007/978-1-4419-1417-0; Tang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04115; Yu DP, 2014, MRS BULL, V39, P157, DOI 10.1557/mrs.2014.6	40	323	335	20	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					547	551		10.1126/science.1259869	http://dx.doi.org/10.1126/science.1259869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25883317	Green Submitted			2022-12-28	WOS:000353778100035
J	Chang, RB; Strochlic, DE; Williams, EK; Umans, BD; Liberles, SD				Chang, Rui B.; Strochlic, David E.; Williams, Erika K.; Umans, Benjamin D.; Liberles, Stephen D.			Vagal Sensory Neuron Subtypes that Differentially Control Breathing	CELL			English	Article							CHEMOSENSORY RECEPTORS; RESPIRATORY GROUPS; NERVE-STIMULATION; AFFERENT NERVES; VAGUS NERVE; C-FIBERS; CAT; PULMONARY; MEDULLA; MOUSE	Breathing is essential for survival and under precise neural control. The vagus nerve is a major conduit between lung and brain required for normal respiration. Here, we identify two populations of mouse vagus nerve afferents (P2ry1, Npy2r), each a few hundred neurons, that exert powerful and opposing effects on breathing. Genetically guided anatomical mapping revealed that these neurons densely innervate the lung and send long-range projections to different brainstem targets. Npy2r neurons are largely slow-conducting C fibers, while P2ry1 neurons are largely fast-conducting A fibers that contact pulmonary endocrine cells (neuroepithelial bodies). Optogenetic stimulation of P2ry1 neurons acutely silences respiration, trapping animals in exhalation, while stimulating Npy2r neurons causes rapid, shallow breathing. Activating P2ry1 neurons did not impact heart rate or gastric pressure, other autonomic functions under vagal control. Thus, the vagus nerve contains intermingled sensory neurons constituting genetically definable labeled lines with different anatomical connections and physiological roles.	[Chang, Rui B.; Strochlic, David E.; Williams, Erika K.; Umans, Benjamin D.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Liberles, SD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	stephen_liberles@hms.harvard.edu		Liberles, Stephen/0000-0002-2177-9741; Umans, Benjamin/0000-0002-8209-9731	NSF; F30 NIH training grant; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); F30 NIH training grant; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bradford Lowell for providing Vglut2-ires-Cre and Lox-L10-GFP mice and for advice on AAV infection, Edward Fox and Jessica Biddinger for technical advice related to nodose/jugular complex injections, Wayne Silver for technical advice on whole nerve electrophysiology, Bernardo Sabatini and Ian Oldenburg for advice on channelrhodopsin studies, Jonathan Tilliss for help with illustrations, and the Nikon Imaging Center at Harvard Medical Center for assistance with microscopy. Genetically modified mice were generated by the Boston Nutrition Obesity Research Center/Boston Area Diabetes Endocrinology Research Center Transgenic Core. We thank Clifford Woolf, Susan Dymecki, and Clifford Saper for valuable comments on the manuscript. Support was from a NSF pre-doctoral fellowship (D.E.S.), an F30 NIH training grant (E.K.W.), and the Harvard-MIT Joint Research Grants Program in Basic Neuroscience (S.D.L.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Andresen MC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00191; Bailey TW, 2006, J NEUROSCI, V26, P11893, DOI 10.1523/JNEUROSCI.2044-06.2006; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Carr MJ, 2003, RESPIROLOGY, V8, P291, DOI 10.1046/j.1440-1843.2003.00473.x; COLERIDGE HM, 1983, J PHYSIOL-LONDON, V340, P415, DOI 10.1113/jphysiol.1983.sp014770; Coleridge JCG, 2011, COMPR PHYSIOL, P395; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Ferrero DM, 2013, NATURE, V502, P368, DOI 10.1038/nature12579; Foley JO, 1937, J COMP NEUROL, V67, P49, DOI 10.1002/cne.900670104; Fox EA, 2001, J NEUROSCI, V21, P8602, DOI 10.1523/JNEUROSCI.21-21-08602.2001; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hellekant G, 1998, PHYSIOL BEHAV, V65, P191, DOI 10.1016/S0031-9384(97)00532-5; KALIA M, 1980, J COMP NEUROL, V193, P467, DOI 10.1002/cne.901930211; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; KUBIN L, 1991, J PHYSIOL-LONDON, V435, P207, DOI 10.1113/jphysiol.1991.sp018506; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; PAINTAL AS, 1973, PHYSIOL REV, V53, P159, DOI 10.1152/physrev.1973.53.1.159; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; SAETHER K, 1987, BRAIN RES, V419, P87, DOI 10.1016/0006-8993(87)90571-3; Schachter SC, 1998, EPILEPSIA, V39, P677, DOI 10.1111/j.1528-1157.1998.tb01151.x; Schelegle ES, 2001, RESP PHYSIOL, V125, P17, DOI 10.1016/S0034-5687(00)00202-4; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; SPECK DF, 1982, J NEUROSCI, V2, P744; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Widdicombe J, 2001, RESP PHYSIOL, V125, P3, DOI 10.1016/S0034-5687(00)00201-2; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yu J, 2007, RESP PHYSIOL NEUROBI, V156, P116, DOI 10.1016/j.resp.2006.11.005	44	196	198	4	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					622	633		10.1016/j.cell.2015.03.022	http://dx.doi.org/10.1016/j.cell.2015.03.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892222	Bronze, Green Accepted			2022-12-28	WOS:000353553600020
J	Diogo, R; Kelly, RG; Christiaen, L; Levine, M; Ziermann, JM; Molnar, JL; Noden, DM; Tzahor, E				Diogo, Rui; Kelly, Robert G.; Christiaen, Lionel; Levine, Michael; Ziermann, Janine M.; Molnar, Julia L.; Noden, Drew M.; Tzahor, Eldad			A new heart for a new head in vertebrate cardiopharyngeal evolution	NATURE			English	Review							CRANIAL MUSCLE DEVELOPMENT; LATERAL PLATE MESODERM; NEURAL CREST CELLS; COMPARATIVE ANATOMY; DEVELOPMENTAL EXPRESSION; MOLECULAR EVIDENCE; MITOCHONDRIAL-DNA; PROGENITOR CELLS; GENE-EXPRESSION; SIMPLE CHORDATE	It has been more than 30 years since the publication of the new head hypothesis, which proposed that the vertebrate head is an evolutionary novelty resulting from the emergence of neural crest and cranial placodes. Neural crest generates the skull and associated connective tissues, whereas placodes produce sensory organs. However, neither crest nor placodes produce head muscles, which are a crucial component of the complex vertebrate head. We discuss emerging evidence for a surprising link between the evolution of head muscles and chambered hearts - both systems arise from a common pool of mesoderm progenitor cells within the cardiopharyngeal field of vertebrate embryos. We consider the origin of this field in non-vertebrate chordates and its evolution in vertebrates.	[Diogo, Rui; Ziermann, Janine M.; Molnar, Julia L.] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Kelly, Robert G.] Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, UMR 7288, F-13288 Marseille, France; [Christiaen, Lionel] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Noden, Drew M.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Tzahor, Eldad] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel	Howard University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; New York University; University of California System; University of California Berkeley; Cornell University; Weizmann Institute of Science	Diogo, R (corresponding author), Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA.	rui.diogo@howard.edu; Robert.Kelly@univ-amu.fr; lc121@nyu.edu; eldad.tzahor@weizmann.ac.il	TZAHOR, ELDAD/AAD-9886-2021; Kelly, Robert G/F-2523-2013; Ziermann, Janine M./C-7155-2014; Molnar, Julia/AAR-3371-2021	Kelly, Robert G/0000-0003-4357-0073; Ziermann, Janine M./0000-0002-1264-9240; Molnar, Julia/0000-0003-1455-0487; Diogo, Rui/0000-0002-9008-1910; Levine, Michael/0000-0001-7629-0081; Christiaen, Lionel/0000-0001-5930-5667	Howard University (HU) College of Medicine; Chair of HU Department of Anatomy; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) [R01GM096032]; NIH/National Heart, Lung and Blood Instiute (NHLBI) [R01HL108643]; European Research Council; Israel Science Foundation; NIH [NS076542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	Howard University (HU) College of Medicine; Chair of HU Department of Anatomy; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Heart, Lung and Blood Instiute (NHLBI); European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Miyashita and F. Razy-Krajka for their detailed reviews of the manuscript. We are thankful to the Dean of Howard University (HU) College of Medicine, M. Johnson, and the Chair of HU Department of Anatomy, D. Orlic, for helping to organize, financially and logistically, the First Evo-Devo Meeting On Heart and Head Muscles at HU (May, 2014) that led to the publication of this Review. We also thank the other participants at the workshop: A. Kahana, P. Okkema, A. Vincent, T. Hirasawa, S. Tajbakhsh, S. Dietrich and R. Knight. L.C. is supported by National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) grant R01GM096032 and NIH/National Heart, Lung and Blood Instiute (NHLBI) grant R01HL108643, E.T. by the European Research Council and Israel Science Foundation, R. D. and J.Z. by HU College of Medicine, R.G.K. by Inserm, the Agence Nationale pour la Recherche, Association Francaise contre les Myopathies and Fondation pour la Recherche Medicale, and M.L. by NIH grant NS076542.	Abdala V, 2010, J ANAT, V217, P536, DOI 10.1111/j.1469-7580.2010.01278.x; Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Adachi N, 2012, EVOL DEV, V14, P257, DOI 10.1111/j.1525-142X.2012.00543.x; Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Belgacem MR, 2011, GENE EXPR PATTERNS, V11, P239, DOI 10.1016/j.gep.2010.12.006; Bothe I, 2006, DEV DYNAM, V235, P2845, DOI 10.1002/dvdy.20903; Boukhatmi H, 2014, DEVELOPMENT, V141, P3761, DOI 10.1242/dev.111005; Butler AB, 2006, J EXP ZOOL PART B, V306B, P419, DOI 10.1002/jez.b.21108; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Castellanos R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095151; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Christiaen L, 2005, DEV BIOL, V277, P557, DOI 10.1016/j.ydbio.2004.10.008; Christiaen L, 2002, GENE, V287, P107, DOI 10.1016/S0378-1119(01)00865-4; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Christiaen L, 2010, DEV BIOL, V340, P179, DOI 10.1016/j.ydbio.2009.11.006; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; Delarbre C, 2000, MOL BIOL EVOL, V17, P519, DOI 10.1093/oxfordjournals.molbev.a026332; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Diogo R, 2008, J ANAT, V213, P391, DOI 10.1111/j.1469-7580.2008.00953.x; Diogo R., 2012, COMP ANATOMY PHYLOGE; Diogo R, 2010, MUSCLES VERTEBRATES; Diogo R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-24; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; Enriquez J, 2012, DEV BIOL, V363, P27, DOI 10.1016/j.ydbio.2011.12.018; GANS C, 1989, BIOL REV, V64, P221, DOI 10.1111/j.1469-185X.1989.tb00471.x; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Gegenbaur C., 1878, ELEMENTS COMP ANATOM; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Gillis JA, 2009, P NATL ACAD SCI USA, V106, P5720, DOI 10.1073/pnas.0810959106; GOLDSCHMIDT R, 1905, WISS ERGEB DTSCH TIE, P1; Graham A, 2013, J ANAT, V222, P32, DOI 10.1111/j.1469-7580.2012.01506.x; Grifone R, 2007, TRENDS GENET, V23, P365, DOI 10.1016/j.tig.2007.05.002; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Harafuji N, 2002, P NATL ACAD SCI USA, V99, P6802, DOI 10.1073/pnas.052024999; Harel I, 2012, P NATL ACAD SCI USA, V109, P18839, DOI 10.1073/pnas.1208690109; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Haun C, 1998, P NATL ACAD SCI USA, V95, P5072, DOI 10.1073/pnas.95.9.5072; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Heude E, 2010, P NATL ACAD SCI USA, V107, P11441, DOI 10.1073/pnas.1001582107; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Holland LZ, 1999, EVOL DEV, V1, P153, DOI 10.1046/j.1525-142x.1999.99019.x; Holland ND, 2003, DEV BIOL, V255, P128, DOI 10.1016/S0012-1606(02)00050-7; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jackman WR, 2000, DEV BIOL, V220, P16, DOI 10.1006/dbio.2000.9630; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Kong P, 2014, HUM MOL GENET, V23, P4215, DOI 10.1093/hmg/ddu140; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuratani S, 2013, SCIENCE, V341, P139, DOI 10.1126/science.1241451; Kuratani S, 2013, J ANAT, V222, P41, DOI 10.1111/j.1469-7580.2012.01505.x; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Kusakabe R, 2011, DEV BIOL, V350, P217, DOI 10.1016/j.ydbio.2010.10.029; Lacalli TC, 1998, PHILOS T ROY SOC B, V353, P1943, DOI 10.1098/rstb.1998.0347; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Lescroart F, 2012, CIRC RES, V111, P1313, DOI 10.1161/CIRCRESAHA.112.271064; Lescroart Fabienne, 2012, Results Probl Cell Differ, V55, P263, DOI 10.1007/978-3-642-30406-4_15; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Mahadevan NR, 2004, DEV GENES EVOL, V214, P559, DOI 10.1007/s00427-004-0433-1; Mallatt J, 2008, ZOOL SCI, V25, P990, DOI 10.2108/zsj.25.990; Mann T, 2009, DEVELOPMENT, V136, P317, DOI 10.1242/dev.022533; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Mazet F, 2005, J EXP ZOOL PART B, V304B, P340, DOI 10.1002/jezmde.b.21054; Mazet F, 2004, GENESIS, V38, P58, DOI 10.1002/gene.20006; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mesbah K, 2012, HUM MOL GENET, V21, P1217, DOI 10.1093/hmg/ddr553; Minchin JEN, 2013, DEVELOPMENT, V140, P2972, DOI 10.1242/dev.090050; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Noden DM, 2006, ADV EXP MED BIOL, V589, P1; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Northcutt RG, 2005, J EXP ZOOL PART B, V304B, P274, DOI 10.1002/jez.b.21063; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Onimaru K, 2011, DEV BIOL, V359, P124, DOI 10.1016/j.ydbio.2011.08.003; Patthey C, 2014, DEV BIOL, V389, P82, DOI 10.1016/j.ydbio.2014.01.017; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ragkousi K, 2011, DEV BIOL, V352, P154, DOI 10.1016/j.ydbio.2011.01.007; Razy-Krajka F, 2014, DEV CELL, V29, P263, DOI 10.1016/j.devcel.2014.04.001; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Romer AS, 1977, VERTEBRATE BODY, V5th; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Sauka-Spengler Tatjana, 2002, Gene Expression Patterns, V2, P99, DOI 10.1016/S0925-4773(02)00301-5; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Schaub C, 2013, DEV BIOL, V376, P245, DOI 10.1016/j.ydbio.2013.01.022; Schaub C, 2012, DEVELOPMENT, V139, P1001, DOI 10.1242/dev.073890; Schubert M, 2003, GENE EXPR PATTERNS, V3, P199, DOI 10.1016/S1567-133X(02)00099-6; Shearman RM, 2009, J EXP ZOOL PART B, V312B, P603, DOI 10.1002/jez.b.21246; Simoes-Costa MS, 2005, DEV BIOL, V277, P1, DOI 10.1016/j.ydbio.2004.09.026; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Theis S, 2010, DEVELOPMENT, V137, P2961, DOI 10.1242/dev.049726; Tiecke E, 2007, DEV GENES EVOL, V217, P691, DOI 10.1007/s00427-007-0181-0; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Tolkin T, 2012, CURR TOP DEV BIOL, V100, P107, DOI 10.1016/B978-0-12-387786-4.00011-7; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Tzahor E, 2011, CARDIOVASC RES, V91, P196, DOI 10.1093/cvr/cvr116; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035; VALENTINE JW, 2004, ORIGIN PHYLA; Wachtler F, 1986, Bibl Anat, P24; Wagner E, 2012, DEVELOPMENT, V139, P2351, DOI 10.1242/dev.078485; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001725; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Willey A., 1894, AMPHIOXUS ANCESTERY; Yasui K, 2014, J MORPHOL, V275, P465, DOI 10.1002/jmor.20228; Ziermann JM, 2014, ZOOL J LINN SOC-LOND, V172, P771, DOI 10.1111/zoj.12186; Ziermann JM, 2014, J MORPHOL, V275, P398, DOI 10.1002/jmor.20223; Ziermann JM, 2013, ANAT REC, V296, P1031, DOI 10.1002/ar.22713	125	140	142	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					466	473		10.1038/nature14435	http://dx.doi.org/10.1038/nature14435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903628	Green Accepted			2022-12-28	WOS:000353334500030
J	Liu, RC				Liu, Robert C.			SENSORY SYSTEMS The yin and yang of cortical oxytocin	NATURE			English	Editorial Material							PLASTICITY; EXPERIENCE; BEHAVIOR	Female mice can learn to respond to distress calls from young mice - an ability that has now been found to be improved through signalling by the hormone oxytocin in the left auditory cortex of the brain.	Emory Univ, Silvio O Conte Ctr Oxytocin & Social Cognit, Dept Biol, Atlanta, GA 30322 USA	Emory University	Liu, RC (corresponding author), Emory Univ, Silvio O Conte Ctr Oxytocin & Social Cognit, Dept Biol, Atlanta, GA 30322 USA.	robert.liu@emory.edu		Liu, Robert/0000-0003-2450-8194	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008343] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC008343] Funding Source: Medline; NIMH NIH HHS [P50 MH100023] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banerjee SB, 2013, FRONT NEUROENDOCRIN, V34, P300, DOI 10.1016/j.yfrne.2013.07.008; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Numan M., 2003, HORM BR BEHAV; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723	14	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					444	445		10.1038/nature14386	http://dx.doi.org/10.1038/nature14386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25874677	Green Accepted			2022-12-28	WOS:000353334500025
J	Yutzey, KE				Yutzey, Katherine E.			REGENERATIVE BIOLOGY Neuregulin 1 makes heart muscle	NATURE			English	Editorial Material							RENEWAL	Three studies reveal that augmentation of a signalling pathway involving the growth factor neuregulin 1 and its receptor protein ERBB2 can promote the generation of muscle cells in zebrafish, mice and infant heart tissue.	Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Yutzey, Katherine/0000-0002-1444-7124				Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Cote GM, 2012, NEW ENGL J MED, V367, P2150, DOI 10.1056/NEJMcibr1203156; D'Uva G., 2015, NATURE CELL BIOL; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reuter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115871; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15	10	19	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					445	446		10.1038/520445a	http://dx.doi.org/10.1038/520445a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903623				2022-12-28	WOS:000353334500026
J	DeLoughery, T				DeLoughery, Thomas			Review: Apixaban reduces bleeding and mortality compared with vitamin K antagonists	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; METAANALYSIS; WARFARIN		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Chai-Adisaksopha C, 2014, BLOOD, V124, P2450, DOI 10.1182/blood-2014-07-590323; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC2	10.7326/ACPJC-2015-162-8-002	http://dx.doi.org/10.7326/ACPJC-2015-162-8-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894047				2022-12-28	WOS:000353244300001
J	Wohlers, A; Wood, BJ				Wohlers, Anke; Wood, Bernard J.			A Mercury-like component of early Earth yields uranium in the core and high mantle Nd-142	NATURE			English	Article							SILICATE LIQUIDS; PLANETARY CORES; SOLAR-SYSTEM; POTASSIUM; EVOLUTION; SULFIDE; LEAD; MESSENGER; MODEL	Recent Nd-142 isotope data indicate that the silicate Earth (its crust plus the mantle) has a samarium to neodymium elemental ratio (Sm/Nd) that is greater than that of the supposed chondritic building blocks of the planet. This elevated Sm/Nd has been ascribed either to a 'hidden' reservoir in the Earth(1,2) or to loss of an early-formed terrestrial crust by impact ablation(3). Since removal of crust by ablation would also remove the heatproducing elements potassium, uranium and thorium such removal would make it extremely difficult to balance terrestrial heat production with the observed heat flow(3). In the 'hidden' reservoir alternative, a complementary low-Sm/Nd layer is usually considered to reside unobserved in the silicate lower mantle. We have previously shown, however, that the core is a likely reservoir for some lithophile elements such as niobium(4). We therefore address the question of whether core formation could have fractionated Nd from Sm and also acted as a sink for heat-producing elements. We show here that addition of a reduced Mercury-like body (or, alternatively, an enstatitechondrite-like body) rich in sulfur to the early Earth would generate a superchondritic Sm/Nd in the mantle and an Nd-142/Nd-144 anomaly of approximately +14 parts per million relative to chondrite. In addition, the sulfur-rich core would partition uranium strongly and thorium slightly, supplying a substantial part of the 'missing' heat source for the geodynamo.	[Wohlers, Anke; Wood, Bernard J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Oxford	Wohlers, A (corresponding author), Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England.	anke.wohlers@earth.ox.ac.uk; berniew@earth.ox.ac.uk	Wood, Bernard J/E-8173-2010	Wood, Bernard J/0000-0003-1038-7301	European Research Council [267764]; Natural Environment Research Council [NE/M000370/1, NE/F018266/1] Funding Source: researchfish; NERC [NE/M000370/1, NE/F018266/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge support from the European Research Council grant number 267764. We thank J. Wade for his advice and comments. A. Hofmann and T. Elliott provided advice and suggestions about Th/U of silicate Earth.	ALLEGRE CJ, 1986, CHEM GEOL, V56, P219, DOI 10.1016/0009-2541(86)90005-7; Blichert-Toft J, 2010, EARTH PLANET SC LETT, V300, P152, DOI 10.1016/j.epsl.2010.10.001; BLUNDY J, 1994, NATURE, V372, P452, DOI 10.1038/372452a0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Campbell IH, 2012, NATURE, V483, P553, DOI 10.1038/nature10901; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; Elliott T, 1999, EARTH PLANET SC LETT, V169, P129, DOI 10.1016/S0012-821X(99)00077-1; Gannoun A, 2011, GEOCHIM COSMOCHIM AC, V75, P3269, DOI 10.1016/j.gca.2011.03.017; Gessmann CK, 2002, EARTH PLANET SC LETT, V200, P63, DOI 10.1016/S0012-821X(02)00593-9; Hofmann A. W., 2011, AM GEOPH UN FALL M; Kinoshita N, 2012, SCIENCE, V335, P1614, DOI 10.1126/science.1215510; Kiseeva ES, 2013, EARTH PLANET SC LETT, V383, P68, DOI 10.1016/j.epsl.2013.09.034; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; Morard G, 2013, EARTH PLANET SC LETT, V373, P169, DOI 10.1016/j.epsl.2013.04.040; MURRELL MT, 1986, J GEOPHYS RES-SOLID, V91, P8126, DOI 10.1029/JB091iB08p08126; Murthy VM, 2003, NATURE, V423, P163, DOI 10.1038/nature01560; Nimmo F, 2004, GEOPHYS J INT, V156, P363, DOI 10.1111/j.1365-246X.2003.02157.x; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; PRESNALL DC, 1978, CONTRIB MINERAL PETR, V66, P203, DOI 10.1007/BF00372159; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Seagle CT, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004091; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; Sprung P, 2013, EARTH PLANET SC LETT, V380, P77, DOI 10.1016/j.epsl.2013.08.018; TATSUMOTO M, 1978, EARTH PLANET SC LETT, V38, P63, DOI 10.1016/0012-821X(78)90126-7; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; Wheeler KT, 2006, GEOCHIM COSMOCHIM AC, V70, P1537, DOI 10.1016/j.gca.2005.11.023; [No title captured]	31	55	55	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					337	+		10.1038/nature14350	http://dx.doi.org/10.1038/nature14350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877203	Green Accepted			2022-12-28	WOS:000352974200036
J	Upton, KR; Gerhardt, DJ; Jesuadian, JS; Richardson, SR; Sanchez-Luque, FJ; Bodea, GO; Ewing, AD; Salvador-Palomeque, C; van der Knaap, MS; Brennan, PM; Vanderver, A; Faulkner, GJ				Upton, Kyle R.; Gerhardt, Daniel J.; Jesuadian, J. Samuel; Richardson, Sandra R.; Sanchez-Luque, Francisco J.; Bodea, Gabriela O.; Ewing, Adam D.; Salvador-Palomeque, Carmen; van der Knaap, Marjo S.; Brennan, Paul M.; Vanderver, Adeline; Faulkner, Geoffrey J.			Ubiquitous L1 Mosaicism in Hippocampal Neurons	CELL			English	Article							SOMATIC MOSAICISM; HUMAN BRAIN; LINE-1 RETROTRANSPOSITION; HUMAN GENOMES; STEM-CELLS; ELEMENTS; HUMANS; ATLAS; TRANSCRIPTION; TRANSDUCTION	Somatic LINE-1 (L1) retrotransposition during neurogenesis is a potential source of genotypic variation among neurons. As a neurogenic niche, the hippocampus supports pronounced L1 activity. However, the basal parameters and biological impact of L1-driven mosaicism remain unclear. Here, we performed single-cell retrotransposon capture sequencing (RC-seq) on individual human hippocampal neurons and glia, as well as cortical neurons. An estimated 13.7 somatic L1 insertions occurred per hippocampal neuron and carried the sequence hallmarks of target-primed reverse transcription. Notably, hippocampal neuron L1 insertions were specifically enriched in transcribed neuronal stem cell enhancers and hippocampus genes, increasing their probability of functional relevance. In addition, bias against intronic L1 insertions sense oriented relative to their host gene was observed, perhaps indicating moderate selection against this configuration in vivo. These experiments demonstrate pervasive L1 mosaicism at genomic loci expressed in hippocampal neurons.	[Upton, Kyle R.; Gerhardt, Daniel J.; Jesuadian, J. Samuel; Richardson, Sandra R.; Sanchez-Luque, Francisco J.; Bodea, Gabriela O.; Ewing, Adam D.; Salvador-Palomeque, Carmen; Faulkner, Geoffrey J.] Univ Queensland, Mater Res Inst, Woolloongabba, Qld 4102, Australia; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Brennan, Paul M.] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Vanderver, Adeline] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Faulkner, Geoffrey J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	Mater Research; University of Queensland; Vrije Universiteit Amsterdam; University of Edinburgh; Children's National Health System; University of Queensland	Faulkner, GJ (corresponding author), Univ Queensland, Mater Res Inst, TRI Bldg, Woolloongabba, Qld 4102, Australia.	faulknergj@gmail.com	Richardson, Sandra/O-8908-2016; Vanderver, Adeline/CAG-5072-2022; Bodea, Gabriela Oana/I-6011-2014; Upton, Kyle R./M-4772-2014; Sanchez-Luque, Francisco J/B-5682-2017; Ewing, Adam D/M-3164-2014; Faulkner, Geoffrey J/M-3168-2014	Richardson, Sandra/0000-0001-5706-3393; Bodea, Gabriela Oana/0000-0002-9670-5237; Upton, Kyle R./0000-0003-1101-8081; Sanchez-Luque, Francisco J/0000-0003-1138-6124; Ewing, Adam D/0000-0002-4544-994X; Faulkner, Geoffrey J/0000-0001-5769-4494; van der Knaap, Marjo/0000-0001-8912-0954; Brennan, Paul/0000-0002-7347-830X	NHMRC [GNT1045237, GNT1042449, GNT1045991, GNT1067983, GNT1068789]; EU FP7 under MODHEP consortium [259743]; Alfonso Martin Escudero Foundation; Wellcome Trust Clinical Fellowship [090386/Z/09/Z]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EU FP7 under MODHEP consortium; Alfonso Martin Escudero Foundation; Wellcome Trust Clinical Fellowship(Wellcome Trust)	We thank Haig Kazazian and Ryan Lister for critical reading of the manuscript. We also thank Marianna Bugiani for her work in the autopsy of AGS-1. G.J.F. acknowledges the support of an NHMRC Career Development Fellowship (GNT1045237), NHMRC Project Grants (GNT1042449, GNT1045991, GNT1067983 and GNT1068789), and the EU FP7 under grant agreement No. 259743 underpinning the MODHEP consortium. F.J.S-L. was supported by the Alfonso Martin Escudero Foundation. P.M.B. was supported by a Wellcome Trust Clinical Fellowship (090386/Z/09/Z).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macfarlane CM, 2013, HUM MUTAT, V34, P974, DOI 10.1002/humu.22327; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Richardson SR, 2014, ANNU REV GENET, V48, P1, DOI 10.1146/annurev-genet-120213-092412; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019	40	210	216	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					228	239		10.1016/j.cell.2015.03.026	http://dx.doi.org/10.1016/j.cell.2015.03.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860606	Green Published, hybrid			2022-12-28	WOS:000352708300017
J	Moler, FW; Silverstein, FS; Holubkov, R; Slomine, BS; Christensen, JR; Nadkarni, VM; Meert, KL; Clark, AE; Browning, B; Pemberton, VL; Page, K; Shankaran, S; Hutchison, JS; Newth, CJL; Bennett, KS; Berger, JT; Topjian, A; Pineda, JA; Koch, JD; Schleien, CL; Dalton, HJ; Ofori-Amanfo, G; Goodman, DM; Fink, EL; McQuillen, P; Zimmerman, JJ; Thomas, NJ; van der Jagt, EW; Porter, MB; Meyer, MT; Harrison, R; Pham, N; Schwarz, AJ; Nowak, JE; Alten, J; Wheeler, DS; Bhalala, US; Lidsky, K; Lloyd, E; Mathur, M; Shah, S; Wu, T; Theodorou, AA; Sanders, RC; Dean, JM				Moler, Frank W.; Silverstein, Faye S.; Holubkov, Richard; Slomine, Beth S.; Christensen, James R.; Nadkarni, Vinay M.; Meert, Kathleen L.; Clark, Amy E.; Browning, Brittan; Pemberton, Victoria L.; Page, Kent; Shankaran, Seetha; Hutchison, Jamie S.; Newth, Christopher J. L.; Bennett, Kimberly S.; Berger, John T.; Topjian, Alexis; Pineda, Jose A.; Koch, Joshua D.; Schleien, Charles L.; Dalton, Heidi J.; Ofori-Amanfo, George; Goodman, Denise M.; Fink, Ericka L.; McQuillen, Patrick; Zimmerman, Jerry J.; Thomas, Neal J.; van der Jagt, Elise W.; Porter, Melissa B.; Meyer, Michael T.; Harrison, Rick; Nga Pham; Schwarz, Adam J.; Nowak, Jeffrey E.; Alten, Jeffrey; Wheeler, Derek S.; Bhalala, Utpal S.; Lidsky, Karen; Lloyd, Eric; Mathur, Mudit; Shah, Samir; Wu, Theodore; Theodorou, Andreas A.; Sanders, Ronald C., Jr.; Dean, J. Michael		THAPCA Trial Investigators	Therapeutic Hypothermia after Out-of-Hospital Cardiac Arrest in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AMERICAN-HEART-ASSOCIATION; TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; CARE; CARDIOPULMONARY; RESUSCITATION; TEMPERATURE; EXPERIENCE; EPIDEMIOLOGY	BACKGROUND Therapeutic hypothermia is recommended for comatose adults after witnessed out-of-hospital cardiac arrest, but data about this intervention in children are limited. METHODS We conducted this trial of two targeted temperature interventions at 38 children's hospitals involving children who remained unconscious after out-of-hospital cardiac arrest. Within 6 hours after the return of circulation, comatose patients who were older than 2 days and younger than 18 years of age were randomly assigned to therapeutic hypothermia (target temperature, 33.0 degrees C) or therapeutic normothermia (target temperature, 36.8 degrees C). The primary efficacy outcome, survival at 12 months after cardiac arrest with a Vineland Adaptive Behavior Scales, second edition (VABS-II), score of 70 or higher (on a scale from 20 to 160, with higher scores indicating better function), was evaluated among patients with a VABS-II score of at least 70 before cardiac arrest. RESULTS A total of 295 patients underwent randomization. Among the 260 patients with data that could be evaluated and who had a VABS-II score of at least 70 before cardiac arrest, there was no significant difference in the primary outcome between the hypothermia group and the normothermia group (20% vs. 12%; relative likelihood, 1.54; 95% confidence interval [CI], 0.86 to 2.76; P=0.14). Among all the patients with data that could be evaluated, the change in the VABS-II score from baseline to 12 months was not significantly different (P=0.13) and 1-year survival was similar (38% in the hypothermia group vs. 29% in the normothermia group; relative likelihood, 1.29; 95% CI, 0.93 to 1.79; P=0.13). The groups had similar incidences of infection and serious arrhythmias, as well as similar use of blood products and 28-day mortality. CONCLUSIONS In comatose children who survived out-of-hospital cardiac arrest, therapeutic hypothermia, as compared with therapeutic normothermia, did not confer a significant benefit in survival with a good functional outcome at 1 year.	[Moler, Frank W.; Silverstein, Faye S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Meert, Kathleen L.; Shankaran, Seetha] Wayne State Univ, Detroit, MI USA; [Holubkov, Richard; Clark, Amy E.; Browning, Brittan; Page, Kent; Bennett, Kimberly S.; Dean, J. Michael] Univ Utah, Salt Lake City, UT USA; [Slomine, Beth S.; Christensen, James R.] Kennedy Krieger Inst, Baltimore, MD USA; [Slomine, Beth S.; Christensen, James R.] Johns Hopkins Univ, Baltimore, MD USA; [Bhalala, Utpal S.] Johns Hopkins Childrens Ctr, Baltimore, MD USA; [Pemberton, Victoria L.] NHLBI, Bethesda, MD 20892 USA; [Nadkarni, Vinay M.; Topjian, Alexis] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Fink, Ericka L.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Hutchison, Jamie S.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Newth, Christopher J. L.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Harrison, Rick] Mattel Childrens Hosp UCLA, Los Angeles, CA USA; [McQuillen, Patrick] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Schwarz, Adam J.] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Mathur, Mudit] Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA; [Berger, John T.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Pineda, Jose A.] Washington Univ, St Louis, MO 63130 USA; [Koch, Joshua D.] Childrens Med Ctr Dallas, Dallas, TX USA; [Koch, Joshua D.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Wu, Theodore] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Schleien, Charles L.] Columbia Univ, Med Ctr, New York Presbyterian Morgan Stanley Childrens Ho, New York, NY USA; [van der Jagt, Elise W.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA; [Dalton, Heidi J.] Phoenix Childrens Hosp, Phoenix, AZ USA; [Theodorou, Andreas A.] Diamond Childrens Med Ctr, Tucson, AZ USA; [Ofori-Amanfo, George] Duke Childrens Hosp & Hlth Ctr, Durham, NC USA; [Goodman, Denise M.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Zimmerman, Jerry J.] Seattle Childrens Hosp, Seattle, WA USA; [Porter, Melissa B.] Univ Louisville, Kosair Childrens Hosp, Louisville, KY 40292 USA; [Meyer, Michael T.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Nga Pham] Childrens Healthcare Atlanta, Atlanta, GA USA; [Nowak, Jeffrey E.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Alten, Jeffrey] Childrens Alabama, Birmingham, AL USA; [Wheeler, Derek S.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Lidsky, Karen] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Lloyd, Eric] Nationwide Childrens Hosp, Columbus, OH USA; [Shah, Samir] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Sanders, Ronald C., Jr.] Arkansas Childrens Hosp, Little Rock, AR 72202 USA	University of Michigan System; University of Michigan; Wayne State University; Utah System of Higher Education; University of Utah; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Hospital Los Angeles; University of California System; University of California San Francisco; Childrens Hospital of Orange County; Children's Hospital Los Angeles; Loma Linda University; Children's National Health System; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; University of Rochester; Phoenix Children's Hospital; Duke University; Ann & Robert H. Lurie Children's Hospital of Chicago; Seattle Children's Hospital; University of Louisville; Medical College of Wisconsin; Children's Healthcare of Atlanta (CHOA); Children's Hospitals & Clinics of Minnesota; Cincinnati Children's Hospital Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Tennessee System; University of Tennessee Health Science Center; Arkansas Children's Hospital	Moler, FW (corresponding author), Univ Michigan Hlth Syst, F-6900 UH South,SPF 5243,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	fmoler@umich.edu	Hahn, Cecil/J-3372-2016; McQuillen, Patrick/AAF-7119-2020; Pineda, Jose/W-2806-2019; Fink, Ericka/AAU-9792-2021	Hahn, Cecil/0000-0002-0887-8761; Goodman, Denise/0000-0001-9766-9453; Stavinoha, Peter L/0000-0002-3955-9579; McQuillen, Patrick/0000-0002-8837-364X; Thomas, Neal/0000-0002-7991-7510; Peters, Mark/0000-0003-3653-4808; Holubkov, Richard/0000-0003-0431-3381; Michelson, David/0000-0002-0600-3523	National Heart, Lung, and Blood Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD049934, UG1HD050096, U10HD050012, U10HD049983, U10HD050096, U10HD049981] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD044955, R34HD050531, U10HD049945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL094339, U01HL094345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS075363] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Heart, Lung, and Blood Institute and others; THAPCA-OH ClinicalTrials.gov number, NCT00878644.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; [Anonymous], 1995, MULL SCAL EARL LEARN; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Doherty DR, 2009, CIRCULATION, V119, P1492, DOI 10.1161/CIRCULATIONAHA.108.791384; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Field D, 2013, PEDIATRICS, V132, pE1247, DOI 10.1542/peds.2013-1754; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Holubkov R, 2015, PEDIATR CRIT CARE ME, V16, P1, DOI 10.1097/PCC.0000000000000272; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Kochanek PM, 2009, J NEUROTRAUM, V26, P421, DOI 10.1089/neu.2008.0587; Laptook A, 2008, PEDIATRICS, V122, P491, DOI 10.1542/peds.2007-1673; Marshall LF, 2001, J NEUROSURG, V95, P733, DOI 10.3171/jns.2001.95.5.0733; Moler FW, 2013, PEDIATR CRIT CARE ME, V14, pE304, DOI 10.1097/PCC.0b013e31828a863a; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pemberton VL, 2013, PEDIATR CRIT CARE ME, V14, P19, DOI 10.1097/PCC.0b013e31825b860b; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Scholefield B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009442.pub2; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sparrow SS., 2005, VINELAND ADAPTIVE BE, V2nd ed, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	37	272	281	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1898	1908		10.1056/NEJMoa1411480	http://dx.doi.org/10.1056/NEJMoa1411480			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1HB	25913022	Bronze, Green Accepted			2022-12-28	WOS:000354493300005
J	Welch, BM; Dere, W; Schiffman, JD				Welch, Brandon M.; Dere, Willard; Schiffman, Joshua D.			Family Health History The Case for Better Tools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Welch, Brandon M.] Med Univ S Carolina, Dept Publ Hlth Sci, Biomed Informat Ctr, Charleston, SC 29425 USA; [Dere, Willard] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Schiffman, Joshua D.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Schiffman, Joshua D.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA	Medical University of South Carolina; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Welch, BM (corresponding author), Med Univ S Carolina, Dept Publ Hlth Sci, Biomed Informat Ctr, 135 Cannon St,Ste 405L,MSC 200, Charleston, SC 29425 USA.	welchbm@musc.edu						Arar N, 2011, PERS MED, V8, P523, DOI 10.2217/PME.11.53; Facio FM, 2010, GENET MED, V12, P370, DOI 10.1097/GIM.0b013e3181e15bd5; Hulse Nathan C, 2008, AMIA Annu Symp Proc, P982; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Qureshi Nadeem, 2009, Evid Rep Technol Assess (Full Rep), P1; Weber GM, 2014, JAMA-J AM MED ASSOC, V311, P2479, DOI 10.1001/jama.2014.4228	6	33	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1711	1712		10.1001/jama.2015.2417	http://dx.doi.org/10.1001/jama.2015.2417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25868012				2022-12-28	WOS:000353921000013
J	Marks, TJ; Hersam, MC				Marks, Tobin J.; Hersam, Mark C.			MATERIALS SCIENCE Semiconductors grown large and thin	NATURE			English	Editorial Material							CHEMICAL-VAPOR-DEPOSITION; ATOMIC LAYER DEPOSITION; MOS2	Atomically thin layers of semiconductors called transition-metal dichalcogenides have been grown uniformly on the square-centimetre scale - paving the way for the ultimate miniaturization of electronic applications. See Letter p.656	[Marks, Tobin J.] Northwestern Univ, Dept Mat Sci & Engn, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Mat Res Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Marks, TJ (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Dept Chem, Evanston, IL 60208 USA.	t-marks@northwestern.edu; m-hersam@northwestern.edu	Hersam, Mark/B-6739-2009; Marks, Tobin/AAG-1472-2019					Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/NCHEM.1589, 10.1038/nchem.1589]; Doll GL, 2010, J THERM SPRAY TECHN, V19, P510, DOI 10.1007/s11666-009-9364-8; Jariwala D, 2014, ACS NANO, V8, P1102, DOI 10.1021/nn500064s; Jariwala D, 2013, P NATL ACAD SCI USA, V110, P18076, DOI 10.1073/pnas.1317226110; Kang K, 2015, NATURE, V520, P656, DOI 10.1038/nature14417; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Li H, 2014, ACCOUNTS CHEM RES, V47, P1067, DOI 10.1021/ar4002312; McCain MN, 2008, CHEM MATER, V20, P5438, DOI 10.1021/cm7026674; Sangwan VK, 2015, NAT NANOTECHNOL, V10, P403, DOI [10.1038/NNANO.2015.56, 10.1038/nnano.2015.56]; Scharf TW, 2004, J MATER RES, V19, P3443, DOI 10.1557/JMR.2004.0459; Song I, 2014, ANGEW CHEM INT EDIT, V53, P1266, DOI 10.1002/anie.201309474	11	30	31	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					631	632		10.1038/520631a	http://dx.doi.org/10.1038/520631a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925475				2022-12-28	WOS:000353689700040
J	Mbengue, A; Bhattacharjee, S; Pandharkar, T; Liu, HN; Estiu, G; Stahelin, RV; Rizk, SS; Njimoh, DL; Ryan, Y; Chotivanich, K; Nguon, C; Ghorbal, M; Lopez-Rubio, JJ; Pfrender, M; Emrich, S; Mohandas, N; Dondorp, AM; Wiest, O; Haldar, K				Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Chotivanich, Kesinee; Nguon, Chea; Ghorbal, Mehdi; Lopez-Rubio, Jose-Juan; Pfrender, Michael; Emrich, Scott; Mohandas, Narla; Dondorp, Arjen M.; Wiest, Olaf; Haldar, Kasturi			A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria	NATURE			English	Article							I-TASSER; PROTEIN; UBIQUITIN; DYNAMICS; ARTESUNATE; ACCURACY; WELL	Artemisinins are the cornerstone of anti-malarial drugs'. Emergence and spread of resistance to them' raises risk of wiping out recent gains achieved in reducing worldwide malaria burden and threatens future malaria control and elimination on a global level. Genome-wide association studies (GWAS) have revealed parasite genetic loci associated with artemisinin resistance'''. However, there is no consensus on biochemical targets of artemisinin. Whether and how these targets interact with genes identified by GWAS, remains unknown. Here we provide biochemical and cellular evidence that artemisinins are potent inhibitors of Plasmodium falciparum phosphatidylinosito1-3-kinase (PfPI3K), revealing an unexpected mechanism of action. In resistant clinical strains, increased PfPI3K was associated with the C580Y mutation in P. falciparum Kelch13 (PfKelch13), a primary marker of artemisinin resistance. Polyubiquitination of PfPI3K and its binding to PfKelch13 were reduced by the PfKelch13 mutation, which limited proteolysis of PfPI3K and thus increased levels of the kinase, as well as its lipid product phosphatidylinosito1-3-phosphate (PI3P). We find PI3P levels to be predictive of artemisinin resistance in both clinical and engineered laboratory parasites as well as across non-isogenic strains. Elevated PI3P induced artemisinin resistance in absence of PfKelch13 mutations, but remained responsive to regulation by PfKelch13. Evidence is presented for PI3P-dependent signalling in which transgenic expression of an additional kinase confers resistance. Together these data present PI3P as the key mediator of artemisinin resistance and the sole PfPI3K as an important target for malaria elimination.	[Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Wiest, Olaf; Haldar, Kasturi] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Pfrender, Michael; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Njimoh, Dieudonne L.] Univ Buea, Fac Sci, Dept Biochem & Mol Biol, Buea, Southwest Regio, Cameroon; [Chotivanich, Kesinee; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh 12302, Cambodia; [Ghorbal, Mehdi; Lopez-Rubio, Jose-Juan] Univ Montpellier 1&2 MiVEGEC, CNRS 5290, IRD 224, Montpellier, France; [Emrich, Scott] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10032 USA; [Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7BN, England; [Wiest, Olaf] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen 518055, Peoples R China	University of Notre Dame; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend; Mahidol University; National Center Parasitology, Entomology & Malaria Control; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Notre Dame; New York Blood Center; University of Oxford; Peking University; University Town of Shenzhen	Haldar, K (corresponding author), Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Hua, QX/HGE-3640-2022; Stahelin, Robert/L-3567-2019; Pfrender, Micheal E./C-5065-2019; lopez-rubio, jose juan/A-4509-2014	Stahelin, Robert/0000-0001-5443-7863; mbengue, Alassane/0000-0002-4210-6167; lopez-rubio, jose juan/0000-0002-0555-1122; Ghorbal, Mehdi/0000-0002-8896-2786	NIH [HL069630, AI039071, HL078826, AI081077, DK26263]; Notre Dame International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826, R01HL069630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071, R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants HL069630, AI039071, HL078826 (K.H.); AI081077 (R.V.S.); DK26263 (N.M.) and a grant from Notre Dame International. All parasite gene/protein sequences were obtained from PlasmoDB (http://www.plasmodb.org). This study is dedicated to the memory of Dr. Martin John Rogers, NIAID for his leadership in antimalarial drug research.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Case DA, 2012, AMBER 12; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fox T, 1996, PROTEINS, V25, P315, DOI 10.1002/(SICI)1097-0134(199607)25:3<315::AID-PROT4>3.0.CO;2-E; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jorgensen W L, 1986, Ann N Y Acad Sci, V482, P198, DOI 10.1111/j.1749-6632.1986.tb20951.x; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mi-Ichi F, 2007, PARASITOLOGY, V134, P1671, DOI 10.1017/S0031182007003137; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; PETERSEN HG, 1995, J CHEM PHYS, V103, P3668, DOI 10.1063/1.470043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WHO, WORLD MALARIA REPORT; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	358	380	2	255	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					683	U246		10.1038/nature14412	http://dx.doi.org/10.1038/nature14412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25874676	Green Submitted, Green Accepted			2022-12-28	WOS:000353689700051
J	Puglisi, JD				Puglisi, Joseph D.			The delicate dance of translation and folding	SCIENCE			English	Editorial Material							MECHANISMS; MEMBRANE		Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051266] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bustamante CJ, 2014, ANNU REV BIOPHYS, V43, P119, DOI 10.1146/annurev-biophys-051013-022811; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Noriega TR, 2014, ELIFE, V3, DOI 10.7554/eLife.04418; O'Brien EP, 2014, ACCOUNTS CHEM RES, V47, P1536, DOI 10.1021/ar5000117; Ramakrishnan V, 2014, CELL, V159, P979, DOI 10.1016/j.cell.2014.10.052; Tsai A, 2014, CELL REP, V7, P1521, DOI 10.1016/j.celrep.2014.04.033	14	7	7	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					399	400		10.1126/science.aab2157	http://dx.doi.org/10.1126/science.aab2157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908811				2022-12-28	WOS:000353338000020
J	Gee, H				Gee, Henry			ORIGIN AND EVOLUTION OF VERTEBRATES	NATURE			English	Editorial Material													Gepts, Paul/B-4417-2009; Gepts, Paul/O-8229-2019	Gepts, Paul/0000-0002-1056-4665; Gepts, Paul/0000-0002-1056-4665; Gee, Henry/0000-0002-9363-7654					0	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					449	449		10.1038/520449a	http://dx.doi.org/10.1038/520449a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB6SA	25903625	Bronze			2022-12-28	WOS:000416659500001
J	Arie, S				Arie, Sophie			Can mobile phones transform healthcare in low and middle income countries?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Mobile technology has the potential to put rural populations in touch with formal health services for the first time, but is the buzz around mobile health justified, asks Sophie Arie				sarie@bmj.com						Agarwal S, 2014, JAMA-J AM MED ASSOC, V312, P229, DOI 10.1001/jama.2014.6371; [Anonymous], 2015, BIG DAT SEL MAK BIG; [Anonymous], 2014, IT NEWS AFR     1212; GSMA, PAN AFR MHEALTH IN; Linda Jamii, MWISHO WA MAWAZO; Minges M, KEY TRENDS DEV MOBIL; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Unicef Zambia, 2012, PROJECT MWANA USING; Vital Wave Consulting, MHEALTH ETH STRAT NE; World Bank, 2012, INF COMM DEV MAX MOB	10	21	22	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h1975	10.1136/bmj.h1975	http://dx.doi.org/10.1136/bmj.h1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25902967				2022-12-28	WOS:000353576700005
J	Beckmann, R; Herrmann, JM				Beckmann, Roland; Herrmann, Johannes M.			Mitoribosome oddities	SCIENCE			English	Editorial Material							MAMMALIAN MITOCHONDRIAL RIBOSOME; SUBUNIT; MEMBRANE		[Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Herrmann, Johannes M.] Univ Kaiserslautern, Cell Biol, D-67663 Kaiserslautern, Germany	University of Munich; University of Kaiserslautern	Beckmann, R (corresponding author), Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany.	hannes.herrmann@biologie.uni-kl.de						Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019; SCHWEET R, 1958, P NATL ACAD SCI USA, V44, P1029, DOI 10.1073/pnas.44.10.1029; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1	10	6	6	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					288	289		10.1126/science.aab1054	http://dx.doi.org/10.1126/science.aab1054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883344				2022-12-28	WOS:000352999000023
J	Renshaw, S; Mohammadi, B				Renshaw, Sara; Mohammadi, Borzoueh			Odynophagia and vomiting eight years after laparoscopic adjustable gastric banding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BARIATRIC SURGERY; POSTOPERATIVE COMPLICATIONS; VOLVULUS; NECROSIS; RARE		[Renshaw, Sara; Mohammadi, Borzoueh] Univ Coll London Hosp, London NW1 2BU, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Renshaw, S (corresponding author), Univ Coll London Hosp, London NW1 2BU, England.	sararenshaw@nhs.net		Mohammadi, Borzoueh/0000-0002-3194-4106				Arbell D, 2007, J LAPAROENDOSC ADV S, V17, P321, DOI 10.1089/lap.2006.0102; Blachar A, 2007, AM J ROENTGENOL, V188, P472, DOI 10.2214/AJR.05.0293; Burton PR, 2011, INT J OBESITY, V35, pS26, DOI 10.1038/ijo.2011.144; Campanile FC, 2013, LANGENBECK ARCH SURG, V398, P669, DOI 10.1007/s00423-013-1077-2; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Frolich MA, 2001, ANESTH ANALG, V93, P215; Hamdan K, 2011, BRIT J SURG, V98, P1345, DOI 10.1002/bjs.7568; Iannelli A, 2005, OBES SURG, V15, P1211, DOI 10.1381/0960892055002194; Kicska G, 2007, AM J ROENTGENOL, V189, P1469, DOI 10.2214/AJR.05.1547; Lancaster RT, 2008, SURG ENDOSC, V22, P2554, DOI 10.1007/s00464-008-0074-y; Levine MS, 2014, RADIOLOGY, V270, P327, DOI 10.1148/radiol.13122520; Lunca S, 2005, OBES SURG, V15, P571, DOI 10.1381/0960892053723420; Medical Norfolk, VASC ACC CALTH LIPS; Mehanna MJ, 2006, AM J ROENTGENOL, V186, P522, DOI 10.2214/AJR.04.0655; O'Brien PE, 2013, ANN SURG, V257, P87, DOI 10.1097/SLA.0b013e31827b6c02; Parys S, 2013, J SURG CASE REP, DOI 10.1093/jscr/rjt053; Pieroni S, 2010, AM J ROENTGENOL, V195, P137, DOI 10.2214/AJR.09.3933; Spivak H, 2002, AM J SURG, V184, p31S, DOI 10.1016/S0002-9610(02)01177-7; Swenson DW, 2014, AM J ROENTGENOL, V203, P10, DOI 10.2214/AJR.13.11650; Yitzhak A, 2005, OBES SURG, V15, P439, DOI 10.1381/0960892053576631	20	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1902	10.1136/bmj.h1902	http://dx.doi.org/10.1136/bmj.h1902			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25881579				2022-12-28	WOS:000353328700009
J	Chikwe, J; Chiang, YP; Egorova, NN; Itagaki, S; Adams, DH				Chikwe, Joanna; Chiang, Yuting P.; Egorova, Natalia N.; Itagaki, Shinobu; Adams, David H.			Survival and Outcomes Following Bioprosthetic vs Mechanical Mitral Valve Replacement in Patients Aged 50 to 69 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VALVULAR HEART-DISEASE; MANAGEMENT; YOUNGER; RISK	IMPORTANCE In nonelderly patients with mitral disease requiring valve replacement, deciding between bioprosthetic and mechanical prosthetic valves is challenging because long-term survival and morbidity are not well defined. OBJECTIVE To quantify survival and major morbidity after mitral valve replacement in patients aged 50 to 69 years. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort analysis of 3433 patients (aged 50-69 years) who underwent primary, isolated mitral valve replacement in New York State hospitals from 1997-2007. Follow-up ended November 30, 2013; median duration was 8.2 years (range, 0-16.8 years). Propensity score matching for 19 baseline characteristics yielded 664 patient pairs. EXPOSURES Bioprosthetic vs mechanical prosthetic mitral valve replacement. MAIN OUTCOMES AND MEASURES All-cause mortality, stroke, reoperation, and major bleeding events. RESULTS No survival difference was observed between use of mechanical prosthetic and bioprosthetic mitral valves in patients aged 50 to 69 years matched by propensity score or in a subgroup analysis of age by decade. Among patients matched by propensity score, the incidences of stroke and bleeding events were both significantly higher in those who received mechanical prosthetic mitral valves compared with those who received bioprosthetic mitral valves; however, the incidence of reoperation was lower in the mechanical prosthesis group compared with the bioprosthesis group. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among patients aged 50 to 69 years undergoing mitral valve replacement in New York State, there was no significant survival difference at 15 years in patients matched by propensity score who underwent mechanical prosthetic vs bioprosthetic mitral valve replacement. Mechanical prosthetic valves were associated with lower risk of reoperation but greater risk of bleeding and stroke. Even though these findings suggest bioprosthetic mitral valve replacement may be a reasonable alternative to mechanical prosthetic valve replacement in patients aged 50 to 69 years, the 15-year follow-up was insufficient to fully assess lifetime risks, particularly of reoperation.	[Chikwe, Joanna; Chiang, Yuting P.; Itagaki, Shinobu; Adams, David H.] Icahn Sch Med Mt Sinai, Dept Cardiovasc Surg, New York, NY 10029 USA; [Egorova, Natalia N.] Icahn Sch Med Mt Sinai, Dept Hlth Evidence & Policy, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chikwe, J (corresponding author), Mt Sinai Hosp, Dept Cardiovasc Surg, 1190 Fifth Ave, New York, NY 10029 USA.	joanna.chikwe@mountsinai.org			Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program	Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program	Mr Chiang was funded by a research stipend from the Icahn School of Medicine at Mount Sinai Patient Oriented Research Training and Leadership (PORTAL) Program.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anyanwu AC, 2014, EUR J CARDIO-THORAC, V45, P352, DOI 10.1093/ejcts/ezt256; Badhwar V, 2012, ANN THORAC SURG, V93, P748, DOI 10.1016/j.athoracsur.2011.12.032; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Breglio A, 2013, ANN THORAC SURG, V95, P1603, DOI 10.1016/j.athoracsur.2013.01.073; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; Carrel TP, 2014, J THORAC CARDIOV SUR, V147, P853, DOI 10.1016/j.jtcvs.2013.10.020; Cen YY, 2001, J THORAC CARDIOV SUR, V122, P569, DOI 10.1067/mtc.2001.115418; Chiang YTP, 2014, JAMA-J AM MED ASSOC, V312, P1323, DOI 10.1001/jama.2014.12679; Daneshmand MA, 2010, ANN THORAC SURG, V90, P1479, DOI 10.1016/j.athoracsur.2010.05.075; Grunkemeier G L, 2000, Curr Probl Cardiol, V25, P73; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Kaneko T, 2014, J THORAC CARDIOV SUR, V147, P117, DOI 10.1016/j.jtcvs.2013.08.028; Kaneko T, 2013, CIRCULATION, V128, P1365, DOI 10.1161/CIRCULATIONAHA.113.002584; Koertke H, 2010, ANN THORAC SURG, V90, P1487, DOI 10.1016/j.athoracsur.2010.06.069; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Oxenham H, 2003, HEART, V89, P715, DOI 10.1136/heart.89.7.715; Potter DD, 2004, ANN THORAC SURG, V78, P67, DOI 10.1016/j.athoracsur.2004.02.014; Rahimtoola SH, 2010, J AM COLL CARDIOL, V55, P2413, DOI 10.1016/j.jacc.2009.10.085; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ruel M, 2005, EUR J CARDIO-THORAC, V27, P425, DOI 10.1016/j.ejcts.2004.12.002; Russo A, 2008, J AM COLL CARDIOL, V51, P1203, DOI 10.1016/j.jacc.2007.10.058; Stassano P, 2009, J AM COLL CARDIOL, V54, P1862, DOI 10.1016/j.jacc.2009.07.032; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	24	73	81	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1435	1442		10.1001/jama.2015.3164	http://dx.doi.org/10.1001/jama.2015.3164			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871669	Bronze			2022-12-28	WOS:000352821200019
J	Snyder, A				Snyder, Alison			Warren Berggren Obituary	LANCET			English	Biographical-Item																		BERGGREN WA, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1390	1390		10.1016/S0140-6736(15)60709-7	http://dx.doi.org/10.1016/S0140-6736(15)60709-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25890411				2022-12-28	WOS:000352719800016
J	Lu, Y; Wang, WP; Kirschner, MW				Lu, Ying; Wang, Weiping; Kirschner, Marc W.			Specificity of the anaphase-promoting complex: A single-molecule study	SCIENCE			English	Article							SUBSTRATE DEGRADATION; MECHANISM; PROTEOLYSIS; CYCLIN; POLYUBIQUITINATION; PROCESSIVITY; DESTRUCTION; CASCADES; INSIGHTS; RECEPTOR	Biological processes require specific enzymatic reactions, paradoxically involving short recognition sequences. As an example, cell-cycle timing depends on a sequence of ubiquitylation events mediated by the anaphase-promoting complex (APC) based on short redundant motifs. To understand the origin of specificity, we designed single-molecule fluorescence assays that capture transient ubiquitylation reactions. We find that the APC-mediated ubiquitylation involves a highly processive initial reaction on the substrate, followed by multiple encounters and reactions at a slower rate. The initial ubiquitylation greatly enhances the substrate's binding affinity in subsequent reactions, by both increasing the on-rate and decreasing the off-rate. We postulate that these cycles of positive feedback enable high specificity for substrates with short recognition motifs in a complex cellular environment.	[Lu, Ying; Wang, Weiping; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu			National Institute of General Medical Sciences [5R01GM039023-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. King for providing plasmids and W. Ma, L. Bai, M. Rape, and R. King for commenting on the manuscript. We are grateful to the Nikon imaging center at Harvard Medical School and in particular to J. Waters for technical support; Y.L. is a Damon Runyon Cancer Research Fellow and a Lallage Feazel Wall Fellow. We acknowledge the continuing support of the National Institute of General Medical Sciences (grant no. 5R01GM039023-26).	Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; BESSMAN MJ, 1974, J MOL BIOL, V88, P409, DOI 10.1016/0022-2836(74)90491-4; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kelly A., 2014, SCIENCE, V56, P232, DOI DOI 10.1016/J.M0LCEL.2014.09.010;PMID:25306918; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034370; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meyer HJ, 2011, SEMIN CELL DEV BIOL, V22, P544, DOI 10.1016/j.semcdb.2011.03.009; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670	29	49	50	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231							1248737	10.1126/science.1248737	http://dx.doi.org/10.1126/science.1248737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859049	Green Accepted			2022-12-28	WOS:000352613700034
J	Jeong, HG; Koo, DL; Nam, H; Kwon, HM				Jeong, Han-Gil; Koo, Dae Lim; Nam, Hyunwoo; Kwon, Hyung-Min			Reversible right heart failure after medullary stroke	LANCET			English	Editorial Material							INFARCTION		[Jeong, Han-Gil; Koo, Dae Lim; Nam, Hyunwoo; Kwon, Hyung-Min] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Government, Dept Neurol, Seoul 156707, South Korea	Seoul National University (SNU); Seoul National University Hospital	Kwon, HM (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Government, Dept Neurol, 20 Boramae Ro 5 Gil, Seoul 156707, South Korea.	hmkwon@snu.ac.kr	Jeong, Han-Gil/K-4171-2019	Kwon, Hyung-Min/0000-0002-6101-7127				BOGOUSSLAVSKY J, 1990, ANN NEUROL, V28, P668, DOI 10.1002/ana.410280511; Korpelainen JT, 1997, STROKE, V28, P2150, DOI 10.1161/01.STR.28.11.2150; Mendoza M, 2013, NEUROLOGY, V80, pE13, DOI 10.1212/WNL.0b013e31827b9096; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Weitzenblum E, 2003, HEART, V89, P225, DOI 10.1136/heart.89.2.225	5	0	0	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1364	1364		10.1016/S0140-6736(15)60682-1	http://dx.doi.org/10.1016/S0140-6736(15)60682-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25890915				2022-12-28	WOS:000352272400043
J	Auster, HU; Apathy, I; Berghofer, G; Fornacon, KH; Remizov, A; Carr, C; Guttler, C; Haerendel, G; Heinisch, P; Hercik, D; Hilchenbach, M; Kuehrt, E; Magnes, W; Motschmann, U; Richter, I; Russell, CT; Przyklenk, A; Schwingenschuh, K; Sierks, H; Glassmeier, KH				Auster, Hans-Ulrich; Apathy, Istvan; Berghofer, Gerhard; Fornacon, Karl-Heinz; Remizov, Anatoli; Carr, Chris; Guettler, Carsten; Haerendel, Gerhard; Heinisch, Philip; Hercik, David; Hilchenbach, Martin; Kuehrt, Ekkehard; Magnes, Werner; Motschmann, Uwe; Richter, Ingo; Russell, Christopher T.; Przyklenk, Anita; Schwingenschuh, Konrad; Sierks, Holger; Glassmeier, Karl-Heinz			The nonmagnetic nucleus of comet 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							MAGNETIC-FIELD OBSERVATIONS; GIOTTO MAGNETOMETER EXPERIMENT; ROSETTA PLASMA CONSORTIUM; SOLAR-NEBULA; DUST; METEORITES; ENCOUNTER; ASTEROIDS; SAMPLES; GASPRA	Knowledge of the magnetization of planetary bodies constrains their origin and evolution, as well as the conditions in the solar nebular at that time. On the basis of magnetic field measurements during the descent and subsequent multiple touchdown of the Rosetta lander Philae on the comet 67P/Churyumov-Gerasimenko (67P), we show that no global magnetic field was detected within the limitations of analysis. The Rosetta Magnetometer and Plasma Monitor (ROMAP) suite of sensors measured an upper magnetic field magnitude of less than 2 nanotesla at the cometary surface at multiple locations, with the upper specific magnetic moment being <3.1 x 10(-5) ampere-square meters per kilogram for meter-size homogeneous magnetized boulders. The maximum dipole moment of 67P is 1.6 x 10(8) ampere-square meters. We conclude that on the meter scale, magnetic alignment in the preplanetary nebula is of minor importance.	[Auster, Hans-Ulrich; Fornacon, Karl-Heinz; Remizov, Anatoli; Heinisch, Philip; Hercik, David; Richter, Ingo; Przyklenk, Anita; Glassmeier, Karl-Heinz] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Apathy, Istvan] Hungarian Acad Sci, Ctr Energy Res, H-1121 Budapest, Hungary; [Berghofer, Gerhard; Magnes, Werner; Schwingenschuh, Konrad] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Remizov, Anatoli] Russian Acad Sci, Space Res Inst, Moscow 117810, Russia; [Carr, Chris] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Guettler, Carsten; Hilchenbach, Martin] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Haerendel, Gerhard; Sierks, Holger; Glassmeier, Karl-Heinz] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Kuehrt, Ekkehard; Motschmann, Uwe] German Aerosp Ctr DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Motschmann, Uwe] Tech Univ Carolo Wilhelmina Braunschweig, Inst Theoret Phys, D-38106 Braunschweig, Germany; [Russell, Christopher T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	Braunschweig University of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Austrian Academy of Sciences; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Imperial College London; Max Planck Society; Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); Braunschweig University of Technology; University of California System; University of California Los Angeles	Auster, HU (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, Mendelssohnstr 3, D-38106 Braunschweig, Germany.	uli.auster@tu-bs.de	Hercik, David/M-3692-2019; Hercik, David/G-1224-2014; Russell, Christopher T/E-7745-2012; Heinisch, Philip/X-8325-2019	Hercik, David/0000-0001-6151-7482; Hercik, David/0000-0001-6151-7482; Russell, Christopher T/0000-0003-1639-8298; Heinisch, Philip/0000-0003-1873-3598; Przyklenk, Anita/0000-0002-6405-2315; Carr, Chris/0000-0002-6879-3970	German Ministerium fur Wirtschaft und Energie; Deutsches Zentrum fur Luft- und Raumfahrt [50QP1401]; STFC [ST/H002383/1, ST/K001051/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H002383/1, ST/K001051/1] Funding Source: researchfish; UK Space Agency [ST/H004262/1, ST/K001698/1] Funding Source: researchfish	German Ministerium fur Wirtschaft und Energie; Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Rosetta is a European Space Agency (ESA) mission with contributions from its member states and NASA. The contribution of the ROMAP and RPC-MAG team was financially supported by the German Ministerium fur Wirtschaft und Energie and the Deutsches Zentrum fur Luft- und Raumfahrt under contract 50QP1401. We are indebted to the whole Rosetta Mission Team, the Lander Control Centre (LCC) in Cologne, the Scientific Operation and Navigation Centre (SONC) in Toulouse, the Science Ground System (SGS) at the European Space Astronomy Centre (ESAC), as well as RMOC in Darmstadt for their outstanding efforts making this mission possible. The ROMAP and RPC-MAG data will be made available through ESA's Planetary Science Archive (PSA) Web site (www.rssd.esa.int/index.php?project=PSA&page=index).	Acuna MH, 2002, ICARUS, V155, P220, DOI 10.1006/icar.2001.6772; Auster HU, 2007, SPACE SCI REV, V128, P221, DOI 10.1007/s11214-006-9033-x; Auster HU, 2010, PLANET SPACE SCI, V58, P1124, DOI 10.1016/j.pss.2010.01.006; Berger EL, 2011, GEOCHIM COSMOCHIM AC, V75, P3501, DOI 10.1016/j.gca.2011.03.026; Blanco-Cano X, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009618; Blum J, 2014, ICARUS, V235, P156, DOI 10.1016/j.icarus.2014.03.016; Carr C, 2007, SPACE SCI REV, V128, P629, DOI 10.1007/s11214-006-9136-4; Fu RR, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003925; Glassmeier K. H., 2014, THE SINGING COMET; Glassmeier KH, 2007, SPACE SCI REV, V128, P649, DOI 10.1007/s11214-006-9114-x; Glassmeier KH, 2007, SPACE SCI REV, V128, P1, DOI 10.1007/s11214-006-9140-8; Guttler C, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200912852; Kataoka A, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201322151; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; KIVELSON MG, 1993, SCIENCE, V261, P331, DOI 10.1126/science.261.5119.331; Kuppers M, 2005, NATURE, V437, P987, DOI 10.1038/nature04236; NEUBAUER FM, 1988, J GEOPHYS RES, V93, P7272, DOI 10.1029/JA093iA07p07272; NEUBAUER FM, 1986, NATURE, V321, P352, DOI 10.1038/321352a0; NEUBAUER FM, 1993, ASTRON ASTROPHYS, V268, pL5; Nubold H, 2000, ICARUS, V144, P149, DOI 10.1006/icar.1999.6273; Ogliore RC, 2010, EARTH PLANET SC LETT, V296, P278, DOI 10.1016/j.epsl.2010.05.011; Parker RL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2001JE001760; Richter I, 2012, PLANET SPACE SCI, V66, P155, DOI 10.1016/j.pss.2011.08.009; Richter I, 2011, PLANET SPACE SCI, V59, P691, DOI 10.1016/j.pss.2011.02.001; Richter I, 2001, GEOPHYS RES LETT, V28, P1913, DOI 10.1029/2000GL012679; Rochette P, 2010, EARTH PLANET SC LETT, V292, P383, DOI 10.1016/j.epsl.2010.02.007; Sierks H., 2014, BOULDER CLOSE UP; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; SINGH PD, 1992, ASTRON J, V104, P848, DOI 10.1086/116279; SMITH EJ, 1986, SCIENCE, V232, P382, DOI 10.1126/science.232.4748.382; Terho M, 1996, EARTH MOON PLANETS, V72, P225, DOI 10.1007/BF00117522; Uehara M, 2012, PHYS EARTH PLANET IN, V200, P113, DOI 10.1016/j.pepi.2012.04.007; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712	33	51	51	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 31	2015	349	6247							aaa5102	10.1126/science.aaa5102	http://dx.doi.org/10.1126/science.aaa5102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN8SP	25873744	Green Submitted			2022-12-28	WOS:000358713300001
J	Zeuzem, S; Ghalib, R; Reddy, KR; Pockros, PJ; Ben Ari, Z; Zhao, Y; Brown, DD; Wan, SY; DiNubile, MJ; Nguyen, BY; Robertson, MN; Wahl, J; Barr, E; Butterton, JR				Zeuzem, Stefan; Ghalib, Reem; Reddy, K. Rajender; Pockros, Paul J.; Ben Ari, Ziv; Zhao, Yue; Brown, Deborah D.; Wan, Shuyan; DiNubile, Mark J.; Bach-Yen Nguyen; Robertson, Michael N.; Wahl, Janice; Barr, Eliav; Butterton, Joan R.			Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERFERON-ALPHA 2A; PLUS RIBAVIRIN; DOUBLE-BLIND; MK-5172; HCV; SOFOSBUVIR; PHASE-2; ABT-450/R-OMBITASVIR; SIMEPREVIR	Background: Novel interferon- and ribavirin-free regimens are needed to treat hepatitis C virus (HCV) infection. Objective: To evaluate the safety and efficacy of grazoprevir (NS3/4A protease inhibitor) and elbasvir (NS5A inhibitor) in treatment-naive patients. Design: Randomized, blinded, placebo-controlled trial. (ClinicalTrials.gov: NCT02105467) Setting: 60 centers in the United States, Europe, Australia, Scandinavia, and Asia. Patients: Cirrhotic and noncirrhotic treatment-naive adults with genotype 1, 4, or 6 infection. Intervention: Oral, once-daily, fixed-dose grazoprevir 100 mg/ elbasvir 50 mg for 12 weeks, stratified by fibrosis and genotype. Patients were randomly assigned 3:1 to immediate or deferred therapy. Measurements: Proportion of patients in the immediate-treatment group achieving unquantifiable HCV RNA 12 weeks after treatment (SVR12); adverse events in both groups. Results: Among 421 participants, 194 (46%) were women, 157 (37%) were nonwhite, 382 (91%) had genotype 1 infection, and 92 (22%) had cirrhosis. Of 316 patients receiving immediate treatment, 299 of 316 (95% [95% Cl, 92% to 97%[) achieved SVR12, including 144 of 157 (92% [Cl, 86% to 96%]) with genotype 1a, 129 of 131 (99% [Cl, 95% to 100%)) with genotype 1b, 18 of 18(100% [Cl, 82% to 100%]) with genotype 4, 8 of 10(80% [Cl, 44% to 98%]) with genotype 6, 68 of 70 (97% [Cl, 90% to 100%]) with cirrhosis, and 231 of 246 (94% [Cl, 90% to 97%]) without cirrhosis. Virologic failure occurred in 13 patients (4%), including 1 case of breakthrough infection and 12 relapses, and was associated with baseline NS5A polymorphisms and emergent NS3 or NS5A variants or both. Serious adverse events occurred in 9(2.8%) and 3(2.9%) patients in the active and placebo groups, respectively (difference <0.05 percentage point (Cl, -5.4 to 3.1 percentage points)); none were considered drug related. The most common adverse events in the active group were headache (17%), fatigue (16%), and nausea (9%). Limitation: The study lacked an active-comparator control group and included relatively few genotype 4 and 6 infections. Conclusion: Grazoprevir-elbasvir achieved high SVR12 rates in treatment-naive cirrhotic and noncirrhotic patients with genotype 1, 4, or 6 infection. This once-daily, all-oral, fixed-combination regimen represents a potent new therapeutic option for chronic HCV infection.	[Zeuzem, Stefan] Goethe Univ Hosp, D-60590 Frankfurt, Germany; Texas Clin Res Inst, Dallas, TX USA; Univ Penn, Philadelphia, PA 19104 USA; Scripps Translat Sci Inst, La Jolla, CA USA; Sheba Med Ctr, Ramat Gan, Israel; Merck & Co Inc, Kenilworth, NJ USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Pennsylvania; Scripps Research Institute; Chaim Sheba Medical Center; Merck & Company	Zeuzem, S (corresponding author), Goethe Univ Hosp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019		Merck Co.	Merck Co.(Merck & Company)	Merck & Co.	AbbVie, 2015, VIEK PAK OMB PAR RIT; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Brown A, 2015, P 50 INT LIV C VIENN; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Forns X, J HEPATOL IN RPESS; Gane EJ, 2014, P 65 ANN M AM ASS ST; Gilead Sciences, 2014, HARV LED SOF TABL OR, P32; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Howe AYM, 2014, CLIN INFECT DIS, V59, P1657, DOI 10.1093/cid/ciu696; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Koletzki Diana, 2013, Methods Mol Biol, V1030, P137, DOI 10.1007/978-1-62703-484-5_12; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lahser F, 2012, P 63 ANN M AM ASS ST; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Manns MP, 2014, GASTROENTEROLOGY, V147, P366, DOI 10.1053/j.gastro.2014.04.006; Naggie S, 2015, P 22 C RETR OPP INF; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; PHENOTYPE WORKING GROUP H DRUG DEVELOPMENT ADVISORY GROUP H, 2012, ANN FORUM COLLAB HIV, V14, P1; Products Janssen, 2014, OL SIM CAPS OR US; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Wyles D, 2015, P 22 C RETR OPP INF; Yeh WW, 2013, P 64 ANN M AM ASS ST	32	429	444	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					1	13		10.7326/M15-0785	http://dx.doi.org/10.7326/M15-0785			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25909356				2022-12-28	WOS:000357442000001
J	Mehrotra, A; Hussey, P				Mehrotra, Ateev; Hussey, Peter			Including Physicians in Bundled Hospital Care Payments Time to Revisit an Old Idea?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mehrotra, Ateev] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hussey, Peter] RAND Corp, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; RAND Corporation	Mehrotra, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				Berenson RA, 2011, NEW ENGL J MED, V364, P1892, DOI 10.1056/NEJMp1102099; Burke RE, 2015, JAMA INTERN MED, V175, P295, DOI 10.1001/jamainternmed.2014.6383; Burns LR, 2008, MILBANK Q, V86, P375, DOI 10.1111/j.1468-0009.2008.00527.x; Casalino LP, 2008, HEALTH AFFAIR, V27, P1305, DOI 10.1377/hlthaff.27.5.1305; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Damberg C.L., 2007, WR474ASPECMS RAND HL; Himmelstein DU, 2014, HEALTH AFFAIR, V33, P1586, DOI 10.1377/hlthaff.2013.1327; Urdapilleta O, 2013, EVALUATION MEDICARE	8	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1907	1908		10.1001/jama.2015.3359	http://dx.doi.org/10.1001/jama.2015.3359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25856460				2022-12-28	WOS:000354691200008
J	Kang, K; Xie, SE; Huang, LJ; Han, YM; Huang, PY; Mak, KF; Kim, CJ; Muller, D; Park, J				Kang, Kibum; Xie, Saien; Huang, Lujie; Han, Yimo; Huang, Pinshane Y.; Mak, Kin Fai; Kim, Cheol-Joo; Muller, David; Park, Jiwoong			High-mobility three-atom-thick semiconducting films with wafer-scale homogeneity	NATURE			English	Article							HIGH-QUALITY MONOLAYER; ELECTRICAL-TRANSPORT PROPERTIES; LAYER MOS2; GROWTH; WS2; TRANSITION; EVOLUTION	The large-scale growth of semiconducting thin films forms the basis of modern electronics and optoelectronics. A decrease in film thickness to the ultimate limit of the atomic, sub-nanometre length scale, a difficult limit for traditional semiconductors (such as Si and GaAs), would bring wide benefits for applications in ultrathin and flexible electronics, photovoltaics and display technology'. For this, transition-metal dichalcogenides (TMDs), which can form stable three-atom-thick monolayers(4), provide ideal semiconducting materials with high electrical carrier mobility'-", and their largescale growth on insulating substrates would enable the batch fabrication of atomically thin high-performance transistors and photodetectors on a technologically relevant scale without film transfer. In addition, their unique electronic band structures provide novel ways of enhancing the functionalities of such devices, including the large excitonic effect", bandgap modulation", indirect-todirect bandgap transition", piezoelectricity' and valleytronics'. However, the large-scale growth of monolayer TMD films with spatial homogeneity and high electrical performance remains an unsolved challenge. Here we report the preparation of high-mobility 4-inch wafer-scale films of monolayer molybdenum disulphide (Mo52) and tungsten disulphide, grown directly on insulating MO, substrates, with excellent spatial homogeneity over the entire films. They are grown with a newly developed, metal-organic chemical vapour deposition technique, and show high electrical performance, including an electron mobility of 30 cm(2) V-1 s(1) at room temperature and 114 cm(2) V-1 s(-1) at 90K for Mo52, with little dependence on position or channel length. With the use of these films we successfully demonstrate the wafer-scale batch fabrication of highperformance monolayer Mo52 field-effect transistors with a 99% device yield and the multi-level fabrication of vertically stacked transistor devices for three-dimensional circuitry. Our work is a step towards the realization of atomically thin integrated circuitry.	[Kang, Kibum; Huang, Lujie; Kim, Cheol-Joo; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Xie, Saien; Han, Yimo; Huang, Pinshane Y.; Muller, David] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Mak, Kin Fai; Muller, David; Park, Jiwoong] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Mak, Kin Fai] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Park, J (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jpark@cornell.edu	Kang, Kibum/A-7225-2018; Mak, Kin Fai/E-9004-2015; Park, Jiwoong/C-2327-2013; Muller, David/A-7745-2010; Kim, Cheol-Joo/A-2217-2010	Kang, Kibum/0000-0003-1674-1826; Mak, Kin Fai/0000-0002-5768-199X; Muller, David/0000-0003-4129-0473; Xie, Saien/0000-0002-1723-8598; Huang, Pinshane/0000-0002-1095-1833; Kim, Cheol-Joo/0000-0002-4312-3866	AFOSR [FA2386-13-1-4118, FA9550-11-1-0033]; Nano Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2012M3A7B4049887]; National Science Foundation (NSF) through the Cornell Center for Materials Research [NSF DMR-1120296]; Samsung Advanced Institute for Technology GRO Program; National Science Foundation [ECS-0335765]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Nano Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; National Science Foundation (NSF) through the Cornell Center for Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Samsung Advanced Institute for Technology GRO Program(Samsung); National Science Foundation(National Science Foundation (NSF))	We thank P. L. McEuen, M.-H. Jo, H. Heo and H.-C. Choi for discussions, and M. Guimaraes and Z. Ziegler for help in preparing the manuscript. This work was supported mainly by the AFOSR (FA2386-13-1-4118 and FA9550-11-1-0033) and the Nano Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2012M3A7B4049887). Additional funding was provided by the National Science Foundation (NSF) through the Cornell Center for Materials Research (NSF DMR-1120296) and by the Samsung Advanced Institute for Technology GRO Program. Device fabrication was performed at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (ECS-0335765).	Baugher BWH, 2013, NANO LETT, V13, P4212, DOI 10.1021/nl401916s; Berkdemir A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01755; Connor P, 1932, J AM CHEM SOC, V54, P4678; Cristol S, 2000, J PHYS CHEM B, V104, P11220, DOI 10.1021/jp0023819; Feng QL, 2014, ADV MATER, V26, P2648, DOI 10.1002/adma.201306095; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Jariwala D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803920; Kaasbjerg K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115317; KING DA, 1997, GROWTH PROPERTIES UL; Ko H, 2010, NATURE, V468, P286, DOI 10.1038/nature09541; Lee YH, 2013, NANO LETT, V13, P1852, DOI 10.1021/nl400687n; Li H, 2012, ADV FUNCT MATER, V22, P1385, DOI 10.1002/adfm.201102111; Lin YC, 2012, NANOSCALE, V4, P6637, DOI 10.1039/c2nr31833d; Liu H, 2013, NANO LETT, V13, P2640, DOI 10.1021/nl400778q; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Najmaei S, 2014, ACS NANO, V8, P7930, DOI 10.1021/nn501701a; Najmaei S, 2013, NAT MATER, V12, P754, DOI [10.1038/NMAT3673, 10.1038/nmat3673]; Ovchinnikov D, 2014, ACS NANO, V8, P8174, DOI 10.1021/nn502362b; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/NMAT3687, 10.1038/nmat3687]; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Schmidt H, 2014, NANO LETT, V14, P1909, DOI 10.1021/nl4046922; Song I, 2014, ANGEW CHEM INT EDIT, V53, P1266, DOI 10.1002/anie.201309474; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Wu WZ, 2014, NATURE, V514, P470, DOI 10.1038/nature13792; Ye ZL, 2014, NATURE, V513, P214, DOI 10.1038/nature13734; Yu YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01866; Zhang Y, 2013, ACS NANO, V7, P8963, DOI 10.1021/nn403454e; Zhao WJ, 2013, ACS NANO, V7, P791, DOI 10.1021/nn305275h	30	1248	1267	74	1522	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					656	660		10.1038/nature14417	http://dx.doi.org/10.1038/nature14417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925478				2022-12-28	WOS:000353689700045
J	Pollock, AM; Roderick, P				Pollock, Allyson M.; Roderick, Peter			FUTURE OF THE NHS Why the Queen's Speech on 19 May should include a bill to reinstate the NHS in England	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pollock, Allyson M.; Roderick, Peter] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Global Publ Hlth Unit, London E1 2AB, England	University of London; Queen Mary University London	Pollock, AM (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Global Publ Hlth Unit, London E1 2AB, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				Barts Health NHS Trust, ANN REP 2013 14; Department of Health, 2000, CM4818I; Greater Manchester Combined Authority, 2015, GREAT MANCH HLTH SOC; Himmelstein DU, 2014, J GEN INTERN MED, V29, P693, DOI 10.1007/s11606-013-2745-1; Institute of Medicine, 2012, BEST CAR LOW COST PA; LaMontagne C., 2014, NERDWALLET; NHS England, 2015, NEW CAR MOD VANG SIT; NHS England Care Quality Commission Public Health England Health Education England Monitor Trust Development Authority, 2014, NHS 5 YEAR FORW VIEW; Roberts N, 2014, GP21; Robertson R, 2015, RISK REWARD CHANGING; Roderick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5603; Williams D., 2015, HLTH SERV J; Woolhandler S, 2007, BRIT MED J, V335, P1126, DOI 10.1136/bmj.39400.549502.94	13	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2015	350								h2257	10.1136/bmj.h2257	http://dx.doi.org/10.1136/bmj.h2257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UR	25924814				2022-12-28	WOS:000353956400003
J	Cheng, Y; Grigorieff, N; Penczek, PA; Walz, T				Cheng, Yifan; Grigorieff, Nikolaus; Penczek, Pawel A.; Walz, Thomas			A Primer to Single-Particle Cryo-Electron Microscopy	CELL			English	Article							MOLECULAR ELECTRON-MICROSCOPY; HIV-1 ENVELOPE GLYCOPROTEINS; BEAM-INDUCED MOTION; CRYO-EM IMAGES; 3-DIMENSIONAL RECONSTRUCTION; ESCHERICHIA-COLI; CONTRAST TRANSFER; CRYOMICROSCOPY; RESOLUTION; MICROGRAPHS	Cryo-electron microscopy (cryo-EM) of single-particle specimens is used to determine the structure of proteins and macromolecular complexes without the need for crystals. Recent advances in detector technology and software algorithms now allow images of unprecedented quality to be recorded and structures to be determined at near-atomic resolution. However, compared with X-ray crystallography, cryo-EM is a young technique with distinct challenges. This primer explains the different steps and considerations involved in structure determination by single-particle cryo-EM to provide an overview for scientists wishing to understand more about this technique and the interpretation of data obtained with it, as well as a starting guide for new practitioners.	[Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Penczek, Pawel A.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	twalz@hms.harvard.edu		Walz, Thomas/0000-0003-2606-2835; Cheng, Yifan/0000-0001-9535-0369; Grigorieff, Nikolaus/0000-0002-1506-909X	NIH [R01 GM098672, R01 GM082893, P50 GM082250, R01 GM60635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, R01GM098672, R01GM082893, P50GM082250, P01GM062580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Rita De Zorzi for providing images of the AMPA receptor and Tim Grant for calculating 2D class averages and an initial reconstruction of the TRPV1 channel using IMAGIC and EMAN2. This work was supported by grants from the NIH (R01 GM098672, R01 GM082893, and P50 GM082250 to Y.C.; R01 GM60635 to P.A.P.). N.G. and T.W. are investigators with the Howard Hughes Medical Institute.	Adiga PSU, 2004, J STRUCT BIOL, V145, P142, DOI 10.1016/j.jsb.2003.10.025; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Brink J, 2004, STRUCTURE, V12, P185, DOI 10.1016/j.str.2004.01.015; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Faruqi AR, 2011, Q REV BIOPHYS, V44, P357, DOI 10.1017/S0033583511000035; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Frank J, 2006, 3 DIMENSIONAL ELECT; Glaeser RM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4830355; Grigorieff N, 2000, ACTA CRYSTALLOGR D, V56, P1270, DOI 10.1107/S0907444900009549; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hall RJ, 2004, J STRUCT BIOL, V145, P19, DOI 10.1016/j.jsb.2003.10.024; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Heymann JB, 2003, NAT STRUCT BIOL, V10, P334, DOI 10.1038/nsb922; Joyeux L, 2002, ULTRAMICROSCOPY, V92, P33, DOI 10.1016/S0304-3991(01)00154-1; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LATA KR, 1995, ULTRAMICROSCOPY, V58, P381, DOI 10.1016/0304-3991(95)00002-I; Lau Wilson C Y, 2013, Methods Mol Biol, V955, P401, DOI 10.1007/978-1-62703-176-9_22; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Ludtke SJ, 2013, CURR OPIN STRUC BIOL, V23, P755, DOI 10.1016/j.sbi.2013.06.003; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002; Meyerson JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07084; Milazzo AC, 2011, J STRUCT BIOL, V176, P404, DOI 10.1016/j.jsb.2011.09.002; Milne JLS, 2013, FEBS J, V280, P28, DOI 10.1111/febs.12078; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orlova EV, 2011, CHEM REV, V111, P7710, DOI 10.1021/cr100353t; Penczek P.A., 2014, SX3DVARIABILITY; Penczek P. A., 2014, SXLOCRES; Penczek P.A., 2014, SXVIPER; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Penczek PA, 2008, INT TABLES CRYSTALLO, P375; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; Penczek PA, 2010, METHOD ENZYMOL, V482, P1, DOI 10.1016/S0076-6879(10)82001-4; Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8; Penczek PA, 2010, METHOD ENZYMOL, V482, P35, DOI 10.1016/S0076-6879(10)82002-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rubinstein J.R., 2014, ARXIV14096789; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sigworth FJ, 2004, J STRUCT BIOL, V145, P111, DOI 10.1016/j.jsb.2003.10.025; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; THON F, 1966, Z NATURFORSCH PT A, VA 21, P476, DOI 10.1515/zna-1966-0417; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WADE RH, 1992, ULTRAMICROSCOPY, V46, P145, DOI 10.1016/0304-3991(92)90011-8; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yoshioka C, 2010, MICROSC MICROANAL, V16, P43, DOI 10.1017/S1431927609991310; Zhu J, 1997, J STRUCT BIOL, V118, P197, DOI 10.1006/jsbi.1997.3845	72	337	352	10	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					438	449		10.1016/j.cell.2015.03.050	http://dx.doi.org/10.1016/j.cell.2015.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910204	Bronze, Green Accepted			2022-12-28	WOS:000353553600006
J	Favero, I				Favero, Ivan			OPTOMECHANICS Listening to quantum grains of sound	NATURE			English	Editorial Material								An optomechanical device has allowed quanta, or 'grains', of mechanical vibration to be counted by optical means. The system may open up new possibilities in acoustics and thermal engineering.	Univ Paris Diderot, CNRS, UMR 7162, Lab Mat & Phenomenes Quant, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Cite	Favero, I (corresponding author), Univ Paris Diderot, CNRS, UMR 7162, Lab Mat & Phenomenes Quant, F-75205 Paris, France.	ivan.favero@univ-paris-diderot.fr						Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Baker C, 2014, OPT EXPRESS, V22, P14072, DOI 10.1364/OE.22.014072; BROWN RH, 1956, NATURE, V178, P1046; Carmon T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.223902; Chan J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747726; Cohen JD, 2015, NATURE, V520, P522, DOI 10.1038/nature14349; Favero I, 2009, NAT PHOTONICS, V3, P201, DOI 10.1038/NPHOTON.2009.42; Hohberger CC, 2004, 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY, P419	8	0	0	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					441	442		10.1038/520441a	http://dx.doi.org/10.1038/520441a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903620				2022-12-28	WOS:000353334500023
J	Levy, A; Goren, MG; Yosef, I; Auster, O; Manor, M; Amitai, G; Edgar, R; Qimron, U; Sorek, R				Levy, Asaf; Goren, Moran G.; Yosef, Ido; Auster, Oren; Manor, Miriam; Amitai, Gil; Edgar, Rotem; Qimron, Udi; Sorek, Rotem			CRISPR adaptation biases explain preference for acquisition of foreign DNA	NATURE			English	Article							ADAPTIVE IMMUNE-SYSTEMS; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; SPACER ACQUISITION; RECBCD ENZYME; CAS SYSTEM; REPLICATION; PROKARYOTES; PLASMIDS; BACTERIA	CRISPR-Cas (clustered, regularly interspaced short palindromic repeats coupled with CRISPR-associated proteins) is a bacterial immunity system that protects against invading phages or plasmids. In the process of CRISPR adaptation, short pieces of DNA ('spacers') are acquired from foreign elements and integrated into the CRISPR array. So far, it has remained a mystery how spacers are preferentially acquired from the foreign DNA while the self chromosome is avoided. Here we show that spacer acquisition is replication-dependent, and that DNA breaks formed at stalled replication forks promote spacer acquisition. Chromosomal hotspots of spacer acquisition were confined by Chi sites, which are sequence octamers highly enriched on the bacterial chromosome, suggesting that these sites limit spacer acquisition from self DNA. We further show that the avoidance of self is mediated by the RecBCD double-stranded DNA break repair complex. Our results suggest that, in Escherichia coli, acquisition of new spacers largely depends on RecBCD-mediated processing of double-stranded DNA breaks occurring primarily at replication forks, and that the preference for foreign DNA is achieved through the higher density of Chi sites on the self chromosome, in combination with the higher number of forks on the foreign DNA. This model explains the strong preference to acquire spacers both from high copy plasmids and from phages.	[Levy, Asaf; Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Goren, Moran G.; Yosef, Ido; Auster, Oren; Manor, Miriam; Edgar, Rotem; Qimron, Udi] Tel Aviv Univ, Sackler Sch Med, Dep Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Qimron, U (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dep Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ehudq@post.tau.ac.il; rotem.sorek@weizmann.ac.il	Gazit, Ehud/AHE-9332-2022; Levy, Asaf/ABA-2623-2020	Qimron, Udi/0000-0003-2169-5270	Israel Science Foundation [1303/12, 1796, 268/14]; European Research Council [260432, 336079]; Human Frontier Science Program [RGP0011/2013]; Abisch-Frenkel foundation; Pasteur-Weizmann Council; Minerva Foundation; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft; Israeli Ministry of Health [9988-3]; Azrieli Foundation	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Abisch-Frenkel foundation; Pasteur-Weizmann Council; Minerva Foundation; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israeli Ministry of Health; Azrieli Foundation	We thank N. Barkai, A. Tanay, E. Mick, S. Doron, A. Stern, T. Dagan and M. Shamir for discussion. We also thank the Skarstad group for providing the MG1655dnaC2 strain, the Michel group for providing the JJC1819 strain and D. Dar for assistance in Illumina sequencing. R.S. was supported, in part, by the Israel Science Foundation (personal grant 1303/12 and I-CORE grant 1796), the European Research Council Starting Grant programme (grant 260432), Human Frontier Science Program (grant RGP0011/2013), the Abisch-Frenkel foundation, the Pasteur-Weizmann Council, the Minerva Foundation, and by a Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft. U.Q. was supported, in part, by the European Research Council Starting Grant programme (grant 336079), the Israel Science Foundation (grant 268/14) and the Israeli Ministry of Health (grant 9988-3). A.L. is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lin L., 1992, THESIS STATE U NEW Y; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shee C, 2013, ELIFE, V2, DOI 10.7554/eLife.01222; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Waldminghaus T, 2012, NUCLEIC ACIDS RES, V40, P5465, DOI 10.1093/nar/gks187; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	37	252	263	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					505	+		10.1038/nature14302	http://dx.doi.org/10.1038/nature14302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25874675	Green Accepted			2022-12-28	WOS:000353334500035
J	Lowe, CJ; Clarke, DN; Medeiros, DM; Rokhsar, DS; Gerhart, J				Lowe, Christopher J.; Clarke, D. Nathaniel; Medeiros, Daniel M.; Rokhsar, Daniel S.; Gerhart, John			The deuterostome context of chordate origins	NATURE			English	Review							HEMICHORDATE SACCOGLOSSUS-KOWALEVSKII; CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; SEA-URCHIN; BODY PLAN; HOX GENES; DEVELOPMENTAL EXPRESSION; GENOMIC ORGANIZATION; MOLECULAR PHYLOGENY; BILATERIAN ANIMALS	Our understanding of vertebrate origins is powerfully informed by comparative morphology, embryology and genomics of chordates, hemichordates and echinoderms, which together make up the deuterostome clade. Striking body-plan differences among these phyla have historically hindered the identification of ancestral morphological features, but recent progress in molecular genetics and embryology has revealed deep similarities in body-axis formation and organization across deuterostomes, at stages before morphological differences develop. These developmental genetic features, along with robust support of pharyngeal gill slits as a shared deuterostome character, provide the foundation for the emergence of chordates.	[Lowe, Christopher J.; Clarke, D. Nathaniel] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Medeiros, Daniel M.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Rokhsar, Daniel S.; Gerhart, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Okinawa Inst Sci & Technol, Onna, Okinawa 9040495, Japan; [Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA	Stanford University; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; Okinawa Institute of Science & Technology Graduate University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Lowe, CJ (corresponding author), Stanford Univ, Dept Biol, Hopkins Marine Stn, 120 Oceanview Blvd, Pacific Grove, CA 93950 USA.	clowe@stanford.edu	Clarke, Nat/L-2946-2019; Clarke, D. Nathaniel/K-7605-2019; Clarke, Donald/A-8212-2019	Clarke, Nat/0000-0002-9774-2582; Clarke, Donald/0000-0002-9774-2582; Lowe, Christopher/0000-0002-7789-8643; Rokhsar, Daniel/0000-0002-8704-2224; MEDEIROS, DANIEL/0000-0002-8182-6028	NASA [NNX13AI68G]; NSF [1258169, IOS1257040]; Okinawa Institute of Science and Technology; US National Institutes of Heath [R01 GM086321]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086321] Funding Source: NIH RePORTER; Direct For Biological Sciences [1258169] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); US National Institutes of Heath; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank K. Bertsche (http://wanderingfalcon.com), for the scientific illustrations, C. Patton and J. Watanabe for photography of invertebrate micrographs, K. Halanych and J. Cannon for providing pterobranch images, and J. Fritzenwanker for the German translation of Grobben, and helpful discussions. We apologize to authors whose work we were unable to cite due to space limitations, and thank M. Kirschner, A. Pani, T. Lacalli, N. Satoh and N. Holland for discussions that helped formulate these ideas. Support for this work was awarded to C.J.L from NASA (NNX13AI68G) and NSF (1258169), to D.M.M. from NSF (IOS1257040). D.S.R. is supported by the Okinawa Institute of Science and Technology and the US National Institutes of Heath through grant R01 GM086321. Work at the Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; [Anonymous], 2014, DEV GENOMICS ASCIDIA; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Aronowicz J, 2006, INTEGR COMP BIOL, V46, P890, DOI 10.1093/icb/icl045; BALSER EJ, 1990, ACTA ZOOL-STOCKHOLM, V71, P235, DOI 10.1111/j.1463-6395.1990.tb01082.x; Bateson W., 1886, Q J MICROSC SCI, V26, P535; Baughman KW, 2014, GENESIS, V52, P952, DOI 10.1002/dvg.22840; Beaster-Jones L, 2008, DEV GENES EVOL, V218, P599, DOI 10.1007/s00427-008-0257-5; Benito-Gutierrez E, 2009, CURR BIOL, V19, pR640, DOI 10.1016/j.cub.2009.06.020; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BONE Q, 1960, J COMP NEUROL, V115, P27, DOI 10.1002/cne.901150105; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Bullock TH, 1940, BIOL BULL-US, V79, P91, DOI 10.2307/1537832; BULLOCK TH, 1945, Q J MICROSC SCI, V86, P55; Cameron CB, 1996, CAN J ZOOL, V74, P15, DOI 10.1139/z96-003; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Conklin EG, 1932, J MORPHOL, V54, P69, DOI 10.1002/jmor.1050540103; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Darwin C., 1871, P475; David B, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-22; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Erwin D. H., 2013, CAMBRIAN EXPLOSION; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Escriva H, 2002, DEVELOPMENT, V129, P2905; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Freeman RM, 2008, BIOL BULL-US, V214, P284, DOI 10.2307/25470670; Freeman R, 2012, CURR BIOL, V22, P2053, DOI 10.1016/j.cub.2012.08.052; Fritzenwanker JH, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-17; Garstang W, 1929, Q J MICROSC SCI, V72, P51; Gee H, 1996, BEFORE THE BACKBONE; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Gerhart J, 2001, INT J DEV BIOL, V45, P133; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gonzalez P, 2009, BIOL J LINN SOC, V98, P898, DOI 10.1111/j.1095-8312.2009.01332.x; Green SA, 2013, DEVELOPMENT, V140, P1024, DOI 10.1242/dev.083790; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Gudo M, 2008, 100 YEARS DEUTEROSTO; Haeckel E., 1874, ANTHROPOGENIE ODER E; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Hara Y, 2006, DEV GENES EVOL, V216, P797, DOI 10.1007/s00427-006-0108-1; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Henry JQ, 2008, DEV BIOL, V317, P368, DOI 10.1016/j.ydbio.2008.02.042; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Holland LZ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-27; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Hyman L.H., 1959, INVERTEBRATES; Irimia M, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-7; Jandzik D, 2015, NATURE, V518, P534, DOI 10.1038/nature14000; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; Kaul S, 2010, J MORPHOL, V271, P1240, DOI 10.1002/jmor.10868; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KNIGHTJONES EW, 1952, PHILOS T ROY SOC B, V236, P315, DOI 10.1098/rstb.1952.0004; Kowalevsky A., 1866, ARCH MIKROSK ANAT, V7, P101; Kowalevsky A., 1866, M EMOIRES LACADEMIE, V7, P16; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Lacalli TC, 2005, CAN J ZOOL, V83, P216, DOI 10.1139/Z04-162; Lacalli T, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-46; Lacalli TC, 2010, ACTA ZOOL-STOCKHOLM, V91, P4, DOI 10.1111/j.1463-6395.2008.00384.x; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Lauri A, 2014, SCIENCE, V345, P1365, DOI 10.1126/science.1253396; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Lu TM, 2012, DEVELOPMENT, V139, P2020, DOI 10.1242/dev.073833; Luttrell S, 2012, INTEGR COMP BIOL, V52, P829, DOI 10.1093/icb/ics117; Martin-Duran JM, 2012, CURR BIOL, V22, P2161, DOI 10.1016/j.cub.2012.09.037; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Mazet F, 2006, CURR BIOL, V16, pR314, DOI 10.1016/j.cub.2006.03.088; Metschnikoff V.E., 1881, ZOOL ANZ, V4, P139; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Miyamoto N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3713; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Morgan T, 1894, J MORPHOL, V9, P1, DOI DOI 10.1002/JMOR.1050090102; Morris VB, 2014, DEV GENES EVOL, V224, P1, DOI 10.1007/s00427-013-0457-5; Nielsen C, 1999, DEV GENES EVOL, V209, P198, DOI 10.1007/s004270050244; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Omori A, 2011, GENE EXPR PATTERNS, V11, P48, DOI 10.1016/j.gep.2010.09.002; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2000, EVOL DEV, V2, P93, DOI 10.1046/j.1525-142x.2000.00042.x; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Range RC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001467; Rottinger E, 2011, DEV BIOL, V354, P173, DOI 10.1016/j.ydbio.2011.03.030; Rottinger E, 2012, DEVELOPMENT, V139, P2463, DOI 10.1242/dev.066712; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Sato A, 2008, GENESIS, V46, P587, DOI 10.1002/dvg.20395; Satoh N, 2008, GENESIS, V46, P614, DOI 10.1002/dvg.20416; Satoh N, 2014, GENESIS, V52, P925, DOI 10.1002/dvg.22831; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stach T, 2008, J ZOOL, V276, P117, DOI 10.1111/j.1469-7998.2008.00497.x; Swalla BJ, 2006, HEREDITY, V97, P235, DOI 10.1038/sj.hdy.6800872; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Wicht H, 2005, CAN J ZOOL, V83, P122, DOI 10.1139/Z04-163; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Wright GM, 2001, CELL TISSUE RES, V304, P165, DOI 10.1007/s004410100374; Yankura KA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-143; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	120	80	82	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					456	465		10.1038/nature14434	http://dx.doi.org/10.1038/nature14434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903627				2022-12-28	WOS:000353334500029
J	Marlin, BJ; Mitre, M; D'amour, JA; Chao, MV; Froemke, RC				Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.			Oxytocin enables maternal behaviour by balancing cortical inhibition	NATURE			English	Article							MOUSE AUDITORY-CORTEX; ULTRASONIC COMMUNICATION; CENTRAL AMYGDALA; SOCIAL-BEHAVIOR; MICE; VASOPRESSIN; RECOGNITION; PARTURITION; NEURONS; HYPOTHALAMUS	Oxytocin is important for social interactions and maternal behaviour. However, little is known about when, where and how oxytocin modulates neural circuits to improve social cognition. Here we show how oxytocin enables pup retrieval behaviour in female mice by enhancing auditory cortical pup call responses. Retrieval behaviour required the left but not right auditory cortex, was accelerated by oxytocin in the left auditory cortex, and oxytocin receptors were preferentially expressed in the left auditory cortex. Neural responses to pup calls were lateralized, with co-tuned and temporally precise excitatory and inhibitory responses in the left cortex of maternal but not pup-naive adults. Finally, pairing calls with oxytocin enhanced responses by balancing the magnitude and timing of inhibition with excitation. Our results describe fundamental synaptic mechanisms by which oxytocin increases the salience of acoustic social stimuli. Furthermore, oxytocin-induced plasticity provides a biological basis for lateralization of auditory cortical processing.	[Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Neurosci Inst, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Froemke, Robert C.] NYU, Sch Med, Dept Otolaryngol, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Mitre, Mariela; Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Mitre, Mariela; Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Chao, Moses V.; Froemke, Robert C.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University; New York University; New York University; New York University; New York University; New York University	Froemke, RC (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	robert.froemke@med.nyu.edu		Froemke, Robert/0000-0002-1230-6811; Chao, Moses/0000-0002-6969-3744	NIDCD [DC009635, DC12557]; Klingenstein Fellowship; McKnight Scholarship; Pew Scholarship; Sloan Research Fellowship; Whitehead Foundation; Skirball Institute Collaborative Research Award; NIMH [T32]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS021072, T32NS086750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012557, K99DC009635, R00DC009635] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Klingenstein Fellowship(Klingenstein Philanthropies); McKnight Scholarship; Pew Scholarship; Sloan Research Fellowship(Alfred P. Sloan Foundation); Whitehead Foundation; Skirball Institute Collaborative Research Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank V. Azzara, R. Alicka, H. Bernstein, G. Buzsaki, I. Carcea, C. Grosso, M. Insanally, M. Jin, K. Kuchibhotla, B. Y. B. Lau, D. Lin, M. A. Long, N. Lopez, J. Marlin, C. McFarlane, E. Morina, S. Norden, D. Okobi, K. Peng, R. Priya, W. Rashid, L. Rubin, S. Shea, R. M. Sullivan, R. W. Tsien, D. Vallentin, L. J. Young and N. Zaika for comments, discussions and technical assistance, A. Mar and the NYU School of Medicine Behavioral Core for assistance with behavioural analysis, and C. A. Loomis and the NYU School of Medicine Histology Core for assistance with anatomical studies. Oxytocin-IRES-Cre mice were obtained from D. Olson and B. Lowell. Oxytocin receptor knockout mice were obtained from R. W. Tsien. Oxytocin receptor plasmid (pAAV-OXTR) was obtained from L. J. Young. Adeno-associated virus was obtained from the U. Penn Vector Core. S. E. Ross created artwork in Fig. 1a. This work was funded by NIDCD (DC009635, DC12557), a Klingenstein Fellowship, a McKnight Scholarship, a Pew Scholarship, a Sloan Research Fellowship, and a Whitehead Foundation Fellowship (R.C.F.); a Skirball Institute Collaborative Research Award (M. V. C. and R.C.F.); and NIMH (T32; B.J.M.).	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bennur S, 2013, HEARING RES, V305, P3, DOI 10.1016/j.heares.2013.08.008; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Chang SWC, 2014, BRAIN RES, V1580, P57, DOI 10.1016/j.brainres.2013.11.006; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fichtel I, 1999, NEUROREPORT, V10, P2341, DOI 10.1097/00001756-199908020-00022; Fraser EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090368; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; HOFSTETTER KM, 1992, J COMP NEUROL, V323, P370, DOI 10.1002/cne.903230306; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Irani BG, 2010, NEUROSCIENCE, V170, P1065, DOI 10.1016/j.neuroscience.2010.07.064; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; KOCH M, 1989, PHYSIOL BEHAV, V45, P771, DOI 10.1016/0031-9384(89)90293-X; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; LORING DW, 1990, NEUROPSYCHOLOGIA, V28, P831, DOI 10.1016/0028-3932(90)90007-B; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; RICHARD P, 1991, PHYSIOL REV, V71, P331, DOI 10.1152/physrev.1991.71.2.331; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; Rudick CN, 2001, J NEUROSCI, V21, P6532, DOI 10.1523/JNEUROSCI.21-17-06532.2001; SEWELL GD, 1970, NATURE, V227, P410, DOI 10.1038/227410a0; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; Wacker DW, 2012, HORM BEHAV, V61, P259, DOI 10.1016/j.yhbeh.2011.08.014; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WINSLOW JT, 1991, J NEUROSCI, V11, P2032; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	56	368	376	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					499	+		10.1038/nature14402	http://dx.doi.org/10.1038/nature14402			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25874674	Green Accepted			2022-12-28	WOS:000353334500034
J	Fottrell, E				Fottrell, Edward			Commentary: The emperor's new phone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL Inst Global Hlth, Epidemiol & Global Hlth, London, England	University of London; University College London	Fottrell, E (corresponding author), UCL Inst Global Hlth, Epidemiol & Global Hlth, London, England.	e.fottrell@ucl.ac.uk		Fottrell, Edward/0000-0003-0518-7161				Bricker JB, 2014, DRUG ALCOHOL DEPEN, V143, P87, DOI 10.1016/j.drugalcdep.2014.07.006; Douglas TS, 2012, SAMJ S AFR MED J, V102, P456, DOI 10.7196/SAMJ.5553; Hall CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25606; Keller B, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2982; Kosmala-Anderson JP, 2014, ARCH MED SCI, V10, P773, DOI 10.5114/aoms.2014.44869; Labrique A., 2015, DAY 2 MORNING S 0128; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Mann DM, 2013, STUD HEALTH TECHNOL, V192, P973, DOI 10.3233/978-1-61499-289-9-973; Mehl G., 2015, DAY 1 MORNING S 0127; Rodrigues R., 2015, DAY 2 MORNING S 0128; Smith C., 2015, DAY 2 MORNING S 0128; Steinberg DM, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2844; UCL Institute for Global Health, 2015, MHEALTH CAN MOB TECH	13	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2051	10.1136/bmj.h2051	http://dx.doi.org/10.1136/bmj.h2051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25903083				2022-12-28	WOS:000353576700008
J	Davis, BJ; Estes, AR				Davis, Benjamin J.; Estes, A. Reed			An Adolescent With Right Shin Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS-FRACTURES		[Davis, Benjamin J.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Orthopaed Surg, Birmingham, AL 35233 USA; [Estes, A. Reed] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Estes, AR (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Surg, Div Orthopaed Surg, 1600 Seventh Ave 5,Lowder Bldg Ste 402, Birmingham, AL 35233 USA.	aestes@uabmc.edu						Boden B P, 2000, J Am Acad Orthop Surg, V8, P344; Fredericson Michael, 2006, Top Magn Reson Imaging, V17, P309; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Kaeding CC, 2005, CLIN J SPORT MED, V15, P442, DOI 10.1097/01.jsm.0000188207.62608.35; Koester MC, 2006, CLIN SPORT MED, V25, P63, DOI 10.1016/j.csm.2005.08.004; MATHESON GO, 1987, AM J SPORT MED, V15, P46, DOI 10.1177/036354658701500107; Rauh MJ, 2010, J ATHL TRAINING, V45, P243, DOI 10.4085/1062-6050-45.3.243; RETTIG AC, 1988, AM J SPORT MED, V16, P250, DOI 10.1177/036354658801600309; Warden Stuart J, 2006, Curr Osteoporos Rep, V4, P103; Ziltener J. -L., 2010, Annals of Physical and Rehabilitation Medicine, V53, P278, DOI 10.1016/j.rehab.2010.03.001	10	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1566	1567		10.1001/jama.2014.17016	http://dx.doi.org/10.1001/jama.2014.17016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898055				2022-12-28	WOS:000353198700022
J	Freitag, A; Kirkwood, G; Pollock, AM				Freitag, Andreas; Kirkwood, Graham; Pollock, Allyson M.			Rugby injury surveillance and prevention programmes: are they effective?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; METAANALYSIS; UNION; SPORT		[Freitag, Andreas; Kirkwood, Graham; Pollock, Allyson M.] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England	University of London; Queen Mary University London	Pollock, AM (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				[Anonymous], 2015, BBC; [Anonymous], 2014, TVNZ 2014 JUL 8; Apple iTunes Store. Rugby Smart app, RUGB SMART APP; Australian Rugby. Smart Rugby, SMART RUGB; BokSmart. Medical Protocols, MED PROT; Brown JC, 2014, INJURY PREV, DOI [10.1136/injuryprev-2014-04132, DOI 10.1136/INJURYPREV-2014-04132]; Bull A, 2013, GUARDIAN; Carmody DJ, 2005, MED J AUSTRALIA, V182, P561, DOI 10.5694/j.1326-5377.2005.tb06814.x; Carter M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h26; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Coaching Toolbox. RugbySmart, RUGBYSMART; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Department for Culture Media and Sport, 2012, CREAT SPORT HAB LIF; Dowswell T, 1996, Inj Prev, V2, P140, DOI 10.1136/ip.2.2.140; England Rugby, 2014, INJ REP; England Rugby. Governance. Regulations, 2013, GOV REG; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Irish Rugby Football Union, SER INJ REP FORM; Jenkins G, 2013, ESPN 2013 SEP 5; Kaplan KM, 2008, BULL HOSP JT DIS, V66, P86; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; MCCOY GF, 1984, J BONE JOINT SURG BR, V66, P500, DOI 10.1302/0301-620X.66B4.6746681; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; New Zealand Rugby Union, INJ REP; O'Rourke KP, 2007, INJURY, V38, P104, DOI 10.1016/j.injury.2006.06.010; PriceWaterhouseCoopers, 2008, ACC COMP CORP NZ SCH; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Rugby Football History, HIST LAWS RUGBY FOOT; Rugby Football Union, COMM RYGB INJ SURV P; Rugby Football Union, 2014, ENGL PROF RUGB SURV; Rugby League International Federation, 2015, RANK; Scottish Rugby. RugbyReady practical course, RUGBYREADY PRACT PRA; Six Nations Rugby, 2014, RBS 6 NAT 2014; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; University of Bath, FMC RUGB PROJ; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	44	25	25	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h1587	10.1136/bmj.h1587	http://dx.doi.org/10.1136/bmj.h1587			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25900039	Green Published			2022-12-28	WOS:000353576300001
J	Bottke, WF; Vokrouhlicky, D; Marchi, S; Swindle, T; Scott, ERD; Weirich, JR; Levison, H				Bottke, W. F.; Vokrouhlicky, D.; Marchi, S.; Swindle, T.; Scott, E. R. D.; Weirich, J. R.; Levison, H.			Dating the Moon-forming impact event with asteroidal meteorites	SCIENCE			English	Article							TERRESTRIAL PLANET FORMATION; CHONDRITE PARENT BODIES; GIANT IMPACT; HEMISPHERIC DICHOTOMY; HEAVY BOMBARDMENT; DISTRIBUTIONS; EARTH; CHRONOLOGY; COLLISIONS; BELT	The inner solar system's biggest and most recent known collision was the Moon-forming giant impact between a large protoplanet and proto-Earth. Not only did it create a disk near Earth that formed the Moon, it also ejected several percent of an Earth mass out of the Earth-Moon system. Here, we argue that numerous kilometer-sized ejecta fragments from that event struck main-belt asteroids at velocities exceeding 10 kilometers per second, enough to heat and degas target rock. Such impacts produce similar to 1000 times more highly heated material by volume than do typical main belt collisions at similar to 5 kilometers per second. By modeling their temporal evolution, and fitting the results to ancient impact heating signatures in stony meteorites, we infer that the Moon formed similar to 4.47 billion years ago, which is in agreement with previous estimates.	[Bottke, W. F.; Marchi, S.; Levison, H.] SW Res Inst, Boulder, CO 80302 USA; [Bottke, W. F.; Marchi, S.; Levison, H.] NASA, SSERVI, ISET, Boulder, CO USA; [Vokrouhlicky, D.] Charles Univ Prague, Inst Astron, CZ-18000 Prague 8, Czech Republic; [Swindle, T.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Swindle, T.] SSERVI Ctr Lunar Sci Explorat, Houston, TX USA; [Scott, E. R. D.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Weirich, J. R.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	National Aeronautics & Space Administration (NASA); Charles University Prague; University of Arizona; University of Hawaii System; University of Hawaii Manoa; Western University (University of Western Ontario)	Bottke, WF (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	bottke@boulder.swri.edu	Vokrouhlický, David/Q-4359-2017	Vokrouhlický, David/0000-0002-6034-5452; Weirich, John/0000-0002-2830-1708	NASA's SSERVI program [NNA14AB03A, NNA14AB07A]; Czech Grant Agency [P209-13-01308S]	NASA's SSERVI program; Czech Grant Agency(Grant Agency of the Czech Republic)	We thank R. Canup, B. Cohen, A. Jackson, A. Parker, P. Renne, and J. Salmon for many useful discussions and our referees for their numerous constructive comments. W.F.B, S.M., and T.S.'s participation was supported by NASA's SSERVI program through institute grant numbers NNA14AB03A and NNA14AB07A. The work of D.V. was partially supported by research grant P209-13-01308S of the Czech Grant Agency. Resources supporting this work were provided by the NASA High-End Computing Program through the NASA Advanced Supercomputing Division at Ames Research Center. Data are available in the main text, supplementary materials, or upon request.	Bogard DD, 2011, CHEM ERDE-GEOCHEM, V71, P207, DOI 10.1016/j.chemer.2011.03.001; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Durda DD, 2007, ICARUS, V186, P498, DOI 10.1016/j.icarus.2006.09.013; Hopp J, 2014, METEORIT PLANET SCI, V49, P358, DOI 10.1111/maps.12243; Jackson AP, 2012, MON NOT R ASTRON SOC, V425, P657, DOI 10.1111/j.1365-2966.2012.21546.x; Jones RH, 2014, GEOCHIM COSMOCHIM AC, V132, P120, DOI 10.1016/j.gca.2014.01.027; Kennedy T, 2013, GEOCHIM COSMOCHIM AC, V115, P162, DOI 10.1016/j.gca.2013.03.040; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Marchi S, 2014, NATURE, V511, P578, DOI 10.1038/nature13539; Marchi S, 2013, NAT GEOSCI, V6, P303, DOI [10.1038/ngeo1769, 10.1038/NGEO1769]; Marinova MM, 2008, NATURE, V453, P1216, DOI 10.1038/nature07070; McSween HY, 2013, METEORIT PLANET SCI, V48, P2090, DOI 10.1111/maps.12108; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Nesvorny D., 2012, NESVORNY HCM ASTEROI; Nimmo F, 2008, NATURE, V453, P1220, DOI 10.1038/nature07025; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Swindle T. D., 2013, SPECIAL PUBLICATIONS, V378, P333; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348	28	62	67	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					321	323		10.1126/science.aaa0602	http://dx.doi.org/10.1126/science.aaa0602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883354				2022-12-28	WOS:000352999000040
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Palliative care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1861	10.1136/bmj.h1861	http://dx.doi.org/10.1136/bmj.h1861			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25876989				2022-12-28	WOS:000353328000006
J	Shore, S; Ho, PM; Lambert-Kerzner, A; Glorioso, TJ; Carey, EP; Cunningham, F; Longo, L; JackeviciusPharmD, C; Rose, A; Turakhia, MP				Shore, Supriya; Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.; Cunningham, Fran; Longo, Lisa; Jackevicius, Cynthia; Rose, Adam; Turakhia, Mintu P.			Site-Level Variation in and Practices Associated With Dabigatran Adherence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-FIBRILLATION; MEDICATION ADHERENCE; STROKE PREVENTION; PHARMACY RECORDS; PATIENT-OUTCOMES; HEALTH; ANTICOAGULATION; WARFARIN; CARE; INSIGHTS	IMPORTANCE Unlike warfarin, which requires routine laboratory testing and dose adjustment, target-specific oral anticoagulants like dabigatran do not. However, optimal follow-up infrastructure and modifiable site-level factors associated with improved adherence to dabigatran are unknown. OBJECTIVES To assess site-level variation in dabigatran adherence and to identify site-level practices associated with higher dabigatran adherence. DESIGN, SETTING, AND PARTICIPANTS Mixed-methods study involving retrospective quantitative and cross-sectional qualitative data. A total of 67 Veterans Health Administration sites with 20 or more patients filling dabigatran prescriptions between 2010 and 2012 for nonvalvular atrial fibrillation were sampled (4863 total patients; median, 51 patients per site). Forty-seven pharmacists from 41 eligible sites participated in the qualitative inquiry. EXPOSURE Site-level practices identified included appropriate patient selection, pharmacist-driven patient education, and pharmacist-led adverse event and adherence monitoring. MAIN OUTCOMES AND MEASURES Dabigatran adherence (intensity of drug use during therapy) defined by proportion of days covered (ratio of days supplied by prescription to follow-up duration) of 80% or more. RESULTS The median proportion of patients adherent to dabigatran was 74% (interquartile range [IQR], 66%-80%). After multivariable adjustment, dabigatran adherence across sites varied by a median odds ratio of 1.57. Review of practices across participating sites showed that appropriate patient selection was performed at 31 sites, pharmacist-led education was provided at 30 sites, and pharmacist-led monitoring at 28 sites. The proportion of adherent patients was higher at sites performing appropriate selection (75% vs 69%), education (76% vs 66%), and monitoring (77% vs 65%). Following multivariable adjustment, association between pharmacist-led education and dabigatran adherence was not statistically significant (relative risk [RR], 0.94; 95% Cl, 0.83-1.06). Appropriate patient selection (RR, 1.14; 95% Cl, 1.05-1.25), and provision of pharmacist-led monitoring (RR, 1.25; 95% Cl, 1.11-1.40 were associated with better patient adherence. Additionally, longer duration of monitoring and providing more intensive care to nonadherent patients in collaboration with the clinician improved adherence. CONCLUSIONS AND RELEVANCE Among nonvalvular atrial fibrillation patients treated with dabigatran, there was variability in patient medication adherence across Veterans Health Administration sites. Specific pharmacist-based activities were associated with greater patient adherence to dabigatran.	[Shore, Supriya] Emory Univ, Sch Med, Atlanta, GA USA; [Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Ho, P. Michael; Glorioso, Thomas J.; Carey, Evan P.] Univ Colorado, Aurora, CO USA; [Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA; [Cunningham, Fran; Longo, Lisa] Pharm Benefits Management Serv, Vet Affairs, Hines, IL USA; [Cunningham, Fran; Longo, Lisa] Ctr Medicat Safety, Hines, IL USA; [Jackevicius, Cynthia] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Jackevicius, Cynthia] Western Univ Hlth Sci, Pomona, CA USA; [Rose, Adam] Bedford Veterabs Affairs Med Ctr, Bedford, MA USA; [Rose, Adam] Boston Univ, Boston, MA 02215 USA; [Turakhia, Mintu P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Turakhia, Mintu P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Western University of Health Sciences; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Turakhia, MP (corresponding author), VA Palo Alto Hlth Care Syst, Dept Cardiol, 3801 Miranda Ave,Ste 111C, Palo Alto, CA 94304 USA.	mintu@stanford.edu	Rose, Adam/HHY-9078-2022	Rose, Adam/0000-0001-8681-6155; Turakhia, Minang/0000-0001-8025-0904	Career Development Award from VA Health Services Research Development; American Heart Association National Scientist Development Grant; Gilead Sciences Cardiovascular Research Scholars Program award	Career Development Award from VA Health Services Research Development; American Heart Association National Scientist Development Grant(American Heart Association); Gilead Sciences Cardiovascular Research Scholars Program award	Dr Turakhia is supported by a Career Development Award from VA Health Services Research & Development, an American Heart Association National Scientist Development Grant, and a Gilead Sciences Cardiovascular Research Scholars Program award.	Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Davis EM, 2014, J MANAG CARE SPEC PH, V20, P741, DOI 10.18553/jmcp.2014.20.7.741; Ho PM, 2014, JAMA INTERN MED, V174, P186, DOI 10.1001/jamainternmed.2013.12944; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hojsgaard S, 2006, J STAT SOFTW, V15; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tsai K, 2013, AM J MANAG CARE, V19; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Turakhia MP, 2013, AM HEART J, V165, P93, DOI 10.1016/j.ahj.2012.10.010; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183	24	100	101	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1443	1450		10.1001/jama.2015.2761	http://dx.doi.org/10.1001/jama.2015.2761			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871670	Bronze			2022-12-28	WOS:000352821200020
J	Oberg, KI; Guzman, VV; Furuya, K; Qi, CH; Aikawa, Y; Andrews, SM; Loomis, R; Wilner, DJ				Oeberg, Karin I.; Guzman, Viviana V.; Furuya, Kenji; Qi, Chunhua; Aikawa, Yuri; Andrews, Sean M.; Loomis, Ryan; Wilner, David J.			The comet-like composition of a protoplanetary disk as revealed by complex cyanides	NATURE			English	Article							T-TAURI STARS; CO SNOW LINE; CHEMICAL-COMPOSITION; X-RAY; ORGANIC-MOLECULES; IMAGING SURVEY; AMINO-ACIDS; LOW-MASS; DM-TAU; CHEMISTRY	Observations of comets and asteroids show that the solar nebula that spawned our planetary system was rich in water and organic molecules. Bombardment brought these organics to the young Earth's surface(1). Unlike asteroids, comets preserve a nearly pristine record of the solar nebula composition. The presence of cyanides in comets, including 0.01 per cent of methyl cyanide (CH3CN) with respect to water, is of special interest because of the importance of C-N bonds for abiotic amino acid synthesis(2). Comet-like compositions of simple and complex volatiles are found in protostars, and can readily be explained by a combination of gas-phase chemistry (to form, for example, HCN) and an active ice-phase chemistry on grain surfaces that advances complexity(3). Simple volatiles, including water and HCN, have been detected previously in solar nebula analogues, indicating that they survive disk formation or are re-formed in situ(4-7). It has hitherto been unclear whether the same holds for more complex organic molecules outside the solar nebula, given that recent observations show a marked change in the chemistry at the boundary between nascent envelopes and young disks due to accretion shocks(8). Here we report the detection of the complex cyanides CH3CN and HC3N (and HCN) in the protoplanetary disk around the young star MWC 480. We find that the abundance ratios of these nitrogen-bearing organics in the gas phase are similar to those in comets, which suggests an even higher relative abundance of complex cyanides in the disk ice. This implies that complex organics accompany simpler volatiles in protoplanetary disks, and that the rich organic chemistry of our solar nebula was not unique.	[Oeberg, Karin I.; Guzman, Viviana V.; Qi, Chunhua; Andrews, Sean M.; Loomis, Ryan; Wilner, David J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Furuya, Kenji] Leiden Univ, Leiden Observ, NL-2300 CA Leiden, Netherlands; [Aikawa, Yuri] Kobe Univ, Nada Ward, Kobe, Hyogo 6570013, Japan	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Leiden University; Leiden University - Excl LUMC; Kobe University	Oberg, KI (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	koberg@cfa.harvard.edu	guzman, viviana/C-6328-2015; Furuya, Kenji/AAY-4836-2020	guzman, viviana/0000-0003-4784-3040; Loomis, Ryan/0000-0002-8932-1219; Wilner, David/0000-0003-1526-7587; Andrews, Sean/0000-0003-2253-2270	Simons Collaboration on the Origins of Life (SCOL); Alfred P. Sloan Foundation; David and Lucile Packard Foundation; NASA Origins of Solar Systems [NNX11AK63]	Simons Collaboration on the Origins of Life (SCOL); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA Origins of Solar Systems(National Aeronautics & Space Administration (NASA))	We acknowledge comments from E. van Dishoeck. This Letter makes use of ALMA data. ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO,AUI/NRAO and NAOJ. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. K.I.O. acknowledges A. Leroy and the NAASC for assistance with calibration and imaging, and also acknowledges funding from the Simons Collaboration on the Origins of Life (SCOL), the Alfred P. Sloan Foundation, and the David and Lucile Packard Foundation. D.J.W. acknowledges funding from NASA Origins of Solar Systems (grant no. NNX11AK63).	Aikawa Y, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/40; Aikawa Y, 1999, ASTRON ASTROPHYS, V351, P233; Bergin E, 2003, ASTROPHYS J, V591, pL159, DOI 10.1086/377148; Brinch C, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201015333; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Cleeves LI, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/204; Collings MP, 2004, MON NOT R ASTRON SOC, V354, P1133, DOI 10.1111/j.1365-2966.2004.08272.x; D'Alessio P., 2004, IAU S, V221, P403; Dartois E, 2003, ASTRON ASTROPHYS, V399, P773, DOI 10.1051/0004-6361:20021638; Dubernet ML, 2012, ASTR SOC P, V461, P335; Dutrey A, 2007, ASTRON ASTROPHYS, V464, P615, DOI 10.1051/0004-6361:20065385; Favre C, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L38; Fayolle EC, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016121; Furuya K, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/97; Garrod RT, 2006, ASTRON ASTROPHYS, V457, P927, DOI 10.1051/0004-6361:20065560; Goldman N, 2010, NAT CHEM, V2, P949, DOI [10.1038/nchem.827, 10.1038/NCHEM.827]; Graninger DM, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/74; Gratier P, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321031; Guilloteau S, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015209; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; LYNDENBELL D, 1974, MON NOT R ASTRON SOC, V168, P603, DOI 10.1093/mnras/168.3.603; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Nomura H, 2007, ASTROPHYS J, V661, P334, DOI 10.1086/513419; Oberg KI, 2010, ASTROPHYS J, V720, P480, DOI 10.1088/0004-637X/720/1/480; Oberg KI, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/98; Pietu V, 2006, ASTRON ASTROPHYS, V460, pL43, DOI 10.1051/0004-6361:20065968; Pizzarello S, 2012, METEORIT PLANET SCI, V47, P1291, DOI 10.1111/j.1945-5100.2012.01390.x; Pontoppidan KM, 2010, ASTROPHYS J, V720, P887, DOI 10.1088/0004-637X/720/1/887; Qi CH, 2008, ASTROPHYS J, V681, P1396, DOI 10.1086/588516; Qi CH, 2013, SCIENCE, V341, P630, DOI 10.1126/science.1239560; Qi CH, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/84; Rosenfeld KA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/136; Sakai N, 2014, NATURE, V507, P78, DOI 10.1038/nature13000; Simon M, 2000, ASTROPHYS J, V545, P1034, DOI 10.1086/317838; Takami M, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/71; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; van Dishoeck EF, 2006, FARADAY DISCUSS, V133, P231, DOI 10.1039/b517564j; VANDISHOECK EF, 1995, ASTROPHYS J, V447, P760, DOI 10.1086/175915; Wakelam V, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/1/21; Walsh C, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322446; Walsh C, 2013, ASTROPHYS J LETT, V766, DOI 10.1088/2041-8205/766/2/L23; Walsh C, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/114; Walsh C, 2010, ASTROPHYS J, V722, P1607, DOI 10.1088/0004-637X/722/2/1607; Wernli M, 2007, ASTRON ASTROPHYS, V464, P1147, DOI 10.1051/0004-6361:20066112; YAMAMOTO T, 1983, ASTRON ASTROPHYS, V122, P171	57	156	158	6	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					198	U128		10.1038/nature14276	http://dx.doi.org/10.1038/nature14276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855455	Green Submitted			2022-12-28	WOS:000352454600033
J	Appleby, J				Appleby, John			DATA BRIEFING The NHS in Wales: faring worse than the rest of the UK?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d566; Bevan G., 2014, 4 HLTH SYSTEMS UK TH; Department of Health Social Services and Public Safety, 2015, EM WAIT TIM; HM Treasury, 2014, CM8902; Hunt J, 2015, HERES WHY LABOURS AT; Information Serves Division, 2015, DAT TABL EM CAR; Lupton R, 2015, COALITIONS SOCIAL PO; Navarro V, 2002, AM J PUBLIC HEALTH, V92, P31, DOI 10.2105/AJPH.92.1.31; NHS England, 2015, A E ATT EM ADM; NHS Wales Informatics, 2015, ACC EM; Williams A, 2001, HEALTH ECON, V10, P93, DOI 10.1002/hec.594; World Health Organization, 2000, WORLD HLTH REP 2000	12	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1750	10.1136/bmj.h1750	http://dx.doi.org/10.1136/bmj.h1750			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9SR	25855644				2022-12-28	WOS:000352907500003
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Innovation team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1749	10.1136/bmj.h1749	http://dx.doi.org/10.1136/bmj.h1749			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25855656				2022-12-28	WOS:000352907500002
J	Buyse, GM; Voit, T; Schara, U; Straathof, CSM; D'Angelo, MG; Bernert, G; Cuisset, JM; Finkel, RS; Goemans, N; McDonald, CM; Rummey, C; Meier, T				Buyse, Gunnar M.; Voit, Thomas; Schara, Ulrike; Straathof, Chiara S. M.; D'Angelo, M. Grazia; Bernert, Guenther; Cuisset, Jean-Marie; Finkel, Richard S.; Goemans, Nathalie; McDonald, Craig M.; Rummey, Christian; Meier, Thomas		DELOS Study Grp	Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial	LANCET			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PEAK EXPIRATORY FLOW; NEUROMUSCULAR DISEASE; NATURAL-HISTORY; MUSCLE WEAKNESS; ULNA LENGTH; COUGH FLOW; IMPAIRMENT; PREVENTION; PREDICTION	Background Cardiorespiratory failure is the leading cause of death in Duchenne muscular dystrophy. Based on preclinical and phase 2 evidence, we assessed the efficacy and safety of idebenone in young patients with Duchenne muscular dystrophy who were not taking concomitant glucocorticoids. Methods In a multicentre phase 3 trial in Belgium, Germany, the Netherlands, Switzerland, France, Sweden, Austria, Italy, Spain, and the USA, patients (age 10-18 years old) with Duchenne muscular dystrophy were randomly assigned in a one-to-one ratio with a central interactive web response system with a permuted block design with four patients per block to receive idebenone (300 mg three times a day) or matching placebo orally for 52 weeks. Study personnel and patients were masked to treatment assignment. The primary endpoint was change in peak expiratory flow (PEF) as percentage predicted (PEF% p) from baseline to week 52, measured with spirometry. Analysis was by intention to treat (ITT) and a modified ITT (mITT), which was prospectively defined to exclude patients with at least 20% difference in the yearly change in PEF% p, measured with hospital-based and weekly home-based spirometry. This study is registered with ClinicalTrials.gov, number NCT01027884. Findings 31 patients in the idebenone group and 33 in the placebo group comprised the ITT population, and 30 and 27 comprised the mITT population. Idebenone significantly attenuated the fall in PEF% p from baseline to week 52 in the mITT (-3.05% p [95% CI -7.08 to 0.97], p=0.134, vs placebo -9.01% p [-13.18 to -4.84], p=0.0001; difference 5.96% p [0.16 to 11.76], p=0.044) and ITT populations (-2.57% p [-6.68 to 1.54], p=0.215, vs -8.84% p [-12.73 to -4.95], p<0.0001; difference 6.27% p [0.61 to 11.93], p=0.031). Idebenone also had a significant effect on PEF (L/min), weekly home-based PEF, FVC, and FEV1. The effect of idebenone on respiratory function outcomes was similar between patients with previous corticosteroid use and steroid-naive patients. Treatment with idebenone was safe and well tolerated with adverse event rates were similar in both groups. Nasopharyngitis and headache were the most common adverse events (idebenone, eight [25%] and six [19%] of 32 patients; placebo, nine [26%] and seven [21%] of 34 patients). Transient and mild diarrhoea was more common in the idebenone group than in the placebo group (eight [25%] vs four [12%] patients). Interpretation Idebenone reduced the loss of respiratory function and represents a new treatment option for patients with Duchenne muscular dystrophy.	[Buyse, Gunnar M.; Goemans, Nathalie] Univ Hosp Leuven, B-3000 Leuven, Belgium; [Voit, Thomas] Univ Paris 06, CNRS, UMR 974, Inst Myol,INSERM,FRE 3617,Grp Hosp Pitie Salpetri, Paris, France; [Schara, Ulrike] Univ Klinikum Essen, Essen, Germany; [Straathof, Chiara S. M.] Leiden Univ, Med Ctr, Leiden, Netherlands; [D'Angelo, M. Grazia] Ist Ricovero & Cura Carattere Sci Eugenio Medea, Lecce, Italy; [Bernert, Guenther] Gottfried von Preyersches Kinderspital, Vienna, Austria; [Cuisset, Jean-Marie] Ctr Hosp Reg Univ Lille, Lille, France; [Finkel, Richard S.] Nemours Childrens Hosp, Orlando, FL USA; [McDonald, Craig M.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Rummey, Christian] 4Pharma, Liestal, Switzerland; [Meier, Thomas] Santhera Pharmaceut, Liestal, Switzerland	KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Duisburg Essen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; IRCCS Eugenio Medea; Universite de Lille - ISITE; CHU Lille; University of California System; University of California Davis	Buyse, GM (corresponding author), Univ Hosp Leuven, Child Neurol, Herestr 49, B-3000 Leuven, Belgium.	gunnar.buyse@uzleuven.be	Kirschner, Janbernd/Q-1493-2019; Kirschner, Janbernd/H-7418-2016; D'Angelo, Maria Grazia/K-4685-2016	Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; D'Angelo, Maria Grazia/0000-0003-1241-4350; McDonald, Craig/0000-0002-8779-3220; Rummey, Christian/0000-0003-4911-911X; Sejersen, Thomas/0000-0001-5961-7097	Santhera Pharmaceuticals	Santhera Pharmaceuticals	Santhera Pharmaceuticals.	Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Buyse GM, 2013, PEDIATR PULM, V48, P912, DOI 10.1002/ppul.22688; Buyse GM, 2011, NEUROMUSCULAR DISORD, V21, P396, DOI 10.1016/j.nmd.2011.02.016; Buyse GM, 2009, EUR HEART J, V30, P116, DOI 10.1093/eurheartj/ehn406; Di Prospero NA, 2007, ARCH NEUROL-CHICAGO, V64, P803, DOI 10.1001/archneur.64.6.803; Domenech-Clar R, 2003, PEDIATR PULM, V35, P126, DOI 10.1002/ppul.10217; Gauld LM, 2005, PEDIATR PULM, V39, P457, DOI 10.1002/ppul.20151; Gauld LM, 2004, DEV MED CHILD NEUROL, V46, P475, DOI 10.1017/S0012162204000787; Gauld LM, 2003, AM J RESP CRIT CARE, V168, P804, DOI 10.1164/rccm.200303-451OC; GODFREY S, 1970, British Journal of Diseases of the Chest, V64, P15, DOI 10.1016/S0007-0971(70)80045-6; Goemans N, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0287-4; GRIGGS RC, 1990, MUSCLE NERVE, V13, pS30, DOI 10.1002/mus.880131310; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Hahn A, 1997, ARCH PHYS MED REHAB, V78, P1, DOI 10.1016/S0003-9993(97)90001-0; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Jaber S, 2015, J BIOENERG BIOMEMBR, V47, P111, DOI 10.1007/s10863-014-9571-y; KHAN Y, 1994, THORAX, V49, P157, DOI 10.1136/thx.49.2.157; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Pedersen OF, 1997, EUR RESPIR J, V10, pS11; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; QUANJER PH, 1989, EUR RESPIR J, V2, pS184; Quanjer PH, 1997, EUR RESPIR J, V10, pS2; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; RIDEAU Y, 1981, MUSCLE NERVE, V4, P155, DOI 10.1002/mus.880040213; Suarez AA, 2002, AM J PHYS MED REHAB, V81, P506, DOI 10.1097/00002060-200207000-00007; Tangsrud SE, 2001, RESP MED, V95, P898, DOI 10.1053/rmed.2001.1177; Tzelepis GE, 1997, AM J RESP CRIT CARE, V156, P1399, DOI 10.1164/ajrccm.156.5.9702009; Tzeng AC, 2000, CHEST, V118, P1390, DOI 10.1378/chest.118.5.1390; VINCKEN W, 1987, AM REV RESPIR DIS, V135, P372; VINCKEN WG, 1987, AM J MED, V83, P673	40	116	125	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1748	1757		10.1016/S0140-6736(15)60025-3	http://dx.doi.org/10.1016/S0140-6736(15)60025-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25907158				2022-12-28	WOS:000353726000030
J	Burrows, J				Burrows, Jeremy			MICROBIOLOGY Malaria runs rings round artemisinin	NATURE			English	Editorial Material							MECHANISM; DRUG	In parts of southeast Asia, malaria parasites are showing resistance to the active ingredient in artemisinin-based antimalarial drugs. Delineation of a cell-signalling pathway might help to explain this phenomenon. See Letter p.683	Med Malaria Venture, CH-1215 Meyrin, Switzerland		Burrows, J (corresponding author), Med Malaria Venture, CH-1215 Meyrin, Switzerland.	burrowsj@mmv.org						Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Das Debashish, 2013, Clin Infect Dis, V56, pe48, DOI 10.1093/cid/cis958; Ding XC, 2011, TRENDS PARASITOL, V27, P73, DOI 10.1016/j.pt.2010.11.006; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Haynes Richard K., 2013, Infectious Disorders - Drug Targets, V13, P217; Haynes RK, 2006, ANGEW CHEM INT EDIT, V45, P2082, DOI 10.1002/anie.200503071; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12	13	9	9	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					628	630		10.1038/nature14387	http://dx.doi.org/10.1038/nature14387			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25874678				2022-12-28	WOS:000353689700038
J	Eckhert, NL; van Zanten, M				Eckhert, N. Lynn; van Zanten, Marta			US-Citizen International Medical Graduates - A Boon for the Workforce?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eckhert, N. Lynn] Partners HealthCare Int, Boston, MA 02115 USA; [van Zanten, Marta] Fdn Adv Int Med Educ & Res, Philadelphia, PA USA	Partners Healthcare System	Eckhert, NL (corresponding author), Partners HealthCare Int, Boston, MA 02115 USA.			van Zanten, Marta/0000-0002-7433-6418				[Anonymous], 2014, RES DAT 2014 MAIN RE; [Anonymous], GAO10412; Eckhert NL, 2014, OVERVIEW FOR PROFIT; Eden J., 2014, GRADUATE MED ED MEET; van Zanten M, 2013, ACAD MED, V88, P276, DOI 10.1097/ACM.0b013e31827c6cd3	5	22	22	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1686	1687		10.1056/NEJMp1415239	http://dx.doi.org/10.1056/NEJMp1415239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG9RF	25923548				2022-12-28	WOS:000353655000003
J	Ni, XL				Ni, Xiaole			CHINA'S RESEARCH & DEVELOPMENT SPEND	NATURE			English	Editorial Material																			0	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S8	S9		10.1038/520S8a	http://dx.doi.org/10.1038/520S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0DQ	25924201	Bronze			2022-12-28	WOS:000353689700001
J	D'Onofrio, G; O'Connor, PG; Pantalon, MV; Chawarski, MC; Busch, SH; Owens, PH; Bernstein, SL; Fiellin, DA				D'Onofrio, Gail; O'Connor, Patrick G.; Pantalon, Michael V.; Chawarski, Marek C.; Busch, Susan H.; Owens, Patricia H.; Bernstein, Steven L.; Fiellin, David A.			Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRIEF INTERVENTION; PRIMARY-CARE; DRUG-USE; HARMFUL DRINKERS; ALCOHOL; SCALE; IMPLEMENTATION; METAANALYSIS; WITHDRAWAL; INDUCTION	IMPORTANCE Opioid-dependent patients often use the emergency department (ED) for medical care. OBJECTIVE To test the efficacy of 3 interventions for opioid dependence: (1) screening and referral to treatment (referral); (2) screening, brief intervention, and facilitated referral to community-based treatment services (brief intervention); and (3) screening, brief intervention, ED-initiated treatment with buprenorphine/naloxone, and referral to primary care for 10-week follow-up (buprenorphine). DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial involving 329 opioid-dependent patients who were treated at an urban teaching hospital ED from April 7, 2009, through June 25, 2013. INTERVENTIONS After screening, 104 patients were randomized to the referral group, 111 to the brief intervention group, and 114 to the buprenorphine treatment group. MAIN OUTCOMES AND MEASURES Enrollment in and receiving addiction treatment 30 days after randomization was the primary outcome. Self-reported days of illicit opioid use, urine testing for illicit opioids, human immunodeficiency virus (HIV) risk, and use of addiction treatment services were the secondary outcomes. RESULTS Seventy-eight percent of patients in the buprenorphine group (89 of 114 [95% CI, 70%-85%]) vs 37% in the referral group (38 of 102 [95% CI, 28%-47%]) and 45% in the brief intervention group (50 of 111 [95% CI, 36%-54%]) were engaged in addiction treatment on the 30th day after randomization (P < .001). The buprenorphine group reduced the number of days of illicit opioid use per week from 5.4 days (95% CI, 5.1-5.7) to 0.9 days (95% CI, 0.5-1.3) vs a reduction from 5.4 days (95% CI, 5.1-5.7) to 2.3 days (95% CI, 1.7-3.0) in the referral group and from 5.6 days (95% CI, 5.3-5.9) to 2.4 days (95% CI, 1.8-3.0) in the brief intervention group (P < .001 for both time and intervention effects; P = .02 for the interaction effect). The rates of urine samples that tested negative for opioids did not differ statistically across groups, with 53.8% (95% CI, 42%-65%) in the referral group, 42.9%(95% CI, 31%-55%) in the brief intervention group, and 57.6%(95% CI, 47%-68%) in the buprenorphine group (P = .17). There were no statistically significant differences in HIV risk across groups (P = .66). Eleven percent of patients in the buprenorphine group (95% CI, 6%-19%) used inpatient addiction treatment services, whereas 37% in the referral group (95% CI, 27%-48%) and 35% in the brief intervention group (95% CI, 25%-37%) used inpatient addiction treatment services (P < .001). CONCLUSIONS AND RELEVANCE Among opioid-dependent patients, ED-initiated buprenorphine treatment vs brief intervention and referral significantly increased engagement in addiction treatment, reduced self-reported illicit opioid use, and decreased use of inpatient addiction treatment services but did not significantly decrease the rates of urine samples that tested positive for opioids or of HIV risk. These findings require replication in other centers before widespread adoption.	[D'Onofrio, Gail; Pantalon, Michael V.; Owens, Patricia H.; Bernstein, Steven L.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06159 USA; [O'Connor, Patrick G.; Fiellin, David A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06159 USA; [Chawarski, Marek C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06159 USA; [Busch, Susan H.; Fiellin, David A.] Yale Univ, Sch Publ Hlth, New Haven, CT 06159 USA	Yale University; Yale University; Yale University; Yale University	D'Onofrio, G (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, 464 Congress Ave,Ste 260, New Haven, CT 06159 USA.	gail.donofrio@yale.edu	Bernstein, Steven L./AAW-1705-2020	Bernstein, Steven L./0000-0002-9964-7036; Fiellin, David/0000-0002-4006-010X	National Institute on Drug Abuse (NIDA) [5R01DA025991]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025991] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by grant 5R01DA025991 from the National Institute on Drug Abuse (NIDA), and Reckitt-Benckiser Pharmaceuticals provided buprenorphine through NIDA.	[Anonymous], 2008, DRUG USE ILLICIT SCR; Barber JP, 1996, PSYCHOTHER RES, V6, P81, DOI 10.1080/10503309612331331608; Berg ML, 2007, DRUG ALCOHOL DEPEN, V86, P239, DOI 10.1016/j.drugalcdep.2006.06.014; Bernstein E, 2009, ACAD EMERG MED, V16, P1174, DOI 10.1111/j.1553-2712.2009.00490.x; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Bernstein SL, 2013, J SUBST ABUSE TREAT, V44, P139, DOI 10.1016/j.jsat.2012.05.005; Bogenschutz MP, 2014, JAMA INTERN MED, V174, P1736, DOI 10.1001/jamainternmed.2014.4052; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; D'Onofrio G, 2005, ACAD EMERG MED, V12, P249, DOI 10.1197/j.aem.2004.10.021; D'Onofrio G, 2008, ANN EMERG MED, V51, P742, DOI 10.1016/j.annemergmed.2007.11.028; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; D'Onofrio G, 2010, ACAD EMERG MED, V17, P903, DOI 10.1111/j.1553-2712.2010.00824.x; DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fiellin DA, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.005; Fiore MC, 2008, RESP CARE, V53, P1217; Gowing L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub4; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Gunderson EW, 2010, ADDICT BEHAV, V35, P537, DOI 10.1016/j.addbeh.2010.01.001; Humeniuk R, 2012, ADDICTION, V107, P957, DOI 10.1111/j.1360-0443.2011.03740.x; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kunins HV, 2013, SUBST ABUS, V34, P242, DOI 10.1080/08897077.2012.752777; Lee JD, 2009, J GEN INTERN MED, V24, P226, DOI 10.1007/s11606-008-0866-8; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; MCLELLAN AT, 1992, J NERV MENT DIS, V180, P101, DOI 10.1097/00005053-199202000-00007; Pantalon MV, 2012, J SUBST ABUSE TREAT, V43, P382, DOI 10.1016/j.jsat.2012.08.011; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Rabe GL, 2013, NICOTINE TOB RES, V15, P643, DOI 10.1093/ntr/nts212; Roy-Byrne P, 2014, JAMA-J AM MED ASSOC, V312, P492, DOI 10.1001/jama.2014.7860; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Schwartz RP, 2006, ARCH GEN PSYCHIAT, V63, P102, DOI 10.1001/archpsyc.63.1.102; Stein MD, 2002, ADDICTION, V97, P691, DOI 10.1046/j.1360-0443.2002.00102.x; Sullivan LE, 2008, ANN INTERN MED, V148, P662, DOI 10.7326/0003-4819-148-9-200805060-00006; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; World Health Organization, 2009, GUIDELINES FOR THE P	38	466	467	3	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1636	1644		10.1001/jama.2015.3474	http://dx.doi.org/10.1001/jama.2015.3474			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919527	Green Accepted, Bronze			2022-12-28	WOS:000353595200014
J	Cole, TJ				Cole, T. J.			Setting number of decimal places for reporting risk ratios: rule of four	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EFFICACY; THERAPY; SAFETY	The Summary statistics are often reported to too many or, less often, too few decimal places. The rule of four provides a simple framework to guide authors in the appropriate number of decimal places to use when reporting risk ratios	UCL Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England	University of London; University College London	Cole, TJ (corresponding author), UCL Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England.	tim.cole@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Medical Research Council [MR/M012069/1]; MRC [MR/M012069/1, MR/J004839/1] Funding Source: UKRI; Medical Research Council [MR/J004839/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TJC is funded by Medical Research Council grant no MR/M012069/1.	Altman DG, 1996, BRIT MED J, V312, P572, DOI 10.1136/bmj.312.7030.572; American Psychological Association, 2020, PUBL MAN AM PSYCH AS, V7th; Banzi R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5856; Barone-Adesi F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5414; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Bowen A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4407; Cochrane Collaboration, 2010, COCHR STYL GUID; Cole TJ, 2015, ARCH DIS CHILD; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; European Association of Science Editors, 2014, EASE GUID AUTH TRANS; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Gerstman BB, 2000, DATA ANAL EPI INFO; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Hopkins WG, 2011, SCAND J MED SCI SPOR, V21, P867, DOI 10.1111/j.1600-0838.2011.01393.x; Lang TA, 2013, SCI EDITORS HDB; Llor C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5762; Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244	17	19	19	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h1845	10.1136/bmj.h1845	http://dx.doi.org/10.1136/bmj.h1845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918351	Green Published, hybrid			2022-12-28	WOS:000353954800002
J	Vaughan, BA; Webster-Gardiner, MS; Cundari, TR; Gunnoe, TB				Vaughan, Benjamin A.; Webster-Gardiner, Michael S.; Cundari, Thomas R.; Gunnoe, T. Brent			A rhodium catalyst for single-step styrene production from benzene and ethylene	SCIENCE			English	Article							C-H BOND; OLEFINS; HYDROPHENYLATION; HYDROARYLATION; ARYLATION; SUBSTITUTION; ALKYLATION; ACTIVATION	Rising global demand for fossil resources has prompted a renewed interest in catalyst technologies that increase the efficiency of conversion of hydrocarbons from petroleum and natural gas to higher-value materials. Styrene is currently produced from benzene and ethylene through the intermediacy of ethylbenzene, which must be dehydrogenated in a separate step. The direct oxidative conversion of benzene and ethylene to styrene could provide a more efficient route, but achieving high selectivity and yield for this reaction has been challenging. Here, we report that the Rh catalyst ((Fl)DAB)Rh(TFA)(eta(2)-C2H4) [(Fl)DAB is N,N'-bis(pentafluorophenyl)-2,3-dimethyl-1,4-diaza-1,3-butadiene; TFA is trifluoroacetate] converts benzene, ethylene, and Cu(II) acetate to styrene, Cu(I) acetate, and acetic acid with 100% selectivity and yields >= 95%. Turnover numbers >800 have been demonstrated, with catalyst stability up to 96 hours.	[Vaughan, Benjamin A.; Webster-Gardiner, Michael S.; Gunnoe, T. Brent] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA; [Cundari, Thomas R.] Univ N Texas, Dept Chem, Ctr Adv Sci Comp & Modeling, Denton, TX 76203 USA	University of Virginia; University of North Texas System; University of North Texas Denton	Gunnoe, TB (corresponding author), Univ Virginia, Dept Chem, Mccormick Rd, Charlottesville, VA 22903 USA.	t@unt.edu; tbg7h@virginia.edu			U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0000776, DE-FG02-03ER15387]; Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center [DE-SC0001298]; AES Corporation Graduate Fellowship in Energy Research	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center; AES Corporation Graduate Fellowship in Energy Research	The authors acknowledge support from the U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0000776 (T.B.G.) and DE-FG02-03ER15387 (T.R.C.)] for studies of styrene catalysis; the Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center (award DE-SC0001298), which funded the initial catalyst discovery; and an AES Corporation Graduate Fellowship in Energy Research (M.S.W.-G). The authors also thank B. McKeown, G. Fortman, S. Kalman (University of Virginia), and R. Nielsen (California Institute of Technology) for helpful discussions.	American Chemical Society, 1961, CHEM ENG NEWS ARCH, V39, P52; Andreatta JR, 2011, J ORGANOMET CHEM, V696, P305, DOI 10.1016/j.jorganchem.2010.09.030; [Anonymous], 1977, CRC HDB CHEM PHYS; Burgess SA, 2014, CHEM SCI, V5, P4355, DOI 10.1039/c4sc01665c; Cejka J, 2002, CATAL REV, V44, P375, DOI 10.1081/CR-120005741; Chen S. S., 2000, KIRK OTHMER ENCY CHE, P325; Eckert M., 2000, ULLMANNS ENCY IND CH, P1; Foley NA, 2009, ACCOUNTS CHEM RES, V42, P585, DOI 10.1021/ar800183j; FUJIWARA Y, 1969, J AM CHEM SOC, V91, P7166, DOI 10.1021/ja01053a047; Gerzeliev IM, 2011, PETROL CHEM+, V51, P39, DOI 10.1134/S0965544111010038; Gomez-Gallego M, 2011, CHEM REV, V111, P4857, DOI 10.1021/cr100436k; Herrmann W. A., 2007, CATALYSIS A Z, P1512; HONG P, 1984, J MOL CATAL, V26, P297, DOI 10.1016/0304-5102(84)85102-0; Jones WD, 1998, INORG CHIM ACTA, V270, P77, DOI 10.1016/S0020-1693(97)05828-3; Jones WD, 2003, ACCOUNTS CHEM RES, V36, P140, DOI 10.1021/ar020148i; Joslin EE, 2012, ORGANOMETALLICS, V31, P6851, DOI 10.1021/om300676e; Kubota A, 2012, ORG LETT, V14, P1760, DOI 10.1021/ol300281p; Lail M, 2004, ORGANOMETALLICS, V23, P5007, DOI 10.1021/om049404g; Lail M, 2003, J AM CHEM SOC, V125, P7506, DOI 10.1021/ja035076k; Lucchini M., 2007, International Patent, Patent No. [WO2007073918A1, 2007073918]; Luedtke AT, 2008, ANGEW CHEM INT EDIT, V47, P7694, DOI 10.1002/anie.200800524; Matsumoto T, 2000, J AM CHEM SOC, V122, P7414, DOI 10.1021/ja0009830; Matsumoto T, 2002, J MOL CATAL A-CHEM, V180, P1, DOI 10.1016/S1381-1169(01)00390-9; Matsumoto T., 2000, U.S. Patent, Patent No. [US6127590A, 6127590, 6127590A]; McKeown BA, 2008, ORGANOMETALLICS, V27, P4031, DOI 10.1021/om8006008; McKeown BA, 2014, ACS CATAL, V4, P1607, DOI 10.1021/cs400988w; McKeown BA, 2013, ORGANOMETALLICS, V32, P3903, DOI 10.1021/om400390e; McKeown BA, 2013, ACS CATAL, V3, P1165, DOI 10.1021/cs400231f; McKeown BA, 2013, ORGANOMETALLICS, V32, P2857, DOI 10.1021/om400306w; McKeown BA, 2011, J AM CHEM SOC, V133, P19131, DOI 10.1021/ja206064v; Olah G. A., 2003, HYDROCARBON CHEM; Oxgaard J, 2004, J AM CHEM SOC, V126, P352, DOI 10.1021/ja034126i; Perego C, 2004, GREEN CHEM, V6, P274, DOI 10.1039/b403277m; Perego C, 2009, ADV NANOPOR MAT, V1, P97, DOI 10.1016/S1878-7959(09)00102-9; Perego C, 2002, CATAL TODAY, V73, P3, DOI 10.1016/S0920-5861(01)00511-9; Process Evaluation/Research Planning (PERP), 1992, 919 PERP CHEM SYST I; SASAKI K, 1988, CHEM LETT, P685, DOI 10.1246/cl.1988.685; Webster-Gardiner MS, 2015, CATAL SCI TECHNOL, V5, P96, DOI 10.1039/c4cy00972j; Wittcoff H. A., 2004, IND ORGANIC CHEM, P100; Yamada T, 2008, NEW J CHEM, V32, P738, DOI 10.1039/b716425d	40	76	78	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					421	424		10.1126/science.aaa2260	http://dx.doi.org/10.1126/science.aaa2260			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908817				2022-12-28	WOS:000353338000030
J	Chaudhry, HJ; Robin, LA; Fish, EM; Polk, DH; Gifford, JD				Chaudhry, Humayun J.; Robin, Lisa A.; Fish, Eric M.; Polk, Donald H.; Gifford, J. Daniel			Improving Access and Mobility - The Interstate Medical Licensure Compact	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chaudhry, Humayun J.; Robin, Lisa A.; Fish, Eric M.; Polk, Donald H.; Gifford, J. Daniel] Federat State Med Boards, Euless, TX 76039 USA		Chaudhry, HJ (corresponding author), Federat State Med Boards, Euless, TX 76039 USA.			Chaudhry, Humayun/0000-0003-3356-1106				Broun Caroline, 2006, EVOLVING USE CHANGIN; Federation of State Medical Boards, 2014, INT MED LIC COMP; Fish EM, 2014, STATE LICENSURE REGU; Maresh B.T., 2014, J MED REGUL, V100, P8; Young Aaron, 2013, J MED REGUL, V99, P11, DOI [10.30770/2572-1852-99.2.11, DOI 10.30770/2572-1852-99.2.11]	5	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1581	1583		10.1056/NEJMp1502639	http://dx.doi.org/10.1056/NEJMp1502639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4XX	25901423				2022-12-28	WOS:000353294000001
J	Marti-Vidal, I; Muller, S; Vlemmings, W; Horellou, C; Aalto, S				Marti-Vidal, Ivan; Muller, Sebastien; Vlemmings, Wouter; Horellou, Cathy; Aalto, Susanne			A strong magnetic field in the jet base of a supermassive black hole	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; FARADAY-ROTATION	Active galactic nuclei (AGN) host some of the most energetic phenomena in the universe. AGN are thought to be powered by accretion of matter onto a rotating disk that surrounds a supermassive black hole. Jet streams can be boosted in energy near the event horizon of the black hole and then flow outward along the rotation axis of the disk. The mechanism that forms such a jet and guides it over scales from a few light-days up to millions of light-years remains uncertain, but magnetic fields are thought to play a critical role. Using the Atacama Large Millimeter/submillimeter Array (ALMA), we have detected a polarization signal (Faraday rotation) related to the strong magnetic field at the jet base of a distant AGN, PKS 1830-211. The amount of Faraday rotation (rotation measure) is proportional to the integral of the magnetic field strength along the line of sight times the density of electrons. The high rotation measures derived suggest magnetic fields of at least tens of Gauss (and possibly considerably higher) on scales of the order of light-days (0.01 parsec) from the black hole.	[Marti-Vidal, Ivan; Muller, Sebastien; Vlemmings, Wouter; Horellou, Cathy; Aalto, Susanne] Chalmers Univ Technol, Dept Earth & Space Sci, Onsala Space Observ, SE-43992 Onsala, Sweden	Chalmers University of Technology	Marti-Vidal, I (corresponding author), Chalmers Univ Technol, Dept Earth & Space Sci, Onsala Space Observ, SE-43992 Onsala, Sweden.	mivan@chalmers.se	Marti-Vidal, Ivan/A-8799-2017	Marti-Vidal, Ivan/0000-0003-3708-9611; /0000-0002-9931-1313; /0000-0002-2700-9916	European Research Council (ERC) [614264]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This paper makes use of the following ALMA data: ADS/JAO. ALMA#2011.0.00405.S, ADS/JAO.ALMA#2012.1.00056.S, and ADS/JAO.ALMA#2013.1.00020. S. ALMA is a partnership of the European Southern Observatory (ESO) (representing its member states), U.S. National Science Foundation (NSF), and National Institutes of Natural Sciences (NINS) of Japan, together with the National Research Council of Canada (NRC) and National Science Council of Taiwan (NSC) and Academia Sinica Institute of Astronomy and Astrophysics (ASIAA) (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities, Inc.-National Radio Astronomy Observatory, and National Astronomical Observatory of Japan. W.V. acknowledges support from the European Research Council (ERC) under ERC grant 614264.	Agudo I, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423366; Bernet ML, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/144; Ciprini S., 2012, ATEL, V4158; Croke SM, 2010, MON NOT R ASTRON SOC, V402, P259, DOI 10.1111/j.1365-2966.2009.15923.x; Gabuzda DC, 2003, MON NOT R ASTRON SOC, V339, P669, DOI 10.1046/j.1365-8711.2003.06204.x; KUO CY, 2014, APJ LET, V783, DOI DOI 10.1088/2041-8205/783/2/L33; Lidman C, 1999, ASTROPHYS J, V514, pL57, DOI 10.1086/311949; Mahmud M, 2009, MON NOT R ASTRON SOC, V400, P2, DOI 10.1111/j.1365-2966.2009.15013.x; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; MARSCHER AP, 1980, ASTROPHYS J, V235, P386, DOI 10.1086/157642; Marti-Vidal I, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322633; Marti-Vidal I, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322131; Muller S, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423646; O'Sullivan SP, 2009, MON NOT R ASTRON SOC, V400, P26, DOI 10.1111/j.1365-2966.2009.15428.x; O'Sullivan SP, 2009, MON NOT R ASTRON SOC, V393, P429, DOI 10.1111/j.1365-2966.2008.14213.x; Plambeck RL, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/66; Trippe S, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118563; Zamaninasab M, 2014, NATURE, V510, P126, DOI 10.1038/nature13399	18	54	54	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					311	314		10.1126/science.aaa1784	http://dx.doi.org/10.1126/science.aaa1784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883352	Green Submitted, Green Published			2022-12-28	WOS:000352999000037
J	Tang, V; Boscardin, WJ; Stijacic-Cenzer, I; Lee, SJ				Tang, Victoria; Boscardin, W. John; Stijacic-Cenzer, Irena; Lee, Sei J.			Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; COLONOSCOPY; PREVENTION; MORTALITY	OBJECTIVE To determine the time to benefit of using flexible sigmoidoscopy for colorectal cancer screening. DESIGN Survival meta-analysis. DATA SOURCES A Cochrane Collaboration systematic review published in 2013, Medline, and Cochrane Library databases. ELIGIBILITY CRITERIA Randomized controlled trials comparing screening flexible sigmoidoscopy with no screening. Trials with fewer than 100 flexible sigmoidoscopy screenings were excluded. RESULTS Four studies were eligible (total n=459 814). They were similar for patients' age (50-74 years), length of follow-up (11.2-11.9 years), and relative risk for colorectal cancer related mortality (0.69-0.78 with flexible sigmoidoscopy screening). For every 1000 people screened at five and 10 years, 0.3 and 1.2 colorectal cancer related deaths, respectively, were prevented. It took 4.3 years (95% confidence interval 2.8 to 5.8) to observe an absolute risk reduction of 0.0002 (one colorectal cancer related death prevented for every 5000 flexible sigmoidoscopy screenings). It took 9.4 years (7.6 to 11.3) to observe an absolute risk reduction of 0.001 (one colorectal cancer related death prevented for every 1000 flexible sigmoidoscopy screenings). CONCLUSION Our findings suggest that screening flexible sigmoidoscopy is most appropriate for older adults with a life expectancy greater than approximately 10 years.	[Tang, Victoria; Boscardin, W. John; Stijacic-Cenzer, Irena; Lee, Sei J.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Boscardin, W. John; Stijacic-Cenzer, Irena; Lee, Sei J.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Tang, V (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	Victoria.Tang@ucsf.edu			Beeson career development award through the American Federation of Aging Research; National Institute on Aging [K23AG040779]; NATIONAL INSTITUTE ON AGING [P30AG044281, K23AG040779] Funding Source: NIH RePORTER	Beeson career development award through the American Federation of Aging Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SJL was supported by the Beeson career development award through the American Federation of Aging Research and National Institute on Aging (K23AG040779). The funding source had no involvement in the design or conduct of the study and had no influence on the collection, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the paper for publication.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; Department of Veterans Affairs, 2012, COL VERS FEC IMM TES; Earle CC, 2000, MED DECIS MAKING, V20, P104, DOI 10.1177/0272989X0002000113; Gerrish C A, 1990, Nurse Educ Today, V10, P118, DOI 10.1016/0260-6917(90)90206-6; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Lee SJ, 2013, JAMA-J AM MED ASSOC, V310, P2609, DOI 10.1001/jama.2013.282612; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Messori A, 2000, CLIN DRUG INVEST, V20, P309, DOI 10.2165/00044011-200020050-00002; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; UK Department of Health, 2011, IMPR OUTC STRAT CANC; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Whitlock EP, 2008, US PREVENTIVE SERVIC; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	30	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1662	10.1136/bmj.h1662	http://dx.doi.org/10.1136/bmj.h1662			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25881903	Green Published, hybrid			2022-12-28	WOS:000353328700003
J	Price, WN; Rai, AK				Price, W. Nicholson, II; Rai, Arti K.			Are trade secrets delaying biosimilars?	SCIENCE			English	Editorial Material									[Price, W. Nicholson, II] Univ New Hampshire, Sch Law, Concord, NH 03301 USA; [Rai, Arti K.] Duke Law Sch, Durham, NC 27705 USA	University System Of New Hampshire; University of New Hampshire; Duke University	Price, WN (corresponding author), Univ New Hampshire, Sch Law, Concord, NH 03301 USA.	nicholson.price@law.unh.edu; rai@law.duke.edu		Price, Nicholson/0000-0003-0729-290X				Falit BP, 2015, HEALTH AFFAIR, V34, P294, DOI 10.1377/hlthaff.2014.0482; Grabowski HG, 2014, HEALTH AFFAIR, V33, P1048, DOI 10.1377/hlthaff.2013.0862; IMS Institute for Healthcare Informatics, 2012, GLOB US MED OUTL 201; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; McCamish M., 2015, GLOBAL HLTH BIOPHARM; McCamish M, 2012, CLIN PHARMACOL THER, V91, P405, DOI 10.1038/clpt.2011.343; Ozturk S., 2005, CELL CULTURE TECHNOL; Sharma B, 2007, BIOTECHNOL ADV, V25, P325, DOI 10.1016/j.biotechadv.2007.01.007; Tavernise Sabrina, 2015, NY TIMES, V20; Teece D.J., 1998, EC PERFORMANCE THEOR; U. S. Food and Drug Administration, 2012, SCI CONS DEM BIOS RE; U. S. Food and Drug Administration, 2012, QUAL CONS DEM BIOS R	12	22	22	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					188	189		10.1126/science.aab1684	http://dx.doi.org/10.1126/science.aab1684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859034				2022-12-28	WOS:000352613700026
J	Canup, RM				Canup, Robin M.			SOLAR SYSTEM An incredible likeness of being	NATURE			English	Editorial Material							EARTH; MOON	Earth and the Moon share many puzzling chemical similarities. New analyses show that the last planet-sized body to hit Earth could have been similar enough to Earth to yield a Moon with an Earth-like composition. See Letter p. 212	SW Res Inst, Boulder, CO 80302 USA		Canup, RM (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	robin@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458				Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chambers JE, 2001, ICARUS, V152, P205, DOI 10.1006/icar.2001.6639; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dauphas N., 2015, 46 LUN PLAN SCI C; Herwartz D, 2014, SCIENCE, V344, P1146, DOI 10.1126/science.1251117; Kruijer T. S., 2015, NATURE; Melosh HJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0168; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Touboul M., 2015, NATURE; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wiechert UH, 2004, EARTH PLANET SC LETT, V221, P373, DOI 10.1016/S0012-821X(04)00090-1	17	0	1	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					169	170		10.1038/520169a	http://dx.doi.org/10.1038/520169a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855453				2022-12-28	WOS:000352454600028
J	Turler, A				Tuerler, Andreas			NUCLEAR CHEMISTRY Lawrencium bridges a knowledge gap	NATURE			English	Editorial Material								The heavy element lawrencium is available in only tiny quantities. Measurement of one of its atomic properties was thus an experimental challenge, but indispensably validates theoretical models of heavy elements. See Letter p. 209	[Tuerler, Andreas] Univ Bern, Villigen PSI, Paul Scherrer Inst, CH-3012 Bern, Switzerland; [Tuerler, Andreas] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Tuerler, Andreas] Univ Bern, Albert Einstein Ctr Fundamental Phys, CH-3012 Bern, Switzerland	Paul Scherrer Institute; University of Bern; University of Bern; University of Bern	Turler, A (corresponding author), Univ Bern, Villigen PSI, Paul Scherrer Inst, CH-3012 Bern, Switzerland.	andreas.tuerler@psi.ch	Türler, Andreas/D-3913-2014	Türler, Andreas/0000-0002-4274-1056				Calvo F, 2013, ANGEW CHEM INT EDIT, V52, P7583, DOI 10.1002/anie.201302742; Oganessian YT, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.044602; Pershina V., 2014, CHEM SUPERHEAVY ELEM, V2, P135, DOI DOI 10.1007/978-3-642-37466-1_3; Pyykko P, 2005, INORG CHIM ACTA, V358, P4113, DOI 10.1016/j.ica.2005.06.028; Ramirez EM, 2012, SCIENCE, V337, P1207, DOI 10.1126/science.1225636; Sato TK, 2015, NATURE, V520, P209, DOI 10.1038/nature14342	6	0	0	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					166	167		10.1038/520166a	http://dx.doi.org/10.1038/520166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855450				2022-12-28	WOS:000352454600026
J	Bharat, TAM; Murshudov, GN; Sachse, C; Lowe, J				Bharat, Tanmay A. M.; Murshudov, Garib N.; Sachse, Carsten; Loewe, Jan			Structures of actin-like ParM filaments show architecture of plasmid-segregating spindles	NATURE			English	Article							BACTERIAL ACTIN; F-ACTIN; DNA SEGREGATION; R1; VISUALIZATION; REPLICATION; RECONSTRUCTION; REFINEMENT; RESOLUTION; MECHANISM	Active segregation of Escherichia coli low-copy-number plasmid R1 involves formation of a bipolar spindle made of left-handed double-helical actin-like ParM filaments(1-6). ParR links the filaments with centromeric parC plasmid DNA, while facilitating the addition of subunits to ParM filaments(3,7-9). Growing ParMRC spindles push sister plasmids to the cell poles(9,10). Here, using modern electron cryomicroscopy methods, we investigate the structures and arrangements of ParM filaments in vitro and in cells, revealing at near-atomic resolution how subunits and filaments come together to produce the simplest known mitotic machinery. To understand the mechanism of dynamic instability, we determine structures of ParM filaments in different nucleotide states. The structure of filaments bound to the ATP analogue AMPPNP is determined at 4.3 angstrom resolution and refined. The ParM filament structure shows strong longitudinal interfaces and weaker lateral interactions. Also using electron cryomicroscopy, we reconstruct ParM doublets forming antiparallel spindles. Finally, with whole-cell electron cryotomography, we show that doublets are abundant in bacterial cells containing low-copy-number plasmids with the ParMRC locus, leading to an asynchronous model of R1 plasmid segregation.	[Bharat, Tanmay A. M.; Murshudov, Garib N.; Loewe, Jan] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 0QH, England; [Sachse, Carsten] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	MRC Laboratory Molecular Biology; European Molecular Biology Laboratory (EMBL)	Lowe, J (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Francis Crick Ave, Cambridge CB2 0QH, England.	jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Sachse, Carsten/H-2727-2012; Sachse, Carsten/AAY-9384-2020	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Bharat, Tanmay/0000-0002-0168-0277; Lowe, Jan/0000-0002-5218-6615	Medical Research Council [U105184326, MC-UP-A025-1012]; Wellcome Trust [095514/Z/11/Z]; Federation of European Biochemical Societies (FEBS); European Molecular Biology Organization (EMBO) [ALTF 3-2013]; Medical Research Council [MC_U105184326] Funding Source: researchfish; MRC [MC_U105184326] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Federation of European Biochemical Societies (FEBS); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. van den Ent, K. Gerdes and P. Gayathri for help with sample preparation, and C. Johnson, C. Savva and F. de Haas for help with data collection. This work was supported by the Medical Research Council (U105184326) and the Wellcome Trust (095514/Z/11/Z). T.A.M.B. is the recipient of Federation of European Biochemical Societies (FEBS) and European Molecular Biology Organization (EMBO) (ALTF 3-2013) long-termfellowships. G.N.M. was funded by Medical Research Council grant MC-UP-A025-1012.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Breuner A, 1996, MOL MICROBIOL, V20, P581, DOI 10.1046/j.1365-2958.1996.5351063.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; GUSTAFSSON P, 1980, J BACTERIOL, V141, P106, DOI 10.1128/JB.141.1.106-110.1980; Izore T, 2014, FEBS LETT, V588, P776, DOI 10.1016/j.febslet.2014.01.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Ozyamak E, 2013, BIOCHEMISTRY-US, V52, P6928, DOI 10.1021/bi4010792; Ozyamak E, 2013, J BIOL CHEM, V288, P4265, DOI 10.1074/jbc.M112.417030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2010, BIOCHEM BIOPH RES CO, V391, P1598, DOI 10.1016/j.bbrc.2009.12.078; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033	39	49	51	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					106	+		10.1038/nature14356	http://dx.doi.org/10.1038/nature14356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25915019	Green Accepted			2022-12-28	WOS:000357169500041
J	Caughey, AB				Caughey, Aaron B.			Should pregnancies be induced for impending macrosomia?	LANCET			English	Editorial Material							INDUCTION; LABOR; RISK		Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University	Caughey, AB (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA.	caughey@ohsu.edu						[Anonymous], 2013, Obstet Gynecol, V121, P911, DOI 10.1097/01.AOG.0000428649.57622.a7; Boulvain M, 2015, LANCET; Cheng YW, 2012, BJOG-INT J OBSTET GY, V119, P402, DOI 10.1111/j.1471-0528.2011.03248.x; COMBS CA, 1993, OBSTET GYNECOL, V81, P492; Esakoff TF, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.035; Gonen O, 1997, OBSTET GYNECOL, V89, P913, DOI 10.1016/S0029-7844(97)00149-X; Nicholson JM, 2008, AM J OBSTET GYNECOL, V198, P511; Stotland NE, 2004, OBSTET GYNECOL, V104, P671, DOI 10.1097/01.AOG.0000139515.97799.f6; Swank ML, 2014, OBESITY, V22, P1997, DOI 10.1002/oby.20790; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267	10	6	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2557	2559		10.1016/S0140-6736(14)62302-3	http://dx.doi.org/10.1016/S0140-6736(14)62302-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25863655				2022-12-28	WOS:000356930000009
J	Wyatt, C; Baeten, JM				Wyatt, Christina; Baeten, Jared M.			Tenofovir alafenamide for HIV infection: is less more?	LANCET			English	Editorial Material							COMBINATION ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; INCOME COUNTRIES; LIFE EXPECTANCY; EMTRICITABINE; ASSOCIATION; PROPHYLAXIS; EXPOSURE; COHORT; WOMEN		[Wyatt, Christina] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; [Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.	jbaeten@uw.edu						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sax PE, 2015, LANCET; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382	11	11	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2559	2560		10.1016/S0140-6736(15)60725-5	http://dx.doi.org/10.1016/S0140-6736(15)60725-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25890672				2022-12-28	WOS:000356930000010
J	Okoye, I; Wang, LH; Pallmer, K; Richter, K; Ichimura, T; Haas, R; Crouse, J; Choi, O; Heathcote, D; Lovo, E; Mauro, C; Abdi, R; Oxenius, A; Rutschmann, S; Ashton-Rickardt, PG				Okoye, Isobel; Wang, Lihui; Pallmer, Katharina; Richter, Kirsten; Ichimura, Takahuru; Haas, Robert; Crouse, Josh; Choi, Onjee; Heathcote, Dean; Lovo, Elena; Mauro, Claudio; Abdi, Reza; Oxenius, Annette; Rutschmann, Sophie; Ashton-Rickardt, Philip G.			The protein LEM promotes CD8(+) T cell immunity through effects on mitochondrial respiration	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; MESSENGER-RNA DECAY; VIRUS-INFECTION; MEMORY; ANTIGEN; DIFFERENTIATION; CANCER; MICE; LYMPHOCYTES; EXHAUSTION	Protective CD8(+) T cell-mediated immunity requires a massive expansion in cell number and the development of long-lived memory cells. Using forward genetics in mice, we identified an orphan protein named lymphocyte expansion molecule (LEM) that promoted antigen-dependent CD8(+) T cell proliferation, effector function, and memory cell generation in response to infection with lymphocytic choriomeningitis virus. Generation of LEM-deficient mice confirmed these results. Through interaction with CR6 interacting factor (CRIF1), LEM controlled the levels of oxidative phosphorylation (OXPHOS) complexes and respiration, resulting in the production of pro-proliferative mitochondrial reactive oxygen species (mROS). LEM provides a link between immune activation and the expansion of protective CD8(+) T cells driven by OXPHOS and represents a pathway for the restoration of long-term protective immunity based on metabolically modified cytotoxic CD8(+) T cells.	[Okoye, Isobel; Wang, Lihui; Choi, Onjee; Heathcote, Dean; Lovo, Elena; Rutschmann, Sophie; Ashton-Rickardt, Philip G.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Immunobiol,Div Inflammat & Immunol, London SW7 2AZ, England; [Pallmer, Katharina; Richter, Kirsten; Crouse, Josh; Oxenius, Annette] ETHZ, Inst Microbiol, CH-8093 Zurich, Switzerland; [Ichimura, Takahuru; Abdi, Reza; Ashton-Rickardt, Philip G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02215 USA; [Haas, Robert; Mauro, Claudio] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; Queen Mary University London	Ashton-Rickardt, PG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Immunobiol,Div Inflammat & Immunol, Exhibit Rd, London SW7 2AZ, England.	p.ashton-rickardt@imperial.ac.uk		Haas, Robert/0000-0003-4826-2379	ETH Zurich; Swiss National Science Foundation [310030_146140]; Medical Research Council (MRC) [G0700795]; NIH [AI091930, AI45108]; Wellcome Trust; Cancer Research UK [A9995]; MRC; British Heart Foundation [FS/12/38/29640]; Medical Research Council [1263270, G0700795] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091930] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Bangham and R. Shattock for helpful comments on the paper. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. The Lem gene sequence is deposited in GenBank accession KP939367. P.G.A.-R. is the inventor on international patent application PCT/GB2014/051603 (International Publication Number WO 2014/188220) A1. The patent covers the use of LEM nucleic acids and polypeptides to activate T cell immunity to cancer and viral infection and agents that down-regulate LEM for the treatment of autoimmune and inflammatory disease. Retro mutant mice are available from P.G.A.-R. under a material transfer agreement with Imperial College London. We thank J. Hehl and S. Stoma from the Scientific Center for Optical and Electron Microscopy ScopeM of the Swiss Federal Institute of Technology ETHZ for technical support. The research was supported by the ETH Zurich, the Swiss National Science Foundation (310030_146140), Medical Research Council (MRC) grant G0700795, and NIH grant AI091930. I.O. and research were supported by a grant from the Wellcome Trust; L.W. and D.H. and research were supported by a grant from Cancer Research UK (A9995); O.C. and research were supported by NIH grant AI45108. R.H. was supported by a MRC Ph.D. studentship, and C.M. was supported by a British Heart Foundation Fellowship (FS/12/38/29640).	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Byrne SM, 2012, J IMMUNOL, V189, P1133, DOI 10.4049/jimmunol.1003406; Choi O, 2012, J IMMUNOL, V188, P3920, DOI 10.4049/jimmunol.1102587; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Georgel Philippe, 2008, V415, P1, DOI 10.1007/978-1-59745-570-1_1; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Laniewski NG, 2004, J VIROL, V78, P11246, DOI 10.1128/JVI.78.20.11246-11257.2004; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Pardoll D, 2002, P NATL ACAD SCI USA, V99, P15840, DOI 10.1073/PNAS.262669499; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Xu CW, 1997, P NATL ACAD SCI USA, V94, P12473, DOI 10.1073/pnas.94.23.12473	29	38	56	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					995	1001		10.1126/science.aaa7516	http://dx.doi.org/10.1126/science.aaa7516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25883318	Green Submitted			2022-12-28	WOS:000355276600039
J	Aiello, LP; Sun, WJ; Das, A; Gangaputra, S; Kiss, S; Klein, R; Cleary, PA; Lachin, JM; Nathan, DM				Aiello, Lloyd Paul; Sun, Wanjie; Das, Arup; Gangaputra, Sapna; Kiss, Szilard; Klein, Ronald; Cleary, Patricia A.; Lachin, John M.; Nathan, David M.		DCCT EDIC Res Grp	Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CATARACT-SURGERY; CARDIOVASCULAR-DISEASE; COMPLICATIONS TRIAL; PROGRESSION; INTERVENTIONS; EPIDEMIOLOGY; GLYCATION; PRODUCTS; LENS; AGE	BACKGROUND The Diabetes Control and Complications Trial (DCCT) showed a beneficial effect of 6.5 years of intensive glycemic control on retinopathy in patients with type 1 diabetes. METHODS Between 1983 and 1989, a total of 1441 patients with type 1 diabetes in the DCCT were randomly assigned to receive either intensive diabetes therapy or conventional therapy aimed at preventing hyperglycemic symptoms. They were treated and followed until 1993. Subsequently, 1375 of these patients were followed in the observational Epidemiology of Diabetes Interventions and Complications (EDIC) study. The self-reported history of ocular surgical procedures was obtained annually. We evaluated the effect of intensive therapy as compared with conventional therapy on the incidence and cost of ocular surgery during these two studies. RESULTS Over a median follow-up of 23 years, 130 ocular operations were performed in 63 of 711 patients assigned to intensive therapy (8.9%) and 189 ocular operations in 98 of 730 patients assigned to conventional therapy (13.4%) (P<0.001). After adjustment for DCCT baseline factors, intensive therapy was associated with a reduction in the risk of any diabetes-related ocular surgery by 48% (95% confidence interval [CI], 29 to 63; P<0.001) and a reduction in the risk of all such ocular procedures by 37% (95% CI, 12 to 55; P = 0.01). Forty-two patients who received intensive therapy and 61 who received conventional therapy underwent cataract extraction (adjusted risk reduction with intensive therapy, 48%; 95% CI, 23 to 65; P = 0.002); 29 patients who received intensive therapy and 50 who received conventional therapy underwent vitrectomy, retinal-detachment surgery, or both (adjusted risk reduction, 45%; 95% CI, 12 to 66; P = 0.01). The costs of surgery were 32% lower in the intensive-therapy group. The beneficial effects of intensive therapy were fully attenuated after adjustment for mean glycated hemoglobin levels over the entire follow-up. CONCLUSIONS Intensive therapy in patients with type 1 diabetes was associated with a substantial reduction in the long-term risk of ocular surgery.	[Aiello, Lloyd Paul] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA; [Aiello, Lloyd Paul; Nathan, David M.] Harvard Univ, Sch Med, Boston, MA USA; [Sun, Wanjie; Cleary, Patricia A.; Lachin, John M.] George Washington Univ, Biostat Ctr, Rockville, MD 20852 USA; [Das, Arup] Univ New Mexico, Albuquerque, NM 87131 USA; [Gangaputra, Sapna; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kiss, Szilard] Weill Cornell Med Coll, New York, NY USA; [Kiss, Szilard] New York Presbyterian Hosp, New York, NY USA; [Nathan, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; George Washington University; University of New Mexico; University of Wisconsin System; University of Wisconsin Madison; Cornell University; NewYork-Presbyterian Hospital; Harvard University; Massachusetts General Hospital	Lachin, JM (corresponding author), George Washington Univ, Biostat Ctr, 6110 Execut Blvd, Rockville, MD 20852 USA.	jml@bsc.gwu.edu	Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011; Zinman, Bernard/E-7266-2013; van der Geest, Rob J/J-8193-2015	Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; van der Geest, Rob J/0000-0002-9084-5597; Kiss, Szilard/0000-0003-3433-8432; Lachin, John/0000-0001-9838-2841	Division of Diabetes, Endocrinology, and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK094176, U01 DK094157]; National Eye Institute; National Institute of Neurological Disorders and Stroke; General Clinical Research Center Program; Clinical and Translational Science Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204, U01DK094157, U01DK094176] Funding Source: NIH RePORTER	Division of Diabetes, Endocrinology, and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Center Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical and Translational Science Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by cooperative agreement grants (1982-1993, 2012-2017) and contracts (1982-2012) with the Division of Diabetes, Endocrinology, and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases (current grant numbers, U01 DK094176 and U01 DK094157), and by the National Eye Institute, the National Institute of Neurological Disorders and Stroke, the General Clinical Research Center Program (1993-2007), and the Clinical and Translational Science Center Awards Program (2006-present). Free or discounted supplies or equipment were contributed by Abbott Diabetes Care, Animas, Becton Dickinson, Diabetes Care by Bayer, Eli Lilly, Extend Nutrition, Insulet, LifeScan, Medtronic Diabetes, Nipro Home Diagnostics, Nova Diabetes Care, Omron, Perrigo Diabetes Care, Roche Diabetes Care, and Sanofi-Aventis.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Busbee BG, 2003, OPHTHALMOLOGY, V110, P2310, DOI 10.1016/S0161-6420(03)00796-6; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Medicare and Medicaid Services, 2010, CUR5R PROC TERM CPT; de Boer IH, 2014, J AM SOC NEPHROL, V25, P2342, DOI 10.1681/ASN.2013091004; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Dowler J, 2001, CURR OPIN OPHTHALMOL, V12, P175, DOI 10.1097/00055735-200106000-00005; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Genuth S, 1999, DIABETES CARE, V22, P99; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Grassi MA, 2013, OPHTHALMOLOGY, V120, P2580, DOI 10.1016/j.ophtha.2013.06.002; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Haddad NMN, 2014, SEMIN OPHTHALMOL, V29, P329, DOI 10.3109/08820538.2014.959197; Hashim Z, 2011, AGE, V33, P377, DOI 10.1007/s11357-010-9177-1; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; KLEIN BEK, 1985, OPHTHALMOLOGY, V92, P1191; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P295, DOI 10.1016/S0002-9394(14)71170-5; Lachin JM, 2011, WILEY SER PROBAB ST, P1; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Monnier VM, 2013, J DIABETES COMPLICAT, V27, P141, DOI 10.1016/j.jdiacomp.2012.10.004; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Nagaraj RH, 2012, AMINO ACIDS, V42, P1205, DOI 10.1007/s00726-010-0778-x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Ramalho J, 1996, GRAEF ARCH CLIN EXP, V234, pS232, DOI 10.1007/BF02343078; SAS Institute, 2008, SAS STAT 9 2 US GUID; Schmier JK, 2009, ARCH OPHTHALMOL-CHIC, V127, P900, DOI 10.1001/archophthalmol.2009.122; SENSI M, 1995, DIABETES RES CLIN PR, V28, P9, DOI 10.1016/0168-8227(94)01061-4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143	34	63	65	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1722	1733		10.1056/NEJMoa1409463	http://dx.doi.org/10.1056/NEJMoa1409463			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923552	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000353655000007
J	Bakardjiev, A				Bakardjiev, Anna			IMMUNOLOGY Stillbirth prevented by signal blockade	NATURE			English	Editorial Material							MATERNAL-FETAL INTERFACE; LISTERIA-MONOCYTOGENES; INFECTION; ACTA	Bacterial infections during pregnancy can cause fetal death. The identification of a cell-signalling pathway induced during infection that recruits dangerous immune cells to the placenta may open up avenues to prevent this.	Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bakardjiev, A (corresponding author), Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA.	anna.bakardjiev@ucsf.edu						Auerbuch V, 2001, INFECT IMMUN, V69, P5953, DOI 10.1128/IAI.69.9.5953-5957.2001; Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Portnoy DA, 2012, MOL BIOL CELL, V23, P1141, DOI 10.1091/mbc.E11-10-0894; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Van Raemdonck K, 2014, CYTOKINE GROWTH FACT; Wegorzewska M, 2014, J IMMUNOL, V192, P1938, DOI 10.4049/jimmunol.1302403	10	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					627	628		10.1038/520627a	http://dx.doi.org/10.1038/520627a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925473				2022-12-28	WOS:000353689700037
J	Kardas-Nelson, M				Kardas-Nelson, Mara			GENERIC DRUGS Can (and should) Africa make its own medicines?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												marajenn@gmail.com						African Union-Unido partnership, 2012, PHARM MAN PLAN AFR; de-Graft Aikins Ama, 2010, Global Health, V6, P6, DOI 10.1186/1744-8603-6-6; Lopes C., 2015, MAIL GUARDIAN AFRICA; Marusak Hermann R., 2013, IP WATCH; Medecins Sans Frontieres, 2013, MED SANS FRONT; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; Ramsurya MV., 2010, EC TIMES; Sidibe M, 2014, B WORLD HEALTH ORGAN, V92, P387, DOI 10.2471/BLT.14.140566; Tomlinson C, 2012, NSP REV; UNAIDS, 2013, ACC ANT THER AFR STA; United Nations Industrial Development Organization, PHARM PROD; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; World Health Organization, 2011, TRENDS LOC PROD MED	13	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2178	10.1136/bmj.h2178	http://dx.doi.org/10.1136/bmj.h2178			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25920478				2022-12-28	WOS:000353955900006
J	Liao, KP; Cai, TX; Savova, GK; Murphy, SN; Karlson, EW; Ananthakrishnan, AN; Gainer, VS; Shaw, SY; Xia, ZQ; Szolovits, P; Churchill, S; Kohane, I				Liao, Katherine P.; Cai, Tianxi; Savova, Guergana K.; Murphy, Shawn N.; Karlson, Elizabeth W.; Ananthakrishnan, Ashwin N.; Gainer, Vivian S.; Shaw, Stanley Y.; Xia, Zongqi; Szolovits, Peter; Churchill, Susanne; Kohane, Isaac			Development of phenotype algorithms using electronic medical records and incorporating natural language processing	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; DISCOVERY RESEARCH; CROHNS-DISEASE; NORMALIZATION; RISK; IDENTIFICATION; PREVALENCE; SYSTEM		[Liao, Katherine P.; Karlson, Elizabeth W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Liao, Katherine P.; Karlson, Elizabeth W.; Shaw, Stanley Y.; Xia, Zongqi; Churchill, Susanne; Kohane, Isaac] Harvard Univ, Sch Med, Boston, MA USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Savova, Guergana K.] Childrens Hosp Boston, Dept Pediat, Boston, MA USA; [Murphy, Shawn N.; Kohane, Isaac] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Dept Gastroenterol, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA; [Gainer, Vivian S.] Partners HealthCare Syst, Partners Res Comp, Boston, MA USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Xia, Zongqi] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Szolovits, Peter] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Liao, KP (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	kliao@partners.org	Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; Szolovits, Peter/0000-0001-8411-6403	US National Institutes of Health [U54LM008748, AR 060257, K08 K23 DK097142]; Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR060257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS079493] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by grants from the US National Institutes of Health (U54LM008748, AR 060257, K08 K23 DK097142), and the Harold and Duval Bowen Fund.	Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P1905, DOI 10.1016/j.cgh.2014.02.034; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1411, DOI 10.1097/MIB.0b013e31828133fd; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P37, DOI [10.1002/ibd.22951, 10.1097/MIB.0b013e3182902ad9]; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Endicott M, 2012, J AHIMA, V82, P60; Garla VN, 2013, J AM MED INFORM ASSN, V20, P882, DOI 10.1136/amiajnl-2012-001350; Jurafsky D., 2009, SPEECH LANGUAGE PROC; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Liao KP, 2014, ANN RHEUM DIS, V73, P1170, DOI 10.1136/annrheumdis-2012-203202; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Liao KP, 2011, RHEUMATOLOGY, P823; McCormick Patrick J, 2008, AMIA Annu Symp Proc, P450; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Pradhan S, 2015, J AM MED INFORM ASSN, V22, P143, DOI 10.1136/amiajnl-2013-002544; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rasmussen LV, 2014, J BIOMED INFORM, V51, P280, DOI 10.1016/j.jbi.2014.06.007; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; US National Library of Medicine, 2014, UN MED LANG SYST TER; Xia ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078927; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	35	157	159	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h1885	10.1136/bmj.h1885	http://dx.doi.org/10.1136/bmj.h1885			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG8RC	25911572	Bronze, Green Published			2022-12-28	WOS:000353577000004
J	Reddy, P; Ocampo, A; Suzuki, K; Luo, J; Bacman, SR; Williams, SL; Sugawara, A; Okamura, D; Tsunekawa, Y; Wu, J; Lam, D; Xiong, X; Montserrat, N; Esteban, CR; Liu, GH; Sancho-Martinez, I; Manau, D; Civico, S; Cardellach, F; O'Callaghan, MD; Campistol, J; Zhao, H; Campistol, JM; Moraes, CT; Belmonte, JCI				Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Bacman, Sandra R.; Williams, Sion L.; Sugawara, Atsushi; Okamura, Daiji; Tsunekawa, Yuji; Wu, Jun; Lam, David; Xiong, Xiong; Montserrat, Nuria; Esteban, Concepcion Rodriguez; Liu, Guang-Hui; Sancho-Martinez, Ignacio; Manau, Dolors; Civico, Salva; Cardellach, Francesc; O'Callaghan, Maria del Mar; Campistol, Jaime; Zhao, Huimin; Campistol, Josep M.; Moraes, Carlos T.; Belmonte, Juan Carlos Izpisua			Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing	CELL			English	Article							DNA MUTATIONS; DISEASE; TRANSMISSION; HETEROPLASMY; DEGRADATION; SEQUENCE; EMBRYOS; DRIFT	Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the trans-generational transmission of human mitochondrial diseases caused by mutations in mtDNA.	[Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Sugawara, Atsushi; Okamura, Daiji; Wu, Jun; Lam, David; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Bacman, Sandra R.; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Tsunekawa, Yuji] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo 6500047, Japan; [Xiong, Xiong; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Montserrat, Nuria] Inst Bioengn Catalonia IBEC, Pluripotent Stem Cells & Organ Regenerat, Barcelona 08028, Spain; [Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Manau, Dolors; Civico, Salva] Univ Barcelona, Hosp Clin, Inst Clin Gynecol Obstet & Neonatol ICGON, E-08036 Barcelona, Spain; [Cardellach, Francesc] Univ Barcelona, IDIBAPS CIBER Rare Dis, Mitochondrial Res Lab, E-08036 Barcelona, Spain; [Cardellach, Francesc] Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain; [O'Callaghan, Maria del Mar; Campistol, Jaime] Hosp Univ St Joan de Deu, Neuropediat Dept CIBERER, Esplugas de Llobregat 08950, Spain; [Campistol, Josep M.] Univ Barcelona, IDIBAPS, Hosp Clin, Renal Div, E-08036 Barcelona, Spain; [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	Salk Institute; University of Miami; RIKEN; University of Illinois System; University of Illinois Urbana-Champaign; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Miami	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	belmonte@salk.edu	Montserrat, Nuria/F-3136-2016; Manau, Dolors M/D-8977-2019; Wu, Jun/AAF-1830-2019; Reddy, Pradeep/G-1770-2014; Moraes, Carlos/AAT-3818-2021	Montserrat, Nuria/0000-0002-1603-1755; Manau, Dolors M/0000-0002-1377-9565; Wu, Jun/0000-0001-9863-1668; Reddy, Pradeep/0000-0002-9173-3845; Josep M, Campistol/0000-0001-6244-0253; Suzuki, Keiichiro/0000-0001-5603-9105; Ocampo, Alejandro/0000-0002-3731-3647	Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; National Basic Research Program of China (973 Program) [2015CB964800, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National Natural Science Foundation of China (NSFC) [81271266, 31222039, 31201111, 81371342]; NIH [5R01EY010804, 1R01AG036871]; JDM Fund; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Florida Department of Health [3KN09]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871, F32AG047770] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDM Fund; Muscular Dystrophy Association(Muscular Dystrophy Association); United Mitochondrial Disease Foundation; Florida Department of Health; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Financial support: M.M. Ku and S. Heinz are supported by the Leona M. and Harry B. Helmsley Charitable Trust. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. G.-H.L. was supported by National Basic Research Program of China (973 Program, 2015CB964800; 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), National Natural Science Foundation of China (NSFC: 81271266; 31222039; 31201111; 81371342). C.T.M. was supported by NIH grants 5R01EY010804, 1R01AG036871, the JDM Fund, the Muscular Dystrophy Association and the United Mitochondrial Disease Foundation. S.L.W. is supported by Florida Department of Health Grant 3KN09. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002).	Alexeyev M., 2013, COLD SPRING HARB PER, V5; Alexeyev MF, 2008, GENE THER, V15, P516, DOI [10.1038/gt.2008.11, 10.1038/sj.gt.2008.11]; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Hayden EC, 2013, NATURE, V502, P284, DOI 10.1038/502284a; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Vogel G, 2014, SCIENCE, V343, P827, DOI 10.1126/science.343.6173.827; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042	32	184	193	2	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					459	469		10.1016/j.cell.2015.03.051	http://dx.doi.org/10.1016/j.cell.2015.03.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910206	Bronze, Green Accepted			2022-12-28	WOS:000353553600008
J	Soufi, A; Garcia, MF; Jaroszewicz, A; Osman, N; Pellegrini, M; Zaret, KS				Soufi, Abdenour; Garcia, Meilin Fernandez; Jaroszewicz, Artur; Osman, Nebiyu; Pellegrini, Matteo; Zaret, Kenneth S.			Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming	CELL			English	Article							CRYSTAL-STRUCTURE; STEM-CELLS; MYC-MAX; COMPLEX; BINDING; RECOGNITION; DOMAIN; OCT4; SPECIFICITY; MECHANISMS	Pioneer transcription factors (TFs) access silent chromatin and initiate cell-fate changes, using diverse types of DNA binding domains (DBDs). FoxA, the paradigm pioneer TF, has a winged helix DBD that resembles linker histone and thereby binds its target sites on nucleosomes and in compacted chromatin. Herein, we compare the nucleosome and chromatin targeting activities of Oct4 (POU DBD), Sox2 (HMG box DBD), Klf4 (zinc finger DBD), and c-Myc (bHLH DBD), which together reprogram somatic cells to pluripotency. Purified Oct4, Sox2, and Klf4 proteins can bind nucleosomes in vitro, and in vivo they preferentially target silent sites enriched for nucleosomes. Pioneer activity relates simply to the ability of a given DBD to target partial motifs displayed on the nucleosome surface. Such partial motif recognition can occur by coordinate binding between factors. Our findings provide insight into how pioneer factors can target naive chromatin sites.	[Soufi, Abdenour; Garcia, Meilin Fernandez; Osman, Nebiyu; Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Soufi, Abdenour; Garcia, Meilin Fernandez; Osman, Nebiyu; Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Epigenet Program,Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jaroszewicz, Artur; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles	Zaret, KS (corresponding author), Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Inst Regenerat Med, Bldg 421,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Soufi, Abdenour/0000-0002-3666-3266; Pellegrini, Matteo/0000-0001-9355-9564; Fernandez Garcia, Meilin/0000-0002-8745-9775	NIH [P01GM099134]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Donahue for advice and G. Blobel, R. Marmorstein, M. Iwafuchi-Doi, and D. Nicetto for comments on the manuscript. The work was supported by NIH grant P01GM099134 to K.S.Z.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; El Omari K, 2013, CELL REP, V4, P135, DOI 10.1016/j.celrep.2013.06.008; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Pogenberg V, 2012, GENE DEV, V26, P2647, DOI 10.1101/gad.198192.112; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sauve S, 2004, J MOL BIOL, V342, P813, DOI 10.1016/j.jmb.2004.07.058; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Soufi A, 2014, CURR OPIN GENET DEV, V25, P101, DOI 10.1016/j.gde.2013.12.007; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083723	60	414	420	7	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					555	568		10.1016/j.cell.2015.03.017	http://dx.doi.org/10.1016/j.cell.2015.03.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892221	Green Accepted, Bronze			2022-12-28	WOS:000353553600015
J	Hankey, GJ				Hankey, Graeme J.			Glyceryl trinitrate did not improve functional outcome in patients with acute stroke and high BP	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Ankolekar S, 2013, STROKE, V44, P3120, DOI 10.1161/STROKEAHA.113.001301; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Wang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097917	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC12	10.7326/ACPJC-2015-162-8-012	http://dx.doi.org/10.7326/ACPJC-2015-162-8-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894045				2022-12-28	WOS:000353244300011
J	Nagasawa, M; Mitsui, S; En, S; Ohtani, N; Ohta, M; Sakuma, Y; Onaka, T; Mogi, K; Kikusui, T				Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Sakuma, Yasuo; Onaka, Tatsushi; Mogi, Kazutaka; Kikusui, Takefumi			Oxytocin-gaze positive loop and the coevolution of human-dog bonds	SCIENCE			English	Article							SOCIAL-INTERACTION; URINARY OXYTOCIN; BRAIN OXYTOCIN; ATTACHMENT; WOLVES; NEOTENY	Human-like modes of communication, including mutual gaze, in dogs may have been acquired during domestication with humans. We show that gazing behavior from dogs, but not wolves, increased urinary oxytocin concentrations in owners, which consequently facilitated owners' affiliation and increased oxytocin concentration in dogs. Further, nasally administered oxytocin increased gazing behavior in dogs, which in turn increased urinary oxytocin concentrations in owners. These findings support the existence of an interspecies oxytocin-mediated positive loop facilitated and modulated by gazing, which may have supported the coevolution of human-dog bonding by engaging common modes of communicating social attachment.	[Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Mogi, Kazutaka; Kikusui, Takefumi] Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan; [Nagasawa, Miho; Onaka, Tatsushi] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi, Japan; [Sakuma, Yasuo] Univ Tokyo Hlth Sci, Tokyo, Japan	Azabu University; Jichi Medical University	Kikusui, T (corresponding author), Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan.	kikusui@azabu-u.ac.jp	Sakuma, Yasuo/C-5604-2011	Sakuma, Yasuo/0000-0001-6816-3779; Onaka, Tatsushi/0000-0001-5666-9035; Mogi, Kazutaka/0000-0002-0689-9761	Japan Society for the Promotion of Science, in Japan [4501]; Grants-in-Aid for Scientific Research [25118008, 26450433] Funding Source: KAKEN	Japan Society for the Promotion of Science, in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Grant-in-Aid for Scientific Research on Innovative Areas (No. 4501) from the Japan Society for the Promotion of Science, in Japan. We thank all human and canine participants, Howlin' Ks Nature School, U.S. Kennel, R. Ooyama and N. Yoshida-Tsuchihashi from Azabu University, and Drs. Kato and Takeda from University of Tokyo Health Sciences. We are also grateful to Cody and Charley for their significant contributions. The analyzed data are included in the supplementary materials.	COPPINGER R, 1987, ETHOLOGY, V75, P89; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; DICKSTEIN S, 1984, INFANT BEHAV DEV, V7, P507, DOI 10.1016/S0163-6383(84)80009-0; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Fox M. W., 1997, THE SOUL OF THE WOLF; Gacsi M, 2013, APPL ANIM BEHAV SCI, V145, P109, DOI 10.1016/j.applanim.2013.02.007; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Kim S, 2014, BRAIN RES, V1580, P133, DOI 10.1016/j.brainres.2013.10.050; Meins E., 1997, SECURITY ATTACHMENT; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mitsui S, 2011, HORM BEHAV, V60, P239, DOI 10.1016/j.yhbeh.2011.05.012; Nagasawa M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00031; Nagasawa M, 2009, JPN PSYCHOL RES, V51, P209, DOI 10.1111/j.1468-5884.2009.00402.x; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Shinozaki J, 2007, NEUROREPORT, V18, P993, DOI 10.1097/WNR.0b013e3281ac2161; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Tuber DS, 1996, J COMP PSYCHOL, V110, P103, DOI 10.1037/0735-7036.110.1.103; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	26	357	368	14	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					333	336		10.1126/science.1261022	http://dx.doi.org/10.1126/science.1261022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883356				2022-12-28	WOS:000352999000044
J	Watanabe, M; Kondo, S				Watanabe, Masakatsu; Kondo, Shigeru			Comment on "Local reorganization of xanthophores fine-tunes and colors the striped pattern of zebrafish"	SCIENCE			English	Editorial Material							ADULT PIGMENT PATTERN; IRIDOPHORES	Mahalwar et al. (Reports, 12 September 2014, p. 1362) observed the onset of pigment pattern formation in zebrafish. They concluded that their data do not support our Turing mechanism-based model and presented an essentially different mechanism. Here, we clarify their misunderstanding that may have caused their conclusion and explain past experimental data that do not support their proposed mechanism.	[Watanabe, Masakatsu; Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Kondo, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	skondo@fbs.osaka-u.ac.jp	WATANABE, Masakatsu/V-9082-2019	WATANABE, Masakatsu/0000-0002-5744-197X; Kondo, Shigeru/0000-0003-0192-5526	Grants-in-Aid for Scientific Research [26291049] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Mahalwar P, 2014, SCIENCE, V345, P1362, DOI 10.1126/science.1254837; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Singh AP, 2014, NAT CELL BIOL, V16, P604, DOI 10.1038/ncb2955; Takahashi G, 2008, PIGM CELL MELANOMA R, V21, P677, DOI 10.1111/j.1755-148X.2008.00504.x; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Watanabe M, 2012, PIGM CELL MELANOMA R, V25, P326, DOI 10.1111/j.1755-148X.2012.00984.x; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104	15	17	17	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232								10.1126/science.1261947	http://dx.doi.org/10.1126/science.1261947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883350				2022-12-28	WOS:000352999000031
J	Livio, M				Livio, Mario			Hubble's legacy	NATURE			English	Editorial Material									Space Telescope Sci Inst STScI, Baltimore, MD 21218 USA	Space Telescope Science Institute	Livio, M (corresponding author), Space Telescope Sci Inst STScI, Baltimore, MD 21218 USA.	mlivio@stsci.edu							0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					287	289		10.1038/520287a	http://dx.doi.org/10.1038/520287a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877188	Bronze			2022-12-28	WOS:000352974200014
J	Tsubogo, T; Oyamada, H; Kobayashi, S				Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu			Multistep continuous-flow synthesis of (R) - and (S) -rolipram using heterogeneous catalysts	NATURE			English	Article							CARBON BOND FORMATION; HYDROGENATION; CHEMISTRY; MECHANISM; REACTORS; TOOLS	Chemical manufacturing is conducted using either batch systems or continuous-flow systems. Flow systems have several advantages over batch systems, particularly in terms of productivity, heat and mixing efficiency, safety, and reproducibility'. However, for over half a century, pharmaceutical manufacturing has used batch systems because the synthesis of complex molecules such as drugs has been difficult to achieve with continuous-flow systems'''. Here we describe the continuous-flow synthesis of drugs using only columns packed with heterogeneous catalysts. Commercially available starting materials were successively passed through four columns containing achiral and chiral heterogeneous catalysts to produce (R)-rolipram', an anti-inflammatory drug and one of the family of y-aminobutyric acid (GABA) derivatives'. In addition, simply by replacing a column packed with a chiral heterogeneous catalyst with another column packed with the opposing enantiomer, we obtained antipole (S)-rolipram. Similarly, we also synthesized (R)-phenibut, another drug belonging to the GABA family. These flow systems are simple and stable with no leaching of metal catalysts. Our results demonstrate that multistep (eight steps in this case) chemical transformations for drug synthesis can proceed smoothly under flow conditions using only heterogeneous catalysts, without the isolation of any intermediates and without the separation of any catalysts, co-products, by-products, and excess reagents. We anticipate that such syntheses will be useful in pharmaceutical manufacturing.	[Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu] Univ Tokyo, Sch Sci, Green & Sustainable Chem Social Cooperat Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Kobayashi, S (corresponding author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Tsubogo, Tetsu/P-8292-2019; Kobayashi, Shu/E-9214-2012	Tsubogo, Tetsu/0000-0003-2615-7287; 	Global COE Program, The University of Tokyo, MEXT, Japan; ACT-C; Center of Innovation (COI) Program; Japan Science and Technology Agency (JST)	Global COE Program, The University of Tokyo, MEXT, Japan; ACT-C; Center of Innovation (COI) Program; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partially supported by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), Global COE Program, The University of Tokyo, MEXT, Japan, the ACT-C and Center of Innovation (COI) Program, and the Japan Science and Technology Agency (JST).	Anastas P. T., 1998, GREEN CHEM THEORY PR; Barnes DM, 2002, J AM CHEM SOC, V124, P13097, DOI 10.1021/ja026788y; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Day JP, 2011, J MED CHEM, V54, P3331, DOI 10.1021/jm200070e; Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c; Geyer K, 2006, CHEM-EUR J, V12, P8434, DOI 10.1002/chem.200600596; Hartman RL, 2011, ANGEW CHEM INT EDIT, V50, P7502, DOI 10.1002/anie.201004637; Hartwig J, 2013, ANGEW CHEM INT EDIT, V52, P9813, DOI 10.1002/anie.201302239; Hopkin MD, 2013, ORG BIOMOL CHEM, V11, P1822, DOI 10.1039/c2ob27002a; Hynes PS, 2008, ORG LETT, V10, P1389, DOI 10.1021/ol800108u; Kirschning A, 2006, CHEM-EUR J, V12, P5972, DOI 10.1002/chem.200600236; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Ley SV, 2002, NAT REV DRUG DISCOV, V1, P573, DOI 10.1038/nrd871; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malykh AG, 2010, DRUGS, V70, P287, DOI 10.2165/11319230-000000000-00000; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Motokura K, 2009, J AM CHEM SOC, V131, P7944, DOI 10.1021/ja9012003; O'Brien M, 2011, CHEM SCI, V2, P1250, DOI 10.1039/c1sc00055a; Ojima I., 2010, CATALYTIC ASYMMETRIC; Oyamada H, 2011, BEILSTEIN J ORG CHEM, V7, P735, DOI 10.3762/bjoc.7.83; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Poechlauer P, 2012, ORG PROCESS RES DEV, V16, P1586, DOI 10.1021/op300159y; Soldi L, 2008, J CATAL, V258, P289, DOI 10.1016/j.jcat.2008.07.005; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Tsubogo T, 2013, ANGEW CHEM INT EDIT, V52, P6590, DOI 10.1002/anie.201210066; Tsubogo T, 2012, CHEM-EUR J, V18, P13624, DOI 10.1002/chem.201202896; VANARNUM P, 2013, PHARM TECHNOL, V37, P78; Webb D, 2010, CHEM SCI, V1, P675, DOI 10.1039/c0sc00381f; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Worrall DL, 1929, ORG SYNTH, V9, P66	30	262	264	16	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					329	332		10.1038/nature14343	http://dx.doi.org/10.1038/nature14343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877201				2022-12-28	WOS:000352974200034
J	Mccoy, RC; Demko, Z; Ryan, A; Banjevic, M; Hill, M; Sigurjonsson, S; Rabinowitz, M; Fraser, HB; Petrov, DA				McCoy, Rajiv C.; Demko, Zachary; Ryan, Allison; Banjevic, Milena; Hill, Matthew; Sigurjonsson, Styrmir; Rabinowitz, Matthew; Fraser, Hunter B.; Petrov, Dmitri A.			Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos	SCIENCE			English	Article							PREIMPLANTATION EMBRYOS; CHROMOSOMAL MOSAICISM; BLASTOMERES; SINGLE; RATES	Aneuploidy, the inheritance of an atypical chromosome complement, is common in early human development and is the primary cause of pregnancy loss. By screening day-3 embryos during in vitro fertilization cycles, we identified an association between aneuploidy of putative mitotic origin and linked genetic variants on chromosome 4 of maternal genomes. This associated region contains a candidate gene, Polo-like kinase 4 (PLK4), that plays a well-characterized role in centriole duplication and has the ability to alter mitotic fidelity upon minor dysregulation. Mothers with the high-risk genotypes contributed fewer embryos for testing at day 5, suggesting that their embryos are less likely to survive to blastocyst formation. The associated region coincides with a signature of a selective sweep in ancient humans, suggesting that the causal variant was either the target of selection or hitchhiked to substantial frequency.	[McCoy, Rajiv C.; Fraser, Hunter B.; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Demko, Zachary; Ryan, Allison; Banjevic, Milena; Hill, Matthew; Sigurjonsson, Styrmir; Rabinowitz, Matthew] Natera Inc, San Carlos, CA 94070 USA	Stanford University	Demko, Z (corresponding author), Natera Inc, San Carlos, CA 94070 USA.	rmccoy@stanford.edu; zdemko@natera.com; dpetrov@stanford.edu	McCoy, Rajiv/AEW-9951-2022	McCoy, Rajiv/0000-0003-0615-146X; Petrov, Dmitri/0000-0002-3664-9130	 [R01 GM100366];  [R01 GM097415];  [R01 GM089926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100366, R01GM097415, R01GM089926] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to C. Hin and J. Layne for computing support; E. Sharon for advice regarding analyses; R. Taylor and other members of the Petrov lab for helpful input; J. Sage, J. Arand, T. Stearns, and O. Cormier for advice regarding functional annotation; and C. Boggs for comments on the manuscript. D.A.P. devised the project. D.A.P., H.B.F., and Z.D. provided guidance throughout the project. R.C.M. performed analyses and wrote the manuscript. Z.D., A. R., M.B., M.H., S.S., and M.R. helped generate the data and design the algorithm by which aneuploidies are detected. All authors read the manuscript and provided comments. D.A.P. has received stock options in Natera, Inc., as consulting fees. Z.D., A.R., M.B., M.H., S.S., and M. R. are full-time employees of and hold stock or options to hold stock in Natera, Inc. De-identified aneuploidy outcome data for all blastomeres are uploaded as supplemental material, as are genome-wide association study summary statistics. Patient genotype data for the associated region are archived at Natera, which will cooperate with qualified researchers attempting to replicate the findings of this study, conditional on institutional research board approval and adherence to a materials transfer agreement. Stanford University filed a provisional patent related to this work with the U.S. Patent and Trademark Office on 14 November 2014 (USSN 62/080,251). This work was partly supported by grants R01 GM100366, R01 GM097415, and R01 GM089926 to D.A.P. Correspondence regarding the data should be addressed to Z.D. (zdemko@natera.com); other correspondence should be addressed to R.C.M. (rmccoy@stanford.edu) or D.A.P. (dpetrov@stanford.edu).	Alexander R.D., 1979, EVOLUTIONARY BIOL HU, P436; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Coonen E, 2004, HUM REPROD, V19, P316, DOI 10.1093/humrep/deh077; Daphnis DD, 2005, HUM REPROD, V20, P129, DOI 10.1093/humrep/deh554; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Vega M, 2014, FERTIL STERIL, V102, P394, DOI 10.1016/j.fertnstert.2014.04.026; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	25	74	78	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					235	238		10.1126/science.aaa3337	http://dx.doi.org/10.1126/science.aaa3337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859044	Green Accepted			2022-12-28	WOS:000352613700046
J	Xue, YL; Prado-Martinez, J; Sudmant, PH; Narasimhan, V; Ayub, Q; Szpak, M; Frandsen, P; Chen, Y; Yngvadottir, B; Cooper, DN; de Manuel, M; Hernandez-Rodriguez, J; Lobon, I; Siegismund, HR; Pagani, L; Quail, MA; Hvilsom, C; Mudakikwa, A; Eichler, EE; Cranfield, MR; Marques-Bonet, T; Tyler-Smith, C; Scally, A				Xue, Yali; Prado-Martinez, Javier; Sudmant, Peter H.; Narasimhan, Vagheesh; Ayub, Qasim; Szpak, Michal; Frandsen, Peter; Chen, Yuan; Yngvadottir, Bryndis; Cooper, David N.; de Manuel, Marc; Hernandez-Rodriguez, Jessica; Lobon, Irene; Siegismund, Hans R.; Pagani, Luca; Quail, Michael A.; Hvilsom, Christina; Mudakikwa, Antoine; Eichler, Evan E.; Cranfield, Michael R.; Marques-Bonet, Tomas; Tyler-Smith, Chris; Scally, Aylwyn			Mountain gorilla genomes reveal the impact of long-term population decline and inbreeding	SCIENCE			English	Article							DIVERSITY	Mountain gorillas are an endangered great ape subspecies and a prominent focus for conservation, yet we know little about their genomic diversity and evolutionary past. We sequenced whole genomes from multiple wild individuals and compared the genomes of all four Gorilla subspecies. We found that the two eastern subspecies have experienced a prolonged population decline over the past 100,000 years, resulting in very low genetic diversity and an increased overall burden of deleterious variation. A further recent decline in the mountain gorilla population has led to extensive inbreeding, such that individuals are typically homozygous at 34% of their sequence, leading to the purging of severely deleterious recessive mutations from the population. We discuss the causes of their decline and the consequences for their future survival.	[Xue, Yali; Narasimhan, Vagheesh; Ayub, Qasim; Szpak, Michal; Chen, Yuan; Yngvadottir, Bryndis; Pagani, Luca; Quail, Michael A.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Prado-Martinez, Javier; de Manuel, Marc; Hernandez-Rodriguez, Jessica; Lobon, Irene; Marques-Bonet, Tomas] Inst Biol Evolut CSIC UPF, Barcelona 08003, Catalonia, Spain; [Sudmant, Peter H.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Narasimhan, Vagheesh] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Frandsen, Peter; Siegismund, Hans R.] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Cooper, David N.] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Pagani, Luca] Univ Bologna, Dept Biol Geol & Environm Sci, I-40134 Bologna, Italy; [Hvilsom, Christina] Copenhagen Zoo, Res & Conservat, DK-2000 Frederiksberg, Denmark; [Mudakikwa, Antoine] Rwanda Dev Board, Kigali, Rwanda; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA; [Cranfield, Michael R.] Univ Calif Davis, Karen C Drayer Wildlife Hlth Ctr, Gorilla Doctors, Davis, CA 95616 USA; [Marques-Bonet, Tomas] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	Wellcome Trust Sanger Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); University of Washington; University of Washington Seattle; University of Cambridge; University of Copenhagen; Cardiff University; University of Bologna; Howard Hughes Medical Institute; University of California System; University of California Davis; University of Cambridge	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	cts@sanger.ac.uk; aos21@cam.ac.uk	Pagani, Luca/G-8511-2017; Frandsen, Peter/O-3698-2019; Marques-Bonet, Tomas/ABF-3734-2020; Quail, michael/ABE-6131-2020; Prado-Martinez, Javier/AAA-6341-2020; Cooper, David N/H-4384-2011	Pagani, Luca/0000-0002-6639-524X; Frandsen, Peter/0000-0001-7131-0944; Marques-Bonet, Tomas/0000-0002-5597-3075; Prado-Martinez, Javier/0000-0001-5402-2721; Cooper, David N/0000-0002-8943-8484; Hvilsom, Christina/0000-0001-7870-6888; Sudmant, Peter/0000-0002-9573-8248; Ayub, Qasim/0000-0003-3291-0917; Narasimhan, Vagheesh/0000-0001-8651-8844; Szpak, Michal/0000-0002-9096-852X; Hernandez-Rodriguez, Jessica/0000-0002-0402-286X	Royal Society [RG130105]; Wellcome Trust [098051, 099769/Z/12/Z]; NIH [HG002385]; European Research Council [260372]; Ministerio de Ciencia e Innovacion [BFU2011-28549]; BIOBASE GmbH; Cardiff University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); BIOBASE GmbH; Cardiff University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Institut Congolais pour la Conservation de la Nature and the Rwandan Development Board for the use of samples; J. Ramer, D. Zimmerman, J. F. Kinani, J. Bosco Noheri, M. Bahizi, J. P. Lukasa, J. Iyanya, M. Kabuyaya, E. Kambale, and J. Sohl of Gorilla Doctors for sample collection and processing; and M. Pollard, P. Hallast, M. Jobling, and L. Lowenstine for assistance. Supported by Royal Society grant RG130105 (A.S.), Wellcome Trust grants 098051 (Q.A., Y.C., V.N., L. P., M.A.Q., M.S., C.T.-S., Y.X., B.Y.) and 099769/Z/12/Z (V.N.), NIH grant HG002385 (E. E. E.), a European Research Council Starting Grant (260372), and Ministerio de Ciencia e Innovacion grant BFU2011-28549 (T.M.-B.). E. E. E. is an investigator of the Howard Hughes Medical Institute. Accession numbers for sequence data are given in table S1. Gorilla blood samples sequenced in this study were collected and transferred in compliance with CITES legislation and subject to a material transfer agreement between the Mountain Gorilla Veterinary Project and the Office Rwandais du Tourisme et des Parcs Nationaux. D.N.C. acknowledges support from BIOBASE GmbH through a license agreement with Cardiff University; E. E. E. is a member of the external scientific advisory board for DNAnexus Inc.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Fossey D., 1983, GORILLAS MIST, P72; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Glemin S, 2003, EVOLUTION, V57, P2678; Gray M, 2013, BIOL CONSERV, V158, P230, DOI 10.1016/j.biocon.2012.09.018; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Harcourt AH, 1996, BIOL CONSERV, V75, P165, DOI 10.1016/0006-3207(95)00059-3; IUCN, 2014, EB OUTBR HIGHL CRIT; Jensen-Seaman MI, 2001, MOL ECOL, V10, P2241, DOI 10.1046/j.0962-1083.2001.01365.x; Le Gouar PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008375; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; McManamon R., 2012, FOWLERS ZOO WILD ANI, V7, P408; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Robbins M., 2008, GORILLA BERINGEI SSP; Routh A., 1997, P BR VET ZOOL SOC AN, P22; Roy J, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0811; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaller G. B., 2010, YEAR GORILLA, P7; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; WEBER AW, 1983, BIOL CONSERV, V26, P341, DOI 10.1016/0006-3207(83)90096-4	24	174	177	6	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					242	245		10.1126/science.aaa3952	http://dx.doi.org/10.1126/science.aaa3952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859046	Green Accepted			2022-12-28	WOS:000352613700048
J	Cifelli, RL				Cifelli, Richard L.			Zofia Kielan-Jaworowska (1925-2015) OBITUARY	NATURE			English	Biographical-Item									Sam Noble Museum, Vertebrate Palaeontol, Norman, OK 73072 USA		Cifelli, RL (corresponding author), Sam Noble Museum, Vertebrate Palaeontol, Norman, OK 73072 USA.	rlc@ou.edu						KIELANJAWOROWSK.Z, PUBLICATION LIST	1	0	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					158	158		10.1038/520158a	http://dx.doi.org/10.1038/520158a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855448	Bronze			2022-12-28	WOS:000352454600020
J	Watson, M				Watson, Matthew			Test the effects of ash on jet engines	NATURE			English	Editorial Material									[Watson, Matthew] Univ Bristol, Sch Earth Sci, Bristol BS8 1TH, Avon, England; [Watson, Matthew] Univ Bristol, Cabot Inst, Bristol BS8 1TH, Avon, England	University of Bristol; University of Bristol	Watson, M (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1TH, Avon, England.	matt.watson@bristol.ac.uk			Natural Environment Research Council [NE/I01554X/1] Funding Source: researchfish; NERC [NE/I01554X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	3	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					133	133		10.1038/520133a	http://dx.doi.org/10.1038/520133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855421	Bronze			2022-12-28	WOS:000352454600004
J	Yacoub, M				Yacoub, Magdi			Cardiac donation after circulatory death: a time to reflect	LANCET			English	Editorial Material							ISCHEMIC CHOLANGIOPATHY; LIVER-TRANSPLANTATION		Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England	Imperial College London	Yacoub, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England.	m.yacoub@imperial.ac.uk						Chan EY, 2008, LIVER TRANSPLANT, V14, P604, DOI 10.1002/lt.21361; Dhital KK, 2015, LANCET; Dunne K, 2011, CONTIN ED ANAESTH CR, V11, P82; Gilman SJ, 2012, ELON L REV, V4, P71; Hoffenberg R, 1997, LANCET, V350, P1320, DOI 10.1016/S0140-6736(97)02306-4; Immer FF, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14062; International Registry in Organ Donation and Transplantation, 2013, FIN NUMB 2012; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; Raynaud CM, 2014, GLOB CARDIOL SCI PRA, V44, P309; Rodsenblum AM, 2012, TRANSPL INT, V25, P801; Spadotto Veronica, 2013, Glob Cardiol Sci Pract, V2013, P163, DOI 10.5339/gcsp.2013.22; Truog RD, 2013, NEW ENGL J MED, V369, P1287, DOI 10.1056/NEJMp1307220; Working Party of the British Transplantation Society, 2013, UK GUID TRANSPL DON; Yacoub M, 2008, AM J TRANSPLANT, V8, P1767, DOI 10.1111/j.1600-6143.2008.02366.x; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	15	13	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2554	2556		10.1016/S0140-6736(15)60683-3	http://dx.doi.org/10.1016/S0140-6736(15)60683-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25888087				2022-12-28	WOS:000356930000007
J	Steinbrook, R				Steinbrook, Robert			The Repeal of Medicare's Sustainable Growth Rate for Physician Payment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						[Anonymous], 2015, NY TIMES; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; MedPAC, 2015, REP C MED PAYM POL; OFF. OF THE NAT'L COORDINATOR FOR HEALTH INFO. TECH, 2015, REP C REP HLTH INF B, P15; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703	5	24	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2025	2026		10.1001/jama.2015.4550	http://dx.doi.org/10.1001/jama.2015.4550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	25885640	Bronze			2022-12-28	WOS:000355142400013
J	Blumenthal, D; McGinnis, JM				Blumenthal, David; McGinnis, J. Michael			Measuring Vital Signs An IOM Report on Core Metrics for Health and Health Care Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blumenthal, David] Commonwealth Fund, New York, NY 10021 USA; [McGinnis, J. Michael] Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Commonwealth Fund; National Academies of Sciences, Engineering & Medicine	Blumenthal, D (corresponding author), Commonwealth Fund, 1E 75th St, New York, NY 10021 USA.	db@cmwf.org						[Anonymous], 2011, C NATL STRAT QUAL IM; Institute of Medicine, 2015, VIT SIGNS COR METR H; US Department of Health and Human Services, 2014, HLTH PEOPL 2020 WEBS	3	77	77	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2015	313	19					1901	1902		10.1001/jama.2015.4862	http://dx.doi.org/10.1001/jama.2015.4862			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4BK	25919301				2022-12-28	WOS:000354691200005
J	Fabre, J				Fabre, John			Create a clinical chief executive role in hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Fabre, J (corresponding author), Kings Coll London, London WC2R 2LS, England.	john.fabre@kcl.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2015	350								h2041	10.1136/bmj.h2041	http://dx.doi.org/10.1136/bmj.h2041			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RA	25908599				2022-12-28	WOS:000353576800003
J	Rosenberg, OS; Dovala, D; Li, XM; Connolly, L; Bendebury, A; Finer-Moore, J; Holton, J; Cheng, YF; Stroud, RM; Cox, JS				Rosenberg, Oren S.; Dovala, Dustin; Li, Xueming; Connolly, Lynn; Bendebury, Anastasia; Finer-Moore, Janet; Holton, James; Cheng, Yifan; Stroud, Robert M.; Cox, Jeffery S.			Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion	CELL			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DNA TRANSLOCATION; VIRULENCE; ESAT-6; SECA; MECHANISM; SYSTEM; SIGNAL; PATHOGENESIS; RECOGNITION	Mycobacterium tuberculosis and Staphylococcus aureus secrete virulence factors via type VII protein secretion (T7S), a system that intriguingly requires all of its secretion substrates for activity. To gain insights into T7S function, we used structural approaches to guide studies of the putative translocase EccC, a unique enzyme with three ATPase domains, and its secretion substrate EsxB. The crystal structure of EccC revealed that the ATPase domains are joined by linker/pocket interactions that modulate its enzymatic activity. EsxB binds via its signal sequence to an empty pocket on the C-terminal ATPase domain, which is accompanied by an increase in ATPase activity. Surprisingly, substrate binding does not activate EccC allosterically but, rather, by stimulating its multimerization. Thus, the EsxB substrate is also an integral T7S component, illuminating a mechanism that helps to explain interdependence of substrates, and suggests a model in which binding of substrates modulates their coordinate release from the bacterium.	[Rosenberg, Oren S.; Connolly, Lynn] Univ Calif San Francisco, Div Infect Dis, Dept Med, UCSF Med Ctr, San Francisco, CA 94143 USA; [Dovala, Dustin; Bendebury, Anastasia; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA; [Li, Xueming] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Finer-Moore, Janet; Holton, James; Cheng, Yifan; Stroud, Robert M.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94158 USA; [Connolly, Lynn] Achaogen Inc, San Francisco, CA 94080 USA; [Holton, James] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; UCSF Medical Center; University of California System; University of California San Francisco; Tsinghua University; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369	NIH [K08AI091656, R01AI081727, P01AI063302, U54GM094625]; NSF [1144247]; U.S. DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; U.S. DOE Office of Biological and Environmental Research; NIH-GMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI091656, R01AI081727, T32AI007641, P01AI063302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094625, R37GM024485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. DOE(United States Department of Energy (DOE)); U.S. DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH-GMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the NIH (K08AI091656 to O.S.R., R01AI081727 and P01AI063302 to J.S.C., and U54GM094625 to R.M.S.) and the NSF (grant no. 1144247 to D.D.). For technical assistance, we thank Rebecca Robbins, Peter Bieling, Jenifer Du Mond, Lara Koehler, R. Stefan Isaac, Yaneth Robles, Diana Romero, Spenser Alexander, and Andrew Rodriguez. For helpful discussions, we thank Ron Vale, John Kuriyan, James Berger, Bennett Penn, Matt Lohse, and Damian Ekiert. We thank R. Rajashankar at the APS beamline NE-CAT 24ID; George Meigs and Jane Tanamachi at ALS BL 8.3.1; and Tzanko Doukov and Lisa Dunn at SSRL. APS is supported by the U.S. DOE Contract DE-AC02-06CH11357. ALS is supported by the U.S. DOE Contract DE-AC02-05CH11231. The SSRL Structural Molecular Biology Program is supported by the U.S. DOE Office of Biological and Environmental Research and by the NIH-GMS (including P41GM103393).	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chatzi KE, 2014, BBA-MOL CELL RES, V1843, P1466, DOI 10.1016/j.bbamcr.2014.02.014; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Guglielmini J, 2013, MOL BIOL EVOL, V30, P315, DOI 10.1093/molbev/mss221; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Huppert LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096267; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pena A, 2011, J BIOL CHEM, V286, P17376, DOI 10.1074/jbc.M110.208942; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ramsdell TL, 2015, J MOL BIOL, V427, P1119, DOI 10.1016/j.jmb.2014.06.013; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Senior AE, 2012, J BIOL CHEM, V287, P30049, DOI 10.1074/jbc.X112.402313; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Sysoeva TA, 2014, P NATL ACAD SCI USA, V111, P7653, DOI 10.1073/pnas.1322200111; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Waksman G, 2012, PHILOS T R SOC B, V367, P1014, DOI 10.1098/rstb.2011.0200; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014	46	82	90	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					501	512		10.1016/j.cell.2015.03.040	http://dx.doi.org/10.1016/j.cell.2015.03.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865481	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000353553600011
J	Sheth, T; Chan, M; Butler, C; Chow, B; Tandon, V; Nagele, P; Mitha, A; Mrkobrada, M; Szczeklik, W; Faridah, Y; Biccard, B; Stewart, LK; Heels-Ansdell, D; Devereaux, PJ				Sheth, Tej; Chan, Matthew; Butler, Craig; Chow, Benjamin; Tandon, Vikas; Nagele, Peter; Mitha, Ayesha; Mrkobrada, Marko; Szczeklik, Wojciech; Faridah, Yang; Biccard, Bruce; Stewart, Lori K.; Heels-Ansdell, Diane; Devereaux, P. J.		Coronary Comp Tomographic	Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERIOPERATIVE CARDIAC EVENTS; ARTERY-DISEASE; CT ANGIOGRAPHY; STRESS ECHOCARDIOGRAPHY; DIAGNOSTIC-ACCURACY; CLINICAL-OUTCOMES; RISK PATIENTS; TASK-FORCE; PREDICTION; MORTALITY	OBJECTIVES To determine if coronary computed tomographic angiography enhances prediction of perioperative risk in patients before non-cardiac surgery and to assess the preoperative coronary anatomy in patients who experience a myocardial infarction after non-cardiac surgery. DESIGN Prospective cohort study. SETTING 12 centers in eight countries. PARTICIPANTS 955 patients with, or at risk of, atherosclerotic disease who underwent non-cardiac surgery. INTERVENTIONS Coronary computed tomographic angiography was performed preoperatively; clinicians were blinded to the results unless left main disease was suspected. Results were classified as normal, non-obstructive (<50% stenosis), obstructive (one or two vessels with >= 50% stenosis), or extensive obstructive (>= 50% stenosis in two vessels including the proximal left anterior descending artery, three vessels, or left main). MAIN OUTCOME MEASURE Composite of cardiovascular death and non-fatal myocardial infarction within 30 days after surgery (primary outcome). This was the dependent variable in Cox regression. The independent variables were scores on the revised cardiac risk index and findings on coronary computed tomographic angiography. RESULTS The primary outcome occurred in 74 patients (8%). The model that included both scores on the revised cardiac risk index and findings on coronary computed tomographic angiography showed that coronary computed tomographic angiography provided independent prognostic information (P=0.014; C index=0.66). The adjusted hazard ratios were 1.51 (95% confidence interval 0.45 to 5.10) for non-obstructive disease; 2.05 (0.62 to 6.74) for obstructive disease; and 3.76 (1.12 to 12.62) for extensive obstructive disease. For the model with coronary computed tomographic angiography compared with the model based on the revised cardiac risk index alone, with 30 day risk categories of <5%, 5-15%, and >15% for the primary outcome, the results of risk reclassification indicate that in a sample of 1000 patients that coronary computed tomographic angiography would have resulted appropriately in 17 net patients receiving a higher risk estimation among the 77 patients who would have experienced the primary outcome (P<0.001). Coronary computed tomographic angiography, however, would have resulted inappropriately in 98 net patients receiving a higher risk estimation, among the 923 patients who would not have experienced the primary outcome (P<0.001). Among patients who had a perioperative myocardial infarction, preoperative coronary anatomy showed extensive obstructive disease in 31% (22/71), obstructive disease in 41% (29/71), non-obstructive disease in 24% (17/71), and normal findings in 4% (3/71). CONCLUSIONS Though findings on coronary computed tomographic angiography can improve estimation of risk for patients who will experience perioperative cardiovascular death or myocardial infarction, findings are more than five times as likely to lead to an inappropriate overestimation of risk among patients who will not experience these outcomes. Perioperative myocardial infarction occurs across the spectrum of coronary artery disease, suggesting that there could be several pathophysiologic mechanisms.	[Sheth, Tej] David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Chan, Matthew] Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Butler, Craig] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB T6G 2B7, Canada; [Chow, Benjamin] Univ Ottawa, Inst Heart, Dept Med Cardiol, Ottawa, ON K1Y 4W7, Canada; [Chow, Benjamin] Univ Ottawa, Inst Heart, Dept Radiol, Ottawa, ON K1Y 4W7, Canada; [Tandon, Vikas] McMaster Univ, St Josephs Healthcare, Dept Med, Div Cardiol, Hamilton, ON L8N 4A6, Canada; [Nagele, Peter] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Mitha, Ayesha] Inkosi Albert Luthuli Cent Hosp, Dept Radiol, ZA-4091 Durban, South Africa; [Mrkobrada, Marko] Univ Western Ontario, Div Gen Internal Med, London, ON N6A 5A5, Canada; [Szczeklik, Wojciech] Jagiellonian Univ, Dept Med, Coll Med, PL-31027 Krakow, Poland; [Faridah, Yang] Univ Malaya, Res Imaging Ctr, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia; [Biccard, Bruce] Univ Kwazulu Natal, ZA-4041 Durban, South Africa; [Stewart, Lori K.] Jurvanski Hosp, Hamilton Hlth Sci, Diagnost Imaging, Hamilton, ON L8V 1C3, Canada; [Heels-Ansdell, Diane; Devereaux, P. J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 3Z5, Canada; [Devereaux, P. J.] McMaster Univ, Dept Med, Hamilton, ON L8S 3Z5, Canada	Population Health Research Institute; Chinese University of Hong Kong; University of Alberta; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; McMaster University; Washington University (WUSTL); Western University (University of Western Ontario); Jagiellonian University; Collegium Medicum Jagiellonian University; Universiti Malaya; University of Kwazulu Natal; McMaster University; McMaster University; McMaster University	Sheth, T (corresponding author), David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	shetht@mcmaster.ca	Mrkobrada, Marko/G-3336-2011; Nagele, Peter/AAW-1651-2020; Devereaux, PJ/AAF-2862-2019; Chan, Matthew/J-2884-2013; Szczeklik, Wojciech/N-8096-2014; Aziz, Yang Faridah Abdul/C-7945-2012; Devereaux, PJ/AAY-1757-2021; ABDUL AZIZ, YANG FARIDAH/C-1063-2010; Nagele, Peter/ABA-5189-2020	Nagele, Peter/0000-0001-8369-3858; Chan, Matthew/0000-0002-3574-7855; Szczeklik, Wojciech/0000-0002-1349-1123; Aziz, Yang Faridah Abdul/0000-0002-0869-1972; Goela, Aashish/0000-0001-9373-1475; Gorka, Jacek/0000-0002-0410-4128; Devereaux, PJ/0000-0003-2935-637X; Chow, Benjamin/0000-0001-8631-0234	Canadian Institutes of Health Research; Hamilton Health Sciences New Investigator Fund; McMaster University Division of Cardiology; University of Western Ontario Department of Radiology; University of Western Ontario Division of General Internal Medicine; Washington University Institute of Clinical and Translational Sciences	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hamilton Health Sciences New Investigator Fund; McMaster University Division of Cardiology; University of Western Ontario Department of Radiology; University of Western Ontario Division of General Internal Medicine; Washington University Institute of Clinical and Translational Sciences	This study was funded by the Canadian Institutes of Health Research, the Hamilton Health Sciences New Investigator Fund, the McMaster University Division of Cardiology, the University of Western Ontario Department of Radiology, the University of Western Ontario Division of General Internal Medicine, and the Washington University Institute of Clinical and Translational Sciences. The study funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Ahn JH, 2013, J AM COLL CARDIOL, V61, P661, DOI 10.1016/j.jacc.2012.09.060; Austen W G, 1975, Circulation, V51, P5; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Beattie WS, 2006, ANESTH ANALG, V102, P8, DOI 10.1213/01.ane.0000189614.98906.43; BROWN KA, 1993, J AM COLL CARDIOL, V21, P325, DOI 10.1016/0735-1097(93)90670-V; Chan A, 1999, ANN R COLL PHYS SURG, V32, P337; Chow BJW, 2011, CIRC-CARDIOVASC IMAG, V4, P463, DOI 10.1161/CIRCIMAGING.111.964155; Chow BJW, 2011, JACC-CARDIOVASC IMAG, V4, P496, DOI 10.1016/j.jcmg.2011.01.015; Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039; COLEY CM, 1992, AM J CARDIOL, V69, P1280, DOI 10.1016/0002-9149(92)91221-O; Das MK, 2000, J AM COLL CARDIOL, V35, P1647, DOI 10.1016/S0735-1097(00)00586-6; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Devereaux PJ, 2009, EVIDENCE BASED CARDI, P47; Duvall WL, 2012, CATHETER CARDIO INTE, V80, P768, DOI 10.1002/ccd.23446; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; Etchells E, 2002, J VASC SURG, V36, P534, DOI 10.1067/mva.2002.126563; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; Gualandro DM, 2012, ATHEROSCLEROSIS, V222, P191, DOI 10.1016/j.atherosclerosis.2012.02.021; Hashimoto J, 2003, J NUCL MED, V44, P385; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Mollet NR, 2005, J AM COLL CARDIOL, V45, P128, DOI 10.1016/j.jacc.2004.09.074; Muhlestein JB, 2014, JAMA-J AM MED ASSOC, V312, P2234, DOI 10.1001/jama.2014.15825; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Rodseth RN, 2014, J AM COLL CARDIOL, V63, P170, DOI 10.1016/j.jacc.2013.08.1630; Rodseth RN, 2013, ANESTHESIOLOGY, V119, P270, DOI 10.1097/ALN.0b013e31829083f1; Sheth T, 2012, BR MED J OPEN, P2; Sheth T, 2008, AM HEART J, V155, P918, DOI 10.1016/j.ahj.2007.11.035; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vanzetto G, 1996, AM J CARDIOL, V77, P143, DOI 10.1016/S0002-9149(96)90585-8	36	61	62	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h1907	10.1136/bmj.h1907	http://dx.doi.org/10.1136/bmj.h1907			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25902738	Green Published, hybrid			2022-12-28	WOS:000353576700002
J	Granwehr, B				Granwehr, Bruno			Quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VACCINES		Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Granwehr, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.		Granwehr, Bruno/S-3997-2019	Granwehr, Bruno/0000-0002-5143-6416				Langer-Gould A, 2014, JAMA NEUROL, V71, P1506, DOI 10.1001/jamaneurol.2014.2633; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC13	10.7326/ACPJC-2015-162-8-013	http://dx.doi.org/10.7326/ACPJC-2015-162-8-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894046				2022-12-28	WOS:000353244300012
J	Hautier, Y; Tilman, D; Isbell, F; Seabloom, EW; Borer, ET; Reich, PB				Hautier, Yann; Tilman, David; Isbell, Forest; Seabloom, Eric W.; Borer, Elizabeth T.; Reich, Peter B.			Anthropogenic environmental changes affect ecosystem stability via biodiversity	SCIENCE			English	Article							PLANT DIVERSITY; GRASSLAND EXPERIMENT; PRODUCTIVITY; EUTROPHICATION; DISTURBANCE; POPULATION	Human-driven environmental changes may simultaneously affect the biodiversity, productivity, and stability of Earth's ecosystems, but there is no consensus on the causal relationships linking these variables. Data from 12 multiyear experiments that manipulate important anthropogenic drivers, including plant diversity, nitrogen, carbon dioxide, fire, herbivory, and water, show that each driver influences ecosystem productivity. However, the stability of ecosystem productivity is only changed by those drivers that alter biodiversity, with a given decrease in plant species numbers leading to a quantitatively similar decrease in ecosystem stability regardless of which driver caused the biodiversity loss. These results suggest that changes in biodiversity caused by drivers of environmental change may be a major factor determining how global environmental changes affect ecosystem stability.	[Hautier, Yann] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Hautier, Yann; Tilman, David; Isbell, Forest; Seabloom, Eric W.; Borer, Elizabeth T.] Univ Minnesota Twin Cities, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, NL-3584 CH Utrecht, Netherlands; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm, Santa Barbara, CA 93106 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia	University of Oxford; University of Minnesota System; University of Minnesota Twin Cities; Utrecht University; University of California System; University of California Santa Barbara; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University	Hautier, Y (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	yann.hautier@plants.ox.ac.uk	Hautier, Yann/I-2526-2019; Isbell, Forest/C-6915-2012; Hautier, Yann/D-5426-2015; Tilman, David/ABD-5309-2021	Hautier, Yann/0000-0003-4347-7741; Isbell, Forest/0000-0001-9689-769X; Hautier, Yann/0000-0003-4347-7741; Borer, Elizabeth/0000-0003-2259-5853; Reich, Peter/0000-0003-4424-662X; Seabloom, Eric/0000-0001-6780-9259	European Union Seventh Framework Programme [298935]; U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek [DEB-8811884, DEB-9411972, DEB-0080382, DEB-0620652, DEB-1234162]; Biocomplexity Coupled Biogeochemical Cycles [DEB-0322057]; Long-Term Research in Environmental Biology [DEB-0716587, DEB-1242531]; Ecosystem Sciences [NSF DEB-1120064]; U.S. Department of Energy (DOE) Program for Ecosystem Research [DE-FG02-96ER62291]; U.S. DOE National Institute for Climatic Change Research [DE-FC02-06ER64158]; Division Of Environmental Biology [1120064] Funding Source: National Science Foundation	European Union Seventh Framework Programme(European Commission); U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek(National Science Foundation (NSF)); Biocomplexity Coupled Biogeochemical Cycles; Long-Term Research in Environmental Biology; Ecosystem Sciences; U.S. Department of Energy (DOE) Program for Ecosystem Research(United States Department of Energy (DOE)); U.S. DOE National Institute for Climatic Change Research; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 298935 to Y.H. and has been supported by the U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek (DEB-8811884, DEB-9411972, DEB-0080382, DEB-0620652, and DEB-1234162), Biocomplexity Coupled Biogeochemical Cycles (DEB-0322057), Long-Term Research in Environmental Biology (DEB-0716587, DEB-1242531), and Ecosystem Sciences (NSF DEB-1120064) Programs, as well as the U.S. Department of Energy (DOE) Program for Ecosystem Research (DE-FG02-96ER62291) and the U.S. DOE National Institute for Climatic Change Research (DE-FC02-06ER64158). We thank T. Mielke, D. Bahauddin, K. Worm, S. Barrott, E. Lind, and many summer interns for their assistance with this research. We also thank R. S. L. Veiga, W. S. Harpole, T. Zust, and M. Tanadini for suggestions that improved the manuscript. For detailed methods and original data, see www.cedarcreek.umn.edu/research/data. See table S1 for links to data for each experiment and supplementary materials for guidance on data access. The authors declare no conflict of interests. Author contributions: Y.H. and D. T. developed and framed the research question; D. T., F.I., E. W. S., E.T.B., and P.B.R. designed research; D. T., E. W. S., E.T.B., and P.B.R. performed research; Y.H. and F.I. analyzed data; and Y.H. wrote the paper with inputs from all coauthors.	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cardinale BJ, 2012, NATURE, V489, P326, DOI 10.1038/nature11373; Collins SL, 2012, J VEG SCI, V23, P563, DOI 10.1111/j.1654-1103.2011.01369.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Hautier Y, 2014, NATURE, V508, P521, DOI 10.1038/nature13014; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leps J, 2004, OIKOS, V107, P64, DOI 10.1111/j.0030-1299.2004.13023.x; MacDougall AS, 2013, NATURE, V494, P86, DOI 10.1038/nature11869; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang ZL, 2011, PLANT SOIL, V345, P315, DOI 10.1007/s11104-011-0784-0	30	358	376	82	860	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					336	340		10.1126/science.aaa1788	http://dx.doi.org/10.1126/science.aaa1788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883357				2022-12-28	WOS:000352999000045
J	MacLean, EL; Hare, B				MacLean, Evan L.; Hare, Brian			Dogs hijack the human bonding pathway	SCIENCE			English	Editorial Material							OXYTOCIN; WOLVES; GAZE		[MacLean, Evan L.; Hare, Brian] Duke Univ, Duke Canine Cognit Ctr, Durham, NC 27706 USA; [MacLean, Evan L.; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Duke University	MacLean, EL (corresponding author), Duke Univ, Duke Canine Cognit Ctr, Durham, NC 27706 USA.	b.hare@duke.edu		MacLean, Evan/0000-0001-7595-662X				Grimm D, 2015, SCIENCE, V348, P274, DOI 10.1126/science.348.6232.274; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B., 2013, GENIUS DOGS DOGS ARE; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Oliva JL, 2015, ANIM COGN, V18, P767, DOI 10.1007/s10071-015-0843-7; Romero T, 2014, P NATL ACAD SCI USA, V111, P9085, DOI 10.1073/pnas.1322868111; Stoeckel LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107205; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Weisman O, 2012, BIOL PSYCHIAT, V72, P982, DOI 10.1016/j.biopsych.2012.06.011	15	28	28	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					280	281		10.1126/science.aab1200	http://dx.doi.org/10.1126/science.aab1200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883339				2022-12-28	WOS:000352999000018
J	Schuur, EAG; McGuire, AD; Schadel, C; Grosse, G; Harden, JW; Hayes, DJ; Hugelius, G; Koven, CD; Kuhry, P; Lawrence, DM; Natali, SM; Olefeldt, D; Romanovsky, VE; Schaefer, K; Turetsky, MR; Treat, CC; Vonk, JE				Schuur, E. A. G.; McGuire, A. D.; Schaedel, C.; Grosse, G.; Harden, J. W.; Hayes, D. J.; Hugelius, G.; Koven, C. D.; Kuhry, P.; Lawrence, D. M.; Natali, S. M.; Olefeldt, D.; Romanovsky, V. E.; Schaefer, K.; Turetsky, M. R.; Treat, C. C.; Vonk, J. E.			Climate change and the permafrost carbon feedback	NATURE			English	Review							SOIL ORGANIC-CARBON; THAWING PERMAFROST; THERMOKARST LAKES; ARCTIC ALASKA; CO2; TEMPERATURE; RELEASE; CH4; VULNERABILITY; ECOSYSTEMS	Large quantities of organic carbon are stored in frozen soils (permafrost) within Arctic and sub-Arctic regions. Awarming climate can induce environmental changes that accelerate the microbial breakdown of organic carbon and the release of the greenhouse gases carbon dioxide and methane. This feedback can accelerate climate change, but the magnitude and timing of greenhouse gas emission from these regions and their impact on climate change remain uncertain. Here we find that current evidence suggests a gradual and prolonged release of greenhouse gas emissions in a warming climate and present a research strategy with which to target poorly understood aspects of permafrost carbon dynamics.	[Schuur, E. A. G.; Schaedel, C.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Schuur, E. A. G.; Schaedel, C.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Schuur, E. A. G.; Schaedel, C.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [McGuire, A. D.] Univ Alaska Fairbanks, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; [Grosse, G.] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, D-14473 Potsdam, Germany; [Harden, J. W.] US Geol Survey, Menlo Pk, CA 94025 USA; [Hayes, D. J.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA; [Hayes, D. J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Hugelius, G.; Kuhry, P.] Stockholm Univ, Dept Phys Geog, S-10691 Stockholm, Sweden; [Koven, C. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Lawrence, D. M.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA; [Natali, S. M.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Olefeldt, D.; Turetsky, M. R.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Olefeldt, D.] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Romanovsky, V. E.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Romanovsky, V. E.] Tyumen State Oil & Gas Univ, Tyumen 625000, Tyumen Oblast, Russia; [Schaefer, K.] Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Treat, C. C.] Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA; [Vonk, J. E.] Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands	Northern Arizona University; Northern Arizona University; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Stockholm University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Center Atmospheric Research (NCAR) - USA; Woods Hole Research Center; University of Guelph; University of Alberta; University of Alaska System; University of Alaska Fairbanks; Tyumen Industrial University; University System Of New Hampshire; University of New Hampshire; Utrecht University	Schuur, EAG (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	ted.schuur@nau.edu	Grosse, Guido/F-5018-2011; Schädel, Christina/F-5948-2013; Treat, Claire/P-7160-2018; Vonk, Jorien E/H-5422-2011; Hugelius, Gustaf/C-9759-2011; Lawrence, David M/C-4026-2011; Olefeldt, David/E-8835-2013; DING, HU/H-3695-2014; Koven, Charles/N-8888-2014	Grosse, Guido/0000-0001-5895-2141; Schädel, Christina/0000-0003-2145-6210; Treat, Claire/0000-0002-1225-8178; Vonk, Jorien E/0000-0002-1206-5878; Hugelius, Gustaf/0000-0002-8096-1594; Lawrence, David M/0000-0002-2968-3023; Olefeldt, David/0000-0002-5976-1475; DING, HU/0000-0001-5749-9445; Koven, Charles/0000-0002-3367-0065; Hayes, Daniel/0000-0002-3011-7934; Harden, Jennifer W/0000-0002-6570-8259	National Science Foundation Vulnerability of Permafrost Carbon Research Coordination Network [955713]; National Science Foundation Research, Synthesis, and Knowledge Transfer in a Changing Arctic: Science Support for the Study of Environmental Arctic Change [1331083]; Department of Energy Office of Science, Office of Biological and Environmental Sciences Division Terrestrial Ecosystem Sciences program [DE-SC0006982]; National Science Foundation Long Term Ecological Research Program [1026415]; Regional and Global Climate Modeling Program (RGCM) of the US Department of Energy's Office of Science (BER) [DE-FC02-97ER62402]; European Research Commission [338335]; Netherlands Organization for Scientific Research [863.12.004]; National Science Foundation Polar Programs [1312402, 856864, 1304271]; National Oceanic and Atmospheric Administration [NA09OAR4310063]; National Aeronautics and Space Agency [NNX10AR63G]; Nordforsk (DEFROST) [23001]; EU [282700]; FORMAS (Bolin Climate Research Centre) [214-2006-1749]; Department of Energy Biological and Environmental Research [3ERKP818]; National Science Foundation, Division of Environmental Biology [724514, 830997]; U.S. Geological Survey Climate and Land Use Program; Department of Energy [DE-AC02-05CH11231]; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1304220, 1304271, 1048987] Funding Source: National Science Foundation	National Science Foundation Vulnerability of Permafrost Carbon Research Coordination Network; National Science Foundation Research, Synthesis, and Knowledge Transfer in a Changing Arctic: Science Support for the Study of Environmental Arctic Change; Department of Energy Office of Science, Office of Biological and Environmental Sciences Division Terrestrial Ecosystem Sciences program(United States Department of Energy (DOE)); National Science Foundation Long Term Ecological Research Program(National Science Foundation (NSF)); Regional and Global Climate Modeling Program (RGCM) of the US Department of Energy's Office of Science (BER)(United States Department of Energy (DOE)); European Research Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation Polar Programs; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Aeronautics and Space Agency; Nordforsk (DEFROST); EU(European Commission); FORMAS (Bolin Climate Research Centre); Department of Energy Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation, Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); U.S. Geological Survey Climate and Land Use Program; Department of Energy(United States Department of Energy (DOE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Initial funding was provided by the National Science Foundation Vulnerability of Permafrost Carbon Research Coordination Network Grant number 955713, with continued support from the National Science Foundation Research, Synthesis, and Knowledge Transfer in a Changing Arctic: Science Support for the Study of Environmental Arctic Change Grant number 1331083. Author contributions were also supported by grants to individuals: Department of Energy Office of Science, Office of Biological and Environmental Sciences Division Terrestrial Ecosystem Sciences program (DE-SC0006982) to E.A.G.S.; National Science Foundation Long Term Ecological Research Program (1026415) to A.D.M.; Department of Energy (DE-AC02-05CH11231, NGEE Arctic, BGC-Feedbacks SFA) to C.D.K.; Regional and Global Climate Modeling Program (RGCM) of the US Department of Energy's Office of Science (BER) Cooperative Agreement (DE-FC02-97ER62402) to D.M.L.; European Research Commission (338335) to G.G.; The Netherlands Organization for Scientific Research (863.12.004) to J.E.V.; National Science Foundation Polar Programs (1312402) to S.M.N.; National Science Foundation Polar Programs (856864 and 1304271) to V.E.R.; National Oceanic and Atmospheric Administration (NA09OAR4310063) and National Aeronautics and Space Agency (NNX10AR63G) to K.S.; Nordforsk (DEFROST; 23001), EU FP7 (PAGE21; 282700) and FORMAS (Bolin Climate Research Centre; 214-2006-1749) to G.H. and P.K.; Department of Energy Biological and Environmental Research (3ERKP818) to D.J.H.; National Science Foundation, Division of Environmental Biology (724514, 830997) to M.R.T. and A.D.M.; U.S. Geological Survey Climate and Land Use Program to J.W.H. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the US Government.	Anthony KMW, 2014, NATURE, V511, P452, DOI 10.1038/nature13560; Avis CA, 2011, NAT GEOSCI, V4, P444, DOI [10.1038/NGEO1160, 10.1038/ngeo1160]; Baltzer JL, 2014, GLOBAL CHANGE BIOL, V20, P824, DOI 10.1111/gcb.12349; Belshe EF, 2013, ECOL LETT, V16, P1307, DOI 10.1111/ele.12164; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Brown J, 2008, PERMAFROST PERIGLAC, V19, P255, DOI 10.1002/ppp.618; Brown JO, 2002, CIRCUM ARCTIC MAP PE; Burke EJ, 2012, CRYOSPHERE, V6, P1063, DOI 10.5194/tc-6-1063-2012; Burke EJ, 2013, J CLIMATE, V26, P4897, DOI 10.1175/JCLI-D-12-00550.1; Christensen TR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018680; Cory RM, 2013, P NATL ACAD SCI USA, V110, P3429, DOI 10.1073/pnas.1214104110; Dmitrenko IA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007218; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Elberling B, 2013, NAT CLIM CHANGE, V3, P890, DOI [10.1038/nclimate1955, 10.1038/NCLIMATE1955]; Feng XJ, 2013, P NATL ACAD SCI USA, V110, P14168, DOI 10.1073/pnas.1307031110; Grosse G., 2013, USGS OPEN-FILE REP, V2013-1078, P1; Harden JW, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051958; Hugelius G, 2014, BIOGEOSCIENCES, V11, P6573, DOI 10.5194/bg-11-6573-2014; Hugelius G, 2013, EARTH SYST SCI DATA, V5, P3, DOI 10.5194/essd-5-3-2013; Hugelius G, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001606; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johansson T, 2006, GLOBAL CHANGE BIOL, V12, P2352, DOI 10.1111/j.1365-2486.2006.01267.x; Jones BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001666; Jones MC, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001766; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; Kanevskiy M, 2011, QUATERNARY RES, V75, P584, DOI 10.1016/j.yqres.2010.12.003; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Knoblauch C, 2013, GLOBAL CHANGE BIOL, V19, P1160, DOI 10.1111/gcb.12116; Koven CD, 2013, J CLIMATE, V26, P1877, DOI 10.1175/JCLI-D-12-00228.1; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Krieger K. E., 2012, THESIS IDAHO STATE U; Lawrence DM, 2012, J CLIMATE, V25, P2207, DOI 10.1175/JCLI-D-11-00334.1; Lawrence DM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000883; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; MacDougall AH, 2012, NAT GEOSCI, V5, P719, DOI [10.1038/NGEO1573, 10.1038/ngeo1573]; McGuire AD, 2012, BIOGEOSCIENCES, V9, P3185, DOI 10.5194/bg-9-3185-2012; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Mishra U, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035020; Myhre G. D., 2013, CLIMATE CHANGE 2013, DOI [10.1017/c bo9781107415324.018, DOI 10.1017/CBO9781107415324.018]; National Research Council, 2013, ABR IMP CLIM CHANG A; National Research Council, 2014, OPP US REM SENS UND; Nicolsky DJ, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002358; Notz D, 2013, NATURE, V500, P529, DOI 10.1038/500529b; Olefeldt D, 2014, GLOBAL CHANGE BIOL, V20, P3122, DOI 10.1111/gcb.12607; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; Osterkamp TE, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000578; Parmentier FJW, 2013, NATURE, V500, P529, DOI 10.1038/500529a; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Ping CL, 2008, NAT GEOSCI, V1, P615, DOI 10.1038/ngeo284; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Roach J, 2011, GLOBAL CHANGE BIOL, V17, P2567, DOI 10.1111/j.1365-2486.2011.02446.x; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P136, DOI 10.1002/ppp.683; Romanovsky V. E., 2011, PERMAFROST ARCTIC RE; Sannel ABK, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001635; Schadel C., 2013, FROZEN GROUND, V37, P7; Schadel C, 2014, GLOBAL CHANGE BIOL, V20, P641, DOI 10.1111/gcb.12417; Schaefer K., 2012, POLICY IMPLICATIONS; Schaefer K, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/085003; Schaefer K, 2011, TELLUS B, V63, P165, DOI 10.1111/j.1600-0889.2011.00527.x; Schaphoff S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014026; Schirrmeister L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001647; Schirrmeister L, 2011, PALAEOGEOGR PALAEOCL, V299, P175, DOI 10.1016/j.palaeo.2010.10.045; Schneider von Deimling T, 2012, BIOGEOSCIENCES, V9, P649, DOI 10.5194/bg-9-649-2012; Schuur EAG, 2013, CLIMATIC CHANGE, V119, P359, DOI 10.1007/s10584-013-0730-7; Schuur E. A. G., 2011, FROZEN GROUND, V35, P6; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2011, NATURE, V480, P32, DOI 10.1038/480032a; Shakhova N, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005602; Shakhova N, 2014, NAT GEOSCI, V7, P64, DOI [10.1038/NGEO2007, 10.1038/ngeo2007]; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Slater AG, 2013, J CLIMATE, V26, P5608, DOI 10.1175/JCLI-D-12-00341.1; Smith LC, 2005, SCIENCE, V308, P1429, DOI 10.1126/science.1108142; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stocker TF, 2013, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]; Strauss J, 2013, GEOPHYS RES LETT, V40, P6165, DOI 10.1002/2013GL058088; Strom L, 2012, SOIL BIOL BIOCHEM, V45, P61, DOI 10.1016/j.soilbio.2011.09.005; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Treat CC, 2014, GLOBAL CHANGE BIOL, V20, P2674, DOI 10.1111/gcb.12572; Treat CC, 2015, GLOBAL CHANGE BIOL, V21, P2787, DOI 10.1111/gcb.12875; Ueyama M, 2013, J GEOPHYS RES-BIOGEO, V118, P1266, DOI 10.1002/jgrg.20095; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Vonk JE, 2012, NATURE, V489, P137, DOI 10.1038/nature11392; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; Vonk JE, 2013, GEOPHYS RES LETT, V40, P2689, DOI 10.1002/grl.50348; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Whiteman G, 2013, NATURE, V499, P401, DOI 10.1038/499401a; Zhuang QL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026972; ZIMOV SA, 2006, GEOPHYS RES LETT, V33, DOI DOI 10.1029/2006GL027484; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zona D, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004037	97	1716	1789	256	2332	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					171	179		10.1038/nature14338	http://dx.doi.org/10.1038/nature14338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855454				2022-12-28	WOS:000352454600029
J	Dirlikov, E; Raviglione, M; Scano, F				Dirlikov, Emilio; Raviglione, Mario; Scano, Fabio			Global Tuberculosis Control: Toward the 2015 Targets and Beyond	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-RESISTANT TUBERCULOSIS; TRENDS; PROSPECTS; PROGRESS; TIME; CARE	Since 1990, progress has been made toward global tuberculosis (TB) control, as measured by targets set for 2015. However, TB remains a major threat to health around the world. In 2013, there were an estimated 11 million prevalent cases, and an estimated 9.0 million incident cases occurred globally. Approximately 1.5 million deaths were caused by TB, including 360 000 among people living with HIV. Substantial challenges threaten future control efforts. These include multidrug-resistant forms and coinfection with HIV, as well as other factors, such as the increased prominence of noncommunicable diseases and adverse socioeconomic conditions. Beyond 2015, TB control must be seen as both a public health imperative unto itself and a vital component of economic development plans. To that end, control strategies should exploit technical and operational innovations to improve TB control and care and should promote universal health coverage and social protection mechanisms to expand access to essential prevention, diagnostics, and treatment services while avoiding catastrophic costs incurred by patients.	McGill Univ, Montreal, PQ H3A 2T7, Canada; Univ Turin, Turin, Italy; Univ Padua, Padua, Italy	McGill University; University of Turin; University of Padua	Dirlikov, E (corresponding author), McGill Univ, Dept Anthropol, 7th Floor,Leacock Bldg,855 Sherbrooke St West, Montreal, PQ H3A 2T7, Canada.	emilio.dirlikov@mail.mcgill.ca		Dirlikov, Emilio/0000-0003-4631-2643; RAVIGLIONE, Mario/0000-0002-9331-2067	Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies [Dossier 136663]	Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies	Mr. Dirlikov's doctoral studies are supported by the Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies (Dossier 136663). No additional external funding was provided for this research.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; [Anonymous], 1993, World Health Forum, V14, P438; [Anonymous], 1993, WORLD DEV REP 1993; [Anonymous], 2015, MIN C TUB SUST DEV A; [Anonymous], 2015, WHO MON XP MTB RIF R; [Anonymous], 2014, MILL DEV GOALS REP 2, P34; Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; CHIANG CY, 2013, INT J TUBERC LUNG D, V17, P714, DOI [DOI 10.5588/IJT1D.12.0989, DOI 10.5588/IJTLD.12.0989]; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Daley CL, 2013, SEMIN RESP CRIT CARE, V34, P44, DOI 10.1055/s-0032-1333546; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Falzon Dennis, 2013, Lancet Respir Med, V1, pe9, DOI 10.1016/S2213-2600(12)70056-5; Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Mnyani CN, 2011, BJOG-INT J OBSTET GY, V118, P226, DOI 10.1111/j.1471-0528.2010.02771.x; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Ogden J, 2003, SOC SCI MED, V57, P179, DOI 10.1016/S0277-9536(02)00373-8; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pai M, 2014, LANCET RESP MED, V2, P25, DOI 10.1016/S2213-2600(13)70256-X; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; PHILLIPS PPJ, 2013, INT J TUBERC LUNG D, V17, P807, DOI DOI 10.5588/IFID.12.0725; Raviglione M, 2012, LANCET, V379, P1077, DOI 10.1016/S0140-6736(12)60373-0; Raviglione Mario, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P6, DOI 10.5588/ijtld.11.0158; Raviglione MC, 2013, NAT MED, V19, P263, DOI 10.1038/nm.3129; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; Reichman LB, 2013, INT J TUBERC LUNG D, V17, P711, DOI 10.5588/ijtld.13.0299; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Warsame A, 2014, INT J TUBERC LUNG D, V18, P61, DOI 10.5588/ijtld.13.0324; WHO, 1998, WHOTB98245; World Economic Forum, 2014, GLOB RISKS 2014; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 1991, 44 WORLD HLTH ASS GE; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2009, 62 WORLD HLTH ASS RE, P25; World Health Organization, 2014, 67 WORLD HLTH ASS GE; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zignol M, 2013, EUR RESPIR J, V42, P701, DOI 10.1183/09031936.00175812	61	48	51	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					52	58		10.7326/M14-2210	http://dx.doi.org/10.7326/M14-2210			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25915859				2022-12-28	WOS:000357442000006
J	Palikaras, K; Lionaki, E; Tavernarakis, N				Palikaras, Konstantinos; Lionaki, Eirini; Tavernarakis, Nektarios			Coordination of mitophagy and mitochondrial biogenesis during ageing in C-elegans	NATURE			English	Article							EXTENDS LIFE-SPAN; CELL-DEATH; NIX; METABOLISM; CLEARANCE; LONGEVITY; AUTOPHAGY; DIAPAUSE; PROTEIN; GENES	Impaired mitochondrial maintenance in disparate cell types is a shared hallmark of many human pathologies and ageing(1-8). How mitochondrial biogenesis coordinates with the removal of damaged or superfluous mitochondria to maintain cellular homeostasis is not well understood. Here we show that mitophagy, a selective type of autophagy targeting mitochondria for degradation, interfaces with mitochondrial biogenesis to regulate mitochondrial content and longevity in Caenorhabditis elegans. We find that DCT-1 is a key mediator of mitophagy and longevity assurance under conditions of stress in C. elegans. Impairment of mitophagy compromises stress resistance and triggers mitochondrial retrograde signalling through the SKN-1 transcription factor that regulates both mitochondrial biogenesis genes and mitophagy by enhancing DCT-1 expression. Our findings reveal a homeostatic feedback loop that integrates metabolic signals to coordinate the biogenesis and turnover of mitochondria. Uncoupling of these two processes during ageing contributes to overproliferation of damaged mitochondria and decline of cellular function.	[Palikaras, Konstantinos; Lionaki, Eirini; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Palikaras, Konstantinos] Univ Crete, Dept Biol, Iraklion 70013, Crete, Greece; [Tavernarakis, Nektarios] Univ Crete, Fac Med, Dept Basic Sci, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Crete	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion 70013, Crete, Greece.	tavernarakis@imbb.forth.gr	Palikaras, Konstantinos/AAI-1300-2020; Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; LIONAKI, EIRINI/0000-0002-7689-0463; Palikaras, Konstantinos/0000-0001-6992-5560	National Center for Research Resources of the National Institutes of Health; National Bioresource Project in Japan; European Research Council; European Commission; Greek General Secretariat for Research and Technology	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Greek General Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	We thank A. Pasparaki for technical support with experiments, N. Kourtis for the GCaMP2.0-expressing C. elegans strain, N. Charmpilas for the neuronal CTS-1::mCherry-expressing C. elegans strain and the unc-43 RNA interference (RNAi) plasmid, and K. Kounakis for the rpn-6 RNAi plasmid. We thank B. P. Braeckman for the Hyper-expressing C. elegans strain and D. Sieburth for the INVOM::RFP-expressing C. elegans strain. We thank R. Devenish for providing the pAS1NB-CS-Rosella plasmid. Mass spectrometry analysis was performed at the Institute of Molecular Biology and Biotechnology Proteomics Facility. We are grateful to M. Aivaliotis for the characterization and relative quantification of DCT-1 tryptic peptides by nanoflow liquid chromatography with tandem mass spectrometry. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources of the National Institutes of Health, and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors. This work was funded by grants from the European Research Council, the European Commission 7th Framework Programme and the Greek General Secretariat for Research and Technology.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back P, 2012, FREE RADICAL BIO MED, V52, P850, DOI 10.1016/j.freeradbiomed.2011.11.037; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Campbell GR, 2012, CURR OPIN NEUROL, V25, P221, DOI 10.1097/WCO.0b013e3283533a25; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Ghose P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004063; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Malpass K, 2013, NAT REV NEUROL, V9, P179, DOI [10.1038/nrneurol.2012.35, 10.1038/nrneurol.2013.55, 10.1038/nrneurol.2013.158, 10.1038/nrneurol.2013.119, 10.1038/nrneurol.2013.138, 10.1038/nrneurol.2013.77, 10.1038/nrneurol.2013.64, 10.1038/nrneurol.2013.35, 10.1038/nrneurol.2012.245]; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mijaljica D, 2011, JOVE-J VIS EXP, DOI 10.3791/2779; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/NCHEMBIO.1352, 10.1038/nchembio.1352]; Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Staab TA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004100; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; Yasuda M, 1998, ONCOGENE, V17, P2525, DOI 10.1038/sj.onc.1202467; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang J, 2012, AUTOPHAGY, V8, P1325, DOI 10.4161/auto.20764; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	38	412	427	27	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					525	U241		10.1038/nature14300	http://dx.doi.org/10.1038/nature14300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25896323				2022-12-28	WOS:000355286600044
J	McHugh, CA; Chen, CK; Chow, A; Surka, CF; Tran, C; McDonel, P; Pandya-Jones, A; Blanco, M; Burghard, C; Moradian, A; Sweredoski, MJ; Shishkin, AA; Su, JL; Lander, ES; Hess, S; Plath, K; Guttman, M				McHugh, Colleen A.; Chen, Chun-Kan; Chow, Amy; Surka, Christine F.; Tran, Christina; McDonel, Patrick; Pandya-Jones, Amy; Blanco, Mario; Burghard, Christina; Moradian, Annie; Sweredoski, Michael J.; Shishkin, Alexander A.; Su, Julia; Lander, Eric S.; Hess, Sonja; Plath, Kathrin; Guttman, Mitchell			The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3	NATURE			English	Article							IDENTIFICATION RATES; MATRIX PROTEIN; X-INACTIVATION; RNA; BINDING; REPRESSION; PRC2; DNA; LOCALIZATION; RECRUITMENT	Many long non-coding RNAs (lncRNAs) affect gene expression(1), but the mechanisms by which they act are still largely unknown(2). One of the best-studied lncRNAs is Xist, which is required for transcriptional silencing of one X chromosome during development in female mammals(3,4). Despite extensive efforts to define the mechanism of Xist-mediated transcriptional silencing, we still do not know any proteins required for this role(3). The main challenge is that there are currently no methods to comprehensively define the proteins that directly interact with a lncRNA in the cell(5). Here we develop a method to purify a lncRNA from cells and identify proteins interacting with it directly using quantitative mass spectrometry. We identify ten proteins that specifically associate with Xist, three of these proteins-SHARP, SAF-A and LBR-are required for Xist-mediated transcriptional silencing. We show that SHARP, which interacts with the SMRT co-repressor(6) that activates HDAC3(7), is not only essential for silencing, but is also required for the exclusion of RNA polymerase II (Pol II) from the inactive X. Both SMRT and HDAC3 are also required for silencing and Pol II exclusion. In addition to silencing transcription, SHARP and HDAC3 are required for Xist-mediated recruitment of the polycomb repressive complex 2 (PRC2) across the X chromosome. Our results suggest that Xist silences transcription by directly interacting with SHARP, recruiting SMRT, activating HDAC3, and deacetylating histones to exclude Pol II across the X chromosome.	[McHugh, Colleen A.; Chen, Chun-Kan; Chow, Amy; Surka, Christine F.; Tran, Christina; Blanco, Mario; Burghard, Christina; Shishkin, Alexander A.; Su, Julia; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [McDonel, Patrick; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu		Pandya-Jones, Amy/0000-0001-5519-4613; Plath, Kathrin/0000-0001-7796-3372	Caltech; NIH NRSA [T32GM07616]; Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NIH [1S10RR029591-01A1, DP5OD012190]; Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115233, T32GM007616] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686, DP5OD012190] Funding Source: NIH RePORTER	Caltech; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Engreitz for extensive discussions, help in adapting the RAP method, and critical comments on the manuscript; A. Gnirke, S. Carr, J. Jaffe and M. Schenone for initial discussions about the RAP-MS method; A. Collazo, E. Lubek, and L. Cai for microscopy help; A. Wutz for providing transgenic cell lines; R. Eggleston-Rangel for assistance with mass spectrometry; S. Grossman, I. Amit, M. Garber and J. Rinn for comments on the manuscript and helpful suggestions; and S. Knemeyer for illustrations. C.A.M. is supported by a post-doctoral fellowship from Caltech. C.-K.C. is supported by an NIH NRSA training grant (T32GM07616). Imaging was performed in the Biological Imaging Facility, with the support of the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation. This work was funded by the Gordon and Betty Moore Foundation (GBMF775), the Beckman Institute, and NIH (1S10RR029591-01A1 to S.H.), an NIH Director's Early Independence Award (DP5OD012190), the Rose Hills Foundation, Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, and funds from the California Institute of Technology.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brown CJ, 1996, SOMAT CELL MOLEC GEN, V22, P403, DOI 10.1007/BF02369896; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Royce-Tolland ME, 2010, NAT STRUCT MOL BIOL, V17, P948, DOI 10.1038/nsmb.1877; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Theodosiou Z, 2007, CYTOM PART A, V71A, P439, DOI 10.1002/cyto.a.20409; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	45	696	723	9	208	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					232	+		10.1038/nature14443	http://dx.doi.org/10.1038/nature14443			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25915022	Green Accepted, Green Submitted			2022-12-28	WOS:000354377800061
J	Kessler, SC; Tiedeken, EJ; Simcock, KL; Derveau, S; Mitchell, J; Softley, S; Stout, JC; Wright, GA				Kessler, Sebastien C.; Tiedeken, Erin Jo; Simcock, Kerry L.; Derveau, Sophie; Mitchell, Jessica; Softley, Samantha; Stout, Jane C.; Wright, Geraldine A.			Bees prefer foods containing neonicotinoid pesticides	NATURE			English	Article							BITTER TASTE; EXPOSURE; INSECTICIDES; HONEYBEES; RESIDUES; POLLEN; NECTAR; MEMORY	The impact of neonicotinoid insecticides on insect pollinators is highly controversial. Sublethal concentrations alter the behaviour of social bees and reduce survival of entire colonies(1-3). However, critics argue that the reported negative effects only arise from neonicotinoid concentrations that are greater than those found in the nectar and pollen of pesticide-treated plants(4). Furthermore, it has been suggested that bees could choose to forage on other available flowers and hence avoid or dilute exposure(4,5). Here, using a two-choice feeding assay, we show that the honeybee, Apis mellifera, and the buff-tailed bumblebee, Bombus terrestris, do not avoid nectar-relevant concentrations of three of the most commonly used neonicotinoids, imidacloprid (IMD), thiamethoxam (TMX), and clothianidin (CLO), in food. Moreover, bees of both species prefer to eat more of sucrose solutions laced with IMD or TMX than sucrose alone. Stimulation with IMD, TMX and CLO neither elicited spiking responses from gustatory neurons in the bees' mouthparts, nor inhibited the responses of sucrose-sensitive neurons. Our data indicate that bees cannot taste neonicotinoids and are not repelled by them. Instead, bees preferred solutions containing IMD or TMX, even though the consumption of these pesticides caused them to eat less food overall. This work shows that bees cannot control their exposure to neonicotinoids in food and implies that treating flowering crops with IMD and TMX presents a sizeable hazard to foraging bees.	[Kessler, Sebastien C.; Simcock, Kerry L.; Softley, Samantha; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Tiedeken, Erin Jo; Stout, Jane C.] Trinity Coll Dublin, Dept Bot, Dublin 2, Ireland; [Derveau, Sophie] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mitchell, Jessica] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England	Newcastle University - UK; Trinity College Dublin; Newcastle University - UK; University of Oxford	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	Serrano, Jose/A-2854-2009; Stout, Jane/AAS-8867-2020; Stout, Jane C/B-1631-2010	Serrano, Jose/0000-0002-1565-5216; Stout, Jane/0000-0002-2027-0863; Stout, Jane C/0000-0002-2027-0863	BBSRC; NERC; Wellcome Trust; Defra; Scottish Government under the Insect Pollinators Initiative [BB/I000143/1]; Leverhulme Trust [RPG-2012-708]; Science Foundation Ireland [10/RFP/EOB2842]; US National Science Foundation [2010097514]; Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant [RS/2010/2147]; BBSRC [BB/I000143/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000143/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government under the Insect Pollinators Initiative; Leverhulme Trust(Leverhulme Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); US National Science Foundation(National Science Foundation (NSF)); Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant(Irish Research Council for Science, Engineering and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Thompson for beekeeping, A. Radcliffe for help with experiments, and C. Rowe, S. Waddell, M. Palmer and N. Millar for comments. This work was funded jointly by a grant from the BBSRC, NERC, the Wellcome Trust, Defra, and the Scottish Government under the Insect Pollinators Initiative (BB/I000143/1) to G.A.W., a Leverhulme Trust research project grant (RPG-2012-708) to G.A.W., a Science Foundation Ireland grant (10/RFP/EOB2842) to J.C.S., a US National Science Foundation Graduate Research Fellowship awarded to E.J.T. (Grant No. 2010097514), and an Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant (RS/2010/2147) to E.J.T.	BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Carreck NL, 2014, J APICULT RES, V53, P607, DOI 10.3896/IBRA.1.53.5.08; CHAPMAN RF, 1991, J EXP BIOL, V158, P241; de Brito Sanchez MG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00025; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Department for Environment Food and Rural Affairs, 2013, ASS KEY EV NEON BEES; Dethier V., 1976, THE HUNGRY FLY; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Dupuis JP, 2011, J NEUROPHYSIOL, V106, P1604, DOI 10.1152/jn.00126.2011; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; The Food and Environment Research Agency, 2013, EFF NEON SEED TREATM; Thompson HM, 2015, PEST MANAG SCI, V71, P946, DOI 10.1002/ps.3868; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WHITEHEAD A T, 1976, International Journal of Insect Morphology and Embryology, V5, P301, DOI 10.1016/0020-7322(76)90030-1; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040	43	271	287	43	686	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					74	U145		10.1038/nature14414	http://dx.doi.org/10.1038/nature14414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901684	Green Accepted			2022-12-28	WOS:000354040900035
J	Maruyama, D; Volz, R; Takeuchi, H; Mori, T; Igawa, T; Kurihara, D; Kawashima, T; Ueda, M; Ito, M; Umeda, M; Nishikawa, S; Gross-Hardt, R; Higashiyama, T				Maruyama, Daisuke; Voelz, Ronny; Takeuchi, Hidenori; Mori, Toshiyuki; Igawa, Tomoko; Kurihara, Daisuke; Kawashima, Tomokazu; Ueda, Minako; Ito, Masaki; Umeda, Masaaki; Nishikawa, Shuh-ichi; Gross-Hardt, Rita; Higashiyama, Tetsuya			Rapid Elimination of the Persistent Synergid through a Cell Fusion Mechanism	CELL			English	Article							PREMATURE CHROMOSOME CONDENSATION; MULTIPLE POLLEN TUBES; DOUBLE FERTILIZATION; ARABIDOPSIS-THALIANA; BLOCK; SPERM; POLYSPERMY; ENDOSPERM; PLANTS; DNA	In flowering plants, fertilization-dependent degeneration of the persistent synergid cell ensures one-on-one pairings of male and female gametes. Here, we report that the fusion of the persistent synergid cell and the endosperm selectively inactivates the persistent synergid cell in Arabidopsis thaliana. The synergid-endosperm fusion causes rapid dilution of pre-secreted pollen tube attractant in the persistent synergid cell and selective disorganization of the synergid nucleus during the endosperm proliferation, preventing attractions of excess number of pollen tubes (polytubey). The synergid-endosperm fusion is induced by fertilization of the central cell, while the egg cell fertilization predominantly activates ethylene signaling, an inducer of the synergid nuclear disorganization. Therefore, two female gametes (the egg and the central cell) control independent pathways yet coordinately accomplish the elimination of the persistent synergid cell by double fertilization.	[Maruyama, Daisuke; Ueda, Minako; Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke; Kawashima, Tomokazu] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Maruyama, Daisuke; Kawashima, Tomokazu] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; [Voelz, Ronny; Gross-Hardt, Rita] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Voelz, Ronny] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia; [Takeuchi, Hidenori; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Mori, Toshiyuki] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698050, Japan; [Igawa, Tomoko] Chiba Univ, Graduate Sch Hort, Matsudo, Chiba 2718510, Japan; [Kawashima, Tomokazu] Gregor Mendel Inst, A-1030 Vienna, Austria; [Ito, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ito, Masaki] Nagoya Univ, Sch Agr Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Umeda, Masaaki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Umeda, Masaaki] CREST, JST, Nara 6300192, Japan; [Nishikawa, Shuh-ichi] Niigata Univ, Grad Sch Sci, Dept Life & Food Sci, Nishi Ku, Niigata 9502181, Japan; [Gross-Hardt, Rita] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany	Nagoya University; Nagoya University; Nagoya University; National University of Singapore; National University of Singapore; Eberhard Karls University of Tubingen; King Abdullah University of Science & Technology; Nagoya University; Waseda University; Chiba University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Nagoya University; Nagoya University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Niigata University; University of Bremen	Maruyama, D (corresponding author), Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	maruyama.daisuke@f.mbox.nagoya-u.ac.jp	Kawashima, Tomo/AAM-9411-2021; Takeuchi, Hidenori/AFG-8500-2022; Ueda, Minako/I-6130-2014; kurihara, daisuke/I-7206-2014; Higashiyama, Tetsuya/C-2882-2012; Mori, Toshiyuki/F-8488-2013; Takeuchi, Hidenori/AAF-1988-2022; Igawa, Tomoko/N-1578-2015; Ito, Masaki/G-4252-2013	Kawashima, Tomo/0000-0003-3803-3070; Takeuchi, Hidenori/0000-0002-0719-3736; kurihara, daisuke/0000-0003-2703-0405; Higashiyama, Tetsuya/0000-0002-7346-360X; Takeuchi, Hidenori/0000-0002-0719-3736; Igawa, Tomoko/0000-0003-1829-6076; Ueda, Minako/0000-0002-6892-2744; Ito, Masaki/0000-0002-9635-9709; Gross-Hardt, Rita/0000-0003-1998-0507	Global Center of Excellence program (Nagoya University); Japan Society for the Promotion of Science [6526, 5834]; Japan Advanced Plant Science Network; Japan Science and Technology Agency (ERATO project); Grants-in-Aid for Scientific Research [26113509, 25840113, 26660290] Funding Source: KAKEN	Global Center of Excellence program (Nagoya University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Advanced Plant Science Network; Japan Science and Technology Agency (ERATO project); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kinoshita, S. McCormick, F. Berger, G.N. Drews, and T. Naka-gawa for the materials, N. Iwata, T. Nishii, and T.M. Vu for assistance in preparing materials, S. Tiedemann for genetic analysis, and A. Schnittger for discussions. F. Berger also provided useful comments on the manuscript. D.M. was supported by the Global Center of Excellence program (Nagoya University). D.M. and H.T. were supported by grants 6526 and 5834 from the Japan Society for the Promotion of Science Fellowships, respectively. This work was supported in part by Japan Advanced Plant Science Network and by a grant from the Japan Science and Technology Agency (ERATO project to T.H.).	Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Beale KM, 2013, CURR OPIN PLANT BIOL, V16, P590, DOI 10.1016/j.pbi.2013.08.005; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; CASS DD, 1970, AM J BOT, V57, P62, DOI 10.2307/2440380; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; ENGELL K, 1989, NORD J BOT, V9, P265, DOI 10.1111/j.1756-1051.1989.tb01002.x; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Guignard M.L., 1899, REV G N BOT, V11, P129; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Igawa T, 2013, J PLANT RES, V126, P387, DOI 10.1007/s10265-012-0528-0; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Ito J, 2002, PLANT CELL, V14, P3201, DOI 10.1105/tpc.006411; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2012, ANNU REV PLANT BIOL, V63, P331, DOI 10.1146/annurev-arplant-042811-105514; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Milligan CE, 1997, BRIT MED BULL, V53, P570; Mori T., 2014, SEXUAL REPROD ANIMAL, P329; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; RAO PN, 1972, J CELL SCI, V10, P495; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; SCHULZ P, 1977, AM J BOT, V64, P384, DOI 10.2307/2441767; Schulz S.R., 1968, AM J BOT, V55, P541; Scott RJ, 2008, MOL PLANT, V1, P611, DOI 10.1093/mp/ssn016; Strasburger E., 1884, NEUE UNTERSUCHUNGEN; SZABADOS L, 1980, EXP CELL RES, V127, P442, DOI 10.1016/0014-4827(80)90450-4; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Tsaadon A, 2006, MOL CELL ENDOCRINOL, V252, P107, DOI 10.1016/j.mce.2006.03.037; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Yin K, 2014, PLANT J, V80, P541, DOI 10.1111/tpj.12652	37	71	74	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					907	918		10.1016/j.cell.2015.03.018	http://dx.doi.org/10.1016/j.cell.2015.03.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913191	Bronze			2022-12-28	WOS:000354175200022
J	Steinhaus, DA; Zimetbaum, PJ				Steinhaus, Daniel A.; Zimetbaum, Peter J.			Update in Cardiology: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AORTIC-VALVE-REPLACEMENT; TRIAL; RISK		[Zimetbaum, Peter J.] Beth Israel Deaconess Med Ctr, 185 Pilgrim Rd,Baker 4, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zimetbaum, PJ (corresponding author), Beth Israel Deaconess Med Ctr, 185 Pilgrim Rd,Baker 4, Boston, MA 02215 USA.	pzimetba@bidmc.harvard.edu						Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Imazio M, 2014, LANCET, V383, P2232, DOI 10.1016/S0140-6736(13)62709-9; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019	13	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W86	W90		10.7326/M15-0272	http://dx.doi.org/10.7326/M15-0272			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927336				2022-12-28	WOS:000379893300002
J	Buizert, C; Adrian, B; Ahn, J; Albert, M; Alley, RB; Baggenstos, D; Bauska, TK; Bay, RC; Bencivengo, BB; Bentley, CR; Brook, EJ; Chellman, NJ; Clow, GD; Cole-Dai, J; Conway, H; Cravens, E; Cuffey, KM; Dunbar, NW; Edwards, JS; Fegyveresi, JM; Ferris, DG; Fitzpatrick, JJ; Fudge, TJ; Gibson, CJ; Gkinis, V; Goetz, JJ; Gregory, S; Hargreaves, GM; Iverson, N; Johnson, JA; Jones, TR; Kalk, ML; Kippenhan, MJ; Koffman, BG; Kreutz, K; Kuhl, TW; Lebar, DA; Lee, JE; Marcott, SA; Markle, BR; Maselli, OJ; McConnell, JR; McGwire, KC; Mitchell, LE; Mortensen, NB; Neff, PD; Nishiizumi, K; Nunn, RM; Orsi, AJ; Pasteris, DR; Pedro, JB; Pettit, EC; Price, PB; Priscu, JC; Rhodes, RH; Rosen, JL; Schauer, AJ; Schoenemann, SW; Sendelbach, PJ; Severinghaus, JP; Shturmakov, AJ; Sigl, M; Slawny, KR; Souney, JM; Sowers, TA; Spencer, MK; Steig, EJ; Taylor, KC; Twickler, MS; Vaughn, BH; Voigt, DE; Waddington, ED; Welten, KC; Wendricks, AW; White, JWC; Winstrup, M; Wong, GJ; Woodruff, TE				Buizert, Christo; Adrian, Betty; Ahn, Jinho; Albert, Mary; Alley, Richard B.; Baggenstos, Daniel; Bauska, Thomas K.; Bay, Ryan C.; Bencivengo, Brian B.; Bentley, Charles R.; Brook, Edward J.; Chellman, Nathan J.; Clow, Gary D.; Cole-Dai, Jihong; Conway, Howard; Cravens, Eric; Cuffey, Kurt M.; Dunbar, Nelia W.; Edwards, Jon S.; Fegyveresi, John M.; Ferris, Dave G.; Fitzpatrick, Joan J.; Fudge, T. J.; Gibson, Chris J.; Gkinis, Vasileios; Goetz, Joshua J.; Gregory, Stephanie; Hargreaves, Geoffrey M.; Iverson, Nels; Johnson, Jay A.; Jones, Tyler R.; Kalk, Michael L.; Kippenhan, Matthew J.; Koffman, Bess G.; Kreutz, Karl; Kuhl, Tanner W.; Lebar, Donald A.; Lee, James E.; Marcott, Shaun A.; Markle, Bradley R.; Maselli, Olivia J.; McConnell, Joseph R.; McGwire, Kenneth C.; Mitchell, Logan E.; Mortensen, Nicolai B.; Neff, Peter D.; Nishiizumi, Kunihiko; Nunn, Richard M.; Orsi, Anais J.; Pasteris, Daniel R.; Pedro, Joel B.; Pettit, Erin C.; Price, P. Buford; Priscu, John C.; Rhodes, Rachael H.; Rosen, Julia L.; Schauer, Andrew J.; Schoenemann, Spruce W.; Sendelbach, Paul J.; Severinghaus, Jeffrey P.; Shturmakov, Alexander J.; Sigl, Michael; Slawny, Kristina R.; Souney, Joseph M.; Sowers, Todd A.; Spencer, Matthew K.; Steig, Eric J.; Taylor, Kendrick C.; Twickler, Mark S.; Vaughn, Bruce H.; Voigt, Donald E.; Waddington, Edwin D.; Welten, Kees C.; Wendricks, Anthony W.; White, James W. C.; Winstrup, Mai; Wong, Gifford J.; Woodruff, Thomas E.		WAIS Divide Project Members	Precise interpolar phasing of abrupt climate change during the last ice age	NATURE			English	Article							ANTARCTIC ICE; CHRONOLOGY AICC2012; ATMOSPHERIC CO2; BIPOLAR SEESAW; CORE RECORD; WAIS DIVIDE; POLAR ICE; GREENLAND; AIR; SCALE	The last glacial period exhibited abrupt Dansgaard-Oeschger climatic oscillations, evidence of which is preserved in a variety of Northern Hemisphere palaeodimate archives'. Ice cores show that Antarctica cooled during the warm phases of the Greenland Dansgaard-Oeschger cycle and vice versa''', suggesting an interhemispheric redistribution of heat through a mechanism called the bipolar seesaw(4-6). Variations in the Atlantic meridional overturning circulation (AMOC) strength are thought to have been important, but much uncertainty remains regarding the dynamics and trigger of these abrupt events'. Key information is contained in the relative phasing of hemispheric climate variations, yet the large, poorly constrained difference between gas age and ice age and the relatively low resolution of methane records from Antarctic ice cores have so far precluded methane-based synchronization at the required sub-centennial precision''''". Here we use a recently drilled high-accumulation Antarctic ice core to show that, on average, abrupt Greenland warming leads the corresponding Antarctic cooling onset by 218 +/- 92 years (2 sigma a) for DansgaardOeschger events, including the Bolling event; Greenland cooling leads the corresponding onset of Antarctic warming by 208 +/- 96 years. Our results demonstrate a north-to-south directionality of the abrupt climatic signal, which is propagated to the Southern Hemisphere high latitudes by oceanic rather than atmospheric processes. The similar interpolar phasing of warming and cooling transitions suggests that the transfer time of the climatic signal is independent of the AMOC background state. Our findings confirm a central role for ocean circulation in the bipolar seesaw and provide clear criteria for assessing hypotheses and model simulations of Dansgaard-Oeschger dynamics.	[Buizert, Christo; Bauska, Thomas K.; Brook, Edward J.; Edwards, Jon S.; Kalk, Michael L.; Lee, James E.; Marcott, Shaun A.; Mitchell, Logan E.; Rhodes, Rachael H.; Rosen, Julia L.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Adrian, Betty; Bencivengo, Brian B.; Hargreaves, Geoffrey M.; Nunn, Richard M.] US Geol Survey, Natl Ice Core Lab, Denver, CO 80225 USA; [Ahn, Jinho] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 151742, South Korea; [Albert, Mary; Gregory, Stephanie] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Alley, Richard B.; Fegyveresi, John M.; Sowers, Todd A.; Voigt, Donald E.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Baggenstos, Daniel; Orsi, Anais J.; Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Bay, Ryan C.; Price, P. Buford] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bentley, Charles R.; Gibson, Chris J.; Goetz, Joshua J.; Johnson, Jay A.; Kuhl, Tanner W.; Lebar, Donald A.; Mortensen, Nicolai B.; Sendelbach, Paul J.; Shturmakov, Alexander J.; Slawny, Kristina R.; Wendricks, Anthony W.] Univ Wisconsin, Ice Drilling Design & Operat, Madison, WI 53706 USA; [Chellman, Nathan J.; Maselli, Olivia J.; McConnell, Joseph R.; McGwire, Kenneth C.; Pasteris, Daniel R.; Sigl, Michael; Taylor, Kendrick C.] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Clow, Gary D.] US Geol Survey, Boulder, CO 80309 USA; [Cole-Dai, Jihong; Ferris, Dave G.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Conway, Howard; Fudge, T. J.; Markle, Bradley R.; Schauer, Andrew J.; Schoenemann, Spruce W.; Steig, Eric J.; Waddington, Edwin D.; Winstrup, Mai] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Cravens, Eric] ADC Management Serv, Lakewood, CO 80226 USA; [Cuffey, Kurt M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94709 USA; [Dunbar, Nelia W.; Iverson, Nels] New Mexico Inst Min & Technol, Earth & Environm Sci Dept, Socorro, NM 87801 USA; [Fitzpatrick, Joan J.] US Geol Survey, Denver, CO 80225 USA; [Gkinis, Vasileios; Jones, Tyler R.; Vaughn, Bruce H.; White, James W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Gkinis, Vasileios; Pedro, Joel B.; Winstrup, Mai] Univ Copenhagen, Ctr Ice & Climate, DK-2100 Copenhagen O, Denmark; [Kippenhan, Matthew J.] Antarctic Support Contract, Lockheed Martin US Antarctic Program, Centennial, CO 80112 USA; [Koffman, Bess G.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Kreutz, Karl] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Kreutz, Karl] Univ Maine, Sch Earth & Climate Sci, Orono, ME 04469 USA; [Marcott, Shaun A.] Univ Wisconsin, Madison, WI 53706 USA; [Neff, Peter D.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6012, New Zealand; [Nishiizumi, Kunihiko; Welten, Kees C.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Orsi, Anais J.] Inst Pierre Simon Laplace, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Pedro, Joel B.] Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; [Pettit, Erin C.] Univ Alaska Fairbanks, Dept Geosci, Fairbanks, AK 99775 USA; [Priscu, John C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Souney, Joseph M.; Twickler, Mark S.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Spencer, Matthew K.] Lake Super State Univ, Sch Phys Sci, Sault Sainte Marie, MI 49783 USA; [Wong, Gifford J.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; [Woodruff, Thomas E.] Purdue Univ, PRIME Lab, W Lafayette, IN 47907 USA	Oregon State University; United States Department of the Interior; United States Geological Survey; Seoul National University (SNU); Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; United States Department of the Interior; United States Geological Survey; South Dakota State University; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; New Mexico Institute of Mining Technology; United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; University of Copenhagen; Columbia University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Wisconsin System; University of Wisconsin Madison; Victoria University Wellington; University of California System; University of California Berkeley; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Washington; University of Washington Seattle; University of Alaska System; University of Alaska Fairbanks; Montana State University System; Montana State University Bozeman; University System Of New Hampshire; University of New Hampshire; Dartmouth College; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Buizert, C (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	buizertc@science.oregonstate.edu	Pedro, Joel/M-5632-2014; Mitchell, Logan E/A-5481-2011; Vaughn, Bruce/AAO-8867-2020; Gkinis, Vasileios/E-8185-2011; Winstrup, Mai/M-5844-2014; Brook, Edward/AAB-7807-2021; Marcott, Shaun A/L-7098-2015; Pedro, Joel Benjamin/L-8918-2019; Taylor, Kendrick/A-3469-2016; Steig, Eric J/G-9088-2015; Cole-Dai, Jihong/B-2510-2009; Baggenstos, Daniel/AAK-5751-2021; Neff, Peter David/ABB-7688-2021; Markle, Bradley R/I-6132-2019; White, James W.C./A-7845-2009	Pedro, Joel/0000-0002-0728-2712; Mitchell, Logan E/0000-0002-8749-954X; Gkinis, Vasileios/0000-0002-5910-1549; Winstrup, Mai/0000-0002-4794-4004; Marcott, Shaun A/0000-0003-3264-0523; Pedro, Joel Benjamin/0000-0002-0728-2712; Taylor, Kendrick/0000-0001-8535-1261; Steig, Eric J/0000-0002-8191-5549; Cole-Dai, Jihong/0000-0003-0921-5916; Baggenstos, Daniel/0000-0001-9756-6884; White, James W.C./0000-0001-6041-4684; Koffman, Bess/0000-0002-9451-4138; Rhodes, Rachael/0000-0001-7511-1969; Bauska, Thomas/0000-0003-1901-0367; Buizert, Christo/0000-0002-2227-1747; Dunbar, Nelia/0000-0002-5181-937X; Welten, Kees/0000-0001-8577-6753; Souney, Joseph/0000-0002-1492-6432; Neff, Peter/0000-0003-1697-0936; Schauer, Andrew/0000-0002-5941-5396; Albert, Mary/0000-0001-7842-2359; Pettit, Erin/0000-0002-6765-9841; Markle, Bradley/0000-0002-2282-6546; Fudge, Tyler/0000-0002-6818-7479; Lee, James/0000-0002-9137-1530; VAUGHN, BRUCE/0000-0001-6503-957X; Ferris, David/0000-0003-2336-6163	US National Science foundation [0944078, 0841308, 1043528, 1142173, 1204172, 1142041, 1043518, 0839066, 0087345, 0944191, 0539232, 0537661, 1142069, 1142115, 0841135, 0839093, 1142166]; USGS Climate and Land Use Change Program; NOM Climate and Global Change Fellowship Program; illum Foundation; Joint Institute for the Study of the Atmosphere and Ocean; Korea Polar Research Institute [PE15010]; WAIS Divide Science Coordination Office at the Desert Research Institute of Nevada; Ice Drilling Program Office and Ice Drilling Design and Operations group for coring activities; NICL; Raytheon Polar Services for logistics support in Antarctica; 109th New York Air National Guard for airlift in Antarctica; The US National Science foundation [1142164, 1142178, 0538657, 1043500, 0944584, 1043313, 0537930, 1043092, 0230149, 0230396, 0440817, 0440819, 0944348, 0944266, 0839137, 0537593, 1043167]; Directorate For Geosciences [0944348, 1142069, 1043508, 1043518] Funding Source: National Science Foundation; EPSCoR [1101245] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [0968391] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1142115, 1043421, 1443328, 1043092, 1043528, 1043167, 1142166] Funding Source: National Science Foundation	US National Science foundation(National Science Foundation (NSF)); USGS Climate and Land Use Change Program(United States Geological Survey); NOM Climate and Global Change Fellowship Program; illum Foundation; Joint Institute for the Study of the Atmosphere and Ocean; Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); WAIS Divide Science Coordination Office at the Desert Research Institute of Nevada; Ice Drilling Program Office and Ice Drilling Design and Operations group for coring activities; NICL; Raytheon Polar Services for logistics support in Antarctica; 109th New York Air National Guard for airlift in Antarctica; The US National Science foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the WAIS Divide Drilling Team (2006-2013) (E Morton, P. Cassidy, M. Jayred, J. Robinson, S. Polishinski, J. Koehler, L Albershardt, J. Goetz, B. Gross, R. Kuhn, S. Haman, W. Neumeister, C. Zander, J. Kyne, L. Augustin, B. Folmer, S. B. Hansen, E. Alexander and J. Fowler) and the dozens of core handlers who processed the ice core in the field and at the National Ice Core Laboratory (NICL). This work is funded through the US National Science foundation grants 0944078,0841308 (to M.A.), 1043528 (to R.B.A., D.E.V. and J.M.F.), 1142173 (to R.B.),1204172,1142041, 1043518 (to E.J.B.), 0839066 (to J.C.-D.), 0087345, 0944191 (to H.C. and E.D.W.), 0539232, 0537661 (to K.M.C.), 1142069, 1142115 (to N.W.D.), 0841135 (to IDDO), 0839093, 1142166 (to J.R.M.), 0440819, 1142164 (to K.C.M.), 1142178 (to P.B.P.), 0538657 (to J.P.S.), 1043500, 0944584 (to T.A.S.), 1043313 (to M.K.S), 0537930, 1043092 (to E.J.S.), 0230149,0230396, 0440817, 0440819,0944191, 0944348 (to K.C.T.), 0944266 (to M.S.T.), 0839137 (to K.C.W. and K.N.), 0537593 and 1043167 (to J.W.C.W.); the USGS Climate and Land Use Change Program (to G.D.C. and J.J.F); the NOM Climate and Global Change Fellowship Program,administered by the University Corporation for Atmospheric Research (to C.B.); the Villum Foundation (to M.W.); the Joint Institute for the Study of the Atmosphere and Ocean (to J.B.P., JISAO contribution no. 2343); and the Korea Polar Research Institute, grant PE15010 (to J.A.). The National Science Foundation Office of Polar Programs also funded the WAIS Divide Science Coordination Office at the Desert Research Institute of Nevada and University of New Hampshire for the collection and distribution of the WAIS Divide ice core and related tasks; the Ice Drilling Program Office and Ice Drilling Design and Operations group for coring activities; the NICL for curation of the core; Raytheon Polar Services for logistics support in Antarctica; and the 109th New York Air National Guard for airlift in Antarctica.	ALLEY RB, 1995, J GLACIOL, V41, P503, DOI 10.3189/S0022143000034845; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Arnaud L., 2000, PHYS ICE CORE RECORD, P285; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BARNOLA JM, 1991, TELLUS B, V43, P83, DOI 10.1034/j.1600-0889.1991.t01-1-00002.x; Battle MO, 2011, ATMOS CHEM PHYS, V11, P11007, DOI 10.5194/acp-11-11007-2011; Baumgartner M, 2014, CLIM PAST, V10, P903, DOI 10.5194/cp-10-903-2014; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Buizert C, 2014, SCIENCE, V345, P1177, DOI 10.1126/science.1254961; Capron E, 2010, QUATERNARY SCI REV, V29, P222, DOI 10.1016/j.quascirev.2009.07.014; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; de Vernal A, 2013, QUATERNARY SCI REV, V79, P1, DOI 10.1016/j.quascirev.2013.08.009; Dlugokencky EJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006035; Dokken TM, 2013, PALEOCEANOGRAPHY, V28, P491, DOI 10.1002/palo.20042; ENGLAND MH, 1995, J PHYS OCEANOGR, V25, P2756, DOI 10.1175/1520-0485(1995)025<2756:TAOWAV>2.0.CO;2; Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Fischer H, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000192; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Fudge T. J., 2014, CLIM PAST DISCUSS, V10, P65; Goujon C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003319; Gutjahr M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002114; HERRON MM, 1980, J GLACIOL, V25, P373, DOI 10.3189/S0022143000015239; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kohler P, 2011, CLIM PAST, V7, P473, DOI 10.5194/cp-7-473-2011; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6520; Kohler P., 2010, CLIM PAST DISCUSS, V6, P1453, DOI DOI 10.5194/CPD-6-1453-2010; Liu ZY, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000172; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Masuda S, 2010, SCIENCE, V329, P319, DOI 10.1126/science.1188703; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Mudelsee M, 2009, EUR PHYS J-SPEC TOP, V174, P49, DOI 10.1140/epjst/e2009-01089-3; Noone D, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004228; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Parrenin F, 2012, CLIM PAST, V8, P1239, DOI 10.5194/cp-8-1239-2012; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Petersen SV, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1029/2012PA002364; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Piotrowski AM, 2008, EARTH PLANET SC LETT, V272, P394, DOI 10.1016/j.epsl.2008.05.011; Rasmussen SO, 2013, CLIM PAST, V9, P2713, DOI 10.5194/cp-9-2713-2013; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Rhodes RH, 2013, EARTH PLANET SC LETT, V368, P9, DOI 10.1016/j.epsl.2013.02.034; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954; Rosen JL, 2014, NAT GEOSCI, V7, P459, DOI [10.1038/ngeo2147, 10.1038/NGEO2147]; Schilt A, 2010, EARTH PLANET SC LETT, V300, P33, DOI 10.1016/j.epsl.2010.09.027; Schmittner A, 2003, QUATERNARY SCI REV, V22, P659, DOI 10.1016/S0277-3791(02)00184-1; Schwander J, 1997, J GEOPHYS RES-ATMOS, V102, P19483, DOI 10.1029/97JD01309; SCHWANDER J, 1984, NATURE, V311, P45, DOI 10.1038/311045a0; Seierstad IK, 2014, QUATERNARY SCI REV, V106, P29, DOI 10.1016/j.quascirev.2014.10.032; Sigl M, 2013, J GEOPHYS RES-ATMOS, V118, P1151, DOI 10.1029/2012JD018603; SOWERS T, 1992, J GEOPHYS RES-ATMOS, V97, P15683, DOI 10.1029/92JD01297; Sowers T, 1997, J GEOPHYS RES-OCEANS, V102, P26527, DOI 10.1029/97JC00633; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stowasser C, 2012, ATMOS MEAS TECH, V5, P999, DOI 10.5194/amt-5-999-2012; Timmermann A, 2010, QUATERNARY SCI REV, V29, P74, DOI 10.1016/j.quascirev.2009.06.021; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Trudinger CM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002545; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Wolff EW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018454	69	213	221	9	283	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					661	U169		10.1038/nature14401	http://dx.doi.org/10.1038/nature14401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925479	Green Submitted, Green Published			2022-12-28	WOS:000353689700046
J	Grayson, M				Grayson, Michelle			Raising standards	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S10	S12		10.1038/520S10a	http://dx.doi.org/10.1038/520S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25924192	Bronze			2022-12-28	WOS:000353689700002
J	Berman, SI				Berman, Scott I.			Gripers and Whiners	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sibshrink225@msn.com						Schiff GD, 2013, JAMA-J AM MED ASSOC, V310, P1233, DOI 10.1001/jama.2013.276133	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1621	1622		10.1001/jama.2014.13628	http://dx.doi.org/10.1001/jama.2014.13628			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919523				2022-12-28	WOS:000353595200010
J	Li, D; Agha, L				Li, Danielle; Agha, Leila			Big names or big ideas: Do peer-review panels select the best science proposals?	SCIENCE			English	Article							US BIOMEDICAL-RESEARCH; IMPACT	This paper examines the success of peer-review panels in predicting the future quality of proposed research. We construct new data to track publication, citation, and patenting outcomes associated with more than 130,000 research project (R01) grants funded by the U.S. National Institutes of Health from 1980 to 2008. We find that better peer-review scores are consistently associated with better research outcomes and that this relationship persists even when we include detailed controls for an investigator's publication history, grant history, institutional affiliations, career stage, and degree types. A one-standard deviation worse peer-review score among awarded grants is associated with 15% fewer citations, 7% fewer publications, 19% fewer high-impact publications, and 14% fewer follow-on patents.	[Li, Danielle] Harvard Univ, Cambridge, MA 02138 USA; [Agha, Leila] Boston Univ, Boston, MA 02215 USA; [Agha, Leila] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Boston University; National Bureau of Economic Research	Li, D (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	dli@hbs.edu; lagha@bu.edu						Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Arrow K., 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024; Azoulay P., 2013, 20889 NBER; Azoulay P, 2011, DIFFUSION SCI KNOWLE; Azoulay P, 2014, MANAGE SCI, V60, P92, DOI 10.1287/mnsc.2013.1755; Berg J., 2011, PRODUCTIVITY METRICS; Campanario JM, 1998, SCI COMMUN, V19, P181, DOI 10.1177/1075547098019003002; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Danthi N, 2014, CIRC RES, V114, P600, DOI 10.1161/CIRCRESAHA.114.302656; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Jacob BA, 2011, RES POLICY, V40, P864, DOI 10.1016/j.respol.2011.04.003; Kerr WR, 2008, REV ECON STAT, V90, P518, DOI 10.1162/rest.90.3.518; Kerr WR, 2008, 08006 HBS; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Tanne JH, 1999, BRIT MED J, V319, P336, DOI 10.1136/bmj.319.7206.336	17	85	87	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					434	438		10.1126/science.aaa0185	http://dx.doi.org/10.1126/science.aaa0185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5NF	25908820				2022-12-28	WOS:000353338000034
J	Hawkes, N				Hawkes, Nigel			Primary care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								General practitioners are said to be demoralised, but this clearly doesn't apply to those shortlisted for the Primary Care Team award, finds Nigel Hawkes. They show plenty of confidence in the role of general practice, across a wide spectrum that includes two projects focusing on the frail and elderly, one that seeks to cut male suicides, and two to improve access to services.				nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h1951	10.1136/bmj.h1951	http://dx.doi.org/10.1136/bmj.h1951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25904545				2022-12-28	WOS:000353576700004
J	Tacchella, S; Carollo, CM; Renzini, A; Schreiber, NMF; Lang, P; Wuyts, S; Cresci, G; Dekel, A; Genzel, R; Lilly, SJ; Mancini, C; Newman, S; Onodera, M; Shapley, A; Tacconi, L; Woo, J; Zamorani, G				Tacchella, S.; Carollo, C. M.; Renzini, A.; Schreiber, N. M. Foerster; Lang, P.; Wuyts, S.; Cresci, G.; Dekel, A.; Genzel, R.; Lilly, S. J.; Mancini, C.; Newman, S.; Onodera, M.; Shapley, A.; Tacconi, L.; Woo, J.; Zamorani, G.			Evidence for mature bulges and an inside-out quenching phase 3 billion years after the Big Bang	SCIENCE			English	Article							EARLY-TYPE GALAXIES; SIMILAR-TO 2; SINS/ZC-SINF SURVEY; STAR-FORMING GALAXIES; STELLAR MASS DENSITY; DISK GALAXIES; KINEMATICS EVIDENCE; MERGER REMNANTS; BLACK-HOLES; DEEP FIELD	Most present-day galaxies with stellar masses >= 10(11) solar masses show no ongoing star formation and are dense spheroids. Ten billion years ago, similarly massive galaxies were typically forming stars at rates of hundreds solar masses per year. It is debated how star formation ceased, on which time scales, and how this "quenching" relates to the emergence of dense spheroids. We measured stellar mass and star-formation rate surface density distributions in star-forming galaxies at redshift 2.2 with similar to 1-kiloparsec resolution. We find that, in the most massive galaxies, star formation is quenched from the inside out, on time scales less than 1 billion years in the inner regions, up to a few billion years in the outer disks. These galaxies sustain high star-formation activity at large radii, while hosting fully grown and already quenched bulges in their cores.	[Tacchella, S.; Carollo, C. M.; Lilly, S. J.; Onodera, M.; Woo, J.] Swiss Fed Inst Technol, Inst Astron, Dept Phys, CH-8093 Zurich, Switzerland; [Renzini, A.; Mancini, C.] Osserv Astron Padova, Ist Nazl Astrofis INAF, I-35122 Padua, Italy; [Schreiber, N. M. Foerster; Lang, P.; Wuyts, S.; Genzel, R.; Tacconi, L.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Cresci, G.] INAF Osservatorio Astron Arcetri, I-50125 Florence, Italy; [Dekel, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Genzel, R.; Newman, S.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Genzel, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Shapley, A.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Zamorani, G.] INAF Osservatorio Astron Bologna, I-40127 Bologna, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; Istituto Nazionale Astrofisica (INAF); University of Padua; Max Planck Society; Istituto Nazionale Astrofisica (INAF); Hebrew University of Jerusalem; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Istituto Nazionale Astrofisica (INAF)	Tacchella, S (corresponding author), Swiss Fed Inst Technol, Inst Astron, Dept Phys, CH-8093 Zurich, Switzerland.	sandro.tacchella@phys.ethz.ch; marcella.carollo@phys.ethz.ch	Cresci, Giovanni/ABD-7239-2020; Dekel, Avishai/ABF-9516-2021; Tacchella, Sandro/AAT-1602-2021	Cresci, Giovanni/0000-0002-5281-1417; Dekel, Avishai/0000-0003-4174-0374; Tacchella, Sandro/0000-0002-8224-4505; Newman, Sarah/0000-0003-3126-5717; mancini, chiara/0000-0002-4297-0561; Renzini, Alvio/0000-0002-7093-7355; Onodera, Masato/0000-0003-3228-7264; Zamorani, Giovanni/0000-0002-2318-301X	Swiss National Science Foundation [200020_140952]; NASA [NAS 5-26555];  [GO9822];  [GO10092];  [GO10924];  [GO11694];  [GO12578];  [GO12060];  [GO12061];  [GO12062];  [GO12063];  [GO12064];  [GO12440];  [GO12442];  [GO12443];  [GO12444];  [GO12445];  [075.A-0466];  [076.A-0527];  [079.A-0341];  [080.A-0330];  [080.A-0339];  [080.A-0635];  [081.A-0672];  [183.A-0781];  [087.A-0081];  [088.A-0202];  [088.A-0209];  [091.A-0126]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NASA(National Aeronautics & Space Administration (NASA)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	S.T. thanks B. Trakhtenbrot for stimulating discussions. We thank the reviewers for their thorough review, comments, and suggestions. We acknowledge support by the Swiss National Science Foundation, grant 200020_140952. This research made use of NASA's Astrophysics Data System; the arXiv.org preprint server; the Python plotting library matplotlib; and astropy, a community-developed core Python package for Astronomy. A.R., G.C., and G.Z. acknowledge support from an INAF PRIN-2012. Based on observations made with the NASA/European Space Agency Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555, and on observations obtained at the Very Large Telescope of the European Southern Observatory, Paranal, Chile. The data used in this paper are archived at https://archive.stsci.edu/hst/ under program ID GO9822, GO10092, GO10924, GO11694, GO12578, GO12060, GO12061, GO12062, GO12063, GO12064, GO12440, GO12442, GO12443, GO12444, and GO12445; and http://archive.eso.org/cms.html under program ID 075.A-0466, 076.A-0527, 079.A-0341, 080.A-0330, 080.A-0339, 080.A-0635, 081.A-0672, 183.A-0781, 087.A-0081, 088.A-0202, 088.A-0209, and 091.A-0126.	BENDER R, 1988, ASTRON ASTROPHYS SUP, V74, P385; Carollo CM, 2007, ASTROPHYS J, V658, P960, DOI 10.1086/511125; Carollo CM, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/71; CAROLLO CM, 1993, MON NOT R ASTRON SOC, V265, P553, DOI 10.1093/mnras/265.3.553; Cox TJ, 2006, ASTROPHYS J, V650, P791, DOI 10.1086/507474; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Dekel A, 2014, MON NOT R ASTRON SOC, V438, P1870, DOI 10.1093/mnras/stt2331; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Faber SM, 1997, ASTRON J, V114, P1771, DOI 10.1086/118606; Fang JJ, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/63; Gargiulo A, 2012, MON NOT R ASTRON SOC, V425, P2698, DOI 10.1111/j.1365-2966.2012.21670.x; Genzel R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/75; Guo YC, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/18; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; LILLY SJ, 1995, ASTROPHYS J, V455, P108, DOI 10.1086/176560; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; Martig M, 2009, ASTROPHYS J, V707, P250, DOI 10.1088/0004-637X/707/1/250; Naab T, 2003, ASTROPHYS J, V597, P893, DOI 10.1086/378581; Nelson EJ, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/1/L16; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Renzini A, 2009, MON NOT R ASTRON SOC, V398, pL58, DOI 10.1111/j.1745-3933.2009.00710.x; Saracco P, 2012, MON NOT R ASTRON SOC, V422, P3107, DOI 10.1111/j.1365-2966.2012.20830.x; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Tacchella S, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/101; Woo J, 2015, MON NOT R ASTRON SOC, V448, P237, DOI 10.1093/mnras/stu2755; Wuyts S, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/135	29	188	188	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					314	317		10.1126/science.1261094	http://dx.doi.org/10.1126/science.1261094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883353	Green Submitted, Green Accepted			2022-12-28	WOS:000352999000038
J	Barker, S; Chen, J; Gong, X; Jonkers, L; Knorr, G; Thornalley, D				Barker, Stephen; Chen, James; Gong, Xun; Jonkers, Lukas; Knorr, Gregor; Thornalley, David			Icebergs not the trigger for North Atlantic cold events	NATURE			English	Article							LAST GLACIAL PERIOD; DEEP-WATER; CLIMATE VARIABILITY; ICE-SHEET; CHRONOLOGY AICC2012; HEINRICH EVENTS; ANTARCTIC ICE; OCEAN; CIRCULATION; SEA	Abrupt climate change is a ubiquitous feature of the Late Pleistocene epoch'. In particular, the sequence of Dansgaard Oeschger events (repeated transitions between warm interstadial and cold stadial conditions), as recorded by ice cores in Greenland', are thought to be linked to changes in the mode of overturning circulation in the Atlantic Ocean'. Moreover, the observed correspondence between North Atlantic cold events and increased iceberg calving and dispersal from ice sheets surrounding the North Atlantic' has inspired many ocean and climate modelling studies that make use of freshwater forcing scenarios to simulate abrupt change across the North Atlantic region and beyond'. On the other hand, previous studies(4,8) identified an apparent lag between North Atlantic cooling events and the appearance of ice-rafted debris over the last glacial cycle, leading to the hypothesis that iceberg discharge may be a consequence of stadial conditions rather than the cause(4,9-11). Here we further establish this relationship and demonstrate a systematic delay between pronounced surface cooling and the arrival of ice-rafted debris at a site southwest of Iceland over the past four glacial cycles, implying that in general icebergs arrived too late to have triggered cooling. Instead we suggest that on the basis of our comparisons of ice-rafted debris and polar planktonic foraminifera abrupt transitions to stadial conditions should be considered as a nonlinear response to more gradual cooling across the North Atlantic. Although the freshwater derived from melting icebergs may provide a positive feedback for enhancing and or prolonging stadial conditions(10,11), it does not trigger northern stadial events.	[Barker, Stephen; Chen, James; Gong, Xun; Jonkers, Lukas] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Knorr, Gregor] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, D-27570 Bremerhaven, Germany; [Thornalley, David] UCL, Dept Geog, London WC1E 6BT, England; [Thornalley, David] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Cardiff University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of London; University College London; Woods Hole Oceanographic Institution	Barker, S (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales.	barkers3@cf.ac.uk	Stephen, Barker/C-2770-2009; Jonkers, Lukas/H-6314-2011	Stephen, Barker/0000-0001-7870-6431; Jonkers, Lukas/0000-0002-0253-2639; Gong, Xun/0000-0001-9308-4431; Knorr, Gregor/0000-0002-8317-5046	Philip Leverhulme Prize; Corner Science and Education Foundation (GCCF3); UK Natural Environment Research Council (NERC) [NE/L006405/1, NE/J008133/1]; 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change); Helmholtz Association of German research centres (HGF); climate change consortium of Wales; NERC [NE/L006405/1] Funding Source: UKRI; Natural Environment Research Council [NE/L006405/1, NE/J008133/1] Funding Source: researchfish	Philip Leverhulme Prize; Corner Science and Education Foundation (GCCF3); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change); Helmholtz Association of German research centres (HGF)(Helmholtz Association); climate change consortium of Wales; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Edwards, L Owen, F. Piggott, L. Skyrme and M. Theobald for assistance in the laboratory and J. McManus for discussions. This study was supported by a Philip Leverhulme Prize to S.B., the Corner Science and Education Foundation (GCCF3) and the UK Natural Environment Research Council (NERC) grants NE/L006405/1 and NE/J008133/1. Additional funding by 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change), a joint research project of the Helmholtz Association of German research centres (HGF), is gratefully acknowledged (G.K.). L.J. was funded by the climate change consortium of Wales (http://www.C3Wales.org). This research used samples provided by the Integrated Ocean Drilling Program (IODP). We thank W. Hale for assistance in sampling and curation. All data and age models presented here are available in the Extended Data.	Alley RB, 2001, PALEOCEANOGRAPHY, V16, P190, DOI 10.1029/2000PA000518; Alvarez-Solas J, 2013, P NATL ACAD SCI USA, V110, P16350, DOI 10.1073/pnas.1306622110; Alvarez-Solas J, 2010, NAT GEOSCI, V3, P122, DOI 10.1038/NGEO752; Andersen K.K., 2007, CLIM PAST DISCUSS, V3, P1235; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Austin WEN, 2012, QUATERNARY SCI REV, V36, P28, DOI 10.1016/j.quascirev.2012.01.015; Barker S, 2014, PALEOCEANOGRAPHY, V29, P489, DOI 10.1002/2014PA002623; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; Boch R, 2011, CLIM PAST, V7, P1247, DOI 10.5194/cp-7-1247-2011; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Braun H, 2005, NATURE, V438, P208, DOI 10.1038/nature04121; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clark P.U., 2007, OCEAN CIRCULATION ME, V173, P209, DOI [10.1029/173GM15, DOI 10.1029/173GM15]; Death R, 2006, PALAEOGEOGR PALAEOCL, V236, P135, DOI 10.1016/j.palaeo.2005.11.040; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Dokken TM, 2013, PALEOCEANOGRAPHY, V28, P491, DOI 10.1002/palo.20042; Elliot M, 1998, PALEOCEANOGRAPHY, V13, P433, DOI 10.1029/98PA01792; Ezat MM, 2014, GEOLOGY, V42, P663, DOI 10.1130/G35579.1; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Grousset FE, 2000, GEOLOGY, V28, P123; Grousset FE, 2001, PALEOCEANOGRAPHY, V16, P240, DOI 10.1029/2000PA000559; Hodell D, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1002/palo.20017; Jonkers L, 2010, QUATERNARY SCI REV, V29, P1791, DOI 10.1016/j.quascirev.2010.03.014; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Jullien E, 2006, GLOBAL PLANET CHANGE, V54, P225, DOI 10.1016/j.gloplacha.2006.06.021; Kageyama M, 2013, CLIM PAST, V9, P935, DOI 10.5194/cp-9-935-2013; Kleiven HF, 2011, GEOLOGY, V39, P343, DOI 10.1130/G31651.1; Knorr G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001604; Li C, 2010, J CLIMATE, V23, P5457, DOI 10.1175/2010JCLI3409.1; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Menviel L, 2014, CLIM PAST, V10, P63, DOI 10.5194/cp-10-63-2014; Moros M, 2004, EARTH PLANET SC LETT, V218, P389, DOI 10.1016/S0012-821X(03)00675-7; Oppo DW, 2006, QUATERNARY SCI REV, V25, P3268, DOI 10.1016/j.quascirev.2006.07.006; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Petersen SV, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1029/2012PA002364; Pflaumann U, 1996, PALEOCEANOGRAPHY, V11, P15, DOI 10.1029/95PA01743; Prins MA, 2002, GEOLOGY, V30, P555, DOI 10.1130/0091-7613(2002)030<0555:OCAIDI>2.0.CO;2; RAHMSTORF S, 1994, NATURE, V372, P82, DOI 10.1038/372082a0; Raymo ME, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000921; Revel M, 1996, MAR GEOL, V131, P233, DOI 10.1016/0025-3227(96)00005-9; RUDDIMAN WF, 1977, GEOL SOC AM BULL, V88, P1813, DOI 10.1130/0016-7606(1977)88<1813:LQDOIS>2.0.CO;2; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Schulz M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016144; Schulz M., 2002, GEOPHYS RES LETT, V29; Scourse JD, 2000, EARTH PLANET SC LETT, V182, P187, DOI 10.1016/S0012-821X(00)00241-7; Shaffer G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020968; van Kreveld S, 2000, PALEOCEANOGRAPHY, V15, P425, DOI 10.1029/1999PA000464; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Watkins SJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001281; Weber SL, 2007, CLIM PAST, V3, P51, DOI 10.5194/cp-3-51-2007; WINTON M, 1993, J PHYS OCEANOGR, V23, P1389, DOI 10.1175/1520-0485(1993)023<1389:TOIBSS>2.0.CO;2; Winton M, 1997, J CLIMATE, V10, P37, DOI 10.1175/1520-0442(1997)010<0037:TEOCCU>2.0.CO;2; Zhang X, 2014, NATURE, V512, P290, DOI 10.1038/nature13592	63	149	153	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					333	+		10.1038/nature14330	http://dx.doi.org/10.1038/nature14330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877202	Green Submitted, Green Accepted			2022-12-28	WOS:000352974200035
J	Chavarri-Guerra, Y; Soto-Perez-de-Celis, E				Chavarri-Guerra, Yanin; Soto-Perez-de-Celis, Enrique			Loss of Fingerprints	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chavarri-Guerra, Yanin; Soto-Perez-de-Celis, Enrique] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Chavarri-Guerra, Y (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico.	yaninchg@gmail.com	Soto-Perez-de-Celis, Enrique/U-5357-2017	Soto-Perez-de-Celis, Enrique/0000-0002-7301-2163					0	20	21	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16							e22	10.1056/NEJMicm1409635	http://dx.doi.org/10.1056/NEJMicm1409635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875278				2022-12-28	WOS:000352856500011
J	Keown, OP; Darzi, A				Keown, Oliver P.; Darzi, Ara			The quality narrative in health care	LANCET			English	Editorial Material									[Keown, Oliver P.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Ctr Hlth Policy, London W2 1NY, England; [Keown, Oliver P.; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Inst Global Hlth Innovat, London W2 1NY, England	Imperial College London; Imperial College London	Keown, OP (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Ctr Hlth Policy, London W2 1NY, England.	o.keown@imperial.ac.uk			National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Darzi A., 2008, HIGH QUALITY CARE AL; Farrar H, 2013, HEALTHCARE LONDON RE; London Health Commission, 2014, BETT HLTH LOND; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1367	1368		10.1016/S0140-6736(15)60639-0	http://dx.doi.org/10.1016/S0140-6736(15)60639-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25890404				2022-12-28	WOS:000352719800004
J	Das, I; Krzyzosiak, A; Schneider, K; Wrabetz, L; D'Antonio, M; Barry, N; Sigurdardottir, A; Bertolotti, A				Das, Indrajit; Krzyzosiak, Agnieszka; Schneider, Kim; Wrabetz, Lawrence; D'Antonio, Maurizio; Barry, Nicholas; Sigurdardottir, Anna; Bertolotti, Anne			Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit	SCIENCE			English	Article							INDUCED GENE-EXPRESSION; PROTEIN-SYNTHESIS; GUANABENZ; PHOSPHORYLATION; DEATH; MICE; ALS	Protein phosphorylation regulates virtually all biological processes. Although protein kinases are popular drug targets, targeting protein phosphatases remains a challenge. Here, we describe Sephin1 (selective inhibitor of a holophosphatase), a small molecule that safely and selectively inhibited a regulatory subunit of protein phosphatase 1 in vivo. Sephin1 selectively bound and inhibited the stress-induced PPP1R15A, but not the related and constitutive PPP1R15B, to prolong the benefit of an adaptive phospho-signaling pathway, protecting cells from otherwise lethal protein misfolding stress. In vivo, Sephin1 safely prevented the motor, morphological, and molecular defects of two otherwise unrelated protein-misfolding diseases in mice, Charcot-Marie-Tooth 1B, and amyotrophic lateral sclerosis. Thus, regulatory subunits of phosphatases are drug targets, a property exploited here to safely prevent two protein misfolding diseases.	[Das, Indrajit; Krzyzosiak, Agnieszka; Schneider, Kim; Barry, Nicholas; Sigurdardottir, Anna; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Wrabetz, Lawrence; D'Antonio, Maurizio] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	MRC Laboratory Molecular Biology; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bertolotti, A (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk	Krzyżosiak, Agnieszka/AAW-3711-2021; Sigurdardottir, Anna G/J-1562-2015; D'Antonio, Maurizio/AHI-1781-2022	Sigurdardottir, Anna G/0000-0002-5225-397X; D'Antonio, Maurizio/0000-0003-0637-8971; Krzyzosiak, Agnieszka/0000-0002-4330-3189; Das, Indrajit/0000-0001-8407-9796	Medical Research Council (UK); European Research Council (ERC) under the European Union/ERC [309516]; European Molecular Biology Organization and Human Frontier Science Program; Swiss National Science Foundation; Italian Ministry of Health [GR-2011-02642791]; NIH [R01-NS55256]; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [MC_U105185860] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055256] Funding Source: NIH RePORTER	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) under the European Union/ERC(European Research Council (ERC)); European Molecular Biology Organization and Human Frontier Science Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Italian Ministry of Health(Ministry of Health, Italy); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Tsaytler for some initial experiments on Sephin1; H. Meziane for the studies on memory; E. Fisher for SOD1<SUP>G93A</SUP> mice; E. Pettinato and C. Ferri for technical assistance; R. Roberts for discussions on CMT; A. Segonds-Pichon for statistical analysis; and members of the Bertolotti laboratory, M. Goedert, M. Hastings, and S. Munro for discussions. A.B. is an honorary fellow of the Clinical Neurosciences Department of Cambridge University. This work was supported by the Medical Research Council (UK) and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 309516. A.K. was supported by the European Molecular Biology Organization and Human Frontier Science Program, K.S. by the Swiss National Science Foundation, M.D. by the Italian Ministry of Health (GR-2011-02642791), and L.W. by NIH R01-NS55256. A.B. is a co-inventor on Great Britain patent WO 2014108520, covering benzylideneguanidine derivatives inhibitors of PPP1R15A. The data presented in this paper are tabulated in the main paper and the supplementary materials.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BROSTROM MA, 1989, J BIOL CHEM, V264, P1638; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALL AH, 1985, ANN INTERN MED, V102, P787, DOI 10.7326/0003-4819-102-6-787; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MEACHAM RH, 1980, J PHARMACOL EXP THER, V214, P594; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Nordlund A, 2008, HFSP J, V2, P354, DOI 10.2976/1.2995726; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006	25	263	272	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					239	242		10.1126/science.aaa4484	http://dx.doi.org/10.1126/science.aaa4484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859045	Green Accepted			2022-12-28	WOS:000352613700047
J	Menghaney, L				Menghaney, Leena			PERSONAL VIEW Bureaucracy and budget revision: how spending cuts are affecting India's public health programmes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Hlth Law & Policy, New Delhi, India		Menghaney, L (corresponding author), Publ Hlth Law & Policy, New Delhi, India.	leenamenghaney@gmail.com						Department of AIDS Control Ministry of Health & Family Welfare, 2013, ANN REPORT; Department of AIDS Control Ministry of Health & Family Welfare, 2015, UN BUDG 2015 16 NOT; Kalra A., 2015, REUTERS; Prasada Rao JVR, 2015, HINDUSTAN TIMES 0319; Working Group on Financial Management, 2011, 1 CONS M 24 26 MAY	5	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1734	10.1136/bmj.h1734	http://dx.doi.org/10.1136/bmj.h1734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25857712				2022-12-28	WOS:000352914700006
J	Bush, A; Kleinert, S; Pavord, ID				Bush, Andrew; Kleinert, Sabine; Pavord, Ian D.			The asthmas in 2015 and beyond: a Lancet Commission	LANCET			English	Editorial Material							EOSINOPHILIC ASTHMA; PERSISTENT ASTHMA; MEPOLIZUMAB		[Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bush, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Kleinert, Sabine] The Lancet, London, England; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX3 7FZ, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; University of Oxford	Pavord, ID (corresponding author), Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX3 7FZ, England.	ian.pavord@ndm.ox.ac.uk		Pavord, Ian/0000-0002-4288-5973	National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01, 10/058] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		[Anonymous], 1990, BMJ, V301, P651; Bush A, 2014, ARCH DIS CHILD, V99, P191, DOI 10.1136/archdischild-2012-303105; Bush A, 2011, THORAX, V66, P367, DOI 10.1136/thx.2011.160861; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hargreave FE, 2009, CLIN EXP ALLERGY, V39, P1652, DOI 10.1111/j.1365-2222.2009.03321.x; Levy M, 2014, WHY ASTHMA STILL KIL; Pavord ID, 2008, LANCET, V372, P1017, DOI 10.1016/S0140-6736(08)61421-X; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Rosenthal M, 2015, THORAX, V70, P112, DOI 10.1136/thoraxjnl-2014-206010; Sabroe I, 2013, THORAX, V68, P1085, DOI 10.1136/thoraxjnl-2013-203773; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	15	25	25	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1273	1275		10.1016/S0140-6736(15)60654-7	http://dx.doi.org/10.1016/S0140-6736(15)60654-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25890896				2022-12-28	WOS:000352272400015
J	Tolia, VN; Patrick, SW; Bennett, MM; Murthy, K; Sousa, J; Smith, PB; Clark, RH; Spitzer, AR				Tolia, Veeral N.; Patrick, Stephen W.; Bennett, Monica M.; Murthy, Karna; Sousa, John; Smith, P. Brian; Clark, Reese H.; Spitzer, Alan R.			Increasing Incidence of the Neonatal Abstinence Syndrome in US Neonatal ICUs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; INFANTS BORN; PREGNANCY; THERAPY; MANAGEMENT; CARE; POPULATION; CLONIDINE; COHORT	BACKGROUND The incidence of the neonatal abstinence syndrome, a drug-withdrawal syndrome that most commonly occurs after in utero exposure to opioids, is known to have increased during the past decade. However, recent trends in the incidence of the syndrome and changes in demographic characteristics and hospital treatment of these infants have not been well characterized. METHODS Using multiple cross-sectional analyses and a deidentified data set, we analyzed data from infants with the neonatal abstinence syndrome from 2004 through 2013 in 299 neonatal intensive care units (NICUs) across the United States. We evaluated trends in incidence and health care utilization and changes in infant and maternal clinical characteristics. RESULTS Among 674,845 infants admitted to NICUs, we identified 10,327 with the neonatal abstinence syndrome. From 2004 through 2013, the rate of NICU admissions for the neonatal abstinence syndrome increased from 7 cases per 1000 admissions to 27 cases per 1000 admissions; the median length of stay increased from 13 days to 19 days (P<0.001 for both trends). The total percentage of NICU days nationwide that were attributed to the neonatal abstinence syndrome increased from 0.6% to 4.0% (P<0.001 for trend), with eight centers reporting that more than 20% of all NICU days were attributed to the care of these infants in 2013. Infants increasingly received pharmacotherapy (74% in 2004-2005 vs. 87% in 2012-2013, P<0.001 for trend), with morphine the most commonly used drug (49% in 2004 vs. 72% in 2013, P<0.001 for trend). CONCLUSIONS From 2004 through 2013, the neonatal abstinence syndrome was responsible for a substantial and growing portion of resources dedicated to critically ill neonates in NICUs nationwide.	[Tolia, Veeral N.] Baylor Univ, Med Ctr, Pediatrix Med Grp, Div Neonatol,Dept Pediat, Dallas, TX 75246 USA; [Bennett, Monica M.] Baylor Scott & White Hlth, Off Chief Qual Officer, Dallas, TX USA; [Patrick, Stephen W.] Vanderbilt Univ, Sch Med, Dept Pediat, Mildred Stahlman Div Neonatol, Nashville, TN 37212 USA; [Patrick, Stephen W.] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Patrick, Stephen W.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Murthy, Karna] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neonatol, Chicago, IL 60611 USA; [Murthy, Karna] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Sousa, John] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Clark, Reese H.; Spitzer, Alan R.] Mednax, Ctr Res Educ & Qual, Sunrise, FL USA; [Smith, P. Brian] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Clark, Reese H.] Greenville Mem Hosp, Pediatrix Med Grp, Greenville, SC USA	Baylor University; Baylor University Medical Center; Baylor Health Care System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; State University System of Florida; Florida Atlantic University; Duke University; Greenville Health System	Tolia, VN (corresponding author), Baylor Univ, Med Ctr, Hoblitzelle Hosp 3, 3500 Gaston Ave, Dallas, TX 75246 USA.	veeral.tolia@baylorhealth.edu	Patrick, Stephen/ABD-8528-2021; Clark, Reese/L-5392-2019	Clark, Reese/0000-0002-7363-4640; Murthy, Karna/0000-0003-3363-9663	NATIONAL INSTITUTE ON DRUG ABUSE [K23DA038720] Funding Source: NIH RePORTER; NIDA NIH HHS [K23 DA038720] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abdel-Latif ME, 2013, J PAEDIATR CHILD H, V49, pE80, DOI 10.1111/j.1440-1754.2012.02471.x; ACOG Committee on Health Care for Underserved Women, 2012, Obstet Gynecol, V119, P1070, DOI 10.1097/AOG.0b013e318256496e; Agthe AG, 2009, PEDIATRICS, V123, pE849, DOI 10.1542/peds.2008-0978; Aliaga S, 2014, PEDIATRICS, V133, P236, DOI 10.1542/peds.2013-0671; [Anonymous], 1983, PEDIATRICS, V72, P895; Autmizguine J, 2015, PEDIATRICS, V135, pE117, DOI 10.1542/peds.2014-2141; Bateman BT, 2014, ANESTHESIOLOGY, V120, P1216, DOI 10.1097/ALN.0000000000000172; Berlin CM, 1998, PEDIATRICS, V101, P1079; Creanga AA, 2012, OBSTET GYNECOL, V119, P924, DOI 10.1097/AOG.0b013e31824ea276; Desai RJ, 2014, OBSTET GYNECOL, V123, P997, DOI 10.1097/AOG.0000000000000208; Drug Enforcement Administration Department of Justice, 2014, Fed Regist, V79, P49661; Eidelman AI, 2012, BREASTFEED MED, V7, P323, DOI 10.1089/bfm.2012.0067; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Epstein RA, 2013, ANN EPIDEMIOL, V23, P498, DOI 10.1016/j.annepidem.2013.05.017; FINNEGAN LP, 1975, ADDICT DIS, V2, P141; Hall ES, 2014, PEDIATRICS, V134, pE527, DOI 10.1542/peds.2013-4036; Hekman KA, 2013, AM J PREV MED, V45, P113, DOI 10.1016/j.amepre.2013.02.019; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Isemann B, 2011, J PERINATOL, V31, P25, DOI 10.1038/jp.2010.66; Jansson LM, 2009, BREASTFEED MED, V4, P225, DOI 10.1089/bfm.2009.9987; Kaltenbach K, 2012, ADDICTION, V107, P45, DOI 10.1111/j.1360-0443.2012.04038.x; Kellogg A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.050; Laughon MM, 2014, JAMA PEDIATR, V168, P130, DOI 10.1001/jamapediatrics.2013.4208; Lind JN, 2015, MMWR-MORBID MORTAL W, V64, P213; Napolitano A, 2013, CLIN OBSTET GYNECOL, V56, P193, DOI 10.1097/GRF.0b013e31827adf91; O'Grady MJ, 2009, ARCH DIS CHILD-FETAL, V94, pF249, DOI 10.1136/adc.2008.152769; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Patrick SW, 2014, J PERINATOL, V34, P867, DOI 10.1038/jp.2014.114; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Paulozzi LJ, 2014, MMWR-MORBID MORTAL W, V63, P563; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Richardson D K, 2001, J Perinatol, V21, P107, DOI 10.1038/sj.jp.7200502; Salihu HM, 2015, AM J PERINAT, V32, P289, DOI 10.1055/s-0034-1384642; Sarkar S, 2006, J PERINATOL, V26, P15, DOI 10.1038/sj.jp.7211427; Spitzer AR, 2010, CLIN PERINATOL, V37, P49, DOI 10.1016/j.clp.2010.01.016; Surran B, 2013, J PERINATOL, V33, P954, DOI 10.1038/jp.2013.95; Trembath A, 2013, J PEDIATR-US, V163, P955, DOI 10.1016/j.jpeds.2013.04.053; US CEQ (United States Council on Environmental Quality), 1981, ADM FDA REF RED BIOP	38	297	298	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2118	2126		10.1056/NEJMsa1500439	http://dx.doi.org/10.1056/NEJMsa1500439			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	25913111				2022-12-28	WOS:000355146800007
J	Gao, J; Zheng, YT; Jehng, JM; Tang, YD; Wachs, IE; Podkolzin, SG				Gao, Jie; Zheng, Yiteng; Jehng, Jih-Mirn; Tang, Yadan; Wachs, Israel E.; Podkolzin, Simon G.			Identification of molybdenum oxide nanostructures on zeolites for natural gas conversion	SCIENCE			English	Article							BRONSTED ACID SITES; METHANE DEHYDROAROMATIZATION; ZSM-5 ZEOLITES; CATALYSTS; BENZENE; AROMATIZATION; DEHYDROGENATION; SPECTROSCOPY; ACTIVATION; AROMATICS	Direct methane conversion into aromatic hydrocarbons over catalysts with molybdenum (Mo) nanostructures supported on shape-selective zeolites is a promising technology for natural gas liquefaction. We determined the identity and anchoring sites of the initial Mo structures in such catalysts as isolated oxide species with a single Mo atom on aluminum sites in the zeolite framework and on silicon sites on the zeolite external surface. During the reaction, the initial isolated Mo oxide species agglomerate and convert into carbided Mo nanoparticles. This process is reversible, and the initial isolated Mo oxide species can be restored by a treatment with gas-phase oxygen. Furthermore, the distribution of the Mo nanostructures can be controlled and catalytic performance can be fully restored, even enhanced, by adjusting the oxygen treatment.	[Gao, Jie; Zheng, Yiteng; Podkolzin, Simon G.] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA; [Jehng, Jih-Mirn; Tang, Yadan; Wachs, Israel E.] Lehigh Univ, Dept Chem Engn, Operando Mol Spect & Catalysis Lab, Bethlehem, PA 18015 USA; [Jehng, Jih-Mirn] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan	Stevens Institute of Technology; Lehigh University; National Chung Hsing University	Wachs, IE (corresponding author), Lehigh Univ, Dept Chem Engn, Operando Mol Spect & Catalysis Lab, Bethlehem, PA 18015 USA.	iew0@lehigh.edu; simon.podkolzin@stevens.edu	Gao, Jie/D-7218-2015; Podkolzin, Simon G./M-3313-2013	Gao, Jie/0000-0003-1941-8936; Podkolzin, Simon G./0000-0002-9536-7176; Jehng, Jih-Mirn/0000-0001-6844-102X; Wachs, Israel/0000-0001-5282-128X	NSF [CBET-1133987, CBET-1134012]; Directorate For Engineering [1133987] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work in S.G.P.'s group at Stevens Institute of Technology was supported by the NSF under grant CBET-1133987. The work in I.E.W.'s group at Lehigh University was supported by the NSF under grant CBET-1134012. The Materials Studio software was used under a collaborative research license from BIOVIA Corp. in San Diego, California. Author contributions: J.G. and Y.Z. obtained the computational and reaction-testing results and discussed the overall results; J.-M.J. and Y.T. obtained the experimental spectroscopic data and discussed the overall results; I.E.W. conceived and supervised the spectroscopic experiments and interpreted the results; and S.G.P. conceived and supervised the calculations and reaction testing, interpreted the results, and prepared the initial manuscript.	Aritani H, 2009, J ENVIRON SCI, V21, P736, DOI 10.1016/S1001-0742(08)62333-5; CHEN LY, 1995, J CATAL, V157, P190, DOI 10.1006/jcat.1995.1279; Choudhary TV, 2003, CATAL REV, V45, P151, DOI 10.1081/CR-120017010; Dedecek J, 2012, CATAL REV, V54, P135, DOI 10.1080/01614940.2012.632662; Gao J, 2014, J PHYS CHEM C, V118, P4670, DOI 10.1021/jp4106053; Guo XG, 2014, SCIENCE, V344, P616, DOI 10.1126/science.1253150; Hoffmann P, 2007, MICROPOR MESOPOR MAT, V106, P122, DOI 10.1016/j.micromeso.2007.02.035; Holmen A, 2009, CATAL TODAY, V142, P2, DOI 10.1016/j.cattod.2009.01.004; International Energy Agency, 2012, GOLD RUL GOLD AG GAS; Ismagilov ZR, 2008, ENERG ENVIRON SCI, V1, P526, DOI 10.1039/b810981h; Khalilpour R, 2012, ENERGY, V40, P317, DOI 10.1016/j.energy.2012.01.068; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Lacheen HS, 2005, J CATAL, V230, P173, DOI 10.1016/j.jcat.2004.11.037; Lee EL, 2007, J PHYS CHEM C, V111, P14410, DOI 10.1021/jp0735482; Lee EL, 2008, J PHYS CHEM C, V112, P20418, DOI 10.1021/jp805265m; Liu ST, 1999, J CATAL, V181, P175, DOI 10.1006/jcat.1998.2310; Lunsford JH, 2000, CATAL TODAY, V63, P165, DOI 10.1016/S0920-5861(00)00456-9; McFarland E, 2012, SCIENCE, V338, P340, DOI 10.1126/science.1226840; Podkolzin SG, 2007, J AM CHEM SOC, V129, P2569, DOI 10.1021/ja066913w; Sklenak S, 2009, PHYS CHEM CHEM PHYS, V11, P1237, DOI 10.1039/b807755j; SOLYMOSI F, 1995, CATAL LETT, V32, P43, DOI 10.1007/BF00806100; Spivey JJ, 2014, CHEM SOC REV, V43, P792, DOI 10.1039/c3cs60259a; Tessonnier JP, 2008, APPL CATAL A-GEN, V336, P79, DOI 10.1016/j.apcata.2007.08.026; Tessonnier JP, 2006, J PHYS CHEM B, V110, P10390, DOI 10.1021/jp0602629; Tian HJ, 2010, J PHYS CHEM C, V114, P14110, DOI 10.1021/jp103269w; WANG LS, 1993, CATAL LETT, V21, P35, DOI 10.1007/BF00767368; Xu YD, 2003, J CATAL, V216, P386, DOI 10.1016/S0021-9517(02)00124-0; Zhang JZ, 1998, CATAL TODAY, V44, P293, DOI 10.1016/S0920-5861(98)00202-8; Zheng H, 2008, J AM CHEM SOC, V130, P3722, DOI 10.1021/ja7110916	29	241	245	27	545	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					686	690		10.1126/science.aaa7048	http://dx.doi.org/10.1126/science.aaa7048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25858978				2022-12-28	WOS:000354045700044
J	Shea, BS; Sharma, A; Mark, EJ				Shea, Barry S.; Sharma, Amita; Mark, Eugene J.			Case 14-2015: A 58-Year-Old Woman with Shortness of Breath	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERSTITIAL LUNG-DISEASE; IDIOPATHIC PLEUROPARENCHYMAL FIBROELASTOSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; CHRONIC EOSINOPHILIC PNEUMONIA; PULMONARY-FIBROSIS; STATINS; SARCOIDOSIS; ENTITY		[Shea, Barry S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shea, Barry S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shea, BS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							ALASALY K, 1995, MEDICINE, V74, P201, DOI 10.1097/00005792-199507000-00004; Azoulay E, 1999, EUR RESPIR J, V14, P971, DOI 10.1034/j.1399-3003.1999.14d41.x; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Becker CD, 2008, MODERN PATHOL, V21, P784, DOI 10.1038/modpathol.2008.56; Boitsios G, 2010, AM J ROENTGENOL, V194, pW354, DOI 10.2214/AJR.10.4345; BUCHANAN DR, 1988, BRIT J DIS CHEST, V82, P186, DOI 10.1016/0007-0971(88)90042-3; Castelino FV, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3097; Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Fernandez AB, 2008, CHEST, V134, P824, DOI 10.1378/chest.08-0943; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Frankel SK, 2004, CHEST, V126, P2007, DOI 10.1378/chest.126.6.2007; Hill C, 1995, AUST NZ J MED, V25, P745, DOI 10.1111/j.1445-5994.1995.tb02870.x; HILLERDAL G, 1983, BRIT J DIS CHEST, V77, P321, DOI 10.1016/S0007-0971(83)80069-2; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Iwasawa T, 2010, JPN J RADIOL, V28, P672, DOI 10.1007/s11604-010-0494-1; JEDERLINIC PJ, 1988, MEDICINE, V67, P154, DOI 10.1097/00005792-198805000-00002; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; KING TE, 1992, CHEST, V102, pS8, DOI 10.1378/chest.102.1_Supplement.8S; Lee HK, 2005, CHEST, V127, P2019, DOI 10.1378/chest.127.6.2019; Marchand E, 1998, MEDICINE, V77, P299, DOI 10.1097/00005792-199809000-00001; Mimori T, 2012, CURR RHEUMATOL REP, V14, P264, DOI 10.1007/s11926-012-0246-6; MULLER NL, 1989, AM J ROENTGENOL, V152, P1179, DOI 10.2214/ajr.152.6.1179; Piciucchi S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-111; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; REICHLIN M, 1984, ARTHRITIS RHEUM, V27, P1150, DOI 10.1002/art.1780271011; Seo P, 2004, AM J MED, V117, P39, DOI 10.1016/j.amjmed.2004.02.030; Shiota S, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P87; Sridhar MK, 1998, LANCET, V352, P114, DOI 10.1016/S0140-6736(98)85019-8; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; von der Thusen JH, 2011, MODERN PATHOL, V24, P1633, DOI 10.1038/modpathol.2011.114; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC; Yousem SA, 2001, AM J SURG PATHOL, V25, P679, DOI 10.1097/00000478-200105000-00018	32	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1749	1758		10.1056/NEJMcpc1415200	http://dx.doi.org/10.1056/NEJMcpc1415200			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923555				2022-12-28	WOS:000353655000011
J	Kroenke, K				Kroenke, Kurt			Telemedicine Screening for Eye Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETIC-RETINOPATHY; DIAGNOSIS; PROGRAM	IMPORTANCE Telemedicine is a useful clinical method to extend health care to patients with limited access. Minimal information exists on the subsequent effect of telemedicine activities on eye care resources. OBJECTIVE To evaluate the effect of a community-based diabetic teleretinal screening program on eye care use and resources. DESIGN, SETTING, AND PARTICIPANTS The current study was a retrospective medical record review of patients who underwent diabetic teleretinal screening in the community-based clinics of the Atlanta Veterans Affairs Medical Center from October 1, 2008, through March 31, 2009, and who were referred for an ophthalmic examination in the eye clinic. EXPOSURES Clinical medical records were reviewed for a 2-year period after patients were referred from teleretinal screening. The following information was collected for analysis: patient demographics, referral and confirmatory diagnoses, ophthalmology clinic visits, diagnostic procedures, surgical procedures, medications, and spectacle prescriptions. MAIN OUTCOMES AND MEASURES The accuracy between referring and final diagnoses and the eye care resources that were used in the care of referred patients. RESULTS The most common referral diagnoses were nonmacular diabetic retinopathy (43.2%), nerve-related disease (30.8%), lens or media opacity (19.1%), age-related macular degeneration (12.9%), and diabetic macular edema (5.6%). The percentage of agreement among these 5 visually significant diagnoses was 90.4%, with a total sensitivity of 73.6%. Diabetic macular edema required the greatest number of ophthalmology clinic visits, diagnostic tests, and surgical procedures. Using Medicare cost data estimates, the mean cost incurred during a 2-year period per patient seen in the eye clinic was approximately $1000. CONCLUSIONS AND RELEVANCE Although a teleretinal screening program can be accurate and sensitive for multiple visually significant diagnoses, measurable resource burdens should be anticipated to adequately prepare for the associated increase in clinical care.	[Kroenke, Kurt] VA HSR & D Ctr Hlth Commun & Informat, Indianapolis, IN USA; [Kroenke, Kurt] Indiana Univ Sch Med, Regenstrief Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, Fifth Floor,1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org		Kroenke, Kurt/0000-0002-0114-4669				Cavallerano JD, 2012, DIABETES CARE, V35, P482, DOI 10.2337/dc11-1317; Chasan JE, 2014, JAMA OPHTHALMOL, V132, P1045, DOI 10.1001/jamaophthalmol.2014.1051; Jackson KM, 2008, ARCH OPHTHALMOL-CHIC, V126, P493, DOI 10.1001/archopht.126.4.493; Jones S, 2010, DIABETIC MED, V27, P249, DOI 10.1111/j.1464-5491.2009.02870.x; Kirkizlar E, 2013, OPHTHALMOLOGY, V120, P2604, DOI 10.1016/j.ophtha.2013.06.029; Williams SL, 2010, BRIT J OPHTHALMOL, V94, P351, DOI 10.1136/bjo.2009.166348; Yen M, 2014, JAMA OPHTHALMOL, V132, P1052, DOI 10.1001/jamaophthalmol.2014.1108	7	8	8	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1666	+		10.1001/jama.2015.107	http://dx.doi.org/10.1001/jama.2015.107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919530	Green Published			2022-12-28	WOS:000353595200017
J	Stewart, LA; Clarke, M; Rovers, M; Riley, RD; Simmonds, M; Stewart, G; Tierney, JF				Stewart, Lesley A.; Clarke, Mike; Rovers, Maroeska; Riley, Richard D.; Simmonds, Mark; Stewart, Gavin; Tierney, Jayne F.		PRISMA-IPD Dev Grp	Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PATIENT DATA; PREDICTION MODELS; RISK; MORTALITY; OUTCOMES; TRIALS	IMPORTANCE Systematic reviews and meta-analyses of individual participant data (IPD) aim to collect, check, and reanalyze individual-level data from all studies addressing a particular research question and are therefore considered a gold standard approach to evidence synthesis. They are likely to be used with increasing frequency as current initiatives to share clinical trial data gain momentum and may be particularly important in reviewing controversial therapeutic areas. OBJECTIVE To develop PRISMA-IPD as a stand-alone extension to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement, tailored to the specific requirements of reporting systematic reviews and meta-analyses of IPD. Although developed primarily for reviews of randomized trials, many items will apply in other contexts, including reviews of diagnosis and prognosis. DESIGN Development of PRISMA-IPD followed the EQUATOR Network framework guidance and used the existing standard PRISMA Statement as a starting point to draft additional relevant material. A web-based survey informed discussion at an international workshop that included researchers, clinicians, methodologists experienced in conducting systematic reviews and meta-analyses of IPD, and journal editors. The statement was drafted and iterative refinements were made by the project, advisory, and development groups. The PRISMA-IPD Development Group reached agreement on the PRISMA-IPD checklist and flow diagram by consensus. FINDINGS Compared with standard PRISMA, the PRISMA-IPD checklist includes 3 new items that address (1) methods of checking the integrity of the IPD (such as pattern of randomization, data consistency, baseline imbalance, and missing data), (2) reporting any important issues that emerge, and (3) exploring variation (such as whether certain types of individual benefit more from the intervention than others). A further additional item was created by reorganization of standard PRISMA items relating to interpreting results. Wording was modified in 23 items to reflect the IPD approach. CONCLUSIONS AND RELEVANCE PRISMA-IPD provides guidelines for reporting systematic reviews and meta-analyses of IPD.	[Stewart, Lesley A.; Simmonds, Mark; Stewart, Gavin] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Clarke, Mike] Queens Univ Belfast, All Ireland Hub Trials Methodol Res, Belfast, Antrim, North Ireland; [Rovers, Maroeska] Radboudumc, Radbound Inst Hlth Sci, Nijmegen, Netherlands; [Riley, Richard D.] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Riley, Richard D.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Stewart, Gavin] Newcastle Univ, Ctr Rural Econ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England; [Tierney, Jayne F.] UCL, MRC Clin Trials Unit, London, England	University of York - UK; Queens University Belfast; Radboud University Nijmegen; Keele University; University of Birmingham; Newcastle University - UK; Medical Research Council Clinical Trials Unit; University of London; University College London	Stewart, LA (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.		Schmid, Christopher H./J-2398-2014; Riley, Richard David/ABE-5877-2020; Rovers, Maroeska/F-2969-2014; Krleza-Jeric, Karmela/M-5253-2018	Schmid, Christopher H./0000-0002-0855-5313; Riley, Richard David/0000-0001-8699-0735; Rovers, Maroeska/0000-0002-3095-170X; Krleza-Jeric, Karmela/0000-0001-9377-0917; Stewart, Lesley/0000-0003-0287-4724; Emberson, Jonathan/0000-0001-7792-9422; Tierney, Jayne/0000-0002-4734-3014; Tudur Smith, Catrin/0000-0003-3051-1445; PIGNON, Jean-Pierre/0000-0003-2047-1582	National Institute for Health Research (NIHR); MRC as part of the MRC-National Institute for Health Research Methodology Research Programme [88053]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MC_UU_12023/24, G0801402] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10259] Funding Source: researchfish; MRC [MC_UU_12023/24, G0801402] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC as part of the MRC-National Institute for Health Research Methodology Research Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The PRISMA-IPD workshop was funded through a National Institute for Health Research (NIHR) Senior Investigator personal award (Dr L. Stewart). Preparatory work was partially supported by the same award and by the MRC as part of the MRC-National Institute for Health Research Methodology Research Programme (grant ID 88053).	Abo-Zaid G, 2013, J CLIN EPIDEMIOL, V66, P865, DOI 10.1016/j.jclinepi.2012.12.017; Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Ahmed Ikhlaaq, 2012, BMJ, V344, pd7762, DOI 10.1136/bmj.d7762; Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3; ALBERTI W, 1995, BRIT MED J, V311, P899; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; Bath PMW, 2009, BRIT J PHARMACOL, V157, P1157, DOI 10.1111/j.1476-5381.2009.00196.x; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Berlin JA, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P35, DOI 10.1002/0470870168.ch3; Burgess S, 2016, STAT METHODS MED RES, V25, P272, DOI 10.1177/0962280212451882; Burgess S, 2013, STAT MED, V32, P4499, DOI 10.1002/sim.5844; CHALMERS I, 1993, ANN NY ACAD SCI, V703, P156, DOI 10.1111/j.1749-6632.1993.tb26345.x; Clarke M, 1998, BRIT J CANCER, V77, P2036, DOI 10.1038/bjc.1998.339; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Krumholz HM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h599; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Phillips RS, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-8; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Schmid CH, 2003, CONTROL CLIN TRIALS, V24, P324, DOI 10.1016/S0197-2456(02)00319-7; Schmidt AF, 2013, PREV VET MED, V112, P414, DOI 10.1016/j.prevetmed.2013.08.011; Selker HP, 1997, ANN INTERN MED, V127, P538, DOI 10.7326/0003-4819-127-7-199710010-00006; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; STEWART LA, 1991, BRIT MED J, V303, P884; Stewart L, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P261; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Vale CL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1088; van der A DL, 2008, CIRC-CARDIOVASC GENE, V1, P43, DOI 10.1161/CIRCGENETICS.108.773176	35	1045	1053	3	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1657	1665		10.1001/jama.2015.3656	http://dx.doi.org/10.1001/jama.2015.3656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919529	Bronze			2022-12-28	WOS:000353595200016
J	Abraham, NS; Singh, S; Alexander, GC; Heien, H; Haas, LR; Crown, W; Shah, ND				Abraham, Neena S.; Singh, Sonal; Alexander, G. Caleb; Heien, Herbert; Haas, Lindsey R.; Crown, William; Shah, Nilay D.			Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; METAANALYSIS; EFFICACY; SAFETY; MANAGEMENT; OLDER	OBJECTIVE To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin. DESIGN Retrospective, propensity matched cohort study. SETTING: Optum Labs Data Warehouse, a large database including administrative claims data on privately insured and Medicare Advantage enrollees. PARTICIPANTS New users of dabigatran, rivaroxaban, and warfarin from 1 November 2010 to 30 September 2013. MAIN OUTCOME MEASURES Incidence rates (events/100 patient years) and propensity score matched Cox proportional hazards models were used to estimate rates of total gastrointestinal bleeds, upper gastrointestinal bleeds, and lower gastrointestinal bleeds for the novel oral anticoagulants compared with warfarin in patients with and without atrial fibrillation. Heterogeneity of treatment effect related to age was examined using a marginal effects model. RESULTS The incidence of gastrointestinal bleeding associated with dabigatran was 2.29 (95% confidence interval 1.88 to 2.79) per 100 patient years and that associated with warfarin was 2.87 (2.41 to 3.41) per 100 patient years in patients with atrial fibrillation. In non-atrial fibrillation patients, the incidence of gastrointestinal bleeding was 4.10 (2.47 to 6.80) per 100 patient years with dabigatran and 3.71 (2.16 to 6.40) per 100 patient years with warfarin. With rivaroxaban, 2.84 (2.30 to 3.52) gastrointestinal bleeding events per 100 patient years occurred in atrial fibrillation patients (warfarin 3.06 (2.49 to 3.77)/100 patient years) and 1.66 (1.23 to 2.24) per 100 patient years in non-atrial fibrillation patients (warfarin 1.57 (1.25 to 1.99)/100 patient years). In propensity score matched models, the risk of gastrointestinal bleeding with novel oral anticoagulants was similar to that with warfarin in atrial fibrillation patients (dabigatran v warfarin, hazard ratio 0.79 (0.61 to 1.03); rivaroxaban v warfarin, 0.93 (0.69 to 1.25)) and in non-AF patients (dabigatran v warfarin, hazard ratio 1.14 (0.54 to 2.39); rivaroxaban v warfarin, 0.89 (0.60 to 1.32)). The risk of gastrointestinal bleeding increased after age 65, such that by age 76 the risk exceeded that with warfarin among atrial fibrillation patients taking dabigatran (hazard ratio 2.49 (1.61 to 3.83)) and patients with and without atrial fibrillation taking rivaroxaban (2.91 (1.65 to 4.81) and 4.58 (2.40 to 8.72), respectively). CONCLUSIONS: The risk of gastrointestinal bleeding related to novel oral anticoagulants was similar to that for warfarin. Caution should be used when prescribing novel oral anticoagulants to older people, particularly those over 75 years of age.	[Abraham, Neena S.] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Scottsdale, AZ 85259 USA; [Abraham, Neena S.; Shah, Nilay D.] Mayo Clin, Dept Hlth Serv Res, Div Hlth Care Policy & Res, Rochester, MN USA; [Abraham, Neena S.; Heien, Herbert; Haas, Lindsey R.; Shah, Nilay D.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Singh, Sonal; Alexander, G. Caleb] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Singh, Sonal; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Singh, Sonal; Alexander, G. Caleb] Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Crown, William] Optum Labs, Cambridge, MA USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Optum	Abraham, NS (corresponding author), Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	abraham.neena@mayo.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X	Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery	Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery	This study was funded by the Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Abraham NS, 2013, CURR OPIN GASTROEN, V29, P676, DOI 10.1097/MOG.0b013e328365d415; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Freedman JE, 2014, CIRCULATION, V130, P129, DOI 10.1161/CIRCULATIONAHA.114.010873; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goodman SG, 2014, J AM COLL CARDIOL, V63, P891, DOI 10.1016/j.jacc.2013.11.013; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Komocsi A, 2012, ARCH INTERN MED, V172, P1537, DOI 10.1001/archinternmed.2012.4026; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	25	250	257	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h1857	10.1136/bmj.h1857	http://dx.doi.org/10.1136/bmj.h1857			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RC	25910928	Green Published, hybrid			2022-12-28	WOS:000353577000003
J	Arie, S				Arie, Sophie			How Europe keeps migrants out of its health system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Europe may not want to rescue migrants crossing the Mediterranean from Africa to enter Europe illegally, but those who reach dry land do receive the healthcare they need. However, asks Sophie Arie, does it last after the cameras have stopped watching?				sarie@bmj.com						UN Refugee Agency, 2015, BURNS VICT REC TREAT; van Ginneken E., 2014, EUROHEALTH OBSERVER, V20, P11	2	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h2216	10.1136/bmj.h2216	http://dx.doi.org/10.1136/bmj.h2216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RC	25911414				2022-12-28	WOS:000353577000008
J	Klink, T; Heverhagen, JT				Klink, Thorsten; Heverhagen, Johannes T.			Mitral Annular Calcification	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klink, Thorsten; Heverhagen, Johannes T.] Univ Hosp Bern, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Klink, T (corresponding author), Univ Hosp Bern, Inselspital, CH-3010 Bern, Switzerland.	klink_t1@ukw.de	Klink, Thorsten/AAJ-3915-2020; Klink, Thorsten/ABB-6125-2021	Heverhagen, Johannes/0000-0002-5416-6650					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17							e23	10.1056/NEJMicm1404772	http://dx.doi.org/10.1056/NEJMicm1404772			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901445	Green Published			2022-12-28	WOS:000353294000012
J	Davidoff, F				Davidoff, Frank			Improvement Interventions RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA	Dartmouth College	Davidoff, F (corresponding author), Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA.							Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Hurley D, 2014, NY TIMES MAGAZINE, P61; Parry GJ, 2013, ACAD PEDIATR, V13, pS23, DOI 10.1016/j.acap.2013.04.007; Solberg LI, 1997, JOINT COMM J QUAL IM, V23, P135, DOI 10.1016/S1070-3241(16)30305-4	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					597	597		10.7326/L15-5071-3	http://dx.doi.org/10.7326/L15-5071-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894034				2022-12-28	WOS:000353244300027
J	Delivanis, DA; Montori, VM				Delivanis, Danae A.; Montori, Victor M.			In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE; SITAGLIPTIN		[Delivanis, Danae A.; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Delivanis, DA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			Montori, Victor/0000-0003-0595-2898				Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Wang KL, 2014, INT J CARDIOL, V177, P86, DOI 10.1016/j.ijcard.2014.09.038; Zannad F, 2014, J AM COLL CARDIOL, V63, pA117, DOI 10.1016/S0735-1097(14)60117-0	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC11	10.7326/ACPJC-2015-162-8-011	http://dx.doi.org/10.7326/ACPJC-2015-162-8-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894044				2022-12-28	WOS:000353244300010
J	Skipper, GE; Pham, JC; Pronovost, PJ				Skipper, Gregory E.; Pham, Julius Cuong; Pronovost, Peter J.			Physician Drug Testing Is Unscientific and Is Unlikely to Achieve Stated Aims RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Skipper, Gregory E.] Promises Treatment Ctr, Santa Monica, CA USA; [Pham, Julius Cuong; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA	Johns Hopkins University	Skipper, GE (corresponding author), Promises Treatment Ctr, Santa Monica, CA USA.							Skipper GE, 2013, PHYS HLTH NEWS   FEB, V18, P4; Stout PR, 2009, J ANAL TOXICOL, V33, P398, DOI 10.1093/jat/33.8.398	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					598	598		10.7326/L15-0078-2	http://dx.doi.org/10.7326/L15-0078-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894036				2022-12-28	WOS:000353244300029
J	Bekerman, E; Einav, S				Bekerman, Elena; Einav, Shirit			Combating emerging viral threats	SCIENCE			English	Editorial Material							DISEASES; ANALOG; HOST		[Bekerman, Elena] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Bekerman, E (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	seinav@stanford.edu			Doris Duke Charitable Foundation [2013100] Funding Source: Medline; NIAID NIH HHS [T32 AI007502, U19 AI109662] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, T32AI007502] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011; Coolidge A., 2014, CINCINNATI ENQUIRER; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107; Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Vela E, 2012, VIRUSES-BASEL, V4, P1802, DOI 10.3390/v4091802; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027	15	119	121	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					282	283		10.1126/science.aaa3778	http://dx.doi.org/10.1126/science.aaa3778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883340	Green Accepted			2022-12-28	WOS:000352999000019
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Mental health team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1856	10.1136/bmj.h1856	http://dx.doi.org/10.1136/bmj.h1856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG5JP	25877875				2022-12-28	WOS:000353328000005
J	Prabhakaran, S; Ruff, I; Bernstein, RA				Prabhakaran, Shyam; Ruff, Ilana; Bernstein, Richard A.			Acute Stroke Intervention A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; TO-NEEDLE TIMES; ENDOVASCULAR THERAPY; MECHANICAL THROMBECTOMY; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; THROMBOLYSIS; REPERFUSION; DOOR	IMPORTANCE Acute ischemic stroke is a major cause of mortality and morbidity in the United States. We review the latest data and evidence supporting catheter-directed treatment for proximal artery occlusion as an adjunct to intravenous thrombolysis in patients with acute stroke. OBJECTIVE To review the pathophysiology of acute brain ischemia and infarction and the evidence supporting various stroke reperfusion treatments. EVIDENCE REVIEW Systematic literature search of MEDLINE databases published between January 1, 1990, and February 11, 2015, was performed to identify studies addressing the role of thrombolysis and mechanical thrombectomy in acute stroke management. Studies included randomized clinical trials, observational studies, guideline statements, and review articles. Sixty-eight articles (N = 108 082 patients) were selected for review. FINDNGS Intravenous thrombolysis is the mainstay of acute ischemic stroke management for any patient with disabling deficits presenting within 4.5 hours from symptom onset. Randomized trials have demonstrated that more patients return to having good function (defined by being independent and having slight disability or less) when treated within 4.5 hours after symptom onset with intravenous recombinant tissue plasminogen activator (IV rtPA) therapy. Mechanical thrombectomy in select patients with acute ischemic stroke and proximal artery occlusions has demonstrated substantial rates of partial or complete arterial recanalization and improved outcomes compared with IV rtPA or best medical treatment alone in multiple randomized clinical trials. Regardless of mode of reperfusion, earlier reperfusion is associated with better clinical outcomes. CONCLUSIONS AND RELEVANCE Intravenous rtPA remains the standard of care for patients with moderate to severe neurological deficits who present within 4.5 hours of symptom onset. Outcomes for some patients with acute ischemic stroke and moderate to severe neurological deficits due to proximal artery occlusion are improved with endovascular reperfusion therapy. Efforts to hasten reperfusion therapy, regardless of the mode, should be undertaken within organized stroke systems of care.	[Prabhakaran, Shyam; Ruff, Ilana; Bernstein, Richard A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Prabhakaran, S (corresponding author), Northwestern Univ, Dept Neurol, 710 N Lake Shore Dr,Ste 1422, Chicago, IL 60611 USA.	shyam.prabhakaran@northwestern.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Prabhakaran reports receiving grant funding from the National Institutes of Health. No other disclosures were reported.	Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Asif KS, 2014, J NEUROINTERV SURG, V6, P505, DOI 10.1136/neurintsurg-2013-010792; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Ciccone A, 2010, J NEUROINTERV SURG, V2, P74, DOI 10.1136/jnis.2009.001388; Ebinger M, 2015, JAMA NEUROL, V72, P25, DOI 10.1001/jamaneurol.2014.3188; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Faiz KW, 2013, EMERG MED J, V30, P669, DOI 10.1136/emermed-2012-201543; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; Gonzalez RG, 2013, STROKE, V44, P3109, DOI 10.1161/STROKEAHA.113.001938; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2014, CIRCULATION, V130, P265, DOI 10.1161/CIRCULATIONAHA.113.007826; Goyal M, 2013, RADIOLOGY, V266, P16, DOI 10.1148/radiol.12112134; Goyal M, 2011, STROKE, V42, P93, DOI 10.1161/STROKEAHA.110.594481; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; JANSEN O, 1995, AM J NEURORADIOL, V16, P1977; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazighi M, 2013, CIRCULATION, V127, P1980, DOI 10.1161/CIRCULATIONAHA.112.000311; Menon BK, 2015, STROKE, V46, P989, DOI 10.1161/STROKEAHA.114.007542; Menon BK, 2014, STROKE, V45, P2024, DOI 10.1161/STROKEAHA.114.005050; Meretoja A, 2013, NEUROLOGY, V81, P1071, DOI 10.1212/WNL.0b013e3182a4a4d2; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Ogawa A, 2007, STROKE, V38, P2633, DOI 10.1161/STROKEAHA.107.488551; Ruff IM, 2014, STROKE, V45, P504, DOI 10.1161/STROKEAHA.113.004073; Sacks D, 2013, CATHETER CARDIO INTE, V82, pE52, DOI 10.1002/ccd.24862; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Saver JL, 2004, ARCH NEUROL-CHICAGO, V61, P1066, DOI 10.1001/archneur.61.7.1066; Saver JL, 2015, INT STROK C FEBR NAS; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; Sun CHJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000859; Sun CHJ, 2013, CIRCULATION, V127, P1139, DOI 10.1161/CIRCULATIONAHA.112.000506; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; WOLPERT SM, 1993, AM J NEURORADIOL, V14, P3; Yoo AJ, 2014, STROKE, V45, P746, DOI 10.1161/STROKEAHA.113.004260; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	65	402	431	12	133	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1451	1462		10.1001/jama.2015.3058	http://dx.doi.org/10.1001/jama.2015.3058			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871671				2022-12-28	WOS:000352821200021
J	Cohen, IG; Savulescu, J; Adashi, EY				Cohen, I. Glenn; Savulescu, Julian; Adashi, Eli Y.			Transatlantic lessons in regulation of mitochondrial replacement therapy	SCIENCE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy, Harvard Law Sch, Biotechnol, Cambridge, MA 02138 USA; [Savulescu, Julian] Univ Oxford, Oxford Uehiro Ctr Pract Eth, Oxford, England; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Harvard University; University of Oxford; Brown University	Cohen, IG (corresponding author), Harvard Univ, Petrie Flom Ctr Hlth Law Policy, Harvard Law Sch, Biotechnol, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu						[Anonymous], 2015, HUMAN FERTILISA 0203; Begley S, 2014, REUTERS; Cohen C.B., 2007, RENEWING STUFF LIFE; Cohen IG, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1105088; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Department of Health and Human Services Food and Drug Administration, 2013, FED REGISTER, V78, P39736; Human Fertilisation and Embryology Authority, 2005, HFEA GRANTS LIC NEWC; Human Fertilisation and Embryology Authority, 2014, NEWC FERT CTR LIF R0; HUMAN FERTILISATION & EMBRYOLOGY AUTH, 2011, SCI REV SAF EFF METH; Human-Fertilisation and Embryology Authority, 2013, MIT REPL CONS ADV GO; Parens E, 2003, HASTINGS CENT REP, V33, pS3; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; The National Academies Current Projects System, 2014, CURR PROJ SYST ETHN; Toynbee P., 2015, GUARDIAN; U. S. Food and Drug Administration Advisory Committees, 2014, 2014 M MAT CELL TISS; U. S. Food and Drug Administration Vaccines Blood and Biologics, 2001, LETT SPONS RES HUM C; Vogel G, 2015, SCIENCE	19	33	33	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					178	180		10.1126/science.aaa8153	http://dx.doi.org/10.1126/science.aaa8153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859028				2022-12-28	WOS:000352613700020
J	Komander, D				Komander, David			Details of destruction, one molecule at a time	SCIENCE			English	Editorial Material							UBIQUITIN CHAIN; ARCHITECTURE; RECOGNITION; DEGRADATION; PROTEASOME; MECHANISM; COMPLEX		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk			MRC [MC_U105192732] Funding Source: UKRI; Medical Research Council [MC_U105192732] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771	15	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					183	184		10.1126/science.aab0931	http://dx.doi.org/10.1126/science.aab0931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859031				2022-12-28	WOS:000352613700023
J	Gouin, E; Torres, JJQ; Cossart, P				Gouin, Edith; Torres, Juan-Jose Quereda; Cossart, Pascale			Intracellular Bacteria Find the Right Motion	CELL			English	Editorial Material							LISTERIA-MONOCYTOGENES; RICKETTSIA-CONORII; SHIGELLA-FLEXNERI; ARP2/3 COMPLEX; F-ACTIN; PROTEIN	Benanti et al. report that Burkholderia pseudomallei and Burkholderia mallei bacteria express proteins that mimic Ena/Vasp family proteins to polymerize actin, thereby inducing actin-based motility. Thus, bacteria can use the various cellular actin polymerization mechanisms for intraand inter-cellular dissemination.	[Gouin, Edith; Torres, Juan-Jose Quereda; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Gouin, Edith; Torres, Juan-Jose Quereda; Cossart, Pascale] Inserm U604, F-75015 Paris, France; [Gouin, Edith; Torres, Juan-Jose Quereda; Cossart, Pascale] INRA USC2020, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr	Quereda, Juan J/A-9949-2018	Quereda, Juan J/0000-0002-1105-9505				Benanti EL, 2015, CELL, V161, P348, DOI 10.1016/j.cell.2015.02.044; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967	9	7	10	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					199	200		10.1016/j.cell.2015.03.035	http://dx.doi.org/10.1016/j.cell.2015.03.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860603	Green Submitted, Bronze			2022-12-28	WOS:000352708300013
J	Lee, DF; Su, J; Kim, HS; Chang, B; Papatsenko, D; Zhao, RY; Yuan, Y; Gingold, J; Xia, WY; Darr, H; Mirzayans, R; Hung, MC; Schaniel, C; Lemischka, IR				Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Zhao, Ruiying; Yuan, Ye; Gingold, Julian; Xia, Weiya; Darr, Henia; Mirzayans, Razmik; Hung, Mien-Chie; Schaniel, Christoph; Lemischka, Ihor R.			Modeling Familial Cancer with Induced Pluripotent Stem Cells	CELL			English	Article							MOUSE MODELS; P53; OSTEOSARCOMA; EXPRESSION; GAIN; H19; DIFFERENTIATION; DERIVATION; MUTATIONS; INDUCTION	In vitro modeling of human disease has recently become feasible with induced pluripotent stem cell (iPSC) technology. Here, we established patient-derived iPSCs from a Li-Fraumeni syndrome (LFS) family and investigated the role of mutant p53 in the development of osteosarcoma (OS). LFS iPSC-derived osteoblasts (OBs) recapitulated OS features including defective osteoblastic differentiation as well as tumorigenic ability. Systematic analyses revealed that the expression of genes enriched in LFS-derived OBs strongly correlated with decreased time to tumor recurrence and poor patient survival. Furthermore, LFS OBs exhibited impaired upregulation of the imprinted gene H19 during osteogenesis. Restoration of H19 expression in LFS OBs facilitated osteoblastic differentiation and repressed tumorigenic potential. By integrating human imprinted gene network (IGN) into functional genomic analyses, we found that H19 mediates suppression of LFS-associated OS through the IGN component DECORIN (DCN). In summary, these findings demonstrate the feasibility of studying inherited human cancer syndromes with iPSCs.	[Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Yuan, Ye; Gingold, Julian; Darr, Henia; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Yuan, Ye; Gingold, Julian; Darr, Henia; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Su, Jie; Kim, Huen Suk; Chang, Betty; Yuan, Ye; Gingold, Julian; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Zhao, Ruiying; Xia, Weiya; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Mirzayans, Razmik] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; UTMD Anderson Cancer Center; Icahn School of Medicine at Mount Sinai; University of Alberta; China Medical University Taiwan; China Medical University Taiwan	Lee, DF (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	dung-fang.lee@mssm.edu; ihor.lemischka@mssm.edu	Schaniel, Christoph/P-3836-2019; Schaniel, Chrisoph/C-9655-2012; Hung, Mien-Chie/ABD-5911-2021; Gingold, Julian/AAD-7321-2020; Papatsenko, Dmitri/G-7375-2016	Schaniel, Christoph/0000-0002-1343-4858; Hung, Mien-Chie/0000-0003-4317-4740; Gingold, Julian/0000-0002-0354-5933; Papatsenko, Dmitri/0000-0002-4390-5446; Su, Jie/0000-0002-3071-7139; Lee, Dung-Fang/0000-0003-2387-597X	NIH [5R01GM078465, K99CA181496]; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) [C024176, C024410]; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Breast Cancer Foundation Inc.; Program for Stem Cell and Regenerative Medicine Frontier Research [Taiwan] [NSC 102-2321-B-039-001]; Canadian Breast Cancer Foundation-Prairies/NWT region; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R00CA181496, K99CA181496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health (NYSTEM); University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Breast Cancer Foundation Inc.; Program for Stem Cell and Regenerative Medicine Frontier Research [Taiwan]; Canadian Breast Cancer Foundation-Prairies/NWT region; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Yang, X. Wei, C.-K. Chou, C. F. Pereira, Y. Liu, and X. Niu, for experimental assistance. We also thank E. Lopez-Rivera and M. Li for CAM assay assistance, the Mount Sinai Genomic Core Facility and Columbia Genome Center for mRNA-seq analysis, as well as Mount Sinai's Flow Cytometry Core for sorting MSCs. We gratefully acknowledge K.A. Moore, and A. Waghray for discussions. This research was funded by grants from the NIH (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM; C024176 and C024410) to I.R.L.; The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund, The National Breast Cancer Foundation Inc., the Program for Stem Cell and Regenerative Medicine Frontier Research (NSC 102-2321-B-039-001 [Taiwan]) to M.-C.H.; the Canadian Breast Cancer Foundation-Prairies/NWT region to R.M.; and NIH Pathway to Independence Award (K99CA181496) to D.-F.L. B.C. is a trainee in NIDCR-Interdisciplinary Training in Systems and Developmental Biology and Birth Defects (T32HD075735).	Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barley RDC, 1998, ONCOGENE, V17, P533, DOI 10.1038/sj.onc.1202271; BRIDGE JA, 1993, CANCER GENET CYTOGEN, V69, P79, DOI 10.1016/0165-4608(93)90080-6; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Eggermann T, 2010, AM J MED GENET C, V154C, P355, DOI 10.1002/ajmg.c.30274; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Joyce JA, 1998, J CLIN PATHOL-MOL PA, V51, P185, DOI 10.1136/mp.51.4.185; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; LI FP, 1969, J NATL CANCER I, V43, P1365; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; LustigYariv O, 1997, ONCOGENE, V15, P169, DOI 10.1038/sj.onc.1201175; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mirzayans R, 2010, J CELL PHYSIOL, V223, P57, DOI 10.1002/jcp.22002; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; PORTER DE, 1992, J BONE JOINT SURG BR, V74, P883; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Varley JM, 2003, HUM MUTAT, V21, P313, DOI 10.1002/humu.10185; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verkerk AJMH, 1997, ONCOGENE, V14, P95, DOI 10.1038/sj.onc.1200802; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yi L, 2012, CANCER RES, V72, P5635, DOI 10.1158/0008-5472.CAN-12-1451; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	127	131	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					240	254		10.1016/j.cell.2015.02.045	http://dx.doi.org/10.1016/j.cell.2015.02.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860607	Green Accepted, Bronze			2022-12-28	WOS:000352708300018
J	Watts, G				Watts, Geoff			Robert Donald Cohen	LANCET			English	Biographical-Item																		COHEN R, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1288	1288		10.1016/S0140-6736(15)60673-0	http://dx.doi.org/10.1016/S0140-6736(15)60673-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25890905				2022-12-28	WOS:000352272400024
J	Cho, MK; Magnus, D; Constantine, M; Lee, SSJ; Kelley, M; Alessi, S; Korngiebel, D; James, C; Kuwana, E; Gallagher, TH; Diekema, D; Capron, AM; Joffe, S; Wilfond, BS				Cho, Mildred K.; Magnus, David; Constantine, Melissa; Lee, Sandra Soo-Jin; Kelley, Maureen; Alessi, Stephanie; Korngiebel, Diane; James, Cyan; Kuwana, Ellen; Gallagher, Thomas H.; Diekema, Douglas; Capron, Alexander M.; Joffe, Steven; Wilfond, Benjamin S.			Attitudes Toward Risk and Informed Consent for Research on Medical Practices A Cross-sectional Survey	ANNALS OF INTERNAL MEDICINE			English	Article							SUPPORT; ETHICS; ACCESS; TRIALS; OHRP	Background: The U.S. Office for Human Research Protections has proposed that end points of randomized trials comparing the effectiveness of standard medical practices are risks of research that would require disclosure and written informed consent, but data are lacking on the views of potential participants. Objective: To assess attitudes of U.S. adults about risks and preferences for notification and consent for research on medical practices. Design: Cross-sectional survey conducted in August 2014. Setting: Web-based questionnaire. Patients: 1095 U.S. adults sampled from an online panel (n = 805) and an online convenience river sample (n = 290). Measurements: Attitudes toward risk, informed consent, and willingness to participate in 3 research scenarios involving medical record review and randomization of usual medical practices. Results: 97% of respondents agreed that health systems should evaluate standard treatments. Most wanted to be asked for per-mission to participate in each of 3 scenarios (range, 75.2% to 80.4%), even if it involved only medical record review, but most would accept nonwritten (oral) permission or general notification if obtaining written permission would make the research too difficult to conduct (range, 70.2% to 82.7%). Most perceived additional risk from each scenario (range, 64.0% to 81.6%). Limitation: Use of hypothetical scenarios and a nonprobability sample that was not fully representative of the U.S. population. Conclusion: Most respondents preferred to be asked for permission to participate in observational and randomized research evaluating usual medical practices, but they are willing to accept less elaborate approaches than written consent if research would otherwise be impracticable. These attitudes are not aligned with proposed regulatory guidance.	Stanford Univ, Stanford, CA 94305 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Univ Oxford, Oxford OX3 7LF, England; Univ Washington, Seattle, WA 98195 USA; Seattle Childrens Res Inst, Seattle, WA 98101 USA; Univ So Calif, Los Angeles, CA 90089 USA; Univ Penn, Philadelphia, PA 19104 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Southern California; University of Pennsylvania	Cho, MK (corresponding author), Stanford Univ, Stanford Ctr Biomed Eth, 1215 Welch Rd, Stanford, CA 94305 USA.	micho@stanford.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384; Kraft, Stephanie/0000-0002-2862-7601; Diekema, Douglas/0000-0002-1703-5176; Kelley, Maureen/0000-0001-8230-5315; Lee, Sandra Soo-Jin/0000-0002-2312-9814	National Center for the Advancement of Translational Sciences at the National Institutes of Health [UL1 TR000423-07S1, UL1 TR001085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085, UL1TR000423] Funding Source: NIH RePORTER	National Center for the Advancement of Translational Sciences at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	By the National Center for the Advancement of Translational Sciences at the National Institutes of Health (grants UL1 TR000423-07S1 [University of Washington and Seattle Children's Research Institute] and UL1 TR001085 [Stanford University]).	[Anonymous], 2014, NEW ENGL J MED, V371, P2125, DOI 10.1056/NEJMe1413296; Baker R., 2010, AAPOR REPORT ONLINE; Baquet CR, 2006, CANCER DETECT PREV, V30, P24, DOI 10.1016/j.cdp.2005.12.001; Buchanan LR, 2013, HUMAN RES PROTECTION; Callegaro M, 2008, PUBLIC OPIN QUART, V72, P1008, DOI 10.1093/poq/nfn065; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Centers for Disease Control and Prevention, NAT HLTH INT SURV 20; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Damschroder LJ, 2007, SOC SCI MED, V64, P223, DOI 10.1016/j.socscimed.2006.08.045; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Hudson KL, 2013, NEW ENGL J MED, V368, P2349, DOI 10.1056/NEJMp1306986; Hull SC, 2008, AM J BIOETHICS, V8, P62, DOI 10.1080/15265160802478404; Kass N, 2012, JAMA-J AM MED ASSOC, V307, P1589, DOI 10.1001/jama.2012.491; Lantos JD, 2014, NEW ENGL J MED, V371, P2129, DOI 10.1056/NEJMhle1413301; Macklin R, 2013, NEW ENGL J MED, V369, pE3, DOI 10.1056/NEJMc1308015; Magnus D, 2015, PEDIATRICS, V135, P208, DOI 10.1542/peds.2014-3578; Magnus D, 2013, NEW ENGL J MED, V368, P1864, DOI 10.1056/NEJMp1305086; Mazor KM, 2009, PHARMACOEPIDEM DR S, V18, P554, DOI 10.1002/pds.1754; NIH Collaboratory, DEM PROJ 2015; Research!America, 2010, RES ENT SURV; Research on Medical Practices Research Team, 2014, APPR ROMP VID; Research on Medical Practices Research Team, 2014, GEN POP PAT SURV; Research on Medical Practices Research Team, 2014, WHICH MED IS BEST VI; Research on Medical Practices Research Team, 2014, INF ASK VID; Trinidad Susan Brown, 2012, AJOB Prim Res, V3, P3; U.S. Department of Health and Human Services, 2014, GUID DISCL IN PRESS; [US Bureau of Labor Statistics US Census Bureau], 2013, CURR POP SURV CPS; Wilfond BS, 2013, NEW ENGL J MED, V368, pE36, DOI 10.1056/NEJMc1307008	30	65	65	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2015	162	10					690	+		10.7326/M15-0166	http://dx.doi.org/10.7326/M15-0166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI8IF	25868119	Green Accepted			2022-12-28	WOS:000355015200018
J	Hillmen, P; Robak, T; Janssens, A; Babu, KG; Kloczko, J; Grosicki, S; Doubek, M; Panagiotidis, P; Kimby, E; Schuh, A; Pettitt, AR; Boyd, T; Montillo, M; Gupta, IV; Wright, O; Dixon, I; Carey, JL; Chang, CN; Lisby, S; McKeown, A; Offner, F				Hillmen, Peter; Robak, Tadeusz; Janssens, Ann; Babu, K. Govind; Kloczko, Janusz; Grosicki, Sebastian; Doubek, Michael; Panagiotidis, Panagiotis; Kimby, Eva; Schuh, Anna; Pettitt, Andrew R.; Boyd, Thomas; Montillo, Marco; Gupta, Ira V.; Wright, Oliver; Dixon, Iestyn; Carey, Jodi L.; Chang, Chai-Ni; Lisby, Steen; McKeown, Astrid; Offner, Fritz		COMPLEMENT 1 Study Investigators	Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial	LANCET			English	Article							MONOCLONAL-ANTIBODIES; 1ST-LINE TREATMENT; ELDERLY-PATIENTS; HUMAN CD20; RITUXIMAB; FLUDARABINE; CYCLOPHOSPHAMIDE; BENDAMUSTINE; CLL; CHEMOIMMUNOTHERAPY	Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based chemoimmunotherapies are mostly not suitable. Chlorambucil remains the standard of care in many countries. We aimed to investigate whether the addition of ofatumumab to chlorambucil could lead to better clinical outcomes than does treatment with chlorambucil alone, while also being tolerable for patients who have few treatment options. Methods We carried out a randomised, open-label, phase 3 trial for treatment-naive patients with chronic lymphocytic leukaemia in 109 centres in 16 countries. We included patients who had active disease needing treatment, but in whom fludarabine-based treatment was not possible. We randomly assigned patients (1: 1) to receive oral chlorambucil (10 mg/m(2)) on days 1-7 of a 28 day treatment course or to receive chlorambucil by this schedule plus intravenous ofatumumab (cycle 1: 300 mg on day 1 and 1000 mg on day 8; subsequent cycles: 1000 mg on day 1) for three to 12 cycles. Assignment was done with a randomisation list that was computer generated at GlaxoSmithKline, and was stratified, in a block size of two, by age, disease stage, and performance status. The primary endpoint was progression-free survival in the intention-to-treat population and assessment was done by an independent review committee that was masked to group assignment. The study is registered with ClinicalTrials.gov, number NCT00748189. Findings We enrolled 447 patients, median age 69 years (range 35-92). Between Dec 22, 2008, and May 26, 2011, we randomly assigned 221 patients to chlorambucil plus ofatumumab and 226 patients to chlorambucil alone. Median progression-free survival was 22.4 months (95% CI 19.0-25.2) in the group assigned to chlorambucil plus ofatumumab compared with 13.1 months (10.6-13.8) in the group assigned to chlorambucil only (hazard ratio 0.57, 95% CI 0.45-0.72; p<0.0001). Grade 3 or greater adverse events were more common in the chlorambucil plus ofatumumab group (109 [50%] patients; vs 98 [43%] given chlorambucil alone), with neutropenia being the most common event (56 [26%] vs 32 [14%]). Grade 3 or greater infections had similar frequency in both groups. Grade 3 or greater infusion-related adverse events were reported in 22 (10%) patients given chlorambucil plus ofatumumab. Five (2%) patients died during treatment in each group. Interpretation Addition of ofatumumab to chlorambucil led to clinically important improvements with a manageable side-effect profile in treatment-naive patients with chronic lymphocytic leukaemia who were elderly or had comorbidities. Chlorambucil plus ofatumumab is therefore an important treatment option for these patients who cannot tolerate more intensive therapy.	[Hillmen, Peter] St James Univ Hosp, Dept Haematol, Leeds LS9 7TF, W Yorkshire, England; [Robak, Tadeusz] Med Univ Lodz, Dept Haematol, Lodz, Poland; [Janssens, Ann] Univ Ziekenhuizen Leuven, Leuven, Belgium; [Babu, K. Govind] Kidwai Mem Inst Oncol, Bangalore, Karnataka, India; [Kloczko, Janusz] Med Univ Bialystok, Bialystok, Poland; [Grosicki, Sebastian] Med Univ Silesia, Katowice, Poland; [Doubek, Michael] Univ Hosp Brno, Dept Haematol & Oncol, Brno, Czech Republic; [Panagiotidis, Panagiotis] Univ Athens, Laikon Gen Hosp, Athens, Greece; [Kimby, Eva] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Schuh, Anna] Churchill Hosp, Oxford OX3 7LJ, England; [Pettitt, Andrew R.] Univ Liverpool, Royal Liverpool & Broadgreen Hosp NHS Trust, Liverpool L69 3BX, Merseyside, England; [Boyd, Thomas] Yakima Valley Mem Hosp, Yakima, WA USA; [Montillo, Marco] Osped Niguarda Ca Granda, Dept Haematol, Milan, Italy; [Wright, Oliver; Dixon, Iestyn; McKeown, Astrid] GlaxoSmithKline, Uxbridge, Middx, England; [Gupta, Ira V.; Carey, Jodi L.] GlaxoSmithKline, Collegeville, PA USA; [Chang, Chai-Ni] GlaxoSmithKline, Res Triangle Pk, NC USA; [Lisby, Steen] Genmab, Copenhagen, Denmark; [Offner, Fritz] Univ Ziekenhuis Gent, Ghent, Belgium	Saint James's University Hospital; Medical University Lodz; KU Leuven; University Hospital Leuven; Kidwai Memorial Institute of Oncology; Medical University of Bialystok; Medical University Silesia; University Hospital Brno; Laiko General Hospital; National & Kapodistrian University of Athens; Karolinska Institutet; Karolinska University Hospital; University of Oxford; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Genmab; Ghent University; Ghent University Hospital	Hillmen, P (corresponding author), St James Univ Hosp, Dept Haematol, Leeds LS9 7TF, W Yorkshire, England.	peter.hillmen@nhs.net	Grosicki, Sebastian/AAG-2917-2019; Robak, Tadeusz/AAW-7365-2021; Doubek, Michael/J-7011-2018	Robak, Tadeusz/0000-0002-3411-6357; Grosicki, Sebastian/0000-0003-2644-1050; Kimby, Eva/0000-0003-3078-6131; Anna, schuh/0000-0002-3938-8490	GlaxoSmithKline; Genmab A/S	GlaxoSmithKline(GlaxoSmithKline); Genmab A/S(Genmab)	GlaxoSmithKline, Genmab A/S.; GlaxoSmithKline and Genmab A/S cofounded this trial. We thank patients and their families, physicians, and site staff for their participation; Geoffrey Chan of GlaxoSmithKline for valuable insight during the set-up of the trial; and Andrew Rawstron for guidance on flow cytometry. Medicus International New York (NY, USA) provided editorial assistance in the preparation of the manuscript, funded by GlaxoSmithKline. Results were presented in part at the Annual Meeting of the American Society of Hematology; New Orleans, LA, USA; Dec 8-11, 2013.	Beum PV, 2008, J IMMUNOL, V181, P822, DOI 10.4049/jimmunol.181.1.822; Blum KA, 2007, J CLIN ONCOL, V25, P5624, DOI 10.1200/JCO.2007.12.1152; Bottcher S, 2012, J CLIN ONCOL, V30, P980, DOI 10.1200/JCO.2011.36.9348; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Craigen JL, 2009, BLOOD, V114, P687, DOI 10.1182/blood.V114.22.1725.1725; Del Giudice I, 2011, LEUKEMIA LYMPHOMA, V52, P2207, DOI 10.3109/10428194.2011.606386; Eichhorst B, 2009, LEUKEMIA LYMPHOMA, V50, P171, DOI 10.1080/10428190802688517; Eichhorst BF, 2009, BLOOD, V114, P3382, DOI 10.1182/blood-2009-02-206185; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Fischer K, 2012, J CLIN ONCOL, V30, P3209, DOI 10.1200/JCO.2011.39.2688; Foa R, 2014, AM J HEMATOL, V89, P480, DOI 10.1002/ajh.23668; Foon KA, 2012, BLOOD, V119, P3184, DOI 10.1182/blood-2012-01-408047; Forconi F, 2008, HEMATOL ONCOL, V26, P247, DOI 10.1002/hon.868; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Hillmen P, 2014, J CLIN ONCOL, V32, P1236, DOI 10.1200/JCO.2013.49.6547; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Knauf WU, 2012, BRIT J HAEMATOL, V159, P67, DOI 10.1111/bjh.12000; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Offner F, 2013, 15 INT WORKSH CHRON; Okroj M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0759-5; Rafiq S, 2013, J IMMUNOL, V190, P2702, DOI 10.4049/jimmunol.1202588; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Rawstron AC, 2007, LEUKEMIA, V21, P956, DOI 10.1038/sj.leu.2404584; Rawstron AC, 2013, LEUKEMIA, V27, P142, DOI 10.1038/leu.2012.216; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; Wierda WG, 2011, BLOOD, V118, P5126, DOI 10.1182/blood-2011-04-348656; Wierda WG, 2010, J CLIN ONCOL, V28, P1749, DOI 10.1200/JCO.2009.25.3187; Woyach JA, 2013, J CLIN ONCOL, V31, P440, DOI 10.1200/JCO.2011.41.5646	36	267	273	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1873	1883		10.1016/S0140-6736(15)60027-7	http://dx.doi.org/10.1016/S0140-6736(15)60027-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25882396				2022-12-28	WOS:000354184500031
J	Mercuri, E; Muntoni, F				Mercuri, Eugenio; Muntoni, Francesco			Efficacy of idebenone in Duchenne muscular dystrophy	LANCET			English	Editorial Material							NONSENSE MUTATION; ATALUREN		[Mercuri, Eugenio] Catholic Univ, Policlin Gemelli, Pediat Neurol Unit, I-00168 Rome, Italy; [Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Muntoni, Francesco] UCL Inst Child Hlth, MRC Ctr Neuromuscular Dis, London, England; [Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 3JH, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Mercuri, E (corresponding author), Catholic Univ, Policlin Gemelli, Pediat Neurol Unit, I-00168 Rome, Italy.	mercuri@rm.unicatt.it	Mercuri, Eugenio/G-1351-2015	Mercuri, Eugenio/0000-0002-9851-5365				Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Buyse GM, 2015, LANCET; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Hahn A, 1997, ARCH PHYS MED REHAB, V78, P1, DOI 10.1016/S0003-9993(97)90001-0; Henricson E, 2013, PLOS CURR, V5, DOI [10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06, DOI 10.1371/CURRENTS.MD.9E17658B007EB79FCD6F723089F79E06]; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Lynn S, 2015, NEUROMUSCULAR DISORD, V25, P96, DOI 10.1016/j.nmd.2014.09.003; Mercuri E, 2013, CURR OPIN PEDIATR, V25, P701, DOI 10.1097/MOP.0b013e328365ace5; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022	13	4	5	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1704	1706		10.1016/S0140-6736(15)60758-9	http://dx.doi.org/10.1016/S0140-6736(15)60758-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH0PZ	25907159				2022-12-28	WOS:000353726000007
J	Tian, P				Tian, Peng			RESEARCH IMPACT A tale of two systems	NATURE			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S28	S30		10.1038/520S28a	http://dx.doi.org/10.1038/520S28a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0DQ	25924197	Bronze			2022-12-28	WOS:000353689700007
J	Wan, Z				Wan, Zheng			China's scientific progress hinges on access to data	NATURE			English	Editorial Material									Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China	Shanghai Maritime University	Wan, Z (corresponding author), Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China.	mrwan@ucdavis.edu							0	6	6	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					587	587		10.1038/520587a	http://dx.doi.org/10.1038/520587a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0DQ	25925438	Bronze			2022-12-28	WOS:000353689700014
J	Stevens, F; Weerkamp, NJ; Cals, JWL				Stevens, Femke; Weerkamp, Nico J.; Cals, Jochen W. L.			10-MINUTE CONSULTATION Foot drop	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stevens, Femke; Cals, Jochen W. L.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands; [Weerkamp, Nico J.] Bronovo Hosp, The Hague, Netherlands	Maastricht University; Haaglanden Medical Center; Bronovo Hospital	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands.	j.cals@maastrichtuniversity.nl	Cals, Jochen WL/A-1262-2007	Cals, Jochen WL/0000-0001-9550-5674				Jeon CH, 2013, SPINE, V38, P257, DOI 10.1097/BRS.0b013e318268c8bc; Marciniak C, 2013, PHYS MED REH CLIN N, V24, P121, DOI 10.1016/j.pmr.2012.08.016; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393	3	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h1736	10.1136/bmj.h1736	http://dx.doi.org/10.1136/bmj.h1736			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918354				2022-12-28	WOS:000353954800001
J	Goldman, DH; Kaiser, CM; Milin, A; Righini, M; Tinoco, I; Bustamante, C				Goldman, Daniel H.; Kaiser, Christian M.; Milin, Anthony; Righini, Maurizio; Tinoco, Ignacio, Jr.; Bustamante, Carlos			Mechanical force releases nascent chain-mediated ribosome arrest in vitro and in vivo	SCIENCE			English	Article							EXIT TUNNEL; EF-P; TRANSLATION; TRANSLOCATION; PEPTIDES	Protein synthesis rates can affect gene expression and the folding and activity of the translation product. Interactions between the nascent polypeptide and the ribosome exit tunnel represent one mode of regulating synthesis rates. The SecM protein arrests its own translation, and release of arrest at the translocon has been proposed to occur by mechanical force. Using optical tweezers, we demonstrate that arrest of SecM-stalled ribosomes can indeed be rescued by force alone and that the force needed to release stalling can be generated in vivo by a nascent chain folding near the ribosome tunnel exit. We formulate a kinetic model describing how a protein can regulate its own synthesis by the force generated during folding, tuning ribosome activity to structure acquisition by a nascent polypeptide.	[Goldman, Daniel H.; Milin, Anthony; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Righini, Maurizio; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Milin, Anthony] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Kavli Energy Nanosci Inst Berkeley, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	kaiser@jhu.edu; carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Milin, Anthony/0000-0002-1923-7441; Righini, Maurizio/0000-0002-8454-8887	NSF's Graduate Research Fellowship; NIH [5K99GM086516, 5R01GM32543, GM10840]; QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); Damon Runyon Cancer Research Foundation [DRG-2096-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840, R01GM032543, R37GM010840, K99GM086516] Funding Source: NIH RePORTER	NSF's Graduate Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Chistol and L. Alexander for guidance regarding data analysis and the kinetic model, and members of the Bustamante and Tinoco laboratories for helpful discussions on the manuscript. D.H.G acknowledges the NSF's Graduate Research Fellowship; C.M.K acknowledges support from the NIH K99 Award 5K99GM086516 and the QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); M.R. acknowledges support from the Damon Runyon Cancer Research Foundation (DRG-2096-11). C.B. acknowledges support from NIH grant 5R01GM32543; I.T. acknowledges support from NIH grant GM10840.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Deutsch, 2014, REGULATORY NASCENT P, P61; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakamori K, 2014, FEBS LETT, V588, P3098, DOI 10.1016/j.febslet.2014.06.038; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nathans P., 1964, NATL ACAD SCI US, V51, P585; Nissley DA, 2014, J AM CHEM SOC, V136, P17892, DOI 10.1021/ja510082j; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Tsai A, 2014, CELL REP, V7, P1521, DOI 10.1016/j.celrep.2014.04.033; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yap MN, 2011, MOL MICROBIOL, V81, P540, DOI 10.1111/j.1365-2958.2011.07713.x	27	139	139	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					457	460		10.1126/science.1261909	http://dx.doi.org/10.1126/science.1261909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908824	Green Accepted			2022-12-28	WOS:000353338000040
J	Radford, J; Illidge, T; Counsell, N; Hancock, B; Pettengell, R; Johnson, P; Wimperis, J; Culligan, D; Popova, B; Smith, P; McMillan, A; Brownell, A; Kruger, A; Lister, A; Hoskin, P; O'Doherty, M; Barrington, S				Radford, John; Illidge, Tim; Counsell, Nicholas; Hancock, Barry; Pettengell, Ruth; Johnson, Peter; Wimperis, Jennie; Culligan, Dominic; Popova, Bilyana; Smith, Paul; McMillan, Andrew; Brownell, Alison; Kruger, Anton; Lister, Andrew; Hoskin, Peter; O'Doherty, Michael; Barrington, Sally			Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; COMBINATION CHEMOTHERAPY; EUROPEAN ORGANIZATION; MALIGNANT LYMPHOMAS; DOSIMETRIC ASPECTS; CLINICAL-TRIALS; FINAL ANALYSIS; EARLY RELAPSE; DISEASE	BACKGROUND It is unclear whether patients with early-stage Hodgkin's lymphoma and negative findings on positron-emission tomography (PET) after three cycles of chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) require radiotherapy. METHODS Patients with newly diagnosed stage IA or stage IIA Hodgkin's lymphoma received three cycles of ABVD and then underwent PET scanning. Patients with negative PET findings were randomly assigned to receive involved-field radiotherapy or no further treatment; patients with positive PET findings received a fourth cycle of ABVD and radiotherapy. This trial assessing the noninferiority of no further treatment was designed to exclude a difference in the 3-year progression-free survival rate of 7 or more percentage points from the assumed 95% progression-free survival rate in the radiotherapy group. RESULTS A total of 602 patients (53.3% male; median age, 34 years) were recruited, and 571 patients underwent PET scanning. The PET findings were negative in 426 of these patients (74.6%), 420 of whom were randomly assigned to a study group (209 to the radiotherapy group and 211 to no further therapy). At a median of 60 months of follow-up, there had been 8 instances of disease progression in the radiotherapy group, and 8 patients had died (3 with disease progression, 1 of whom died from Hodgkin's lymphoma); there had been 20 instances of disease progression in the group with no further therapy, and 4 patients had died (2 with disease progression and none from Hodgkin's lymphoma). In the radiotherapy group, 5 of the deaths occurred in patients who received no radiotherapy. The 3-year progression-free survival rate was 94.6% (95% confidence interval [CI], 91.5 to 97.7) in the radiotherapy group and 90.8% (95% CI, 86.9 to 94.8) in the group that received no further therapy, with an absolute risk difference of -3.8 percentage points (95% CI, -8.8 to 1.3). CONCLUSIONS The results of this study did not show the noninferiority of the strategy of no further treatment after chemotherapy with regard to progression-free survival. Nevertheless, patients in this study with early-stage Hodgkin's lymphoma and negative PET findings after three cycles of ABVD had a very good prognosis either with or without consolidation radiotherapy.	[Radford, John; Illidge, Tim] Univ Manchester, Inst Canc Sci, Manchester M20 4BX, Lancs, England; [Radford, John; Illidge, Tim] Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M20 4BX, Lancs, England; [Counsell, Nicholas; Popova, Bilyana; Smith, Paul] Canc Res UK, London, England; [Counsell, Nicholas; Popova, Bilyana; Smith, Paul] UCL, Canc Trials Ctr, Inst Canc, London, England; [Pettengell, Ruth] Univ London, St Georges Hosp, London, England; [Lister, Andrew] St Bartholomews Hosp, London, England; [O'Doherty, Michael; Barrington, Sally] Kings Coll London, St Thomas Hosp, Kings Hlth Partners, PET Imaging Ctr,Div Imaging Sci & Biomed Engn, London, England; [Hancock, Barry] Univ Sheffield, Sheffield, S Yorkshire, England; [Hancock, Barry] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Johnson, Peter] Canc Res UK Ctr, Southampton, Hants, England; [Wimperis, Jennie] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Culligan, Dominic] Aberdeen Royal Infirm, Aberdeen, Scotland; [McMillan, Andrew] City Hosp Nottingham, Nottingham, England; [Brownell, Alison] Queens Hosp, Romford, Essex, England; [Kruger, Anton] Royal Cornwall Hosp NHS Trust, Truro, England; [Hoskin, Peter] Mt Vernon Hosp, Ctr Canc, Northwood HA6 2RN, Middx, England	University of Manchester; Christie NHS Foundation Trust; University of Manchester; Cancer Research UK; University of London; University College London; St Georges University London; University of London; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Sheffield; Weston Park Hospital; Cancer Research UK; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of Aberdeen; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Royal Cornwall Hospital	Radford, J (corresponding author), Univ Manchester, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	john.radford@manchester.ac.uk	Johnson, Peter/L-2403-2018; , andrew.mcmillan@nhs.net/N-1627-2019; ILLIDGE, Tim M/M-3659-2015; Johnson, Peter/O-3529-2019; Radford, John A/N-1331-2015	Johnson, Peter/0000-0003-2306-4974; ILLIDGE, Tim M/0000-0003-3191-7324; Johnson, Peter/0000-0003-2306-4974; Radford, John A/0000-0001-7898-2786; Hoskin, Peter/0000-0001-8323-9567; Barrington, Sally/0000-0002-2516-5288; Counsell, Nicholas/0000-0002-0688-9192	Leukaemia and Lymphoma Research; Cancer Research UK [9619, 15953, 16463] Funding Source: researchfish	Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK)	Funded by Leukaemia and Lymphoma Research and others; RAPID ClinicalTrials.gov number, NCT00943423.	ANDERSON H, 1984, BRIT J CANCER, V49, P695, DOI 10.1038/bjc.1984.110; Barrington SF, 2011, ANN ONCOL, V22, P739, DOI 10.1093/annonc/mdq428; Barrington SF, 2010, EUR J NUCL MED MOL I, V37, P1824, DOI 10.1007/s00259-010-1490-5; BOIVIN JF, 1995, JNCI-J NATL CANCER I, V87, P732, DOI 10.1093/jnci/87.10.732; BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Deniz K, 2003, LANCET ONCOL, V4, P207, DOI 10.1016/S1470-2045(03)01033-7; Eich HT, 2010, J CLIN ONCOL, V28, P4199, DOI 10.1200/JCO.2010.29.8018; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Engert A, 2009, J CLIN ONCOL, V27, P4548, DOI 10.1200/JCO.2008.19.8820; Ferme C, 2007, NEW ENGL J MED, V357, P1916, DOI 10.1056/NEJMoa064601; Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; Hoskin PJ, 2009, J CLIN ONCOL, V27, P5390, DOI 10.1200/JCO.2009.23.3239; Hutchings M, 2005, ANN ONCOL, V16, P1160, DOI 10.1093/annonc/mdi200; Hutchings M, 2006, BLOOD, V107, P52, DOI 10.1182/blood-2005-06-2252; Kobe C, 2008, BLOOD, V112, P3989, DOI 10.1182/blood-2008-06-155820; Kostakoglu L, 2002, J NUCL MED, V43, P1018; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; PAGE V, 1970, RADIOLOGY, V96, P619; PAGE V, 1970, RADIOLOGY, V96, P609, DOI 10.1148/96.3.609; Radford J, 2012, J CLIN ONCOL, V30, P3783, DOI 10.1200/JCO.2012.43.2773; Raemaekers JMM, 2014, J CLIN ONCOL, V32, P1188, DOI 10.1200/JCO.2013.51.9298; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; van der Kaaij MAE, 2012, J CLIN ONCOL, V30, P291, DOI 10.1200/JCO.2011.37.1989; von Tresckow B, 2012, J CLIN ONCOL, V30, P907, DOI 10.1200/JCO.2011.38.5807; WHITEHEAD E, 1982, CANCER, V49, P418, DOI 10.1002/1097-0142(19820201)49:3<418::AID-CNCR2820490304>3.0.CO;2-A	31	435	444	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1598	1607		10.1056/NEJMoa1408648	http://dx.doi.org/10.1056/NEJMoa1408648			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901426	Green Published, Bronze			2022-12-28	WOS:000353294000005
J	Thursz, MR; Richardson, P; Allison, M; Austin, A; Bowers, M; Day, CP; Downs, N; Gleeson, D; MacGilchrist, A; Grant, A; Hood, S; Masson, S; McCune, A; Mellor, J; O'Grady, J; Patch, D; Ratcliffe, I; Roderick, P; Stanton, L; Vergis, N; Wright, M; Ryder, S; Forrest, EH				Thursz, Mark R.; Richardson, Paul; Allison, Michael; Austin, Andrew; Bowers, Megan; Day, Christopher P.; Downs, Nichola; Gleeson, Dermot; MacGilchrist, Alastair; Grant, Allister; Hood, Steven; Masson, Steven; McCune, Anne; Mellor, Jane; O'Grady, John; Patch, David; Ratcliffe, Ian; Roderick, Paul; Stanton, Louise; Vergis, Nikhil; Wright, Mark; Ryder, Stephen; Forrest, Ewan H.		STOPAH Trial	Prednisolone or Pentoxifylline for Alcoholic Hepatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHORT-TERM SURVIVAL; STEROIDS; THERAPY; TRIAL	BACKGROUND Alcoholic hepatitis is a clinical syndrome characterized by jaundice and liver impairment that occurs in patients with a history of heavy and prolonged alcohol use. The short-term mortality among patients with severe disease exceeds 30%. Prednisolone and pentoxifylline are both recommended for the treatment of severe alcoholic hepatitis, but uncertainty about their benefit persists. METHODS We conducted a multicenter, double-blind, randomized trial with a 2-by-2 factorial design to evaluate the effect of treatment with prednisolone or pentoxifylline. The primary end point was mortality at 28 days. Secondary end points included death or liver transplantation at 90 days and at 1 year. Patients with a clinical diagnosis of alcoholic hepatitis and severe disease were randomly assigned to one of four groups: a group that received a pentoxifylline-matched placebo and a prednisolone-matched placebo, a group that received prednisolone and a pentoxifylline-matched placebo, a group that received pentoxifylline and a prednisolone-matched placebo, or a group that received both prednisolone and pentoxifylline. RESULTS A total of 1103 patients underwent randomization, and data from 1053 were available for the primary end-point analysis. Mortality at 28 days was 17% (45 of 269 patients) in the placebo-placebo group, 14% (38 of 266 patients) in the prednisolone-placebo group, 19% (50 of 258 patients) in the pentoxifylline-placebo group, and 13% (35 of 260 patients) in the prednisolone-pentoxifylline group. The odds ratio for 28-day mortality with pentoxifylline was 1.07 (95% confidence interval [CI], 0.77 to 1.49; P = 0.69), and that with prednisolone was 0.72 (95% CI, 0.52 to 1.01; P = 0.06). At 90 days and at 1 year, there were no significant between-group differences. Serious infections occurred in 13% of the patients treated with prednisolone versus 7% of those who did not receive prednisolone (P = 0.002). CONCLUSIONS Pentoxifylline did not improve survival in patients with alcoholic hepatitis. Prednisolone was associated with a reduction in 28-day mortality that did not reach significance and with no improvement in outcomes at 90 days or 1 year.	[Thursz, Mark R.; Vergis, Nikhil] Univ London Imperial Coll Sci Technol & Med, London W2 1NY, England; [O'Grady, John] Kings Coll Hosp London, London, England; [Patch, David] Royal Free Hosp, London NW3 2QG, England; [Richardson, Paul] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Hood, Steven] Aintree Hosp, Liverpool, Merseyside, England; [Allison, Michael] Addenbrookes Hosp, Cambridge, England; Derby Royal Hosp, Derby, England; [Bowers, Megan; Downs, Nichola; Mellor, Jane; Ratcliffe, Ian; Roderick, Paul; Stanton, Louise] Univ Southampton, Southampton Clin Trials Unit, Southampton, Hants, England; [Wright, Mark] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Day, Christopher P.] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Masson, Steven] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Gleeson, Dermot] Sheffield Teaching Hosp Fdn Trust, Sheffield, S Yorkshire, England; [MacGilchrist, Alastair] Royal Edinburgh Infirm, Edinburgh, Midlothian, Scotland; [Grant, Allister] Leicester Royal Infirm, Leicester, Leics, England; [McCune, Anne] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England; [Ryder, Stephen] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Ryder, Stephen] Queens Med Ctr, Natl Inst Hlth Res Biomed Res Unit, Nottingham NG7 2UH, England; [Forrest, Ewan H.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland	Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Aintree University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Royal Infirmary of Edinburgh; University of Leicester; Bristol Royal Infirmary; Nottingham University Hospital NHS Trust; University of Nottingham; University of Glasgow	Thursz, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hepatol Sect, Norfolk Pl, London W2 1NY, England.	m.thursz@imperial.ac.uk	Day, Christopher/Z-3305-2019; Newsome, Philip/D-4495-2018	ALA, AFTAB/0000-0001-6257-3160; Stanton, Louise/0000-0001-8181-840X; Ryder, Stephen David/0000-0001-9649-4444; Newsome, Philip/0000-0001-6085-3652; Aspinall, Richard/0000-0002-5208-8185; Allison, Michael/0000-0003-3677-3294; Masson, Steven/0000-0003-1041-9844; Ch'ng, Chin Lye/0000-0003-3179-9313; Thursz, Mark/0000-0002-8218-192X; Forton, Daniel/0000-0002-0903-9169; Forrest, Ewan/0000-0002-7293-2574	National Institute for Health Research Health Technology Assessment program; STOPAH EudraCT [2009-013897-42]; Cancer Research UK [15956] Funding Source: researchfish; National Institute for Health Research [08/14/44] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment program; STOPAH EudraCT; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research Health Technology Assessment program; STOPAH EudraCT number, 2009-013897-42, and Current Controlled Trials number, ISRCTN88782125.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; De BK, 2009, WORLD J GASTROENTERO, V15, P1613, DOI 10.3748/wjg.15.1613; Forrest E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-262; Forrest EH, 2012, J HEPATOL, V56, P1427, DOI 10.1016/j.jhep.2011.12.028; Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 1996, GASTROENTEROLOGY, V110, P1847, DOI 10.1053/gast.1996.v110.pm8964410; Mathurin P, 2013, JAMA-J AM MED ASSOC, V310, P1033, DOI 10.1001/jama.2013.276300; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; MENDENHALL CL, 1984, NEW ENGL J MED, V311, P1464, DOI 10.1056/NEJM198412063112302; Nguyen-Khac E, 2011, NEW ENGL J MED, V365, P1781, DOI 10.1056/NEJMoa1101214; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Park SH, 2014, J HEPATOL, V61, P792, DOI 10.1016/j.jhep.2014.05.014; Parker R, 2013, Aliment Pharmacol Ther, V37, P845, DOI 10.1111/apt.12279; Potts JR, 2013, ALIMENT PHARM THER, V38, P584, DOI 10.1111/apt.12427; Rambaldi A, 2008, ALIMENT PHARM THER, V27, P1167, DOI 10.1111/j.1365-2036.2008.03685.x; RAMOND MJ, 1992, NEW ENGL J MED, V326, P507, DOI 10.1056/NEJM199202203260802; Sidhu SS, 2012, DIGEST DIS SCI, V57, P1664, DOI 10.1007/s10620-012-2097-4; Singal Ashwani K, 2013, World J Gastrointest Pharmacol Ther, V4, P16, DOI 10.4292/wjgpt.v4.i2.16; Whitfield K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007339.pub2	22	398	410	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1619	1628		10.1056/NEJMoa1412278	http://dx.doi.org/10.1056/NEJMoa1412278			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901427	Bronze			2022-12-28	WOS:000353294000007
J	Crowley, RA				Crowley, Ryan A.		Amer Coll Phys	Electronic Nicotine Delivery Systems: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							E-CIGARETTES; YOUTH	Electronic nicotine delivery systems (ENDS), which include electronic cigarettes, or e-cigarettes, are growing in popularity, but their safety and efficacy as a smoking cessation aid are not well understood. Some argue that they have the potential to reduce tobacco-related morbidity and mortality and could be a useful tool for reducing tobacco-related harm. Others express concern that the health effects of ENDS use are unknown, that they may appeal to young people, and that they may encourage dual use of ENDS and traditional tobacco products. Although ENDS are a new and unregulated product, the U.S. Food and Drug Administration has proposed regulations that would deem ENDS to be subject to the Family Smoking Prevention and Tobacco Control Act, which regulates cigarettes and other tobacco products. In this position paper, the American College of Physicians offers policy recommendations on ENDS regulation and oversight, taxation, flavorings, promotion and marketing, indoor and public use, and research. This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policy-makers, and regulators on how to address these products.	[Crowley, Ryan A.] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	RCrowley@mail.acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abrams D, 2014, COMMUNICATION; Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; American Cancer Society and American Cancer Society Cancer Action Network, 2013, COMM AM CANC SOC ACS; American Nonsmokers' Rights Foundation, 2014, US STAT LOC LAW REG; [Anonymous], 2010, TOB CONTR PREV; Begley S, 2014, REUTERS; Belluz J, 2014, VOX             0711; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Blucigs.com, TAKE BACK YOUR FREED; Breland AB, 2014, J ADDICT MED, V8, P223, DOI 10.1097/ADM.0000000000000049; Brown JE, 2014, NEW ENGL J MED, V370, P2250, DOI 10.1056/NEJMc1403015; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Cahn Z, 2011, J PUBLIC HEALTH POL, V32, P16, DOI 10.1057/jphp.2010.41; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Carpenter CM, 2005, HEALTH AFFAIR, V24, P1601, DOI 10.1377/hlthaff.24.6.1601; Centers for Disease Control and Prevention, 2014, KEY FIND TRENDS AW U; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Cobb NK, 2015, TOB CONTROL, V24, P128, DOI 10.1136/tobaccocontrol-2013-051185; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Duke JC, 2014, PEDIATRICS, V134, pE29, DOI 10.1542/peds.2014-0269; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Esterl M., 2014, WALL STREET J; Farsalinos KE, 2014, JAMA PEDIATR, V168, P775, DOI 10.1001/jamapediatrics.2014.727; Food and Drug Administration, 2010, CONS UPD E CIG QUEST; Fox L., 2013, NY TIMES; Gibson A., 2014, BLOOMBERG BNA   0806; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P595, DOI 10.1001/jama.2014.7883; Gourdet CK, 2014, TOB CONTROL, V23, P37, DOI 10.1136/tobaccocontrol-2013-051459; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Harrell PT, 2014, OTOLARYNG HEAD NECK, V151, P381, DOI 10.1177/0194599814536847; Harris EA, 2014, NY TIMES; Kandra KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103462; Legacy, 2014, VAP E CIG ADV YOUTH; McNamee D, 2014, MED NEWS TODAY; National Institute on Drug Abuse, 2014, MON FUT STUD TRENDS; Nelson S, 2014, US NEWS WORLD REP; Pepper J. K., 2014, Tobacco Control, V23, piii31, DOI 10.1136/tobaccocontrol-2014-051718; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Pringle S, 2014, DEAL PIPELINE   0604; Sebastian M., 2014, ADVERTISING AGE 0425; Sebastian M, 2013, ADVERTISING AGE 0904; Shaefer RM, 2015, ELECT CIGARETTE USE; Steinberg MB, 2014, J GEN INTERN MED, V29, P1444, DOI 10.1007/s11606-014-2889-7; Thompson D., 2014, E CIGARETTE VAPORS P; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; U.S. Preventive Services Task Force, AHRQ PUBLICATION; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Viebeck E., 2014, THE HILL        0825; Villacorta N., 2014, POLITICO PRO    0825; Villanti AC, 2013, AM J PREV MED, V44, P388, DOI 10.1016/j.amepre.2012.11.031; Warren Graham W, 2013, J Carcinog, V12, P1, DOI 10.4103/1477-3163.106680; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Winters P., 2014, BLOOMBERG       0307; World Health Organization, 2014, EL NIC DEL SYST REP	58	39	39	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					583	+		10.7326/M14-2481	http://dx.doi.org/10.7326/M14-2481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894027				2022-12-28	WOS:000353244300019
J	Mukherjee, D				Mukherjee, Debabrata			After drug-eluting stent placement, 6 months of dual antiplatelet therapy was noninferior to 12 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas Tech Univ, Hlth Sci Ctr, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Mukherjee, D (corresponding author), Texas Tech Univ, Hlth Sci Ctr, El Paso, TX 79905 USA.		Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC6	10.7326/ACPJC-2015-162-8-006	http://dx.doi.org/10.7326/ACPJC-2015-162-8-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894051				2022-12-28	WOS:000353244300005
J	Sacks, HS				Sacks, Henry S.			Review: Some TNF inhibitors increase adverse events in patients with rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MALIGNANCIES; METAANALYSIS; THERAPY; RISK		Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Launois R, 2011, J RHEUMATOL, V38, P835, DOI 10.3899/jrheum.100665; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Warren Fiona C, 2014, Stat Med, V33, P2449, DOI 10.1002/sim.6131	5	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC10	10.7326/ACPJC-2015-162-8-010	http://dx.doi.org/10.7326/ACPJC-2015-162-8-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894043				2022-12-28	WOS:000353244300009
J	Leffler, DA; Lamont, JT				Leffler, Daniel A.; Lamont, J. Thomas			Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANTIBIOTIC-ASSOCIATED DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; TOXIN-A; ANTIBODY-RESPONSE; DOUBLE-BLIND; RISK-FACTOR; DISEASE; EPIDEMIC; COMMUNITY; STRAIN		[Leffler, Daniel A.; Lamont, J. Thomas] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Leffler, DA (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	dleffler@bidmc.harvard.edu						Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; BINGLEY PJ, 1987, POSTGRAD MED J, V63, P993, DOI 10.1136/pgmj.63.745.993; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Bouza E, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/1469-0691.12064; Carignan A, 2008, CLIN INFECT DIS, V46, P1838, DOI 10.1086/588291; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Dancer SJ, 2013, INT J ANTIMICROB AG, V41, P137, DOI 10.1016/j.ijantimicag.2012.10.013; Davies KA, 2014, LANCET INFECT DIS, V14, P1208, DOI 10.1016/S1473-3099(14)70991-0; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2014, GUID IND EN IN PRESS; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; EGLOW R, 1992, J CLIN INVEST, V90, P822, DOI 10.1172/JCI115957; EISEMAN B, 1958, SURGERY, V44, P854; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; Feuerstadt P, 2014, AM J GASTROENTEROL, V109, P1265, DOI 10.1038/ajg.2014.167; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Ghose C, 2007, INFECT IMMUN, V75, P2826, DOI 10.1128/IAI.00127-07; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Koo HL, 2014, INFECT CONT HOSP EP, V35, P667, DOI 10.1086/676433; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Leffler DA, 2009, GASTROENTEROLOGY, V136, P1899, DOI 10.1053/j.gastro.2008.12.070; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Lofgren ET, 2014, EPIDEMIOLOGY, V25, P570, DOI 10.1097/EDE.0000000000000119; Longtin Y, 2013, CLIN INFECT DIS, V56, P67, DOI 10.1093/cid/cis840; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Neal MD, 2011, ANN SURG, V254, P423, DOI 10.1097/SLA.0b013e31822ade48; Novack L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110790; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Rousseau C, 2012, CLIN INFECT DIS, V55, P1209, DOI 10.1093/cid/cis637; Rupnik M, 2007, CLIN MICROBIOL INFEC, V13, P457, DOI 10.1111/j.1469-0691.2007.01687.x; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shin H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075729, 10.1371/journal.pone.0081330]; Shivashankar R, 2014, ALIMENT PHARM THER, V40, P518, DOI 10.1111/apt.12864; Siddiqui F, 2012, J INFECT DIS, V205, P128, DOI 10.1093/infdis/jir688; Steiner C, 2014, 201401 HCUP AG HEALT; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zainah H, 2015, DIGEST DIS SCI, V60, P181, DOI 10.1007/s10620-014-3296-y; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	77	617	654	7	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1539	1548		10.1056/NEJMra1403772	http://dx.doi.org/10.1056/NEJMra1403772			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875259				2022-12-28	WOS:000352856500009
J	Rupnik, M				Rupnik, Maja			Toward a True Bacteriotherapy for Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICROBIOTA		[Rupnik, Maja] Univ Maribor, Natl Lab Hlth Environm & Food, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Maribor; University of Maribor	Rupnik, M (corresponding author), Univ Maribor, Natl Lab Hlth Environm & Food, SLO-2000 Maribor, Slovenia.							Adamu BO, 2013, CURR OPIN MICROBIOL, V16, P596, DOI 10.1016/j.mib.2013.06.009; Brandt LJ, 2013, GASTROINTEST ENDOSC, V78, P240, DOI 10.1016/j.gie.2013.03.1329; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828	4	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1566	1568		10.1056/NEJMcibr1500270	http://dx.doi.org/10.1056/NEJMcibr1500270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875262				2022-12-28	WOS:000352856500014
J	Rusbridger, A				Rusbridger, Alan			Scientists must speak up on fossil-fuel divestment	NATURE			English	Editorial Material												alan.rusbridger@theguardian.com							0	1	1	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					265	265		10.1038/520265a	http://dx.doi.org/10.1038/520265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG0RI	25877168	Bronze			2022-12-28	WOS:000352974200005
J	Branch, WT				Branch, William T., Jr.			The Ethics of Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOCTOR		Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, Atlanta, GA 30303 USA	Emory University	Branch, WT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, Atlanta, GA 30303 USA.	wbranch@emory.edu						[Anonymous], PHILOS MED REBORN PE; [Anonymous], 1983, DIFFERENT VOICE PSYC; [Anonymous], WHAT MATTERS; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, V7th; Branch WT, 2014, HASTINGS CENT REP, V44, P15, DOI 10.1002/hast.250; Branch WT, 2014, MED EDUC, V48, P67, DOI 10.1111/medu.12369; Branch WT, 2000, ACAD MED, V75, P127, DOI 10.1097/00001888-200002000-00006; Noddings N., 1984, HAPPINESS ED	9	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1421	1422		10.1001/jama.2015.1080	http://dx.doi.org/10.1001/jama.2015.1080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871666				2022-12-28	WOS:000352821200014
J	Metzger, MJ; Reinisch, C; Sherry, J; Goff, SP				Metzger, Michael J.; Reinisch, Carol; Sherry, James; Goff, Stephen P.			Horizontal Transmission of Clonal Cancer Cells Causes Leukemia in Soft-Shell Clams	CELL			English	Article							FACIAL-TUMOR DISEASE; MOLLUSK MYA-ARENARIA; HEMIC NEOPLASIA; HEMATOPOIETIC NEOPLASIA; SOFTSHELL CLAMS; FLOW-CYTOMETRY; POPULATIONS; INDUCTION; PREVALENCE; ACTIVATION	Outbreaks of fatal leukemia-like cancers of marine bivalves throughout the world have led to massive population loss. The cause of the disease is unknown. We recently identified a retrotransposon, Steamer, that is highly expressed and amplified to high copy number in neoplastic cells of soft-shell clams (Mya arenaria). Through analysis of Steamer integration sites, mitochondrial DNA single-nucleotide polymorphisms (SNPs), and polymorphic microsatellite alleles, we show that the genotypes of neoplastic cells do not match those of the host animal. Instead, neoplastic cells from dispersed locations in New York, Maine, and Prince Edward Island (PEI), Canada, all have nearly identical genotypes that differ from those of the host. These results indicate that the cancer is spreading between animals in the marine environment as a clonal transmissible cell derived from a single original clam. Our findings suggest that horizontal transmission of cancer cells is more widespread in nature than previously supposed.	[Metzger, Michael J.; Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Reinisch, Carol; Sherry, James] Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada	Columbia University; Howard Hughes Medical Institute; Environment & Climate Change Canada	Goff, SP (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014; Metzger, Michael/AAA-3635-2022	Goff, Stephen P/0000-0003-0693-5547; Metzger, Michael/0000-0001-7855-1388	Howard Hughes Medical Institute; National Institutes of Health (NIH) [T32 CA009503]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gloria Arriagada for work on the Steamer element, Brian Beal (University of Maine at Machias) for M. arenaria samples from Maine, Annette Murray for help in collection and diagnosis of M. arenaria from PEI, and Charles Walker and Sarah Mercier (University of New Hampshire) for help in acquisition of leukemic sample ME-HL01. We also thank Anne Gifford for putting the laboratories in contact to initiate the studies. This work was supported by the Howard Hughes Medical Institute and by the National Institutes of Health (NIH) Training Grant T32 CA009503 (to M.J.M.).	AboElkhair M, 2012, J INVERTEBR PATHOL, V109, P97, DOI 10.1016/j.jip.2011.10.008; Arriagada G, 2014, P NATL ACAD SCI USA, V111, P14175, DOI 10.1073/pnas.1409945111; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Beal BF, 2002, AQUACULTURE, V208, P81, DOI 10.1016/S0044-8486(01)00900-0; Brown R.S, 1977, Annals NY Acad Sci, V298, P522, DOI 10.1111/j.1749-6632.1977.tb19287.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; COOPER KR, 1982, J INVERTEBR PATHOL, V39, P149, DOI 10.1016/0022-2011(82)90004-0; da Silva PM, 2005, DIS AQUAT ORGAN, V67, P133, DOI 10.3354/dao067133; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delaporte M, 2008, J INVERTEBR PATHOL, V98, P190, DOI 10.1016/j.jip.2007.12.005; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KATZIR N, 1985, P NATL ACAD SCI USA, V82, P1054, DOI 10.1073/pnas.82.4.1054; Kopelman NM, 2015, MOL ECOL RESOUR; Krapal AM, 2012, INT J MOL SCI, V13, P2515, DOI 10.3390/ijms13022515; MCLAUGHLIN S M, 1992, In Vivo (Attiki), V6, P367; MIOSKY DL, 1989, J INVERTEBR PATHOL, V53, P32, DOI 10.1016/0022-2011(89)90071-2; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Muttray A, 2012, SCI TOTAL ENVIRON, V424, P130, DOI 10.1016/j.scitotenv.2012.02.029; OPRANDY JJ, 1981, J INVERTEBR PATHOL, V38, P45, DOI 10.1016/0022-2011(81)90033-1; OPRANDY JJ, 1983, J INVERTEBR PATHOL, V42, P196, DOI 10.1016/0022-2011(83)90062-9; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pritchard JK, 2000, GENETICS, V155, P945; RENO PW, 1994, J INVERTEBR PATHOL, V64, P163, DOI 10.1016/S0022-2011(94)90025-6; Rodzen JA, 2002, GENOME, V45, P1064, DOI [10.1139/g02-083, 10.1139/G02-083]; Siah A, 2011, DEV COMP IMMUNOL, V35, P151, DOI 10.1016/j.dci.2010.09.012; Siddle HV, 2015, IMMUNOLOGY, V144, P11, DOI 10.1111/imm.12377; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; SMOLOWITZ RM, 1989, J INVERTEBR PATHOL, V53, P41, DOI 10.1016/0022-2011(89)90072-4; St-Onge P, 2013, MAR BIOL, V160, P1065, DOI 10.1007/s00227-012-2157-5; Strasser CA, 2009, CONSERV GENET, V10, P803, DOI 10.1007/s10592-008-9641-y; SUNILA I, 1989, DIS AQUAT ORGAN, V7, P111, DOI 10.3354/dao007111; Taraska NG, 2013, J INVERTEBR PATHOL, V112, P94, DOI 10.1016/j.jip.2012.10.001; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Vassilenko EI, 2010, MUTAT RES-GEN TOX EN, V701, P145, DOI 10.1016/j.mrgentox.2010.06.001; Voskoboynik A, 2013, SCIENCE, V341, P384, DOI 10.1126/science.1238036; Walker C, 2009, BIOL BULL-US, V216, P23; Weinberg JR, 1997, J INVERTEBR PATHOL, V69, P183, DOI 10.1006/jipa.1996.4641; YANG TJ, 1987, BRIT J CANCER, V55, P131, DOI 10.1038/bjc.1987.27; Yevich P.P, 1977, Annals NY Acad Sci, V298, P409, DOI 10.1111/j.1749-6632.1977.tb19281.x	43	120	125	3	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					255	263		10.1016/j.cell.2015.02.042	http://dx.doi.org/10.1016/j.cell.2015.02.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860608	Green Accepted, Bronze			2022-12-28	WOS:000352708300019
J	Blazer, DG; Yaffe, K; Karlawish, J				Blazer, Dan G.; Yaffe, Kristine; Karlawish, Jason			Cognitive Aging A Report From the Institute of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blazer, Dan G.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Yaffe, Kristine] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Karlawish, Jason] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Duke University; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Blazer, DG (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Div Community & Family Med, 3521 Hosp S,POB 3003, Durham, NC 27710 USA.	blaze001@mc.duke.edu						AARP, 2013, 2012 MEMB OP SURV IS; Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; MetLife Mature Market Institute National Committee for the Prevention of Elder Abuse and Virginia Tech, 2011, METLIFE STUD ELD FIN	3	62	64	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2121	2122		10.1001/jama.2015.4380	http://dx.doi.org/10.1001/jama.2015.4380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	25875498				2022-12-28	WOS:000355430900007
J	Guiteras, R; Levinsohn, J; Mobarak, AM				Guiteras, Raymond; Levinsohn, James; Mobarak, Ahmed Mushfiq			Encouraging sanitation investment in the developing world: A cluster-randomized trial	SCIENCE			English	Article							INCOME SETTINGS; INDIA; WATER	Poor sanitation contributes to morbidity and mortality in the developing world, but there is disagreement on what policies can increase sanitation coverage. To measure the effects of alternative policies on investment in hygienic latrines, we assigned 380 communities in rural Bangladesh to different marketing treatments-community motivation and information; subsidies; a supply-side market access intervention; and a control-in a cluster-randomized trial. Community motivation alone did not increase hygienic latrine ownership (+1.6 percentage points, P = 0.43), nor did the supply-side intervention (+0.3 percentage points, P = 0.90). Subsidies to the majority of the landless poor increased ownership among subsidized households (+22.0 percentage points, P < 0.001) and their unsubsidized neighbors (+8.5 percentage points, P = 0.001), which suggests that investment decisions are interlinked across neighbors. Subsidies also reduced open defecation by 14 percentage points (P < 0.001).	[Guiteras, Raymond] Univ Maryland, Dept Econ, College Pk, MD 20742 USA; [Levinsohn, James; Mobarak, Ahmed Mushfiq] Yale Univ, Sch Management, New Haven, CT 06520 USA	University System of Maryland; University of Maryland College Park; Yale University	Mobarak, AM (corresponding author), Yale Univ, Sch Management, New Haven, CT 06520 USA.	ahmed.mobarak@yale.edu	Kuang, Jinyi/L-8488-2017	Kuang, Jinyi/0000-0003-4173-3246; Guiteras, Raymond/0000-0002-4333-6829	Bill and Melinda Gates Foundation (BMGF)	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	We are grateful to WaterAid Bangladesh and VERC for implementing the interventions and Innovations for Poverty Action for assistance running the study. We also thank the study participants for generously giving their time, as well as the field officers for their dedication to the quality of data collected. I. Ahmed, M. Ali, B. Atuesta, M. Bakhtiar, Z. Chen, L. Feeney, M. Khan, R. Mahbub, A. Moderson-Kox, L. Moore, A. Vargas, D. Wolfson, and T. Zelenska provided excellent project management and research assistance. We thank The Bill and Melinda Gates Foundation (BMGF) for generous funding. BMGF, WaterAid Bangladesh, and VERC were involved in the study design but played no role in data collection, analysis, the decision to publish, or manuscript preparation. The activities associated with this research were approved by the Yale University Human Subject Committee Protocol no. 1203009864. The authors declare no conflicts of interest. Data and replication code are publicly available at the Harvard Dataverse Network (doi:10.7910/DVN/GJDUTV).	Ahuja A, 2010, ANNU REV RESOUR ECON, V2, P237, DOI 10.1146/annurev.resource.012809.103919; [Anonymous], 2012, WHAT DOES IT TAKE SC; [Anonymous], 2012, SANITATION MARKETS U; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barnard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071438; Census Organization of India, 2011, 15 IND CENS HOUS HOU; Clasen T, 2012, ENVIRON SCI TECHNOL, V46, P3295, DOI 10.1021/es2036702; Coffey D, 2014, WORKING PAPER; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; Dickinson K, 2009, OPEN SKY LATRINES DO; Dupas P, 2014, SCIENCE, V345, P1279, DOI 10.1126/science.1256973; Geruso M., 2015, WORKING PAPER; Hanchett S., 2011, 35 WEDC INT C FUT WA; Hueso A, 2013, WATER POLICY, V15, P1001, DOI 10.2166/wp.2013.032; Jenkins MW, 2014, INT J ENV RES PUB HE, V11, P8319, DOI 10.3390/ijerph110808319; Kar K., 2005, 257 IDS U SUSS; Kar K., 2003, 184 IDS U SUSS; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Mobarak AM, 2012, P NATL ACAD SCI USA, V109, P10815, DOI 10.1073/pnas.1115571109; Mojumdar S., 2014, W11042342014NBA; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Pattanayak SK, 2009, B WORLD HEALTH ORGAN, V87, P580, DOI 10.2471/BLT.08.057422; Prasad S., 2014, SWACHCHH BHAR 2019; Press Trust of India, 2013, HINDUSTAN TIMES  OCT; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Sigler R, 2015, HEALTH PROMOT INT, V30, P16, DOI 10.1093/heapro/dau073; Spears D., 2013, 6659 WORLD BANK SUST; Spears D., 2013, 6351 WORLD BANK POL; Spears D., 2012, EFFECTS RURAL SANITA; Spears D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073784; WHO/UNICEF(WHO/UnitedNationsInternationalChildren's Fund), 2014, PROGR DRINK WAT SAN; World Bank WSP, 2013, WAT SAN END YEAR REP	33	110	110	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					903	906		10.1126/science.aaa0491	http://dx.doi.org/10.1126/science.aaa0491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25883316				2022-12-28	WOS:000354877900042
J	Leek, JT; Peng, RD				Leek, Jeffrey T.; Peng, Roger D.			P values are just the tip of the iceberg	NATURE			English	Editorial Material									[Leek, Jeffrey T.; Peng, Roger D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Leek, JT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	jleek@jhsph.edu		Leek, Jeffrey/0000-0002-2873-2671				CLEVELAND WS, 1985, SCIENCE, V229, P828, DOI 10.1126/science.229.4716.828; Fisher A, 2014, PEERJ, V2, DOI 10.7717/peerj.589; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Leek JT, 2015, P NATL ACAD SCI USA, V112, P1645, DOI 10.1073/pnas.1421412111; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Trafimow D, 2014, BASIC APPL SOC PSYCH, V36, P1, DOI [10.1080/01973533.2014.865505, 10.1080/01973533.2015.1064290]	6	105	106	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					612	612		10.1038/520612a	http://dx.doi.org/10.1038/520612a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925460	Bronze			2022-12-28	WOS:000353689700024
J	Smith, JM				Smith, Jeanette M.			Galleries of the Stelvio-Lake Como Sanford Robinson Gifford	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		AVERY KJ, 2003, HUDSON RIVER SCH VIS, P1	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1600	1601		10.1001/jama.2014.11695	http://dx.doi.org/10.1001/jama.2014.11695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919510				2022-12-28	WOS:000353595200026
J	Sedgwick, P				Sedgwick, Philip			Measuring the benefit of treatment: number needed to treat	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, Med Stat, London, England; [Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, Med Educ, London, England	University of London; University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134	1	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h2206	10.1136/bmj.h2206	http://dx.doi.org/10.1136/bmj.h2206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918350				2022-12-28	WOS:000353954800004
J	D'Astolfo, DS; Pagliero, RJ; Pras, A; Karthaus, WR; Clevers, H; Prasad, V; Lebbink, RJ; Rehmann, H; Geijsen, N				D'Astolfo, Diego S.; Pagliero, Romina J.; Pras, Anita; Karthaus, Wouter R.; Clevers, Hans; Prasad, Vikram; Lebbink, Robert Jan; Rehmann, Holger; Geijsen, Niels			Efficient Intracellular Delivery of Native Proteins	CELL			English	Article							MEDIATED DELIVERY; HOST FACTORS; HUMAN-CELLS; STEM-CELLS; IN-VITRO; GENOME; TRANSDUCTION; PATHOGENS; GROWTH; LYSIS	Modulation of protein function is used to intervene in cellular processes but is often done indirectly by means of introducing DNA or mRNA encoding the effector protein. Thus far, direct intracellular delivery of proteins has remained challenging. We developed a method termed iTOP, for induced transduction by osmocytosis and propanebetaine, in which a combination of NaCl hypertonicity-induced macropinocytosis and a transduction compound (propanebetaine) induces the highly efficient transduction of proteins into a wide variety of primary cells. We demonstrate that iTOP is a useful tool in systems in which transient cell manipulation drives permanent cellular changes. As an example, we demonstrate that iTOP can mediate the delivery of recombinant Cas9 protein and short guide RNA, driving efficient gene targeting in a non-integrative manner.	[D'Astolfo, Diego S.; Pras, Anita; Karthaus, Wouter R.; Clevers, Hans; Geijsen, Niels] KNAW Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [D'Astolfo, Diego S.; Pagliero, Romina J.; Karthaus, Wouter R.; Clevers, Hans; Lebbink, Robert Jan; Rehmann, Holger; Geijsen, Niels] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Prasad, Vikram] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Geijsen, Niels] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University System of Ohio; University of Cincinnati; Utrecht University	Geijsen, N (corresponding author), KNAW Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	n.geijsen@hubrecht.eu	Lebbink, Robert Jan/GNH-5209-2022	Karthaus, Wouter R./0000-0002-9234-9044; Lebbink, Robert Jan/0000-0002-1981-0420	Netherlands Organization for Scientific Research (NWO) [91796323, 91610138]; Netherlands Organization for Scientific Research (American Heart Association) [11BGIA7720005]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (American Heart Association)	The authors thank Sarah Opitz for critically reading the manuscript; Nune Schelling for technical support; Stefan van der Elst of the Hubrecht Institute FACS facility for help with cell sorting; Anko de Graaf of the Hubrecht Institute imaging facility; David Egan of the Cell Screening facility at the UMCU; Gustavo Mostoslavsky for providing lentiviral vectors; Saravanan Manikam and Antoinette Killian for help with NDSB analysis; Thijn Brummelkamp for providing the KBM7 cells; Liqun Luo and Paul Krimpenfort for providing mTmG reporter mice; and Bart van Steen and Jack den Hartog for help with compound synthesis. This work was funded in part by The Netherlands Organization for Scientific Research (NWO, project 91796323 and 91610138, and American Heart Association 11BGIA7720005). D.S.D. and N.G. are co-inventors on a patent application describing the transduction technology PCT/IB2014/064127 and co-founders of NTrans technologies.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Louis Sharon A, 2005, Methods Mol Biol, V290, P265; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; OKADA CY, 1982, CELL, V29, P33, DOI 10.1016/0092-8674(82)90087-3; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Redon CE, 2011, P NATL ACAD SCI USA, V108, P20281, DOI 10.1073/pnas.1117713109; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Zhou J, 2006, CANCER RES, V66, P8954, DOI 10.1158/0008-5472.CAN-06-1726; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	20	207	220	3	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					674	690		10.1016/j.cell.2015.03.028	http://dx.doi.org/10.1016/j.cell.2015.03.028			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910214	Bronze			2022-12-28	WOS:000353553600024
J	Ticau, S; Friedman, LJ; Ivica, NA; Gelles, J; Bell, SP				Ticau, Simina; Friedman, Larry J.; Ivica, Nikola A.; Gelles, Jeff; Bell, Stephen P.			Single-Molecule Studies of Origin Licensing Reveal Mechanisms Ensuring Bidirectional Helicase Loading	CELL			English	Article							DNA-REPLICATION; MCM2-7 HELICASE; ATP-HYDROLYSIS; COMPLEX; ACTIVATION; MICROSCOPY; INITIATION	Loading of the ring-shaped Mcm2-7 replicative helicase around DNA licenses eukaryotic origins of replication. During loading, Cdc6, Cdt1, and the origin-recognition complex (ORC) assemble two heterohexameric Mcm2-7 complexes into a head-to-head double hexamer that facilitates bidirectional replication initiation. Using multi-wavelength single-molecule fluorescence to monitor the events of helicase loading, we demonstrate that double-hexamer formation is the result of sequential loading of individual Mcm2-7 complexes. Loading of each Mcm2-7 molecule involves the ordered association and dissociation of distinct Cdc6 and Cdt1 proteins. In contrast, one ORC molecule directs loading of both helicases in each double hexamer. Based on single-molecule FRET, arrival of the second Mcm2-7 results in rapid double-hexamer formation that anticipates Cdc6 and Cdt1 release, suggesting that Mcm-Mcm interactions recruit the second helicase. Our findings reveal the complex protein dynamics that coordinate helicase loading and indicate that distinct mechanisms load the oppositely oriented helicases that are central to bidirectional replication initiation.	[Ticau, Simina; Ivica, Nikola A.; Bell, Stephen P.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Friedman, Larry J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; spbell@mit.edu		/0000-0002-0124-0087; Bell, Stephen/0000-0002-2876-610X; Friedman, Larry/0000-0003-4946-8731	NIH [GM52339, R01 GM81648]; G. Harold and Leila Y. Mathers Foundation; NIH Pre-Doctoral Training Grant [GM007287]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081648, R01GM052339, T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Bell laboratory for useful discussions. We thank Daniel Duzdevich and Eric C. Greene for comments on the manuscript and helpful discussions. We thank Jonathan B. Grimm and Luke D. Lavis for graciously providing the Janelia Fluors. This work was supported by NIH grants GM52339 (S.P.B.) and R01 GM81648 (J.G.) and a grant from the G. Harold and Leila Y. Mathers Foundation (J.G.). S.T. was supported in part by an NIH Pre-Doctoral Training Grant (GM007287). S.P.B. is an investigator with the Howard Hughes Medical Institute.	Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Crawford DJ, 2013, P NATL ACAD SCI USA, V110, P6783, DOI 10.1073/pnas.1219305110; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duzdevich D., 2015, MOL CELL, V58; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Siddiqui K, 2013, COLD SPRING HARB PER, V5; Stratmann SA, 2014, CHEM SOC REV, V43, P1201, DOI 10.1039/c3cs60391a; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Takara TJ, 2011, EMBO J, V30, P4885, DOI 10.1038/emboj.2011.394; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738	28	125	128	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					513	525		10.1016/j.cell.2015.03.012	http://dx.doi.org/10.1016/j.cell.2015.03.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892223	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000353553600012
J	Wu, XL; Zhang, ZH; Schramm, CA; Joyce, MG; Do Kwon, Y; Zhou, TQ; Sheng, ZZ; Zhang, BS; O'Dell, S; Mckee, K; Georgiev, IS; Chuang, GY; Longo, NS; Lynch, RM; Saunders, KO; Soto, C; Srivatsan, S; Yang, YP; Bailer, RT; Louder, MK; Mullikin, JC; Connors, M; Kwong, PD; Mascola, JR; Shapiro, L				Wu, Xueling; Zhang, Zhenhai; Schramm, Chaim A.; Joyce, M. Gordon; Do Kwon, Young; Zhou, Tongqing; Sheng, Zizhang; Zhang, Baoshan; O'Dell, Sijy; Mckee, Krisha; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Longo, Nancy S.; Lynch, Rebecca M.; Saunders, Kevin O.; Soto, Cinque; Srivatsan, Sanjay; Yang, Yongping; Bailer, Robert T.; Louder, Mark K.; Mullikin, James C.; Connors, Mark; Kwong, Peter D.; Mascola, John R.; Shapiro, Lawrence		Program, NCS	Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; B-CELL RECEPTORS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POTENT NEUTRALIZATION; CD4-BINDING SITE; RATIONAL DESIGN; ENVELOPE TRIMER; BINDING-SITE; GENE USAGE	HIV-1-neutralizing antibodies develop in most HIV-1-infected individuals, although highly effective antibodies are generally observed only after years of chronic infection. Here, we characterize the rate of maturation and extent of diversity for the lineage that produced the broadly neutralizing antibody VRC01 through longitudinal sampling of peripheral B cell transcripts over 15 years and co-crystal structures of lineage members. Next-generation sequencing identified VRC01-lineage transcripts, which encompassed diverse antibodies organized into distinct phylogenetic clades. Prevalent clades maintained characteristic features of antigen recognition, though each evolved binding loops and disulfides that formed distinct recognition surfaces. Over the course of the study period, VRC01-lineage clades showed continuous evolution, with rates of similar to 2 substitutions per 100 nucleotides per year, comparable to that of HIV-1 evolution. This high rate of antibody evolution provides a mechanism by which antibody lineages can achieve extraordinary diversity and, over years of chronic infection, develop effective HIV-1 neutralization.	[Wu, Xueling; Zhang, Zhenhai; Joyce, M. Gordon; Do Kwon, Young; Zhou, Tongqing; Zhang, Baoshan; O'Dell, Sijy; Mckee, Krisha; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Longo, Nancy S.; Lynch, Rebecca M.; Saunders, Kevin O.; Soto, Cinque; Srivatsan, Sanjay; Yang, Yongping; Bailer, Robert T.; Louder, Mark K.; Kwong, Peter D.; Mascola, John R.; Shapiro, Lawrence] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wu, Xueling] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Zhang, Zhenhai; Schramm, Chaim A.; Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zhang, Zhenhai; Schramm, Chaim A.; Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Zhang, Zhenhai] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Zhenhai] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Guangzhou 510515, Guangdong, Peoples R China; [Mullikin, James C.; Program, NCS] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; Columbia University; Columbia University; Southern Medical University - China; Southern Medical University - China; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov; lss8@columbia.edu	Sheng, Zizhang/AFR-8049-2022; Zhou, Tongqing/A-6880-2010; Zhang, Zhenhai/GRX-5887-2022; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010; Shapiro, Lawrence/AAE-7172-2019	Sheng, Zizhang/0000-0002-3253-3309; Zhou, Tongqing/0000-0002-3935-4637; Zhang, Zhenhai/0000-0002-4310-0525; Do Kwon, Young/0000-0002-1188-7458; 	Intramural Research Program of the VRC; NHGRI; NIH [P01-AI104722]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005095, ZIAAI005022, ZICAI005113, ZIAAI001090, P01AI104722, ZICAI005111] Funding Source: NIH RePORTER	Intramural Research Program of the VRC; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Turk and C.-L. Lin for technical assistance with large neutralization panels. We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Humoral Immunology Core Section, Vaccine Research Center (VRC), NIAID, NIH, for comments and suggestions on the manuscript. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panel. The sequences of NIH45-177 and NIH45-243 were kindly provided by J. Scheid and M. Nussenzweig. We thank F. Alt for helpful discussions on antibody lineage development and rates. Support for this work was provided by the Intramural Research Program of the VRC and the NHGRI and by NIH grant P01-AI104722. Use of sector 22 at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chaillon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044163; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Vrancken B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003505; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu L, 2006, VACCINE, V24, P4995, DOI 10.1016/j.vaccine.2006.03.083; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	49	161	165	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					470	485		10.1016/j.cell.2015.03.004	http://dx.doi.org/10.1016/j.cell.2015.03.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865483	Green Accepted, Bronze			2022-12-28	WOS:000353553600009
J	Furu, K; Kieler, H; Haglund, B; Engeland, A; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H; Artama, M; Gissler, M; Malm, H; Norgaard, M				Furu, Kari; Kieler, Helle; Haglund, Bengt; Engeland, Anders; Selmer, Randi; Stephansson, Olof; Valdimarsdottir, Unnur Anna; Zoega, Helga; Artama, Miia; Gissler, Mika; Malm, Heli; Norgaard, Mette			Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL USE; ANTIDEPRESSANT USE; 1ST-TRIMESTER USE; HEART-DEFECTS; MALFORMATIONS; DEPRESSION; PAROXETINE; EXPOSURE; DRUGS; 1ST	OBJECTIVE To assess whether use of specific selective serotonin reuptake inhibitors (SSRIs) or venlafaxine in early pregnancy is associated with an increased risk of birth defects, with emphasis on cardiovascular birth defects even when accounting for lifestyle or other familial confounding. DESIGN Multicountry population based cohort study, including sibling controlled design. SETTING Nordic population (Denmark, Finland, Iceland, Norway, and Sweden) identified from nationwide health registers at different periods in 1996-2010. POPULATION The full study cohort included women giving birth to 2.3 million live singletons. The sibling cohort included 2288 singleton live births. The sibling controlled analyses included sibling pairs who were discordant for exposure to SSRIs or venlafaxine and birth defects. MAIN OUTCOME MEASURE Prevalence of birth defects, including subtypes of cardiac defects. Odds ratio of birth defects from logistic and conditional logistic regression. RESULTS Among 36 772 infants exposed to any SSRI in early pregnancy, 3.7% (n=1357) had a birth defect compared with 3.1% of 2 266 875 unexposed infants, yielding a covariate adjusted odds ratio of 1.13 (95% confidence interval 1.06 to 1.20). In the sibling controlled analysis the adjusted odds ratio decreased to 1.06 (0.91 to 1.24). The odds ratios for any cardiac birth defect with use of any SSRI or venlafaxine were 1.15 (95% confidence interval 1.05 to 1.26) in the covariate adjusted analysis and 0.92 (0.72 to 1.17) in the sibling controlled analysis. For atrial and ventricular septal defects the covariate adjusted odds ratio was 1.17 (1.05 to 1.31). Exposure to any SSRI or venlafaxine increased the prevalence of right ventricular outflow tract obstruction defects, with a covariate adjusted odds ratio of 1.48 (1.15 to 1.89). In the sibling controlled analysis the adjusted odds ratio decreased to 0.56 (0.21 to 1.49) for any exposure to SSRIs or venlafaxine and right ventricular outflow tract obstruction defects. CONCLUSIONS In this large Nordic study no substantial increase was found in prevalence of overall cardiac birth defects among infants exposed to SSRIs or venlafaxine in utero. Although the prevalence of septal defects and right ventricular outflow tract defects was higher in exposed infants, the lack of an association in the sibling controlled analyses points against a teratogenic effect of these drugs.	[Furu, Kari; Engeland, Anders; Selmer, Randi] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Pharmacoepidemiol, NO-0403 Oslo, Norway; [Kieler, Helle; Haglund, Bengt; Stephansson, Olof] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Engeland, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Valdimarsdottir, Unnur Anna; Zoega, Helga] Univ Iceland, Fac Med, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur Anna] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Artama, Miia] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Artama, Miia] Univ Turku, Dept Child Psychiat, Turku, Finland; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Malm, Heli] HUSLAB, Teratol Informat Serv, Helsinki, Finland; [Malm, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Malm, Heli] Univ Helsinki, Dept Clin Pharmacol, SF-00250 Helsinki, Finland; [Norgaard, Mette] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Norwegian Institute of Public Health (NIPH); Karolinska Institutet; University of Bergen; Karolinska Institutet; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Helsinki; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Aarhus University	Furu, K (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Pharmacoepidemiol, PB 4404 Nydalen, NO-0403 Oslo, Norway.	kari.furu@fhi.no	Zoega, Helga/M-1968-2015; Engeland, Anders/AAG-7437-2021	Valdimarsdottir, Unnur/0000-0001-5382-946X; Kieler, Helle/0000-0001-9338-7133; Gissler, Mika/0000-0001-8254-7525; Stephansson, Olof/0000-0003-1528-4563	Swedish pharmacy company Apoteksbolaget	Swedish pharmacy company Apoteksbolaget	This study was funded by the authors' affiliations and the Swedish pharmacy company Apoteksbolaget. Apoteksbolaget had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Bakker MK, 2010, BIRTH DEFECTS RES A, V88, P94, DOI 10.1002/bdra.20641; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Kieler H, 2015, BJOG-INT J OBSTET GY, V122, P1618, DOI 10.1111/1471-0528.13164; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Kieler Helle, 2010, Clin Epidemiol, V2, P205, DOI 10.2147/CLEP.S10426; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Laugesen K, 2013, BMJ OPEN, V3; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P942, DOI 10.1002/pds.3462; Mitchell AA, 2012, PHARMACOEPIDEM DR S, P487, DOI DOI 10.1002/9781119959946.CH28; Nebigil CG, 2003, CIRCULATION, V108, P902, DOI 10.1161/01.CIR.0000081520.25714.D9; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; O'Keane V, 2007, BMJ-BRIT MED J, V334, P1003, DOI 10.1136/bmj.39189.662581.55; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Polen KND, 2013, BIRTH DEFECTS RES A, V97, P28, DOI 10.1002/bdra.23096; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Reis M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002166; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sari Y, 2003, INT J DEV NEUROSCI, V21, P417, DOI 10.1016/j.ijdevneu.2003.10.002; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Tuccori M, 2010, POSTGRAD MED, V122, P49, DOI 10.3810/pgm.2010.07.2175; Vasilakis-Scaramozza C, 2013, PHARMACOTHERAPY, V33, P693, DOI 10.1002/phar.1211; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627	44	110	115	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2015	350								h1798	10.1136/bmj.h1798	http://dx.doi.org/10.1136/bmj.h1798			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JZ	25888213	Green Published, hybrid			2022-12-28	WOS:000353329100001
J	Cole, TB				Cole, Thomas B.			The Girls on the Bridge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1400	1401		10.1001/jama.2014.11681	http://dx.doi.org/10.1001/jama.2014.11681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871656				2022-12-28	WOS:000352821200001
J	Watts, G				Watts, Geoff			Ralph Kohn: philanthropic pharmacologist with all the right notes	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1387	1387		10.1016/S0140-6736(15)60707-3	http://dx.doi.org/10.1016/S0140-6736(15)60707-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25890409	Bronze			2022-12-28	WOS:000352719800014
J	Gamerdinger, M; Hanebuth, MA; Frickey, T; Deuerling, E				Gamerdinger, Martin; Hanebuth, Marie Anne; Frickey, Tancred; Deuerling, Elke			The principle of antagonism ensures protein targeting specificity at the endoplasmic reticulum	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE-ASSOCIATED COMPLEX; CAENORHABDITIS-ELEGANS; MEMBRANE INTERACTION; NASCENT CHAINS; BETA-NAC; TRANSLOCATION; RIBOSOMES; BINDING; SEQUENCE	The sorting of proteins to the appropriate compartment is one of the most fundamental cellular processes. We found that in the model organism Caenorhabditis elegans, correct cotranslational endoplasmic reticulum (ER) transport required the suppressor activity of the nascent polypeptide-associated complex (NAC). NAC did not affect the accurate targeting of ribosomes to ER translocons mediated by the signal recognition particle (SRP) pathway but inhibited additional unspecific contacts between ribosomes and translocons by blocking their autonomous binding affinity. NAC depletion shortened the life span of Caenorhabditis elegans, caused global mistargeting of translating ribosomes to the ER, and provoked incorrect import of mitochondrial proteins into the ER lumen, resulting in a strong impairment of protein homeostasis in both compartments. Thus, the antagonistic targeting activity of NAC is important in vivo to preserve the robustness and specificity of cellular protein-sorting routes.	[Gamerdinger, Martin; Hanebuth, Marie Anne; Deuerling, Elke] Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78457 Constance, Germany; [Frickey, Tancred] Univ Konstanz, Appl Bioinformat Lab, Dept Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Deuerling, E (corresponding author), Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78457 Constance, Germany.	elke.deuerling@uni-konstanz.de		Gamerdinger, Martin/0000-0003-1483-8181	German Science Foundation (DFG) [SFB969/A01]; Human Frontier in Science Program (HFSP) [RGP025]	German Science Foundation (DFG)(German Research Foundation (DFG)); Human Frontier in Science Program (HFSP)	We gratefully acknowledge the help of A. Dillin and K. Steffen to get started with this C. elegans project. We thank the Caenorhabditis Genetics Center for strains and E. Schulze for the microinjection training. We also thank A. Page, W. Neupert, and C. Bargmann for providing reagents. We thank R. Schloemer, K. Turgay, C. Schlatterer, S. Zboron, and E. Oberer-Bley for their critical discussions and valuable help with the manuscript. This work was supported by research grants from the German Science Foundation (DFG; SFB969/A01) and from Human Frontier in Science Program (HFSP; RGP025) to E.D. Data are deposited in Gene Expression Omnibus under accession no. GSE63928.	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; Markesich DC, 2000, DEVELOPMENT, V127, P559; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Pech Markus, 2010, J Biol Chem, V285, P19679, DOI 10.1074/jbc.M109.092536; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112	42	82	83	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					201	207		10.1126/science.aaa5335	http://dx.doi.org/10.1126/science.aaa5335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859040	Green Submitted			2022-12-28	WOS:000352613700037
J	Vohr, SH; Green, RE				Vohr, Samuel H.; Green, Richard E.			Aneuploidy and mother's genes	SCIENCE			English	Editorial Material							DIVISION; EMBRYOS		[Vohr, Samuel H.; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Cruz	Vohr, SH (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95060 USA.	ed@soe.ucsc.edu		Green, Richard/0000-0003-0516-5827; Vohr, Samuel/0000-0002-4338-3756				Bayefsky M, 2015, HASTINGS CENT REP, V45, P7, DOI 10.1002/hast.412; Brezina PR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7611; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Kirby T, 2010, LANCET, V376, P1293, DOI 10.1016/S0140-6736(10)61903-4; Mccoy RC, 2015, SCIENCE, V348, P235, DOI 10.1126/science.aaa3337; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	10	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					180	181		10.1126/science.aab0877	http://dx.doi.org/10.1126/science.aab0877			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859029				2022-12-28	WOS:000352613700021
J	Sato, TK; Asai, M; Borschevsky, A; Stora, T; Sato, N; Kaneya, Y; Tsukada, K; Dullmann, CE; Eberhardt, K; Eliav, E; Ichikawa, S; Kaldor, U; Kratz, JV; Miyashita, S; Nagame, Y; Ooe, K; Osa, A; Renisch, D; Runke, J; Schadel, M; Thorle-Pospiech, P; Toyoshima, A; Trautmann, N				Sato, T. K.; Asai, M.; Borschevsky, A.; Stora, T.; Sato, N.; Kaneya, Y.; Tsukada, K.; Duellmann, Ch E.; Eberhardt, K.; Eliav, E.; Ichikawa, S.; Kaldor, U.; Kratz, J. V.; Miyashita, S.; Nagame, Y.; Ooe, K.; Osa, A.; Renisch, D.; Runke, J.; Schaedel, M.; Thoerle-Pospiech, P.; Toyoshima, A.; Trautmann, N.			Measurement of the first ionization potential of lawrencium, element 103	NATURE			English	Article							TRANSITION ENERGIES; CHEMICAL-CHARACTERIZATION; BASIS-SETS; LUTETIUM	The chemical properties of an element are primarily governed by the configuration of electrons in the valence shell. Relativistic effects influence the electronic structure of heavy elements in the sixth row of the periodic table, and these effects increase dramatically in the seventh row including the actinides even affecting ground-state configurations(1,2). Atomic s and p(1/2) orbitals are stabilized by relativistic effects, whereas p(3/2), d and f orbitals are destabilized, so that ground-state configurations of heavy elements may differ from those of lighter elements in the same group. The first ionization potential (IP1) is a measure of the energy required to remove one valence electron from a neutral atom, and is an atomic property that reflects the outermost electronic configuration. Precise and accurate experimental determination of IP1 gives information on the binding energy of valence electrons, and also, therefore, on the degree of relativistic stabilization. However, such measurements are hampered by the difficulty in obtaining the heaviest elements on scales of more than one atom at a time(3-5). Here we report that the experimentally obtained IP1 of the heaviest actinide, lawrencium (Lr, atomic number 103), is 4.96(-0.07)(+0.08) electronvolts. The IP1 of Lr was measured with Lr-256. (half-life 27 seconds) using an efficient surface ion-source and a radioisotope detection system coupled to a mass separator. The measured IP1 is in excellent agreement with the value of 4.963(15) electronvolts predicted here by state-of-the-art relativistic calculations. The present work provides a reliable benchmark for theoretical calculations and also opens the way for IP1 measurements of superheavy elements (that is, transactinides) on an atom-at-a-time scale.	[Sato, T. K.; Asai, M.; Sato, N.; Kaneya, Y.; Tsukada, K.; Ichikawa, S.; Nagame, Y.; Osa, A.; Schaedel, M.; Toyoshima, A.] JAEA, Tokai, Ibaraki 3191195, Japan; [Borschevsky, A.] Massey Univ, New Zealand Inst Adv Study, Ctr Theoret Chem & Phys, Auckland, New Zealand; [Borschevsky, A.; Duellmann, Ch E.; Eberhardt, K.; Thoerle-Pospiech, P.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Stora, T.] CERN, ISOLDE, CH-1211 Geneva 23, Switzerland; [Kaneya, Y.; Nagame, Y.] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Duellmann, Ch E.; Runke, J.] GSI Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany; [Duellmann, Ch E.; Eberhardt, K.; Kratz, J. V.; Renisch, D.; Thoerle-Pospiech, P.; Trautmann, N.] Johannes Gutenberg Univ Mainz, Inst Kernchem, D-55099 Mainz, Germany; [Eliav, E.; Kaldor, U.] Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel; [Ichikawa, S.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Miyashita, S.] Hiroshima Univ, Grad Sch Sci, Kagamiyama, Higashi Hiroshi 7398526, Japan; [Ooe, K.] Niigata Univ, Inst Sci & Technol, Niigata 9102181, Japan	Japan Atomic Energy Agency; Massey University; European Organization for Nuclear Research (CERN); Ibaraki University; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz; Tel Aviv University; RIKEN; Hiroshima University; Niigata University	Nagame, Y (corresponding author), JAEA, Tokai, Ibaraki 3191195, Japan.	nagame.yuichiro@jaea.go.jp	Sato, Tetsuya K/T-9755-2018; Eliav, Ephraim/AAC-9546-2022; Düllmann, Christoph E/L-3401-2017	Sato, Tetsuya K/0000-0002-5490-9178; Düllmann, Christoph E/0000-0002-1194-0423; Eliav, Ephraim/0000-0002-2656-4934; Borschevsky, Anastasia/0000-0002-6558-1921	Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division of the US Department of Energy; Helmholtz-Institut Mainz; Ministry of Education, Science, Sports and Culture (MEXT) [26390119]	Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division of the US Department of Energy(United States Department of Energy (DOE)); Helmholtz-Institut Mainz; Ministry of Education, Science, Sports and Culture (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the JAEA tandem accelerator crew for supplying intense and stable beams for the experiments. The <SUP>249</SUP>Cf was made available by H. Nitsche (Univ. California, Berkeley); it was produced in the form of <SUP>249</SUP>Bk through the former Transplutonium Element Production Program at Oak Ridge National Laboratory (ORNL) under the auspices of the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division of the US Department of Energy. Financial support by the Helmholtz-Institut Mainz is acknowledged. This work has been partly supported by the Grant-in-Aid for Scientific Research (C) no. 26390119 of the Ministry of Education, Science, Sports and Culture (MEXT).	Borschevsky A, 2007, EUR PHYS J D, V45, P115, DOI 10.1140/epjd/e2007-00130-9; Cao XY, 2003, J CHEM PHYS, V118, P487, DOI 10.1063/1.1521431; DESCLAUX JP, 1980, J PHYS-PARIS, V41, P943, DOI 10.1051/jphys:01980004109094300; Dullmann CE, 2002, NATURE, V418, P859, DOI 10.1038/nature00980; Dzuba VA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.012504; Eichler R, 2000, NATURE, V407, P63, DOI 10.1038/35024044; Eichler R, 2007, NATURE, V447, P72, DOI 10.1038/nature05761; ELIAV E, 1994, PHYS REV A, V49, P1724, DOI 10.1103/PhysRevA.49.1724; ELIAV E, 1995, PHYS REV A, V52, P291, DOI 10.1103/PhysRevA.52.291; Even J, 2014, SCIENCE, V345, P1491, DOI 10.1126/science.1255720; Faegri K, 2001, THEOR CHEM ACC, V105, P252, DOI 10.1007/s002140000209; KIRCHNER R, 1990, NUCL INSTRUM METH A, V292, P203, DOI 10.1016/0168-9002(90)90377-I; Kohler S, 1996, ANGEW CHEM INT EDIT, V35, P2856, DOI 10.1002/anie.199628561; Kramida A., 2013, NIST ATOMIC SPECTRA; Liu WJ, 1998, PHYS REV A, V58, P1103, DOI 10.1103/PhysRevA.58.1103; MAEDA H, 1989, J PHYS B-AT MOL OPT, V22, pL511, DOI 10.1088/0953-4075/22/18/002; Oganessian Y, 2007, J PHYS G NUCL PARTIC, V34, pR165, DOI 10.1088/0954-3899/34/4/R01; Pershina V, 2010, CHALL ADV COMPUT CHE, V10, P451, DOI 10.1007/978-1-4020-9975-5_11; Peterson JR, 1998, J ALLOY COMPD, V271, P876, DOI 10.1016/S0925-8388(98)00238-2; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Rothe S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2819; Sato N, 2014, RADIOCHIM ACTA, V102, P211, DOI 10.1515/ract-2014-2142; Sato TK, 2015, J RADIOANAL NUCL CH, V303, P1253, DOI 10.1007/s10967-014-3467-5; Sato TK, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4789772; Schadel, 2014, CHEM SUPERHEAVY ELEM; Schadel M, 1997, NATURE, V388, P55, DOI 10.1038/40375; Sewtz M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.163002; Shabaev VM, 2015, COMPUT PHYS COMMUN, V189, P175, DOI 10.1016/j.cpc.2014.12.002; Stora T., CERN2013007, P331; Turler A, 2013, CHEM REV, V113, P1237, DOI 10.1021/cr3002438; Visscher L, 1997, ATOM DATA NUCL DATA, V67, P207, DOI 10.1006/adnd.1997.0751; Visscher L., 2013, DIRAC RELATIVISTIC A; Zandberg ?.Ya., 1959, SOV PHYS USP, V2, P255, DOI [10.1070/pu1959v002n02abeh003123, DOI 10.1070/PU1959V002N02ABEH003123]; Zou Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183001	34	101	104	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					209	U153		10.1038/nature14342	http://dx.doi.org/10.1038/nature14342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855457	Green Submitted			2022-12-28	WOS:000352454600036
J	Andersen, DS; Colombani, J; Palmerini, V; Chakrabandhu, K; Boone, E; Rothlisberger, M; Toggweiler, J; Basler, K; Mapelli, M; Hueber, AO; Leopold, P				Andersen, Ditte S.; Colombani, Julien; Palmerini, Valentina; Chakrabandhu, Krittalak; Boone, Emilie; Roethlisberger, Michael; Toggweiler, Janine; Basler, Konrad; Mapelli, Marina; Hueber, Anne-Odile; Leopold, Pierre			The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth	NATURE			English	Article							TUMOR-SUPPRESSOR; RETINAL DEGENERATION; GENETIC SCREEN; CRUMBS COMPLEX; ONCOGENIC RAS; EIGER; SUPERFAMILY; MELANOGASTER; ACTIVATION; MECHANISM	Disruption of epithelial polarity is a key event in the acquisition of neoplastic growth. JNK signalling is known to play an important part in driving the malignant progression of many epithelial tumours, although the link between loss of polarity and JNK signalling remains elusive. In a Drosophila genome-wide genetic screen designed to identify molecules implicated in neoplastic growth(1), we identified grindelwald (grnd), a gene encoding a transmembrane protein with homology to members of the tumour necrosis factor receptor (TNFR) superfamily. Here we show that Grnd mediates the pro-apoptotic functions of Eiger (Egr), the unique Drosophila TNF, and that overexpression of an active form of Grnd lacking the extracellular domain is sufficient to activate JNK signalling in vivo. Grnd also promotes the invasiveness of Ras(V12)/scrib(-/-) tumours through Egr-dependent Matrix metallo-protease-1 (Mmp1) expression. Grnd localizes to the subapical membrane domain with the cell polarity determinant Crumbs (Crb) and couples Crb-induced loss of polarity with JNK activation and neoplastic growth through physical interaction with Veli (also known as Lin-7). Therefore, Grnd represents the first example of a TNFR that integrates signals from both Egr and apical polarity determinants to induce JNK-dependent cell death or tumour growth.	[Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] CNRS, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] INSERM, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Boone, Emilie; Leopold, Pierre] Inst Biol Valrose, Genet & Physiol Growth Lab, F-06108 Nice, France; [Palmerini, Valentina; Mapelli, Marina] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Chakrabandhu, Krittalak; Hueber, Anne-Odile] Inst Biol Valrose, Death Receptors Signalling & Canc Therapy Lab, F-06108 Nice, France; [Roethlisberger, Michael; Toggweiler, Janine; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; IRCCS European Institute of Oncology (IEO); UDICE-French Research Universities; Universite Cote d'Azur; University of Zurich	Colombani, J (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, Parc Valrose, F-06108 Nice, France.	julien.colombani@unice.fr; leopold@unice.fr	Mapelli, Marina/AAC-7346-2022; Palmerini, Valentina/AAQ-1639-2020; Anne-Odile, Hueber/G-4352-2013; Anne-Odile, Hueber/P-9860-2019	Mapelli, Marina/0000-0001-8502-0649; Anne-Odile, Hueber/0000-0003-3816-2446; Anne-Odile, Hueber/0000-0003-3816-2446; Colombani, Julien/0000-0002-8250-4899; Andersen, Ditte/0000-0003-1209-6102; Basler, Konrad/0000-0003-3534-1529	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Association pour la Recherche contre le Cancer [PJA20131200042]; European Research Council [268813]; Marie Curie Life Long Training grant [252373]; Labex Signalife program [ANR-11-LABX-0028-01]; Italian Association for Cancer Research (AIRC) [IG-12877]; Italian Ministry of Health [GR-2008-1134103]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); European Research Council(European Research Council (ERC)European Commission); Marie Curie Life Long Training grant; Labex Signalife program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	We thank G. Jarretou for technical assistance, the Vienna Drosophila RNAi Centers, the Drosophila Genetics Resource Center, the Bloomington Stock Center, N. Caridi and S. Pasqualato for technical assistance and P.L. laboratory members for comments on the manuscript This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, Association pour la Recherche contre le Cancer (grant no. PJA20131200042 to J.C.), European Research Council (Advanced grant no. 268813 to P.L.), Marie Curie Life Long Training (grant no. 252373 to D.S.A.), the Labex Signalife program (grant ANR-11-LABX-0028-01 to P.L.), the Italian Association for Cancer Research (AIRC IG-12877) and the Italian Ministry of Health (GR-2008-1134103) to M.M.	Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bachmann A, 2008, EUR J CELL BIOL, V87, P123, DOI 10.1016/j.ejcb.2007.11.002; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Geuking P, 2005, GENETICS, V171, P1683, DOI 10.1534/genetics.105.045534; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Narasimamurthy R, 2009, CELL RES, V19, P392, DOI 10.1038/cr.2009.16; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vidal M, 2010, CELL CYCLE, V9, P3851, DOI 10.4161/cc.9.19.13280; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006	33	98	101	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					482	+		10.1038/nature14298	http://dx.doi.org/10.1038/nature14298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	25874673				2022-12-28	WOS:000356782900051
J	Jovin, TG; Chamorro, A; Cobo, E; de Miquel, MA; Molina, CA; Rovira, A; San Roman, L; Serena, J; Abilleira, S; Ribo, M; Millan, M; Urra, X; Cardona, P; Lopez-Cancio, E; Tomasello, A; Castano, C; Blasco, J; Aja, L; Dorado, L; Quesada, H; Rubiera, M; Hernandez-Perez, M; Goyal, M; Demchuk, AM; von Kummer, R; Gallofre, M; Davalos, A				Jovin, T. G.; Chamorro, A.; Cobo, E.; de Miquel, M. A.; Molina, C. A.; Rovira, A.; San Roman, L.; Serena, J.; Abilleira, S.; Ribo, M.; Millan, M.; Urra, X.; Cardona, P.; Lopez-Cancio, E.; Tomasello, A.; Castano, C.; Blasco, J.; Aja, L.; Dorado, L.; Quesada, H.; Rubiera, M.; Hernandez-Perez, M.; Goyal, M.; Demchuk, A. M.; von Kummer, R.; Gallofre, M.; Davalos, A.		REVASCAT Trial Investigators	Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVASCULAR THERAPY; ALTEPLASE; OUTCOMES; TRIALS	BACKGROUND We aimed to assess the safety and efficacy of thrombectomy for the treatment of stroke in a trial embedded within a population-based stroke reperfusion registry. METHODS During a 2-year period at four centers in Catalonia, Spain, we randomly assigned 206 patients who could be treated within 8 hours after the onset of symptoms of acute ischemic stroke to receive either medical therapy (including intravenous alteplase when eligible) and endovascular therapy with the Solitaire stent retriever (thrombectomy group) or medical therapy alone (control group). All patients had confirmed proximal anterior circulation occlusion and the absence of a large infarct on neuroimaging. In all study patients, the use of alteplase either did not achieve revascularization or was contraindicated. The primary outcome was the severity of global disability at 90 days, as measured on the modified Rankin scale (ranging from 0 [no symptoms] to 6 [death]). Although the maximum planned sample size was 690, enrollment was halted early because of loss of equipoise after positive results for thrombectomy were reported from other similar trials. RESULTS Thrombectomy reduced the severity of disability over the range of the modified Rankin scale (adjusted odds ratio for improvement of 1 point, 1.7; 95% confidence interval [CI], 1.05 to 2.8) and led to higher rates of functional independence (a score of 0 to 2) at 90 days (43.7% vs. 28.2%; adjusted odds ratio, 2.1; 95% CI, 1.1 to 4.0). At 90 days, the rates of symptomatic intracranial hemorrhage were 1.9% in both the thrombectomy group and the control group (P = 1.00), and rates of death were 18.4% and 15.5%, respectively (P = 0.60). Registry data indicated that only eight patients who met the eligibility criteria were treated outside the trial at participating hospitals. CONCLUSIONS Among patients with anterior circulation stroke who could be treated within 8 hours after symptom onset, stent retriever thrombectomy reduced the severity of post-stroke disability and increased the rate of functional independence.	[Jovin, T. G.] Univ Pittsburgh, Dept Neurol, Med Ctr, Stroke Inst, Pittsburgh, PA 15260 USA; [Chamorro, A.; Urra, X.] Hosp Clin, Stroke Unit, Lhospitalet De Llobregat, Spain; [San Roman, L.; Blasco, J.] Hosp Clin, Dept Radiol, Lhospitalet De Llobregat, Spain; [Cobo, E.] Univ Politecn Cataluna, Dept Biostat, Lhospitalet De Llobregat, Spain; [de Miquel, M. A.; Aja, L.] Bellvitge Hosp, Dept Radiol, Lhospitalet De Llobregat, Spain; [Cardona, P.; Quesada, H.] Bellvitge Hosp, Stroke Unit, Lhospitalet De Llobregat, Spain; [Molina, C. A.; Ribo, M.; Rubiera, M.] Stroke Unit, Barcelona, Spain; [Rovira, A.; Tomasello, A.] Dept Radiol, Barcelona, Spain; [Serena, J.] Hosp Valle De Hebron, Barcelona, Spain; [Abilleira, S.; Goyal, M.] Agcy Hlth Qual & Assessment Catalonia, Stroke Program, Barcelona, Spain; [Millan, M.; Lopez-Cancio, E.; Castano, C.; Dorado, L.; Hernandez-Perez, M.; Davalos, A.] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, Barcelona 08916, Spain; [Millan, M.; Lopez-Cancio, E.; Castano, C.; Dorado, L.; Hernandez-Perez, M.; Davalos, A.] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Trial Off Coordinat, Barcelona 08916, Spain; [Serena, J.] Hosp Josep Trueta, Stroke Unit, Ginona, Spain; [Demchuk, A. M.; Gallofre, M.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Radiol, Calgary, AB, Canada; [Demchuk, A. M.; Gallofre, M.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [von Kummer, R.] Univ Dresden, Dept Radiol, Dresden, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universitat Politecnica de Catalunya; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Calgary; University of Calgary; Technische Universitat Dresden	Davalos, A (corresponding author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, Avda Canyet, Barcelona 08916, Spain.	adavalos.germanstrias@gencat.cat	von Kummer, Rüdiger/AAA-4478-2019; Ribo, Marc/ABG-3202-2021; Urra, Xabier/B-7637-2019; Demchuk, Andrew M/E-1103-2012; Remollo, Sebastian/AAU-4803-2021; Cobo, Erik/H-6230-2011; Ariño, Helena/C-3248-2018; Rudilosso, Salvatore/B-9265-2018; Goyal, Mayank/AAE-7323-2019; Rovira, Alex/AAX-3973-2020	von Kummer, Rüdiger/0000-0003-0119-4604; Ribo, Marc/0000-0001-9242-043X; Urra, Xabier/0000-0002-4763-5252; Demchuk, Andrew M/0000-0002-4930-7789; Remollo, Sebastian/0000-0002-8514-5529; Cobo, Erik/0000-0002-3534-5602; Ariño, Helena/0000-0003-4036-1671; Rudilosso, Salvatore/0000-0002-8775-6884; Munoz-Narbona, Lucia/0000-0002-0884-3024; Lopez-Rueda, Antonio/0000-0001-7914-9948; San Roman, Luis/0000-0003-0735-4373; Castano Duque, Carlos/0000-0001-9165-340X; Balasa, Mircea/0000-0002-1795-4228; Abilleira, Sonia/0000-0002-5587-128X; Rubiera Del Fueyo, Marta A/0000-0001-8100-9477; SANJUAN, ESTELA/0000-0001-6333-0785; Hernandez-Perez, Maria/0000-0001-8279-7954; Munuera, Josep/0000-0001-5154-1796; Lucente, Giuseppe/0000-0003-1120-9136; Blasco, Jordi/0000-0002-7703-4642; MUCHADA, MARIAN/0000-0002-9876-285X; Puyalto, Paloma/0000-0002-0767-9752; Macho Fernandez, Juan Miguel/0000-0002-8417-7094	Fundacio Ictus Malaltia Vascular through Covidien; Alberta Innovates [201300690] Funding Source: researchfish	Fundacio Ictus Malaltia Vascular through Covidien; Alberta Innovates	Funded by Fundacio Ictus Malaltia Vascular through an unrestricted grant from Covidien and others; REVASCAT ClinicalTrials.gov number, NCT01692379.	Abilleira S, 2014, STROKE, V45, P1046, DOI 10.1161/STROKEAHA.113.003489; Berkhemer OA, 2015, NEW ENGL J MED, V372, P394; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2014, STROKE, V45, P3116, DOI 10.1161/STROKEAHA.114.006288; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Khatri P, STROKE IN PRESS; McTaggart RA, 2015, STROKE, V46, P407, DOI 10.1161/STROKEAHA.114.006564; Molina CA, 2013, INT J STROKE; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	15	3044	3248	6	153	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2296	2306		10.1056/NEJMoa1503780	http://dx.doi.org/10.1056/NEJMoa1503780			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	25882510	Green Published			2022-12-28	WOS:000356019200005
J	McWilliams, JM; Chernew, ME; Landon, BE; Schwartz, AL				McWilliams, J. Michael; Chernew, Michael E.; Landon, Bruce E.; Schwartz, Aaron L.			Performance Differences in Year 1 of Pioneer Accountable Care Organizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACO PAYMENT MODELS; MEDICARE BENEFICIARIES; QUALITY; LEADERSHIP; OWNERSHIP; CONTRACT	BACKGROUND In 2012, a total of 32 organizations entered the Pioneer accountable care organization (ACO) program, in which providers can share savings with Medicare if spending falls below a financial benchmark. Performance differences associated with characteristics of Pioneer ACOs have not been well described. METHODS In a difference-in-differences analysis of Medicare fee-for-service claims, we compared Medicare spending for beneficiaries attributed to Pioneer ACOs (ACO group) with other beneficiaries (control group) before (2009 through 2011) and after (2012) the start of Pioneer ACO contracts, with adjustment for geographic area and beneficiaries' sociodemographic and clinical characteristics. We estimated differential changes in spending for several subgroups of ACOs: those with and those without clear financial integration between hospitals and physician groups, those with higher and those with lower baseline spending, and the 13 ACOs that withdrew from the Pioneer program after 2012 and the 19 that did not. RESULTS Adjusted Medicare spending and spending trends were similar in the ACO group and the control group during the precontract period. In 2012, the total adjusted per-beneficiary spending differentially changed in the ACO group as compared with the control group (-$29.2 per quarter, P = 0.007), consistent with a 1.2% savings. Savings were significantly greater for ACOs with baseline spending above the local average, as compared with those with baseline spending below the local average (P = 0.05 for interaction), and for those serving high-spending areas, as compared with those serving low-spending areas (P = 0.04). Savings were similar in ACOs with financial integration between hospitals and physician groups and those without, as well as in ACOs that withdrew from the program and those that did not. CONCLUSIONS Year 1 of the Pioneer ACO program was associated with modest reductions in Medicare spending. Savings were greater for ACOs with higher baseline spending than for those with lower baseline spending and were unrelated to withdrawal from the program.	[McWilliams, J. Michael; Chernew, Michael E.; Landon, Bruce E.; Schwartz, Aaron L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG032952, F30AG044106] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and others.	Advisory Board, 2013, CASS WHY SOM PION AC; Agency for Healthcare Research and Quality, 2013, PREV QUAL IND TECHN; Anderson RE, 2014, J GEN INTERN MED, V29, P1296, DOI 10.1007/s11606-014-2900-3; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Center for Medicare and Medicaid Innovation, 2011, POIN ACO AL FIN REC; Center for Medicare and Medicaid Innovation, 2012, SEL PART PION ACO MO; Center for Medicare and Medicaid Innovation, 2014, MED PION ACO MOD PER; Centers for Medicare and Medicaid Innovation, 2011, POIN ACC CAR ORG ACO; Centers for Medicare and Medicaid Services, 2014, REQ INF EV ACO IN CM; Centers for Medicare and Medicaid Services, 2013, PION ACC CAR ORG SUC; Centers for Medicare and Medicaid Services, GUID QUAL PERF SCOR; Centers for Medicare and Medicaid Services, MED SHAR SAV PROGR A; Centers for Medicare & Medicaid Services, MED SHAR SAV PROGR Q; Centers for Medicare & Medicaid Services (CMS), 2015, MED SHAR SAV PROGR S; Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; Douven R, 2015, HEALTH AFFAIR, V34, P143, DOI 10.1377/hlthaff.2014.0444; Fisher ES, 2012, HEALTH AFFAIR, V31, P2368, DOI 10.1377/hlthaff.2012.0544; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; Gold J, 2014, KAISER HLTH NEW 0716; Herman B, 2014, SHARP HEALTHCARE ACO; Kranker K., 2022, EVALUATION MEDICARE; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; McWilliams JM, 2014, J GEN INTERN MED, V29, P1328, DOI 10.1007/s11606-014-2868-z; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302; McWilliams JM, 2013, HEALTH SERV RES, V48, P1526, DOI 10.1111/1475-6773.12032; McWilliams JM, 2012, NEW ENGL J MED, V366, pE29, DOI 10.1056/NEJMp1202004; Medicare Payment Advisory Commission, 2014, COMMUNICATION; Medicare Payment Advisory Committee, 2014, REP C MED PAYM POL; Mostashari F, 2014, JAMA-J AM MED ASSOC, V311, P1855, DOI 10.1001/jama.2014.4086; National Plan and Provider Enumeration System (NPPES), NAT PROV ID REG; Pham HH, 2014, JAMA-J AM MED ASSOC, V312, P1635, DOI 10.1001/jama.2014.13109; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Shortell SM, 2014, HEALTH SERV RES, V49, P1519, DOI 10.1111/1475-6773.12167; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; U.S. Census Bureau, 2010, AM COMM SURV 5 YEARS; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Yun HF, 2010, HEALTH SERV OUTCOME, V10, P100, DOI 10.1007/s10742-010-0060-4; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	40	181	181	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1927	1936		10.1056/NEJMsa1414929	http://dx.doi.org/10.1056/NEJMsa1414929			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25875195	Bronze, Green Accepted			2022-12-28	WOS:000354493300008
J	Zhang, HT; Unal, H; Gati, C; Han, GW; Liu, W; Zatsepin, NA; James, D; Wang, DJ; Nelson, G; Weierstall, U; Sawaya, MR; Xu, QP; Messerschmidt, M; Williams, GJ; Boutet, S; Yefanov, OM; White, TA; Wang, C; Ishchenko, A; Tirupula, KC; Desnoyer, R; Coe, J; Conrad, CE; Fromme, P; Stevens, RC; Katritch, V; Karnik, SS; Cherezov, V				Zhang, Haitao; Unal, Hamiyet; Gati, Cornelius; Han, Gye Won; Liu, Wei; Zatsepin, Nadia A.; James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe; Sawaya, Michael R.; Xu, Qingping; Messerschmidt, Marc; Williams, Garth J.; Boutet, Sebastien; Yefanov, Oleksandr M.; White, Thomas A.; Wang, Chong; Ishchenko, Andrii; Tirupula, Kalyan C.; Desnoyer, Russell; Coe, Jesse; Conrad, Chelsie E.; Fromme, Petra; Stevens, Raymond C.; Katritch, Vsevolod; Karnik, Sadashiva S.; Cherezov, Vadim			Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography	CELL			English	Article							II TYPE-1 RECEPTOR; AT(1A) CARBOXYL-TERMINUS; LIPIDIC CUBIC PHASE; AGONISTIC AUTOANTIBODIES; PROXIMAL REGION; OPIOID RECEPTOR; BINDING; GPCR; ACTIVATION; MANAGEMENT	Angiotensin II type 1 receptor (AT(1)R) is a G protein-coupled receptor that serves as a primary regulator for blood pressure maintenance. Although several anti-hypertensive drugs have been developed as AT(1)R blockers (ARBs), the structural basis for AT(1)R ligand-binding and regulation has remained elusive, mostly due to the difficulties of growing high-quality crystals for structure determination using synchrotron radiation. By applying the recently developed method of serial femtosecond crystallography at an X-ray free-electron laser, we successfully determined the room-temperature crystal structure of the human AT(1)R in complex with its selective antagonist ZD7155 at 2.9-angstrom resolution. The AT(1)R-ZD7155 complex structure revealed key structural features of AT(1)R and critical interactions for ZD7155 binding. Docking simulations of the clinically used ARBs into the AT(1)R structure further elucidated both the common and distinct binding modes for these antihypertensive drugs. Our results thereby provide fundamental insights into AT(1)R structure-function relationship and structure-based drug design.	[Zhang, Haitao; Stevens, Raymond C.; Katritch, Vsevolod] Univ So Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Unal, Hamiyet; Tirupula, Kalyan C.; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gati, Cornelius; Yefanov, Oleksandr M.; White, Thomas A.] DESY, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [Han, Gye Won; Ishchenko, Andrii; Stevens, Raymond C.; Cherezov, Vadim] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Liu, Wei; Coe, Jesse; Conrad, Chelsie E.; Fromme, Petra] Arizona State Univ, Ctr Appl Struct Discovery, Biodesign Inst, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Xu, Qingping] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Light Source, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Messerschmidt, Marc] BioXFEL Sci & Technol Ctr, Buffalo, NY 14203 USA; [Williams, Garth J.; Boutet, Sebastien] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Wang, Chong] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China	University of Southern California; Cleveland Clinic Foundation; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Southern California; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Harvard University; ShanghaiTech University	Cherezov, V (corresponding author), Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA.	cherezov@usc.edu	Messerschmidt, Marc/Y-8929-2019; Messerschmidt, Marc/F-3796-2010; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Y-2721-2019; Zatsepin, Nadia/AAF-2451-2019; Karnik, Sadashiva/Y-2477-2019; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Zhang, Haitao/L-7612-2015; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8673-2022; Liu, Wei/F-1820-2011; Han, Gye Won/GLT-1531-2022	Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; Stevens, Raymond/0000-0002-4522-8725; Karnik, Sadashiva/0000-0003-0746-2753; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Zhang, Haitao/0000-0003-4879-2951; Katritch, Vsevolod/0000-0003-3883-4505; Sawaya, Michael/0000-0003-0874-9043; Zatsepin, Nadia/0000-0003-1757-0205; James, Daniel/0000-0002-8348-6661; Yefanov, Oleksandr/0000-0001-8676-0091	NIH [R01 GM108635, U54 GM094618, P41 GM103393, R01 HL57470, R01 HL115964, U54 GM094599, R01 GM095583, U54 GM094586]; National Research Service [HL007914]; NSF BioXFEL Science and Technology center [1231306]; Helmholtz Gemeinschaft; BMBF [FKZ 05K12CH1]; PIER Helmholtz Graduate School; Helmholtz Association; Chinese 1000 Talent Program; DFG Cluster of Excellence "Center for Ultrafast Imaging''; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964, T32HL007914, R01HL057470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, P41GM103393, R01GM095583, R01GM108635, U54GM094586, U54GM094618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NSF BioXFEL Science and Technology center; Helmholtz Gemeinschaft(Helmholtz Association); BMBF(Federal Ministry of Education & Research (BMBF)); PIER Helmholtz Graduate School; Helmholtz Association(Helmholtz Association); Chinese 1000 Talent Program; DFG Cluster of Excellence "Center for Ultrafast Imaging''(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in parts by the NIH grants R01 GM108635 (V.C.), U54 GM094618 (target GPCR-11) (V.K., V.C., R.C.S.), P41 GM103393 (S.B.), R01 HL57470 (S.S.K.), R01 HL115964 (S.S.K.), U54 GM094599 (P.F.), R01 GM095583 (P.F.), U54 GM094586 (Q.X.), and National Research Service award HL007914 (H.U.). Further support was provided by the NSF BioXFEL Science and Technology center grant 1231306 (P.F., U.W, G.N.); the Helmholtz Gemeinschaft, the DFG Cluster of Excellence "Center for Ultrafast Imaging''; the BMBF project FKZ 05K12CH1 (C.G., O.M.Y., T.A.W.); the PIER Helmholtz Graduate School and the Helmholtz Association (C.G.); and the Chinese 1000 Talent Program (R.C.S.). Parts of this research were carried out at the LCLS, a National User Facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences, and at the GM/CA CAT of the Argonne Photon Source, Argonne National Laboratory. We thank J. Velasquez for help with molecular biology; T. Trinh and M. Chu for help with baculovirus expression; M. Metz, D. Oberthuer, A. Barty, S. Basu, and R. Fromme for help with the XFEL data collection and analysis, and R. Miller, K. Kadyshevskaya, and A. Walker for assistance with manuscript preparation. We are grateful to J. Spence and H. Chapman for their encouragement and support.	Akazawa H, 2013, CURR PHARM DESIGN, V19, P2988; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Balakumar P, 2012, CURR DIABETES REV, V8, P183, DOI 10.2174/157339912800563972; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Bricogne G, 2009, BUSTER VERSION 2 8 0; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fu MLX, 2000, J HYPERTENS, V18, P945, DOI 10.1097/00004872-200018070-00017; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hart P., 2012, NUCL SCI S MED IM C; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Junggren IL, 1996, J PHARM PHARMACOL, V48, P829, DOI 10.1111/j.2042-7158.1996.tb03983.x; Kamimori H, 2005, ANAL SCI, V21, P171, DOI 10.2116/analsci.21.171; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0314; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079914; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Mozsolits H, 2002, BIOCHEMISTRY-US, V41, P7830, DOI 10.1021/bi0121813; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Ramanath VS, 2009, MAYO CLIN PROC, V84, P465, DOI 10.1016/S0025-6196(11)60566-1; Ramchandran R, 2006, P NATL ACAD SCI USA, V103, P19087, DOI 10.1073/pnas.0602715103; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Shenoy S.K., 2005, SCI STKE 2005, V2005, pcm14; Takezako T, 2004, J BIOL CHEM, V279, P15248, DOI 10.1074/jbc.M312728200; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Thomas WG, 1999, FEBS LETT, V455, P367, DOI 10.1016/S0014-5793(99)00904-7; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Unal H, 2014, J FINANC SERV RES, V45, P1, DOI 10.1007/s10693-014-0191-9; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xia Y, 2013, CIRC RES, V113, P78, DOI 10.1161/CIRCRESAHA.113.300752; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	55	253	256	3	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					833	844		10.1016/j.cell.2015.04.011	http://dx.doi.org/10.1016/j.cell.2015.04.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913193	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-28	WOS:000354175200016
J	Perez, K; Hailey, CJ; Bauer, FE; Krivonos, RA; Mori, K; Baganoff, FK; Barriere, NM; Boggs, SE; Christensen, FE; Craig, WW; Grefenstette, BW; Grindlay, JE; Harrison, FA; Hong, J; Madsen, KK; Nynka, M; Stern, D; Tomsick, JA; Wik, DR; Zhang, S; Zhang, WW; Zoglauer, A				Perez, Kerstin; Hailey, Charles J.; Bauer, Franz E.; Krivonos, Roman A.; Mori, Kaya; Baganoff, Frederick K.; Barriere, Nicolas M.; Boggs, Steven E.; Christensen, Finn E.; Craig, William W.; Grefenstette, Brian W.; Grindlay, Jonathan E.; Harrison, Fiona A.; Hong, Jaesub; Madsen, Kristin K.; Nynka, Melania; Stern, Daniel; Tomsick, John A.; Wik, Daniel R.; Zhang, Shuo; Zhang, William W.; Zoglauer, Andreas			Extended hard-X-ray emission in the inner few parsecs of the Galaxy	NATURE			English	Article							XMM-NEWTON OBSERVATIONS; BLACK-HOLE; CANDIDATE; SGR; VARIABILITY; LUMINOSITY; SPECTRA; FLUX	The Galactic Centre hosts a puzzling stellar population in its inner few parsecs, with a high abundance of surprisingly young, relatively massive stars bound within the deep potential well of the central supermassive black hole, Sagittarius A* (ref. 1). Previous studies suggest that the population of objects emitting soft X-rays (less than 10 kiloelectronvolts) within the surrounding hundreds of parsecs, as well as the population responsible for unresolved X-ray emission extending along the Galactic plane, is dominated by accreting white dwarf systems'. Observations of diffuse hardX-ray (more than 10 kiloelectronvolts) emission in the inner 10 parsecs, however, have been hampered by the limited spatial resolution of previous instruments. Here we report the presence of a distinct hard-X-ray component within the central 4 X 8 parsecs, as revealed by subarcminute-resolution images in the 20-40 kiloelectronvolt range. This emission is more sharply peaked towards the Galactic Centre than is the surface brightness of the soft-X-ray population'. This could indicate a significantly more massive population of accreting white dwarfs, large populations of lowmass X-ray binaries or millisecond pulsars, or particle outflows interacting with the surrounding radiation field, dense molecular material or magnetic fields. However, all these interpretations pose significant challenges to our understanding of stellar evolution, binary formation, and cosmic-ray production in the Galactic Centre.	[Perez, Kerstin; Hailey, Charles J.; Mori, Kaya; Nynka, Melania; Zhang, Shuo] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Perez, Kerstin] Haverford Coll, Haverford, PA 19041 USA; [Bauer, Franz E.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago 22, Chile; [Bauer, Franz E.] Millennium Inst Astrophys, Santiago 7820436, Chile; [Bauer, Franz E.] Space Sci Inst, Boulder, CO 80301 USA; [Krivonos, Roman A.; Barriere, Nicolas M.; Boggs, Steven E.; Craig, William W.; Tomsick, John A.; Zoglauer, Andreas] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Baganoff, Frederick K.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Christensen, Finn E.] Tech Univ Denmark, Natl Space Inst, DTU Space, DK-2800 Lyngby, Denmark; [Craig, William W.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Grefenstette, Brian W.; Harrison, Fiona A.; Madsen, Kristin K.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Grindlay, Jonathan E.; Hong, Jaesub] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Stern, Daniel] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Wik, Daniel R.; Zhang, William W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Columbia University; Haverford College; Pontificia Universidad Catolica de Chile; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Perez, K (corresponding author), Columbia Univ, Columbia Astrophys Lab, 550 West 120th St,Room 1027, New York, NY 10027 USA.	kperez1@haverford.edu	Krivonos, Roman/AAO-4707-2021; Boggs, Steven E/E-4170-2015; Mori, Kaya/ABH-2066-2021; christensen, finn/AAB-8622-2020	Krivonos, Roman/0000-0003-2737-5673; Boggs, Steven E/0000-0001-9567-4224; Madsen, Kristin/0000-0003-1252-4891; Stern, Daniel/0000-0003-2686-9241; Bauer, Franz Erik/0000-0002-8686-8737; Baganoff, Frederick/0000-0003-3852-6545; Zhang, Shuo/0000-0002-2967-790X	NASA [NNG08FD60C]; Basal-CATA [PFB-06/2007]; CONICYT-Chile [FONDECYT 1141218, EMBIGGEN Anillo ACT1101]; Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo [IC120009]	NASA(National Aeronautics & Space Administration (NASA)); Basal-CATA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo	This work was supported by NASA contract no. NNGO8FD60C, and made use of data from the NuSTAR mission, a project led by the California Institute of Technology, managed by the Jet Propulsion Laboratory, and funded by NASA. We thank the NuSTAR Operations, Software and Calibration teams for support with the execution and analysis of these observations. This research has made use of the NuSTAR Data Analysis Software (NuSTARDAS) jointly developed by the ASI Science Data Center (ASDC, Italy) and the California Institute of Technology (USA). We also than kA. Canipe, J. Dodaro, D. Hong and T.V.T. Luu for assistance with data preparation and analysis. F.E.B. acknowledges support from Basal-CATA PFB-06/2007, CONICYT-Chile (FONDECYT 1141218 and EMBIGGEN Anillo ACT1101), and Project IC120009 "Millennium Institute of Astrophysics (MAS)" funded by the Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo.	An H., 2014, P SOC PHOTO-OPT INS, V9144, P1; Arnaud KA, 1996, ASTR SOC P, V101, P17; Bamba A, 2010, ASTROPHYS J LETT, V719, pL116, DOI 10.1088/2041-8205/719/2/L116; Barriere NM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/46; Belanger G, 2006, ASTROPHYS J, V636, P275, DOI 10.1086/497629; Christopher MH, 2005, ASTROPHYS J, V622, P346, DOI 10.1086/427911; DAVIDSON JA, 1992, ASTROPHYS J, V387, P189, DOI 10.1086/171071; Degenaar N, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219470; Degenaar N, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015322; Fan JJ, 2013, PHYS DARK UNIVERSE, V2, P139, DOI 10.1016/j.dark.2013.07.001; Fruscione A. A., 2006, P SOC PHOTO-OPT INS, V6270, P1; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Goldwurm A, 2011, ASTR SOC P, V439, P391; Heard V, 2013, MON NOT R ASTRON SOC, V428, P3462, DOI 10.1093/mnras/sts284; Heinke CO, 2010, ASTROPHYS J, V714, P894, DOI 10.1088/0004-637X/714/1/894; Homan J, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/9; Hooper D, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.123005; Johnson SP, 2009, MON NOT R ASTRON SOC, V399, P1429, DOI 10.1111/j.1365-2966.2009.15362.x; Krivonos R, 2007, ASTRON ASTROPHYS, V463, P957, DOI 10.1051/0004-6361:20065626; Lu FJ, 2008, ASTROPHYS J, V673, P915, DOI 10.1086/524369; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Menou K, 1999, ASTROPHYS J, V513, P811, DOI 10.1086/306878; Menten KM, 1997, ASTROPHYS J, V475, pL111, DOI 10.1086/310472; Merrit D., 2013, PRINCETON SERIES AST; Muno MP, 2009, ASTROPHYS J SUPPL S, V181, P110, DOI 10.1088/0067-0049/181/1/110; Muno MP, 2005, ASTROPHYS J, V622, pL113, DOI 10.1086/429721; Muno MP, 2004, ASTROPHYS J, V613, P1179, DOI 10.1086/423164; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; Nynka M, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/119; Nynka M, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L31; Park S, 2005, ASTROPHYS J, V631, P964, DOI 10.1086/432639; Quataert E, 2005, ASTROPHYS J, V635, pL45, DOI 10.1086/499126; Revnivtsev M, 2009, NATURE, V458, P1142, DOI 10.1038/nature07946; Sakano M, 2004, MON NOT R ASTRON SOC, V350, P129, DOI 10.1111/j.1365-2966.2004.07571.x; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; Suleimanov V, 2005, ASTRON ASTROPHYS, V435, P191, DOI 10.1051/0004-6361:20041283; Takata J, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/100; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Wang QD, 2006, MON NOT R ASTRON SOC, V367, P937, DOI 10.1111/J.1365-2966.2006.09998.X; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Yuasa T, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/129; Zavlin VE, 2006, ASTROPHYS J, V638, P951, DOI 10.1086/449308; Zhang S, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/6; Zhao J.-H., 2014, IAU S, V303, P364	46	53	54	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					646	U138		10.1038/nature14353	http://dx.doi.org/10.1038/nature14353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925477	Green Accepted			2022-12-28	WOS:000353689700043
J	Allred, BW; Smith, WK; Twidwell, D; Haggerty, JH; Running, SW; Naugle, DE; Fuhlendorf, SD				Allred, Brady W.; Smith, W. Kolby; Twidwell, Dirac; Haggerty, Julia H.; Running, Steven W.; Naugle, David E.; Fuhlendorf, Samuel D.			Ecosystem services lost to oil and gas in North America	SCIENCE			English	Editorial Material							ENERGY DEVELOPMENT; FRAMEWORK; FRACKING; RISKS		[Allred, Brady W.; Smith, W. Kolby; Running, Steven W.; Naugle, David E.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Smith, W. Kolby] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Twidwell, Dirac] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA; [Haggerty, Julia H.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Fuhlendorf, Samuel D.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	University of Montana System; University of Montana; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; Montana State University System; Montana State University Bozeman; Oklahoma State University System; Oklahoma State University - Stillwater	Allred, BW (corresponding author), Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA.	brady.allred@umontana.edu	Noojipady, Praveen/B-2511-2010; Fuhlendorf, Samuel/A-2931-2011	Twidwell, Dirac/0000-0002-0280-3339; Fuhlendorf, Samuel/0000-0002-8726-9402; Smith, William/0000-0002-5785-6489; Haggerty, Julia/0000-0003-2073-4063	Office of Integrative Activities [1443108] Funding Source: National Science Foundation	Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))		Butt N, 2013, SCIENCE, V342, P425, DOI 10.1126/science.1237261; Drummond M. A., 2012, LAND COVER TRENDS US; Food and Agriculture Organization of the United Nations, 2014, WAT EN FOOD NEX; Gassert F., 2013, WORKING PAPER; International Energy Agency, 2013, WORLD EN OUTL 2013; Jackson RB, 2014, ANNU REV ENV RESOUR, V39, P327, DOI 10.1146/annurev-environ-031113-144051; Jacquet JB, 2014, ENVIRON SCI TECHNOL, V48, P8321, DOI 10.1021/es404647x; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Mitchell AL, 2011, ENVIRON SCI TECHNOL, V45, P9506, DOI 10.1021/es2021796; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Peters DPC, 2008, FRONT ECOL ENVIRON, V6, P229, DOI 10.1890/070098; Rabe BG, 2014, ENVIRON SCI TECHNOL, V48, P8369, DOI 10.1021/es4051132; Smith WK, 2012, ENVIRON SCI TECHNOL, V46, P3536, DOI 10.1021/es203935d; Sontag D, 2014, NEW YORK TIMES; US Energy Information Administration, 2013, INT EN OUTL; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Warner B, 2013, PUBLIUS J FEDERALISM, V43, P474, DOI 10.1093/publius/pjt014; Weber JG, 2012, ENERG ECON, V34, P1580, DOI 10.1016/j.eneco.2011.11.013; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	20	176	184	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					401	402		10.1126/science.aaa4785	http://dx.doi.org/10.1126/science.aaa4785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5NF	25908812				2022-12-28	WOS:000353338000021
J	Kiers, ET; West, SA				Kiers, E. Toby; West, Stuart A.			Evolving new organisms via symbiosis	SCIENCE			English	Editorial Material							TRANSMISSION		[Kiers, E. Toby] Vrije Univ, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Vrije Universiteit Amsterdam; University of Oxford	Kiers, ET (corresponding author), Vrije Univ, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.	toby.kiers@vu.nl	Toby, Kiers/H-4819-2017; West, Stuart/M-3608-2014	Toby, Kiers/0000-0002-0597-1653; West, Stuart/0000-0003-2152-3153				Archibald J, 2014, ONE PLUS ONE EQUALS; Bennett GM, 2013, GENOME BIOL EVOL, V5, P1675, DOI 10.1093/gbe/evt118; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Gruber-Vodicka HR, 2011, P NATL ACAD SCI USA, V108, P12078, DOI 10.1073/pnas.1105347108; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; McCutcheon JP, 2014, CURR BIOL, V24, pR654, DOI 10.1016/j.cub.2014.05.073; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Porter SS, 2014, ECOL LETT, V17, P1121, DOI 10.1111/ele.12318; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Szathmary E, 1995, MAJOR TRANSITIONS EV; Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047	15	48	48	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					392	394		10.1126/science.aaa9605	http://dx.doi.org/10.1126/science.aaa9605			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908807				2022-12-28	WOS:000353338000016
J	Schwartzstein, RM				Schwartzstein, Richard M.			Getting the Right Medical Students - Nature versus Nurture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schwartzstein, Richard M.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Schwartzstein, Richard M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Schwartzstein, RM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.		Schwartzstein, Richard/AGO-8549-2022; Schwartzstein, Richard/L-4420-2019					Association of American Medical Colleges, 2014, GRAD RAT ATTR FACT U; Krupat E, 2009, ACAD MED, V84, P582, DOI 10.1097/ACM.0b013e31819fa92d; Schwartzstein RM, 2013, ACAD MED, V88, P560, DOI 10.1097/ACM.0b013e31828c4ae0; Smith S, 2014, JAMA-J AM MED ASSOC, V312, P2407, DOI 10.1001/jama.2014.16066; Woloschuk W, 2004, MED EDUC, V38, P522, DOI 10.1046/j.1365-2929.2004.01820.x	5	18	20	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1586	1587		10.1056/NEJMp1501440	http://dx.doi.org/10.1056/NEJMp1501440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4XX	25901425	Bronze			2022-12-28	WOS:000353294000003
J	Zhong, M; Sun, H				Zhong, Ming; Sun, Hui			A Genetic Clog in the Vitamin A Transport Machinery	CELL			English	Editorial Material							CELLULAR UPTAKE; RECEPTOR; RETINOL; STRA6	Chou et al. discover a new mode of maternal inheritance by analyzing human mutations in plasma retinol binding protein (RBP). Mechanistically, these mutations simultaneously lower RBP's affinity for vitamin A and greatly increase its affinity for its cell-surface receptor, thus dominantly blocking the transmembrane transport of vitamin A.	[Zhong, Ming; Sun, Hui] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Physiol, Los Angeles, CA 90095 USA; [Zhong, Ming; Sun, Hui] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Physiol, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu			NATIONAL EYE INSTITUTE [R01EY018144] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY018144] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Green M. H., 1994, VITAMIN A HLTH DIS; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; Zhong M, 2012, NUTRIENTS, V4, P2069, DOI 10.3390/nu4122069	9	1	2	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					435	437		10.1016/j.cell.2015.04.020	http://dx.doi.org/10.1016/j.cell.2015.04.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910203	Bronze			2022-12-28	WOS:000353553600005
J	Boyce, WT				Boyce, W. Thomas			Fostering Early Brain Development	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Severe neglect in early life is associated with compromises in brain development and associated behavioral functioning. Although early intervention has been shown to support more normative trajectories of brain development, specific improvements in the white matter pathways that underlie emotional and cognitive development are unknown. OBJECTIVE To examine associations among neglect in early life, early intervention, and the microstructural integrity of white matter pathways in middle childhood. DESIGN, SETTING, AND PARTICIPANTS The Bucharest Early Intervention Project is a randomized clinical trial of high-quality foster care as an intervention for institutionally reared children in Bucharest, Romania, from 2000 through the present. During infancy, children were randomly selected to remain in an institution or to be placed in foster care. Those who remained in institutions experienced neglect, including social, emotional, linguistic, and cognitive impoverishment. Developmental trajectories of these children were compared with a group of sociodemographically matched children reared in biological families at baseline and several points throughout development. At approximately 8 years of age, 69 of the original 136 children underwent structural magnetic resonance imaging scans. MAIN OUTCOMES AND MEASURES Four estimates of white matter integrity (fractional anisotropy [FA] and mean [MD], radial [RD], and axial [AD] diffusivity) for 48 white matter tracts throughout the brain were obtained through diffusion tensor imaging. RESULTS Significant associations emerged between neglect in early life and microstructural integrity of the body of the corpus callosum (FA, beta = 0.01 [P =.01]; RD, beta = -0.02 [P = .005]; MD, beta = -0.01 [P = .02]) and tracts involved in limbic circuitry (fornix crus [AD, beta = 0.02 (P = .046)] and cingulum [RD, beta = -0.01 (P = .02); MD, beta = -0.01 (P = .049)]), frontostriatal circuitry (anterior [AD, beta = -0.01 (P = .02)] and superior [AD, beta = -0.02 (P = .02); MD, beta = -0.01 (P = .03)] corona radiata and external capsule [right FA, beta = 0.01 (P = .03); left FA, beta = 0.01 (P = .03); RD, beta = -0.01 (P = .01); MD, beta = -0.01 (P = .03)]), and sensory processing (medial lemniscus [AD, beta = -0.02 (P = .045); MD, beta = -0.01 (P = .04)] and retrolenticular internal capsule [FA, beta = -0.01 (P = .002); RD, beta = 0.01 (P = .003); MD, beta = 0.01 (P = .04)]). Follow-up analyses revealed that early intervention promoted more normative white matter development among previously neglected children who entered foster care. CONCLUSIONS AND RELEVANCE Results suggest that removal from conditions of neglect in early life and entry into a high-quality family environment can support more normative trajectories of white matter growth. Our findings have implications for public health and policy efforts designed to promote normative brain development among vulnerable children.	[Boyce, W. Thomas] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Boyce, W. Thomas] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Boyce, W. Thomas] Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Canadian Institute for Advanced Research (CIFAR)	Boyce, WT (corresponding author), Dept Pediat, 550 16th St,Fourth Floor, San Francisco, CA 94158 USA.	tom.boyce@ucsf.edu						Bick J, 2015, JAMA PEDIATR, V169, P211, DOI 10.1001/jamapediatrics.2014.3212; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Zeanah, 2014, ROMANIAS ABANDONED C	5	2	2	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1564	+		10.1001/jama.2015.34	http://dx.doi.org/10.1001/jama.2015.34			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898054	Green Published			2022-12-28	WOS:000353198700021
J	Kelley, NP; Pyenson, ND				Kelley, Neil P.; Pyenson, Nicholas D.			Evolutionary innovation and ecology in marine tetrapods from the Triassic to the Anthropocene	SCIENCE			English	Review							SEA-SNAKES ELAPIDAE; CONVERGENT EVOLUTION; FOSSIL CALIBRATIONS; SPECIES-DIVERSITY; MIOCENE EPOCH; PACIFIC-OCEAN; LIFE-HISTORY; GRAY WHALES; CLIMATE; ORIGIN	Many top consumers in today's oceans are marine tetrapods, a collection of lineages independently derived from terrestrial ancestors. The fossil record illuminates their transitions from land to sea, yet these initial invasions account for a small proportion of their evolutionary history. We review the history of marine invasions that drove major changes in anatomy, physiology, and ecology over more than 250 million years. Many innovations evolved convergently in multiple clades, whereas others are unique to individual lineages. The evolutionary arcs of these ecologically important clades are framed against the backdrop of mass extinctions and regime shifts in ocean ecosystems. Past and present human disruptions to marine tetrapods, with cascading impacts on marine ecosystems, underscore the need to link macroecology with evolutionary change.	[Kelley, Neil P.; Pyenson, Nicholas D.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20013 USA; [Kelley, Neil P.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37240 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal & Paleontol, Seattle, WA 98195 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Vanderbilt University	Kelley, NP (corresponding author), Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20013 USA.	kelleynp@si.edu		Pyenson, Nicholas/0000-0003-4678-5782	Smithsonian Institution Peter Buck Postdoctoral Fellowship; Smithsonian Institution National Museum of Natural History Small Grant Award; Remington Kellogg Fund; Basis Foundation	Smithsonian Institution Peter Buck Postdoctoral Fellowship; Smithsonian Institution National Museum of Natural History Small Grant Award; Remington Kellogg Fund; Basis Foundation	We thank D. Erwin, J. Jackson, M. Carrano, J. Goldbogen, J. Parham, J. Velez-Juarbe, and J. Oster for helpful comments on previous versions of this paper, and three anonymous reviewers for helpful suggestions. D. Johnston provided the penguin photograph for Fig. 2. Supported by a Smithsonian Institution Peter Buck Postdoctoral Fellowship (N.P.K.), a Smithsonian Institution National Museum of Natural History Small Grant Award and the Remington Kellogg Fund (N.D.P.), and the Basis Foundation (N.D.P. and N.P.K.).	Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Alter SE, 2015, MOL ECOL, V24, P1510, DOI 10.1111/mec.13121; Amson E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0192; Ando T, 2014, PALAEOGEOGR PALAEOCL, V400, P50, DOI 10.1016/j.palaeo.2013.08.002; Aubret F, 2008, FUNCT ECOL, V22, P317, DOI 10.1111/j.1365-2435.2007.01359.x; Aubret F, 2007, FUNCT ECOL, V21, P1154, DOI 10.1111/j.1365-2435.2007.01310.x; Bardet Nathalie, 1994, Historical Biology, V7, P313; Bardet N, 2008, B SOC GEOL FR, V179, P605, DOI 10.2113/gssgfbull.179.6.605; Benson RBJ, 2014, BIOL REV, V89, P1, DOI 10.1111/brv.12038; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; BONNELL ML, 1974, SCIENCE, V184, P908, DOI 10.1126/science.184.4139.908; Brischoux F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092617; BUTTEMER WA, 1993, OECOLOGIA, V96, P56, DOI 10.1007/BF00318031; Caldwell MW, 2012, B SOC GEOL FR, V183, P7, DOI 10.2113/gssgfbull.183.1.7; Caldwell MW, 2002, AM J MED GENET, V112, P236, DOI 10.1002/ajmg.10773; CARROLL RL, 1981, PHILOS T ROY SOC B, V293, P315, DOI 10.1098/rstb.1981.0079; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; COSTA DP, 1984, PHYSIOL ZOOL, V57, P199, DOI 10.1086/physzool.57.2.30163705; Cramp RL, 2008, J EXP BIOL, V211, P1482, DOI 10.1242/jeb.015636; de Bruyn PJN, 2013, BIOL REV, V88, P62, DOI 10.1111/j.1469-185X.2012.00239.x; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; DOMNING DP, 1976, SYST ZOOL, V25, P352, DOI 10.2307/2412510; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Elliott KH, 2013, P NATL ACAD SCI USA, V110, P9380, DOI 10.1073/pnas.1304838110; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fiedler PC, 2002, MAR ECOL PROG SER, V244, P265, DOI 10.3354/meps244265; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Fossi MC, 2014, MAR ENVIRON RES, V100, P17, DOI 10.1016/j.marenvres.2014.02.002; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Fulton TL, 2012, P ROY SOC B-BIOL SCI, V279, P2339, DOI 10.1098/rspb.2011.2599; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; Garrett JN, 2015, MAR MAMMAL SCI, V31, P459, DOI 10.1111/mms.12170; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; Gerrodette T, 2011, MAR MAMMAL SCI, V27, pE101, DOI 10.1111/j.1748-7692.2010.00449.x; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Gradstein F. M., 2012, GEOLOGIC TIME SCALE; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Heatwole H, 2012, INTEGR COMP BIOL, V52, P257, DOI 10.1093/icb/ics080; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hirayama R, 1998, NATURE, V392, P705, DOI 10.1038/33669; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Houssaye A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118409; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Howell A.B., 1930, AQUATIC MAMMALS THEI; Hubbs C. L., 1971, ANTARCTIC PINNIPEDIA, P35; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jones TL, 2008, P NATL ACAD SCI USA, V105, P4105, DOI 10.1073/pnas.0711140105; Joyce WG, 2013, J PALEONTOL, V87, P612, DOI 10.1666/12-149; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kelley NP, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0709; Kelley NP, 2014, PALAEOGEOGR PALAEOCL, V400, P9, DOI 10.1016/j.palaeo.2012.07.026; Krahl A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-123; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lindgren J, 2014, NATURE, V506, P484, DOI 10.1038/nature12899; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; LIPPS J H, 1976, Paleobiology, V2, P147; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; Maisch Michael W., 2010, Palaeodiversity, P151; Martin JE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5658; Martin JE, 2012, PALAEONTOLOGY, V55, P995, DOI 10.1111/j.1475-4983.2012.01159.x; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Mazzillo FFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082477; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Monson DH, 2000, OIKOS, V90, P457, DOI 10.1034/j.1600-0706.2000.900304.x; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Motani R, 2015, NATURE, V517, P485, DOI 10.1038/nature13866; Motani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088640; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Murphy JC, 2012, INTEGR COMP BIOL, V52, P217, DOI 10.1093/icb/ics060; Neenan JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2633; Noakes SE, 2013, PALAEOGEOGR PALAEOCL, V392, P502, DOI 10.1016/j.palaeo.2013.10.005; Norris RD, 2013, SCIENCE, V341, P492, DOI 10.1126/science.1240543; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; O'Keefe FR, 2002, PALEOBIOLOGY, V28, P101, DOI 10.1666/0094-8373(2002)028<0101:TEOPAP>2.0.CO;2; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; Organ CL, 2009, NATURE, V461, P389, DOI 10.1038/nature08350; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Pineiro G, 2012, ACTA PALAEONTOL POL, V57, P299, DOI 10.4202/app.2010.0113; Pyenson ND, 2014, PALAEOGEOGR PALAEOCL, V400, P1, DOI 10.1016/j.palaeo.2014.02.018; Pyenson ND, 2009, MAR MAMMAL SCI, V25, P714, DOI 10.1111/j.1748-7692.2008.00266.x; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; Rick T. C., 2008, HUMAN IMPACTS ON ANC; Ritter Fabian, 2012, Journal of Cetacean Research and Management, V12, P119; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sanders KL, 2010, J EVOLUTION BIOL, V23, P2685, DOI 10.1111/j.1420-9101.2010.02131.x; Sanders KL, 2013, MOL PHYLOGENET EVOL, V66, P575, DOI 10.1016/j.ympev.2012.09.021; Scheel DM, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.409.6244; Scheyer TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088987; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Smith AB, 2012, P ROY SOC B-BIOL SCI, V279, P4489, DOI 10.1098/rspb.2012.1793; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Thomas DB, 2011, BIOL LETTERS, V7, P461, DOI 10.1098/rsbl.2010.0993; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Turvey ST, 2006, BIOL LETTERS, V2, P94, DOI 10.1098/rsbl.2005.0415; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Velez-Juarbe J., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031304, DOI 10.1371/JOURNAL.PONE.0031304]; Velez-Juarbe J, 2007, P ROY SOC B-BIOL SCI, V274, P1245, DOI 10.1098/rspb.2006.0455; Velez-Juarbe J, 2014, PALAEOGEOGR PALAEOCL, V400, P41, DOI 10.1016/j.palaeo.2013.05.012; Vermeij GJ, 2013, ANNU REV EARTH PL SC, V41, P1, DOI 10.1146/annurev-earth-050212-124123; VERMEIJ GJ, 1993, CONSERV BIOL, V7, P391, DOI 10.1046/j.1523-1739.1993.07020391.x; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P419, DOI 10.1666/0094-8373(2000)026<0419:DHATAO>2.0.CO;2; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Worthy TH, 2007, J SYST PALAEONTOL, V5, P1, DOI 10.1017/S1477201906001957; Wright LI, 2012, P ROY SOC B-BIOL SCI, V279, P2122, DOI 10.1098/rspb.2011.2285	142	96	99	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232							aaa3716	10.1126/science.aaa3716	http://dx.doi.org/10.1126/science.aaa3716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883362				2022-12-28	WOS:000352999000033
J	Langner-Wegscheider, BJ; Krause, R				Langner-Wegscheider, Beate J.; Krause, Robert			Hyphema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Langner-Wegscheider, Beate J.; Krause, Robert] Med Univ Graz, Graz, Austria	Medical University of Graz	Langner-Wegscheider, BJ (corresponding author), Med Univ Graz, Graz, Austria.	robert.krause@medunigraz.at							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1549	1549		10.1056/NEJMicm1108425	http://dx.doi.org/10.1056/NEJMicm1108425			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875260				2022-12-28	WOS:000352856500010
J	Marx, V				Marx, Vivien			A MOST EXCEPTIONAL RESPONSE	NATURE			English	Editorial Material							EVEROLIMUS											Costello J. C., 2015, NAT BIOTECHNOL, V32, P1202; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352	6	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					389	393		10.1038/520389a	http://dx.doi.org/10.1038/520389a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877204				2022-12-28	WOS:000352974200050
J	Hoorn, C; Flantua, S				Hoorn, Carina; Flantua, Suzette			An early start for the Panama land bridge	SCIENCE			English	Editorial Material							MIDDLE MIOCENE; EVOLUTION; ISTHMUS; LANDSCAPE; AMAZONIA		[Hoorn, Carina; Flantua, Suzette] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands	University of Amsterdam	Hoorn, C (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands.	m.c.hoorn@uva.nl	Flantua, Suzette/AAY-7004-2021; Hoorn, Carina/A-9372-2015	Flantua, Suzette/0000-0001-6526-3037; Hoorn, Carina/0000-0001-5402-6191				Bacon CD, 2013, BOT J LINN SOC, V171, P287, DOI 10.1111/j.1095-8339.2012.01281.x; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Boonstra M, 2015, PALAEOGEOGR PALAEOCL, V417, P176, DOI 10.1016/j.palaeo.2014.10.032; Boschman LM, 2014, EARTH-SCI REV, V138, P102, DOI 10.1016/j.earscirev.2014.08.007; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Farris DW, 2011, GEOLOGY, V39, P1007, DOI 10.1130/G32237.1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; MARSHALL LG, 1982, SCIENCE, V215, P1351, DOI 10.1126/science.215.4538.1351; Molnar P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001574; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Montes C, 2012, GEOL SOC AM BULL, V124, P780, DOI 10.1130/B30528.1; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Sepulchre P, 2014, PALEOCEANOGRAPHY, V29, P176, DOI 10.1002/2013PA002501; Stone R, 2013, SCIENCE, V341, P230, DOI 10.1126/science.341.6143.230	15	27	29	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					186	187		10.1126/science.aab0099	http://dx.doi.org/10.1126/science.aab0099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859033				2022-12-28	WOS:000352613700025
J	Mastrobuono-Battisti, A; Perets, HB; Raymond, SN				Mastrobuono-Battisti, Alessandra; Perets, Hagai B.; Raymond, Sean N.			A primordial origin for the compositional similarity between the Earth and the Moon	NATURE			English	Article							GIANT IMPACT; SIMULATIONS; ACCRETION; ISOTOPES	Most of the properties of the Earth-Moon system can be explained by a collision between a planetary embryo (giant impactor) and the growing Earth late in the accretion process'. Simulations show that most of the material that eventually aggregates to form the Moon originates from the impactor(1,4,5). However, analysis of the terrestrial and lunar isotopic compositions show them to be highly similar(6-11). In contrast, the compositions of other Solar System bodies are significantly different from those of the Earth and Moon(12-14), suggesting that different Solar System bodies have distinct compositions. This challenges the giant impact scenario, because the Moon-forming impactor must then also be thought to have a composition different from that of the proto-Earth. Here we track the feeding zones of growing planets in a suite of simulations of planetary accretion(15), to measure the composition of Moon-forming impactors. We find that different planets formed in the same simulation have distinct compositions, but the compositions of giant impactors are statistically more similar to the planets they impact. A large fraction of planet-impactor pairs have almost identical compositions. Thus, the similarity in composition between the Earth and Moon could be a natural consequence of a late giant impact.	[Mastrobuono-Battisti, Alessandra; Perets, Hagai B.] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Raymond, Sean N.] CNRS, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Raymond, Sean N.] Univ Bordeaux, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France	Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Mastrobuono-Battisti, A (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	amastrobuono@physics.technion.ac.il; hperets@physics.technion.ac.il	Perets, Hagai B/K-9605-2015	Perets, Hagai B/0000-0002-5004-199X; Mastrobuono-Battisti, Alessandra/0000-0002-2386-9142; Raymond, Sean/0000-0001-8974-0758	BSF [2012384]; Minerva Center for Life under Extreme Planetary Conditions; ISF I-CORE [1829/12]; Marie Curie IRG [333644 'GRAND']; Agence Nationale pour la Recherche [ANR-13-BS05-0003-002]	BSF(US-Israel Binational Science Foundation); Minerva Center for Life under Extreme Planetary Conditions; ISF I-CORE; Marie Curie IRG(European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	H.B.P. acknowledges support from BSF grant number 2012384, the Minerva Center for Life under Extreme Planetary Conditions, the ISF I-CORE grant number 1829/12 and the Marie Curie IRG 333644 'GRAND' grant S.N.R. acknowledges funding from the Agence Nationale pour la Recherche via grant ANR-13-BS05-0003-002 (project MOJO). We thank O. Aharonson for remarks on an early version of this manuscript. We thank N. Kaib and N. Cowan for helpful discussions on their related work.	Asphaug E, 2014, ANNU REV EARTH PL SC, V42, P551, DOI 10.1146/annurev-earth-050212-124057; Belbruno E, 2005, ASTRON J, V129, P1724, DOI 10.1086/427539; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Canup RM, 2008, ICARUS, V196, P518, DOI 10.1016/j.icarus.2008.03.011; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Elliott T, 2013, NATURE, V504, P90, DOI 10.1038/504090a; Herwartz D, 2014, SCIENCE, V344, P1146, DOI 10.1126/science.1251117; Jacobson SA, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0174; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond S. N., 2014, PROTOSTARS PLANETS, P585; Raymond SN, 2006, ICARUS, V183, P265, DOI 10.1016/j.icarus.2006.03.011; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; RINGWOOD AE, 1986, NATURE, V322, P323, DOI 10.1038/322323a0; Salmon J, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/83; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	26	49	50	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					212	U165		10.1038/nature14333	http://dx.doi.org/10.1038/nature14333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855458	Green Submitted			2022-12-28	WOS:000352454600037
J	Mulder, R				Mulder, Roger			Depression relapse: importance of a long-term perspective	LANCET			English	Editorial Material							DRUG-TREATMENT; PREVENTION; DISORDERS		Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand	University of Otago	Mulder, R (corresponding author), Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand.	roger.mulder@otago.ac.nz						Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Bateman AW, 2015, LANCET, V385, P735, DOI 10.1016/S0140-6736(14)61394-5; Beshai S, 2011, CLIN PSYCHOL REV, V31, P1349, DOI 10.1016/j.cpr.2011.09.003; Borges S, 2014, J CLIN PSYCHIAT, V75, P205, DOI 10.4088/JCP.13r08722; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Kraepelin E., 1919, CUTTING SHEPHERD; Kuyken W., 2015, LANCET; Mulder RT, 2014, AUST NZ J PSYCHIAT, V48, P224, DOI 10.1177/0004867413514490; Mulder RT, 2009, J AFFECT DISORDERS, V114, P263, DOI 10.1016/j.jad.2008.08.002; Segal Z. V., 2002, MINDFULNESS BASED CO; Steinert C, 2014, J AFFECT DISORDERS, V152, P65, DOI 10.1016/j.jad.2013.10.017	11	7	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					10	12		10.1016/S0140-6736(14)62448-X	http://dx.doi.org/10.1016/S0140-6736(14)62448-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM2OA	25907156	hybrid			2022-12-28	WOS:000357519400008
J	Dhital, KK; Iyer, A; Connellan, M; Chew, HC; Gao, L; Doyle, A; Hicks, M; Kumarasinghe, G; Soto, C; Dinale, A; Cartwright, B; Nair, P; Granger, E; Jansz, P; Jabbour, A; Kotlyar, E; Keogh, A; Hayward, C; Graham, R; Spratt, P; Macdonald, P				Dhital, Kumud K.; Iyer, Arjun; Connellan, Mark; Chew, Hong C.; Gao, Ling; Doyle, Aoife; Hicks, Mark; Kumarasinghe, Gayathri; Soto, Claude; Dinale, Andrew; Cartwright, Bruce; Nair, Priya; Granger, Emily; Jansz, Paul; Jabbour, Andrew; Kotlyar, Eugene; Keogh, Anne; Hayward, Christopher; Graham, Robert; Spratt, Phillip; Macdonald, Peter			Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series	LANCET			English	Article							CARDIAC-DEATH; HUMAN DONATION; DCD DONORS; ALLOGRAFTS; OUTCOMES; REANIMATION; SURVIVAL; KIDNEYS	Background Orthotopic heart transplantation is the gold-standard long-term treatment for medically refractive endstage heart failure. However, suitable cardiac donors are scarce. Although donation after circulatory death has been used for kidney, liver, and lung transplantation, it is not used for heart transplantation. We report a case series of heart transplantations from donors after circulatory death. Methods The recipients were patients at St Vincent's Hospital, Sydney, Australia. They received Maastricht category III controlled hearts donated after circulatory death from people younger than 40 years and with a maximum warm ischaemic time of 30 min. We retrieved four hearts through initial myocardial protection with supplemented cardioplegia and transferred to an Organ Care System (Transmedics) for preservation, resuscitation, and transportation to the recipient hospital. Findings Three recipients (two men, one woman; mean age 52 years) with low transpulmonary gradients (<8 mm Hg) and without previous cardiac surgery received the transplants. Donor heart warm ischaemic times were 28 min, 25 min, and 22 min, with ex-vivo Organ Care System perfusion times of 257 min, 260 min, and 245 min. Arteriovenous lactate values at the start of perfusion were 8.3-8.1 mmol/L for patient 1, 6.79-6.48 mmol/L for patient 2, and 7.6-7.4 mmol/L for patient 3. End of perfusion lactate values were 3.6-3.6 mmol/L, 2.8-2.3 mmol/L, and 2.69-2.54 mmol/L, respectively, showing favourable lactate uptake. Two patients needed temporary mechanical support. All three recipients had normal cardiac function within a week of transplantation and are making a good recovery at 176, 91, and 77 days after transplantation. Interpretation Strict limitations on donor eligibility, optimised myocardial protection, and use of a portable ex-vivo organ perfusion platform can enable successful, distantly procured orthotopic transplantation of hearts donated after circulatory death.	[Dhital, Kumud K.; Iyer, Arjun; Connellan, Mark; Chew, Hong C.; Granger, Emily; Jansz, Paul; Kotlyar, Eugene; Keogh, Anne; Hayward, Christopher; Spratt, Phillip; Macdonald, Peter] St Vincents Hosp, Heart & Lung Transplant Unit, Sydney, NSW 2010, Australia; [Dhital, Kumud K.; Iyer, Arjun; Connellan, Mark; Chew, Hong C.; Soto, Claude; Dinale, Andrew; Granger, Emily; Jansz, Paul; Spratt, Phillip] St Vincents Hosp, Dept Cardiothorac Surg, Sydney, NSW 2010, Australia; [Jabbour, Andrew; Kotlyar, Eugene; Keogh, Anne; Hayward, Christopher; Graham, Robert; Macdonald, Peter] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Cartwright, Bruce] St Vincents Hosp, Dept Anaesthesia, Sydney, NSW 2010, Australia; [Soto, Claude; Dinale, Andrew] St Vincents Hosp, Dept Clin Perfus, Sydney, NSW 2010, Australia; [Hicks, Mark] St Vincents Hosp, Dept Clin Pharmacol, Sydney, NSW 2010, Australia; [Nair, Priya] St Vincents Hosp, Dept Intens Care, Sydney, NSW 2010, Australia; [Dhital, Kumud K.; Iyer, Arjun; Chew, Hong C.; Gao, Ling; Doyle, Aoife; Kumarasinghe, Gayathri; Jabbour, Andrew; Graham, Robert; Macdonald, Peter] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Dhital, Kumud K.; Granger, Emily; Jansz, Paul; Jabbour, Andrew; Kotlyar, Eugene; Keogh, Anne; Hayward, Christopher; Graham, Robert; Spratt, Phillip; Macdonald, Peter] Univ New S Wales, St Vincents Clin Sch, Fac Med, Randwick, NSW, Australia; [Hicks, Mark] Univ New S Wales, Dept Physiol & Pharmacol, Randwick, NSW, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney	Dhital, KK (corresponding author), St Vincents Hosp, 390 Victoria St, Darlinghurst, NSW 2010, Australia.	kumud.dhital@svha.org.au	Macdonald, Peter/Q-3188-2019	Jansz, Paul/0000-0002-4721-5549	NHMRC; John T Reid Charitable Trust; EVOS Trust Fund; Harry Windsor Trust Fund; National Health and Medical Research Council [573732]; National Heart Foundation of Australia [G04S 1619, G07S 3044]; St Vincent's Clinic Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); John T Reid Charitable Trust; EVOS Trust Fund; Harry Windsor Trust Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); St Vincent's Clinic Foundation	NHMRC, John T Reid Charitable Trust, EVOS Trust Fund, Harry Windsor Trust Fund.; This study was funded by the National Health and Medical Research Council (Program Grant 573732), the John T Reid Charitable Trust, the EVOS Trust Fund, National Heart Foundation of Australia (grants G04S 1619 and G07S 3044), St Vincent's Clinic Foundation, and the Harry Windsor Trust Fund. We thank the Ministry of Health, NSW, Australia. Abdominal transplant surgeons: Michael Crawford, Henry Pleass, and Deborah Verran. Transplant coordinators: Peta Tunnicliff, Elyn Montgomery, Angela Smith, Natalie Hay, Vicky Morgan, Michelle Harkess, and Sara Shaw. Staff at New South Wales donor hospital intensive care units: P Saul, John Hunter Hospital; A Aneman, Liverpool Hospital; A Rajamani, Nepean Hospital; G Flynn, Prince of Wales Hospital; R Raper, Royal North Shore Hospital; R Herkes, Royal Prince Alfred Hospital; A Cheng, St George Hospital; S Al-Soufi, St Vincent's Hospital; D Goh, Westmead Hospital; M MacPartlin, Wollongong Hospital.	Ali AA, 2011, AM J TRANSPLANT, V11, P1621, DOI 10.1111/j.1600-6143.2011.03622.x; Ali A, 2009, J HEART LUNG TRANSPL, V28, P290, DOI 10.1016/j.healun.2008.12.014; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Cypel M, 2013, J HEART LUNG TRANSPL, V32, pS15, DOI 10.1016/j.healun.2013.01.017; Dubbeld J, 2010, BRIT J SURG, V97, P259; Hamed A, 2009, J HEART LUNG TRANSPL, V28, pS71, DOI 10.1016/j.healun.2008.11.025; Iyer A, 2015, AM J TRANSPLANT, V15, P371, DOI 10.1111/ajt.12994; Iyer A, 2014, AM J TRANSPLANT, V14, P1744, DOI 10.1111/ajt.12782; Iyer A, 2014, J HEART LUNG TRANSPL, V33, pS119, DOI 10.1016/j.healun.2014.01.038; Iyer A, 2013, TRANSPLANTATION, V96, pS217; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; Levvey BJ, 2012, AM J TRANSPLANT, V12, P2406, DOI 10.1111/j.1600-6143.2012.04193.x; Listijono DR, 2011, J HEART LUNG TRANSPL, V30, P783, DOI 10.1016/j.healun.2011.01.728; Longnus SL, 2014, NAT REV CARDIOL, V11, P354, DOI 10.1038/nrcardio.2014.45; Messer S, 2015, TRANSPL INT, V28, P634, DOI 10.1111/tri.12361; Osaki S, 2006, ANN THORAC SURG, V81, P2167, DOI 10.1016/j.athoracsur.2006.01.066; Osaki S, 2014, J THORAC CARDIOV SUR, V148, P1123, DOI 10.1016/j.jtcvs.2014.06.050; Osaki S, 2010, EUR J CARDIO-THORAC, V37, P74, DOI 10.1016/j.ejcts.2009.07.005; Repse S, 2010, J HEART LUNG TRANSPL, V29, P747, DOI 10.1016/j.healun.2010.02.009; Rosenfeldt F, 2014, HEART LUNG CIRC, V23, P88, DOI 10.1016/j.hlc.2013.07.011; Rudge C, 2012, BRIT J ANAESTH, V108, pI48, DOI 10.1093/bja/aer399; Russo MJ, 2007, J THORAC CARDIOV SUR, V133, P554, DOI 10.1016/j.jtcvs.2006.09.019; Saez DG, 2014, ANN THORAC SURG, V98, P2099, DOI 10.1016/j.athoracsur.2014.06.098; Singhal AK, 2005, J HEART LUNG TRANSPL, V24, P1657, DOI 10.1016/j.healun.2004.11.043; Snoeijs MG, 2010, J AM SOC NEPHROL, V21, P1015, DOI 10.1681/ASN.2009121203; Summers DM, 2010, LANCET, V376, P1303, DOI 10.1016/S0140-6736(10)60827-6; Watson AJ, 2013, AM J TRANSPLANT, V13, P1676, DOI 10.1111/ajt.12249; Windsor H, 1968, Med J Aust, V1, P869	29	235	240	2	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2585	2591		10.1016/S0140-6736(15)60038-1	http://dx.doi.org/10.1016/S0140-6736(15)60038-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25888085				2022-12-28	WOS:000356930000025
J	Garon, EB; Rizvi, NA; Hui, RN; Leighl, N; Balmanoukian, AS; Eder, JP; Patnaik, A; Aggarwal, C; Gubens, M; Horn, L; Carcereny, E; Ahn, MJ; Felip, E; Lee, JS; Hellmann, MD; Hamid, O; Goldman, JW; Soria, JC; Dolled-Filhart, M; Rutledge, RZ; Zhang, J; Lunceford, JK; Rangwala, R; Lubiniecki, GM; Roach, C; Emancipator, K; Gandhi, L				Garon, Edward B.; Rizvi, Naiyer A.; Hui, Rina; Leighl, Natasha; Balmanoukian, Ani S.; Eder, Joseph Paul; Patnaik, Amita; Aggarwal, Charu; Gubens, Matthew; Horn, Leora; Carcereny, Enric; Ahn, Myung-Ju; Felip, Enriqueta; Lee, Jong-Seok; Hellmann, Matthew D.; Hamid, Omid; Goldman, Jonathan W.; Soria, Jean-Charles; Dolled-Filhart, Marisa; Rutledge, Ruth Z.; Zhang, Jin; Lunceford, Jared K.; Rangwala, Reshma; Lubiniecki, Gregory M.; Roach, Charlotte; Emancipator, Kenneth; Gandhi, Leena		KEYNOTE-001 Investigators	Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-PD-L1 ANTIBODY; PD-L1 EXPRESSION; BLOCKADE; B7-H1; CHEMOTHERAPY; SAFETY; CRIZOTINIB; RESPONSES; THERAPY; LIGANDS	BACKGROUND We assessed the efficacy and safety of programmed cell death 1 (PD-1) inhibition with pembrolizumab in patients with advanced non-small-cell lung cancer enrolled in a phase 1 study. We also sought to define and validate an expression level of the PD-1 ligand 1 (PD-L1) that is associated with the likelihood of clinical benefit. METHODS We assigned 495 patients receiving pembrolizumab (at a dose of either 2 mg or 10 mg per kilogram of body weight every 3 weeks or 10 mg per kilogram every 2 weeks) to either a training group (182 patients) or a validation group (313 patients). We assessed PD-L1 expression in tumor samples using immunohistochemical analysis, with results reported as the percentage of neoplastic cells with staining for membranous PD-L1 (proportion score). Response was assessed every 9 weeks by central review. RESULTS Common side effects that were attributed to pembrolizumab were fatigue, pruritus, and decreased appetite, with no clear difference according to dose or schedule. Among all the patients, the objective response rate was 19.4%, and the median duration of response was 12.5 months. The median duration of progression-free survival was 3.7 months, and the median duration of overall survival was 12.0 months. PD-L1 expression in at least 50% of tumor cells was selected as the cutoff from the training group. Among patients with a proportion score of at least 50% in the validation group, the response rate was 45.2%. Among all the patients with a proportion score of at least 50%, median progression-free survival was 6.3 months; median overall survival was not reached. CONCLUSIONS Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer. PD-L1 expression in at least 50% of tumor cells correlated with improved efficacy of pembrolizumab.	[Garon, Edward B.; Goldman, Jonathan W.] UCLA, David Geffen Sch Med, Santa Monica, CA 90404 USA; [Balmanoukian, Ani S.; Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA; [Gubens, Matthew] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Roach, Charlotte] Dako, Carpinteria, CA USA; [Rizvi, Naiyer A.] Columbia Univ, New York, NY USA; [Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hellmann, Matthew D.] Weill Cornell Med Coll, New York, NY USA; [Hui, Rina] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Leighl, Natasha] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Eder, Joseph Paul] Yale Univ, New Haven, CT USA; [Patnaik, Amita] South Texas Accelerated Res Therapeut, San Antonio, TX USA; [Aggarwal, Charu] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Horn, Leora] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Carcereny, Enric] Catalan Inst Oncol Badalona, Badalona, Spain; [Felip, Enriqueta] Vall dHebron Univ Hosp, Barcelona, Spain; [Felip, Enriqueta] Vall dHebron Inst Oncol, Barcelona, Spain; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Lee, Jong-Seok] Seoul Natl Univ, Seoul, South Korea; [Soria, Jean-Charles] Inst Gustave Roussy, Villejuif, France; [Soria, Jean-Charles] Univ Paris 11, Villejuif, France; [Dolled-Filhart, Marisa; Rutledge, Ruth Z.; Zhang, Jin; Lunceford, Jared K.; Rangwala, Reshma; Lubiniecki, Gregory M.; Emancipator, Kenneth] Merck, Kenilworth, NJ USA; [Gandhi, Leena] Dana Farber Canc Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Angeles Clinic & Research Institute; University of California System; University of California San Francisco; Columbia University; Memorial Sloan Kettering Cancer Center; Cornell University; University of Sydney; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Yale University; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Catalan Institute of Oncology; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Merck & Company; Harvard University; Dana-Farber Cancer Institute	Garon, EB (corresponding author), UCLA, David Geffen Sch Med, Translat Oncol Res Lab, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA.	egaron@mednet.ucla.edu	Zhang, Jin/E-8298-2017; Soria, Jean-Charles/F-3619-2014; Garassino, Marina/D-7128-2017	INSA, AMELIA/0000-0002-3438-6170; Balmana, Judith/0000-0002-0762-6415; Gandhi, Leena/0000-0002-2398-9179; Santini, Daniele/0000-0002-9118-3337; FELIP, ENRIQUETA/0000-0002-7620-0098; Garassino, Marina/0000-0002-3821-5598	Merck Sharp & Dohme, a subsidiary of Merck; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Merck Sharp & Dohme, a subsidiary of Merck; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Merck Sharp & Dohme, a subsidiary of Merck.	Ahamadi M, 2014, 23 M POP APPR GROUP; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2013, GLOBOCAN 2012 VERSIO, V11; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gandhi L, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-CT105; Gerber DE, 2013, J CLIN ONCOL, V31, P1009, DOI 10.1200/JCO.2012.43.7459; Gettinger S, 2014, CANCER J, V20, P281, DOI 10.1097/PPO.0000000000000063; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Leighl NB, 2012, CURR ONCOL, V19, pS52, DOI 10.3747/co.19.1114; Lindauer A, 2014, 23 M POP APPR GROUP; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Robert C, 2014, ANN ONCOL, V25, pLBA34; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sorensen S, 2014, ANN ONCOL         S4, V25, p1328P; Sun JM, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8066; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang A, 2015, EJSO-EUR J SURG ONC, V41, P450, DOI 10.1016/j.ejso.2015.01.020; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	40	4094	4275	16	411	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2018	2028		10.1056/NEJMoa1501824	http://dx.doi.org/10.1056/NEJMoa1501824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25891174				2022-12-28	WOS:000354809300008
J	Drost, J; van Jaarsveld, RH; Ponsioen, B; Zimberlin, C; van Boxtel, R; Buijs, A; Sachs, N; Overmeer, RM; Offerhaus, GJ; Begthel, H; Korving, J; van de Wetering, M; Schwank, G; Logtenberg, M; Cuppen, E; Snippert, HJ; Medema, JP; Kops, GJPL; Clevers, H				Drost, Jarno; van Jaarsveld, Richard H.; Ponsioen, Bas; Zimberlin, Cheryl; van Boxtel, Ruben; Buijs, Arjan; Sachs, Norman; Overmeer, Rene M.; Offerhaus, G. Johan; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Snippert, Hugo J.; Medema, Jan Paul; Kops, Geert J. P. L.; Clevers, Hans			Sequential cancer mutations in cultured human intestinal stem cells	NATURE			English	Article							IN-VITRO EXPANSION; STRUCTURAL BASIS; ORGANOIDS; ADENOMAS; REVEALS; COLON	Crypt stem cells represent the cells of origin for intestinal neoplasia. Both mouse and human intestinal stem cells can be cultured in medium containing the stem-cell-niche factors WNT, R-spondin, epidermal growth factor (EGF) and noggin over long time periods as epithelial organoids that remain genetically and phenotypically stable. Here we utilize CRISPR/Cas9 technology for targeted gene modification of four of the most commonly mutated colorectal cancer genes (APC, P53 (also known as TP53), KRAS and SMAD4) in cultured human intestinal stem cells. Mutant organoids can be selected by removing individual growth factors from the culture medium. Quadruple mutants grow independently of all stem-cell-niche factors and tolerate the presence of the P53 stabilizer nutlin-3. Upon xenotransplantation into mice, quadruple mutants grow as tumours with features of invasive carcinoma. Finally, combined loss of APC and P53 is sufficient for the appearance of extensive aneuploidy, a hallmark of tumour progression.	[Drost, Jarno; van Boxtel, Ruben; Sachs, Norman; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; van Boxtel, Ruben; Sachs, Norman; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Clevers, Hans] UMC Utrecht, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; van Jaarsveld, Richard H.; Ponsioen, Bas; Zimberlin, Cheryl; van Boxtel, Ruben; Sachs, Norman; Overmeer, Rene M.; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Snippert, Hugo J.; Medema, Jan Paul; Kops, Geert J. P. L.; Clevers, Hans] UMC Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands; [van Jaarsveld, Richard H.; Ponsioen, Bas; Overmeer, Rene M.; Snippert, Hugo J.; Kops, Geert J. P. L.] UMC Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Zimberlin, Cheryl; Medema, Jan Paul] AMC, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; [Buijs, Arjan] UMC Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Offerhaus, G. Johan] UMC Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [van de Wetering, Marc] Fdn Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Drost, Jarno/J-9758-2012; Drost, Jarno/M-6964-2017; Cuppen, Edwin/F-5696-2011; Schwank, Gerald/A-8586-2018; Cuppen, Edwin/H-2389-2016; Schwank, Gerald/AAE-6640-2020; Overmeer, René M/E-5698-2011	Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; Cuppen, Edwin/0000-0002-0400-9542; Schwank, Gerald/0000-0003-0767-2953; Cuppen, Edwin/0000-0002-0400-9542; Schwank, Gerald/0000-0003-0767-2953; Kops, Geert/0000-0003-3555-5295; Logtenberg, Meike/0000-0002-8981-1189; van Jaarsveld, Richard H/0000-0001-5247-6965; van Boxtel, Ruben/0000-0003-1285-2836; Medema, Jan Paul/0000-0003-3045-2924	Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant [91614138]; University of Amsterdam [2012-5735]; Dutch Digestive Diseases Foundation (MLDS) [FP13-07]; Netherlands Institute of Regenerative Medicine; Dutch Cancer Society (KWF) [KWF/PF-HUBR 2007-3956, UU2013-6070]; Stand Up to Cancer/Stichting Vrienden van het Hubrecht; NWO-ZonMw [116.005.002]; CancerGenomics.nl (NWO Gravitation) program	Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam; Dutch Digestive Diseases Foundation (MLDS); Netherlands Institute of Regenerative Medicine; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Stand Up to Cancer/Stichting Vrienden van het Hubrecht; NWO-ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); CancerGenomics.nl (NWO Gravitation) program	We would like to thank H. M. Rodermond for help with in vivo transplantation assays and members of the contributing laboratories for support. We thank A. Pronk, W. van Houdt and J. van Gorp for facilitating human colon tissue. We are grateful for support from the following: The Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant to J.D. (91614138); University of Amsterdam (2012-5735) and The Dutch Digestive Diseases Foundation (MLDS) (FP13-07) to C.Z. and J.P.M.; Netherlands Institute of Regenerative Medicine (N.S. and G.S.); Dutch Cancer Society (KWF) (KWF/PF-HUBR 2007-3956 for H.B.; KWF Fellowship UU2013-6070 for H.J.S.); Stand Up to Cancer/Stichting Vrienden van het Hubrecht (M.v.d.W.); NWO-ZonMw (116.005.002 for R.v.B.); and the CancerGenomics.nl (NWO Gravitation) program.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; HERBERGS J, 1994, INT J CANCER, V57, P781, DOI 10.1002/ijc.2910570604; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Van de Wetering M., CELL IN PRESS; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	32	608	630	20	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					43	U329		10.1038/nature14415	http://dx.doi.org/10.1038/nature14415			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924068				2022-12-28	WOS:000354040900028
J	Padian, K				Padian, Kevin			PALAEONTOLOGY Dinosaur up in the air	NATURE			English	Editorial Material							FLIGHT		[Padian, Kevin] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Padian, Kevin] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Padian, K (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kpadian@berkeley.edu						Agnolin F.L., 2013, AVIAN ANCESTORS REV; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Ji Q., 1997, CHINESE GEOL, V238, P38; Long J.A., 2008, FEATHERED DINOSAURS; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; PADIAN K, 1997, ENCY DINOSAURS, P71; PENNYCUICK CJ, 1972, ANIMAL FLIGHT; RAYNER JMV, 1979, J EXP BIOL, V80, P17; Xu X, 2015, NATURE, V521, P70, DOI 10.1038/nature14423	9	1	1	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					40	41		10.1038/nature14392	http://dx.doi.org/10.1038/nature14392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924067				2022-12-28	WOS:000354040900026
J	MacGregor, GA; He, FJ; Pombo-Rodrigues, S				MacGregor, Graham A.; He, Feng J.; Pombo-Rodrigues, Sonia			Food and the responsibility deal: how the salt reduction strategy was derailed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[MacGregor, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Cardiovasc Med, Wolfson Inst Prevent Med, London EC1M 6BQ, England; [He, Feng J.; Pombo-Rodrigues, Sonia] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	MacGregor, GA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Cardiovasc Med, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	g.macgregor@qmul.ac.uk	Pombo-Rodrigues, Sonia/ABA-7019-2020; He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744				Brinsden HC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002936; Department of Health, PUBL HLTH RESP DEAL; Department of Health, 2011, ASS DIET SOD LEV AD; Department of Health, RESP DEAL; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2006, NEW SALT RED TARG PU; Food Standards Agency, UK SALT RED IN; Food Standards Agency, 2009, SALT RED TARG; Food Standards Scotland, 2017, 2017 SALT TARG; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Health Education Authority, 1994, NUTR ASP CARD DIS; Institute for Health Metrics and Evaluation, 2010, DIET RISKS AR LEAD C; Ji C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002246; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacGregor GA, 1996, BRIT MED J, V312, P1287, DOI 10.1136/bmj.312.7041.1287; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS; O'Dowd A, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1702; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Scottish Food and Drink Federation, HIGHL BAK RED SALT C; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Webster J, 2014, NUTRIENTS, V6, P3274, DOI 10.3390/nu6083274; World Health Organization, WHO FRAM CONV TOB CO	24	28	27	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h1936	10.1136/bmj.h1936	http://dx.doi.org/10.1136/bmj.h1936			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25922339				2022-12-28	WOS:000353955900001
J	Reynolds, L; McKee, M				Reynolds, Lucy; McKee, Martin			FUTURE OF THE NHS Is the NHS really safe from international trade agreements?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reynolds, Lucy] London Sch Hyg & Trop Med, London, England; [McKee, Martin] London Sch Hyg & Trop Med, European Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Reynolds, L (corresponding author), London Sch Hyg & Trop Med, London, England.	lucy.reynolds@lshtm.ac.uk; martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Reynolds, Dr L/CAG-7830-2022	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; 				Cable V, 2014, LETT ALL MEMBERS PAR; Davis J., 2015, NHS SALE MYTHS LIES; Freeman S., 2015, HUFFINGTON POST; Hepburn J, 2015, IA REPORTER     0402; Holden D, 2014, NEW STATESMAN; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2031; Jarman H, 2014, EUR J PUBLIC HEALTH, V24, P181, DOI 10.1093/eurpub/ckt201; Kaucher L., 2013, OPEN DEMOCRACY; Malmstrom C, 2015, NHS TTIP LETT EU TRA; McKee M, 2002, IMPACT EU LAW HLTH C; Steele S, J PUBL HLTH IN PRESS; Weiss, 2015, TRADING HLTH UK FACU; Wintour P., 2014, GUARDIAN	13	9	9	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2179	10.1136/bmj.h2179	http://dx.doi.org/10.1136/bmj.h2179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25920527	Green Accepted			2022-12-28	WOS:000353955900007
J	Yeung, LY; Ash, JL; Young, ED				Yeung, Laurence Y.; Ash, Jeanine L.; Young, Edward D.			Biological signatures in clumped isotopes of O-2	SCIENCE			English	Article							WATER GAS TRANSFER; O BOND FORMATION; PHOTOSYSTEM-II; OXYGEN ISOTOPES; FRACTIONATION; OXIDATION; EXCHANGE; COMPLEX; METHANE; PRECIPITATION	The abundances of molecules containing more than one rare isotope have been applied broadly to determine formation temperatures of natural materials. These applications of "clumped" isotopes rely on the assumption that isotope-exchange equilibrium is reached, or at least approached, during the formation of those materials. In a closed-system terrarium experiment, we demonstrate that biological oxygen (O-2) cycling drives the clumped-isotope composition of O-2 away from isotopic equilibrium. Our model of the system suggests that unique biological signatures are present in clumped isotopes of O-2-and not formation temperatures. Photosynthetic O-2 is depleted in (OO)-O-18-O-18 and (OO)-O-17-O-18 relative to a stochastic distribution of isotopes, unlike at equilibrium, where heavy-isotope pairs are enriched. Similar signatures may be widespread in nature, offering new tracers of biological and geochemical cycling.	[Yeung, Laurence Y.; Ash, Jeanine L.; Young, Edward D.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Yeung, Laurence Y.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA	University of California System; University of California Los Angeles; Rice University	Yeung, LY (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	lyeung@rice.edu; jlash@ucla.edu	Yeung, Laurence Y/D-4574-2009	Yeung, Laurence Y/0000-0001-9901-2607; Young, Edward/0000-0002-1299-0801; Ash, Jeanine/0000-0003-4062-3942	National Science Foundation [EAR-1049655, DGE-1144087]; National Aeronautics and Space Administration Cosmochemistry program; Deep Carbon Observatory	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration Cosmochemistry program; Deep Carbon Observatory	We thank H. Hu and N. Levin for performing oxygen triple-isotope analyses of the terrarium water at Johns Hopkins University, and E. Schauble for helpful discussions during the course of this work. This research was supported in part by the National Science Foundation (EAR-1049655 and DGE-1144087), the National Aeronautics and Space Administration Cosmochemistry program, and the Deep Carbon Observatory. The data and model parameters used in this study are available in the supplementary materials (tables S1 to S3).	Affek HP, 2014, GEOCHIM COSMOCHIM AC, V143, P319, DOI 10.1016/j.gca.2014.08.005; Affek HP, 2013, AM J SCI, V313, P309, DOI 10.2475/04.2013.02; Angeles-Boza AM, 2014, CHEM SCI, V5, P1141, DOI 10.1039/c3sc51919h; Angeles-Boza AM, 2012, INORG CHEM, V51, P4722, DOI 10.1021/ic202745n; Angert A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001933; Cheah MH, 2014, ANAL CHEM, V86, P5171, DOI 10.1021/ac501086n; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Guo WF, 2009, GEOCHIM COSMOCHIM AC, V73, P7203, DOI 10.1016/j.gca.2009.05.071; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Helman Y, 2005, PLANT PHYSIOL, V138, P2292, DOI 10.1104/pp.105.063768; Hillier W, 2008, COORDIN CHEM REV, V252, P306, DOI 10.1016/j.ccr.2007.09.004; Hoffman BM, 2013, ACCOUNTS CHEM RES, V46, P587, DOI 10.1021/ar300267m; Juranek LW, 2013, ANNU REV MAR SCI, V5, P503, DOI 10.1146/annurev-marine-121211-172430; KNOX M, 1992, J GEOPHYS RES-OCEANS, V97, P20335, DOI 10.1029/92JC00949; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Luz B, 2005, GEOCHIM COSMOCHIM AC, V69, P1099, DOI 10.1016/j.gca.2004.09.001; Luz B, 1999, NATURE, V400, P547, DOI 10.1038/22987; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Ono S, 2014, ANAL CHEM, V86, P6487, DOI 10.1021/ac5010579; Passey BH, 2012, EARTH PLANET SC LETT, V351, P223, DOI 10.1016/j.epsl.2012.07.021; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; RICHET P, 1977, ANNU REV EARTH PL SC, V5, P65, DOI 10.1146/annurev.ea.05.050177.000433; STEVENS CLR, 1975, PLANT PHYSIOL, V56, P126, DOI 10.1104/pp.56.1.126; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Tang JW, 2014, GEOCHIM COSMOCHIM AC, V134, P120, DOI 10.1016/j.gca.2014.03.005; Tempest KE, 2013, MAR CHEM, V153, P39, DOI 10.1016/j.marchem.2013.04.002; Thurston RS, 2010, CHEM GEOL, V269, P252, DOI 10.1016/j.chemgeo.2009.10.001; Urey HC, 1935, J AM CHEM SOC, V57, P321, DOI 10.1021/ja01305a026; Wang ZG, 2004, GEOCHIM COSMOCHIM AC, V68, P4779, DOI 10.1016/j.gca.2004.05.039; Yeung LY, 2014, J GEOPHYS RES-ATMOS, V119, P10552, DOI 10.1002/2014JD021909; Yeung LY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017992	33	40	43	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					431	434		10.1126/science.aaa6284	http://dx.doi.org/10.1126/science.aaa6284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908819				2022-12-28	WOS:000353338000033
J	Daschle, T; Dorsey, ER				Daschle, Thomas; Dorsey, E. Ray			The Return of the House Call	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH-CARE; HOME; HOSPITALIZATIONS; MEDICARE; FUTURE		[Daschle, Thomas] Daschle Grp, Washington, DC 20001 USA; [Dorsey, E. Ray] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester	Dorsey, ER (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, 265 Crittenden Blvd,CU 420694, Rochester, NY 14642 USA.	ray.dorsey@chet.rochester.edu						Dorsey ER, 2013, JAMA NEUROL, V70, P565, DOI 10.1001/jamaneurol.2013.123; Grabowski DC, 2014, HEALTH AFFAIR, V33, P244, DOI 10.1377/hlthaff.2013.0922; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Kao H, 2009, CLIN GERIATR MED, V25, P19, DOI 10.1016/j.cger.2008.10.005; Landers SH, 2005, JAMA-J AM MED ASSOC, V294, P2435, DOI 10.1001/jama.294.19.2435-b; Landers SH, 2010, NEW ENGL J MED, V363, P1690, DOI 10.1056/NEJMp1000401; Leff B, 2001, J GERONTOL A-BIOL, V56, pM603, DOI 10.1093/gerona/56.10.M603; Meyer GS, 1997, NEW ENGL J MED, V337, P1815, DOI 10.1056/NEJM199712183372507; Pearl R, 2014, HEALTH AFFAIR, V33, P251, DOI 10.1377/hlthaff.2013.1005; Willis AW, 2012, NEUROLOGY, V79, P1774, DOI 10.1212/WNL.0b013e3182703f92	10	27	27	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					587	+		10.7326/M14-2769	http://dx.doi.org/10.7326/M14-2769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894028				2022-12-28	WOS:000353244300021
J	Kelly, JP; Hernandez, AF				Kelly, Jacob P.; Hernandez, Adrian F.			Pooled RCTs: beta-blockers reduce mortality in heart failure patients with sinus rhythm but not in those with AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TASK-FORCE; GUIDELINES		[Kelly, Jacob P.; Hernandez, Adrian F.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Kelly, JP (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.		Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616				McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC7	10.7326/ACPJC-2015-162-8-007	http://dx.doi.org/10.7326/ACPJC-2015-162-8-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894052				2022-12-28	WOS:000353244300006
J	March, L				March, Lyn			An exercise program for hands and arms improved hand function in RA controlled with medication	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[March, Lyn] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW, Australia; [March, Lyn] Univ Sydney, Royal N Shore Hosp, Sydney, NSW, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney	March, L (corresponding author), Univ Sydney, Inst Bone & Joint Res, Sydney, NSW, Australia.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC9	10.7326/ACPJC-2015-162-8-009	http://dx.doi.org/10.7326/ACPJC-2015-162-8-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894054				2022-12-28	WOS:000353244300008
J	Luedtke, K; Rushton, A; Wright, C; Jurgens, T; Polzer, A; Mueller, G; May, A				Luedtke, Kerstin; Rushton, Alison; Wright, Christine; Juergens, Tim; Polzer, Astrid; Mueller, Gerd; May, Arne			Effectiveness of transcranial direct current stimulation preceding cognitive behavioural management for chronic low back pain: sham controlled double blinded randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE END-POINTS; INTENTION-TO-TREAT; OF-THE-ART; MOTOR CORTEX; PRIMARY-CARE; CLINICAL-TRIALS; CENTRAL SENSITIZATION; STATISTICS NOTES; BASE-LINE; MODULATION	OBJECTIVE To evaluate the effectiveness of transcranial direct current stimulation alone and in combination with cognitive behavioural management in patients with non-specific chronic low back pain. DESIGN Double blind parallel group randomised controlled trial with six months' follow-up conducted May 2011-March 2013. Participants, physiotherapists, assessors, and analyses were blinded to group allocation. SETTING Interdisciplinary chronic pain centre. PARTICIPANTS 135 participants with non-specific chronic low back pain >12 weeks were recruited from 225 patients assessed for eligibility. INTERVENTION Participants were randomised to receive anodal (20 minutes to motor cortex at 2 mA) or sham transcranial direct current stimulation (identical electrode position, stimulator switched off after 30 seconds) for five consecutive days immediately before cognitive behavioural management (four week multidisciplinary programme of 80 hours). MAIN OUTCOMES MEASURES Two primary outcome measures of pain intensity (0-100 visual analogue scale) and disability (Oswestry disability index) were evaluated at two primary endpoints after stimulation and after cognitive behavioural management. RESULTS Analyses of covariance with baseline values (pain or disability) as covariates showed that transcranial direct current stimulation was ineffective for the reduction of pain (difference between groups on visual analogue scale 1 mm (99% confidence interval -8.69 mm to 6.3 mm; P=0.68)) and disability (difference between groups 1 point (-1.73 to 1.98; P=0.86)) and did not influence the outcome of cognitive behavioural management (difference between group 3 mm (-10.32 mm to 6.73 mm); P=0.58; difference between groups on Oswestry disability index 0 point (-2.45 to 2.62); P=0.92). The stimulation was well tolerated with minimal transitory side effects. CONCLUSIONS This results of this trial on the effectiveness of transcranial direct current stimulation for the reduction of pain and disability do not support its clinical use for managing non-specific chronic low back pain.	[Luedtke, Kerstin; Juergens, Tim; Polzer, Astrid; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany; [Rushton, Alison; Wright, Christine] Univ Birmingham, Coll Life & Environm Sci, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England; [Mueller, Gerd] Backpain Clin Am Michel, D-20459 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Birmingham	May, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Martinistr 52, D-20246 Hamburg, Germany.	a.may@uke.de	Luedtke, Kerstin/AAM-9722-2020; Rushton, Alison/V-1260-2017	Luedtke, Kerstin/0000-0002-7308-5469; Rushton, Alison/0000-0001-8114-7669	Deutsche Forschungsgemeinschaft DFG [MA 1862/10-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft DFG (MA 1862/10-1).	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Antal A, 2008, CLIN J PAIN, V24, P56, DOI 10.1097/AJP.0b013e318157233b; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beck J.S., 2011, COGNITIVE BEHAV THER, P19; Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2009, CLIN J PAIN, V25, P691, DOI 10.1097/AJP.0b013e3181af1414; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Cleophas TJ, 2006, CURR CLIN PHARMACOL, V1, P1, DOI 10.2174/157488406775268228; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cosentino G, 2012, EUR J NEUROSCI, V35, P119, DOI 10.1111/j.1460-9568.2011.07939.x; Csifcsak G, 2009, PAIN MED, V10, P122, DOI 10.1111/j.1526-4637.2008.00508.x; DosSantos Marcos Fabio, 2012, Front Psychiatry, V3, P93, DOI 10.3389/fpsyt.2012.00093; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Dunn KM, 2005, SPINE, V30, P1887, DOI 10.1097/01.brs.0000173900.46863.02; Fenton BW, 2009, BRAIN STIMUL, V2, P103, DOI 10.1016/j.brs.2008.09.009; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Field A., 2018, DISCOVERING STAT USI, V5th, DOI DOI 10.1016/B978-012691360-6/50012-4; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Grotle M, 2005, SPINE, V30, P976, DOI 10.1097/01.brs.0000158972.34102.6f; Grundmann L, 2011, BRAIN STIMUL, V4, P253, DOI 10.1016/j.brs.2010.12.002; Gurcay E, 2009, DISABIL REHABIL, V31, P840, DOI 10.1080/09638280802355163; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Henschke Nicholas, 2008, BMJ, V337, pa171, DOI 10.1136/bmj.a171; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Herbert RD, 2005, AUST J PHYSIOTHER, V51, P58, DOI 10.1016/S0004-9514(05)70058-1; Hinz A, 2009, PSYCHOTHER PSYCH MED, V59, P394, DOI 10.1055/s-2008-1067578; Holsheimer J, 2007, ACTA NEUROCHIR SUPPL, V97, P57; Ihle K, 2014, PAIN, V155, P2080, DOI 10.1016/j.pain.2014.07.018; Jurgens TP, 2012, EUR J PAIN, V16, P1251, DOI 10.1002/j.1532-2149.2012.00135.x; Kaapa EF, 2008, SPINE, V31, P371; Knotkova H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00628; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kohlmann T, 1996, Rehabilitation (Stuttg), V35, pI; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lambert M, 2010, AM FAM PHYSICIAN, V82, P434; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lang Eberhard, 2003, Spine J, V3, P270, DOI 10.1016/S1529-9430(03)00028-7; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; Luedtke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048857; Luedtke K, 2012, CLIN J PAIN, V28, P452, DOI 10.1097/AJP.0b013e31823853e3; Maughan EF, 2010, EUR SPINE J, V19, P1484, DOI 10.1007/s00586-010-1353-6; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/00007632-200211150-00033; Medeiros Liciane Fernandes, 2012, Front Psychiatry, V3, P110, DOI 10.3389/fpsyt.2012.00110; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Neuhauser M, 2006, FUND CLIN PHARMACOL, V20, P515, DOI 10.1111/j.1472-8206.2006.00437.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3; O'Connell NE, 2013, CLIN J PAIN, V29, P26, DOI 10.1097/AJP.0b013e318247ec09; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pagano RL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.08.003; Pfingsten M, 2000, EUR J PAIN-LONDON, V4, P259, DOI 10.1053/eujp.2000.0178; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Polit DF, 2010, RES NURS HEALTH, V33, P355, DOI 10.1002/nur.20386; Polit DF, 2009, NURS RES, V58, P391, DOI 10.1097/NNR.0b013e3181bf1505; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; Reidler JS, 2012, J PAIN, V13, P450, DOI 10.1016/j.jpain.2012.01.005; Riberto Marcelo, 2011, Open Rheumatol J, V5, P45, DOI 10.2174/1874312901105010045; Roche N, 2012, CLIN NEUROPHYSIOL, V123, P1027, DOI 10.1016/j.clinph.2011.09.011; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Scascighini L, 2008, RHEUMATOLOGY, V47, P670, DOI 10.1093/rheumatology/ken021; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; ten Klooster PM, 2006, PAIN, V121, P151, DOI 10.1016/j.pain.2005.12.021; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turk DC, 2008, PAIN, V139, P485, DOI 10.1016/j.pain.2008.06.025; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Twisk J, 2013, J CLIN EPIDEMIOL, V66, P1022, DOI 10.1016/j.jclinepi.2013.03.017; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zelman DC, 2003, PAIN, V106, P35, DOI 10.1016/S0304-3959(03)00274-4; Zhang L, 2005, EUR J NEUROSCI, V22, P1141, DOI 10.1111/j.1460-9568.2005.04302.x	90	46	48	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1640	10.1136/bmj.h1640	http://dx.doi.org/10.1136/bmj.h1640			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25883244	Green Published, hybrid			2022-12-28	WOS:000353328700002
J	Bencivenga, F; Cucini, R; Capotondi, F; Battistoni, A; Mincigrucci, R; Giangrisostomi, E; Gessini, A; Manfredda, M; Nikolov, IP; Pedersoli, E; Principi, E; Svetina, C; Parisse, P; Casolari, F; Danailov, MB; Kiskinova, M; Masciovecchio, C				Bencivenga, F.; Cucini, R.; Capotondi, F.; Battistoni, A.; Mincigrucci, R.; Giangrisostomi, E.; Gessini, A.; Manfredda, M.; Nikolov, I. P.; Pedersoli, E.; Principi, E.; Svetina, C.; Parisse, P.; Casolari, F.; Danailov, M. B.; Kiskinova, M.; Masciovecchio, C.			Four-wave mixing experiments with extreme ultraviolet transient gratings	NATURE			English	Article							FREE-ELECTRON LASER; X-RAY; COHERENT; SPECTROSCOPY; SCATTERING; OPTICS; PULSES; PHASE	Four-wave mixing (FWM) processes, based on third-order nonlinear light-matter interactions, can combine ultrafast time resolution with energy and wavevector selectivity, and enable the exploration of dynamics inaccessible by linear methods(1-7). The coherent and multi-wave nature of the FWM approach has been crucial in the development of advanced technologies, such as silicon photonice, subwavelength imaging' and quantum communications(10). All these technologies operate at optical wavelengths, which limits the spatial resolution and does not allow the probing of excitations with energy in the electronvolt range. Extension to shorter wavelengths that is, the extreme ultraviolet and soft-X-ray ranges would allow the spatial resolution to be improved and the excitation energy range to be expanded, as well as enabling elemental selectivity to be achieved by exploiting core resonances(5-7,11-14). So far, FWM applications at such wavelengths have been prevented by the absence of coherent sources of sufficient brightness and of suitable experimental set-ups. Here we show how transient gratings, generated by the interference of coherent extreme-ultraviolet pulses delivered by the FERMI free-electron laser(15), can be used to stimulate FWM processes at suboptical wavelengths. Furthermore, we have demonstrated the possibility of observing the time evolution of the FWM signal, which shows the dynamics of coherent excitations as molecular vibrations. This result opens the way to FWM with nanometre spatial resolution and elemental selectivity, which, for example, would enable the investigation of charge-transfer dynamics(5-7). The theoretical possibility of realizing these applications has already stimulated ongoing developments of free-electron lasers(16-20): our results show that FWM at suboptical wavelengths is feasible, and we hope that they will enable advances in present and future photon sources.	[Bencivenga, F.; Cucini, R.; Capotondi, F.; Battistoni, A.; Mincigrucci, R.; Giangrisostomi, E.; Gessini, A.; Manfredda, M.; Nikolov, I. P.; Pedersoli, E.; Principi, E.; Svetina, C.; Parisse, P.; Casolari, F.; Danailov, M. B.; Kiskinova, M.; Masciovecchio, C.] Elettra Sincrotrone Trieste, I-34012 Trieste, Italy; [Battistoni, A.; Giangrisostomi, E.; Svetina, C.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Mincigrucci, R.] Univ Perugia, Dipartimento Fis & Geol, I-06123 Perugia, Italy	Elettra Sincrotrone Trieste; University of Trieste; University of Perugia	Bencivenga, F (corresponding author), Elettra Sincrotrone Trieste, Str Statale 14 Km 163,5 Area Sci Pk, I-34012 Trieste, Italy.	filippo.bencivenga@elettra.eu; claudio.masciovecchio@elettra.eu	Svetina, Cristian/AAG-1776-2021; Parisse, P./AAJ-2246-2021; Principi, Emiliano/ABI-5617-2020; Mincigrucci, Riccardo/AAH-8768-2021	Parisse, P./0000-0002-7420-2778; Pedersoli, Emanuele/0000-0003-0572-6735; CAPOTONDI, Flavio/0000-0003-1980-6162; PRINCIPI, Emiliano/0000-0002-7508-462X; Danailov, Miltcho/0000-0002-1888-1331; Masciovecchio, Claudio/0000-0002-8571-3522; NIKOLOV, Ivaylo/0000-0002-4201-5038	Italian Ministry of University and Research [FIRB-RBAP045JF2, FIRB-RBAP06AWK3]; European Research Council [202804-TIMER]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission)	We acknowledge support from the Italian Ministry of University and Research through grants FIRB-RBAP045JF2 and FIRB-RBAP06AWK3, and from the European Research Council through grant 202804-TIMER. We thank M. Svandrlik and the FERMI-FEL team for support.	Adams B, 2011, NAT PHYS, V7, P675, DOI 10.1038/nphys2056; Allaria E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3476; Allaria E, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113009; ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Bencivenga F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123023; Bencivenga F, 2009, NUCL INSTRUM METH A, V606, P785, DOI 10.1016/j.nima.2009.05.147; Bencivenga F, 2014, FARADAY DISCUSS, V171, P487, DOI 10.1039/c4fd00100a; Beye M, 2013, NATURE, V501, P191, DOI 10.1038/nature12449; BLOEMBERGEN N, 1982, REV MOD PHYS, V54, P685, DOI 10.1103/RevModPhys.54.685; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Boyer V, 2008, SCIENCE, V321, P544, DOI 10.1126/science.1158275; BUCHENAU U, 1984, PHYS REV LETT, V53, P2316, DOI 10.1103/PhysRevLett.53.2316; Casolari F, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875906; Chen PY, 2011, NANO LETT, V11, P5514, DOI 10.1021/nl203354b; Cinquegrana P, 2014, PHYS REV SPEC TOP-AC, V17, DOI 10.1103/PhysRevSTAB.17.040702; Cucini R, 2011, OPT LETT, V36, P1032, DOI 10.1364/OL.36.001032; Cucini R, 2011, NUCL INSTRUM METH A, V635, pS69, DOI 10.1016/j.nima.2010.10.099; Cundiff ST, 2013, PHYS TODAY, V66, P44, DOI 10.1063/PT.3.2047; Danailov MB, 2014, OPT EXPRESS, V22, P12869, DOI 10.1364/OE.22.012869; DHAR L, 1994, CHEM REV, V94, P157, DOI 10.1021/cr00025a006; Ferrante C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2826; Foster MA, 2006, NATURE, V441, P960, DOI 10.1038/nature04932; Gahl C, 2008, NAT PHOTONICS, V2, P165, DOI 10.1038/nphoton.2007.298; Glover TE, 2012, NATURE, V488, P603, DOI 10.1038/nature11340; Hara T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3919; Hehlen B, 2000, PHYS REV LETT, V84, P5355, DOI 10.1103/PhysRevLett.84.5355; Kalampounias AG, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2136878; Lutman AA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.254801; Lutman AA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.134801; Marcus G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.024801; Rohringer N, 2012, NATURE, V481, P488, DOI 10.1038/nature10721; RUHMAN S, 1987, J CHEM PHYS, V86, P6563, DOI 10.1063/1.452400; Schirmacher W, 2008, PHYS STATUS SOLIDI C, V5, P862, DOI 10.1002/pssc.200777584; Shwartz S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163901; Sistrunk E. F., 2014, 19 INT C ULTR PHEN; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/NPHOTON.2014.10, 10.1038/nphoton.2014.10]; Tamasaku K, 2011, NAT PHYS, V7, P705, DOI [10.1038/NPHYS2044, 10.1038/nphys2044]; Tanaka S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.043001; Tanaka S, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.063405; Tobey RI, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336591; Zangrando M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3262502	43	146	146	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					205	U149		10.1038/nature14341	http://dx.doi.org/10.1038/nature14341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855456	Green Accepted			2022-12-28	WOS:000352454600035
J	Brewer, C; Irwin, M				Brewer, Colin; Irwin, Michael			END OF LIFE CARE In support of assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												CBrewerbrewerismo@gmail.com	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431					0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1828	10.1136/bmj.h1828	http://dx.doi.org/10.1136/bmj.h1828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25857306				2022-12-28	WOS:000352914700012
J	Kalia, LV; Lang, AE				Kalia, Lorraine V.; Lang, Anthony E.			Parkinson's disease	LANCET			English	Article							PATHOLOGICAL ALPHA-SYNUCLEIN; SLEEP BEHAVIOR DISORDER; PLACEBO-CONTROLLED TRIAL; DEEP BRAIN-STIMULATION; LEWY BODY; DOUBLE-BLIND; NEURODEGENERATIVE DISEASE; CEREBROSPINAL-FLUID; SYDNEY MULTICENTER; NONMOTOR FEATURES	Parkinson's disease is a neurological disorder with evolving layers of complexity. It has long been characterised by the classical motor features of parkinsonism associated with Lewy bodies and loss of dopaminergic neurons in the substantia nigra. However, the symptomatology of Parkinson's disease is now recognised as heterogeneous, with clinically significant non-motor features. Similarly, its pathology involves extensive regions of the nervous system, various neurotransmitters, and protein aggregates other than just Lewy bodies. The cause of Parkinson's disease remains unknown, but risk of developing Parkinson's disease is no longer viewed as primarily due to environmental factors. Instead, Parkinson's disease seems to result from a complicated interplay of genetic and environmental factors affecting numerous fundamental cellular processes. The complexity of Parkinson's disease is accompanied by clinical challenges, including an inability to make a definitive diagnosis at the earliest stages of the disease and difficulties in the management of symptoms at later stages. Furthermore, there are no treatments that slow the neurodegenerative process. In this Seminar, we review these complexities and challenges of Parkinson's disease.	[Kalia, Lorraine V.; Lang, Anthony E.] Univ Toronto, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada; [Kalia, Lorraine V.; Lang, Anthony E.] Univ Toronto, Toronto Western Hosp, Div Neurol, Dept Med, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lang, AE (corresponding author), Toronto Western Hosp, Disorders Ctr, Toronto, ON M5T 2S8, Canada.	lang@uhnres.utoronto.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667; Kalia, Lorraine/0000-0002-9384-1305	Parkinson's UK; Michael J Fox Foundation; Canadian Institutes of Health Research; Brain Canada; Edmond J. Safra Philanthropic Foundation; National Parkinson Foundation; Ontario Brain Institute; Parkinson Society Canada; Tourette Syndrome Association; W Garfield Weston Foundation	Parkinson's UK(Parkinson's UK); Michael J Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada; Edmond J. Safra Philanthropic Foundation; National Parkinson Foundation; Ontario Brain Institute; Parkinson Society Canada; Tourette Syndrome Association; W Garfield Weston Foundation	LVK declares educational support from Allergan; funding from Parkinson's UK, and Michael J Fox Foundation; and holds a Clinician-Scientist Award from the Canadian Institutes of Health Research. AEL has served as an adviser for Abbvie, Allon Therapeutics, Avanir Pharmaceuticals, Biogen Idec, Boerhinger-Ingelheim, Ceregene, Medtronic, Merck, Novartis, Neurophage Pharmaceuticals, Teva, and UCB; declares grants from Brain Canada, Canadian Institutes of Health Research, Edmond J. Safra Philanthropic Foundation, Michael J Fox Foundation, National Parkinson Foundation, Ontario Brain Institute, Parkinson Society Canada, Tourette Syndrome Association, and W Garfield Weston Foundation; publishing royalties from Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press; served as an expert witness in cases related to the welding industry; and holds the Jack Clark Chair in Parkinson's Disease Research at the University of Toronto and the Lily Safra Chair in Movement Disorders at the University Health Network, Toronto, Canada. The authors were not paid to write this article by a pharmaceutical company or other agency.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Aurora RN, 2010, J CLIN SLEEP MED, V6, P85; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Bauso DJ, 2012, EUR J NEUROL, V19, P1108, DOI 10.1111/j.1468-1331.2012.03683.x; Beach TG, 2010, ACTA NEUROPATHOL, V119, P689, DOI 10.1007/s00401-010-0664-3; Benamer HTS, 2008, MOVEMENT DISORD, V23, P1205, DOI 10.1002/mds.22041; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Berg D, 2013, LANCET NEUROL, V12, P514, DOI 10.1016/S1474-4422(13)70047-4; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Bjorklund A, 2013, MOVEMENT DISORD, V28, P110, DOI 10.1002/mds.25343; Bottner M, 2012, NEUROBIOL DIS, V48, P474, DOI 10.1016/j.nbd.2012.07.018; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks DJ, 2011, PROG NEUROBIOL, V95, P614, DOI 10.1016/j.pneurobio.2011.08.009; Burn D, 2006, MOVEMENT DISORD, V21, P1899, DOI 10.1002/mds.21077; Butcher NJ, 2013, JAMA NEUROL, V70, P1359, DOI 10.1001/jamaneurol.2013.3646; Charles D, 2014, PARKINSONISM RELAT D, V20, P731, DOI 10.1016/j.parkreldis.2014.03.019; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Chen XQ, 2012, CURR NEUROL NEUROSCI, V12, P367, DOI 10.1007/s11910-012-0282-7; Chung KA, 2010, NEUROLOGY, V75, P1263, DOI 10.1212/WNL.0b013e3181f6128c; Cipriani S, 2010, BIOMARK MED, V4, P701, DOI 10.2217/BMM.10.94; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Coelho M, 2012, NAT REV NEUROL, V8, P435, DOI 10.1038/nrneurol.2012.126; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Cookson MR, 2012, BIOCHEM SOC T, V40, P1070, DOI 10.1042/BST20120165; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Coune PG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009431; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cummings J, 2014, LANCET, V383, P533, DOI 10.1016/S0140-6736(13)62106-6; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Doherty KM, 2013, JAMA NEUROL, V70, P571, DOI 10.1001/jamaneurol.2013.172; Donadio V, 2014, NEUROLOGY, V82, P1362, DOI 10.1212/WNL.0000000000000316; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Duncan GW, 2014, MOVEMENT DISORD, V29, P195, DOI 10.1002/mds.25664; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; Eller M, 2009, NAT REV NEUROL, V5, P561, DOI 10.1038/nrneurol.2009.135; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2; Foubert-Samier A, 2012, NEUROLOGY, V79, P1615, DOI 10.1212/WNL.0b013e31826e25ce; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; Gold A, 2013, MOVEMENT DISORD, V28, P237, DOI 10.1002/mds.25298; Goldman SM, 2012, ANN NEUROL, V71, P776, DOI 10.1002/ana.22629; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hauser RA, 2013, LANCET NEUROL, V12, P346, DOI 10.1016/S1474-4422(13)70025-5; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henderson EJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-188; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Iranzo A, 2014, MOVEMENT DISORD, V29, P410, DOI 10.1002/mds.25825; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Iwanaga K, 1999, NEUROLOGY, V52, P1269, DOI 10.1212/WNL.52.6.1269; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kalia LV, 2013, MOVEMENT DISORD, V28, P131, DOI 10.1002/mds.25273; Kalia SK, 2013, CURR OPIN NEUROL, V26, P374, DOI 10.1097/WCO.0b013e3283632d08; Kempster PA, 2010, BRAIN, V133, P1755, DOI 10.1093/brain/awq059; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Kovacs GG, 2012, ACTA NEUROPATHOL, V124, P37, DOI 10.1007/s00401-012-0964-x; Kraemmer J, 2014, MOVEMENT DISORD, V29, P1767, DOI 10.1002/mds.25975; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Lang AE, 2014, LANCET, V384, P1164, DOI 10.1016/S0140-6736(14)60962-4; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lee S, 2012, BIOCHEM SOC T, V40, P1047, DOI 10.1042/BST20120113; Lehericy S, 2014, MOVEMENT DISORD, V29, P1574, DOI 10.1002/mds.26043; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lindvall O, 2013, MOVEMENT DISORD, V28, P268, DOI 10.1002/mds.25378; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Marek K, 2014, NEUROLOGY, V82, P1791, DOI 10.1212/WNL.0000000000000424; Marras C, 2013, J NEUROL NEUROSUR PS, V84, P409, DOI 10.1136/jnnp-2012-303455; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Masters CL, 2011, PATHOLOGY, V43, P93, DOI 10.1097/PAT.0b013e3283426eee; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]; Mortimer JA, 2012, NEUROLOGY, V79, P1174, DOI 10.1212/WNL.0b013e3182698ced; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Okubadejo NU, 2006, MOVEMENT DISORD, V21, P2150, DOI 10.1002/mds.21153; Olanow CW, 2014, LANCET NEUROL, V13, P141, DOI 10.1016/S1474-4422(13)70293-X; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parkinson Study Group, 2000, JAMA, V284, P1931; Parkkinen L, 2008, ACTA NEUROPATHOL, V115, P399, DOI 10.1007/s00401-008-0346-6; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Richard IH, 2012, NEUROLOGY, V78, P1229, DOI 10.1212/WNL.0b013e3182516244; Ritz B, 2014, NEUROLOGY, V83, P1396, DOI 10.1212/WNL.0000000000000879; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Salsone M, 2012, MOVEMENT DISORD, V27, P1068, DOI 10.1002/mds.25002; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Schulte EC, 2012, NEUROGENETICS, V13, P281, DOI 10.1007/s10048-012-0334-9; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stewart T, 2014, NEUROBIOL AGING, V35, P418, DOI 10.1016/j.neurobiolaging.2013.08.008; Strickland D, 2004, MOVEMENT DISORD, V19, P318, DOI 10.1002/mds.10619; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Tucci A, 2012, NEUROSCI LETT, V518, P19, DOI 10.1016/j.neulet.2012.04.033; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Visanji NP, 2015, NEUROLOGY, V84, P609, DOI 10.1212/WNL.0000000000001240; Visanji NP, 2014, MOVEMENT DISORD, V29, P444, DOI 10.1002/mds.25789; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Yarnall A, 2011, MOVEMENT DISORD, V26, P2496, DOI 10.1002/mds.23932; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	173	2782	2907	92	1055	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					896	912		10.1016/S0140-6736(14)61393-3	http://dx.doi.org/10.1016/S0140-6736(14)61393-3			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	25904081				2022-12-28	WOS:000360290000033
J	Howell, BL; Conway, PH; Rajkumar, R				Howell, Benjamin L.; Conway, Patrick H.; Rajkumar, Rahul			Guiding Principles for Center for Medicare & Medicaid Innovation Model Evaluations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Howell, Benjamin L.; Conway, Patrick H.; Rajkumar, Rahul] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Conway, PH (corresponding author), Ctr Medicare & Medicaid Serv, 7500 Security Blvd,Mailstop S3-02-01, Baltimore, MD 21244 USA.	patrick.conway@cms.hhs.gov						Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Center for Medicare & Medicaid Services, PION ACO MOD; Centers for Medicare and Medicaid Services, BUNDL PAYM CAR IMPR; Centers for Medicare & Medicaid Services, PRIOR MEAS MON EV; Centers for Medicare & Medicaid Services, DAT REP; Centers for Medicare & Medicaid Services, COMPR PRIM CAR IN; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703	8	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2317	2318		10.1001/jama.2015.2902	http://dx.doi.org/10.1001/jama.2015.2902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	25893889				2022-12-28	WOS:000356300200011
J	Rundlof, M; Andersson, GKS; Bommarco, R; Fries, I; Hederstrom, V; Herbertsson, L; Jonsson, O; Klatt, BK; Pedersen, TR; Yourstone, J; Smith, HG				Rundlof, Maj; Andersson, Georg K. S.; Bommarco, Riccardo; Fries, Ingemar; Hederstrom, Veronica; Herbertsson, Lina; Jonsson, Ove; Klatt, Bjorn K.; Pedersen, Thorsten R.; Yourstone, Johanna; Smith, Henrik G.			Seed coating with a neonicotinoid insecticide negatively affects wild bees	NATURE			English	Article							BOMBUS-IMPATIENS HYMENOPTERA; COMBINED PESTICIDE; TREATED CANOLA; COLONY HEALTH; POLLINATORS; EXPOSURE; CLOTHIANIDIN; MEGACHILIDAE; TRAITS; IMPACT	Understanding the effects of neonicotinoid insecticides on bees is vital because of reported declines in bee diversity and distribution(1-3) and the crucial role bees have as pollinators in ecosystems and agriculture(4). Neonicotinoids are suspected to pose an unacceptable risk to bees, partly because of their systemic uptake in plants(5), and the European Union has therefore introduced a moratorium on three neonicotinoids as seed coatings in flowering crops that attract bees(6). The moratorium has been criticized for being based on weak evidence(7), particularly because effects have mostly been measured on bees that have been artificially fed neonicotinoids(8-11). Thus, the key question is how neonicotinoids influence bees, and wild bees in particular, in real-world agricultural landscapes(11-13). Here we show that a commonly used insecticide seed coating in a flowering crop can have serious consequences for wild bees. In a study with replicated and matched landscapes, we found that seed coating with Elado, an insecticide containing a combination of the neonicotinoid clothianidin and the non-systemic pyrethroid beta-cyfluthrin, applied to oilseed rape seeds, reduced wild bee density, solitary bee nesting, and bumblebee colony growth and reproduction under field conditions. Hence, such insecticidal use can pose a substantial risk to wild bees in agricultural landscapes, and the contribution of pesticides to the global decline of wild bees(1-3) may have been underestimated. The lack of a significant response in honeybee colonies suggests that reported pesticide effects on honeybees cannot always be extrapolated to wild bees.	[Rundlof, Maj; Andersson, Georg K. S.; Hederstrom, Veronica; Yourstone, Johanna; Smith, Henrik G.] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Andersson, Georg K. S.; Herbertsson, Lina; Klatt, Bjorn K.; Smith, Henrik G.] Lund Univ, Ctr Environm & Climate Res, S-22362 Lund, Sweden; [Bommarco, Riccardo; Fries, Ingemar] Swedish Univ Agr Sci, Dept Ecol, S-75007 Uppsala, Sweden; [Jonsson, Ove] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Jonsson, Ove] Swedish Univ Agr Sci, Ctr Chem Pesticides, S-75007 Uppsala, Sweden; [Pedersen, Thorsten R.] Swedish Board Agr, S-55182 Jonkoping, Sweden	Lund University; Lund University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Rundlof, M (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	maj.rundlof@biol.lu.se	Hederström, Veronica/ABB-8862-2021; Rundlöf, Maj/AAB-7401-2022; Hederstrom, Veronica/E-5205-2016; Yourstone, Johanna/N-3841-2017; Andersson, Georg/AAD-5985-2021; Bommarco, Riccardo/E-7109-2016	Hederström, Veronica/0000-0002-9231-3156; Rundlöf, Maj/0000-0003-3014-1544; Hederstrom, Veronica/0000-0002-9231-3156; Yourstone, Johanna/0000-0002-5667-1538; Andersson, Georg/0000-0002-9669-6895; Bommarco, Riccardo/0000-0001-8888-0476; Klatt, Bjorn/0000-0001-8241-6445	Swedish Civil Contingencies Agency; Carl Tryggers Foundation for Scientific Research; Royal Physiographic Society; Swedish Research Council [330-2014-6439]; Formas	Swedish Civil Contingencies Agency; Carl Tryggers Foundation for Scientific Research; Royal Physiographic Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas)	We thank the farmers for collaboration, the project group for feedback, A. Gunnarson for farmer contacts and seeds, M. Ahlstrom Olsson and Lindesro AB for bumblebee colonies, A. Andersson and C. Du Rietz for examining bumblebee colonies, B. Andreasson, T. Carling and A. Andersson for producing and assessing honeybee colonies, J. Kreuger for discussions on pesticide quantification, and M. Stjernman for extracting land use information. Funding was provided by the Swedish Civil Contingencies Agency to R.B., I.F., T.R.P. and H.G.S., by the Carl Tryggers Foundation for Scientific Research, the Royal Physiographic Society, and the Swedish Research Council (330-2014-6439) to M.R, and by Formas to H.G.S. and R.B.	[Anonymous], 2003, Bulletin OEPP, V33, P113, DOI 10.1046/j.1365-2338.2003.00618.x; [Anonymous], 2006, SAS MIXED MODELS; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dicks L, 2013, NATURE, V494, P283, DOI 10.1038/494283a; Douwes P., 2004, INSEKTER FALTHANDBOK; Dupont YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025172; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009; Franklin MT, 2004, J ECON ENTOMOL, V97, P369, DOI 10.1603/0022-0493-97.2.369; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garthwaite D. G., 2013, 250 PEST US SURV DEP; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Gunnarson A., 2013, SVENSK FROTIDNING, V2, P9; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holmstrom G., 2007, HUMLOR SVERIGES ARTE; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Hughes J., 2014, The Dundee Conference. Crop Protection in Northern Britain 2014, Dundee, UK, 25-26 February 2014, P21; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Imdorf A., 2001, COURSE DETERMINATION; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jonsson O, 2013, MICROSAMPLING PHARM, P68; Jonsson O, 2012, BIOANALYSIS, V4, P1989, DOI [10.4155/BIO.12.177, 10.4155/bio.12.177]; Jonsson O, 2012, BIOANALYSIS, V4, P661, DOI [10.4155/BIO.12.25, 10.4155/bio.12.25]; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Lodhi A., 2000, PAK J BIOL SCI, V3, P104; Meier U. E., 2001, ENTWICKLUNGSSTADIEN; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mossberg B., 2012, HUMLOR SVERIGE 40 AR; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; Rundlof M, 2014, BIOL CONSERV, V172, P138, DOI 10.1016/j.biocon.2014.02.027; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; The Centre for Ecology and Hydrology, 2014, LARG SCAL FIELD EXPT; TORCHIO PF, 1984, J KANSAS ENTOMOL SOC, V57, P517; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	56	626	647	46	1050	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					77	U162		10.1038/nature14420	http://dx.doi.org/10.1038/nature14420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901681				2022-12-28	WOS:000354040900036
J	Nojima, T; Gomes, T; Grosso, AR; Kimura, H; Dye, MJ; Dhir, S; Carmo-Fonseca, M; Proudfoot, NJ				Nojima, Takayuki; Gomes, Tomas; Fialho Grosso, Ana Rita; Kimura, Hiroshi; Dye, Michael J.; Dhir, Somdutta; Carmo-Fonseca, Maria; Proudfoot, Nicholas J.			Mammalian NET-Seq Reveals Genome-wide Nascent Transcription Coupled to RNA Processing	CELL			English	Article							PRE-MESSENGER-RNA; POLYMERASE-II CTD; TERMINAL DOMAIN; POLYADENYLATION; END; CLEAVAGE; SITES; PHOSPHORYLATION; INITIATION; PROMOTERS	Transcription is a highly dynamic process. Consequently, we have developed native elongating transcript sequencing technology for mammalian chromatin (mNET-seq), which generates single-nucleotide resolution, nascent transcription profiles. Nascent RNA was detected in the active site of RNA polymerase II (Pol II) along with associated RNA processing intermediates. In particular, we detected 5'splice site cleavage by the spliceosome, showing that cleaved upstream exon transcripts are associated with Pol II CTD phosphorylated on the serine 5 position (S5P), which is accumulated over downstream exons. Also, depletion of termination factors substantially reduces Pol II pausing at gene ends, leading to termination defects. Notably, termination factors play an additional promoter role by restricting non-productive RNA synthesis in a Pol II CTD S2P-specific manner. Our results suggest that CTD phosphorylation patterns established for yeast transcription are significantly different in mammals. Taken together, mNET-seq provides dynamic and detailed snapshots of the complex events underlying transcription in mammals.	[Nojima, Takayuki; Dye, Michael J.; Dhir, Somdutta; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Gomes, Tomas; Fialho Grosso, Ana Rita; Carmo-Fonseca, Maria] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal; [Kimura, Hiroshi] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Oxford; Universidade de Lisboa; Tokyo Institute of Technology	Carmo-Fonseca, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.	carmo.fonseca@medicina.ulisboa.pt; nicholas.proudfoot@path.ox.ac.uk	Kimura, Hiroshi/B-9524-2015; Grosso, Ana Rita/I-6656-2013	Kimura, Hiroshi/0000-0003-0854-083X; Grosso, Ana Rita/0000-0001-6974-4209; Proudfoot, Nicholas/0000-0001-8646-3222; Gomes, Tomas/0000-0003-1333-0191; Nojima, Takayuki/0000-0003-1236-4162; Carmo-Fonseca, Maria/0000-0002-3402-7143	KANAE foundation; JSPS KAKENHI; JST CREST; Wellcome Trust Programme [091805/Z/10/Z]; ERC Advanced Grants [339270]; Fundacao Ciencia e Tecnologia, Portugal	KANAE foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Wellcome Trust Programme(Wellcome Trust); ERC Advanced Grants; Fundacao Ciencia e Tecnologia, Portugal	We thank the N.J.P. lab and Dr. M. Dienstbier for critical discussion. T.N. was supported by the KANAE foundation. H.K. was supported by JSPS KAKENHI and JST CREST. This work was supported by funding to N.J.P. (Wellcome Trust Programme [091805/Z/10/Z] and ERC Advanced [339270] Grants) and to M.C.-F. (Fundacao Ciencia e Tecnologia, Portugal).	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Conrad T, 2014, CELL REP, V9, P542, DOI 10.1016/j.celrep.2014.09.007; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Grosso AR, 2012, GENOME RES, V22, P1447, DOI 10.1101/gr.138057.112; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	58	311	312	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					526	540		10.1016/j.cell.2015.03.027	http://dx.doi.org/10.1016/j.cell.2015.03.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910207	hybrid, Green Published			2022-12-28	WOS:000353553600013
J	Butterfield, LH				Butterfield, Lisa H.			Cancer vaccines	BMJ-BRITISH MEDICAL JOURNAL			English	Review							T-CELL RESPONSES; POLYINOSINIC-POLYCYTIDYLIC ACID; AUTOLOGOUS TUMOR VACCINES; PHASE-II TRIAL; METASTATIC MELANOMA; DENDRITIC CELLS; GM-CSF; SUPPRESSOR-CELLS; CLINICAL-RESPONSES; PEPTIDE VACCINE	Cancer vaccines are designed to promote tumor specific immune responses, particularly cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines, which were developed in 1994-95, tested non-mutated, shared tumor associated antigens that had been shown to be immunogenic and capable of inducing clinical responses in a minority of people with late stage cancer. Technological developments in the past few years have enabled the investigation of vaccines that target mutated antigens that are patient specific. Several platforms for cancer vaccination are being tested, including peptides, proteins, antigen presenting cells, tumor cells, and viral vectors. Standard of care treatments, such as surgery and ablation, chemotherapy, and radiotherapy, can also induce antitumor immunity, thereby having cancer vaccine effects. The monitoring of patients' immune responses at baseline and after standard of care treatment is shedding light on immune biomarkers. Combination therapies are being tested in clinical trials and are likely to be the best approach to improving patient outcomes.	Univ Pittsburgh, Sch Med, Dept Med Surg & Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterfield, LH (corresponding author), Univ Pittsburgh, Sch Med, Dept Med Surg & Surg, Pittsburgh, PA 15213 USA.	butterfieldl@upmc.edu		Butterfield, Lisa/0000-0002-3439-9844	NIH/NCI [R01 CA138635]; NIH [P50 CA121973, P30 CA047904]; NATIONAL CANCER INSTITUTE [P50CA121973, P30CA047904, R01CA138635] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LHB is supported by NIH/NCI R01 CA138635, NIH P50 CA121973, and NIH P30 CA047904.	American Cancer Society, 2014, CANC FACTS FIG; Aranda F, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26621; Arthur JF, 1997, CANCER GENE THER, V4, P17; Ayaru L, 2007, J IMMUNOL, V178, P1914, DOI 10.4049/jimmunol.178.3.1914; BAKKER ABH, 1995, CANCER RES, V55, P5330; Banchereau J, 2001, CANCER RES, V61, P6451; Barth RJ, 2010, CLIN CANCER RES, V16, P5548, DOI 10.1158/1078-0432.CCR-10-2138; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Britten CM, 2009, CANCER IMMUNOL IMMUN, V58, P1701, DOI 10.1007/s00262-009-0681-z; Butterfield L, 2013, TUMOR IMMUNOENVIRONM, P663, DOI DOI 10.1007/978-94-007-6217-629; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Butterfield LH, 1999, CANCER RES, V59, P3134; Butterfield LH, 2008, J IMMUNOTHER, V31, P294, DOI 10.1097/CJI.0b013e31816a8910; Butterfield LH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00454; Butterfield LH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-86; Butterfield LH, 2011, CLIN CANCER RES, V17, P3064, DOI 10.1158/1078-0432.CCR-10-2234; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chakraborty NG, 1998, CANCER IMMUNOL IMMUN, V47, P58, DOI 10.1007/s002620050504; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cheng HY, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8027; Coggin JH, 1999, ANTICANCER RES, V19, P5535; CONRY RM, 1995, CANCER GENE THER, V2, P33; Conry RM, 2002, CLIN CANCER RES, V8, P2782; Cotter SE, 2011, ARCH DERMATOL, V147, P870, DOI 10.1001/archdermatol.2011.176; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Demaria S, 2014, RADIAT RES, V182, P170, DOI 10.1667/RR13500.1; Di Nicolantonio F, 2013, CLIN CANCER RES, V19, P2794, DOI 10.1158/1078-0432.CCR-13-0339; Diaz-Montero CM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-62; Disis ML, 2013, CANCER PREV RES, V6, P1273, DOI 10.1158/1940-6207.CAPR-13-0182; Disis ML, 2011, CANCER IMMUNOL IMMUN, V60, P433, DOI 10.1007/s00262-010-0960-8; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Disis ML, 1996, J IMMUNOL, V156, P3151; Drake AC, 2013, CELL MOL IMMUNOL, V10, P284, DOI 10.1038/cmi.2013.21; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Eshhar Z, 2001, J IMMUNOL METHODS, V248, P67, DOI 10.1016/S0022-1759(00)00343-4; Finley DS, 2011, EXPERT REV ANTICANC, V11, P107, DOI [10.1586/era.10.174, 10.1586/ERA.10.174]; FINN OJ, 1995, IMMUNOL REV, V145, P61, DOI 10.1111/j.1600-065X.1995.tb00077.x; Finn OJ, 2009, TUMOR ASS ANTIGENS I, P23; Fourcade J, 2008, J IMMUNOTHER, V31, P781, DOI 10.1097/CJI.0b013e318183af0b; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geiger J, 2000, LANCET, V356, P1163, DOI 10.1016/S0140-6736(00)02762-8; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gravante G, 2009, LIVER INT, V29, P18, DOI 10.1111/j.1478-3231.2008.01915.x; Gulley JL, 2010, CANCER IMMUNOL IMMUN, V59, P663, DOI 10.1007/s00262-009-0782-8; Guo ZS, 2005, CANCER RES, V65, P9991, DOI 10.1158/0008-5472.CAN-05-1630; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hirschler B, 2014, 2 GSK CANC VACCINE F; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Hu YN, 2014, CANCER IMMUNOL IMMUN, V63, P779, DOI 10.1007/s00262-014-1551-x; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041632; IRIE RF, 1979, J NATL CANCER I, V63, P367; Janetzki S, 2008, CANCER IMMUNOL IMMUN, V57, P303, DOI 10.1007/s00262-007-0380-6; Janetzki S, 2012, METHODS MOL BIOL, V792, P25, DOI 10.1007/978-1-61779-325-7_2; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; John LB, 2012, CANCER RES, V72, P1651, DOI 10.1158/0008-5472.CAN-11-2788; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kanerva A, 2013, CLIN CANCER RES, V19, P2734, DOI 10.1158/1078-0432.CCR-12-2546; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaufman HL, 2010, FUTURE ONCOL, V6, P941, DOI 10.2217/FON.10.66; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Kiertscher SM, 2000, J IMMUNOL, V164, P1269, DOI 10.4049/jimmunol.164.3.1269; Kim TS, 2006, J IMMUNOTHER, V29, P261, DOI 10.1097/01.cji.0000197097.46100.bb; Kimura T, 2013, CANCER PREV RES, V6, P18, DOI 10.1158/1940-6207.CAPR-12-0275; Kirk CJ, 2000, HUM GENE THER, V11, P797, DOI 10.1089/10430340050015419; Kirkwood JM, 2009, CLIN CANCER RES, V15, P1443, DOI 10.1158/1078-0432.CCR-08-1231; Komita H, 2008, CANCER RES, V68, P8076, DOI 10.1158/0008-5472.CAN-08-0387; Krauze MT, 2011, SEMIN IMMUNOPATHOL, V33, P385, DOI 10.1007/s00281-011-0247-y; Kumar V, 1996, NAT MED, V2, P857, DOI 10.1038/nm0896-857; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2012, SEMIN ONCOL, V39, P311, DOI 10.1053/j.seminoncol.2012.02.008; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Li J, 2012, NEOPLASIA, V14, P1115, DOI 10.1593/neo.121272; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Luiten RM, 2005, J CLIN ONCOL, V23, P8978, DOI 10.1200/JCO.2005.01.6816; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; MCBRIDE WH, 1992, CANCER RES, V52, P3931; Meng WS, 2005, EXPERT OPIN BIOL TH, V5, P1019, DOI 10.1517/14712598.5.8.1019; Meng WS, 2001, CANCER RES, V61, P8782; Mincheff M, 2000, EUR UROL, V38, P208, DOI 10.1159/000020281; Mizukoshi E, 2013, HEPATOLOGY, V57, P1448, DOI 10.1002/hep.26153; Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781; Nemunaitis J, 2004, J NATL CANCER I, V96, P326, DOI 10.1093/jnci/djh028; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; NORDLUND JJ, 1983, J AM ACAD DERMATOL, V9, P689, DOI 10.1016/S0190-9622(83)70182-9; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Overwijk WW, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-11; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pollack IF, 2014, J CLIN ONCOL, V32, P2050, DOI 10.1200/JCO.2013.54.0526; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Radkevich-Brown O, 2010, CANCER IMMUNOL IMMUN, V59, P409, DOI 10.1007/s00262-009-0760-1; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ribas A, 2004, J IMMUNOTHER, V27, P354, DOI 10.1097/00002371-200409000-00004; Ribas A, 2003, TRENDS IMMUNOL, V24, P58, DOI 10.1016/S1471-4906(02)00029-7; Rosalia RA, 2013, EUR J IMMUNOL, V43, P2554, DOI 10.1002/eji.201343324; Rosenberg S, 2010, J IMMUNOTHER, V33, P557; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2003, HUM GENE THER, V14, P709, DOI 10.1089/104303403765255110; Rosenblatt J, 2013, CLIN CANCER RES, V19, P3640, DOI 10.1158/1078-0432.CCR-13-0282; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schaefer C, 2012, INT J CANCER, V131, P874, DOI 10.1002/ijc.26481; Schaue D, 2012, INT J RADIAT ONCOL, V83, P1306, DOI 10.1016/j.ijrobp.2011.09.049; Schumacher L, 2004, J IMMUNOTHER, V27, P191, DOI 10.1097/00002371-200405000-00003; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Slingluff CL, 2013, CLIN CANCER RES, V19, P4228, DOI 10.1158/1078-0432.CCR-13-0002; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Slingluff CL, 2011, J CLIN ONCOL, V29, P2924, DOI 10.1200/JCO.2010.33.8053; Smith MR, 2010, J CLIN ONCOL, V28, pE58, DOI 10.1200/JCO.2009.26.3111; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; SONDERGAARD K, 1985, AM J DERMATOPATH, V7, P1; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tani K, 2004, MOL THER, V10, P799, DOI 10.1016/j.ymthe.2004.07.001; Tarhini AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087705; Tarhini AA, 2012, J IMMUNOTHER, V35, P702, DOI 10.1097/CJI.0b013e318272569b; Timmerman JM, 2004, NAT MED, V10, P1279, DOI 10.1038/nm1204-1279a; TOPALIAN SL, 1994, P NATL ACAD SCI USA, V91, P9461, DOI 10.1073/pnas.91.20.9461; Townsend KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082406; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI DOI 10.4161/0NCI.24238; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25771; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Vollmer CM, 1999, CANCER RES, V59, P3064; Vonderheide RH, 2013, NAT MED, V19, P1098, DOI 10.1038/nm.3317; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Weide B, 2014, CLIN CANCER RES, V20, P1601, DOI 10.1158/1078-0432.CCR-13-2508; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; World Health Organization, 2015, NONC DIS FACT SHEET; Xia JZ, 2012, ULTRASOUND MED BIOL, V38, P1363, DOI 10.1016/j.ultrasmedbio.2012.03.009; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051; Zhao X, 2012, J IMMUNOL, V188, P1782, DOI 10.4049/jimmunol.1101644; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	158	155	170	5	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h988	10.1136/bmj.h988	http://dx.doi.org/10.1136/bmj.h988			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25904595	Green Published			2022-12-28	WOS:000353576700001
J	Cornfield, JM				Cornfield, Julie M.			Addie's Hope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Palo Alto High Sch, Palo Alto, CA 94301 USA		Cornfield, JM (corresponding author), Palo Alto High Sch, Palo Alto, CA 94301 USA.	julie.cornfield@gmail.com							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1517	1517		10.1001/jama.2014.7871	http://dx.doi.org/10.1001/jama.2014.7871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898046				2022-12-28	WOS:000353198700013
J	Kamerow, D				Kamerow, Douglas			Teenagers, smoking, and vaping	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Dennis B., 2015, WASHINGTON POST; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2083; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; US Department of Health and Human Services, 2012, PREV TOB US YOUTH YO, P708	5	0	0	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h2110	10.1136/bmj.h2110	http://dx.doi.org/10.1136/bmj.h2110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25900140				2022-12-28	WOS:000353576300016
J	Shafazand, S				Shafazand, Shirin			Review: In patients with obstructive sleep apnea, continuous positive airway pressure increases weight	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Miami, Miami, FL 33124 USA	University of Miami	Shafazand, S (corresponding author), Univ Miami, Miami, FL 33124 USA.							Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Katz ES, 2014, PEDIATRICS, V134, P282, DOI 10.1542/peds.2014-0591; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC8	10.7326/ACPJC-2015-162-8-008	http://dx.doi.org/10.7326/ACPJC-2015-162-8-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894053				2022-12-28	WOS:000353244300007
J	Iacobucci, G				Iacobucci, Gareth			UK GENERAL ELECTION Election watch: NHS funding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						[Anonymous], 2015, BBC; [Anonymous], 2015, LIB DEM INCR NHS FUN; Appleby J, 2015, NHS COALITION GOVT 2; Charlesworth A, 2015, MOUNTAIN CLIMB NHS F; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6430	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h2009	10.1136/bmj.h2009	http://dx.doi.org/10.1136/bmj.h2009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25876906				2022-12-28	WOS:000353328000008
J	Holcom, JB; Hoyt, DB				Holcom, John B.; Hoyt, David B.			Comprehensive Injury Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DAMAGE CONTROL RESUSCITATION; TRAUMA; DEATHS	IMPORTANCE Analysis of combat deaths provides invaluable epidemiologic and quality-improvement data for trauma centers and is particularly important under rapidly evolving battlefield conditions. OBJECTIVE To analyze the evolution of injury patterns, early care, and resuscitation among patients who subsequently died in the hospital, before and after implementation of damage control resuscitation (DCR) policies. DESIGN. SETTING, AND PARTICIPANTS In a review of the Joint Theater Trauma Registry (2002-2011) of US forward combat hospitals, cohorts of patients with vital signs at presentation and subsequent in-hospital death were grouped into 2 time periods: pre-DCR (before 2006) and OCR (2006-2011). MAIN OUTCOMES AND MEASURES Injury types and Injury Severity Scores (ISSs), timing and locationof death, and initial (24-hour)and total volume of blood products and fluid administered. RESULTS Of 57 179 soldiers admitted to a forward combat hospital, 2565 (4.5%) subsequently died in the hospital. The majority of patients (74%) were severely injured (ISS > 15), and 80% died within 24 hours of admission. Damage control resuscitation policies were widely implemented by 2006 and resulted in a decrease in mean 24-hour crystalloid infusion volume (6.1-3.2 L) and increased fresh frozen plasma use (3.2-10.1 U) (both P <.05) in this population. The mean packed red blood cells to fresh frozen plasma ratio changed from 2.6:1 during the pre-DCR period to 1.4:1 during the OCR period (P <.01). There was a significant increase in mean ISS between cohorts (pre-DCR ISS = 23 vs DCR ISS = 27; P <.05) and a marked shift in injury patterns favoring more severe head trauma in the OCR cohort. CONCLUSIONS AND RELEVANCE There has been a significant shift in resuscitation practices in forward combat hospitals indicating widespread military adoption of OCR. Patients who died in a hospital during the OCR period were more likely to be severely injured and have a severe brain injury, consistent with a decrease in deaths among potentially salvageable patients.	[Holcom, John B.] UTHealth, Ctr Translat Injury Res, Dept Surg, Houston, TX 77030 USA; [Hoyt, David B.] Amer Coll Surg, Chicago, IL USA	University of Texas System; University of Texas Health Science Center Houston; American College of Surgeons	Holcom, JB (corresponding author), UTHealth, 6410 Fannin St,Ste 1100, Houston, TX 77030 USA.	john.holcomb@uth.tmc.edu		holcomb, john/0000-0001-8312-9157				Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; Committee on Trauma and Committee on Shock Division of Medical Sciences National Academy of Sciences National Research Council, 1966, ACC DEATH DIS NEGL D; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	9	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1463	+		10.1001/jama.2014.16802	http://dx.doi.org/10.1001/jama.2014.16802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871672				2022-12-28	WOS:000352821200022
J	Creager, RL; Li, YL; MacAlpine, DM				Creager, Rachel L.; Li, Yulong; MacAlpine, David M.			SnapShot: Origins of DNA Replication	CELL			English	Editorial Material							PROGRAM		[Creager, Rachel L.; Li, Yulong; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Creager, RL (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.				NCI NIH HHS [T-32 CA059365] Funding Source: Medline; NIGMS NIH HHS [R01 GM104097] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104097] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Ding QY, 2011, CRIT REV BIOCHEM MOL, V46, P165, DOI 10.3109/10409238.2011.560139; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Mechali M, 2013, CURR OPIN GENET DEV, V23, P124, DOI 10.1016/j.gde.2013.02.010; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032	9	6	8	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					418	+		10.1016/j.cell.2015.03.043	http://dx.doi.org/10.1016/j.cell.2015.03.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860614	Bronze			2022-12-28	WOS:000352708300032
J	Sedgwick, P; Joekes, K				Sedgwick, Philip; Joekes, Katherine			Evaluating the performance of a screening test for depression in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip] Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England; [Joekes, Katherine] Univ London, Inst Med & Biomed Educ, Clin Commun, London, England	University of London; University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Sedgwick P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3986	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1801	10.1136/bmj.h1801	http://dx.doi.org/10.1136/bmj.h1801			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858900				2022-12-28	WOS:000352914700008
J	Kirby, T				Kirby, Tony			Ian Anderson: transforming Indigenous medicine and education	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1285	1285		10.1016/S0140-6736(15)60671-7	http://dx.doi.org/10.1016/S0140-6736(15)60671-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25890903				2022-12-28	WOS:000352272400022
J	Snyder, EL; Stramer, SL; Benjamin, RJ				Snyder, Edward L.; Stramer, Susan L.; Benjamin, Richard J.			The Safety of the Blood Supply - Time to Raise the Bar	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; TRANSFUSION; DONORS; VIRUS		[Snyder, Edward L.] Yale Univ, New Haven, CT 06520 USA; [Stramer, Susan L.; Benjamin, Richard J.] Amer Red Cross, Blood Serv, Rockville, MD USA	Yale University; American Red Cross	Snyder, EL (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Bracey AW, 2008, ADVISORY COMMITTEE B; Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x	5	50	51	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1882	1885		10.1056/NEJMp1500154	http://dx.doi.org/10.1056/NEJMp1500154			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25902384				2022-12-28	WOS:000354493300003
J	Hubbard, JM; Grothey, A				Hubbard, Joleen M.; Grothey, Axel			When less is more: maintenance therapy in colorectal cancer	LANCET			English	Editorial Material							PHASE-III; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; IRINOTECAN; SURVIVAL; TRIAL; BEVACIZUMAB; PROGRESSION; IMPROVES		[Hubbard, Joleen M.; Grothey, Axel] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA	Mayo Clinic	Hubbard, JM (corresponding author), Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA.	grothey.axel@mayo.edu						Allegra C, 2007, J CLIN ONCOL, V25, P3572, DOI 10.1200/JCO.2007.12.1368; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Hegewisch-Becker S, 2014, ANN ONCOL         S4, V25, piv167; Kaplan R, 2013, J CLIN ONCOL, V31, P4562, DOI 10.1200/JCO.2013.50.7905; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Schmoll H, 2014, ANN ONCOL         S4, V25, piv209; Shi Q, 2015, J CLIN ONCOL, V33, P22, DOI 10.1200/JCO.2014.56.5887; Simkens LHJ, 2015, LANCET; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201	11	13	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1808	1810		10.1016/S0140-6736(14)62350-3	http://dx.doi.org/10.1016/S0140-6736(14)62350-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25862518				2022-12-28	WOS:000354184500006
J	Xu, X; Zheng, XT; Sullivan, C; Wang, XL; Xing, LD; Wang, Y; Zhang, XM; O'Connor, JK; Zhang, FC; Pan, YH				Xu, Xing; Zheng, Xiaoting; Sullivan, Corwin; Wang, Xiaoli; Xing, Lida; Wang, Yan; Zhang, Xiaomei; O'Connor, Jingmai K.; Zhang, Fucheng; Pan, Yanhong			A bizarre Jurassic maniraptoran theropod with preserved evidence of membranous wings	NATURE			English	Article							EVOLUTION; CHINA; DINOSAURS	The wings of birds and their closest theropod relatives share a uniform fundamental architecture, with pinnate flight feathers as the key component(1-3). Here we report a new scansoriopterygid theropod, Yi qi gen. et sp. nov., based on a new specimen from the Middle-Upper Jurassic period Tiaojishan Formation of Hebei Province, China(4). Yi is nested phylogenetically among winged theropods but has large stiff filamentous feathers of an unusual type on both the forelimb and hindlimb. However, the filamentous feathers of Yi resemble pinnate feathers in bearing morphologically diverse melanosomes(5). Most surprisingly, Yi has a long rod-like bone extending from each wrist, and patches of membranous tissue preserved between the rod-like bones and the manual digits. Analogous features are unknown in any dinosaur but occur in various flying and gliding tetrapods(6-10), suggesting the intriguing possibility that Yi had membranous aerodynamic surfaces totally different from the archetypal feathered wings of birds and their closest relatives. Documentation of the unique forelimbs of Yi greatly increases the morphological disparity known to exist among dinosaurs, and highlights the extraordinary breadth and richness of the evolutionary experimentation that took place close to the origin of birds.	[Xu, Xing; Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China; [Xu, Xing; Sullivan, Corwin; O'Connor, Jingmai K.; Zhang, Fucheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Zheng, Xiaoting; Zhang, Xiaomei] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Xing, Lida] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Pan, Yanhong] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; China University of Geosciences; Chinese Academy of Sciences	Xu, X (corresponding author), Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com; ty4291666@163.com	Xiaoli, Wang/H-1079-2014	Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41372014, 41472023, 41120124002, 41125008]; Major Basic Research Projects of the Ministry of Science and Technology, China [2012CB821900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Projects of the Ministry of Science and Technology, China	We thank Z. Zhou, R. Dudley, J. Clarke and T. Stidham for discussion, X. Ding for specimen preparation, Y. Liu and Y. Han for providing illustrations, Z. Zhang for assistance with the EDS analysis, and Y. Hou for CT scanning the specimen. This research was funded by the National Natural Science Foundation of China (41372014, 41472023, 41120124002 and 41125008) and Major Basic Research Projects of the Ministry of Science and Technology, China (2012CB821900).	Bennett SC, 2007, J VERTEBR PALEONTOL, V27, P881, DOI 10.1671/0272-4634(2007)27[881:AAFOTP]2.0.CO;2; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Czerkas SA, 2014, J ORNITHOL, V155, P841, DOI 10.1007/s10336-014-1098-9; Feduccia A, 2013, AUK, V130, P1, DOI 10.1525/auk.2013.130.1.1; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jackson SM, 2000, MAMMAL REV, V30, P9, DOI 10.1046/j.1365-2907.2000.00056.x; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; JOHNSONMURRAY JL, 1977, J MAMMAL, V58, P374, DOI 10.2307/1379336; Li QG, 2014, NATURE, V507, P350, DOI 10.1038/nature12973; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; O'Connor Jingmai K., 2014, Vertebrata Palasiatica, V52, P3; Schutt William A. Jr., 1998, Journal of Mammalian Evolution, V5, P1; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Storch G, 1996, NATURE, V379, P439, DOI 10.1038/379439a0; Sullivan C, 2014, J VERTEBR PALEONTOL, V34, P243, DOI 10.1080/02724634.2013.787316; Thorington RW, 1998, J MAMMAL, V79, P245, DOI 10.2307/1382860; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	24	103	108	5	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					70	U131		10.1038/nature14423	http://dx.doi.org/10.1038/nature14423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924069				2022-12-28	WOS:000354040900034
J	Doerschuk, CM				Doerschuk, Claire M.			Pulmonary Alveolar Proteinosis and Macrophage Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPY		Univ N Carolina, Dept Med, Marsico Lung Inst, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Doerschuk, CM (corresponding author), Univ N Carolina, Dept Med, Marsico Lung Inst, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA.							Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Kleff V, 2008, MOL THER, V16, P757, DOI 10.1038/mt.2008.7; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108	5	14	16	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1762	1764		10.1056/NEJMcibr1413035	http://dx.doi.org/10.1056/NEJMcibr1413035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923557	Green Published			2022-12-28	WOS:000353655000013
J	Grayson, M				Grayson, Michelle			ASSESSING SCIENCE	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S1	S1		10.1038/520S1a	http://dx.doi.org/10.1038/520S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VB6SE	25924191	Bronze			2022-12-28	WOS:000416660400001
J	D'Silva, J				D'Silva, Jeetha			PUBLIC HEALTH Swine flu: how well did India respond?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2015, NDTV; [Anonymous], 2015, IBN LIVE; [Anonymous], 2015, BBC; [Anonymous], 2015, RFI; [Anonymous], 2015, EC TIMES        0406; Deshpande V., 2015, HINDU; Ministry of Health and Family Welfare, CAS INFL H; NHS Choices, 2015, FLU FREEZ WEATH MAY; Pal S., 2015, DNA; Press Trust of India, 2015, DNA; Roos R., 2013, STUDY PUTS GLOBAL 20; Tandon A., 2015, TRIBUNE	12	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2015	350								h2286	10.1136/bmj.h2286	http://dx.doi.org/10.1136/bmj.h2286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UR	25925535				2022-12-28	WOS:000353956400005
J	Morton, D; Bicknell, CD				Morton, Dion; Bicknell, Colin D.			Should surgical training include involvement in a clinical trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIALS; SURGERY; MULTICENTER; METAANALYSIS; CANCER	The next generation of surgical consultants will need research experience to advance the specialty, writes Dion Morton, but Colin Bicknell worries about increasing the time trainees spend away from the operating theatre, where they learn their craft	[Morton, Dion] Univ Hosp Birmingham NHS Fdn Trust, Acad Dept Surg, Surg, Birmingham B15 2TH, W Midlands, England; [Bicknell, Colin D.] Univ London Imperial Coll Sci Technol & Med, London, England	University of Birmingham; Imperial College London	Morton, D (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Acad Dept Surg, Surg, Birmingham B15 2TH, W Midlands, England.	dion.morton@uhb.nhs.uk; colin.bicknell@imperial.ac.uk		Morton, Dion/0000-0001-6784-1689; Bicknell, Colin/0000-0003-0158-1831				Bhangu A, 2013, LANCET, V382, P1091, DOI 10.1016/S0140-6736(13)62013-9; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Cancer Research UK, STUD LOOK POSS NEW W; Cancer Research UK, TRIAL COMP SURG ACT; Clinical Practice Research Datalink, OBS DAT; Collinson FJ, 2012, INT J COLORECTAL DIS, V27, P233, DOI 10.1007/s00384-011-1313-6; Datta ST, 2014, BMC MED ED S1, V14, pS12; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Gomez-Izquierdo JC, 2015, BRIT J SURG, V102, P577, DOI 10.1002/bjs.9747; Greco M, 2014, WORLD J SURG, V38, P1531, DOI 10.1007/s00268-013-2416-8; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hamilton E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-249; Intercollegiate Surgical Curriculum Programme, SURG CURR; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; Royal College of Anaesthetists, ED EV RES; Weeks JC, 2002, JAMA-J AM MED ASSOC, V287, P321, DOI 10.1001/jama.287.3.321; World Health Organization, CLIN TRIALS	18	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2045	10.1136/bmj.h2045	http://dx.doi.org/10.1136/bmj.h2045			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25904564				2022-12-28	WOS:000353576700007
J	Metcalfe, R; Reed, M; Winter, A				Metcalfe, Rebecca; Reed, Michael; Winter, Andrew			A limp with an unusual cause	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Metcalfe, Rebecca; Winter, Andrew] Sandyford Sexual Hlth Serv, Genitourinary Med, Glasgow G3 7NB, Lanark, Scotland; [Reed, Michael] Glasgow Royal Infirm, Dept Rheumatol, Rheumatol, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Metcalfe, R (corresponding author), Sandyford Sexual Hlth Serv, Genitourinary Med, Glasgow G3 7NB, Lanark, Scotland.	rebeccametcalfe@nhs.net		Metcalfe, Rebecca/0000-0003-1897-6223				Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Bignell C, 2012, UK NATL GUIDELINE GO; British Association of Sexual Health and HIV, 2008, UK NAT GUID MAN SEX; Coakley G, 2006, RHEUMATOLOGY, V45, P1039, DOI 10.1093/rheumatology/kel163a; European Centre for Disease Prevention and Control, 2012, SURV REP SEX TRANSM; Garcia-Arias M, 2011, BEST PRACT RES CL RH, V25, P407, DOI 10.1016/j.berh.2011.02.001; Garcia-De La Torre I, 2009, RHEUM DIS CLIN N AM, V35, P63, DOI 10.1016/j.rdc.2009.03.001; Health Protection Agency (HPA), 2013, GON RES ANT SURV PRO; Health Protection Scotland, 2014, SURV REP; International Union against Sexually Transmitted Infections, 2012, 2012 EUR GUID DIAGN; Mathews CJ, 2010, LANCET, V375, P846, DOI 10.1016/S0140-6736(09)61595-6; Public Health England, SEX REPR HLTH PROF; Rice PA, 2005, INFECT DIS CLIN N AM, V19, P853, DOI 10.1016/j.idc.2005.07.003; Selmi C, 2014, AUTOIMMUN REV, V13, P546, DOI 10.1016/j.autrev.2014.01.005; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Vestra MD, 2008, RHEUMATOL INT, V29, P81, DOI 10.1007/s00296-008-0623-7	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h1985	10.1136/bmj.h1985	http://dx.doi.org/10.1136/bmj.h1985			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25901011				2022-12-28	WOS:000353576300005
J	Carlson, RW				Carlson, Richard W.			A new recipe for Earth formation	NATURE			English	News Item								Experimental results suggest that if Earth initially grew by the accumulation of highly chemically reduced material, its core could contain enough uranium to drive the planet's magnetic field throughout Earth's history.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Carlson, RW (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	rcarlson@carnegiescience.edu						Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; Weider SZ, 2015, EARTH PLANET SC LETT, V416, P109, DOI 10.1016/j.epsl.2015.01.023; Wohlers A, 2015, NATURE, V520, P337, DOI 10.1038/nature14350	6	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					299	300		10.1038/520299a	http://dx.doi.org/10.1038/520299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877198				2022-12-28	WOS:000352974200024
J	Yu, M; Selvaraj, SK; Liang-Chu, MMY; Aghajani, S; Busse, M; Yuan, J; Lee, G; Peale, F; Klijn, C; Bourgon, R; Kaminker, JS; Neve, RM				Yu, Mamie; Selvaraj, Suresh K.; Liang-Chu, May M. Y.; Aghajani, Sahar; Busse, Matthew; Yuan, Jean; Lee, Genee; Peale, Franklin; Klijn, Christiaan; Bourgon, Richard; Kaminker, Joshua S.; Neve, Richard M.			A resource for cell line authentication, annotation and quality control	NATURE			English	Article							SPECIES IDENTIFICATION; CROSS-CONTAMINATION; CANCER	Cell line misidentification, contamination and poor annotation affect scientific reproducibility. Here we outline simple measures to detect or avoid cross-contamination, present a framework for cell line annotation linked to short tandem repeat and single nucleotide polymorphism profiles, and provide a catalogue of synonymous cell lines. This resource will enable our community to eradicate the use of misidentified lines and generate credible cell-based data.	[Yu, Mamie; Selvaraj, Suresh K.; Liang-Chu, May M. Y.; Lee, Genee; Neve, Richard M.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Aghajani, Sahar; Busse, Matthew; Yuan, Jean; Klijn, Christiaan; Bourgon, Richard; Kaminker, Joshua S.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Peale, Franklin] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Neve, RM (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.	neve.richard@gene.com		Klijn, Christiaan/0000-0003-0878-4121; Bourgon, Richard/0000-0002-5890-4374				[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; [Anonymous], 2009, NATURE, V457, P935, DOI 10.1038/457935b; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Buehring GC, 2004, IN VITRO CELL DEV-AN, V40, P211; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Centers for Disease Control and Prevention, INT CLASSIFICATION D; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Didion JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-847; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; ICLAC, 2014, DAT CROSS CONT MIS C; ICLAC, 2014, NAM CELL LIN; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lorsch JR, 2014, SCIENCE, V346, P1452, DOI 10.1126/science.1259110; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Much M, 2014, HUM PATHOL, V45, P549, DOI 10.1016/j.humpath.2013.10.022; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Sarntivijai S, 2008, BIOINFORMATICS, V24, P2760, DOI 10.1093/bioinformatics/btn502; Steube KG, 2003, IN VITRO CELL DEV-AN, V39, P468; TANABE H, 1999, TISSUE CULT RES COMM, V18, P329, DOI DOI 10.11418/JTCA1981.18.4_329; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Wellcome Trust Sanger Institute, 2015, CELL LIN PROJ; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	35	141	144	3	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					307	+		10.1038/nature14397	http://dx.doi.org/10.1038/nature14397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877200				2022-12-28	WOS:000352974200029
J	Berger, D				Berger, David			IF I RULED THE NHS Set our talented professionals free	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berger, David] Broome Hosp, Emergency Med, Broome, WA, Australia		Berger, D (corresponding author), Broome Hosp, Emergency Med, Broome, WA, Australia.	daveberger@gmail.com						Kmietowicz Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h633	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1811	10.1136/bmj.h1811	http://dx.doi.org/10.1136/bmj.h1811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25857575				2022-12-28	WOS:000352914700010
J	Blake, GA; Bergin, EA				Blake, Geoffrey A.; Bergin, Edwin A.			PLANETARY SCIENCE Prebiotic chemistry on the rocks	NATURE			English	Editorial Material							MOLECULES; DISKS	Organic compounds called nitriles have been detected in material surrounding a young star. The finding hints at a vast reservoir of ice and volatile species that can seed the surfaces of young rocky planets or moons. See Letter p. 198	[Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Bergin, Edwin A.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	California Institute of Technology; University of Michigan System; University of Michigan	Blake, GA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	gab@gps.caltech.edu; ebergin@umich.edu			Direct For Mathematical & Physical Scien [1109857] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		ALMA Partnership, 2015, PREPRINT; Bergin E, 2014, FARADAY DISCUSS, V168, P61, DOI 10.1039/c4fd00003j; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Men'shchikov AB, 1999, ASTROPHYS J, V519, P257, DOI 10.1086/307333; Ros K, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220536	8	3	3	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					161	162		10.1038/520161a	http://dx.doi.org/10.1038/520161a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855449				2022-12-28	WOS:000352454600022
J	Chang, J				Chang, Jeffrey			Reward bioinformaticians	NATURE			English	Editorial Material									[Chang, Jeffrey] Univ Texas Hlth Sci Ctr Houston, Bioinformat Serv Ctr, Houston, TX 77030 USA; [Chang, Jeffrey] Univ Texas Hlth Sci Ctr Houston, Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chang, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Bioinformat Serv Ctr, Houston, TX 77030 USA.	jeffrey.t.chang@uth.tmc.edu						Lewitter F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000372; Lewitter F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000368	2	28	28	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					151	152		10.1038/520151a	http://dx.doi.org/10.1038/520151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855439	Bronze			2022-12-28	WOS:000352454600011
J	Gagliani, N; Vesely, MCA; Iseppon, A; Brockmann, L; Xu, H; Palm, NW; de Zoete, MR; Licona-Limon, P; Paiva, RS; Ching, T; Weaver, C; Zi, XY; Pan, XH; Fan, R; Garmire, LX; Cotton, MJ; Drier, Y; Bernstein, B; Geginat, J; Stockinger, B; Esplugues, E; Huber, S; Flavell, RA				Gagliani, Nicola; Vesely, Maria Carolina Amezcua; Iseppon, Andrea; Brockmann, Leonie; Xu, Hao; Palm, Noah W.; de Zoete, Marcel R.; Licona-Limon, Paula; Paiva, Ricardo S.; Ching, Travers; Weaver, Casey; Zi, Xiaoyuan; Pan, Xinghua; Fan, Rong; Garmire, Lana X.; Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley; Geginat, Jens; Stockinger, Brigitta; Esplugues, Enric; Huber, Samuel; Flavell, Richard A.			TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation	NATURE			English	Article							T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-10; FOXP3(+); RECEPTOR; ABSENCE; IL-10; GAMMA	Inflammation is a beneficial host response to infection but can contribute to inflammatory disease if unregulated. The TH17 lineage of T helper (TH) cells can cause severe human inflammatory diseases. These cells exhibit both instability (they can cease to express their signature cytokine, IL-17A)(1) and plasticity (they can start expressing cytokines typical of other lineages)(1,2) upon in vitro re-stimulation. However, technical limitations have prevented the transcriptional profiling of pre- and post-conversion TH17 cells ex vivo during immune responses. Thus, it is unknown whether TH17 cell plasticity merely reflects change in expression of a few cytokines, or if TH17 cells physiologically undergo global genetic reprogramming driving their conversion from one T helper cell type to another, a process known as transdifferentiation(3,4). Furthermore, although TH17 cell instability/plasticity has been associated with pathogenicity(1,2,5), it is unknown whether this could present a therapeutic opportunity, whereby formerly pathogenic TH17 cells could adopt an anti-inflammatory fate. Here we used two new fate-mapping mouse models to track TH17 cells during immune responses to show that CD4(+) T cells that formerly expressed IL-17A go on to acquire an anti-inflammatory phenotype. The transdifferentiation of TH17 into regulatory T cells was illustrated by a change in their signature transcriptional profile and the acquisition of potent regulatory capacity. Comparisons of the transcriptional profiles of pre-and post-conversion TH17 cells also revealed a role for canonical TGF-beta signalling and consequently for the aryl hydrocarbon receptor (AhR) in conversion. Thus, TH17 cells transdifferentiate into regulatory cells, and contribute to the resolution of inflammation. Our data suggest that TH17 cell instability and plasticity is a therapeutic opportunity for inflammatory diseases.	[Gagliani, Nicola; Vesely, Maria Carolina Amezcua; Iseppon, Andrea; Xu, Hao; Palm, Noah W.; de Zoete, Marcel R.; Licona-Limon, Paula; Paiva, Ricardo S.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Brockmann, Leonie; Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin, D-20246 Hamburg, Germany; [de Zoete, Marcel R.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Ching, Travers; Garmire, Lana X.] Univ Hawaii, Ctr Canc, Manoa, HI 96813 USA; [Weaver, Casey] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zi, Xiaoyuan; Fan, Rong] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Pan, Xinghua] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Howard Hughes Med Inst, Boston, MA 02114 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Geginat, Jens] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, I-20122 Milan, Italy; [Stockinger, Brigitta] MRCNat Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Esplugues, Enric] Icahn Sch Med Mt Sinai, Mt Sinai Sch Med, Immunol Inst, New York, NY 10029 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; Yale University; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Alabama System; University of Alabama Birmingham; Yale University; Yale University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	s.huber@uke.de; richard.flavell@yale.edu	de Zoete, Marcel/ABA-7918-2021; de Zoete, Marcel R/O-3012-2014; Esplugues, Enric/AAD-4245-2020; Geginat, Jens/AAA-5818-2019; Drier, Yotam/K-5208-2012	Geginat, Jens/0000-0003-4813-0384; Drier, Yotam/0000-0003-1725-2995; de Sousa e Paiva, Ricardo/0000-0001-5898-0126; Gagliani, Nicola/0000-0001-8514-1395; Ching, Travers/0000-0002-5577-3516; Palm, Noah/0000-0001-7262-9455; Stockinger, Brigitta/0000-0001-8781-336X; AMEZCUA VESELY, MARIA CAROLINA/0000-0001-9631-1249; Esplugues, Enric/0000-0002-8130-0413; Pan, Xinghua (Victor)/0000-0002-7421-8155; de Zoete, Marcel/0000-0002-6561-5810; Huber, Samuel/0000-0001-9325-8227	NIH/BD2K [K01ES025434]; NIH/NIGMS [P20 COBRE GM103457]; DFG [EXC 257 NeuroCure, SFB633, HU1714/3]; Crohn's & Colitis Foundation of America [311143]; Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute; Ernst Jung-Stiftung Hamburg; Howard Hughes Medical Institute; Cariplo foundation [2013-0937]; AbbVie-Yale Collaboration; Francis Crick Institute; MRC [MC_U117512792] Funding Source: UKRI; Medical Research Council [MC_U117512792] Funding Source: researchfish; The Francis Crick Institute [10159] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER	NIH/BD2K; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DFG(German Research Foundation (DFG)); Crohn's & Colitis Foundation of America; Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute; Ernst Jung-Stiftung Hamburg; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cariplo foundation(Fondazione Cariplo); AbbVie-Yale Collaboration(AbbVie); Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank C. Lieber, P. Musco, E. Hughes-Picard and J. Alderman for expert administrative assistance. J. Stein, L. Evangelisti and C. Hughes for generating the IL-17A IRES-eGFP-CRE-ERT2 constructs, embryonic stem cells and chimaeric mice, respectively. We thank E. Baiocchi for remote key support. LXG is supported by grants K01ES025434 from NIH/BD2K and P20 COBRE GM103457 from NIH/NIGMS. E. E. was supported by the DFG (EXC 257 NeuroCure and SFB633) and by the Crohn's & Colitis Foundation of America (#311143). N.G. is supported by the Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute. S.H. is supported by the DFG (HU1714/3) and by Ernst Jung-Stiftung Hamburg and has an endowed Hofschneider-Professorship from the Stiftung Experimentelle Biomedizin. This work was supported, by the Howard Hughes Medical Institute, by Cariplo foundation (2013-0937 to J.G. and R.A.F.), by the AbbVie-Yale Collaboration (R.A.F.) and by the Francis Crick Institute (B.S.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Okamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7329; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Panzer M, 2012, J IMMUNOL, V188, P615, DOI 10.4049/jimmunol.1101164; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	38	504	529	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					221	U225		10.1038/nature14452	http://dx.doi.org/10.1038/nature14452			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	25924064	Green Accepted			2022-12-28	WOS:000357695900037
J	Lassey, AT				Lassey, Anyetei Tonyeli			Bladder catheterisation after female genital fistula repair	LANCET			English	Editorial Material							OBSTETRIC FISTULA		Korle Bu Teaching Hosp, Dept Obstet & Gynecol, Korle Bu, Accra, Ghana		Lassey, AT (corresponding author), Korle Bu Teaching Hosp, Dept Obstet & Gynecol, POB KB 36, Korle Bu, Accra, Ghana.	atlassey@yahoo.co.uk						Arrowsmith SD, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-73; Barone MA, 2015, LANCET; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; Frajzyngier V, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.02.006; Nardos R, 2008, INT J GYNECOL OBSTET, V103, P30, DOI 10.1016/j.ijgo.2008.05.021; Nardos R, 2012, INT J GYNECOL OBSTET, V118, P21, DOI 10.1016/j.ijgo.2012.01.024; Ruminjo JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-220; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wall L L, 2005, Obstet Gynecol Surv, V60, pS3, DOI 10.1097/00006254-200507001-00002	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					9	10		10.1016/S0140-6736(15)60729-2	http://dx.doi.org/10.1016/S0140-6736(15)60729-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25911171				2022-12-28	WOS:000357519400007
J	Boulvain, M; Senat, MV; Perrotin, F; Winer, N; Beucher, G; Subtil, D; Bretelle, F; Azria, E; Hejaiej, D; Vendittelli, F; Capelle, M; Langer, B; Matis, R; Connan, L; Gillard, P; Kirkpatrick, C; Ceysens, G; Faron, G; Irion, O; Rozenberg, P				Boulvain, Michel; Senat, Marie-Victoire; Perrotin, Franck; Winer, Norbert; Beucher, Gael; Subtil, Damien; Bretelle, Florence; Azria, Elie; Hejaiej, Dominique; Vendittelli, Francoise; Capelle, Marianne; Langer, Bruno; Matis, Richard; Connan, Laure; Gillard, Philippe; Kirkpatrick, Christine; Ceysens, Gilles; Faron, Gilles; Irion, Olivier; Rozenberg, Patrick		GROG	Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial	LANCET			English	Article							SHOULDER DYSTOCIA; FETAL MACROSOMIA; MORBIDITY; DELIVERY; OUTCOMES	Background Macrosomic fetuses are at increased risk of shoulder dystocia. We aimed to compare induction of labour with expectant management for large-for-date fetuses for prevention of shoulder dystocia and other neonatal and maternal morbidity associated with macrosomia. Methods We did this pragmatic, randomised controlled trial between Oct 1, 2002, and Jan 1, 2009, in 19 tertiary-care centres in France, Switzerland, and Belgium. Women with singleton fetuses whose estimated weight exceeded the 95th percentile, were randomly assigned (1:1), via computer-generated permuted-block randomisation (block size of four to eight) to receive induction of labour within 3 days between 37(+0) weeks and 38(+6) weeks of gestation, or expectant management. Randomisation was stratified by centre. Participants and caregivers were not masked to group assignment. Our primary outcome was a composite of clinically significant shoulder dystocia, fracture of the clavicle, brachial plexus injury, intracranial haemorrhage, or death. We did analyses by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00190320. Findings We randomly assigned 409 women to the induction group and 413 women to the expectant management group, of whom 407 women and 411 women, respectively, were included in the final analysis. Mean birthweight was 3831 g (SD 324) in the induction group and 4118 g (392) in the expectant group. Induction of labour significantly reduced the risk of shoulder dystocia or associated morbidity (n=8) compared with expectant management (n=25; relative risk [RR] 0.32, 95% CI 0.15-0.71; p=0.004). We recorded no brachial plexus injuries, intracranial haemorrhages, or perinatal deaths. The likelihood of spontaneous vaginal delivery was higher in women in the induction group than in those in the expectant management group (RR 1.14, 95% CI 1.01-1.29). Caesarean delivery and neonatal morbidity did not diff er significantly between the groups. Interpretation Induction of labour for suspected large-for-date fetuses is associated with a reduced risk of shoulder dystocia and associated morbidity compared with expectant management. Induction of labour does not increase the risk of caesarean delivery and improves the likelihood of spontaneous vaginal delivery. These benefits should be balanced with the effects of early-term induction of labour.	[Boulvain, Michel; Irion, Olivier] Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland; [Boulvain, Michel; Irion, Olivier] Univ Geneva, Fac Med, Geneva, Switzerland; [Senat, Marie-Victoire] Univ Paris 11, Hop Bicetre, Hop Antoine Beclere, APHP,Fac Med,Dept Gynecol Obstet, Paris, France; [Perrotin, Franck] CHRU Tours, Hop Bretonneau, Pole Gynecol Obstet, Tours, France; [Winer, Norbert] Hop Mere Enfant, Dept Obstet Gynecol, Nantes, France; [Beucher, Gael] CHU Caen, Dept Gynecol Obstet & Med Reprod, F-14000 Caen, France; [Subtil, Damien] Hop Jeanne de Flandre, Dept Obstet Gynecol, Lille, France; [Bretelle, Florence] Hop Nord Marseille, Dept Obstet Gynecol, Marseille, France; [Azria, Elie] Hop Bichat Claude Bernard, AP HP, Dept Obstet Gynecol, F-75877 Paris, France; [Hejaiej, Dominique] Ctr Hosp Reg, Dept Obstet Gynecol, Annecy, France; [Vendittelli, Francoise] Hop Estaing, CHU Clermont Ferrand, Pole Gynecol Obstet & Reprod Humaine, Clermont Ferrand, France; [Capelle, Marianne] Hop Conception, Dept Obstet Gynecol, Marseille, France; [Langer, Bruno] Hop Hautepierre, Dept Obstet Gynecol, Strasbourg, France; [Matis, Richard] Grp Hosp Inst Catholique Lille, Lille, France; [Connan, Laure] Hop Paul de Viguier, Dept Obstet Gynecol, Toulouse, France; [Gillard, Philippe] Hop Hotel Dieu, Pole Gynecol Obstet, Angers, France; [Kirkpatrick, Christine; Ceysens, Gilles] Free Univ Brussels, Hop Erasme, Dept Obstet Gynecol, B-1070 Brussels, Belgium; [Ceysens, Gilles] Hop Ambroise Pare, Dept Obstet Gynecol, Mons, Belgium; [Faron, Gilles] Hop Brugmann, Dept Obstet Gynecol, Brussels, Belgium; [Rozenberg, Patrick] Univ Versailles St Quentin, Hop Poissy St Germain, Dept Obstet Gynecol, Versailles, France	University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Antoine-Beclere - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Tours; Nantes Universite; CHU de Nantes; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Annecy Genevois; CHU Clermont Ferrand; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique de Lille; CHU de Toulouse; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay	Boulvain, M (corresponding author), Matern HUG, CH-1211 Geneva, Switzerland.	michel.boulvain@hcuge.ch	Perrotin, Franck/AAL-8833-2021	Perrotin, Franck/0000-0001-9694-6658; Bretelle, Florence/0000-0002-0909-3202; Azria, Elie/0000-0002-6159-6253	Assistance Publique-Hopitaux de Paris; University of Geneva; Departement a la Recherche Clinique Ile-de-France; Assistance Publique-Hopitaux de Paris [PHRC AOM 04038]; Department of Gynecology and Obstetrics of the University of Geneva	Assistance Publique-Hopitaux de Paris; University of Geneva; Departement a la Recherche Clinique Ile-de-France; Assistance Publique-Hopitaux de Paris; Department of Gynecology and Obstetrics of the University of Geneva	Assistance Publique-Hopitaux de Paris and the University of Geneva.; This trial was supported by a research grant from the Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris (number PHRC AOM 04038) and by the Department of Gynecology and Obstetrics of the University of Geneva. We thank Jo Ann Cahn for doing the final editing of the manuscript; Eric Antonelli for participation in the study design; Nicole Jastrow for participation in the report writing; Riccardo Pfister for participation in the design of the neonatal data collection forms and discussions of the results for the neonate; Veronique Othenin-Girard for participation in the recruitment of participants and data collection in Geneva; and Shoreh Azimi for opening the trial's sites, verifying the data collection, and monitoring the study in France. This work was presented orally at the 32nd Congress of the Society for Maternal-Fetal Medicine (SMFM), Dallas, TX, USA, 2012.	ACOG Committee on Practice Bulletins-Gynecology The American College of Obstetrician and Gynecologists, 2002, Obstet Gynecol, V100, P1045; Beall MH, 1998, AM J OBSTET GYNECOL, V179, P934, DOI 10.1016/S0002-9378(98)70191-7; Chauhan SP, 2000, OBSTET GYNECOL, V95, P639, DOI 10.1016/S0029-7844(99)00606-7; Cheng YW, 2012, BJOG-INT J OBSTET GY, V119, P402, DOI 10.1111/j.1471-0528.2011.03248.x; Clark SL, 2009, AM J OBSTET GYNECOL, V200; De Luca R, 2009, PEDIATRICS, V123, pE1064, DOI 10.1542/peds.2008-2407; Ehrenthal DB, 2011, OBSTET GYNECOL, V118, P1047, DOI 10.1097/AOG.0b013e3182319c58; Ghartey K, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.022; Gonen O, 1997, OBSTET GYNECOL, V89, P913, DOI 10.1016/S0029-7844(97)00149-X; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Irion O, 2000, COCHRANE DB SYST REV, V2; Kayem G, 2009, ULTRASOUND OBST GYN, V34, P566, DOI 10.1002/uog.6378; King JR, 2012, J MATERN-FETAL NEO M, V25, P1953, DOI 10.3109/14767058.2012.674990; Little SE, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.065; MacKenzie IZ, 2007, OBSTET GYNECOL, V110, P1059, DOI 10.1097/01.AOG.0000287615.35425.5c; Maisels MJ, 2004, PEDIATRICS, V114, P297; Mavroforou A, 2005, MED LAW, V24, P1; NAEF RW, 1995, OBSTET GYN CLIN N AM, V22, P247; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480; Royal College of Obstetricians and Gynaecologists, 2012, SHOULD DYST; Sanchez-Ramos L, 2002, OBSTET GYNECOL, V100, P997, DOI 10.1016/S0029-7844(02)02321-9; SIMON NV, 1987, J CLIN ULTRASOUND, V15, P376, DOI 10.1002/jcu.1870150604; Tey A., 1995, American Journal of Obstetrics and Gynecology, V172, P293; Tutdibi E, 2010, PEDIATRICS, V125, pE577, DOI 10.1542/peds.2009-0314; Vidarsdottir H, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.036	25	145	159	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2600	2605		10.1016/S0140-6736(14)61904-8	http://dx.doi.org/10.1016/S0140-6736(14)61904-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25863654	Green Published			2022-12-28	WOS:000356930000027
J	Hepworth, MR; Fung, TC; Masur, SH; Kelsen, JR; McConnell, FM; Dubrot, J; Withers, DR; Hugues, S; Farrar, MA; Reith, W; Eberl, G; Baldassano, RN; Laufer, TM; Elson, CO; Sonnenberg, GF				Hepworth, Matthew R.; Fung, Thomas C.; Masur, Samuel H.; Kelsen, Judith R.; McConnell, Fiona M.; Dubrot, Juan; Withers, David R.; Hugues, Stephanie; Farrar, Michael A.; Reith, Walter; Eberl, Gerard; Baldassano, Robert N.; Laufer, Terri M.; Elson, Charles O.; Sonnenberg, Gregory F.			Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLASS-II EXPRESSION; NEGATIVE SELECTION; PROMOTER-IV; MICROBIOTA; HOMEOSTASIS; APOPTOSIS; THYMUS; REPERTOIRE; RESPONSES	Inflammatory CD4(+) T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII+ ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4(+) T cells in the intestine and suggest that this process is dysregulated in human IBD.	[Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Div Gastroenterol, New York, NY 10021 USA; [Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10021 USA; [Fung, Thomas C.; Laufer, Terri M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Masur, Samuel H.; Kelsen, Judith R.; Baldassano, Robert N.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [McConnell, Fiona M.; Withers, David R.] Univ Birmingham, MRC, Coll Med & Dent Sci, Ctr Immune Regulat, Birmingham, W Midlands, England; [Hugues, Stephanie; Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Farrar, Michael A.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Cornell University; Cornell University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Birmingham; University of Geneva; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sonnenberg, GF (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Div Gastroenterol, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu	Withers, David/C-7055-2015; Eberl, Gerard/A-1160-2013; Dubrot, Juan/ABI-1676-2020; Farrar, Michael A/M-7802-2013	Withers, David/0000-0003-3757-7594; Dubrot, Juan/0000-0002-8093-2208; Farrar, Michael/0000-0002-5569-0366; hugues, stephanie/0000-0002-1031-5909; Hepworth, Matthew/0000-0002-9613-7858; Eberl, Gerard/0000-0002-1119-5638	National Institutes of Health [DP5OD012116, DK071176]; National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the U.S. National Center for Research Resources) [UL1-RR024134]; Crohn's and Colitis Foundation of America (CCFA) [297365]; Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant; Wellcome Trust Research Career Development Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the U.S. National Center for Research Resources); Crohn's and Colitis Foundation of America (CCFA); Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant; Wellcome Trust Research Career Development Fellowship(Wellcome Trust); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank members of the Sonnenberg laboratory for discussions and critical reading of the manuscript. We thank C. Hunter and S. Wagage (University of Pennsylvania) for the Ahr-deficient mice; I. Brodsky (University of Pennsylvania) for the Caspase 1/11-deficient mice; and M. Jenkins, J. Walter, and T. Dileepan (University of Minnesota) for tetramer reagents and protocols. Data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Microarray data are accessible at Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) via accession number GSE67076. CBir1 Tg mice are available from University of Alabama, Rorc(gamma t)-Gfp<SUP>TG</SUP> and Rorc<SUP>Cre</SUP> mice are available from Institut Pasteur, STAT5-CA mice are available from University of Minnesota, IAbbSTOP<SUP>fl/fl</SUP> mice and CD11c Tg mice are available from University of Pennsylvania, and Il23a deficient mice are available from Janssen Research and Development LLC, all under Material Transfer Agreement. Research in the Sonnenberg laboratory is supported by the National Institutes of Health (DP5OD012116), the National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity, and the Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (UL1-RR024134 from the U.S. National Center for Research Resources). M.R.H. is supported by a research fellowship from the Crohn's and Colitis Foundation of America (CCFA, no. 297365). T.C.F. is supported by a Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant. D.R.W. is supported by a Wellcome Trust Research Career Development Fellowship. C.O.E. is supported by the National Institutes of Health (DK071176).	Ai TL, 2014, IMMUNOL REV, V259, P60, DOI 10.1111/imr.12171; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; Bollrath J, 2013, SEMIN IMMUNOL, V25, P352, DOI 10.1016/j.smim.2013.09.002; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Laufer TM, 1999, SEMIN IMMUNOL, V11, P65, DOI 10.1006/smim.1998.9997; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Neurath MF, 2001, TRENDS IMMUNOL, V22, P21, DOI 10.1016/S1471-4906(00)01798-1; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	41	294	316	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1031	1035		10.1126/science.aaa4812	http://dx.doi.org/10.1126/science.aaa4812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25908663	Green Accepted			2022-12-28	WOS:000355276600048
J	Benazzi, S; Slon, V; Talamo, S; Negrino, F; Peresani, M; Bailey, SE; Sawyer, S; Panetta, D; Vicino, G; Starnini, E; Mannino, MA; Salvadori, PA; Meyer, M; Paabo, S; Hublin, JJ				Benazzi, S.; Slon, V.; Talamo, S.; Negrino, F.; Peresani, M.; Bailey, S. E.; Sawyer, S.; Panetta, D.; Vicino, G.; Starnini, E.; Mannino, M. A.; Salvadori, P. A.; Meyer, M.; Paeaebo, S.; Hublin, J. -J.			The makers of the Protoaurignacian and implications for Neandertal extinction	SCIENCE			English	Article							HUMAN-CLIMATE INTERACTION; MODERN HUMANS; PROTO-AURIGNACIAN; GENOME SEQUENCE; ADAPTIVE SHIFT; HYPOTHESIS; DISPERSAL; REMAINS; GROTTE; RENNE	The Protoaurignacian culture is pivotal to the debate about the timing of the arrival of modern humans in western Europe and the demise of Neandertals. However, which group is responsible for this culture remains uncertain. We investigated dental remains associated with the Protoaurignacian. The lower deciduous incisor from Riparo Bombrini is modern human, based on its morphology. The upper deciduous incisor from Grotta di Fumane contains ancient mitochondrial DNA of a modern human type. These teeth are the oldest human remains in an Aurignacian-related archaeological context, confirming that by 41,000 calendar years before the present, modern humans bearing Protoaurignacian culture spread into southern Europe. Because the last Neandertals date to 41,030 to 39,260 calendar years before the present, we suggest that the Protoaurignacian triggered the demise of Neandertals in this area.	[Benazzi, S.] Univ Bologna, Dept Cultural Heritage, I-48121 Ravenna, Italy; [Benazzi, S.; Talamo, S.; Bailey, S. E.; Mannino, M. A.; Hublin, J. -J.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Slon, V.; Sawyer, S.; Meyer, M.; Paeaebo, S.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Negrino, F.] Univ Genoa, Dipartimento Antichita Filosofia Storia & Geog, I-16126 Genoa, Italy; [Peresani, M.] Univ Ferrara, Dipartimento Studi Umanist, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Bailey, S. E.] NYU, Ctr Study Human Origins, Dept Anthropol, New York, NY 10003 USA; [Panetta, D.; Salvadori, P. A.] CNR, CNR Inst Clin Physiol, I-56124 Pisa, Italy; [Vicino, G.] Museo Archeol Finale, I-17024 Finale Ligure Borgo, Italy; [Starnini, E.] Univ Turin, Dipartimento Studi Stor, Scuola Sci Umanist, I-10124 Turin, Italy; [Starnini, E.] Museo Preistor Nazl Balzi Rossi, I-18039 Ventimiglia, Italy	University of Bologna; Max Planck Society; Max Planck Society; University of Genoa; University of Ferrara; New York University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Turin	Benazzi, S (corresponding author), Univ Bologna, Dept Cultural Heritage, Via Ariani 1, I-48121 Ravenna, Italy.	stefano.benazzi@unibo.it	Talamo, Sahra/AAD-1774-2022; Starnini, Elisabetta/AAN-8466-2020; Starnini, Elisabetta/N-3651-2017; Panetta, Daniele/A-8580-2013; Peresani, Marco/X-1343-2019; Salvadori, Piero A/B-2342-2012; Benazzi, Stefano/AAH-3923-2020	Talamo, Sahra/0000-0002-2406-3132; Starnini, Elisabetta/0000-0002-3933-0854; Starnini, Elisabetta/0000-0002-3933-0854; Panetta, Daniele/0000-0002-4184-0175; Salvadori, Piero A/0000-0001-6114-1059; Negrino, Fabio/0000-0001-7539-2959; Sawyer, Susanna/0000-0002-8477-6089; Peresani, Marco/0000-0001-6562-6336; Bailey, Shara/0000-0002-4626-9262; Benazzi, Stefano/0000-0003-4305-6920	Ministry of Culture-Veneto Archaeological Superintendency; Lessinia Mountain Community Regional Natural Park; Fumane Municipality; Veneto Region Department for Cultural Heritage; Max Planck Society	Ministry of Culture-Veneto Archaeological Superintendency; Lessinia Mountain Community Regional Natural Park; Fumane Municipality; Veneto Region Department for Cultural Heritage(Regione Veneto); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors are grateful to H. Temming for technical support. Research at Fumane is coordinated by Ferrara University in the framework of a project supported by the Ministry of Culture-Veneto Archaeological Superintendency; public institutions (Lessinia Mountain Community Regional Natural Park, Fumane Municipality, and the Veneto Region Department for Cultural Heritage); and private associations and companies. We are indebted for technical assistance to L. Radisch and S. Steinbrenner of the Department of Human Evolution at the Max Planck Institute for Evolutionary Anthropology. We thank A. Hubner and C. Barbieri for their input on the phylogenetic analyses. The data described in the paper are archived in the supplementary materials. The sequence data for the Fumane 2 specimen have been submitted to GenBank and are available under accession number KP718913. The Bombrini tooth is housed at the Museo Preistorico Nazionale dei Balzi Rossi (Ventimiglia, Italy); the Fumane 2 is temporarily housed at the Dipartimento di Studi Umanistici, Universita di Ferrara (Ferrara, Italy). This research is supported by the Max Planck Society. S.B., F.N., M.P., M.A.M., and J.-J.H. initiated and organized the project. S.B. collected the fossil and modern human comparative samples for enamel thickness analysis. D.P. and P.A.S. carried out the microCT scan of the teeth and reconstructed the digital models. S.B. and S.E.B. provided the morphological description of the fossil sample. S.B. carried out the digital morphometric analysis of the teeth. V.S., M.M., and S.S. carried out ancient DNA analysis. S.B., J.-J.H., V.S., S.S., M.M., and S.P. analyzed the data. S.T. initiated and performed the radiocarbon dating project at Riparo Bombrini. S.B., V.S., S.T., F.N., M.P., S.E.B., G.V., M.A.M., M.M., S.P., and J.-J.H. discussed the results. S.B., V.S., S.T., F.N., M.P., S.E.B., D.P., E.S., M.A.M., M.M., S.P., and J.-J.H. wrote and edited the manuscript.	Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bar-Yosef O., 2003, MORE MEETS EYE STUDI, P265; BARTOLOMEI G, 1992, PREISTORIA ALPINA, V28, P131; Beckouche S., 1981, PIAGE SITE PREHISTOR, P159; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P305, DOI 10.1002/ajpa.22421; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Formicola V., 1989, RIV ANTROPOL, V67, P287; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Hublin J-J., 2014, QUAT SCI REV; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Ronchitelli A, 2014, J HUM EVOL, V73, P107, DOI 10.1016/j.jhevol.2013.12.010; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stringer C., 1989, PALEORIENT, V15, P99, DOI DOI 10.3406/paleo.1989.4512; White M, 2012, EUR J ARCHAEOL, V15, P392, DOI 10.1179/1461957112Y.0000000019	35	118	125	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					793	796		10.1126/science.aaa2773	http://dx.doi.org/10.1126/science.aaa2773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25908660	Green Published			2022-12-28	WOS:000354428700042
J	Mismetti, P; Laporte, S; Pellerin, O; Ennezat, PV; Couturaud, F; Elias, A; Falvo, N; Meneveau, N; Quere, I; Roy, PM; Sanchez, O; Schmidt, J; Seinturier, C; Sevestre, MA; Beregi, JP; Tardy, B; Lacroix, P; Presles, E; Leizorovicz, A; Decousus, H; Barral, FG; Meyer, G				Mismetti, Patrick; Laporte, Silvy; Pellerin, Olivier; Ennezat, Pierre-Vladimir; Couturaud, Francis; Elias, Antoine; Falvo, Nicolas; Meneveau, Nicolas; Quere, Isabelle; Roy, Pierre-Marie; Sanchez, Olivier; Schmidt, Jeannot; Seinturier, Christophe; Sevestre, Marie-Antoinette; Beregi, Jean-Paul; Tardy, Bernard; Lacroix, Philippe; Presles, Emilie; Leizorovicz, Alain; Decousus, Herve; Barral, Fabrice-Guy; Meyer, Guy		PREPIC2 Study Grp	Effect of a Retrievable Inferior Vena Cava Filter Plus Anticoagulation vs Anticoagulation Alone on Risk of Recurrent Pulmonary Embolism A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENOUS THROMBOEMBOLISM; PREVENTION; GUIDELINES; EXPERIENCE; SOCIETY; FONDAPARINUX; MANAGEMENT; THROMBOSIS	IMPORTANCE Although retrievable inferior vena cava filters are frequently used in addition to anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is unclear. OBJECTIVE To evaluate the efficacy and safety of retrievable vena cava filters plus anticoagulation vs anticoagulation alone for preventing pulmonary embolism recurrence in patients presenting with acute pulmonary embolism and a high risk of recurrence. DESIGN, SETTING, AND PARTICIPANTS Randomized, open-label, blinded end point trial (PREPIC2) with 6-month follow-up conducted from August 2006 to January 2013. Hospitalized patients with acute, symptomatic pulmonary embolism associated with lower-limb vein thrombosis and at least 1 criterion for severity were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filter group; n = 200) or anticoagulation alone with no filter implantation (control group; n = 199). Initial hospitalization with ambulatory follow-up occurred in 17 French centers. INTERVENTIONS Full-dose anticoagulation for at least 6 months in all patients. Insertion of a retrievable inferior vena cava filter in patients randomized to the filter group. Filter retrieval was planned at 3 months from placement. MAIN OUTCOMES AND MEASURES Primary efficacy outcome was symptomatic recurrent pulmonary embolism at 3 months. Secondary outcomes were recurrent pulmonary embolism at 6 months, symptomatic deep vein thrombosis, major bleeding, death at 3 and 6 months, and filter complications. RESULTS In the filter group, the filter was successfully inserted in 193 patients and was retrieved as planned in 153 of the 164 patients in whom retrieval was attempted. By 3 months, recurrent pulmonary embolism had occurred in 6 patients (3.0%; all fatal) in the filter group and in 3 patients (1.5%; 2 fatal) in the control group (relative risk with filter, 2.00 [95% CI, 0.51-7.89]; P = .50). Results were similar at 6 months. No difference was observed between the 2 groups regarding the other outcomes. Filter thrombosis occurred in 3 patients. CONCLUSIONS AND RELEVANCE Among hospitalized patients with severe acute pulmonary embolism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anticoagulation alone did not reduce the risk of symptomatic recurrent pulmonary embolism at 3 months. These findings do not support the use of this type of filter in patients who can be treated with anticoagulation.	[Mismetti, Patrick] Ctr Hosp Univ St Etienne, Serv Med Vasc & Therapeut, St Priest En Jarez, France; [Mismetti, Patrick; Laporte, Silvy] Univ St Etienne, Grp Invest & Rech Clin Thrombose, St Etienne, France; [Mismetti, Patrick; Laporte, Silvy; Presles, Emilie] Ctr Hosp Univ St Etienne, Unite Pharmacol Clin, St Priest En Jarez, France; [Pellerin, Olivier] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Pellerin, Olivier] Hop Europeen Georges Pompidou, AP HP, Serv Radiol Intervent, Paris, France; [Ennezat, Pierre-Vladimir] Ctr Hosp Univ Grenoble, Dept Cardiol, La Tronche, France; [Couturaud, Francis] Univ Bretagne Occidentale, Dept Med Interne & Pneumol, Hop La Cavale Blanche, Brest, France; [Elias, Antoine] Ctr Hosp Intercommunal Toulon La Seyne Mer, Hop St Musse, Pole Cardiol Vasc, Serv Med Vasc & Med Interne, La Seyne Sur Mer, France; [Falvo, Nicolas] Ctr Hosp Univ Dijon Bocage, Dept Pathol Vasc, Dijon, France; [Meneveau, Nicolas] Ctr Hosp Reg Univ Hop Jean Minjoz, Dept Cardiol, Besancon, France; [Quere, Isabelle] Univ Montpellier I, Ctr Hosp Univ Montpellier, Serv Med Vasc, F-34006 Montpellier, France; [Roy, Pierre-Marie] Ctr Hosp Univ Angers, Cardioprotect Remodelage & Thrombose, Angers, France; [Roy, Pierre-Marie] Ctr Hosp Univ Angers, Serv Urgences, Angers, France; [Roy, Pierre-Marie; Meyer, Guy] Univ Nantes Angers, Le Mans, France; [Sanchez, Olivier] Univ Paris 05, Sorbonne Paris Cite, Serv Pneumol, Hop Europeen Georges Pompidou, Paris, France; [Schmidt, Jeannot] Ctr Hosp Univ Gabriel Montpied, Pole Urgences, Clermont Ferrand, France; [Schmidt, Jeannot] Univ 1 Auvergne, Clermont Ferrand, France; [Seinturier, Christophe] Ctr Hosp Univ Grenoble, Serv Med Vasc, Grenoble, France; [Sevestre, Marie-Antoinette] Ctr Hosp Univ Amiens, Serv Med Vasc, Amiens, France; [Beregi, Jean-Paul] Ctr Hosp Univ Lille, Hop Cardiol, Serv Radiol, Lille, France; [Tardy, Bernard] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Med Urgences & Reanimat, F-42055 St Etienne, France; [Tardy, Bernard] Univ St Etienne, Univ Lyon, St Etienne, France; [Lacroix, Philippe] Ctr Hosp Univ Limoges, Serv Med Vasc, Limoges, France; [Leizorovicz, Alain] Univ Lyon, CNRS, UMR, Lyon, France; [Decousus, Herve] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Med Vasc & Therapeut, F-42055 St Etienne, France; [Barral, Fabrice-Guy] Ctr Hosp Univ St Etienne, Serv Radiol, St Etienne, France; [Barral, Fabrice-Guy] Univ St Etienne, St Etienne, France	CHU de St Etienne; Universite Jean Monnet; CHU de St Etienne; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Brest; Universite de Bretagne Occidentale; CHU Dijon Bourgogne; Universite de Franche-Comte; CHU Besancon; Universite de Montpellier; CHU de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille; CHU de St Etienne; Universite Jean Monnet; CHU Limoges; Centre National de la Recherche Scientifique (CNRS); CHU de St Etienne; CHU de St Etienne; Universite Jean Monnet	Mismetti, P (corresponding author), Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Unite Rech Clin Innovat & Pharmacol, Batiment Rech,Ave Albert Raimond, F-42055 St Etienne, France.	patrick.mismetti2@chu-st-etienne.fr	BEREGI, Jean-Paul/C-2777-2012; Roy, Pierre-Marie/AAA-7737-2022; Couturaud, Francis/Q-1366-2019; Pellerin, Olivier/A-7839-2018; Quere, Isabelle/AAB-8519-2020; falvo, nicolas/AAT-1864-2021	Couturaud, Francis/0000-0002-1855-8032; Pellerin, Olivier/0000-0003-2493-6607; Quere, Isabelle/0000-0002-1492-9764; tromeur, cecile/0000-0001-9161-7521; BERTOLETTI, Laurent/0000-0001-8214-3010; SANCHEZ, Olivier/0000-0003-1633-8391	Programme Hospitalier de Recherche Clinique (French Department of Health); Fondation de l'Avenir; Fondation de France; University Hospital of Saint-Etienne	Programme Hospitalier de Recherche Clinique (French Department of Health); Fondation de l'Avenir; Fondation de France(Fondation de France); University Hospital of Saint-Etienne	The study was supported by grants from the Programme Hospitalier de Recherche Clinique (French Department of Health), Fondation de l'Avenir and Fondation de France. Filters were packaged and provided free of charge by ALN Implants Chirurgicaux. The study sponsor was the University Hospital of Saint-Etienne. An academic steering committee assumed overall responsibility for all these steps. An independent data and safety monitoring committee periodically reviewed the main safety outcomes.	Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Angel LF, 2011, J VASC INTERV RADIOL, V22, P1522, DOI 10.1016/j.jvir.2011.08.024; Ansell J, 2005, CIRCULATION, V112, P298, DOI 10.1161/CIRCULATIONAHA.105.547828; Athanasoulis CA, 2000, RADIOLOGY, V216, P54, DOI 10.1148/radiology.216.1.r00jl1254; Barginear MF, 2012, SUPPORT CARE CANCER, V20, P2865, DOI 10.1007/s00520-012-1413-z; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2004, NEW ENGL J MED, V350, P423; Caplin DM, 2011, J VASC INTERV RADIOL, V22, P1499, DOI 10.1016/j.jvir.2011.07.012; Caronno R, 2006, EUR J VASC ENDOVASC, V32, P596, DOI 10.1016/j.ejvs.2006.05.004; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Douketis JD, 2001, AM J MED, V110, P515, DOI 10.1016/S0002-9343(01)00661-1; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 2004, LANCET, V363, P1295, DOI 10.1016/S0140-6736(04)16004-2; Hammond CJ, 2009, CLIN RADIOL, V64, P502, DOI 10.1016/j.crad.2009.01.009; Imberti D, 2005, J THROMB HAEMOST, V3, P1370, DOI 10.1111/j.1538-7836.2005.01448.x; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kaufman JA, 2006, J VASC INTERV RADIOL, V17, P449, DOI 10.1097/01.RVI.0000203418-39769.0D; Kearon C, 2012, CHEST S, V141, pe4195; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Lagana D, 2013, RADIOL MED, V118, P816, DOI 10.1007/s11547-012-0893-7; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Mismetti P, 2003, HAEMATOLOGICA, V88, P67; Mismetti P, 2007, CHEST, V131, P223, DOI 10.1378/chest.06-0631; Pancione L, 2006, Minerva Chir, V61, P501; Pellerin O, 2008, CARDIOVASC INTER RAD, V31, P889, DOI 10.1007/s00270-008-9357-x; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Spencer FA, 2010, ARCH INTERN MED, V170, P1456, DOI 10.1001/archinternmed.2010.272; Stein PD, 2014, AM J MED, V127, P222, DOI 10.1016/j.amjmed.2013.11.003; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Stein PD, 2011, AM J MED, V124, P655, DOI 10.1016/j.amjmed.2011.02.021; Stein PD, 2004, ARCH INTERN MED, V164, P1541, DOI 10.1001/archinte.164.14.1541; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Uberoi R, 2013, CARDIOVASC INTER RAD, V36, P1548, DOI 10.1007/s00270-013-0606-2	39	284	292	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1627	1635		10.1001/jama.2015.3780	http://dx.doi.org/10.1001/jama.2015.3780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919526	Bronze			2022-12-28	WOS:000353595200013
J	Viatte, S; Plant, D; Han, B; Fu, B; Yarwood, A; Thomson, W; Symmons, DPM; Worthington, J; Young, A; Hyrich, KL; Morgan, AW; Wilson, AG; Isaacs, JD; Raychaudhuri, S; Barton, A				Viatte, Sebastien; Plant, Darren; Han, Buhm; Fu, Bo; Yarwood, Annie; Thomson, Wendy; Symmons, Deborah P. M.; Worthington, Jane; Young, Adam; Hyrich, Kimme L.; Morgan, Ann W.; Wilson, Anthony G.; Isaacs, John D.; Raychaudhuri, Soumya; Barton, Anne			Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC SUSCEPTIBILITY MARKERS; INFLAMMATORY POLYARTHRITIS; VARIABLE MODELS; DISEASE; PREDICTORS; CRITERIA; DAMAGE	IMPORTANCE Advances have been made in identifying genetic susceptibility loci for autoimmune diseases, but evidence is needed regarding their association with prognosis and treatment response. OBJECTIVE To assess whether specific HLA-DRB1 haplotypes associated with rheumatoid arthritis (RA) susceptibility are also associated with radiological severity, mortality, and response to tumor necrosis factor (TNF) inhibitor drugs. DESIGN, SETTING, AND PARTICIPANTS The Norfolk Arthritis Register (NOAR; 1691 patients and 2811 radiographs; recruitment: 1989-2008; 2008 as final follow-up) was used as a discovery cohort and the Early Rheumatoid Arthritis Study (421 patients and 3758 radiographs; recruitment: 1986-1999; 2005 as final follow-up) as an independent replication cohort for studies of radiographic outcome. Mortality studies were performed in the NOAR cohort (2432 patients; recruitment: 1990-2007; 2011 as final follow-up) and studies of treatment response in the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort (1846 patients enrolled at initiation of TNF inhibitor; recruitment: 2006-2010; 2011 as final follow-up). Longitudinal statistical modeling was performed to integrate multiple radiograph records per patient over time. All patients were from the United Kingdom and had self-reported white ancestry. EXPOSURES Sixteen HLA-DRB1 haplotypes defined by amino acids at positions 11, 71, and 74. MAIN OUTCOMES AND MEASURES Radiological outcome using the Larsen score (range: 0 [none] to 200 [severe joint damage]) and erosions of the hands and feet on radiographs, all-cause mortality, and treatment response measured by change in Disease Activity Score based on 28 joint counts and European League Against Rheumatism (EULAR) response. RESULTS Patients with RA and valine at position 11 of HLA-DRB1 had the strongest association with radiological damage (OR, 1.75 [95% CI, 1.51-2.05], P = 4.6E-13). By year 5, the percentages of patients with erosions of the hands and feet were 48% of noncarriers (150/314) of valine at position 11, 61% of heterozygote carriers (130/213), and 74% of homozygote carriers (43/58). Valine at position 11 also was associated with higher all-cause mortality in patients with inflammatory polyarthritis (hazard ratio, 1.16 [95% CI, 1.03-1.31], P = .01) (noncarriers: 319 deaths in 1398 patients over 17 196 person-years, mortality rate of 1.9% per year; carriers: 324 deaths in 1116 patients in 13 208 person-years, mortality rate of 2.5% per year) and with better EULAR response to TNF inhibitor therapy (OR, 1.14 [95% CI, 1.01-1.30], P = .04) (noncarriers: 78% [439/561 patients] with moderate or good EULAR response; heterozygote carriers: 81% [698/866]; and homozygote carriers: 86%[277/322]). The risk hierarchy defined by HLA-DRB1 haplotypes was correlated between disease susceptibility, severity, and mortality, but inversely correlated with TNF inhibitor treatment response. CONCLUSIONS AND RELEVANCE Among patients with RA, the HLA-DRB1 locus, which is associated with disease susceptibility, was also associated with radiological severity, mortality, and treatment response. Replication of these findings in other cohorts is needed as a next step in evaluating the role of HLA-DRB1 haplotype analysis for management of RA.	[Viatte, Sebastien; Plant, Darren; Fu, Bo; Yarwood, Annie; Thomson, Wendy; Worthington, Jane; Raychaudhuri, Soumya; Barton, Anne] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Manchester M13 9PT, Lancs, England; [Plant, Darren; Thomson, Wendy; Symmons, Deborah P. M.; Worthington, Jane; Barton, Anne] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Han, Buhm; Raychaudhuri, Soumya] Broad Inst Massachusetts Inst Technol & Harvard U, Program Med & Populat Genet, Cambridge, MA USA; [Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol & Genet, Boston, MA 02115 USA; [Han, Buhm; Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Fu, Bo] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester M13 9PT, Lancs, England; [Symmons, Deborah P. M.; Hyrich, Kimme L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res, Manchester M13 9PT, Lancs, England; [Young, Adam] St Albans Hosp, St Albans, England; [Young, Adam] Univ Hertfordshire, Hlth & Human Sci Res Inst, Hatfield AL10 9AB, Herts, England; [Morgan, Ann W.] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Morgan, Ann W.] Univ Leeds, Sch Med, Leeds Inst Rheumat & Musculoskeletal Med, St Jamess Univ Hosp, Leeds LS2 9JT, W Yorkshire, England; [Wilson, Anthony G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Isaacs, John D.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Biomed Res Ctr, Natl Inst Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England; [Isaacs, John D.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Manchester; University of Manchester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; University of Manchester; University of Manchester; University of Hertfordshire; Chapel Allerton Hospital; Leeds Biomedical Research Centre; University of Leeds; Saint James's University Hospital; University of Leeds; University College Dublin; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Barton, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anne.barton@manchester.ac.uk	Han, Buhm/AAQ-9672-2020; Viatte, Sebastien/B-4253-2015; Barton, Anne/N-2053-2014	Viatte, Sebastien/0000-0001-6471-3358; Barton, Anne/0000-0003-3316-2527; Thomson, Wendy/0000-0002-9022-5179; Raychaudhuri, Soumya/0000-0002-1901-8265; Morgan, Ann/0000-0003-1109-624X; Symmons, Deborah/0000-0002-8625-1200; Isaacs, John/0000-0002-6103-7056; Hyrich, Kimme/0000-0001-8242-9262	Arthritis Research UK [20385]; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Innovative Medicines Initiative Be The Cure [115142-2]; Swiss Foundation for Medical-Biological Scholarships [PASMP3_134380]; Novartis; Arthritis Foundation; Doris Duke Foundation; National Institutes of Health [1RO1AR063759-O1A1, 1RO1ARO62886-O1, 5UO1GMO92691]; MRC [G1001518, MR/L01629X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; Medical Research Council [G1001518, MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [IS-BRC-0211-10046, NF-SI-0510-10211] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH120307, BH121055, BH142386] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Innovative Medicines Initiative Be The Cure; Swiss Foundation for Medical-Biological Scholarships; Novartis(Novartis); Arthritis Foundation; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	This work was funded by core programme grant 20385 from Arthritis Research UK, by the National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, and by the Innovative Medicines Initiative Be The Cure (contract 115142-2). At the start of this project, Dr Viatte was supported by research grant PASMP3_134380 from the Swiss Foundation for Medical-Biological Scholarships, managed by the Swiss National Science Foundation. That grant is financed by a donation from Novartis to the Swiss Foundation for Medical-Biological Scholarships. Dr Raychaudhuri is supported by the Arthritis Foundation, the Doris Duke Foundation, and National Institutes of Health grants 1RO1AR063759-O1A1, 1RO1ARO62886-O1, and 5UO1GMO92691.	Ajeganova S, 2013, J RHEUMATOL, V40, P1958, DOI 10.3899/jrheum.130365; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barra L, 2009, J RHEUMATOL, V36, P1421, DOI 10.3899/jrheum.081122; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Bukhari M, 2007, ARTHRITIS RHEUM-US, V56, P2929, DOI 10.1002/art.22868; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; Farragher TM, 2010, ARTHRIT CARE RES, V62, P676, DOI 10.1002/acr.20208; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Ibrahim I, 2014, ANN RHEUM DIS, V73, P787, DOI 10.1136/annrheumdis-2013-204330; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Norton S, 2013, RHEUMATOLOGY, V52, P2016, DOI 10.1093/rheumatology/ket253; Plant D, 2014, NAT REV RHEUMATOL, V10, P329, DOI 10.1038/nrrheum.2014.16; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plant D, 2011, RHEUMATOLOGY, V50, P78, DOI 10.1093/rheumatology/keq032; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2008, STAT METHODS MED RES, V17, P5, DOI 10.1177/0962280207081236; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Solymossy C, 1999, RHEUMATOLOGY, V38, P1127, DOI 10.1093/rheumatology/38.11.1127; Symmons DPM, 2003, CLIN EXP RHEUMATOL, V21, pS94; Thomson W, 1999, ARTHRITIS RHEUM, V42, P757, DOI 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Viatte S, 2012, EUR MUSCULOSKELETAL, V7, P102; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Viatte S, 2013, J RHEUMATOL, V40, P144, DOI 10.3899/jrheum.121034; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Yarwood A, 2015, ANN RHEUM DIS, V74, P170, DOI 10.1136/annrheumdis-2013-204133	37	101	103	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1645	1656		10.1001/jama.2015.3435	http://dx.doi.org/10.1001/jama.2015.3435			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919528	Green Accepted, Bronze			2022-12-28	WOS:000353595200015
J	Passey, BH				Passey, Benjamin H.			Biogeochemical tales told by isotope clumps	SCIENCE			English	Editorial Material							TEMPERATURES; MINERALS		Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Passey, BH (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	bhpassey@jhu.edu		Passey, Benjamin/0000-0002-3483-4148				Angeles-Boza AM, 2012, INORG CHEM, V51, P4722, DOI 10.1021/ic202745n; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Eiler JM, 2013, ANNU REV EARTH PL SC, V41, P411, DOI 10.1146/annurev-earth-042711-105348; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Garzione CN, 2014, EARTH PLANET SC LETT, V393, P173, DOI 10.1016/j.epsl.2014.02.029; Schauble EA, 2006, GEOCHIM COSMOCHIM AC, V70, P2510, DOI 10.1016/j.gca.2006.02.011; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Wang DT, 2015, SCIENCE, V348, P428, DOI 10.1126/science.aaa4326; Wang ZG, 2004, GEOCHIM COSMOCHIM AC, V68, P4779, DOI 10.1016/j.gca.2004.05.039; Yeung LY, 2015, SCIENCE, V348, P431, DOI 10.1126/science.aaa6284	12	3	5	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					394	395		10.1126/science.aab1604	http://dx.doi.org/10.1126/science.aab1604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908808				2022-12-28	WOS:000353338000017
J	Green, SA; Simoes-Costa, M; Bronner, ME				Green, Stephen A.; Simoes-Costa, Marcos; Bronner, Marianne E.			Evolution of vertebrates as viewed from the crest	NATURE			English	Review							TRUNK NEURAL CREST; GENE REGULATORY NETWORK; SCHWANN-CELL PRECURSORS; TRANSCRIPTION FACTOR; REVEALS MULTIPOTENCY; CRANIOFACIAL MUSCLES; CIONA-INTESTINALIS; GENOME DUPLICATION; CRANIAL PLACODES; AMPHIOXUS GENOME	The origin of vertebrates was accompanied by the advent of a novel cell type: the neural crest. Emerging from the central nervous system, these cells migrate to diverse locations and differentiate into numerous derivatives. By coupling morphological and gene regulatory information from vertebrates and other chordates, we describe how addition of the neural-crest-specification program may have enabled cells at the neural plate border to acquire multipotency and migratory ability. Analysis of the topology of the neural crest gene regulatory network can serve as a useful template for understanding vertebrate evolution, including elaboration of neural crest derivatives.	[Green, Stephen A.; Simoes-Costa, Marcos; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Bronner, ME (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Simoes-Costa, Marcos/AAX-4780-2020	Bronner, Marianne/0000-0003-4274-1862	National Institutes of Health (NIH) [R01NS086907]; Pew Foundation; NIH [1K99DE024232]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE024232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086907] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank H. Parker, C. Rogers and L. Kerosuo for their comments and helpful discussion on this manuscript. This work was supported by National Institutes of Health (NIH) grant R01NS086907. M.S.-C. was funded by a fellowship from the Pew Foundation and by NIH grant 1K99DE024232.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Aguiar DP, 2014, DEVELOPMENT, V141, P2494, DOI 10.1242/dev.101790; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; Calloni GW, 2009, P NATL ACAD SCI USA, V106, P8947, DOI 10.1073/pnas.0903780106; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Coelho-Aguiar JM, 2013, DEV BIOL, V384, P13, DOI 10.1016/j.ydbio.2013.09.030; COLLAZO A, 1993, DEVELOPMENT, V118, P363; Creuzet SE, 2006, P NATL ACAD SCI USA, V103, P14033, DOI 10.1073/pnas.0605899103; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Davidson EH, 2010, REGULATORY GENOME; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Donoghue PCJ, 2002, MICROSC RES TECHNIQ, V59, P352, DOI 10.1002/jemt.10217; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Donoghue PCJ, 2014, PALAEONTOLOGY, V57, P879, DOI 10.1111/pala.12125; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dupin E, 2010, CELL CYCLE, V9, P238, DOI 10.4161/cc.9.2.10491; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; FRANK E, 1991, DEVELOPMENT, V111, P895; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gee H., 1996, BACKBONE VIEWS ORIGI; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Graham A, 2008, J EXP ZOOL PART B, V310B, P336, DOI 10.1002/jez.b.21182; Graham A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-24; Green SA, 2014, DIFFERENTIATION, V87, P44, DOI 10.1016/j.diff.2014.02.001; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; Hall BK, 2000, EVOL DEV, V2, P3, DOI 10.1046/j.1525-142x.2000.00032.x; Hall BK, 2013, J ANAT, V222, P19, DOI 10.1111/j.1469-7580.2012.01495.x; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hirasawa T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3107; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-27; Holland LZ, 2013, SEMIN CELL DEV BIOL, V24, P101, DOI 10.1016/j.semcdb.2012.12.007; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOLLAND PWH, 1994, DEVELOPMENT, P125; Ivashkin E, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-12; Jandzik D, 2015, NATURE, V518, P534, DOI 10.1038/nature14000; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2013, NATURE, V502, P457, DOI 10.1038/nature12695; Jeffery WR, 2008, DEV BIOL, V324, P152, DOI 10.1016/j.ydbio.2008.08.022; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; JOHNELS A. G., 1956, ACTA ZOOL [STOCKHOLM], V37, P251; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kelly RG, 2010, EXP CELL RES, V316, P3034, DOI 10.1016/j.yexcr.2010.04.029; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Kontges G, 1996, DEVELOPMENT, V122, P3229; Krause MP, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.011; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Le Douarin NM, 2012, DEV BIOL, V366, P74, DOI 10.1016/j.ydbio.2012.01.007; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LEDOUARI.NM, 1974, DEV BIOL, V41, P162, DOI 10.1016/0012-1606(74)90291-7; Lee GH, 2011, CELL MOL LIFE SCI, V68, P4065, DOI 10.1007/s00018-011-0637-2; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Lee RTH, 2013, CURR BIOL, V23, pR336, DOI 10.1016/j.cub.2013.02.055; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; McGonnell IM, 2002, CURR BIOL, V12, P767, DOI 10.1016/S0960-9822(02)00818-7; McKeown SJ, 2005, DEV DYNAM, V233, P430, DOI 10.1002/dvdy.20341; Medeiros DM, 2013, WIRES DEV BIOL, V2, P1, DOI 10.1002/wdev.85; Meulemans D, 2005, J EXP ZOOL PART B, V304B, P298, DOI 10.1002/jez.b.21047; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Mongera A, 2013, CURR BIOL, V23, pR338, DOI 10.1016/j.cub.2013.02.056; Mongera A, 2013, DEVELOPMENT, V140, P916, DOI 10.1242/dev.091066; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Murdock DJE, 2013, NATURE, V502, P546, DOI 10.1038/nature12645; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Northcutt RG, 2005, J EXP ZOOL PART B, V304B, P274, DOI 10.1002/jez.b.21063; NORTHCUTT RG, 1983, Q REV BIOL, V58, P1, DOI 10.1086/413055; Ohno S., 1970, EVOLUTION GENE DUPLI; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Ono H, 2014, DEV BIOL, V385, P396, DOI 10.1016/j.ydbio.2013.11.010; Oram KF, 2005, GENETICS, V170, P971, DOI 10.1534/genetics.105.041277; Ota KG, 2007, INTEGR COMP BIOL, V47, P329, DOI 10.1093/icb/icm022; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Parker HJ, 2014, NATURE, V514, P490, DOI 10.1038/nature13723; Patthey C, 2014, DEV BIOL, V389, P82, DOI 10.1016/j.ydbio.2014.01.017; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rogers CD, 2013, J CELL BIOL, V203, P835, DOI 10.1083/jcb.201305050; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Sauka-Spengler T, 2008, GENESIS, V46, P673, DOI 10.1002/dvg.20436; Schlosser G, 2014, DEV BIOL, V389, P98, DOI 10.1016/j.ydbio.2014.01.019; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Simoes-Costa MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003142; Sire JY, 2009, J ANAT, V214, P409, DOI 10.1111/j.1469-7580.2009.01046.x; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Smith J. D. H., 2014, PREPRINT; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; SMITH M, 1994, P ROY SOC B-BIOL SCI, V256, P137, DOI 10.1098/rspb.1994.0061; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Yasui K, 2014, J MORPHOL, V275, P465, DOI 10.1002/jmor.20228; Yu JK, 2004, DEV BIOL, V274, P452, DOI 10.1016/j.ydbio.2004.07.010; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108; Yu JKS, 2010, ZOOLOGY, V113, P1, DOI 10.1016/j.zool.2009.06.001	124	133	135	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					474	482		10.1038/nature14436	http://dx.doi.org/10.1038/nature14436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903629	Green Accepted			2022-12-28	WOS:000353334500031
J	Gornall, J				Gornall, Jonathan			Slaying the dragon: how the tobacco industry refuses to die	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathangornall@mac.com						BAT, 2013, FOC HARM RED WHY IT; BAT, DEL TOD INV TOM ANN; British American Tobacco, 2013, ANN REP DEL TOD INV; British American Tobacco, 2015, STRONG PERF TOUGH EN; Eriksen M, 2015, TOBACCO ATLAS; Hawkes Nigel, 2014, BMJ, V348, pg3419, DOI 10.1136/bmj.g3419; HM Treasury, 2014, TOB LEV CONS; House of Commons, REG MEMB FIN INT; Imperial Tobacco, ANN REP ACC 2014; Imperial Tobacco, 2015, STAT UK PLAIN PACK; Japan Tobacco, ANN REP FY2013; Kmietowicz Zosia, 2014, BMJ, V348, pg2034, DOI 10.1136/bmj.g2034; Office for National Statistics, 2014, OP LIF SURV AD SMOK; United Nation, 2013, WORLD POP PROSP 2012; WHO Tobacco Free Initiative, WATCH COUNT IND; Wintour P., 2014, GUARDIAN	16	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2052	10.1136/bmj.h2052	http://dx.doi.org/10.1136/bmj.h2052			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25902873				2022-12-28	WOS:000353576700009
J	Bearss, K; Johnson, C; Smith, T; Lecavalier, L; Swiezy, N; Aman, M; McAdam, DB; Butter, E; Stillitano, C; Minshawi, N; Sukhodolsky, DG; Mruzek, DW; Turner, K; Neal, T; Hallett, V; Mulick, JA; Green, B; Handen, B; Deng, YH; Dziura, J; Scahill, L				Bearss, Karen; Johnson, Cynthia; Smith, Tristram; Lecavalier, Luc; Swiezy, Naomi; Aman, Michael; McAdam, David B.; Butter, Eric; Stillitano, Charmaine; Minshawi, Noha; Sukhodolsky, Denis G.; Mruzek, Daniel W.; Turner, Kylan; Neal, Tiffany; Hallett, Victoria; Mulick, James A.; Green, Bryson; Handen, Benjamin; Deng, Yanhong; Dziura, James; Scahill, Lawrence			Effect of Parent Training vs Parent Education on Behavioral Problems in Children With Autism Spectrum Disorder A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; YOUNG-CHILDREN; PROGRAM	IMPORTANCE Disruptive behavior is common in children with autism spectrum disorder. Behavioral interventions are used to treat disruptive behavior but have not been evaluated in large-scale randomized trials. OBJECTIVE To evaluate the efficacy of parent training for children with autism spectrum disorder and disruptive behavior. DESIGN, SETTING, AND PARTICIPANTS This 24-week randomized trial compared parent training (n = 89) to parent education (n = 91) at 6 centers (Emory University, Indiana University, Ohio State University, University of Pittsburgh, University of Rochester, Yale University). We screened 267 children; 180 children (aged 3-7 years) with autism spectrum disorder and disruptive behaviors were randomly assigned (86% white, 88% male) between September 2010 and February 2014. INTERVENTIONS Parent training (11 core, 2 optional sessions; 2 telephone boosters; 2 home visits) provided specific strategies to manage disruptive behavior. Parent education (12 core sessions, 1 home visit) provided information about autism but no behavior management strategies. MAIN OUTCOMES AND MEASURES Parents rated disruptive behavior and noncompliance on co-primary outcomes: the Aberrant Behavior Checklist-Irritability subscale (range, 0-45) and the Home Situations Questionnaire-Autism Spectrum Disorder (range, 0-9). On both measures, higher scores indicate greater severity and a 25% reduction indicates clinical improvement. A clinician blind to treatment assignment rated the Improvement scale of the Clinical Global Impression (range, 1-7), a secondary outcome, with a positive response less than 3. RESULTS At week 24, the Aberrant Behavior Checklist-Irritability subscale declined 47.7% in parent training (from 23.7 to 12.4) compared with 31.8% for parent education (23.9 to 16.3) (treatment effect, -3.9; 95% CI, -6.2 to -1.7; P < .001, standardized effect size = 0.62). The Home Situations Questionnaire-Autism Spectrum Disorder declined 55% (from 4.0 to 1.8) compared with 34.2% in parent education (3.8 to 2.5) (treatment effect, -0.7; 95% CI, -1.1 to -0.3; P < .001, standardized effect size = 0.45). Neither measure met the prespecified minimal clinically important difference. The proportions with a positive response on the Clinical Global Impression-Improvement scale were 68.5% for parent training vs 39.6% for parent education (P < .001). CONCLUSIONS AND RELEVANCE For children with autism spectrum disorder, a 24-week parent training program was superior to parent education for reducing disruptive behavior on parent-reported outcomes, although the clinical significance of the improvement is unclear. The rate of positive response judged by a blinded clinician was greater for parent training vs parent education.	[Bearss, Karen; Green, Bryson; Scahill, Lawrence] Childrens Healthcare Atlanta, Marcus Autism Ctr, Dept Pediat, Atlanta, GA 30329 USA; [Bearss, Karen; Green, Bryson; Scahill, Lawrence] Emory Univ, Atlanta, GA 30329 USA; [Johnson, Cynthia; Stillitano, Charmaine] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Smith, Tristram; McAdam, David B.; Mruzek, Daniel W.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Lecavalier, Luc; Aman, Michael] Ohio State Univ, Nisonger Ctr, UCEDD, Dept Psychol, Columbus, OH 43210 USA; [Lecavalier, Luc; Aman, Michael] Ohio State Univ, Nisonger Ctr, UCEDD, Dept Psychiat, Columbus, OH 43210 USA; [Swiezy, Naomi; Minshawi, Noha; Neal, Tiffany] Indiana Univ, Dept Psychiat, Indianapolis, IN 46204 USA; [Butter, Eric; Mulick, James A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Butter, Eric; Mulick, James A.] Natl Childrens Hosp, Columbus, OH USA; [Sukhodolsky, Denis G.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Turner, Kylan] Arizona State Univ, Mary Lou Fulton Teachers Coll, Div Educ Leadership & Innovat, Tempe, AZ USA; [Hallett, Victoria] Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Handen, Benjamin] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Deng, Yanhong] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Dziura, James] Yale Univ, Dept Emergency Med, New Haven, CT USA	Children's Healthcare of Atlanta (CHOA); Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Yale University; Arizona State University; Arizona State University-Tempe; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Yale University	Scahill, L (corresponding author), Childrens Healthcare Atlanta, Marcus Autism Ctr, 1920 Briarcliff NE, Atlanta, GA 30329 USA.	lawrence.scahill@emory.edu	Sukhodolsky, Denis/Z-3532-2019; Handen, Benjamin/GRY-0095-2022; Swiezy, Naomi/AAZ-5697-2021; Butter, Eric/AAS-8595-2021	Sukhodolsky, Denis/0000-0002-5401-792X; 	National Institute of Mental Health [MH081148, MH080965, MH081105, MH081221, MH080906]; University of Rochester from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [UL1 TR000042]; National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024139, 5KL2RR024138]; NIH Roadmap for Medical Research; Public Health Service grant from the CTSA program of the NIH NCRR at Emory University School of Medicine [UL1 RR025008]; Marcus Foundation; Joseph B. Whitehead Foundation; Children's Healthcare of Atlanta Foundation; Cox Foundation;  [MH079130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, KL2RR024138, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH079130, R01MH081221, R01MH081148, R01MH081105, U54MH066397, R01MH080906] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Rochester from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); National Center for Research Resources (NCRR), a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service grant from the CTSA program of the NIH NCRR at Emory University School of Medicine; Marcus Foundation; Joseph B. Whitehead Foundation; Children's Healthcare of Atlanta Foundation; Cox Foundation; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health by grants to Yale University/Emory University (MH081148; principal investigator: Dr Scahill), the University of Pittsburgh (MH080965; principal investigator: Dr Johnson), Ohio State University (MH081105; principal investigator: Dr Lecavalier), Indiana University (MH081221; principal investigator: Dr Swiezy), and the University of Rochester (MH080906; principal investigator: Dr Smith). The project described in this publication also was supported by MH079130 (principal investigator: Dr Sukhodolsky); a University of Rochester Clinical and Translational Scholar Award (CTSA) (UL1 TR000042) from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); a CTSA (UL1 RR024139) and grant from the National Center for Research Resources (NCRR) (5KL2RR024138), a component of the NIH; and the NIH Roadmap for Medical Research. This work was supported in part by a Public Health Service grant (UL1 RR025008) from the CTSA program of the NIH NCRR at Emory University School of Medicine and also supported by the Marcus Foundation, Joseph B. Whitehead Foundation, Children's Healthcare of Atlanta Foundation, and Cox Foundation.	AMAN MG, 1985, AM J MENT DEF, V89, P492; Aman MG, 2009, J AM ACAD CHILD PSY, V48, P1143, DOI 10.1097/CHI.0b013e3181bfd669; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bearss K, 2013, NEUROPSYCHIATRY-LOND, V3, P169, DOI 10.2217/NPY.13.14; Chowdhury M, 2010, J INTELL DISABIL RES, V54, P281, DOI 10.1111/j.1365-2788.2010.01259.x; Dretzke Janine, 2009, Child Adolesc Psychiatry Ment Health, V3, P7, DOI 10.1186/1753-2000-3-7; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Gadow K.D., 2002, CHILDHOOD SYMPTOM IN; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Guy W., 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Handen BL, 2013, J DEV PHYS DISABIL, V25, P355, DOI 10.1007/s10882-012-9316-y; Hartley SL, 2008, J INTELL DISABIL RES, V52, P819, DOI 10.1111/j.1365-2788.2008.01065.x; Hayes SA, 2013, J AUTISM DEV DISORD, V43, P629, DOI 10.1007/s10803-012-1604-y; Kaat AJ, 2014, J AUTISM DEV DISORD, V44, P1103, DOI 10.1007/s10803-013-1970-0; King BH, 2009, ARCH GEN PSYCHIAT, V66, P583, DOI 10.1001/archgenpsychiatry.2009.30; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Lecavalier L, 2006, J INTELL DISABIL RES, V50, P172, DOI 10.1111/j.1365-2788.2005.00732.x; Maskey M, 2013, J AUTISM DEV DISORD, V43, P851, DOI 10.1007/s10803-012-1622-9; Mazurek MO, 2013, RES AUTISM SPECT DIS, V7, P455, DOI 10.1016/j.rasd.2012.11.004; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; Oono IP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009774.pub2; Scahill L, 2012, J AM ACAD CHILD PSY, V51, P136, DOI 10.1016/j.jaac.2011.11.010; Sofronoff K, 2004, AUTISM, V8, P301, DOI 10.1177/1362361304045215; Sparrow SS., 2005, VINELAND ADAPTIVE BE, V2nd ed, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Tonge B, 2014, AUTISM, V18, P166, DOI 10.1177/1362361312458186; Whittingham K, 2009, J ABNORM CHILD PSYCH, V37, P469, DOI 10.1007/s10802-008-9285-x	27	205	207	2	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1524	1533		10.1001/jama.2015.3150	http://dx.doi.org/10.1001/jama.2015.3150			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3SA	25898050	Bronze, Green Accepted			2022-12-28	WOS:000353198700017
J	Chan, HK; Zhang, HR; Yang, F; Fischer, G				Chan, Hon-Ki; Zhang, Huarong; Yang, Feng; Fischer, Gunter			Improve customs systems to monitor global wildlife trade	SCIENCE			English	Editorial Material									[Chan, Hon-Ki; Zhang, Huarong; Yang, Feng; Fischer, Gunter] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China		Chan, HK (corresponding author), Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China.	honkichan@gmail.com	Chan, Ki/AAA-8944-2021	Chan, Ki/0000-0003-0864-0451				Bannon I, 2003, NATURAL RESOURCES VI; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; FAO, 2012, SUPP MAT FAO REV PRO, P1; Flavia, 2020, LIFEGATE; Fragoso G, 2008, CONSERV BIOL, V22, P1648, DOI 10.1111/j.1523-1739.2008.01094.x; Gerson H, 2008, CONSERV BIOL, V22, P1651, DOI 10.1111/j.1523-1739.2008.01095.x; Goetzl A., 2005, ITTO Tropical Forest Update, V15, P8; Gratwicke B, 2010, FRONT ECOL ENVIRON, V8, P438, DOI 10.1890/090111; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; OECD, 2012, ILL TRAD ENV SENS GO; WCO, 2015, WILDL TRAFF TARG SOL	11	34	35	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					291	292		10.1126/science.aaa3141	http://dx.doi.org/10.1126/science.aaa3141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG0YC	25883346				2022-12-28	WOS:000352999000025
J	Lega, S; Rabach, I; Barbi, E; Ventura, A				Lega, Sara; Rabach, Ingrid; Barbi, Egidio; Ventura, Alessandro			A young soccer player with sudden pain after kicking the ball	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AVULSION FRACTURES; INJURIES; PELVIS; HIP		[Lega, Sara; Rabach, Ingrid; Barbi, Egidio] Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Ventura, Alessandro] Inst Maternal & Child Hlth, Paediat, I-34137 Trieste, Italy		Rabach, I (corresponding author), Inst Maternal & Child Hlth, I-34137 Trieste, Italy.	ingridrabach@gmail.com	LEGA, SARA/AAB-8758-2019; Barbi, Egidio/K-4016-2018	Barbi, Egidio/0000-0002-6343-846X; Ventura, Alessandro/0000-0002-4657-1760				Boyd KT, 1997, SPORTS MED, V24, P273, DOI 10.2165/00007256-199724040-00005; Bylak J, 1998, SPORTS MED, V26, P119, DOI 10.2165/00007256-199826020-00005; Dhinsa BS, 2011, J ORTHOP TRAUMATOL, V12, P173, DOI 10.1007/s10195-011-0153-z; ElKhoury GY, 1996, SKELETAL RADIOL, V25, P3, DOI 10.1007/s002560050024; Kjellin I, 2010, SPORTS HEALTH, V2, P247, DOI 10.1177/1941738109347976; Lazovic D, 1996, Knee Surg Sports Traumatol Arthrosc, V3, P234, DOI 10.1007/BF01466625; McKinney BI, 2009, ORTHOPEDICS, V32, P42, DOI 10.3928/01477447-20090101-12; Naude M, 2003, S AFR J SPORTS MED, V15, P18; Ortega HW, 2014, J EMERG MED, V47, P140, DOI 10.1016/j.jemermed.2014.04.036; Pisacano RM, 2003, AM J ROENTGENOL, V181, P223, DOI 10.2214/ajr.181.1.1810223; Pointinger H, 2003, BRIT J SPORT MED, V37, P361, DOI 10.1136/bjsm.37.4.361; Rossi F, 2001, SKELETAL RADIOL, V30, P127, DOI 10.1007/s002560000319	12	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1944	10.1136/bmj.h1944	http://dx.doi.org/10.1136/bmj.h1944			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25881580	Green Published			2022-12-28	WOS:000353328700010
J	Atala, A; Murphy, S				Atala, Anthony; Murphy, Sean			Regenerative Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		[Atala, Anthony; Murphy, Sean] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA	Wake Forest University	Atala, A (corresponding author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA.	aatala@wakehealth.edu						Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; US Department of Health and Human Services, 2006, 2020 NEW VIS FUT REG	8	15	15	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1413	1414		10.1001/jama.2015.1492	http://dx.doi.org/10.1001/jama.2015.1492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871665				2022-12-28	WOS:000352821200010
J	Limb, M				Limb, Matthew			QUALITY OF CARE From "special measures" to "good" in less than a year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com						Care Quality Commission, 2014, BAS U HOSP QUAL REP; Keogh B., 2013, KEOGH MORTALITY REV; NHS Choices, SPEC MEAS	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1976	10.1136/bmj.h1976	http://dx.doi.org/10.1136/bmj.h1976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25873047				2022-12-28	WOS:000353327500015
J	Chen, CC; Wang, L; Plikus, MV; Jiang, TX; Murray, PJ; Ramos, R; Guerrero-Juarez, CF; Hughes, MW; Lee, OK; Shi, ST; Widelitz, RB; Lander, AD; Chuong, CM				Chen, Chih-Chiang; Wang, Lei; Plikus, Maksim V.; Jiang, Ting Xin; Murray, Philip J.; Ramos, Raul; Guerrero-Juarez, Christian F.; Hughes, Michael W.; Lee, Oscar K.; Shi, Songtao; Widelitz, Randall B.; Lander, Arthur D.; Chuong, Cheng Ming			Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations	CELL			English	Article							MORPHOGEN GRADIENT; SKIN; ACTIVATION; FOLLICLE; GROWTH; NICHE; ESTABLISHMENT; MACROPHAGES; CHEMOKINES; BACTERIA	Coordinated organ behavior is crucial for an effective response to environmental stimuli. By studying regeneration of hair follicles in response to patterned hair plucking, we demonstrate that organ-level quorum sensing allows coordinated responses to skin injury. Plucking hair at different densities leads to a regeneration of up to five times more neighboring, unplucked resting hairs, indicating activation of a collective decision-making process. Through data modeling, the range of the quorum signal was estimated to be on the order of 1 mm, greater than expected for a diffusible molecular cue. Molecular and genetic analysis uncovered a two-step mechanism, where release of CCL2 from injured hairs leads to recruitment of TNF-alpha-secreting macrophages, which accumulate and signal to both plucked and unplucked follicles. By coupling immune response with regeneration, this mechanism allows skin to respond predictively to distress, disregarding mild injury, while meeting stronger injury with full-scale cooperative activation of stem cells.	[Chen, Chih-Chiang; Jiang, Ting Xin; Widelitz, Randall B.; Chuong, Cheng Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Chen, Chih-Chiang] Taipei Vet Gen Hosp, Dept Dermatol, Taipei 112, Taiwan; [Chen, Chih-Chiang; Chuong, Cheng Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chih-Chiang; Chuong, Cheng Ming] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan; [Wang, Lei] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.; Lander, Arthur D.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.; Lander, Arthur D.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Murray, Philip J.] Univ Dundee, Div Math, Dundee DD1 4HN, Scotland; [Hughes, Michael W.] Natl Cheng Kung Univ, Int Lab Wound Repair & Regenerat, Tainan 701, Taiwan; [Hughes, Michael W.] Natl Cheng Kung Univ, Inst Clin Med, Tainan 701, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Taipei & Ctr Stem Cell Res, Dept Orthopaed & Traumatol, Taipei 112, Taiwan; [Lee, Oscar K.] Vet Gen Hosp, Taipei 112, Taiwan; [Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Lander, Arthur D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Chuong, Cheng Ming] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan	University of Southern California; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Air Force Military Medical University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Dundee; National Cheng Kung University; National Cheng Kung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Pennsylvania; University of California System; University of California Irvine; National Taiwan University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu	Lander, Arthur D/C-9008-2011; Lander, Arthur/L-2827-2019	Lander, Arthur D/0000-0002-4380-5525; Lander, Arthur/0000-0002-4380-5525; Plikus, Maksim/0000-0002-8845-2559; Hughes, Michael W./0000-0002-8899-9773; Murray, Philip/0000-0003-0332-5356	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1-AR42177, AR 47364, AR60306]; NSC [100-2314-B-075-044, 101-2314-B-075-008-MY3]; Taipei Veterans General Hospital [VN103-12, V103C-010, V102B-009, R-1100403]; NIGMS [P50-GM076516]; NIH [R01DE17449]; National Natural Science Foundation of China [81270015]; NIAMS [R01-AR067273]; Edward Mallinckrodt Jr. Foundation grant; California Institute of Regenerative Medicine (CIRM) [TG2-01152]; National Science Foundation Graduate Research Fellowship Program [DGE-1321846]; Northern Research Parternship (NRP); Top Notch University plan of CKU, Taiwan; University of Southern California [D2014-0054, 2014-255]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067273, R01AR047364, R01AR042177, R01AR060306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NSC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Edward Mallinckrodt Jr. Foundation grant; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Northern Research Parternship (NRP); Top Notch University plan of CKU, Taiwan; University of Southern California; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.M.C., T.X.J., and R.B.W. are supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) RO1-AR42177, AR 47364, and AR60306. C.C.C. is supported by NSC 100-2314-B-075-044, NSC 101-2314-B-075-008-MY3, and the Taipei Veterans General Hospital (VN103-12, V103C-010, V102B-009, R-1100403). A.D.L. is supported by NIGMS P50-GM076516. S.S. is supported by NIH R01DE17449. L.W. is supported by the National Natural Science Foundation of China (81270015). M.V.P. is supported by NIAMS R01-AR067273 and Edward Mallinckrodt Jr. Foundation grant. R.R. is supported by a California Institute of Regenerative Medicine (CIRM) training grant (TG2-01152). C.F.G.-J. is supported by the National Science Foundation Graduate Research Fellowship Program (DGE-1321846). P.J.M. is supported by a post-doctoral and early career researcher exchange fellowship from the Northern Research Parternship (NRP). M.W.H. is supported by Top Notch University plan of CKU, Taiwan. We thank Drs. Jaw-Ching Wu, Han-Nan Liu, and Yun-Ting Chang of National Yang Ming University/Taipei Veterans General hospital for their support. Invention number 2014-255 "Enhance hair growth via plucking'' (D2014-0054) was disclosed to University of Southern California.	Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Collins HH, 1918, J EXP ZOOL, V27, P73, DOI 10.1002/jez.1400270106; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jahoda CAB, 2011, CELL, V146, P678, DOI 10.1016/j.cell.2011.08.020; Jiang S, 2010, J DERMATOL SCI, V60, P143, DOI 10.1016/j.jdermsci.2010.10.008; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Murray PJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002804; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nagao K, 2012, STEM CELLS, V30, P1781, DOI 10.1002/stem.1153; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; SILVER AF, 1970, DEV BIOL, V21, P440, DOI 10.1016/0012-1606(70)90134-X; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782	41	143	150	5	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					277	290		10.1016/j.cell.2015.02.016	http://dx.doi.org/10.1016/j.cell.2015.02.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860610	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000352708300021
J	Goldberg, MS				Goldberg, Michael S.			Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy	CELL			English	Review							T-CELLS; TARGETING NANOPARTICLES; DENDRITIC CELLS; TUMOR-CELLS; IN-VIVO	Although cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date. Encouragingly, nanotechnology can enhance the efficacy of immunostimulatory small molecules and biologics by altering their co-localization, biodistribution, and release kinetics.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Goldberg, MS (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 450 Brookline Ave, Boston, MA 02215 USA.	michael_goldberg1@dfci.harvard.edu			Cancer Research Institute; Melanoma Research Alliance; Ovarian Cancer Research Fund	Cancer Research Institute; Melanoma Research Alliance; Ovarian Cancer Research Fund	The author thanks the Cancer Research Institute, Melanoma Research Alliance, and Ovarian Cancer Research Fund for their support and apologizes to those investigators whose work could not be referenced because of space limitations.	Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359; Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2; Chow EKH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005872; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Cruz LJ, 2012, METHOD ENZYMOL, V509, P143, DOI 10.1016/B978-0-12-391858-1.00008-3; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Kanapathipillai M, 2012, NANO LETT, V12, P3213, DOI 10.1021/nl301206p; Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071; Kwong B, 2013, CANCER RES, V73, P1547, DOI 10.1158/0008-5472.CAN-12-3343; Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Salmon H, 2012, ONCOIMMUNOLOGY, V1, P992, DOI 10.4161/onci.20239; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Stephan SB, 2015, NAT BIOTECHNOL, V33, P97, DOI 10.1038/nbt.3104; Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039; Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050; Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037	23	190	195	5	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					201	204		10.1016/j.cell.2015.03.037	http://dx.doi.org/10.1016/j.cell.2015.03.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860604	Bronze			2022-12-28	WOS:000352708300014
J	Sax, PE; Wohl, D; Yin, MT; Post, F; DeJesus, E; Saag, M; Pozniak, A; Thompson, M; Podzamczer, D; Molina, JM; Oka, S; Koenig, E; Trottier, B; Andrade-Villanueva, J; Crofoot, G; Custodio, JM; Plummer, A; Zhong, LJ; Cao, HY; Martin, H; Callebaut, C; Cheng, AK; Fordyce, MW; McCallister, S				Sax, Paul E.; Wohl, David; Yin, Michael T.; Post, Frank; DeJesus, Edwin; Saag, Michael; Pozniak, Anton; Thompson, Melanie; Podzamczer, Daniel; Molina, Jean Michel; Oka, Shinichi; Koenig, Ellen; Trottier, Benoit; Andrade-Villanueva, Jaime; Crofoot, Gordon; Custodio, Joseph M.; Plummer, Andrew; Zhong, Lijie; Cao, Huyen; Martin, Hal; Callebaut, Christian; Cheng, Andrew K.; Fordyce, Marshall W.; McCallister, Scott		GS-US-292-0104 0111 Study Team	Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials	LANCET			English	Article							BONE-MINERAL DENSITY; ANTIRETROVIRAL THERAPY; ABACAVIR-LAMIVUDINE; KIDNEY-DISEASE; LOPINAVIR/RITONAVIR; EXPOSURE; SAFETY; ADULTS; COUNT; RATES	Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide is a novel tenofovir prodrug with a 90% reduction in plasma tenofovir concentrations. Tenofovir alafenamide-containing regimens can have improved renal and bone safety compared with tenofovir disoproxil fumarate-containing regimens. Methods In these two controlled, double-blind phase 3 studies, we recruited treatment-naive HIV-infected patients with an estimated creatinine clearance of 50 mL per min or higher from 178 outpatient centres in 16 countries. Patients were randomly assigned (1:1) to receive once-daily oral tablets containing 150 mg elvitegravir, 150 mg cobicistat, 200 mg emtricitabine, and 10 mg tenofovir alafenamide (E/C/F/tenofovir alafenamide) or 300 mg tenofovir disoproxil fumarate (E/C/F/tenofovir disoproxil fumarate) with matching placebo. Randomisation was done by a computer-generated allocation sequence (block size 4) and was stratified by HIV-1 RNA, CD4 count, and region (USA or ex-USA). Investigators, patients, study staff, and those assessing outcomes were masked to treatment group. All participants who received one dose of study drug were included in the primary intention-to-treat efficacy and safety analyses. The main outcomes were the proportion of patients with plasma HIV-1 RNA less than 50 copies per mL at week 48 as defined by the the US Food and Drug Adminstration (FDA) snapshot algorithm (pre-specified non-inferiority margin of 12%) and pre-specified renal and bone endpoints at 48 weeks. These studies are registered with ClinicalTrials.gov, numbers NCT01780506 and NCT01797445. Findings We recruited patients from Jan 22, 2013, to Nov 4, 2013 (2175 screened and 1744 randomly assigned), and gave treatment to 1733 patients (866 given E/C/F/tenofovir alafenamide and 867 given E/C/F/tenofovir disoproxil fumarate). E/C/F/tenofovir alafenamide was non-inferior to E/C/F/tenofovir disoproxil fumarate, with 800 (92%) of 866 patients in the tenofovir alafenamide group and 784 (90%) of 867 patients in the tenofovir disoproxil fumarate group having plasma HIV-1 RNA less than 50 copies per mL (adjusted difference 2.0%, 95% CI -0.7 to 4.7). Patients given E/C/F/tenofovir alafenamide had significantly smaller mean serum creatinine increases than those given E/C/F/tenofovir disoproxil fumarate (0.08 vs 0.12 mg/dL; p<0.0001), significantly less proteinuria (median % change -3 vs 20; p<0.0001), and a significantly smaller decrease in bone mineral density at spine (mean % change -1.30 vs -2.86; p<0.0001) and hip (-0.66 vs -2.95; p<0.0001) at 48 weeks. Interpretation Through 48 weeks, more than 90% of patients given E/C/F/tenofovir alafenamide or E/C/F/tenofovir disoproxil fumarate had virological success. Renal and bone effects were significantly reduced in patients given E/C/F/tenofovir alafenamide. Although these studies do not have the power to assess clinical safety events such as renal failure and fractures, our data suggest that E/C/F/tenofovir alafenamide will have a favourable long-term renal and bone safety profile.	[Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sax, Paul E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wohl, David] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Yin, Michael T.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Post, Frank] Kings Coll London, Hosp NHS Fdn Trust, Dept HIV Med, London WC2R 2LS, England; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Saag, Michael] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Pozniak, Anton] NHS Fdn Trust, Chelsea & Westminster Hosp, Dept Med, London, England; [Thompson, Melanie] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Podzamczer, Daniel] Hosp Univ Bellvitge, Infect Dis Serv, HIV Unit, Barcelona, Spain; [Molina, Jean Michel] Hop St Louis, Paris, France; [Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Koenig, Ellen] IDEV, Santo Domingo, Dominican Rep; [Trottier, Benoit] Clin Med Actuale Montreal, Montreal, PQ, Canada; [Andrade-Villanueva, Jaime] Univ Guadalajara, CUCS, Hosp Civil Guadalajara, Unidad VIH, Guadalajara 44430, Jalisco, Mexico; [Crofoot, Gordon] Gordon Crofoot Res, Houston, TX USA; [Custodio, Joseph M.; Plummer, Andrew; Zhong, Lijie; Cao, Huyen; Martin, Hal; Callebaut, Christian; Cheng, Andrew K.; Fordyce, Marshall W.; McCallister, Scott] Gilead Sci Inc, Foster City, CA 94404 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of London; King's College London; Orlando Immunology Center; University of Alabama System; University of Alabama Birmingham; Imperial College London; Oxford University Hospitals NHS Foundation Trust; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; National Center for Global Health & Medicine - Japan; Universidad de Guadalajara; Gilead Sciences	Sax, PE (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	psax@partners.org	Berenguer, Juan/A-1347-2009; Knobel, Hernando/B-5223-2016; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Berenguer, Juan/0000-0001-8541-8200; Knobel, Hernando/0000-0003-3186-6416; Oka, Shinichi/0000-0002-9283-2167; Yin, Michael T/0000-0002-9346-9056; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X; Taylor, stephen/0000-0001-5496-6482; Rijnders, Bart/0000-0003-3343-9610; cheng, andrew/0000-0002-1121-8051; Kozal, Michael/0000-0002-3100-8254	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	[Anonymous], 2011, GUID US ANT AG HIV 1, P1; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bedimo RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106221; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Fux CA, 2007, ANTIVIR THER, V12, P1165; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Grant PM, 2013, CLIN INFECT DIS, V57, P1483, DOI 10.1093/cid/cit538; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Koch GG, 1989, STAT METHODOLOGY PHA, P41; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Mateo L, 2016, CLIN RHEUMATOL, V35, P1271, DOI 10.1007/s10067-014-2627-x; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Morlat P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066223; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Shepherd JA, 2007, J CLIN DENSITOM, V10, P249, DOI 10.1016/j.jocd.2007.05.002; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tungsiripat M, 2010, AIDS, V24, P1781, DOI 10.1097/QAD.0b013e32833ad8b4; US Department of Health and Human Services  U.S. Department of Health and Human Services, 2013, GUID IND HUM IMM VIR; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Wiens BL, 2005, J BIOPHARM STAT, V15, P929, DOI 10.1080/10543400500265660	27	432	447	0	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2606	2615		10.1016/S0140-6736(15)60616-X	http://dx.doi.org/10.1016/S0140-6736(15)60616-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25890673				2022-12-28	WOS:000356930000028
J	Selph, S; Dana, T; Blazina, I; Bougatsos, C; Patel, H; Chou, R				Selph, Shelley; Dana, Tracy; Blazina, Ian; Bougatsos, Christina; Patel, Hetal; Chou, Roger			Screening for Type 2 Diabetes Mellitus: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE CONTROL; INTENSIVE MULTIFACTORIAL TREATMENT; TERM-FOLLOW-UP; FASTING GLUCOSE; CARDIOVASCULAR OUTCOMES; CLINICAL-PRACTICE; ADDITION-EUROPE	Background: Screening for type 2 diabetes mellitus could lead to earlier identification and treatment of asymptomatic diabetes, impaired fasting glucose (IFG), or impaired glucose tolerance (IGT), potentially resulting in improved outcomes. Purpose: To update the 2008 U.S. Preventive Services Task Force review on diabetes screening in adults. Data Sources: Cochrane databases and MEDUNE (2007 through October 2014) and relevant studies from previous Task Force reviews. Study Selection: Randomized, controlled trials; controlled, observational studies; and systematic reviews. Data Extraction: Data were abstracted by 1 investigator and checked by a second; 2 investigators independently assessed study quality. Data Synthesis: In 2 trials, screening for diabetes was associated with no 10-year mortality benefit versus no screening (hazard ratio, 1.06 [95% Cl, 0.90 to 1.25]). Sixteen trials consistently found that treatment of IFG or IGT was associated with delayed progression to diabetes. Most trials of treatment of IFG or IGT found no effects on all-cause or cardiovascular mortality, although lifestyle modification was associated with decreased risk for both outcomes after 23 years in 1 trial. For screen-detected diabetes, 1 trial found no effect of an intensive multifactorial intervention on risk for all-cause or cardiovascular mortality versus standard control. In diabetes that was not specifically screen-detected, 9 systematic reviews found that intensive glucose control did not reduce risk for all-cause or cardiovascular mortality and results for intensive blood pressure control were inconsistent. Limitation: The review was restricted to English-language articles, and few studies were conducted in screen-detected populations. Conclusion: Screening for diabetes did not improve mortality rates after 10 years of follow-up. More evidence is needed to determine the effectiveness of treatments for screen-detected diabetes. Treatment of IFG or IGT was associated with delayed progression to diabetes.	Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA; [Selph, Shelley] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Selph, S (corresponding author), Oregon Hlth & Sci Univ, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	selphs@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American Academy of Family Physicians, 2012, SUMM REC CLIN PREV S, P19; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Armato J, 2012, ENDOCR PRACT, V18, P342, DOI 10.4158/EP11194.OR; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Buehler AM, 2013, CARDIOVASC THER, V31, P147, DOI 10.1111/j.1755-5922.2011.00308.x; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Colagiuri S, 2009, NATL EVIDENCE BASED; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Diabetes UK, 2014, POS STAT EARL ID PEO; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dyson PA, 1997, METABOLISM, V46, P50, DOI 10.1016/S0026-0495(97)90318-8; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Florez H, 2012, J GEN INTERN MED, V27, P1594, DOI 10.1007/s11606-012-2122-5; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Harris MI, 2000, DIABETES-METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO;2-N; Harris R, 2003, ANN INTERN MED, V138, P215, DOI 10.7326/0003-4819-138-3-200302040-00015; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Howard BV, 2008, JAMA-J AM MED ASSOC, V299, P1678, DOI 10.1001/jama.299.14.1678; Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lindahl B, 2009, SCAND J PUBLIC HEALT, V37, P434, DOI 10.1177/1403494808101373; Lindblad U, 2011, DIABETES OBES METAB, V13, P185, DOI 10.1111/j.1463-1326.2010.01331.x; Lu YH, 2011, ADV THER, V28, P511, DOI 10.1007/s12325-011-0022-4; Ma J, 2009, NUTR METAB CARDIOVAS, V19, P596, DOI 10.1016/j.numecd.2009.07.004; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Nijpels G, 2008, DIABETES-METAB RES, V24, P611, DOI 10.1002/dmrr.839; Norris SL, 2008, AHRQ PUBLICATION; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Paddison CAM, 2011, BRIT J HEALTH PSYCH, V16, P213, DOI 10.1348/135910710X495366; Pan CY, 2003, DIABETES RES CLIN PR, V61, P183, DOI 10.1016/S0168-8227(03)00117-7; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Penn L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-342; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Poulter NR, 2009, J HYPERTENS, V27, pS3, DOI 10.1097/01.hjh.0000354417.70192.be; Rahman M, 2012, DIABETIC MED, V29, P886, DOI 10.1111/j.1464-5491.2012.03570.x; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x; Rasmussen SS, 2008, SCAND J PRIM HEALTH, V26, P166, DOI 10.1080/02813430802264624; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Sakane N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-40; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub3; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Selph S, 2014, AHRQ PUBLICATION; Simmons RK, 2012, DIABETIC MED, V29, pE409, DOI 10.1111/j.1464-5491.2012.03759.x; Simmons RK, 2011, DIABETOLOGIA, V54, P312, DOI 10.1007/s00125-010-1949-8; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Swinburn BA, 2001, DIABETES CARE, V24, P619, DOI 10.2337/diacare.24.4.619; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Preventive Services Task Force Procedure Manual, 2008, AHRQ PUBLICATION, V08-05118-EF; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Van den Donk M, 2013, DIABETOLOGIA; Watanabe M, 2003, DIABETES CARE, V26, P3209, DOI 10.2337/diacare.26.12.3209; Wu H, 2010, CHINESE MED J-PEKING, V123, P2908, DOI 10.3760/cma.j.issn.0366-6999.2010.20.029; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	92	93	94	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					765	776		10.7326/M14-2221	http://dx.doi.org/10.7326/M14-2221			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25867111				2022-12-28	WOS:000355572300004
J	Barisic, M; Sousa, RSE; Tripathy, SK; Magiera, MM; Zaytsev, AV; Pereira, AL; Janke, C; Grishchuk, EL; Maiato, H				Barisic, Marin; Silva e Sousa, Ricardo; Tripathy, Suvranta K.; Magiera, Maria M.; Zaytsev, Anatoly V.; Pereira, Ana L.; Janke, Carsten; Grishchuk, Ekaterina L.; Maiato, Helder			Microtubule detyrosination guides chromosomes during mitosis	SCIENCE			English	Article							NONTYROSINATED ALPHA-TUBULIN; KINESIN CENP-E; CONGRESSION; MOTOR; CODE; TYROSINATION; MECHANISMS; TRANSPORT; SPINDLE	Before chromosomes segregate into daughter cells, they align at the mitotic spindle equator, a process known as chromosome congression. Centromere-associated protein E (CENP-E)/Kinesin-7 is a microtubule plus-end-directed kinetochore motor required for congression of pole-proximal chromosomes. Because the plus-ends of many astral microtubules in the spindle point to the cell cortex, it remains unknown how CENP-E guides pole-proximal chromosomes specifically toward the equator. We found that congression of pole-proximal chromosomes depended on specific posttranslational detyrosination of spindle microtubules that point to the equator. In vitro reconstitution experiments demonstrated that CENP-E-dependent transport was strongly enhanced on detyrosinated microtubules. Blocking tubulin tyrosination in cells caused ubiquitous detyrosination of spindle microtubules, and CENP-E transported chromosomes away from spindle poles in random directions. Thus, CENP-E-driven chromosome congression is guided by microtubule detyrosination.	[Barisic, Marin; Pereira, Ana L.; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Barisic, Marin; Pereira, Ana L.; Maiato, Helder] Univ Porto, I3S, P-4150180 Oporto, Portugal; [Silva e Sousa, Ricardo; Tripathy, Suvranta K.; Zaytsev, Anatoly V.; Grishchuk, Ekaterina L.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Magiera, Maria M.; Janke, Carsten] Inst Curie, F-91405 Orsay, France; [Magiera, Maria M.; Janke, Carsten] Paris Sci & Lettres PSL Res Univ, F-75005 Paris, France; [Magiera, Maria M.; Janke, Carsten] CNRS, UMR 3348, F-91405 Orsay, France; [Zaytsev, Anatoly V.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Zaytsev, Anatoly V.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Universidade do Porto	Grishchuk, EL (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	gekate@mail.med.upenn.edu; maiato@ibmc.up.pt	Tripathy, Suvranta/ABB-5152-2020; Magiera, Maria M./Y-8754-2019; Zaytsev, Anatoly/R-9422-2016; Janke, Carsten/A-7279-2011; Barisic, Marin/K-2301-2013; Maiato, Helder/J-9466-2013	Magiera, Maria M./0000-0003-4847-3053; Janke, Carsten/0000-0001-7053-2000; Barisic, Marin/0000-0001-7587-3867; Maiato, Helder/0000-0002-6200-9997; Tripathy, Suvranta/0000-0002-6658-1691	National Institutes of Health [R01-GM098389]; American Cancer Society [RSG-14-018-01-CCG]; Institut Curie; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; L'Agence Nationale de la Recherche (ANR) [ANR-12-BSV2-0007, INCA_6517, ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL]; L'Agence Nationale de la Recherche (ANR) part of the IDEX Idex PSL; Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science; PRECISE grant from the European Research Council; RAS Presidium; Russian Fund for Basic Research [12-04-00111-a, 13-00-40188]; Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BPD/66707/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Institut Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); L'Agence Nationale de la Recherche (ANR) part of the IDEX Idex PSL(French National Research Agency (ANR)); Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science; PRECISE grant from the European Research Council; RAS Presidium(Russian Academy of Sciences); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. I. Ataullakhanov for help with the laser trap and data analysis; A. Kiyatkin, V. Mustyatsa, M. Molodtsov, A. Gautreau, G. Lakisic, and M. Barisic for technical assistance; and members of our laboratories for stimulating discussions. This work was supported by National Institutes of Health grant R01-GM098389 and RSG-14-018-01-CCG from the American Cancer Society to E.L.G.; by the Institut Curie, the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the L'Agence Nationale de la Recherche (ANR) award ANR-12-BSV2-0007, INCA_6517, ANR-10-LBX-0038, part of the IDEX Idex PSL, ANR-10-IDEX-0001-02 PSL to C.J.; and Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science 2020 and PRECISE grant from the European Research Council to H.M. A.V.Z. is supported by the RAS Presidium Grants "Mechanisms of the Molecular Systems Integration," " Molecular and Cell Biology programs," and Russian Fund for Basic Research Grant 12-04-00111-a and 13-00-40188. R.S.S. is supported by a fellowship from the Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto. A.L.P. is supported by fellowship SFRH/BPD/66707/2009 from Fundacao para a Ciencia e a Tecnologia of Portugal. M.B., R.S.S., S.K.T., M.M.M., C.J., E.L.G., and H.M. designed the experiments; M.B. performed all experiments in cells; M. M. M. established and performed the tubulin purification protocol from HeLa cells; R.S.S. performed single-molecule experiments; S.K.T. performed force measurements; A.L.P. provided reagents; all authors analyzed data; H.M., E.L.G., and M.B. wrote the paper, with contributions from all authors; H.M. conceived and coordinated the project. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; WILSON PJ, 1989, CELL MOTIL CYTOSKEL, V14, P237, DOI 10.1002/cm.970140210; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	26	142	147	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					799	803		10.1126/science.aaa5175	http://dx.doi.org/10.1126/science.aaa5175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25908662	Green Accepted, Green Submitted			2022-12-28	WOS:000354428700044
J	Hemrajani, RH; Call, SA				Hemrajani, Reena H.; Call, Stephanie A.			Update in General Internal Medicine: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VENOUS THROMBOEMBOLISM; ATRIAL-FIBRILLATION; AMERICAN-COLLEGE; D-DIMER; ANTICOAGULATION; DABIGATRAN; WARFARIN; STROKE; RISK; THROMBOSIS		[Hemrajani, Reena H.; Call, Stephanie A.] Virginia Commonwealth Univ, Richmond, VA USA	Virginia Commonwealth University	Call, SA (corresponding author), POB 980509,1200 East Broad St, Richmond, VA 23298 USA.	scall@mcvh-vcu.edu						AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Bridges CB, 2014, ANN INTERN MED, V160, P190, DOI 10.7326/M13-2826; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clemens A, 2014, AM J CARDIOL, V114, P849, DOI 10.1016/j.amjcard.2014.06.015; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Flint AC, 2012, STROKE, V43, P2788, DOI 10.1161/STROKEAHA.112.665844; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Goldstein LB, 2001, STROKE, V32, P1091, DOI 10.1161/01.STR.32.5.1091; Gonzales R, 2013, JAMA INTERN MED, V173, P267, DOI 10.1001/jamainternmed.2013.1589; Graham R, 2011, CLIN PRACTICE GUIDEL; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Palareti G, 2014, BLOOD, V124, P196, DOI 10.1182/blood-2014-01-548065; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Smith SM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000245.PUB2]	30	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W80	W85		10.7326/M15-0274	http://dx.doi.org/10.7326/M15-0274			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927277				2022-12-28	WOS:000379893300001
J	Schork, NJ				Schork, Nicholas J.			Time for one-person trials	NATURE			English	Editorial Material									[Schork, Nicholas J.] J Craig Venter Inst, La Jolla, CA 92037 USA; [Schork, Nicholas J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Schork, Nicholas J.] Translat Genom Res Inst TGen, Phoenix, AZ USA	J. Craig Venter Institute; University of California System; University of California San Diego; Translational Genomics Research Institute	Schork, NJ (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	nschork@jcvi.org		Schork, Nicholas/0000-0003-0920-5013				[Anonymous], 2014, DESIGN IMPLEMENTATIO; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; Drescher CW, 2013, J CLIN ONCOL, V31, P387, DOI 10.1200/JCO.2012.43.6691; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Mukherjee D, 2002, PROG CARDIOVASC DIS, V44, P479, DOI 10.1053/pcad.2002.123467; Scuffham PA, 2010, J GEN INTERN MED, V25, P906, DOI 10.1007/s11606-010-1352-7; U.S. Food And Drug Administration, 2013, PAV WAY PERS MED FDA; Uryniak T, 2011, STAT BIOPHARM RES, V3, P476, DOI 10.1198/sbr.2011.10070	10	618	629	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					609	611		10.1038/520609a	http://dx.doi.org/10.1038/520609a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925459	Bronze			2022-12-28	WOS:000353689700023
J	Yang, CS; Robinson-Bostom, L				Yang, Catherine S.; Robinson-Bostom, Leslie			Lindsay's Nails in Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Catherine S.; Robinson-Bostom, Leslie] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Yang, CS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	catherine_yang@brown.edu							0	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1748	1748		10.1056/NEJMicm1406572	http://dx.doi.org/10.1056/NEJMicm1406572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923554				2022-12-28	WOS:000353655000009
J	Warren, FC; Abel, G; Lyratzopoulos, G; Elliott, MN; Richards, S; Barry, HE; Roland, M; Campbell, JL				Warren, Fiona C.; Abel, Gary; Lyratzopoulos, Georgios; Elliott, Marc N.; Richards, Suzanne; Barry, Heather E.; Roland, Martin; Campbell, John L.			Characteristics of service users and provider organisations associated with experience of out of hours general practitioner care in England: population based cross sectional postal questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; PATIENT EXPERIENCE; NONRESPONSE RATES; TELEPHONE TRIAGE; SATISFACTION; PERFORMANCE; IMPACT; BIAS	OBJECTIVE To investigate the experience of users of out of hours general practitioner services in England, UK. DESIGN Population based cross sectional postal questionnaire survey. SETTING General Practice Patient Survey 2012-13. Main outcome measures Potential associations between sociodemographic factors (including ethnicity and ability to take time away from work during working hours to attend a healthcare consultation) and provider organisation type (not for profit, NHS, or commercial) and service users' experience of out of hours care (timeliness, confidence and trust in the out of hours clinician, and overall experience of the service), rated on a scale of 0-100. Which sociodemographic/provider characteristics were associated with service users' experience, the extent to which any observed differences could be because of clustering of service users of a particular sociodemographic group within poorer scoring providers, and the extent to which observed differences in experience varied across types of provider. RESULTS The overall response rate was 35%; 971 232/2 750 000 patients returned surveys. Data from 902 170 individual service users were mapped through their registered practice to one of 86 providers of out of hours GP care with known organisation type. Commercial providers of out of hours GP care were associated with poorer reports of overall experience of care, with a mean difference of -3.13 (95% confidence interval -4.96 to -1.30) compared with not for profit providers. Asian service users reported lower scores for all three experience outcomes than white service users (mean difference for overall experience of care -3.62, -4.36 to -2.89), as did service users who were unable to take time away from work compared with service users who did not work (mean difference for overall experience of care -4.73, -5.29 to -4.17). CONCLUSIONS Commercial providers of out of hours GP care were associated with poorer experience of care. Targeted interventions aimed at improving experience for patients from ethnic minorities and patients who are unable to take time away from work might be warranted.	[Warren, Fiona C.; Richards, Suzanne; Barry, Heather E.; Campbell, John L.] Univ Exeter, Sch Med, Dept Primary Care, Exeter EX1 2LU, Devon, England; [Abel, Gary; Lyratzopoulos, Georgios; Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Inst Publ Hlth, Cambridge, England; [Lyratzopoulos, Georgios] UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England; [Elliott, Marc N.] RAND Corp, Santa Monica, CA USA	University of Exeter; University of Cambridge; University of London; University College London; RAND Corporation	Warren, FC (corresponding author), Univ Exeter, Sch Med, Dept Primary Care, Exeter EX1 2LU, Devon, England.	f.c.warren@exeter.ac.uk	Campbell, John/A-5792-2011; Lyratzopoulos, Georgios/O-8260-2019; Barry, Heather Elizabeth/H-8011-2019; Abel, Gary/ABE-1765-2021	Campbell, John/0000-0002-6752-3493; Lyratzopoulos, Georgios/0000-0002-2873-7421; Barry, Heather Elizabeth/0000-0002-9684-8182; Abel, Gary/0000-0003-2231-5161; Roland, Martin/0000-0002-8533-3060; Richards, Suzanne/0000-0003-1416-0569; Warren, Fiona/0000-0002-3833-0182	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0608-10050]; National Institute for Health Research [PDF-2011-04-047]; Cancer Research UK clinician scientist fellowship award [A18180]; Cancer Research UK [18180] Funding Source: researchfish; National Institute for Health Research [RP-PG-0608-10050] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK clinician scientist fellowship award; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (Grant Reference RP-PG-0608-10050). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The UK National Institute for Health Research had no direct involvement in the design and conduct of the study, the collection, management, analysis and interpretation of the data, or in the preparation, review or approval of the manuscript. GL was supported by a postdoctoral fellowship by the National Institute for Health Research (PDF-2011-04-047) 2012-2014 and by a Cancer Research UK clinician scientist fellowship award (A18180) from March 2015.	[Anonymous], 2010, IMPR OUT HOURS CAR W; [Anonymous], 2014, GEN PRACT PAT SURV; Brogan C, 1998, BRIT MED J, V316, P524, DOI 10.1136/bmj.316.7130.524; Campbell J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-57; Campbell JL, 2014, LANCET, V384, P1859, DOI 10.1016/S0140-6736(14)61058-8; Care Quality Commission, 2013, FRESH START REG INSP; Care Quality Commission, 2014, OUR NEW APPR INSP NH; Colin-Thome D, 2010, GEN PRACTICE OUT OF; Department of Health, 2004, NAT QUAL REQ DEL OUT; Department of Health, 2006, NAT QUAL REQ DEL OUT; Department of Health, 2013, NHS OUTC FRAM 2014 1; Department of Health and NHS England, 2014, OUT OF HOURS GP SERV; Elliott MN, 2009, HEALTH SERV RES, V44, P542, DOI 10.1111/j.1475-6773.2008.00922.x; Elliott MN, 2009, HEALTH SERV RES, V44, P501, DOI 10.1111/j.1475-6773.2008.00914.x; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Harris-Kojetin LD, 1999, MED CARE, V37, pMS10, DOI 10.1097/00005650-199903001-00002; Huibers L, 2014, SCAND J PRIM HEALTH, V32, P44, DOI 10.3109/02813432.2014.898974; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; Lyratzopoulos G, 2012, BMJ QUAL SAF, V21, P21, DOI 10.1136/bmjqs-2011-000088; McKinley RK, 2002, FAM PRACT, V19, P333, DOI 10.1093/fampra/19.4.333; McLennan D., 2011, ENGLISH INDICES DEPR; Office for National Statistics, 2011, POP EST ETHN GROUP M; Paddison CAM, 2015, HEALTH EXPECT, V18, P1081, DOI 10.1111/hex.12081; Paddison CAM, 2013, AM J KIDNEY DIS, V61, P440, DOI 10.1053/j.ajkd.2012.10.009; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Roland M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3851; Salisbury C, 1997, BRIT MED J, V314, P1594, DOI 10.1136/bmj.314.7094.1594; Shipman C, 1999, FAM PRACT, V16, P23, DOI 10.1093/fampra/16.1.23; van Uden CJT, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-6; Warren FC, 2015, BMJ QUAL SAF, V24, P572, DOI 10.1136/bmjqs-2015-003937	33	25	25	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2015	350								h2040	10.1136/bmj.h2040	http://dx.doi.org/10.1136/bmj.h2040			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH3UR	25926616	Green Published, hybrid			2022-12-28	WOS:000353956400001
J	Richardson, JJ; Bjornmalm, M; Caruso, F				Richardson, Joseph J.; Bjoernmalm, Mattias; Caruso, Frank			Technology-driven layer-by-layer assembly of nanofilms	SCIENCE			English	Review							MULTILAYER THIN-FILMS; POLYELECTROLYTE MULTILAYERS; COLLOIDAL PARTICLES; IMMOBILIZED PARTICLES; MICROFLUIDIC CHANNELS; BUILDUP MECHANISM; AUTOMATED PROCESS; DEPOSITION METHOD; APPLIED VOLTAGE; FABRICATION	Multilayer thin films have garnered intense scientific interest due to their potential application in diverse fields such as catalysis, optics, energy, membranes, and biomedicine. Here we review the current technologies for multilayer thin-film deposition using layer-by-layer assembly, and we discuss the different properties and applications arising from the technologies. We highlight five distinct routes of assembly-immersive, spin, spray, electromagnetic, and fluidic assembly-each of which offers material and processing advantages for assembling layer-by-layer films. Each technology encompasses numerous innovations for automating and improving layering, which is important for research and industrial applications. Furthermore, we discuss how judicious choice of the assembly technology enables the engineering of thin films with tailor-made physicochemical properties, such as distinct-layer stratification, controlled roughness, and highly ordered packing.	[Caruso, Frank] Univ Melbourne, Australian Res Council, Ctr Excellence Convergent Bionano Sci & Technol, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Caruso, F (corresponding author), Univ Melbourne, Australian Res Council, Ctr Excellence Convergent Bionano Sci & Technol, Parkville, Vic 3010, Australia.	fcaruso@unimelb.edu.au	Björnmalm, Mattias/H-7721-2014; Caruso, Frank/A-9587-2011; Richardson, Joseph J./T-3417-2017	Björnmalm, Mattias/0000-0002-9876-7079; Caruso, Frank/0000-0002-0197-497X; Richardson, Joseph J./0000-0001-8618-4127	ARC [FL120100030]; Australian government through an Australian Postgraduate Award; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]	ARC(Australian Research Council); Australian government through an Australian Postgraduate Award(Australian Government); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council)	This work was supported by the ARC under the Australian Laureate Fellowship (FL120100030 to F.C.) and the Australian government through an Australian Postgraduate Award (to M.B.). This work was also supported by the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (project number CE140100036).	Alongi J, 2013, CARBOHYD POLYM, V92, P114, DOI 10.1016/j.carbpol.2012.08.086; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Barker SLR, 2000, ANAL CHEM, V72, P5925, DOI 10.1021/ac0008690; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Castleberry SA, 2014, ACS NANO, V8, P6580, DOI 10.1021/nn501963q; Chiarelli PA, 2001, ADV MATER, V13, P1167, DOI 10.1002/1521-4095(200108)13:15<1167::AID-ADMA1167>3.0.CO;2-A; Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dey S, 2010, LANGMUIR, V26, P9627, DOI 10.1021/la101132z; Dierendonck M, 2014, SOFT MATTER, V10, P804, DOI 10.1039/c3sm52202d; Donath E, 1997, LANGMUIR, V13, P5294, DOI 10.1021/la970090u; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a; Fou AC, 1996, J APPL PHYS, V79, P7501, DOI 10.1063/1.362421; Fu Y, 2011, LANGMUIR, V27, P672, DOI 10.1021/la104524k; Fujimoto K, 2005, JPN J APPL PHYS 2, V44, pL126, DOI 10.1143/JJAP.44.L126; Fukao N, 2011, MACROMOLECULES, V44, P2964, DOI 10.1021/ma200024w; GAINES GL, 1983, THIN SOLID FILMS, V99, P243, DOI 10.1016/0040-6090(83)90387-5; Gittleson FS, 2012, ACS NANO, V6, P3703, DOI 10.1021/nn204384f; GOLANDER CG, 1982, COLLOID SURFACE, V5, P1, DOI 10.1016/0166-6622(82)80053-X; Grigoriev DO, 2008, LANGMUIR, V24, P999, DOI 10.1021/la702873f; Hamedi M, 2013, ANGEW CHEM INT EDIT, V52, P12038, DOI 10.1002/anie.201305137; Hirsjarvi S, 2010, EUR J PHARM BIOPHARM, V76, P200, DOI 10.1016/j.ejpb.2010.07.010; Hirsjarvi S, 2006, COLLOID SURFACE B, V49, P93, DOI 10.1016/j.colsurfb.2006.03.009; Hong HP, 1998, ADV MATER, V10, P1104, DOI 10.1002/(SICI)1521-4095(199810)10:14<1104::AID-ADMA1104>3.3.CO;2-6; Hong X, 2004, CHEM MATER, V16, P4022, DOI 10.1021/cm049422o; Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y; ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3; Izquierdo A, 2005, LANGMUIR, V21, P7558, DOI 10.1021/la047407s; Jang H, 2003, LANGMUIR, V19, P3094, DOI 10.1021/la026788b; Jiang C, 2014, J MATER CHEM A, V2, P14048, DOI 10.1039/c4ta02437k; Kantak C, 2011, LAB CHIP, V11, P1030, DOI 10.1039/c01c00381f; Katayama H, 1998, ANAL CHEM, V70, P5272, DOI 10.1021/ac980522l; Kharlampieva E, 2009, LANGMUIR, V25, P14017, DOI 10.1021/la9014042; Kim HJ, 2005, LANGMUIR, V21, P8532, DOI 10.1021/la0511182; KIRKLAND JJ, 1965, ANAL CHEM, V37, P1458, DOI 10.1021/ac60231a004; Ko YH, 2011, MACROMOLECULES, V44, P2866, DOI 10.1021/ma102112a; Kong BS, 2009, CHEM COMMUN, P2174, DOI 10.1039/b821920f; Krogman KC, 2007, LANGMUIR, V23, P3137, DOI 10.1021/la063085b; Krogman KC, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/045005; Krogman KC, 2009, NAT MATER, V8, P512, DOI [10.1038/NMAT2430, 10.1038/nmat2430]; Lee D, 2006, NANO LETT, V6, P2305, DOI 10.1021/nl061776m; Leporatti S, 2000, LANGMUIR, V16, P4059, DOI 10.1021/la991429a; Li JA, 2010, LANGMUIR, V26, P15554, DOI 10.1021/la1020498; Li M, 2013, CHEM COMMUN, V49, P6879, DOI 10.1039/c3cc43629b; Li M, 2011, J AM CHEM SOC, V133, P7348, DOI 10.1021/ja202768k; Liu H, 2014, RSC ADV, V4, P16751, DOI 10.1039/c4ra00089g; Ma LX, 2012, LANGMUIR, V28, P9849, DOI 10.1021/la301553w; Madaboosi N, 2012, MACROMOL RAPID COMM, V33, P1775, DOI 10.1002/marc.201200353; Mateos AJ, 2014, IND ENG CHEM RES, V53, P6409, DOI 10.1021/ie500122u; Matosevic S, 2013, NAT CHEM, V5, P958, DOI [10.1038/nchem.1765, 10.1038/NCHEM.1765]; Merrill MH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075606; Mets JM, 2013, ADV HEALTHC MATER, V2, P266, DOI 10.1002/adhm.201200148; Morton SW, 2013, ADV MATER, V25, P4707, DOI 10.1002/adma.201302025; Mu B, 2011, J POLYM SCI POL CHEM, V49, P1969, DOI 10.1002/pola.24623; Mulhearn WD, 2012, SOFT MATTER, V8, P10419, DOI 10.1039/c2sm26456k; Ngankam AP, 2005, LANGMUIR, V21, P5865, DOI 10.1021/la050066d; Omura Y, 2014, IND ENG CHEM RES, V53, P11727, DOI 10.1021/ie403736r; Ott P, 2010, LANGMUIR, V26, P18182, DOI 10.1021/la1035882; Patel PA, 2007, LANGMUIR, V23, P12589, DOI 10.1021/la7020676; PEIFFRE DG, 1981, POLYMER, V22, P450, DOI 10.1016/0032-3861(81)90159-2; Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g; Priest C, 2008, LAB CHIP, V8, P2182, DOI 10.1039/b808826h; Qi AS, 2011, ACS NANO, V5, P9583, DOI 10.1021/nn202833n; Raman N, 2014, J CONTROL RELEASE, V191, P54, DOI 10.1016/j.jconrel.2014.05.026; Reyes DR, 2004, LANGMUIR, V20, P8805, DOI 10.1021/la049249a; Richardson JJ, 2014, NANOSCALE, V6, P13416, DOI 10.1039/c4nr04348k; Richardson JJ, 2014, LANGMUIR, V30, P10028, DOI 10.1021/la502176g; Richardson JJ, 2013, ADV MATER, V25, P6874, DOI 10.1002/adma.201302696; Richardson JJ, 2013, ANGEW CHEM INT EDIT, V52, P6455, DOI 10.1002/anie.201302092; Rydzek G, 2010, LANGMUIR, V26, P2816, DOI 10.1021/la902874k; Sadovoy AV, 2011, PHYS CHEM CHEM PHYS, V13, P4005, DOI 10.1039/c0cp01762k; Sasaki T, 2008, J NANOMATER, V2008, DOI 10.1155/2008/185632; Schaaf P, 2012, ADV MATER, V24, P1001, DOI 10.1002/adma.201104227; Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i; Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114; Seo J, 2008, LANGMUIR, V24, P7995, DOI 10.1021/la800906x; Shi LX, 2003, BIOMACROMOLECULES, V4, P1161, DOI 10.1021/bm030003e; Shim BS, 2007, NANO LETT, V7, P3266, DOI 10.1021/nl071245d; Shim BS, 2005, LANGMUIR, V21, P9381, DOI 10.1021/la050992s; Shiratori SS, 2000, POLYM ADVAN TECHNOL, V11, P810, DOI 10.1002/1099-1581(200008/12)11:8/12<810::AID-PAT58>3.0.CO;2-4; Shutava TG, 2012, SOFT MATTER, V8, P9418, DOI 10.1039/c2sm25683e; Sochol R. D., 2011, TRANSDUCERS 2011 - 2011 16th International Solid-State Sensors, Actuators and Microsystems Conference, P1761, DOI 10.1109/TRANSDUCERS.2011.5969455; Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1; Sun JQ, 2001, J NANOSCI NANOTECHNO, V1, P133, DOI 10.1166/jnn.2001.029; Szczepanowicz K, 2010, LANGMUIR, V26, P12592, DOI 10.1021/la102061s; Tang HQ, 2013, POLYM CHEM-UK, V4, P5621, DOI 10.1039/c3py00617d; Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x; THOMAS IM, 1987, APPL OPTICS, V26, P4688, DOI 10.1364/AO.26.004688; Van Tassel PR, 2012, CURR OPIN COLLOID IN, V17, P106, DOI 10.1016/j.cocis.2011.08.008; Voigt A, 1999, IND ENG CHEM RES, V38, P4037, DOI 10.1021/ie9900925; Vozar S, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3078009; Wang HJ, 2012, J AM CHEM SOC, V134, P10819, DOI 10.1021/ja303773z; Wang YF, 2011, ADV MATER, V23, P5817, DOI 10.1002/adma.201103726; Wang ZL, 2014, CARBOHYD POLYM, V103, P38, DOI 10.1016/j.carbpol.2013.12.007; Wilson JT, 2011, J AM CHEM SOC, V133, P7054, DOI 10.1021/ja110926s; Wilson R, 2007, J MATER CHEM, V17, P4400, DOI 10.1039/b708174j; Yan Y, 2014, CHEM MATER, V26, P452, DOI 10.1021/cm402126n; Zhang GJ, 2011, LANGMUIR, V27, P2093, DOI 10.1021/la104120b; Zhang X, 2007, CHEM COMMUN, P1395, DOI 10.1039/b615590a	101	1034	1060	73	1343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233							aaa2491	10.1126/science.aaa2491	http://dx.doi.org/10.1126/science.aaa2491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908826	Green Submitted			2022-12-28	WOS:000353338000026
J	Mayer, A; di Iulio, J; Maleri, S; Eser, U; Vierstra, J; Reynolds, A; Sandstrom, R; Stamatoyannopoulos, JA; Churchman, LS				Mayer, Andreas; di Iulio, Julia; Maleri, Seth; Eser, Umut; Vierstra, Jeff; Reynolds, Alex; Sandstrom, Richard; Stamatoyannopoulos, John A.; Churchman, L. Stirling			Native Elongating Transcript Sequencing Reveals Human Transcriptional Activity at Nucleotide Resolution	CELL			English	Article							RNA-POLYMERASE-II; DIVERGENT TRANSCRIPTION; P-TEFB; DROSOPHILA-MELANOGASTER; BIDIRECTIONAL PROMOTERS; DNA-METHYLATION; START SITES; IN-VITRO; GENE; INITIATION	Major features of transcription by human RNA polymerase II (Pol II) remain poorly defined due to a lack of quantitative approaches for visualizing Pol II progress at nucleotide resolution. We developed a simple and powerful approach for performing native elongating transcript sequencing (NET-seq) in human cells that globally maps strand-specific Pol II density at nucleotide resolution. NET-seq exposes a mode of antisense transcription that originates downstream and converges on transcription from the canonical promoter. Convergent transcription is associated with a distinctive chromatin configuration and is characteristic of lower-expressed genes. Integration of NET-seq with genomic footprinting data reveals stereotypic Pol II pausing coincident with transcription factor occupancy. Finally, exons retained in mature transcripts display Pol II pausing signatures that differ markedly from skipped exons, indicating an intrinsic capacity for Pol II to recognize exons with different processing fates. Together, human NET-seq exposes the topography and regulatory complexity of human gene expression.	[Mayer, Andreas; di Iulio, Julia; Maleri, Seth; Eser, Umut; Churchman, L. Stirling] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Vierstra, Jeff; Reynolds, Alex; Sandstrom, Richard; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98104 USA; [Stamatoyannopoulos, John A.] Univ Washington, Div Oncol, Dept Med, Seattle, WA 98104 USA	Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Churchman, LS (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	churchman@genetics.med.harvard.edu	Mayer, Andreas/AAA-5173-2021	DI IULIO, JULIA/0000-0001-9343-127X; Sandstrom, Richard/0000-0002-3356-1547; Mayer, Andreas/0000-0002-4532-9382; Vierstra, Jeff/0000-0001-6406-8563	US National Institutes of Health NHGRI [R01HG007173, U54HG007010]; Damon Runyon Dale F. Frey Award; Burroughs Wellcome Fund Career Award; Long-Term Postdoctoral Fellowships of the Human Frontier Science Program [LT000314/2013-L]; EMBO [ALTF858-2012]; Swiss National Science Foundation Postdoc Mobility Fellowship; US National Science Foundation Graduate Research Fellowship [DGE-071824]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010, R01HG007173] Funding Source: NIH RePORTER	US National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Damon Runyon Dale F. Frey Award; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Long-Term Postdoctoral Fellowships of the Human Frontier Science Program; EMBO(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation Postdoc Mobility Fellowship; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank F. Winston, J. Gray, M. Couvillion, S. Doris, and E. Feinberg for critical comments on the manuscript. We thank J. Gray and A. Snavely for help with eRNA analysis. We thank F. Winston, K. Struhl, S. Buratowski, A. Ciuffi, and A. Regev for advice and discussions. We thank M. Gebremeskel for tissue culture support; K. Waraska at the HMS Biopolymers Facility and Z. Herbert at the DFCI Molecular Biology Core Facilities for sequencing; and N. Pho and B.D. Kim at HMS Research Computing for computing support. This work was supported by US National Institutes of Health NHGRI grants R01HG007173 to L.S.C. and U54HG007010 to J.A.S.; a Damon Runyon Dale F. Frey Award for Breakthrough Scientists (to L.S.C.); and a Burroughs Wellcome Fund Career Award at the Scientific Interface (to L.S.C). A.M. was supported by Long-Term Postdoctoral Fellowships of the Human Frontier Science Program (LT000314/2013-L) and EMBO (ALTF858-2012). J.d.I. was supported by the Swiss National Science Foundation Postdoc Mobility Fellowship. J.V. was supported by US National Science Foundation Graduate Research Fellowship under grant DGE-071824.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; CAI H, 1987, J BIOL CHEM, V262, P298; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davis-Turak JC, 2015, NUCLEIC ACIDS RES, V43, P699, DOI 10.1093/nar/gku1338; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Dujardin G, 2013, BBA-GENE REGUL MECH, V1829, P134, DOI 10.1016/j.bbagrm.2012.08.005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrari F, 2013, CELL REP, V5, P629, DOI 10.1016/j.celrep.2013.09.037; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lis JT, 2000, GENE DEV, V14, P792; MAIZELS NM, 1973, P NATL ACAD SCI USA, V70, P3585, DOI 10.1073/pnas.70.12.3585; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Skene PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02042; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	81	211	213	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					541	554		10.1016/j.cell.2015.03.010	http://dx.doi.org/10.1016/j.cell.2015.03.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910208	Green Accepted, Bronze			2022-12-28	WOS:000353553600014
J	Parker, IM; Saunders, M; Bontrager, M; Weitz, AP; Hendricks, R; Magarey, R; Suiter, K; Gilbert, GS				Parker, Ingrid M.; Saunders, Megan; Bontrager, Megan; Weitz, Andrew P.; Hendricks, Rebecca; Magarey, Roger; Suiter, Karl; Gilbert, Gregory S.			Phylogenetic structure and host abundance drive disease pressure in communities	NATURE			English	Article							INFECTIOUS-DISEASES; TROPICAL FOREST; PLANT-DISEASE; BIODIVERSITY; PATHOGENS; ECOLOGY; HERBIVORES; EMERGENCE; ESCAPE; SIGNAL	Pathogens play an important part in shaping the structure and dynamics of natural communities, because species are not affected by them equally(1,2). A shared goal of ecology and epidemiology is to predict when a species is most vulnerable to disease. A leading hypothesis asserts that the impact of disease should increase with host abundance, producing a 'rare-species advantage'(3-5). However, the impact of a pathogen may be decoupled from host abundance, because most pathogens infect more than one species, leading to pathogen spillover onto closely related species(6,7). Here we show that the phylogenetic and ecological structure of the surrounding community can be important predictors of disease pressure. We found that the amount of tissue lost to disease increased with the relative abundance of a species across a grassland plant community, and that this rare-species advantage had an additional phylogenetic component: disease pressure was stronger on species with many close relatives. We used a global model of pathogen sharing as a function of relatedness between hosts, which provided a robust predictor of relative disease pressure at the local scale. In our grassland, the total amount of disease was most accurately explained not by the abundance of the focal host alone, but by the abundance of all species in the community weighted by their phylogenetic distance to the host. Furthermore, the model strongly predicted observed disease pressure for 44 novel host species we introduced experimentally to our study site, providing evidence for a mechanism to explain why phylogenetically rare species are more likely to become invasive when introduced(8,9). Our results demonstrate how the phylogenetic and ecological structure of communities can have a key role in disease dynamics, with implications for the maintenance of biodiversity, biotic resistance against introduced weeds, and the success of managed plants in agriculture and forestry.	[Parker, Ingrid M.; Bontrager, Megan; Weitz, Andrew P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Parker, Ingrid M.; Gilbert, Gregory S.] Smithsonian Trop Res Inst, Balboa, Panama; [Saunders, Megan; Hendricks, Rebecca; Gilbert, Gregory S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Magarey, Roger; Suiter, Karl] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27606 USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Santa Cruz; University of North Carolina; North Carolina State University	Parker, IM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	imparker@ucsc.edu	Parker, Ingrid M./ABH-2014-2020	Parker, Ingrid M./0000-0002-4847-1827; Weitz, Andrew/0000-0001-9799-5574; Magarey, Roger/0000-0002-5651-5965	National Science Foundation [DEB-0842059, DEB-1136626]; G.S.G. [14-8130-1472-CA]; US Department of Agriculture APHIS-PPQ-CPHST PERAL [14-8130-1472-CA]; Direct For Biological Sciences [1136626] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); G.S.G.; US Department of Agriculture APHIS-PPQ-CPHST PERAL; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Webb for development of the methods of phylogenetic ecology. We thank J. Velzy for greenhouse support and the many undergraduates and volunteers who helped with fieldwork and disease assessments from scanned leaves. Editorial comments were provided by M. Kilpatrick, B. Lyon, C. Fresquez, D. Gordon, S. Grove, S. Gulamhussein, J. Harrower, C. Ray, K. Ross and M. Shu; K. Tanner revised Fig. 1. This research was funded by National Science Foundation grants DEB-0842059 and DEB-1136626, and by a Cooperative Agreement 14-8130-1472-CA between G.S.G. and US Department of Agriculture APHIS-PPQ-CPHST PERAL funded from Section 10201 of the Farm Bill.	Alexander HM, 2010, PLANT DIS, V94, P492, DOI 10.1094/PDIS-94-5-0492; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2008, ASSESS 2 0 IMAGE ANA; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; CONNELL J H, 1971, P298; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Elton C. S., 1958, ECOLOGY INVASIONS AN; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert GS, 2012, EVOL APPL, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; Gilbert GS, 2010, EVOL APPL, V3, P144, DOI 10.1111/j.1752-4571.2009.00107.x; GILLETT J. B., 1962, SYST ASS PUBLICATION, V4, P37; Goodell K, 2000, INCORPORATING SCIENCE ECONOMICS AND SOCIOLOGY IN DEVELOPING SANITARY AND PHYTOSANITARY STANDARDS IN INTERNATIONAL TRADE: PROCEEDINGS OF A CONFENENCE, P87; Haff TM, 2008, NATURAL HIST UC SANT; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Mack R. N., 1996, Proceedings of the 9th international symposium on biological control of weeds, Stellenbosch, South Africa, 19-26 January 1996., P39; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; SAWYER J.O., 2012, JEPSON MANUAL VASCUL, P1152; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x	37	193	199	14	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					542	+		10.1038/nature14372	http://dx.doi.org/10.1038/nature14372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903634	Green Published			2022-12-28	WOS:000353334500043
J	Appleby, J				Appleby, John			Manifesto pledges: more money for the NHS ... problem solved?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J, 2015, NHS COAL GOVT 2; Appleby J, 2014, NHS PROD CHALL EXP F; Conservative Party, 2015, MANIFESTO; Department of Health, ANN REP ACC 2013 14; Ipsos-Mori, POL MON APR 2015; NHS England, 2014, BOARD M MAY; NHS England, 2014, 5 YEAR FORW VIEW; NHS England, 2015, CONS 2014 15 FIN REP; Office for Budget Responsibility, 2014, FISCAL SUST REP	9	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h2109	10.1136/bmj.h2109	http://dx.doi.org/10.1136/bmj.h2109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25904539				2022-12-28	WOS:000353576700011
J	Odden, MC; Pletcher, MJ; Coxson, PG; Thekkethala, D; Guzman, D; Heller, D; Goldman, L; Bibbins-Domingo, K				Odden, Michelle C.; Pletcher, Mark J.; Coxson, Pamela G.; Thekkethala, Divya; Guzman, David; Heller, David; Goldman, Lee; Bibbins-Domingo, Kirsten			Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; GLOBAL BURDEN; STROKE INCIDENCE; PREDICTIVE-VALUE; ISCHEMIC-STROKE; RISK; CHOLESTEROL; THERAPY	Background: Evidence to guide primary prevention in adults aged 75 years or older is limited. Objective: To project the population impact and cost-effectiveness of statin therapy in adults aged 75 years or older. Design: Forecasting study using the Cardiovascular Disease Policy Model, a Markov model. Data Sources: Trial, cohort, and nationally representative data sources. Target Population: U.S. adults aged 75 to 94 years. Time Horizon: 10 years. Perspective: Health care system. Intervention: Statins for primary prevention based on low-density lipoprotein cholesterol threshold of 4.91 mmol/L (190 mg/dL), 4.14 mmol/L (160 mg/dL), or 3.36 mmol/L (130 mg/dL); presence of diabetes; or 10-year risk score of at least 7.5%. Outcome Measures: Myocardial infarction (MI), coronary heart disease (CHD) death, disability-adjusted life-years, and costs. Results of Base-Case Analysis: All adults aged 75 years or older in the National Health and Nutrition Examination Survey have a 10-year risk score greater than 7.5%. If statins had no effect on functional limitation or cognitive impairment, all primary prevention strategies would prevent MIs and CHD deaths and be cost-effective. Treatment of all adults aged 75 to 94 years would result in 8 million additional users and prevent 105 000 (4.3%) incident MIs and 68 000 (2.3%) CHD deaths at an incremental cost per disability-adjusted life-year of $25 200. Results of Sensitivity Analysis: An increased relative risk for functional limitation or mild cognitive impairment of 1.10 to 1.29 could offset the cardiovascular benefits. Limitation: Limited trial evidence targeting primary prevention in adults aged 75 years or older. Conclusion: At effectiveness similar to that in trials, statins are projected to be cost-effective for primary prevention; however, even a small increase in geriatric-specific adverse effects could offset the cardiovascular benefit. Improved data on the potential benefits and harms of statins are needed to inform decision making.	[Odden, Michelle C.] Oregon State Univ, Corvallis, OR 97331 USA; [Pletcher, Mark J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; Columbia Univ, New York, NY USA	Oregon State University; University of California System; University of California San Francisco; Columbia University	Odden, MC (corresponding author), Oregon State Univ, 141B Milam Hall, Corvallis, OR 97331 USA.			Heller, David/0000-0003-0060-8393	American Heart Association Western States Affiliate; National Institute on Aging; National Institute for Diabetes on Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK103992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG039387] Funding Source: NIH RePORTER	American Heart Association Western States Affiliate(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Diabetes on Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	American Heart Association Western States Affiliate, National Institute on Aging, and the National Institute for Diabetes on Digestive and Kidney Diseases.	Agency for Healthcare Research and Quality, 2014, MED EXP PAN SURV PUB; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; [Anonymous], 2000, CAL PAT DISCH DAT JA; Appelros P, 2011, ACTA NEUROL SCAND, V124, P383, DOI 10.1111/j.1600-0404.2011.01500.x; Average Cost to Community Hospitals per Patient, 1998, STAT ANSTR US BUR CE, P136; BEHAR S, 1991, AM J MED, V91, P45, DOI 10.1016/0002-9343(91)90072-6; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Bureau of Labor Statistics: U.S. Department of Labor, 2014, CONS PRIC IND; California Office of Statewide Health Planning and Development, 2008, ANN FIN DAT; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Center for Disease Control and Prevention (CDC), 2021, NATL HLTH NUTR EXAMI; Centers for Medicare & Medicaid Services, 2015, NAT PHYS FEE SCHED 2; Centers for Medicare & Medicaid Services, 2014, NAT AV DRUG ACQ COST; Centers for Medicare & Medicaid Services, 2000, PERS HLTH CAR SPEND; Centers for Medicare & Medicaid Services, 2014, CLIN LAB FEE SCHED 2; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ford ES, 2003, ETHNIC DIS, V13, P85; Freedman VA, 2013, DEMOGRAPHY, V50, P661, DOI 10.1007/s13524-012-0167-z; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Groeneveld PW, 2003, CIRCULATION, V108, P286, DOI 10.1161/01.CIR.0000079164.95019.5A; Gross R, 1996, Public Health Rev, V24, P167; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lakshminarayan K, 2011, STROKE, V42, P1556, DOI 10.1161/STROKEAHA.110.605600; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Lee DSH, 2014, JAMA INTERN MED, V174, P1263, DOI 10.1001/jamainternmed.2014.2266; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lo-Ciganic WH, 2013, ANN PHARMACOTHER, V47, P984, DOI 10.1345/aph.1S050; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Center for Health Statistics, 2012, CDC WONDER DAT; National Center for Health Statistics, 2012, NAT HLTH INT SURV 20; National Center for Health Statistics, 2010, NAT HOSP DISCH SURV; National Center for Health Statistics, 2004, ICD 10 COD; Packer M, 1999, AM J CARDIOL, V83, p1A; Padala KP, 2010, J AM GERIATR SOC, V58, P1214, DOI 10.1111/j.1532-5415.2010.02889.x; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pletcher MJ, 2014, CIRC-CARDIOVASC QUAL, V7, P276, DOI 10.1161/CIRCOUTCOMES.113.000799; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Rieves D, 2000, AM J CARDIOL, V85, P147, DOI 10.1016/S0002-9149(99)00652-9; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Schiattarella Gabriele Giacomo, 2012, Aging Clin Exp Res, V24, P47; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Society for Post-Acute and Long-Term Care Medicine, 2013, 5 THINGS PHYS PAT SH; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; U.S. Census Bureau, 2011, MONTH RES POP SINGL; U.S. Census Bureau, 2012, PROJ POP SINGL YEAR; U.S. Census Bureau, 2012, METH ASS 2012 NAT PR; Vaccarino V, 2009, ARCH INTERN MED, V169, P1767, DOI 10.1001/archinternmed.2009.332; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006	80	82	82	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					533	+		10.7326/M14-1430	http://dx.doi.org/10.7326/M14-1430			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4GT	25894023	Green Accepted			2022-12-28	WOS:000353244300013
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Stop relying on charity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Breakthrough Breast Cancer, 2013, ANN REP ACC 2012 201; Cancer Research UK, 2014, CANC INC MORT UK; Charities Aid Foundation, 2015, UK GIV 2014; Li Y, 2015, HDB RES METHODS APPL; Roy Castle Lung Cancer Foundation, 2013, REP FIN STAT YEAR EN; University of Manchester, 2013, POOR MOR GEN RICH RE	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2015	350								h2034	10.1136/bmj.h2034	http://dx.doi.org/10.1136/bmj.h2034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8PY	25896975	Bronze			2022-12-28	WOS:000353572900003
J	Sennett, R; Rendl, M				Sennett, Rachel; Rendl, Michael			A scar is born: Origins of fibrotic skin tissue	SCIENCE			English	Editorial Material							FIBROBLAST HETEROGENEITY		[Sennett, Rachel; Rendl, Michael] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Sennett, Rachel; Rendl, Michael] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Rendl, Michael] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sennett, R (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	michael.rendl@mssm.edu		Rendl, Michael/0000-0001-6326-620X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR065847, R01AR059143, R01AR063151] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063151, R01AR063151, F30AR065847, R01AR059143, R01 AR059143] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; O'Sullivan B, 2003, SEMIN RADIAT ONCOL, V13, P274, DOI 10.1016/S1053-4296(03)00037-7; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786	11	7	7	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					284	285		10.1126/science.aab0120	http://dx.doi.org/10.1126/science.aab0120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883341				2022-12-28	WOS:000352999000020
J	Gupta, V; Sugg, N; Butners, M; Allen-White, G; Molnar, A				Gupta, Vin; Sugg, Nancy; Butners, Marite; Allen-White, Gillian; Molnar, Alexandra			Tuberculosis among the Homeless - Preventing Another Outbreak through Community Action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION		[Gupta, Vin] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Gupta, Vin; Sugg, Nancy; Molnar, Alexandra] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; [Butners, Marite] Butners Consulting Serv, Seattle, WA USA; [Allen-White, Gillian] Grand Cent Bakery, Seattle, WA USA	Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle	Gupta, V (corresponding author), Brigham & Womens Hosp, Dept Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.			Molnar, Alexandra/0000-0003-3258-6782				Centers for Disease Control and Prevention, 2012, TB NOTES NEWSL; Centers for Disease Control and Prevention, 2014, REP TUB US; Dye C, 2011, NEW ENGL J MED, V365, P2230, DOI 10.1056/NEJMe1111859; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875	5	17	18	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1483	1485		10.1056/NEJMp1501316	http://dx.doi.org/10.1056/NEJMp1501316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9BL	25875254	Bronze			2022-12-28	WOS:000352856500002
J	Liu, V; Musen, MA; Chou, T				Liu, Vincent; Musen, Mark A.; Chou, Timothy			Data Breaches of Protected Health Information in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SYSTEM		[Liu, Vincent] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Musen, Mark A.] Stanford Ctr Biomed Informat Res, Stanford, CA USA; [Chou, Timothy] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Kaiser Permanente; Stanford University	Liu, V (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	vincent.x.liu@kp.org		Musen, Mark/0000-0003-3325-793X	NIGMS NIH HHS [K23 GM112018] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM112018] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler-Milstein J, 2012, JAMA-J AM MED ASSOC, V307, P1695, DOI 10.1001/jama.2012.525; Blumenthal D, 2011, NEW ENGL J MED, V365, P2323, DOI 10.1056/NEJMsr1110507; Schneeweiss S, 2014, NEW ENGL J MED, V370, P2161, DOI 10.1056/NEJMp1401111; Symantec Corporation, 2013, 2013 COST DAT BREACH; U. S. Department of Health and Human Services Office for Civil Rights, BREACH AFF 500 MOR I	5	69	69	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1471	1473		10.1001/jama.2015.2252	http://dx.doi.org/10.1001/jama.2015.2252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871675	Green Accepted, Bronze			2022-12-28	WOS:000352821200025
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Forever indebted to pharma-doctors must take control of our own education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2015	350								h1965	10.1136/bmj.h1965	http://dx.doi.org/10.1136/bmj.h1965			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JE	25869648	Bronze			2022-12-28	WOS:000353326800008
J	Chappell, LC; Milne, F; Shennan, A				Chappell, Lucy C.; Milne, Fiona; Shennan, Andrew			Is early induction or expectant management more beneficial in women with late preterm pre-eclampsia?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chappell, Lucy C.; Shennan, Andrew] Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England; [Milne, Fiona] Act Preeclampsia, Evesham, England	University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk		Shennan, Andrew/0000-0001-5273-3132	National Institute for Health Research [RP-2014-05-019, 12/25/03] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X; Churchill D, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003106.PUB2.SEE; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Langenveld J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-50; Myatt L, 2014, HYPERTENSION, V63, P1293, DOI 10.1161/HYPERTENSIONAHA.113.02664; National Institute for Health and Clinical Excellence, 2010, CG107 NAT I HLTH CLI; Owens Michelle Y, 2014, J Miss State Med Assoc, V55, P208; Reddy UM, 2009, PEDIATRICS, V124, P234, DOI 10.1542/peds.2008-3232; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7	13	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2015	350								h191	10.1136/bmj.h191	http://dx.doi.org/10.1136/bmj.h191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VS	25861796				2022-12-28	WOS:000352915900001
J	Maire, T; Youk, H				Maire, Theo; Youk, Hyun			A Collective Path toward Regeneration	CELL			English	Editorial Material								How do cells collectively control an organ's behavior? By plucking various numbers of hairs from the mouse skin, Chen et al. show that hairs regenerate only when a sufficiently high density of them are plucked. Remarkably, a hair follicle can only regenerate in concert with other follicles, but not autonomously.	[Maire, Theo; Youk, Hyun] Delft Univ Technol, Dept Bionanosci, NL-2628 CJ Delft, Netherlands; [Maire, Theo; Youk, Hyun] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology; Delft University of Technology	Youk, H (corresponding author), Delft Univ Technol, Dept Bionanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	h.youk@tudelft.nl	Youk, Hyun/E-2661-2016	Youk, Hyun/0000-0003-1687-5760				Chen CC, 2015, CELL, V161, P277, DOI 10.1016/j.cell.2015.02.016; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; Hart Y, 2014, CELL, V158, P1022, DOI 10.1016/j.cell.2014.07.033; Jahoda CAB, 2011, CELL, V146, P678, DOI 10.1016/j.cell.2011.08.020; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pai A, 2014, ACS SYNTH BIOL, V3, P220, DOI 10.1021/sb400069w; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Sgro AE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145352; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782	9	2	2	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					195	196		10.1016/j.cell.2015.03.039	http://dx.doi.org/10.1016/j.cell.2015.03.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860601	Bronze			2022-12-28	WOS:000352708300011
J	Davies, JI; Meara, JG				Davies, Justine I.; Meara, John G.			Global surgery-going beyond the Lancet Commission	LANCET			English	Editorial Material							HEALTH		[Davies, Justine I.] The Lancet, London, England; [Meara, John G.] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Global Surg & Social Change, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Meara, JG (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Global Surg & Social Change, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu		Davies, Justine/0000-0001-6834-1838; Meara, John G./0000-0003-4369-3209				Canfin P, 2013, LANCET, V381, P1885, DOI 10.1016/S0140-6736(13)60952-6; Debas HT, 2015, DIS CONTROL PRIORITI, V1; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Makasa EM, 2014, LANCET, V384, P1748, DOI 10.1016/S0140-6736(14)62012-2; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X	6	17	18	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					507	509		10.1016/S0140-6736(15)60465-2	http://dx.doi.org/10.1016/S0140-6736(15)60465-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	25924835				2022-12-28	WOS:000359431900005
J	Ardehali, A; Esmailian, F; Deng, M; Soltesz, E; Hsich, E; Naka, Y; Mancini, D; Camacho, M; Zucker, M; Leprince, P; Padera, R; Kobashigawa, J				Ardehali, Abbas; Esmailian, Fardad; Deng, Mario; Soltesz, Edward; Hsich, Eileen; Naka, Yoshifumi; Mancini, Donna; Camacho, Margarita; Zucker, Mark; Leprince, Pascal; Padera, Robert; Kobashigawa, Jon		PROCEED II Trial Investigators	Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial	LANCET			English	Article							ORGAN CARE SYSTEM; MACHINE PERFUSION; ISCHEMIC TIME; PRESERVATION; SURVIVAL; AUTOPERFUSION; ALLOCATION; OUTCOMES; STORAGE; LUNGS	Background The Organ Care System is the only clinical platform for ex-vivo perfusion of human donor hearts. The system preserves the donor heart in a warm beating state during transport from the donor hospital to the recipient hospital. We aimed to assess the clinical outcomes of the Organ Care System compared with standard cold storage of human donor hearts for transplantation. Methods We did this prospective, open-label, multicentre, randomised non-inferiority trial at ten heart-transplant centres in the USA and Europe. Eligible heart-transplant candidates (aged >18 years) were randomly assigned (1: 1) to receive donor hearts preserved with either the Organ Care System or standard cold storage. Participants, investigators, and medical staff were not masked to group assignment. The primary endpoint was 30 day patient and graft survival, with a 10% non-inferiority margin. We did analyses in the intention-to-treat, as-treated, and per-protocol populations. This trial is registered with ClinicalTrials.gov, number NCT00855712. Findings Between June 29, 2010, and Sept 16, 2013, we randomly assigned 130 patients to the Organ Care System group (n=67) or the standard cold storage group (n=63). 30 day patient and graft survival rates were 94% (n=63) in the Organ Care System group and 97% (n=61) in the standard cold storage group (difference 2.8%, one-sided 95% upper confidence bound 8.8; p=0.45). Eight (13%) patients in the Organ Care System group and nine (14%) patients in the standard cold storage group had cardiac-related serious adverse events. Interpretation Heart transplantation using donor hearts adequately preserved with the Organ Care System or with standard cold storage yield similar short-term clinical outcomes. The metabolic assessment capability of the Organ Care System needs further study. Funding TransMedics.	[Ardehali, Abbas; Deng, Mario] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90049 USA; [Esmailian, Fardad; Kobashigawa, Jon] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Soltesz, Edward; Hsich, Eileen] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Naka, Yoshifumi; Mancini, Donna] Columbia Univ, Med Ctr, New York, NY USA; [Camacho, Margarita; Zucker, Mark] Newark Beth Israel Med Ctr, St Barnabas Heart Ctr, Newark, NJ USA; [Leprince, Pascal] Hop La Pitie Salpetriere, Paris, France; [Padera, Robert] Brigham & Womens Hosp, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cedars Sinai Medical Center; Cleveland Clinic Foundation; Columbia University; Newark Beth Israel Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital	Ardehali, A (corresponding author), Univ Calif Los Angeles, Med Ctr, Div Cardiac Surg, Los Angeles, CA 90049 USA.	aardehali@mednet.ucla.edu		Kobashigawa, Jon/0000-0001-9308-3172; LIVI, Ugolino/0000-0003-1394-736X; Zucker, Mark/0000-0002-2999-0146	TransMedics	TransMedics	TransMedics.	Banner NR, 2008, TRANSPLANTATION, V86, P542, DOI 10.1097/TP.0b013e31818149b9; CHIEN S, 1991, J HEART LUNG TRANSPL, V10, P401; CHIEN S, 1988, J THORAC CARDIOV SUR, V95, P55; Dhital KK, 2015, LANCET; Hamed A, 2009, J HEART LUNG TRANSPL, V28, pS71, DOI 10.1016/j.healun.2008.11.025; HARDESTY RL, 1987, J THORAC CARDIOV SUR, V93, P11; Hassanein WH, 1998, J THORAC CARDIOV SUR, V116, P821, DOI 10.1016/S0022-5223(98)00452-8; Hunt SA, 2008, J AM COLL CARDIOL, V52, P587, DOI 10.1016/j.jacc.2008.05.020; Hunt SA, 2006, NEW ENGL J MED, V355, P231, DOI 10.1056/NEJMp068048; Kobashigawa JA, 2015, AM J TRANSPLANT, V15, P55, DOI 10.1111/ajt.13033; Koemer MM, 2014, HEART SURG FORUM, V3, P141; Krakauer H, 2005, J HEART LUNG TRANSPL, V24, P680, DOI 10.1016/j.healun.2004.04.015; Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003; Messer S, 2015, TRANSPL INT, V28, P634, DOI 10.1111/tri.12361; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; Parolari A, 2002, ANN THORAC SURG, V73, P682, DOI 10.1016/S0003-4975(01)03029-6; Rosenstrauch D, 2003, TEX HEART I J, V30, P121; Russo MJ, 2007, J THORAC CARDIOV SUR, V133, P554, DOI 10.1016/j.jtcvs.2006.09.019; Russo MJ, 2010, TRANSPLANTATION, V90, P444, DOI 10.1097/TP.0b013e3181e6f1eb; Saez DG, 2014, ANN THORAC SURG, V98, P2099, DOI 10.1016/j.athoracsur.2014.06.098; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Van Raemdonck D, 2013, CURR OPIN ORGAN TRAN, V18, P24, DOI 10.1097/MOT.0b013e32835c494f; Warnecke G, 2012, LANCET, V380, P1851, DOI 10.1016/S0140-6736(12)61344-0; Yeen W, 2013, TRANSPL P, V45, P2399, DOI 10.1016/j.transproceed.2013.04.003	24	260	269	3	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2577	2584		10.1016/S0140-6736(15)60261-6	http://dx.doi.org/10.1016/S0140-6736(15)60261-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25888086				2022-12-28	WOS:000356930000024
J	Goede, V; Hallek, M				Goede, Valentin; Hallek, Michael			Towards improved frontline treatment of CLL in the elderly	LANCET			English	Editorial Material							CHRONIC LYMPHOCYTIC-LEUKEMIA; FLUDARABINE PLUS CYCLOPHOSPHAMIDE; INITIAL THERAPY; OPEN-LABEL; CHLORAMBUCIL; OBINUTUZUMAB; RITUXIMAB		[Goede, Valentin; Hallek, Michael] Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol Cologne Bonn, German CLL Study Grp, D-50924 Cologne, Germany	University of Cologne	Goede, V (corresponding author), Univ Cologne, Dept Internal Med 1, Ctr Integrated Oncol Cologne Bonn, German CLL Study Grp, D-50924 Cologne, Germany.	valentin.goede@uk-koeln.de	Hallek, Michael/Y-3191-2019	Hallek, Michael/0000-0002-7425-4455				Badoux XC, 2011, BLOOD, V118, P3489, DOI 10.1182/blood-2011-03-339077; Baumann T, 2014, HAEMATOLOGICA, V99, P1599, DOI 10.3324/haematol.2014.107326; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; Flinn IW, 2007, J CLIN ONCOL, V25, P793, DOI 10.1200/JCO.2006.08.0762; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Goede V, 2015, LEUKEMIA, V29, P1602, DOI 10.1038/leu.2015.14; Goede V, 2014, HAEMATOLOGICA, V99, P1095, DOI 10.3324/haematol.2013.096792; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hillmen P, 2015, LANCET; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; O'Brien SG, 2014, BLOOD, V124; O'Brien S, 2014, LANCET ONCOL, V15, P48, DOI 10.1016/S1470-2045(13)70513-8; Zelenetz AD, 2014, BLOOD, V124	14	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1814	1815		10.1016/S0140-6736(15)60293-8	http://dx.doi.org/10.1016/S0140-6736(15)60293-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25882395				2022-12-28	WOS:000354184500009
J	Liu, YH; Zhang, XN; Han, C; Wan, GH; Huang, XX; Ivan, C; Jiang, DH; Rodriguez-Aguayo, C; Lopez-Berestein, G; Rao, PH; Maru, DM; Pahl, A; He, XM; Sood, AK; Ellis, LM; Anderl, J; Lu, XB				Liu, Yunhua; Zhang, Xinna; Han, Cecil; Wan, Guohui; Huang, Xingxu; Ivan, Cristina; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Rao, Pulivarthi H.; Maru, Dipen M.; Pahl, Andreas; He, Xiaoming; Sood, Anil K.; Ellis, Lee M.; Anderl, Jan; Lu, Xiongbin			TP53 loss creates therapeutic vulnerability in colorectal cancer	NATURE			English	Article							CRISPR-CAS9 SYSTEM; P53 PATHWAY; HUMAN-CELLS; AMANITIN; INHIBITION; PHENOTYPE	TP53, a well-known tumour suppressor gene that encodes p53, is frequently inactivated by mutation or deletion in most human tumours'''. A tremendous effort has been made to restore p53 activity in cancer therapies'''. However, no effective p53-based therapy has been successfully translated into clinical cancer treatment owing to the complexity of p53 signalling. Here we demonstrate that genomic deletion of TP53 frequently encompasses essential neighbouring genes, rendering cancer cells with hemizygous TP53 deletion vulnerable to further suppression of such genes. POLR2A is identified as such a gene that is almost always co-deleted with TP53 in human cancers. It encodes the largest and catalytic subunit of the RNA polymerase II complex, which is specifically inhibited by a-amanitin". Our analysis of The Cancer Genome Atlas (TCGA) and Cancer Cell Line Encyclopedia (CCLE) databases reveals that POLR2A expression levels are tightly correlated with its gene copy numbers in human colorectal cancer. Suppression of POLR2A with alpha-amanitin or small interfering RNAs selectively inhibits the proliferation, survival and tumorigenic potential of colorectal cancer cells with hemizygous TP53 loss in a p53-independent manner. Previous clinical applications of a-amanitin have been limited owing to its liver toxicity'. However, we found that alpha-amanitin-based antibody-drug conjugates are highly effective therapeutic agents with reduced toxicity". Here we show that low doses of alpha-amanitin-conjugated anti-epithelial cell adhesion molecule (EpCAM) antibody lead to complete tumour regression in mouse models of human colorectal cancer with hemizygous deletion of POLR2A. We anticipate that inhibiting POLR2A will be a new therapeutic approach for human cancers containing such common genomic alterations.	[Liu, Yunhua; Han, Cecil; Wan, Guohui; Sood, Anil K.; Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Xinna; Ivan, Cristina; Jiang, Dahai; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynaecol Oncol & Reprod Med, Houston, TX 77030 USA; [Zhang, Xinna; Ivan, Cristina; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.; Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Rao, Pulivarthi H.] Baylor Coll Med, Dept Paediat, Houston, TX 77030 USA; [Maru, Dipen M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Pahl, Andreas; Anderl, Jan] Heidelberg Pharma GmbH, D-68526 Ladenburg, Germany; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; ShanghaiTech University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Lu, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	xlu2@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; Wan, Guohui/G-3904-2011; He, Xiaoming/C-5499-2008; Liu, Yunhua/I-8149-2015	Sood, Anoop Kumar/0000-0001-5702-4108; Wan, Guohui/0000-0001-5170-7282; He, Xiaoming/0000-0003-0125-6086; huang, xingxu/0000-0001-8934-1247; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Ivan, Cristina/0000-0002-4848-0168	National Institutes of Health (NIH), MD Anderson Moon Shots Program [R01 CA136549]; NIH [U54 CA151668]; NATIONAL CANCER INSTITUTE [R21CA185742, U54CA151668, R01CA136549, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH), MD Anderson Moon Shots Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Zhang and I. J. Fidler for technical support in orthotopic tumour experiments. We thank L. Huang and M. Bar-Eli for lentivirus production. This work was supported by grants to X.L. (National Institutes of Health (NIH) R01 CA136549, MD Anderson Moon Shots Program) and to A.K.S. (NIH U54 CA151668).	Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; FAULSTICH H, 1985, METHOD ENZYMOL, V112, P225, DOI 10.1016/S0076-6879(85)12019-7; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Haupt S, 2004, SEMIN CANCER BIOL, V14, P244, DOI 10.1016/j.semcancer.2004.04.003; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu YH, 2012, J VIROL, V86, P1372, DOI 10.1128/JVI.06245-11; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026	28	150	158	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					697	U286		10.1038/nature14418	http://dx.doi.org/10.1038/nature14418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901683	Green Accepted			2022-12-28	WOS:000353689700054
J	Yang, S				Yang, Shu			Supramolecular lattices from tetrahedral nanobuilding blocks	SCIENCE			English	Editorial Material							CRYSTALLINE; PHASES		Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Yang, S (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	shuyang@seas.upenn.edu	Yang, Shu/D-9758-2011	Yang, Shu/0000-0001-8834-3320				Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Dai JY, 2006, CHEM MATER, V18, P3404, DOI 10.1021/cm052452m; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487; Grason GM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058304; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Huang MJ, 2015, SCIENCE, V348, P424, DOI 10.1126/science.aaa2421; Lee S, 2014, P NATL ACAD SCI USA, V111, P17723, DOI 10.1073/pnas.1408678111; Ziherl P, 2001, J PHYS CHEM B, V105, P10147, DOI 10.1021/jp010944q	10	6	6	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					396	397		10.1126/science.aab0478	http://dx.doi.org/10.1126/science.aab0478			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908809				2022-12-28	WOS:000353338000018
J	Kaye, TL; O'Connor, A; Burke, D; Tolan, DJM				Kaye, Tom L.; O'Connor, Anthony; Burke, Dermot; Tolan, Damian J. M.			A young woman with recurrent perianal sepsis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FISTULIZING CROHNS-DISEASE; IN-ANO; INFLIXIMAB; FISTULAS; MRI; ENDOSONOGRAPHY; FISTULOGRAPHY; DIAGNOSIS		[Kaye, Tom L.; Tolan, Damian J. M.] St James Univ Hosp, Dept Radiol, Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England; [O'Connor, Anthony] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Dept Gastroenterol, Leeds LS9 7TF, W Yorkshire, England; [Burke, Dermot] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Dept Surg, Gastrointestinal Surg, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Kaye, TL (corresponding author), St James Univ Hosp, Dept Radiol, Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England.	thomas.kaye@nhs.net	Tolan, Damian/HHN-4673-2022	Burke, Dermot/0000-0002-4342-7464				Bleier JIS, 2010, DIS COLON RECTUM, V53, P43, DOI 10.1007/DCR.0b013e3181bb869f; Bouguen G, 2013, CLIN GASTROENTEROL H, V11, P975, DOI 10.1016/j.cgh.2012.12.042; Buchanan G, 2002, LANCET, V360, P1661, DOI 10.1016/S0140-6736(02)11605-9; Buchanan GN, 2004, RADIOLOGY, V233, P674, DOI 10.1148/radiol.2333031724; CHOEN S, 1991, BRIT J SURG, V78, P445, DOI 10.1002/bjs.1800780418; Criado JD, 2012, RADIOGRAPHICS, V32, P175, DOI 10.1148/rg.321115040; Halligan S, 2006, RADIOLOGY, V239, P18, DOI 10.1148/radiol.2391041043; Hamadani A, 2009, DIS COLON RECTUM, V52, P217, DOI 10.1007/DCR.0b013e31819a5c52; Hammond TM, 2006, COLORECTAL DIS, V8, P328, DOI 10.1111/j.1463-1318.2005.00926.x; Jacob TJ, 2010, COCHRANE DB SYST REV, V5; KUIJPERS HC, 1985, DIS COLON RECTUM, V28, P103, DOI 10.1007/BF02552656; Mardini Houssam E, 2007, Curr Treat Options Gastroenterol, V10, P211, DOI 10.1007/s11938-007-0014-2; Morris Y, 2000, RADIOGRAPHICS, V20, P623, DOI 10.1148/radiographics.20.3.g00mc15623; O'Malley RB, 2012, AM J ROENTGENOL, V199, pW43, DOI 10.2214/AJR.11.8361; PARKS AG, 1976, BRIT J SURG, V63, P1, DOI 10.1002/bjs.1800630102; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; SCHRATTERSEHN AU, 1993, ENDOSCOPY, V25, P582, DOI 10.1055/s-2007-1010409; Schwartz DA, 2002, GASTROENTEROLOGY, V122, P875, DOI 10.1053/gast.2002.32362; Simpson JA, 2012, BMJ-BRIT MED J, V345, pe6705; Soltani A, 2010, DIS COLON RECTUM, V53, P486, DOI 10.1007/DCR.0b013e3181ce8b01; Steele SR, 2011, DIS COLON RECTUM, V54, P1465, DOI 10.1097/DCR.0b013e31823122b3; Szurowska E, 2007, ABDOM IMAGING, V32, P705, DOI 10.1007/s00261-007-9188-2; Van Assche G, 2003, AM J GASTROENTEROL, V98, P332, DOI 10.1016/S0002-9270(02)05909-9; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; WEISMAN RI, 1991, DIS COLON RECTUM, V34, P181, DOI 10.1007/BF02049995; Zawadzki A, 2012, COLORECTAL DIS, V14, pe608, DOI 10.1111/j.1463-1318.2012.03047.x	27	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2015	350								h1969	10.1136/bmj.h1969	http://dx.doi.org/10.1136/bmj.h1969			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RA	25908600				2022-12-28	WOS:000353576800002
J	Rungta, RL; Choi, HB; Tyson, JR; Malik, A; Dissing-Olesen, L; Lin, PJC; Cain, SM; Cullis, PR; Snutch, TP; MacVicar, BA				Rungta, Ravi L.; Choi, Hyun B.; Tyson, John R.; Malik, Aqsa; Dissing-Olesen, Lasse; Lin, Paulo J. C.; Cain, Stuart M.; Cullis, Pieter R.; Snutch, Terrance P.; MacVicar, Brian A.			The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema	CELL			English	Article							SPREADING DEPRESSION; CHLORIDE TRANSPORTER; ANION-EXCHANGERS; BRAIN; EXPRESSION; SLC26A11; RELEASE; CALCIUM; SODIUM; NMDA	Cytotoxic brain edema triggered by neuronal swelling is the chief cause of mortality following brain trauma and cerebral infarct. Using fluorescence lifetime imaging to analyze contributions of intracellular ionic changes in brain slices, we find that intense Na+ entry triggers a secondary increase in intracellular Cl- that is required for neuronal swelling and death. Pharmacological and siRNA-mediated knockdown screening identified the ion exchanger SLC26A11 unexpectedly acting as a voltage-gated Cl- channel that is activated upon neuronal depolarization to membrane potentials lower than -20 mV. Blockade of SLC26A11 activity attenuates both neuronal swelling and cell death. Therefore cytotoxic neuronal edema occurs when sufficient Na+ influx and depolarization is followed by Cl- entry via SLC26A11. The resultant NaCl accumulation causes subsequent neuronal swelling leading to neuronal death. These findings shed light on unique elements of volume control in excitable cells and lay the ground for the development of specific treatments for brain edema.	[Rungta, Ravi L.; Choi, Hyun B.; Tyson, John R.; Malik, Aqsa; Dissing-Olesen, Lasse; Cain, Stuart M.; Snutch, Terrance P.; MacVicar, Brian A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 2B5, Canada; [Tyson, John R.; Cain, Stuart M.; Snutch, Terrance P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Lin, Paulo J. C.; Cullis, Pieter R.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 2B5, Canada.	bmacvicar@brain.ubc.ca	Snutch, Terrance P/L-3464-2019; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	Snutch, Terrance P/0000-0001-5182-1296; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Rungta, Ravi/0000-0003-3505-2743	Canadian Institutes of Health Research (CIHR); BC Epilepsy Society; CIHR [10677, 8545, 115121]; Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology; CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines [FRN:111627]; CRC in Neuroscience; Fondation Leducq; MIRI grant from Brain Canada; Genome British Columbia; Michael Smith Foundation for Health Research; Koerner Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Epilepsy Society; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology; CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines; CRC in Neuroscience; Fondation Leducq(Leducq Foundation); MIRI grant from Brain Canada; Genome British Columbia; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Koerner Foundation	R.L.R. was supported by a studentship from the Canadian Institutes of Health Research (CIHR), S.L.C. by a fellowship from the BC Epilepsy Society, T.P.S. by an operating grant from the CIHR (# 10677) and a Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology, P.R.C. by a CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines (FRN:111627) and B.A.M. by a CRC in Neuroscience and CIHR operating grants (# 8545 and # 115121) and the Fondation Leducq. We thank Dr. Xiling Zhou and Dr. Anne Marie Craig for supplying neuronal cultures and Jeff LeDue for assistance with establishing the FLIM methodology. We thank Kate Campbell for illustrations. The work was also supported by a MIRI grant from Brain Canada, Genome British Columbia, the Michael Smith Foundation for Health Research, and the Koerner Foundation. P.R.C. has greater than 5% ownership of Precision Nanosystems Inc. that makes the systems to formulate the lipid nanoparticles.	Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; AlvarezLeefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P1; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beierlein M, 2004, J NEUROPHYSIOL, V92, P591, DOI 10.1152/jn.00057.2004; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; CHOI DW, 1987, J NEUROSCI, V7, P369; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kajta M, 2005, DEV BRAIN RES, V160, P40, DOI 10.1016/j.devbrainres.2005.08.002; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HJ, 2012, OTOL NEUROTOL, V33, P1664, DOI 10.1097/MAO.0b013e31826bf3d3; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Miles R., 2012, JASPERS BASIC MECH E; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rahmati N, 2013, PFLUG ARCH EUR J PHY, V465, P1583, DOI 10.1007/s00424-013-1300-6; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Rungta RL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.65; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SMITH RL, 1995, J NEUROSCI, V15, P4057; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V301, pC289, DOI 10.1152/ajpcell.00089.2011; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Xu J, 2011, KIDNEY INT, V80, P926, DOI 10.1038/ki.2011.196; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	49	130	130	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					610	621		10.1016/j.cell.2015.03.029	http://dx.doi.org/10.1016/j.cell.2015.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910210	Bronze, Green Submitted			2022-12-28	WOS:000353553600019
J	Hawkes, N				Hawkes, Nigel			Patient safety team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Improving patient safety is a never ending quest. The shortlist for The BMJ Award for Patient Safety Team exemplifies how varied are the ways in which safety can be improved and outcomes bettered, says Nigel Hawkes. Two projects sought to enhance medical skills at the bedside to detect the deteriorating patient, two to reduce risks associated with innovation in treatments and in drug dispensing, and one to improve care of broken hip, a common misadventure of elderly people that too often leads to death.				nigel.hawkes1@btinternet.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h1922	10.1136/bmj.h1922	http://dx.doi.org/10.1136/bmj.h1922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25904558				2022-12-28	WOS:000353576700003
J	Bhagirath, V; Bosch, J; Eikelboom, J				Bhagirath, Vinai; Bosch, Jacqueline; Eikelboom, John			Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bhagirath, Vinai; Bosch, Jacqueline; Eikelboom, John] McMaster Univ, Hamilton, ON, Canada	McMaster University	Bhagirath, V (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Eikelboom, John/AAG-6117-2019; Bosch, Jacqueline/AAP-6910-2021	Eikelboom, John/0000-0003-4126-1285; Bosch, Jacqueline/0000-0001-6292-4207				Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC4	10.7326/ACPJC-2015-162-8-004	http://dx.doi.org/10.7326/ACPJC-2015-162-8-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894049				2022-12-28	WOS:000353244300003
J	Jain, A; Marshall, J; Buikema, A; Bancroft, T; Kelly, JP; Newschaffer, CJ				Jain, Anjali; Marshall, Jaclyn; Buikema, Ami; Bancroft, Tim; Kelly, Jonathan P.; Newschaffer, Craig J.			Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPECTRUM DISORDERS; SAFETY CONCERNS; MEASLES; RECURRENCE; MUMPS; RISK	IMPORTANCE Despite research showing no link between the measles-mumps-rubella (MMR) vaccine and autism spectrum disorders (ASD), beliefs that the vaccine causes autism persist, leading to lower vaccination levels. Parents who already have a child with ASD may be especially wary of vaccinations. OBJECTIVE To report ASD occurrence by MMR vaccine status in a large sample of US children who have older siblings with and without ASD. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study using an administrative claims database associated with a large commercial health plan. Participants included children continuously enrolled in the health plan from birth to at least 5 years of age during 2001-2012 who also had an older sibling continuously enrolled for at least 6 months between 1997 and 2012. EXPOSURES MMR vaccine receipt (0, 1, 2 doses) between birth and 5 years of age. MAIN OUTCOMES AND MEASURES ASD status defined as 2 claims with a diagnosis code in any position for autistic disorder or other specified pervasive developmental disorder (PDD) including Asperger syndrome, or unspecified PDD (International Classification of Diseases, Ninth Revision, Clinical Modification 299.0x, 299.8x, 299.9x). RESULTS Of 95 727 children with older siblings, 994 (1.04%) were diagnosed with ASD and 1929 (2.01%) had an older sibling with ASD. Of those with older siblings with ASD, 134 (6.9%) had ASD, vs 860 (0.9%) children with unaffected siblings (P < .001). MMR vaccination rates (>= 1 dose) were 84%(n = 78 564) at age 2 years and 92%(n = 86 063) at age 5 years for children with unaffected older siblings, vs 73%(n = 1409) at age 2 years and 86%(n = 1660) at age 5 years for children with affected siblings. MMR vaccine receipt was not associated with an increased risk of ASD at any age. For children with older siblings with ASD, at age 2, the adjusted relative risk (RR) of ASD for 1 dose of MMR vaccine vs no vaccine was 0.76 (95% CI, 0.49-1.18; P = .22), and at age 5, the RR of ASD for 2 doses compared with no vaccine was 0.56 (95% CI, 0.31-1.01; P = .052). For children whose older siblings did not have ASD, at age 2, the adjusted RR of ASD for 1 dose was 0.91 (95% CI, 0.67-1.20; P = .50) and at age 5, the RR of ASD for 2 doses was 1.12 (95% CI, 0.78-1.59; P = .55). CONCLUSIONS AND RELEVANCE In this large sample of privately insured children with older siblings, receipt of the MMR vaccine was not associated with increased risk of ASD, regardless of whether older siblings had ASD. These findings indicate no harmful association between MMR vaccine receipt and ASD even among children already at higher risk for ASD.	[Jain, Anjali; Marshall, Jaclyn; Kelly, Jonathan P.] Lewin Grp, Falls Church, VA 22042 USA; [Buikema, Ami; Bancroft, Tim] Optum, Eden Prairie, MN USA; [Newschaffer, Craig J.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Optum; Drexel University	Jain, A (corresponding author), Lewin Grp, 3130 Fairview Pk Dr,Ste SOO, Falls Church, VA 22042 USA.	anjali.jain@lewin.com		Buikema, Ami/0000-0002-2481-4872	National Institute of Mental Health, National Institutes of Health; US Department of Health and Human Services [HHSN-271-2010-00033-C]	National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Department of Health and Human Services	This project was funded by the National Institute of Mental Health, National Institutes of Health, and the US Department of Health and Human Services under contract HHSN-271-2010-00033-C.	Abu Kuwaik G, 2014, AUTISM, V18, P148, DOI 10.1177/1362361312459111; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; Centers for Disease Control and Prevention, 2011, EPIDEMIOLOGY PREVENT, V60, P40; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; DeFrank Jessica T, 2007, Prev Chronic Dis, V4, pA60; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; Doja A, 2006, CAN J NEUROL SCI, V33, P341, DOI 10.1017/S031716710000528X; Feudtner C, 2000, PEDIATRICS, V106, P205; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Gronborg TK, 2013, JAMA PEDIATR, V167, P947, DOI 10.1001/jamapediatrics.2013.2259; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Harrington JW, 2006, J DEV BEHAV PEDIATR, V27, pS156, DOI 10.1097/00004703-200604002-00014; Lash TL., 2009, APPL QUANTITATIVE BI; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Mercer L, 2006, J Genet Couns, V15, P41, DOI 10.1007/s10897-005-9002-7; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Rosenberg RE, 2013, CLIN PEDIATR, V52, P871, DOI 10.1177/0009922812438435; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; The Lewin Group, 2012, STUD HLTH OUTC CHILD; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; US Census Bureau, 2015, STAT COUNT QUICKF DA; Wingate M, 2014, MMWR SURVEILL SUMM, V63	27	101	106	1	250	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1534	1540		10.1001/jama.2015.3077	http://dx.doi.org/10.1001/jama.2015.3077			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3SA	25898051				2022-12-28	WOS:000353198700018
J	Moin, T; Li, JN; Duru, OK; Ettner, S; Turk, N; Keckhafer, A; Ho, S; Mangione, CM				Moin, Tannaz; Li, Jinnan; Duru, O. Kenrik; Ettner, Susan; Turk, Norman; Keckhafer, Abigail; Ho, Sam; Mangione, Carol M.			Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012 A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTIONS; IMPAIRED GLUCOSE-TOLERANCE; DIABETES PREVENTION; FOLLOW-UP; REDUCTION; INDUCTION; OVULATION	Background: Prediabetes affects 1 in 3 Americans. Both intensive lifestyle intervention and metformin can prevent or delay progression to diabetes. Over the past decade, lifestyle interventions have been translated across various settings, but little is known about the translation of evidence surrounding metformin use. Objective: To examine metformin prescription for diabetes prevention and patient characteristics that may affect metformin prescription. Design: Retrospective cohort analysis over a 3-year period. Setting: Employer groups that purchased health plans from the nation's largest private insurer. Participants: A national sample of 17 352 working-age adults with prediabetes insured for 3 continuous years between 2010 and 2012. Measurements: Percentage of health plan enrollees with prediabetes who were prescribed metformin. Results: Only 3.7% of patients with prediabetes were prescribed metformin over the 3-year study window. After adjust-ment for age, income, and education, the predicted probability of metformin prescription was almost 2 times higher among women and obese patients and more than 1.5 times higher among patients with 2 or more comorbid conditions. Limitation: Missing data on lifestyle interventions, possible misclassification of prediabetes and metformin use, and inability to define eligible patients exactly as defined in the American Diabetes Association guidelines. Conclusion: Evidence shows that metformin is rarely prescribed for diabetes prevention in working-age adults. Future studies are needed to understand potential barriers to wider adoption of this safe, tolerable, evidence-based, and cost-effective prediabetes therapy.	Vet Affairs Hlth Serv Res & Dev Serv, Vet Affairs Greater Angeles Hlth Syst, Washington, DC USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; UnitedHealthcare, Minneapolis, MN USA	University of California System; University of California Los Angeles	Moin, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave, Los Angeles, CA 90024 USA.	tmoin@mednet.ucla.edu			Centers for Disease Control and Prevention (Division of Diabetes Translation); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (Division of Diabetes Translation)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Centers for Disease Control and Prevention (Division of Diabetes Translation) and the National Institute of Diabetes and Digestive and Kidney Diseases.	Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Baran S, 2010, ARCH GYNECOL OBSTET, V282, P439, DOI 10.1007/s00404-010-1497-y; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Cardona-Morrell M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-653; Centers for Disease Control and Prevention, 2014, PRED COULD IT BE YOU; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Crandall J, 2006, J GERONTOL A-BIOL, V61, P1075; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Duru OK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120150; Fradkin JE, 2012, NEW ENGL J MED, V367, P1177, DOI 10.1056/NEJMp1208169; Heilbrunn E, 2013, TOP HLTH INSURANCE C; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mathur R, 2008, AM J OBSTET GYNECOL, V199, P596, DOI 10.1016/j.ajog.2008.09.010; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Schmittdiel JA, 2014, DIABETES CARE, V37, P565, DOI 10.2337/dc13-1223; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xiao JS, 2012, GYNECOL ENDOCRINOL, V28, P956, DOI 10.3109/09513590.2012.705368	30	61	61	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					542	+		10.7326/M14-1773	http://dx.doi.org/10.7326/M14-1773			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894024	Green Published, Green Accepted			2022-12-28	WOS:000353244300014
J	Shortell, SM; Addicott, R; Walsh, N; Ham, C				Shortell, Stephen M.; Addicott, Rachael; Walsh, Nicola; Ham, Chris			The NHS five year forward view: lessons from the United States in developing new care models	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORGANIZATIONS		[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Addicott, Rachael; Walsh, Nicola; Ham, Chris] Kings Fund, London, England	University of California System; University of California Berkeley	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	shortell@berkeley.edu	Walsh, Nicola/GPS-8962-2022					Burns LR, 2012, HEALTH AFFAIR, V31, P2407, DOI 10.1377/hlthaff.2011.0675; Casalino LP, 2011, GP COMMISSIONING NHS; Centers for Medicare and Medicaid Services, 2014, FACT SHEET MED ACOS; Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; Curry N, 2010, CLIN SERVICE INTEGRA; Dixon A., 2013, DELIVERING BETTER SE; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; Ham C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h322; Ham C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d905; Hibbard J, 2014, SUPPORTING PATIENTS; Markovich P, 2012, HEALTH AFFAIR, V31, P1969, DOI 10.1377/hlthaff.2012.0358; McWilliams JM, 2015, N ENGL J MED; Muhlestein D, 2014, TAXONOMY ACCOUNTABLE; NHS England, 2014, 5 YEAR FORW VIEW; Shortell S, 2014, ACCOUNTABLE CARE ORG; Shortell SM, 2014, HEALTH SERV RES, V49, P1883, DOI 10.1111/1475-6773.12234; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026	17	13	14	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h2005	10.1136/bmj.h2005	http://dx.doi.org/10.1136/bmj.h2005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG8QX	25899794				2022-12-28	WOS:000353576300006
J	Bradner, JE				Bradner, James E.			CANCER An essential passenger with p53	NATURE			English	Editorial Material							VULNERABILITIES	Deletion of the TP53 gene, an event seen in colorectal cancers, often occurs with co-deletion of a gene that encodes an enzyme subunit governing gene transcription. This creates a vulnerability ripe for therapeutic development. See Letter p.697	[Bradner, James E.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Bradner, JE (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	james_bradner@dfci.harvard.edu						Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430	7	15	16	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					626	627		10.1038/nature14390	http://dx.doi.org/10.1038/nature14390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901678				2022-12-28	WOS:000353689700036
J	Janne, PA; Yang, JCH; Kim, DW; Planchard, D; Ohe, Y; Ramalingam, SS; Ahn, MJ; Kim, SW; Su, WC; Horn, L; Haggstrom, D; Felip, E; Kim, JH; Frewer, P; Cantarini, M; Brown, KH; Dickinson, PA; Ghiorghiu, S; Ranson, M				Jaenne, Pasi A.; Yang, James Chih-Hsin; Kim, Dong-Wan; Planchard, David; Ohe, Yuichiro; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Su, Wu-Chou; Horn, Leora; Haggstrom, Daniel; Felip, Enriqueta; Kim, Joo-Hang; Frewer, Paul; Cantarini, Mireille; Brown, Kathryn H.; Dickinson, Paul A.; Ghiorghiu, Serban; Ranson, Malcolm			AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-RESISTANCE; IRREVERSIBLE EGFR; OPEN-LABEL; PHASE-III; GEFITINIB; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; AFATINIB; PLACEBO	BACKGROUND The EGFR T790M mutation is the most common mechanism of drug resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in patients who have lung cancer with an EGFR mutation (EGFR-mutated lung cancer). In preclinical models, the EGFR inhibitor AZD9291 has been shown to be effective against both EGFR tyrosine kinase inhibitor-sensitizing and T790M resistance mutations. METHODS We administered AZD9291 at doses of 20 to 240 mg once daily in patients with advanced lung cancer who had radiologically documented disease progression after previous treatment with EGFR tyrosine kinase inhibitors. The study included dose-escalation cohorts and dose-expansion cohorts. In the expansion cohorts, prestudy tumor biopsies were required for central determination of EGFR T790M status. Patients were assessed for safety, pharmacokinetics, and efficacy. RESULTS A total of 253 patients were treated. Among 31 patients enrolled in the dose-escalation cohorts, no dose-limiting toxic effects occurred at the doses evaluated. An additional 222 patients were treated in five expansion cohorts. The most common all-cause adverse events were diarrhea, rash, nausea, and decreased appetite. The overall objective tumor response rate was 51% (95% confidence interval [CI], 45 to 58). Among 127 patients with centrally confirmed EGFR T790M who could be evaluated for response, the response rate was 61% (95% CI, 52 to 70). In contrast, among 61 patients without centrally detectable EGFR T790M who could be evaluated for response, the response rate was 21% (95% CI, 12 to 34). The median progression-free survival was 9.6 months (95% CI, 8.3 to not reached) in EGFR T790M-positive patients and 2.8 months (95% CI, 2.1 to 4.3) in EGFR T790M-negative patients. CONCLUSIONS AZD9291 was highly active in patients with lung cancer with the EGFR T790M mutation who had had disease progression during prior therapy with EGFR tyrosine kinase inhibitors.	[Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02215 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Yang, James Chih-Hsin] Natl Taiwan Univ, Taipei 10764, Taiwan; [Yang, James Chih-Hsin] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Su, Wu-Chou] Cheng Kung Univ Hosp, Taipei, Taiwan; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Ahn, Myung-Ju] Yonsei Univ Hlth Syst, Samsung Med Ctr, Seoul, South Korea; [Kim, Sang-We] Yonsei Univ Hlth Syst, Asan Med Ctr, Seoul, South Korea; [Kim, Joo-Hang] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea; [Planchard, David] Inst Gustave Roussy, Villejuif, France; [Ohe, Yuichiro] Natl Canc Ctr, Tokyo, Japan; [Ramalingam, Suresh S.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Horn, Leora] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Haggstrom, Daniel] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA; [Felip, Enriqueta] Vall dHebron Univ Hosp, Barcelona, Spain; [Felip, Enriqueta] Vall dHebron Inst Oncol, Barcelona, Spain; [Frewer, Paul; Cantarini, Mireille; Brown, Kathryn H.; Dickinson, Paul A.; Ghiorghiu, Serban] AstraZeneca, Macclesfield, Cheshire, England; [Ranson, Malcolm] Univ Manchester, Christie Hosp, Manchester, Lancs, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; UNICANCER; Gustave Roussy; National Cancer Center - Japan; Emory University; Vanderbilt University; Carolinas HealthCare System; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); AstraZeneca; Christie NHS Foundation Trust; Christie Hospital; University of Manchester	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 450 Brookline Ave,HIM 223, Boston, MA 02215 USA.	pasi_janne@dfci.harvard.edu	Yang, James Chih-Hsin/W-1587-2019; Kim, Dong-Wan/J-5391-2012; FELIP, ENRIQUETA/AAG-6316-2019; Ramalingam, Suresh/AAV-7478-2020	FELIP, ENRIQUETA/0000-0002-7620-0098; Su, Wu-Chou/0000-0003-2953-4105; Yang, James Chih-Hsin/0000-0002-5586-5138; Balmana, Judith/0000-0002-0762-6415	AstraZeneca; Boehringer Ingelheim; Chugai Pharmaceuticals; Pfizer; Merrimack Pharmaceuticals; Clovis Oncology; Roche; Novartis; Merck Sharp Dohme; Roche-Genentech; Eli Lilly; Merck Serono; Astellas Pharma; Celgene; InnoPharma; Genentech; Amgen; Biodesix; Ariad Pharmaceuticals; Bristol-Myers Squibb; Merck	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chugai Pharmaceuticals; Pfizer(Pfizer); Merrimack Pharmaceuticals; Clovis Oncology; Roche(Roche Holding); Novartis(Novartis); Merck Sharp Dohme(Merck & Company); Roche-Genentech(Roche HoldingGenentech); Eli Lilly(Eli Lilly); Merck Serono(Merck & Company); Astellas Pharma(Astellas Pharmaceuticals); Celgene(Bristol-Myers SquibbCelgene Corporation); InnoPharma; Genentech(Roche HoldingGenentech); Amgen(Amgen); Biodesix; Ariad Pharmaceuticals; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company)	Supported by AstraZeneca.; Dr. Janne reports receiving consulting fees from AstraZeneca, Boehringer Ingelheim, Chugai Pharmaceuticals, Pfizer, Merrimack Pharmaceuticals, and Clovis Oncology and lecture fees from Roche and owning stock in Gatekeeper Pharmaceuticals. He also reports receiving royalties from patents related to a method of determining responsiveness of cancer to epidermal growth factor receptor (EGFR)-targeting treatments from LabCorp (U.S. patent numbers, 7,294,468; 8,465,916; 7,964,349; and 8,105,769; licensed to LabCorp) and a pending patent related to EGFR inhibitors and methods of treating disorders (U.S. patent application number, 13/319,079; licensed to Gatekeeper Pharmaceuticals). Dr. Yang reports receiving fees for serving on advisory boards from AstraZeneca, Clovis Oncology, Novartis, Boehringer Ingelheim, Merck Sharp & Dohme, Roche-Genentech, Eli Lilly, Pfizer, Merck Serono, Astellas Pharma, Celgene, and InnoPharma, lecture fees from AstraZeneca, Boehringer Ingelheim, and Eli Lilly, travel support from AstraZeneca, Boehringer Ingelheim, Roche-Genentech, and Eli Lilly, grant support from Boehringer Ingelheim, and supplies for preclinical laboratory work from AstraZeneca and Boehringer Ingelheim. Dr. D.-W. Kim reports receiving consulting fees from Novartis and honoraria from Pfizer. Dr. Planchard reports receiving fees for serving on advisory boards from AstraZeneca, Roche, and Boehringer Ingelheim. Dr. Ramalingam reports receiving fees for serving on advisory boards from Genentech, Boehringer Ingelheim, Amgen, Biodesix, Ariad Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, Celgene, and Novartis. Dr. Horn reports serving on a steering committee for Bayer, acting as an unpaid consultant for Xcovery, and receiving fees for serving on advisory boards from Clovis Oncology, Genentech, and Merck, lecture fees from Boehringer Ingelheim, and grant support from Astellas Pharma. Dr. Felip reports receiving consulting fees from Eli Lilly, Pfizer, Roche, and Boehringer Ingelheim and lecture fees from AstraZeneca and Novartis. Mr. Frewer and Drs. Cantarini, Brown, Dickinson, and Ghiorghiu report being employees of and holding stock in AstraZeneca. Dr. Ranson reports serving on an independent data and safety monitoring committee for AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Ellis PM, 2014, ASCO M, V32, P8036; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Goldberg SB, 2013, ONCOLOGIST, V18, P1214, DOI 10.1634/theoncologist.2013-0168; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Janjigian YY, 2014, CANCER DISCOV, V4, P1036, DOI 10.1158/2159-8290.CD-14-0326; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Miller VA, 2012, LANCET ONCOL, V13, pE186; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Oh IJ, 2012, LUNG CANCER, V77, P121, DOI 10.1016/j.lungcan.2012.01.012; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; Wakelee H., 2010, J CLIN ONCOL, V28, P3017; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	27	1495	1586	9	293	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1689	1699		10.1056/NEJMoa1411817	http://dx.doi.org/10.1056/NEJMoa1411817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923549				2022-12-28	WOS:000353655000004
J	Namburi, P; Beyeler, A; Yorozu, S; Calhoon, GG; Halbert, SA; Wichmann, R; Holden, SS; Mertens, KL; Anahtar, M; Felix-Ortiz, AC; Wickersham, IR; Gray, JM; Tye, KM				Namburi, Praneeth; Beyeler, Anna; Yorozu, Suzuko; Calhoon, Gwendolyn G.; Halbert, Sarah A.; Wichmann, Romy; Holden, Stephanie S.; Mertens, Kim L.; Anahtar, Melodi; Felix-Ortiz, Ada C.; Wickersham, Ian R.; Gray, Jesse M.; Tye, Kay M.			A circuit mechanism for differentiating positive and negative associations	NATURE			English	Article							BASOLATERAL AMYGDALA; CONDITIONED FEAR; REWARD-SEEKING; NEURONS; MEMORY; NUCLEUS; MICROCIRCUIT; POTENTIATION; EXPRESSION; PLASTICITY	The ability to differentiate stimuli predicting positive or negative outcomes is critical for survival, and perturbations of emotional processing underlie many psychiatric disease states. Synaptic plasticity in the basolateral amygdala complex (BLA) mediates the acquisition of associative memories, both positive(1'2) and negative'. Different populations of BLA neurons may encode fearful or rewarding associations'', but the identifying features of these populations and the synaptic mechanisms of differentiating positive and negative emotional valence have remained unknown. Here we show that BLA neurons projecting to the nucleus accumbens (NAc projectors) or the centromedial amygdala (CeM projectors) undergo opposing synaptic changes following fear or reward conditioning. We find that photostimulation of NAc projectors supports positive reinforcement while photostimulation of CeM projectors mediates negative reinforcement. Photoinhibition of CeM projectors impairs fear conditioning and enhances reward conditioning. We characterize these functionally distinct neuronal populations by comparing their electrophysiological, morphological and genetic features. Overall, we provide a mechanistic explanation for the representation of positive and negative associations within the amygdala.	[Namburi, Praneeth; Beyeler, Anna; Calhoon, Gwendolyn G.; Halbert, Sarah A.; Wichmann, Romy; Holden, Stephanie S.; Mertens, Kim L.; Anahtar, Melodi; Felix-Ortiz, Ada C.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Namburi, Praneeth; Felix-Ortiz, Ada C.] MIT, Neurosci Grad Program, Cambridge, MA 02139 USA; [Yorozu, Suzuko; Gray, Jesse M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Halbert, Sarah A.] Wellesley Coll, Undergrad Program Neurosci, Wellesley, MA 02481 USA; [Holden, Stephanie S.; Anahtar, Melodi] MIT, Undergrad Program Neurosci, Cambridge, MA 02139 USA; [Mertens, Kim L.] Univ Amsterdam, Masters Program Biomed Sci, NL-1098 XH Amsterdam, Netherlands; [Wickersham, Ian R.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Wellesley College; Massachusetts Institute of Technology (MIT); University of Amsterdam; Massachusetts Institute of Technology (MIT)	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	kaytye@mit.edu	Beyeler, Anna/V-9934-2019; Core, Vector/CAF-4832-2022	/0000-0003-2371-5706	NIMH [R01-MH102441-01, R01-MH101528-01]; NIDDK [DP2-DK-102256-01]; JPB Foundation (PIIF); JPB Foundation (PNDRF); NARSAD Foundation; Klingenstein Foundation; Whitehall Foundation; Sloan Foundation; Singleton fellowship; Leventhal fellowship; Whitaker fellowship; Swiss National Science Foundation; Simons Center for the Social Brain; Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program; McGovern Institute for Brain Research; Picower Institute for Learning and Memory; MIT Department of Brain and Cognitive Sciences; BRAIN Initiative award from NIMH [U01-MH106018, U01-N5090473]; BRAIN Initiative award from NINDS [U01-MH106018, U01-N5090473]; NSF [IOS-1451202]; BRAIN Initiative award from NEI [U01-MH106018, U01-N5090473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104785, U01MH106018, R01MH101528, R01MH102441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090473] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JPB Foundation (PIIF); JPB Foundation (PNDRF); NARSAD Foundation(NARSAD); Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Singleton fellowship; Leventhal fellowship; Whitaker fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Center for the Social Brain; Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program(Netherlands Organization for Scientific Research (NWO)); McGovern Institute for Brain Research; Picower Institute for Learning and Memory; MIT Department of Brain and Cognitive Sciences; BRAIN Initiative award from NIMH; BRAIN Initiative award from NINDS; NSF(National Science Foundation (NSF)); BRAIN Initiative award from NEI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Wildes, G. Glober, R. Luck and G. F. Conyers for technical assistance. We thank the entire Tye laboratory, B. Okaty, U. Eser, J. di lulio and A. Pfenning for helpful discussion. We thank E. J. Kremer for providing the CAV2-Cre virus, R. Neve for the HSV virus carrying Cre recombinase and mCherry, and the UNC vector core for the AAV viruses carrying double floxed constructs. K.M.T. is a New York Stem Cell Foundation Robertson Investigator and holds a Whitehead Career Development Chair. This work was supported by funds from NIMH (R01-MH102441-01), NIDDK (DP2-DK-102256-01), the JPB Foundation (PIIF and PNDRF), NARSAD, Klingenstein, Whitehall and Sloan Foundations (K.M.T.). Additionally, S.Y. and J.G. were supported by NIMH (R01-MH101528-01), P.N. was supported by Singleton, Leventhal and Whitaker fellowships, and A.B. was supported by a fellowship from the Swiss National Science Foundation. R.W. was supported by post-doctoral fellowships from the Simons Center for the Social Brain and the Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program. I.R.W. was supported by seed grants from the McGovern Institute for Brain Research, the Picower Institute for Learning and Memory, the MIT Department of Brain and Cognitive Sciences, and the Simons Center for the Social Brain, as well as by BRAIN Initiative awards from NIMH, NEI, and NINDS (U01-MH106018 and U01-N5090473) and NSF (IOS-1451202).	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fontanini A, 2009, J NEUROSCI, V29, P2486, DOI 10.1523/JNEUROSCI.3898-08.2009; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jimenez SA, 2009, LEARN MEMORY, V16, P766, DOI 10.1101/lm.1607109; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Novak P, 2006, ANN BIOMED ENG, V34, P1201, DOI 10.1007/s10439-006-9140-6; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; SHOLL DA, 1953, J ANAT, V87, P387; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	37	320	323	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					675	U208		10.1038/nature14366	http://dx.doi.org/10.1038/nature14366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925480	Green Accepted, Green Submitted			2022-12-28	WOS:000353689700049
J	Sequist, LV; Soria, JC; Goldman, JW; Wakelee, HA; Gadgeel, SM; Varga, A; Papadimitrakopoulou, V; Solomon, BJ; Oxnard, GR; Dziadziuszko, R; Aisner, DL; Doebele, RC; Galasso, C; Garon, EB; Heist, RS; Logan, J; Neal, JW; Mendenhall, MA; Nichols, S; Piotrowska, Z; Wozniak, AJ; Raponi, M; Karlovich, CA; Jaw-Tsai, S; Isaacson, J; Despain, D; Matheny, SL; Rolfe, L; Allen, AR; Camidge, DR				Sequist, L. V.; Soria, J-C; Goldman, J. W.; Wakelee, H. A.; Gadgeel, S. M.; Varga, A.; Papadimitrakopoulou, V.; Solomon, B. J.; Oxnard, G. R.; Dziadziuszko, R.; Aisner, D. L.; Doebele, R. C.; Galasso, C.; Garon, E. B.; Heist, R. S.; Logan, J.; Neal, J. W.; Mendenhall, M. A.; Nichols, S.; Piotrowska, Z.; Wozniak, A. J.; Raponi, M.; Karlovich, C. A.; Jaw-Tsai, S.; Isaacson, J.; Despain, D.; Matheny, S. L.; Rolfe, L.; Allen, A. R.; Camidge, D. R.			Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITORS; PHASE-II TRIAL; ACQUIRED-RESISTANCE; MUTATIONS; ERLOTINIB; GEFITINIB; AFATINIB; CHEMOTHERAPY; ADENOCARCINOMA	BACKGROUND Non-small-cell lung cancer (NSCLC) with a mutation in the gene encoding epidermal growth factor receptor (EGFR) is sensitive to approved EGFR inhibitors, but resistance develops, mediated by the T790M EGFR mutation in most cases. Rociletinib (CO-1686) is an EGFR inhibitor active in preclinical models of EGFR-mutated NSCLC with or without T790M. METHODS In this phase 1-2 study, we administered rociletinib to patients with EGFR-mutated NSCLC who had disease progression during previous treatment with an existing EGFR inhibitor. In the expansion (phase 2) part of the study, patients with T790M-positive disease received rociletinib at a dose of 500 mg twice daily, 625 mg twice daily, or 750 mg twice daily. Key objectives were assessment of safety, side-effect profile, pharmacokinetics, and preliminary antitumor activity of rociletinib. Tumor biopsies to identify T790M were performed during screening. Treatment was administered in continuous 21-day cycles. RESULTS A total of 130 patients were enrolled. The first 57 patients to be enrolled received the free-base form of rociletinib (150 mg once daily to 900 mg twice daily). The remaining patients received the hydrogen bromide salt (HBr) form (500 mg twice daily to 1000 mg twice daily). A maximum tolerated dose (the highest dose associated with a rate of dose-limiting toxic effects of less than 33%) was not identified. The only common dose-limiting adverse event was hyperglycemia. In an efficacy analysis that included patients who received free-base rociletinib at a dose of 900 mg twice daily or the HBr form at any dose, the objective response rate among the 46 patients with T790M-positive disease who could be evaluated was 59% (95% confidence interval [CI], 45 to 73), and the rate among the 17 patients with T790M-negative disease who could be evaluated was 29% (95% CI, 8 to 51). CONCLUSIONS Rociletinib was active in patients with EGFR-mutated NSCLC associated with the T790M resistance mutation.	[Sequist, L. V.; Heist, R. S.; Logan, J.; Piotrowska, Z.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sequist, L. V.; Oxnard, G. R.; Heist, R. S.; Piotrowska, Z.] Harvard Univ, Sch Med, Boston, MA USA; [Oxnard, G. R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Soria, J-C] Univ Paris 11, Drug Dev Dept, Villejuif, France; [Varga, A.] Inst Gustave Roussy, Villejuif, France; [Goldman, J. W.; Garon, E. B.; Mendenhall, M. A.; Nichols, S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wakelee, H. A.; Neal, J. W.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Gadgeel, S. M.; Galasso, C.; Wozniak, A. J.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Papadimitrakopoulou, V.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Solomon, B. J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Dziadziuszko, R.] Med Univ Gdansk, Gdansk, Poland; [Aisner, D. L.; Camidge, D. R.] Univ Colorado, Aurora, CO USA; [Doebele, R. C.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Raponi, M.; Karlovich, C. A.; Jaw-Tsai, S.; Matheny, S. L.; Allen, A. R.] Clovis Oncol, San Francisco, CA USA; [Isaacson, J.; Despain, D.] Clovis Oncol, Boulder, CO USA; [Rolfe, L.] Clovis Oncol, Cambridge, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford Cancer Institute; Stanford University; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Texas System; UTMD Anderson Cancer Center; Peter Maccallum Cancer Center; Fahrenheit Universities; Medical University Gdansk; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sequist, LV (corresponding author), Massachusetts Gen Hosp, Dept Med, 32 Fruit St,Yawkey 7B, Boston, MA 02114 USA.	lvsequist@partners.org	Wakelee, Heather/P-2623-2019; Soria, Jean-Charles/F-3619-2014; Oxnard, Geoffrey R./HCH-4397-2022; Dziadziuszko, Rafal/U-7036-2018; Camidge, David Ross/AAG-9144-2019; Doebele, Robert C./I-8230-2019	Dziadziuszko, Rafal/0000-0001-8080-9843; Doebele, Robert C./0000-0001-6728-6857; Solomon, Benjamin/0000-0003-3059-5730	Clovis Oncology; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Clovis Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Clovis Oncology.	Aaronson N. K., 1991, EFFECT CANC QUALITY, P185; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Goldberg SB, 2013, ONCOLOGIST, V18, P1214, DOI 10.1634/theoncologist.2013-0168; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Janjigian YY, 2014, CANCER DISCOV, V4, P1036, DOI 10.1158/2159-8290.CD-14-0326; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TSK, 2014, EUR SOC MED ONC 2014; Piotrowska Z, 2014, INT J RADIAT ONCOL, V90, pS6, DOI 10.1016/j.ijrobp.2014.08.032; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Vazquez-Martin A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02560; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	25	519	544	3	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1700	1709		10.1056/NEJMoa1413654	http://dx.doi.org/10.1056/NEJMoa1413654			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923550				2022-12-28	WOS:000353655000005
J	van Ommen, T				van Ommen, Tas			PALAEOCLIMATE Northern push for the bipolar see-saw	NATURE			English	Editorial Material							LAST DEGLACIATION	Antarctic ice-core data show that abrupt changes of climate in the Northern Hemisphere in the last glacial period preceded associated shifts in Antarctica by about 200 years - indicating an oceanic coupling process. See Letter p.661	Univ Tasmania, Australian Antarctic Div, Antarctic Climate & Ecosyst CRC, Hobart, Tas 7050, Australia	Australian Antarctic Division; University of Tasmania	van Ommen, T (corresponding author), Univ Tasmania, Australian Antarctic Div, Antarctic Climate & Ecosyst CRC, Hobart, Tas 7050, Australia.	tas.van.ommen@aad.gov.au	van Ommen, Tas D/B-5020-2012	van Ommen, Tas D/0000-0002-2463-1718				Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Landais A, 2015, QUATERNARY SCI REV, V114, P18, DOI 10.1016/j.quascirev.2015.01.031; Morgan V, 2002, SCIENCE, V297, P1862, DOI 10.1126/science.1074257; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Rahmstorf S., 2015, NATURE CLIM CHANGE; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920	9	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					630	631		10.1038/520630a	http://dx.doi.org/10.1038/520630a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925474				2022-12-28	WOS:000353689700039
J	Chilingarian, I; Zolotukhin, I				Chilingarian, Igor; Zolotukhin, Ivan			Isolated compact elliptical galaxies: Stellar systems that ran away	SCIENCE			English	Article							DWARF GALAXIES; CLUSTERS; MASS; MERGER; STAR; DISCOVERY; REGIONS; SPACE; FIELD	Compact elliptical galaxies form a rare class of stellar system (similar to 30 presently known) characterized by high stellar densities and small sizes and often harboring metal-rich stars. They were thought to form through tidal stripping of massive progenitors, until two isolated objects were discovered where massive galaxies performing the stripping could not be identified. By mining astronomical survey data, we have now found 195 compact elliptical galaxies in all types of environment. They all share similar dynamical and stellar population properties. Dynamical analysis for nonisolated galaxies demonstrates the feasibility of their ejection from host clusters and groups by three-body encounters, which is in agreement with numerical simulations. Hence, isolated compact elliptical and isolated quiescent dwarf galaxies are tidally stripped systems that ran away from their hosts.	[Chilingarian, Igor] Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; [Chilingarian, Igor; Zolotukhin, Ivan] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow 119992, Russia; [Zolotukhin, Ivan] Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France	Harvard University; Smithsonian Institution; Lomonosov Moscow State University	Chilingarian, I (corresponding author), Smithsonian Astrophys Observ, 60 Garden St MS09, Cambridge, MA 02138 USA.	igor.chilingarian@cfa.harvard.edu	; Chilingarian, Igor/N-5117-2016	Zolotukhin, Ivan/0000-0002-5544-9476; Chilingarian, Igor/0000-0002-7924-3253	Russian Science Foundation [14-22-00041]; M. V. Lomonosov Moscow State University Program of Development; NASA; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England	Russian Science Foundation(Russian Science Foundation (RSF)); M. V. Lomonosov Moscow State University Program of Development; NASA(National Aeronautics & Space Administration (NASA)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Japanese Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	The authors are greatful to F. Combes (Observatoire de Paris), I. Katkov (Sternberg Astronomical Institute), and M. Kurtz (Smithsonian Astrophysical Observatory) for useful discussions and critical reading of the manuscript. This result emerged from the tutorial run by the authors at the Astronomical Data Analysis Software and Systems conference in 2012. The authors acknowledge support by the Russian Science Foundation project 14-22-00041 "VOLGA-A View On the Life of GAlaxies.". The project used computational resourses funded by the M. V. Lomonosov Moscow State University Program of Development. This research has made use of Aladin developed by the Centre de Donnees Astronomiques de Strasbourg; TOPCAT and STILTS software packages developed by M. Taylor; "exploresdss" script by G. Mamon; the VizieR catalog access tool, CDS, Strasbourg, France; and the NASA/IPAC NED, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, the U.S. Department of Energy, NASA, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS Web Site is www.sdss.org. GALEX and SDSS databases used in our study are available via the CasJobs web-site http://skyserver.sdss.org/CasJobs.	Abazajian K. N., 2009, J SUPPL SER, V182, P543; Amorisco NC, 2014, NATURE, V507, P335, DOI 10.1038/nature12995; Biviano A, 2003, ASTROPHYS J, V585, P205, DOI 10.1086/345893; Brown WR, 2005, ASTROPHYS J, V622, pL33, DOI 10.1086/429378; Caldwell N, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/1/L11; Carlberg RG, 1997, ASTROPHYS J, V478, P462, DOI 10.1086/303805; Chilingarian I., 2007, IAU S, P175; Chilingarian I, 2009, SCIENCE, V326, P1379, DOI 10.1126/science.1175930; Chilingarian IV, 2012, MON NOT R ASTRON SOC, V419, P1727, DOI 10.1111/j.1365-2966.2011.19837.x; Chilingarian IV, 2010, MON NOT R ASTRON SOC, V405, pL11, DOI 10.1111/j.1745-3933.2010.00849.x; Cole S, 2000, MON NOT R ASTRON SOC, V319, P168, DOI 10.1046/j.1365-8711.2000.03879.x; De Lucia G, 2007, MON NOT R ASTRON SOC, V375, P2, DOI 10.1111/j.1365-2966.2006.11287.x; Diaferio A, 1997, ASTROPHYS J, V481, P633, DOI 10.1086/304075; Diaferio A, 1999, MON NOT R ASTRON SOC, V309, P610, DOI 10.1046/j.1365-8711.1999.02864.x; Drinkwater MJ, 2003, NATURE, V423, P519, DOI 10.1038/nature01666; Fakhouri O, 2010, MON NOT R ASTRON SOC, V406, P2267, DOI 10.1111/j.1365-2966.2010.16859.x; Geha M, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/85; Huxor AP, 2013, MON NOT R ASTRON SOC, V430, P1956, DOI 10.1093/mnras/stt014; Huxor AP, 2011, MON NOT R ASTRON SOC, V414, P3557, DOI 10.1111/j.1365-2966.2011.18655.x; KAISER N, 1987, MON NOT R ASTRON SOC, V227, P1; Norris MA, 2014, MON NOT R ASTRON SOC, V443, P1151, DOI 10.1093/mnras/stu1186; Paudel S, 2014, MON NOT R ASTRON SOC, V443, P446, DOI 10.1093/mnras/stu1171; Pfeffer J, 2013, MON NOT R ASTRON SOC, V433, P1997, DOI 10.1093/mnras/stt867; Price J, 2009, MON NOT R ASTRON SOC, V397, P1816, DOI 10.1111/j.1365-2966.2009.15122.x; Rich RM, 2012, NATURE, V482, P192, DOI 10.1038/nature10837; Sales LV, 2007, MON NOT R ASTRON SOC, V379, P1475, DOI 10.1111/j.1365-2966.2007.12026.x; SPITZER L, 1969, ASTROPHYS J, V158, pL139, DOI 10.1086/180451; Tempel E, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118687; Wetzel AR, 2014, MON NOT R ASTRON SOC, V439, P2687, DOI 10.1093/mnras/stu122	32	27	27	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					418	421		10.1126/science.aaa3344	http://dx.doi.org/10.1126/science.aaa3344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908816	Green Submitted			2022-12-28	WOS:000353338000029
J	Alter, G; Barouch, DH				Alter, Galit; Barouch, Dan H.			Natural Evolution of Broadly Neutralizing Antibodies	CELL			English	Editorial Material							VACCINE; VIRUS	Wu et al. couple next-generation sequencing with structural analysis to illuminate the key processes that enable the natural evolution and selection of broadly neutralizing antibodies to HIV-1, providing a potential roadmap for the development of HIV-1 vaccine strategies to accelerate the induction of protective antibodies.	[Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02138 USA; [Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center	Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02138 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019		NIAID NIH HHS [U19 AI096040, R01 AI084794, U19 AI078526] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, U19AI078526, R01AI084794] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	6	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					427	428		10.1016/j.cell.2015.04.007	http://dx.doi.org/10.1016/j.cell.2015.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910199	Green Accepted, Bronze			2022-12-28	WOS:000353553600001
J	Bollenbach, T; Heisenberg, CP				Bollenbach, Tobias; Heisenberg, Carl-Philipp			Gradients Are Shaping Up	CELL			English	Editorial Material							MORPHOGEN GRADIENT	In animal embryos, morphogen gradients determine tissue patterning and morphogenesis. Shyer et al. provide evidence that, during vertebrate gut formation, tissue folding generates graded activity of signals required for subsequent steps of gut growth and differentiation, thereby revealing an intriguing link between tissue morphogenesis and morphogen gradient formation.	[Bollenbach, Tobias; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Heisenberg, CP (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	heisenberg@ist.ac.at	Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; COULOMBRE AJ, 1958, J EMBRYOL EXP MORPH, V6, P403; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Durdu S, 2014, NATURE, V515, P120, DOI 10.1038/nature13852; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kicheva A, 2012, CURR OPIN GENET DEV, V22, P527, DOI 10.1016/j.gde.2012.08.004; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	7	5	5	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					431	432		10.1016/j.cell.2015.04.009	http://dx.doi.org/10.1016/j.cell.2015.04.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910201	Bronze			2022-12-28	WOS:000353553600003
J	Guidotti, LG; Inverso, D; Sironi, L; Di Lucia, P; Fioravanti, J; Ganzer, L; Fiocchi, A; Vacca, M; Aiolfi, R; Sammicheli, S; Mainetti, M; Cataudella, T; Raimondi, A; Gonzalez-Aseguinolaza, G; Protzer, U; Ruggeri, ZM; Chisari, FV; Isogawa, M; Sitia, G; Iannacone, M				Guidotti, Luca G.; Inverso, Donato; Sironi, Laura; Di Lucia, Pietro; Fioravanti, Jessica; Ganzer, Lucia; Fiocchi, Amleto; Vacca, Maurizio; Aiolfi, Roberto; Sammicheli, Stefano; Mainetti, Marta; Cataudella, Tiziana; Raimondi, Andrea; Gonzalez-Aseguinolaza, Gloria; Protzer, Ulrike; Ruggeri, Zaverio M.; Chisari, Francis V.; Isogawa, Masanori; Sitia, Giovanni; Iannacone, Matteo			Immunosurveillance of the Liver by Intravascular Effector CD8(+) T Cells	CELL			English	Article							VIRUS; PLATELETS; MIGRATION; HYALURONAN; GENERATION; CLEARANCE; NETWORKS; DYNAMICS; ENTRY; CD44	Effector CD8(+) T cells (CD8 T-E) play a key role during hepatotropic viral infections. Here, we used advanced imaging in mouse models of hepatitis B virus (HBV) pathogenesis to understand the mechanisms whereby these cells home to the liver, recognize antigens, and deploy effector functions. We show that circulating CD8 T-E arrest within liver sinusoids by docking onto platelets previously adhered to sinusoidal hyaluronan via CD44. After the initial arrest, CD8 T-E actively crawl along liver sinusoids and probe sub-sinusoidal hepatocytes for the presence of antigens by extending cytoplasmic protrusions through endothelial fenestrae. Hepatocellular antigen recognition triggers effector functions in a diapedesis-independent manner and is inhibited by the processes of sinusoidal defenestration and capillarization that characterize liver fibrosis. These findings reveal the dynamic behavior whereby CD8 T-E control hepatotropic pathogens and suggest how liver fibrosis might reduce CD8 T-E immune surveillance toward infected or transformed hepatocytes.	[Guidotti, Luca G.; Inverso, Donato; Sironi, Laura; Di Lucia, Pietro; Fioravanti, Jessica; Ganzer, Lucia; Fiocchi, Amleto; Vacca, Maurizio; Aiolfi, Roberto; Sammicheli, Stefano; Mainetti, Marta; Cataudella, Tiziana; Sitia, Giovanni; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Guidotti, Luca G.; Chisari, Francis V.; Isogawa, Masanori] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Inverso, Donato; Aiolfi, Roberto; Iannacone, Matteo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Sironi, Laura; Ganzer, Lucia] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy; [Raimondi, Andrea; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, I-20132 Milan, Italy; [Gonzalez-Aseguinolaza, Gloria] Ctr Appl Med Res, Gene Therapy & Gene Regulat Program, Pamplona 31008, Spain; [Protzer, Ulrike] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Ruggeri, Zaverio M.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Scripps Research Institute; Vita-Salute San Raffaele University; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Navarra; Technical University of Munich; Scripps Research Institute	Guidotti, LG (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.	guidotti.luca@hsr.it; iannacone.matteo@hsr.it	Aiolfi, Roberto/H-2290-2019; Protzer, Ulrike/D-5915-2015; Sironi, Laura/AAA-5384-2022; Sitia, Giovanni/K-1036-2016; Guidotti, Luca G. G/I-8542-2018; Inverso, Donato/AAA-5387-2022; Fioravanti, Jessica/AAS-1245-2020; Sitia, Giovanni/U-2114-2019; Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Raimondi, Andrea/AAN-2475-2020; Isogawa, Masanori/AAN-8969-2021; Iannacone, Matteo/I-8507-2018	Aiolfi, Roberto/0000-0003-2066-4536; Protzer, Ulrike/0000-0002-9421-1911; Sitia, Giovanni/0000-0003-1024-9128; Guidotti, Luca G. G/0000-0002-0205-2678; Fioravanti, Jessica/0000-0001-6263-4306; Sitia, Giovanni/0000-0003-1024-9128; Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Isogawa, Masanori/0000-0001-8730-4303; Iannacone, Matteo/0000-0002-9370-2671; Di Lucia, Pietro/0000-0002-0726-1532; Chisari, Francis/0000-0002-4832-1044; Inverso, Donato/0000-0003-0987-3345; SIRONI, LAURA/0000-0002-6638-7709; Raimondi, Andrea/0000-0002-4563-386X	European Research Council (ERC) [250219, 281648]; NIH RO1 grant [AI40696, HL-42846]; Italian Association for Cancer Research (AIRC) grant [9965]; Career Development Award from the Giovanni Armenise-Harvard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042846, R01HL042846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040696] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (AIRC) grant(Fondazione AIRC per la ricerca sul cancro); Career Development Award from the Giovanni Armenise-Harvard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Raso for technical support; R. Serra for secretarial assistance; S. Jalkanen for providing anti-VAP-1 Abs; S. Wieland for providing pCMV-beta-gal; M. Bader for providing TPH-1<SUP>-/-</SUP> mice; J. Egen for advice on the liver surgical preparation for the inverted microscope setup; C. Tacchetti for advice on correlative microscopy; L. Suarez-Amaran for help with the generation of recombinant adeno-associated viruses; P. Dellabona and R. Pardi for critical reading of the manuscript and the members of the M. Iannacone and L.G.G. laboratories for helpful discussions. We would like to acknowledge the PhD program in Basic and Applied Immunology at San Raffaele University, as D.I. conducted this study as partial fulfillment of his PhD in Molecular Medicine within that program. This work was supported by European Research Council (ERC) grants 250219 (to L.G.G.) and 281648 (to M. Iannacone); NIH RO1 grant AI40696 (to L.G.G.) and HL-42846 (to Z.M.R.); Italian Association for Cancer Research (AIRC) grant 9965 (to M. Iannacone); and a Career Development Award from the Giovanni Armenise-Harvard Foundation (to M. Iannacone).	ANDO K, 1994, J IMMUNOL, V153, P482; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Ji CH, 2012, HEPATOLOGY, V56, P2027, DOI 10.1002/hep.25875; Johnsson C, 1999, TRANSPLANT INT, V12, P235, DOI 10.1007/s001470050216; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mueller SN, 2013, IMMUNOL CELL BIOL, V91, P290, DOI 10.1038/icb.2012.75; Sironi L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07341; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485	34	191	204	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					486	500		10.1016/j.cell.2015.03.005	http://dx.doi.org/10.1016/j.cell.2015.03.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892224	Green Published, Bronze			2022-12-28	WOS:000353553600010
J	McDonough, JE				McDonough, John E.			The Demise of Vermont's Single-Payer Plan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	McDonough, JE (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.							True M., 2014, VTDIGGER CASTLETON P; UMass Medical School Center for Health Law and Economics and the Wakely Consulting Group, 2013, STAT VERM HLTH CAR F	2	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1584	1585		10.1056/NEJMp1501050	http://dx.doi.org/10.1056/NEJMp1501050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4XX	25901424				2022-12-28	WOS:000353294000002
J	Roberts, RG; Lian, OB				Roberts, Richard G.; Lian, Olav B.			DATING TECHNIQUES Illuminating the past	NATURE			English	Editorial Material							OPTICALLY STIMULATED LUMINESCENCE; MIDDLE STONE-AGE; HUMAN-BEHAVIOR; SOUTH-AFRICA; SEDIMENTS; AUSTRALIA; PROGRESS; SINGLE; QUARTZ	The technique of optical dating was first reported 30 years ago, and has since revolutionized studies of events that occurred during the past 500,000 years. Here, two practitioners of optical dating assess its impact and consider its future.	[Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Lian, Olav B.] Univ Fraser Valley, Dept Geog & Environm, Abbotsford, BC V2S 7M8, Canada	University of Wollongong; University of Fraser Valley	Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au; olav.lian@ufv.ca	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Aitken M.J., 1998, INTRO OPTICAL DATING; Botter-Jensen L., 2003, OPTICALLY STIMULATED; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Herman F, 2010, EARTH PLANET SC LETT, V297, P183, DOI 10.1016/j.epsl.2010.06.019; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUTT G, 1988, QUATERNARY SCI REV, V7, P381, DOI 10.1016/0277-3791(88)90033-9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Kalchgruber R, 2007, PLANET SPACE SCI, V55, P2203, DOI 10.1016/j.pss.2007.09.002; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Liritzis I., 2013, LUMINESCENCE DATING; Murray AS, 1998, RADIAT MEAS, V29, P503, DOI 10.1016/S1350-4487(98)00044-4; Prescott JR, 2008, AUST J EARTH SCI, V55, P997, DOI 10.1080/08120090802097468; Rhodes EJ, 2011, ANNU REV EARTH PL SC, V39, P461, DOI [10.1146/annurev-earth-040610-133425, 10.1146/annurev-earth-040610-13425]; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Roberts RG, 2015, J ARCHAEOL SCI, V56, P41, DOI 10.1016/j.jas.2015.02.028; SMITH BW, 1986, RADIAT PROT DOSIM, V17, P229; WINTLE AG, 1979, NATURE, V279, P710, DOI 10.1038/279710a0	20	20	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					438	439		10.1038/520438a	http://dx.doi.org/10.1038/520438a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903619				2022-12-28	WOS:000353334500021
J	Rinkevich, Y; Walmsley, GG; Hu, MS; Maan, ZN; Newman, AM; Drukker, M; Januszyk, M; Krampitz, GW; Gurtner, GC; Lorenz, HP; Weissman, IL; Longaker, MT				Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Maan, Zeshaan N.; Newman, Aaron M.; Drukker, Micha; Januszyk, Michael; Krampitz, Geoffrey W.; Gurtner, Geoffrey C.; Lorenz, H. Peter; Weissman, Irving L.; Longaker, Michael T.			Identification and isolation of a dermal lineage with intrinsic fibrogenic potential	SCIENCE			English	Article							STROMAL CELLS; CIRCULATING FIBROCYTES; BREAST FIBROBLASTS; PROTEIN-ALPHA; HOST-CELLS; SKIN; MYOFIBROBLASTS; EXPRESSION; FIBROSIS; CANCER	Dermal fibroblasts represent a heterogeneous population of cells with diverse features that remain largely undefined. We reveal the presence of at least two fibroblast lineages in murine dorsal skin. Lineage tracing and transplantation assays demonstrate that a single fibroblast lineage is responsible for the bulk of connective tissue deposition during embryonic development, cutaneous wound healing, radiation fibrosis, and cancer stroma formation. Lineage-specific cell ablation leads to diminished connective tissue deposition in wounds and reduces melanoma growth. Using flow cytometry, we identify CD26/DPP4 as a surface marker that allows isolation of this lineage. Small molecule-based inhibition of CD26/DPP4 enzymatic activity during wound healing results in diminished cutaneous scarring. Identification and isolation of these lineages hold promise for translational medicine aimed at in vivo modulation of fibrogenic behavior.	[Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Newman, Aaron M.; Drukker, Micha; Krampitz, Geoffrey W.; Weissman, Irving L.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Newman, Aaron M.; Drukker, Micha; Krampitz, Geoffrey W.; Weissman, Irving L.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA; [Walmsley, Graham G.; Hu, Michael S.; Maan, Zeshaan N.; Januszyk, Michael; Gurtner, Geoffrey C.; Lorenz, H. Peter; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Ludwig Ctr Canc Stem Cell Biol & Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Rinkevich, Y (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA.	ryuval@stanford.edu; irv@stanford.edu; longaker@stanford.edu	Rinkevich, Yuval/B-7854-2018; Newman, Aaron M/ABE-1620-2021; Rinkevich, Yuval/B-7647-2018	Rinkevich, Yuval/0000-0001-6290-7271; Newman, Aaron M/0000-0002-1857-8172; Rinkevich, Yuval/0000-0002-9022-7668; Drukker, Micha/0000-0002-4279-1125; Maan, Zeshaan/0000-0002-7683-1914	NIH [R01 GM087609, U01 HL099776, U01 HL099999]; California Institute of Regenerative Medicine [RC1 00354]; Smith Family Trust; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Gunn/Olivier fund; Stanford School of Medicine; Stanford Medical Scientist Training Program; National Institute of General Medical Sciences [GM07365]; Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation Fellowship; Siebel Scholarship; California Institute for Regenerative Medicine [TG2-01159]; Plastic Surgery Foundation [114288]; Translational Research and Applied Medicine program pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776, U01HL099999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087609, T32GM007365] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Smith Family Trust; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Gunn/Olivier fund; Stanford School of Medicine; Stanford Medical Scientist Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation Fellowship; Siebel Scholarship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Plastic Surgery Foundation; Translational Research and Applied Medicine program pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank D. T. Montoro and S. D. Morrison for their early contribution to developing the live fibroblast harvest protocol. This work was supported in part by NIH grant R01 GM087609 (to H.P.L.), a gift from Ingrid Lai and Bill Shu in honor of Anthony Shu (to H.P.L.), the California Institute of Regenerative Medicine (RC1 00354 to I.L.W.), the Smith Family Trust (to I.L.W.), the Hagey Laboratory for Pediatric Regenerative Medicine and The Oak Foundation (to M.T.L., H.P.L., and G.C.G.), NIH grants U01 HL099776 (to M.T.L.) and U01 HL099999 (to I.L.W.), the Virginia and D. K. Ludwig Fund for Cancer Research (to I.L.W.), and the Gunn/Olivier fund (to M.T.L. and I.L.W.). G.G.W. was supported by the Stanford School of Medicine, the Stanford Medical Scientist Training Program, and National Institute of General Medical Sciences training grant GM07365. Y.R. was supported by the Human Frontier Science Program (HFSP) Long Term Fellowship, the Machiah Foundation Fellowship, and the Siebel Scholarship. M.S.H. was supported by the California Institute for Regenerative Medicine Clinical Fellow training grant TG2-01159. Z.N.M. was supported by the Plastic Surgery Foundation Research Fellowship grant 114288 and the Translational Research and Applied Medicine program pilot grant. Microarray data are available at the Gene Expression Omnibus (GEO) at www.ncbi.nlm.nih.gov/geo, under accession number GSE65402. Author contributions: Y.R. and G.G.W. conceived, designed, and oversaw the experiments, with suggestions from I.L.W. and M.T.L. Y.R., G.G.W., M.S.H., and Z.N.M. performed the experiments and analyzed the data. A.M.N. and M.J. assisted with collection and analysis of data. M.D. assisted with microarray preparations, and A.M.N. analyzed the microarray data. Y.R., G.G.W., M.S.H., and Z.N.M. wrote the manuscript, with helpful suggestions from G.C.G., H.P.L., I.L.W., and M.T.L. The authors have no competing interests.	Ahren B, 2007, BEST PRACT RES CL EN, V21, P517, DOI 10.1016/j.beem.2007.07.005; Arwert EN, 2012, ONCOGENE, V31, P992, DOI 10.1038/onc.2011.298; ATHERTON AJ, 1992, INT J CANCER, V50, P15, DOI 10.1002/ijc.2910500105; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Glotzbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021211; Gottlober P, 2001, INT J RADIAT ONCOL, V50, P159, DOI 10.1016/S0360-3016(00)01542-X; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hiramatsu H, 2004, BIOL CHEM, V385, P561, DOI 10.1515/BC.2004.068; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Januszyk M, 2014, DIABETES, V63, P3047, DOI 10.2337/db13-1366; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Labrousse AL, 2004, CRIT REV ONCOL HEMAT, V49, P269, DOI 10.1016/j.critrevonc.2003.10.007; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levi B, 2011, J BIOL CHEM, V286, P39497, DOI 10.1074/jbc.M111.256529; MOORE K, 1977, INT J CANCER, V19, P803, DOI 10.1002/ijc.2910190610; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; WEBER L, 1984, J INVEST DERMATOL, V82, P156, DOI 10.1111/1523-1747.ep12259720; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	43	379	387	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232							aaa2151	10.1126/science.aaa2151	http://dx.doi.org/10.1126/science.aaa2151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883361	Green Accepted			2022-12-28	WOS:000352999000034
J	Kramer, G; Guilbride, DL; Bukau, B				Kramer, Guenter; Guilbride, D. Lys; Bukau, Bernd			Finding nascent proteins the right home	SCIENCE			English	Editorial Material							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; POLYPEPTIDE-ASSOCIATED COMPLEX; RIBOSOMES; NAC; CHAINS; SITE		[Kramer, Guenter] Univ Heidelberg ZMBH, Ctr Mol Biol, D-69120 Heidelberg, Germany; DKFZ ZMBH, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Kramer, G (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg		Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199				del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; LAURING B, 1995, P NATL ACAD SCI USA, V92, P9435, DOI 10.1073/pnas.92.21.9435; Lesnik C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6711; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Moller I, 1998, FEBS LETT, V441, P1, DOI 10.1016/S0014-5793(98)01440-9; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Pech Markus, 2010, J Biol Chem, V285, P19679, DOI 10.1074/jbc.M109.092536; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112	14	1	1	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					182	183		10.1126/science.aab1335	http://dx.doi.org/10.1126/science.aab1335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859030				2022-12-28	WOS:000352613700022
J	Basnyat, B; Baker, S				Basnyat, Buddha; Baker, Stephen			Typhoid carriage in the gallbladder	LANCET			English	Editorial Material									[Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci, Kathmandu, Nepal; [Baker, Stephen] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Basnyat, B (corresponding author), Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci, Kathmandu, Nepal.	Buddhabasnyat@gmail.com		Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [089276, 100087] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2015	386	9998					1074	1074		10.1016/S0140-6736(15)60029-0	http://dx.doi.org/10.1016/S0140-6736(15)60029-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2VQ	25892678	Bronze			2022-12-28	WOS:000361189200027
J	Navarese, EP; Kolodziejczak, M; Schulze, V; Gurbel, PA; Tantry, U; Lin, YF; Brockmeyer, M; Kandzari, DE; Kubica, JM; D'Agostino, RB; Kubica, J; Volpe, M; Agewall, S; Kereiakes, DJ; Kelm, M				Navarese, Eliano Pio; Kolodziejczak, Michalina; Schulze, Volker; Gurbel, Paul A.; Tantry, Udaya; Lin, Yingfeng; Brockmeyer, Maximilian; Kandzari, David E.; Kubica, Julia M.; D'Agostino, Ralph B., Sr.; Kubica, Jacek; Volpe, Massimo; Agewall, Stefan; Kereiakes, Dean J.; Kelm, Melte			Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN CHOLESTEROL; PLACEBO-CONTROLLED TRIAL; EVOLOCUMAB AMG 145; MONOCLONAL-ANTIBODY; STATIN THERAPY; DOUBLE-BLIND; CARDIOVASCULAR RISK; RANDOMIZED-TRIALS; PCSK9 INHIBITION	Background: Guidelines recommend statins as first-line therapy for dyslipidemia. Monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) is a new lipid-lowering approach. Purpose: To assess the efficacy and safety of PCSK9 antibodies in adults with hypercholesterolemia. Data Sources: MEDLINE, PubMed Central, and Google Scholar; conference proceedings; and the ClinicalTrials.gov registry through 4 April 2015. Study Selection: Phase 2 or 3 randomized, controlled trials (RCTs) comparing treatment using PCSK9 antibodies with no anti-PCSK9 therapy in adults with hypercholesterolemia. Data Extraction: Two investigators independently extracted data on study characteristics and lipid and clinical outcomes, and rated risk of bias of trials. Prespecified primary end points were all-cause and cardiovascular mortality. Data Synthesis: Twenty-four RCTs comprising 10 159 patients were included. Compared with no antibody, treatment with PCSK9 antibodies led to marked reductions in low-density lipoprotein cholesterol levels (mean difference, -47.49% [95% Cl, -69.64% to -25.35%]; P < 0.001] and other atherogenic lipid fractions, and it reduced all-cause mortality (odds ratio [OR], 0.45 [Cl, 0.23 to 0.86]; P = 0.015; heterogeneity P = 0.63;12 7 0%) and cardiovascular mortality (OR, 0.50 [Cl, 0.23 to 1.10]; P = 0.084; heterogeneity P = 0.78; I-2 = 0%). The rate of myocardial infarction was significantly reduced with use of PCSK9 antibodies (OR, 0.49 [Cl, 0.26 to 0.93]; P = 0.030; heterogeneity P = 0.45; I-2 = 0%), and increases in the serum creatine kinase level were reduced (OR, 0.72 [Cl, 0.54 to 0.96]; P = 0.026; heterogeneity P = 0.65; I-2 = 0%). Serious adverse events did not increase with administration of PCSK9 antibodies. Limitation: Results were derived from study-level data rather than patient-level data, and clinical outcome data are rare. Conclusion: PCSK9 antibodies seem to be safe and effective for adults with dyslipidemia.	Univ Dusseldorf, D-40225 Dusseldorf, Germany; Coll Med, Bydgoszcz, Poland; Nicholas Copernicus Univ, Torun, Poland; Sinai Hosp, Sinai Ctr Thrombosis Res, Baltimore, MD 21215 USA; Piedmont Heart Inst, Atlanta, GA USA; Boston Univ, Inst Math & Stat Biostat & Epidemiol, Boston, MA 02215 USA; Univ Roma La Sapienza, St Andrea Hosp, I-00185 Rome, Italy; Oslo Univ Hosp, Ulleval, Norway; Univ Oslo, Inst Clin Sci, Oslo, Norway; Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA; Lindner Res Ctr, Cincinnati, OH USA	Heinrich Heine University Dusseldorf; Nicolaus Copernicus University; Nicolaus Copernicus University; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Piedmont Heart Institute; Boston University; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Oslo; University of Oslo; Christ Hospital - Ohio	Navarese, EP (corresponding author), Univ Dusseldorf, Dept Internal Med, Div Cardiol Pulmonol & Vasc Med, Univ Str 1, D-40225 Dusseldorf, Germany.	eliano.navarese@med.uni-duesseldorf.de	Volpe, Massimo/K-5240-2016; Kołodziejczak, Michalina/AAL-3968-2020; Agewall, Stefan/ABE-6327-2020	Volpe, Massimo/0000-0002-9642-8380; Kołodziejczak, Michalina/0000-0001-5969-6055; Uminska, Julia/0000-0003-2309-2369; Kelm, Malte/0000-0003-0060-1052; Navarese, Eliano/0000-0002-2355-4589; Kubica, Jacek/0000-0001-8250-754X	Masterswitches in Myocardial Ischemia, German Research Council DFG [CRC 1116]	Masterswitches in Myocardial Ischemia, German Research Council DFG	CRC 1116 Masterswitches in Myocardial Ischemia, German Research Council DFG.	Amgen, 2014, PROFICIO EV CLIN TRI; [Anonymous], 2015, ODYSSEY CLIN TRIAL P; Bays H, 2014, AM HEART ASS SCI SES; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615; Califf RM, 2003, J INTERN MED, V254, P426, DOI 10.1046/j.1365-2796.2003.01238.x; Cannon CP, 2014, AM HEART ASS SCI SES; Cannon CP, 2014, EUR SOC CARD C BARC; De Luca G, 2009, EUR HEART J, V30, P2705, DOI 10.1093/eurheartj/ehp118; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Ginsberg HN, 2014, AM HEART ASS SCI SES; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirayama A, 2014, CIRC J, V78, P1073, DOI 10.1253/circj.CJ-14-0130; Kastelein JJP, 2014, EUR SOC CARD C BARC; Kataoka Y, 2014, AM J CARDIOL, V114, P549, DOI 10.1016/j.amjcard.2014.05.035; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moriarty P M, 2014, AM HEART ASS SCI SES; Navarese EP, 2014, AM J CARDIOVASC DRUG, V14, P79, DOI 10.1007/s40256-013-0053-0; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Robinson JG, 2015, N ENGL J MED, DOI 101056/NEJMoa1501031; Roth EM, 2014, INT J CARDIOL, V176, P55, DOI 10.1016/j.ijcard.2014.06.049; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Sabatine MS, 2015, N ENGL J MED; Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Toth Peter P, 2008, Expert Rev Cardiovasc Ther, V6, P955, DOI 10.1586/14779072.6.7.955; Willeit P, 2014, J AM COLL CARDIOL, V64, P851, DOI 10.1016/j.jacc.2014.03.061	44	314	321	3	109	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					40	51		10.7326/M14-2957	http://dx.doi.org/10.7326/M14-2957			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25915661				2022-12-28	WOS:000357442000005
J	Freed, DH; White, CW				Freed, Darren H.; White, Christopher W.			Donor heart preservation: straight up, or on the rocks?	LANCET			English	Editorial Material							OUTCOMES		[Freed, Darren H.; White, Christopher W.] Univ Alberta Hosp, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2B7, Canada	University of Alberta	Freed, DH (corresponding author), Univ Alberta Hosp, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2B7, Canada.	dhfreed@ualberta.ca		Freed, Darren/0000-0002-6239-1444				Ardehali A, 2015, LANCET; Gallagher J., 2014, SURG TRANSPLANT HEAR; Hamed A, 2009, J HEART LUNG TRANSPL, V28, pS71, DOI 10.1016/j.healun.2008.11.025; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Iyer A, 2015, AM J TRANSPLANT, V15, P371, DOI 10.1111/ajt.12994; Iyer A, 2014, AM J TRANSPLANT, V14, P1744, DOI 10.1111/ajt.12782; Khush KK, 2013, CIRC-HEART FAIL, V6, P300, DOI 10.1161/CIRCHEARTFAILURE.112.000165; Langendorff O., 1895, PFLUGERS ARCH, V61, P291, DOI [10.1007/BF01812150, 10.1007/bf01812150, DOI 10.1007/BF01812150]; Messer S, 2015, TRANSPL INT, V28, P634, DOI 10.1111/tri.12361; Quader MA, 2013, J HEART LUNG TRANSPL, V32, P1090, DOI 10.1016/j.healun.2013.08.002; Stamp NL, 2015, HEART LUNG CIRC, V24, P611, DOI 10.1016/j.hlc.2015.01.005; Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Zimmer HG, 1998, NEWS PHYSIOL SCI, V13, P203	13	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2552	2554		10.1016/S0140-6736(15)60614-6	http://dx.doi.org/10.1016/S0140-6736(15)60614-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25888084				2022-12-28	WOS:000356930000006
J	Postow, MA; Chesney, J; Pavlick, AC; Robert, C; Grossmann, K; McDermott, D; Linette, GP; Meyer, N; Giguere, JK; Agarwala, SS; Shaheen, M; Ernstoff, MS; Minor, D; Salama, AK; Taylor, M; Ott, PA; Rollin, LM; Horak, C; Gagnier, P; Wolchok, JD; Hodi, FS				Postow, Michael A.; Chesney, Jason; Pavlick, Anna C.; Robert, Caroline; Grossmann, Kenneth; McDermott, David; Linette, Gerald P.; Meyer, Nicolas; Giguere, Jeffrey K.; Agarwala, Sanjiv S.; Shaheen, Montaser; Ernstoff, Marc S.; Minor, David; Salama, April K.; Taylor, Matthew; Ott, Patrick A.; Rollin, Linda M.; Horak, Christine; Gagnier, Paul; Wolchok, Jedd D.; Hodi, F. Stephen			Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEK INHIBITION; COMBINED BRAF; VEMURAFENIB; RESPONSES; SAFETY; PD-1; ASSOCIATION; DABRAFENIB; ANTI-PD-1; SURVIVAL	BACKGROUND In a phase 1 dose-escalation study, combined inhibition of T-cell checkpoint pathways by nivolumab and ipilimumab was associated with a high rate of objective response, including complete responses, among patients with advanced melanoma. METHODS In this double-blind study involving 142 patients with metastatic melanoma who had not previously received treatment, we randomly assigned patients in a 2: 1 ratio to receive ipilimumab (3 mg per kilogram of body weight) combined with either nivolumab (1 mg per kilogram) or placebo once every 3 weeks for four doses, followed by nivolumab (3 mg per kilogram) or placebo every 2 weeks until the occurrence of disease progression or unacceptable toxic effects. The primary end point was the rate of investigator-assessed, confirmed objective response among patients with BRAF V600 wild-type tumors. RESULTS Among patients with BRAF wild-type tumors, the rate of confirmed objective response was 61% (44 of 72 patients) in the group that received both ipilimumab and nivolumab (combination group) versus 11% (4 of 37 patients) in the group that received ipilimumab and placebo (ipilimumab-monotherapy group) (P<0.001), with complete responses reported in 16 patients (22%) in the combination group and no patients in the ipilimumab-monotherapy group. The median duration of response was not reached in either group. The median progression-free survival was not reached with the combination therapy and was 4.4 months with ipilimumab monotherapy (hazard ratio associated with combination therapy as compared with ipilimumab monotherapy for disease progression or death, 0.40; 95% confidence interval, 0.23 to 0.68; P<0.001). Similar results for response rate and progression-free survival were observed in 33 patients with BRAF mutation-positive tumors. Drug-related adverse events of grade 3 or 4 were reported in 54% of the patients who received the combination therapy as compared with 24% of the patients who received ipilimumab monotherapy. Select adverse events with potential immunologic causes were consistent with those in a phase 1 study, and most of these events resolved with immune-modulating medication. CONCLUSIONS The objective-response rate and the progression-free survival among patients with advanced melanoma who had not previously received treatment were significantly greater with nivolumab combined with ipilimumab than with ipilimumab monotherapy. Combination therapy had an acceptable safety profile.	[Postow, Michael A.; Wolchok, Jedd D.] NYU, Mem Sloan Kettering Canc Ctr, New York, NY USA; [Postow, Michael A.; Wolchok, Jedd D.] NYU, Weill Cornell Med Coll, New York, NY USA; [Pavlick, Anna C.] NYU, Perlmutter Canc Ctr, New York, NY USA; [Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Robert, Caroline] Inst Gustave Roussy, Villejuif, France; [Robert, Caroline] Univ Paris Sud, Orsay, France; [Meyer, Nicolas] Inst Univ Canc, Toulouse, France; [Grossmann, Kenneth] Huntsman Canc Inst, Salt Lake City, UT USA; [McDermott, David] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ott, Patrick A.; Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02215 USA; [Linette, Gerald P.] Washington Univ, St Louis, MO USA; [Giguere, Jeffrey K.] Greenville Hlth Syst, Greenville, SC USA; [Agarwala, Sanjiv S.] St Lukes Canc Ctr, Bethlehem, PA USA; [Shaheen, Montaser] Univ New Mexico, Albuquerque, NM 87131 USA; [Ernstoff, Marc S.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA; [Minor, David] Calif Pacific Ctr Melanoma Res, San Francisco, CA USA; [Salama, April K.] Duke Univ, Durham, NC USA; [Taylor, Matthew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Horak, Christine] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Rollin, Linda M.; Gagnier, Paul] Bristol Myers Squibb Co, Wallingford, CT 06492 USA	Memorial Sloan Kettering Cancer Center; New York University; Cornell University; New York University; New York University; University of Louisville; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Huntsman Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Greenville Health System; University of New Mexico; Cleveland Clinic Foundation; Duke University; Oregon Health & Science University; Bristol-Myers Squibb; Bristol-Myers Squibb	Hodi, FS (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	wolchokj@mskcc.org; stephen_hodi@dfci.harvard.edu	Robert, Caroline/G-6157-2018	Robert, Caroline/0000-0002-9493-0238; Salama, April/0000-0002-8105-5374; Meyer, Nicolas/0000-0003-4519-8666	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb.	Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Hodi FS, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9002; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Kluger H, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu344.1; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Selby M, 2013, J CLIN ONCOL, V31; Shahabi V, 2012, CANCER IMMUNOL IMMUN, V61, P733, DOI 10.1007/s00262-012-1227-3; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weber JS, 2015, LANCET ONCOL; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	25	1960	2041	2	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2015	372	21					2006	2017		10.1056/NEJMoa1414428	http://dx.doi.org/10.1056/NEJMoa1414428			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI5PD	25891304	Green Accepted, Bronze			2022-12-28	WOS:000354809300007
J	Green, JB				Green, Jennifer B.			Update in Endocrinology: Evidence Published in 2014	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR RISK-FACTORS; STYLE		[Green, Jennifer B.] Duke Univ, Med Ctr, Durham, NC USA	Duke University	Green, JB (corresponding author), DUMC, Div Endocrinol, Box 3850,2400 Pratt St,Room 7039,North Pavil, Durham, NC 27705 USA.	green094@mc.duke.edu						Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Funk D, 2014, CRIT CARE MED, V42, P2333, DOI 10.1097/CCM.0000000000000518; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Parekh TM, 2014, JAMA INTERN MED, V174, P1605, DOI 10.1001/jamainternmed.2014.3293; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988	11	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					W91	W95		10.7326/M15-0153	http://dx.doi.org/10.7326/M15-0153			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR4SS	25927403				2022-12-28	WOS:000379893300003
J	Lundstrom, S; Reichenberg, A; Anckarsater, H; Lichtenstein, P; Gillberg, C				Lundstrom, Sebastian; Reichenberg, Abraham; Anckarsater, Henrik; Lichtenstein, Paul; Gillberg, Christopher			Autism phenotype versus registered diagnosis in Swedish children: prevalence trends over 10 years in general population samples	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; AFFECTED SIBLING PAIRS; COMORBIDITIES A-TAC; SPECTRUM DISORDERS; TELEPHONE INTERVIEW; CHILDHOOD AUTISM; EPIDEMIOLOGY; SUBSTITUTION; INVENTORY; ADULTS	OBJECTIVE To compare the annual prevalence of the autism symptom phenotype and of registered diagnoses for autism spectrum disorder during a 10 year period in children. DESIGN Population based study. SETTING Child and Adolescent Twin Study and national patient register, Sweden. PARTICIPANTS 19 993 twins (190 with autism spectrum disorder) and all children (n=1 078 975; 4620 with autism spectrum disorder) born in Sweden over a 10 year period from 1993 to 2002. MAIN OUTCOME MEASURES Annual prevalence of the autism symptom phenotype (that is, symptoms on which the diagnostic criteria are based) assessed by a validated parental telephone interview (the Autism-Tics, ADHD and other Comorbidities inventory), and annual prevalence of reported diagnoses of autism spectrum disorder in the national patient register. RESULTS The annual prevalence of the autism symptom phenotype was stable during the 10 year period (P=0.87 for linear time trend). In contrast, there was a monotonic significant increase in prevalence of registered diagnoses of autism spectrum disorder in the national patient register (P<0.001 for linear trend). CONCLUSIONS The prevalence of the autism symptom phenotype has remained stable in children in Sweden while the official prevalence for registered, clinically diagnosed, autism spectrum disorder has increased substantially. This suggests that administrative changes, affecting the registered prevalence, rather than secular factors affecting the pathogenesis, are important for the increase in reported prevalence of autism spectrum disorder.	[Lundstrom, Sebastian; Gillberg, Christopher] Univ Gothenburg, Gillberg Neuropsychiat Ctr, S-41119 Gothenburg, Sweden; [Lundstrom, Sebastian; Anckarsater, Henrik] Univ Gothenburg, Ctr Eth Law & Mental Hlth, S-41119 Gothenburg, Sweden; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Gothenburg; University of Gothenburg; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet	Lundstrom, S (corresponding author), Univ Gothenburg, Gillberg Neuropsychiat Ctr, Kungsgatan 12, S-41119 Gothenburg, Sweden.	sebastian.lundstrom@gnc.gu.se	Reichenberg, Abraham/GQB-1227-2022; Lundström, Sebastian/N-2303-2015; Romanova, Raisa/O-5724-2018		Swedish Council for Working Life under the ALF; Soderstrom-Konigska Foundation; Swedish Research Council (Medicine); Swedish Research Council (SIMSAM)	Swedish Council for Working Life under the ALF; Soderstrom-Konigska Foundation; Swedish Research Council (Medicine)(Swedish Research Council); Swedish Research Council (SIMSAM)(Swedish Research Council)	The Child and Adolescent Twin Study in Sweden study was supported by the Swedish Council for Working Life, funds under the ALF agreement, the Soderstrom-Konigska Foundation, and the Swedish Research Council (Medicine and SIMSAM). The current study received no specific funding. The funding sources had no involvement in the study design; collection, analysis, and interpretation of the data; or the decision to submit this paper for publication.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anckarsater H, 2011, TWIN RES HUM GENET, V14, P495, DOI 10.1375/twin.14.6.495; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Betancur C, 2002, AM J HUM GENET, V70, P1381, DOI 10.1086/340364; Bishop DVM, 2008, DEV MED CHILD NEUROL, V50, P341, DOI 10.1111/j.1469-8749.2008.02057.x; Blenner S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3088; Blumberg S. J., 2013, NATL HLTH STAT REPOR; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Coo H, 2008, J AUTISM DEV DISORD, V38, P1036, DOI 10.1007/s10803-007-0478-x; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Cubo E, 2011, AN PEDIATR, V75, P40, DOI 10.1016/j.anpedi.2011.01.008; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; GILLBERG C, 1991, BRIT J PSYCHIAT, V158, P403, DOI 10.1192/bjp.158.3.403; GILLBERG C, 1983, J CHILD PSYCHOL PSYC, V24, P377, DOI 10.1111/j.1469-7610.1983.tb00116.x; Gillberg C, 2014, J AUTISM DEV DISORD, V44, P3274, DOI 10.1007/s10803-014-2163-1; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Greenberg DA, 2001, AM J HUM GENET, V69, P1062, DOI 10.1086/324191; Hallerback MU, 2012, PSYCHIAT RES, V198, P12, DOI 10.1016/j.psychres.2012.01.016; Hallmayer J, 2002, AM J HUM GENET, V71, P941, DOI 10.1086/342990; Hansen SN, 2015, JAMA PEDIATR, V169, P56, DOI 10.1001/jamapediatrics.2014.1893; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Idring S, 2014, J AUTISM DEV DISORD; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; Larson T, 2014, PSYCHOL REP, V114, P93, DOI 10.2466/03.15.PR0.114k10w1; Larson T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-233; Larson T, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-1; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lundstrom S, 2014, J CHILD PSYCHOL PSYC; Perlman L, 2000, PROF PSYCHOL-RES PR, V31, P221, DOI 10.1037/0735-7028.31.2.221; PETTI TA, 1990, J AM ACAD CHILD PSY, V29, P327, DOI 10.1097/00004583-199005000-00001; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Shattuck PT, 2009, PSYCHIAT SERV, V60, P549, DOI 10.1176/appi.ps.60.4.549; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; Wazana A, 2007, J AM ACAD CHILD PSY, V46, P721, DOI 10.1097/chi.0b013e31804a7f3b; Wing L, 2002, MENT RETARD DEV D R, V8, P151, DOI 10.1002/mrdd.10029; WING L, 1976, PSYCHOL MED, V6, P89, DOI 10.1017/S0033291700007522; World Health Organization, 1979, INT STAT CLASS DIS R; World Health Organization, 2018, INT CLASSIFICATION D	44	107	108	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h1961	10.1136/bmj.h1961	http://dx.doi.org/10.1136/bmj.h1961			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH3UM	25922345	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000353955900003
J	Cohen, JD; Meenehan, SM; MacCabe, GS; Groblacher, S; Safavi-Naeini, AH; Marsili, F; Shaw, MD; Painter, O				Cohen, Justin D.; Meenehan, Sean M.; MacCabe, Gregory S.; Groeblacher, Simon; Safavi-Naeini, Amir H.; Marsili, Francesco; Shaw, Matthew D.; Painter, Oskar			Phonon counting and intensity interferometry of a nanomechanical resonator	NATURE			English	Article							QUANTUM; NOISE; LASER	In optics, the ability to measure individual quanta of light (photons) enables a great many applications, ranging from dynamic imaging within living organisms(1) to secure quantum communication(2). Pioneering photon counting experiments, such as the intensity interferometry performed by Hanbury Brown and Twiss(3) to measure the angular width of visible stars, have played a critical role in our understanding of the full quantum nature of light(4). As with matter at the atomic scale, the laws of quantum mechanics also govern the properties of macroscopic mechanical objects, providing fundamental quantum limits to the sensitivity of mechanical sensors and transducers. Current research in cavity optomechanics seeks to use light to explore the quantum properties of mechanical systems ranging in size from kilogram-mass mirrors to nanoscale membranes(5), as well as to develop technologies for precision sensing(6) and quantum information processing(7,8). Here we use an optical probe and single-photon detection to study the acoustic emission and absorption processes in a silicon nanomechanical resonator, and perform a measurement similar to that used by Hanbury Brown and Twiss to measure correlations in the emitted phonons as the resonator undergoes a parametric instability formally equivalent to that of a laser(9). Owing to the cavity-enhanced coupling of light with mechanical motion, this effective phonon counting technique has a noise equivalent phonon sensitivity of 0.89 +/- 0.05. With straightforward improvements to this method, a variety of quantum state engineering tasks using mesoscopic mechanical resonators would be enabled(10), including the generation and heralding of single-phonon Fock states(11) and the quantum entanglement of remote mechanical elements(12,13).	[Cohen, Justin D.; Meenehan, Sean M.; MacCabe, Gregory S.; Groeblacher, Simon; Painter, Oskar] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Cohen, Justin D.; Meenehan, Sean M.; MacCabe, Gregory S.; Groeblacher, Simon; Safavi-Naeini, Amir H.; Painter, Oskar] CALTECH, Thomas J Watson Senior Lab Appl Phys, Pasadena, CA 91125 USA; [Groeblacher, Simon] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol VCQ, A-1090 Vienna, Austria; [Safavi-Naeini, Amir H.] Stanford Univ, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Marsili, Francesco; Shaw, Matthew D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; California Institute of Technology; University of Vienna; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Painter, O (corresponding author), CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA.	opainter@caltech.edu	Groeblacher, Simon/O-2455-2014	Groeblacher, Simon/0000-0003-3932-7820; Painter, Oskar/0000-0002-1581-9209; Safavi-Naeini, Amir H./0000-0001-6176-1274	DARPA; Institute for Quantum Information and Matter; NSF Physics Frontiers Center; Gordon and Betty Moore Foundation; Kavli Nanoscience Institute at Caltech; NASA; NSERC; Marie Curie International Out-going Fellowship within the 7th European Community Framework Programme	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Institute for Quantum Information and Matter; NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Kavli Nanoscience Institute at Caltech; NASA(National Aeronautics & Space Administration (NASA)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Marie Curie International Out-going Fellowship within the 7th European Community Framework Programme	We thank F. Marquardt and A. G. Krause for discussions, and V. B. Verma, R. P. Miriam and S. W. Nam for their help with the single-photon detectors used in this work. This work was supported by the DARPA ORCHID and MESO programmes, the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with the support of the Gordon and Betty Moore Foundation, and the Kavli Nanoscience Institute at Caltech. Part of the research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. A.H.S.-N. acknowledges support from NSERC. S.G. was supported by a Marie Curie International Out-going Fellowship within the 7th European Community Framework Programme.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Borkje K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.123601; BROWN RH, 1956, NATURE, V178, P1046; Chan J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747726; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; FETTER AL, 1965, PHYS REV, V139, P1616; Galland C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143602; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; Grudinin IS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083901; Hoover EE, 2013, NAT PHOTONICS, V7, P93, DOI [10.1038/nphoton.2013.361, 10.1038/nphoton.2012.361]; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Kronwald A, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013847; LAX M, 1967, PHYS REV, V160, P290, DOI 10.1103/PhysRev.160.290; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Lorch N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011015; Meenehan SM, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.011803; Pike R, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10047s; Qian J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253601; RICE PR, 1994, PHYS REV A, V50, P4318, DOI 10.1103/PhysRevA.50.4318; Rodrigues DA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.053601; Safavi-Naeini AH, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035007; Stannigel K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.013603; Stannigel K, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.042341; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Vanner MR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010504	28	133	133	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					522	525		10.1038/nature14349	http://dx.doi.org/10.1038/nature14349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903632	Green Submitted			2022-12-28	WOS:000353334500038
J	Yang, R; Willett, SD; Goren, L				Yang, Rong; Willett, Sean D.; Goren, Liran			In situ low-relief landscape formation as a result of river network disruption	NATURE			English	Article							SURFACE UPLIFT; STREAM-POWER; TIBETAN PLATEAU; TECTONICS; EVOLUTION; DEFORMATION; CONSTRAINTS; GROWTH; MARGIN; EAST	Landscapes on Earth retain a record of the tectonic, environmental and climatic history under which they formed. Landscapes tend towards an equilibrium in which rivers attain a stable grade that balances the tectonic production of elevation and with hillslopes that attain a gradient steep enough to transport material to river channels. Equilibrium low-relief surfaces are typically found at low elevations, graded to sea level. However, there are many examples of high-elevation, low-relief surfaces, often referred to as relict landscapes(1,2), or as elevated peneplains(3). These do not grade to sea level and are typically interpreted as uplifted old landscapes, preserving former, more moderate tectonic conditions(4). Here we test this model of landscape evolution through digital topographic analysis of a set of purportedly relict landscapes on the southeastern margin of the Tibetan Plateau, one of the most geographically complex, climatically varied and biologically diverse regions of the world. We find that, in contrast to theory, the purported surfaces are not consistent with progressive establishment of a new, steeper, river grade, and therefore they cannot necessarily be interpreted as a remnant of an old, low relief surface. We propose an alternative model, supported by numerical experiments, in which tectonic deformation has disrupted the regional river network, leaving remnants of it isolated and starved of drainage area and thus unable to balance tectonic uplift. The implication is that the state of low relief with low erosion rate is developing in situ, rather than preserving past erosional conditions.	[Yang, Rong; Willett, Sean D.] Swiss Fed Inst Technol, Geol Inst, CH-8092 Zurich, Switzerland; [Goren, Liran] Ben Gurion Univ Negev, Geol & Environm Sci, IL-84105 Beer Sheva, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ben Gurion University	Yang, R (corresponding author), Swiss Fed Inst Technol, Geol Inst, CH-8092 Zurich, Switzerland.	rong.yang@erdw.ethz.ch	Willett, Sean D/B-1716-2008	Goren, Liran/0000-0002-4704-5009				Babault J, 2005, TECTONICS, V24, DOI 10.1029/2004TC001697; Bookhagen B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032011; Burchfiel B. C., 2012, GEOLOGICAL SOC AM; Clark MK, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000294; Clark MK, 2000, GEOLOGY, V28, P703, DOI 10.1130/0091-7613(2000)28<703:TOBTEM>2.0.CO;2; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Clift PD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027772; Davis WM, 1902, J GEOL, V10, P77, DOI 10.1086/620982; Duvall AR, 2012, TECTONICS, V31, DOI 10.1029/2011TC002969; ENGLAND P, 1986, J GEOPHYS RES-SOLID, V91, P3664, DOI 10.1029/JB091iB03p03664; ENGLAND P, 1990, NATURE, V344, P140, DOI 10.1038/344140a0; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Goren L, 2014, EARTH SURF PROC LAND, V39, P522, DOI 10.1002/esp.3514; Hallet B, 2001, J GEOPHYS RES-SOL EA, V106, P13697, DOI 10.1029/2000JB900335; Henck AC, 2011, EARTH PLANET SC LETT, V303, P71, DOI 10.1016/j.epsl.2010.12.038; Hoke GD, 2014, EARTH PLANET SC LETT, V394, P270, DOI 10.1016/j.epsl.2014.03.007; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Liu-Zeng J, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000897; Ouimet WB, 2009, GEOLOGY, V37, P579, DOI 10.1130/G30013A.1; Perron JT, 2013, EARTH SURF PROC LAND, V38, P570, DOI 10.1002/esp.3302; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Royden L, 2013, J GEOPHYS RES-EARTH, V118, P497, DOI 10.1002/jgrf.20031; Schoenbohm LM, 2004, GEOL SOC AM BULL, V116, P895, DOI 10.1130/B25364.1; Seidl M.A., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; Sklar L, 1998, GEOPH MONOG SERIES, V107, P237; TAPPONNIER P, 1982, GEOLOGY, V10, P611, DOI 10.1130/0091-7613(1982)10<611:PETIAN>2.0.CO;2; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Weissel JK, 1998, GEOPH MONOG SERIES, V107, P189; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Willett S. D., 1943, SCIENCE, P343; Wilson CJL, 2011, GEOL SOC AM BULL, V123, P1966, DOI 10.1130/B30331.1; Xu GQ, 2000, J GEOPHYS RES-SOL EA, V105, P19231, DOI 10.1029/2000JB900159	33	159	188	9	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					526	+		10.1038/nature14354	http://dx.doi.org/10.1038/nature14354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903633				2022-12-28	WOS:000353334500039
J	Abina, SHB; Gaspar, HB; Blondeau, J; Caccavelli, L; Charrier, S; Buckland, K; Picard, C; Six, E; Himoudi, N; Gilmour, K; McNicol, AM; Hara, H; Xu-Bayford, JH; Rivat, C; Touzot, F; Mavilio, F; Lim, A; Treluyer, JM; Heritier, S; Lefrere, F; Magalon, J; Pengue-Koyi, I; Honnet, G; Blanche, S; Sherman, EA; Male, F; Berry, C; Malani, N; Bushman, FD; Fischer, A; Thrasher, AJ; Galy, A; Cavazzana, M				Abina, Salima Hacein-Bey; Gaspar, H. Bobby; Blondeau, Johanna; Caccavelli, Laure; Charrier, Sabine; Buckland, Karen; Picard, Capucine; Six, Emmanuelle; Himoudi, Nourredine; Gilmour, Kimberly; McNicol, Anne-Marie; Hara, Havinder; Xu-Bayford, Jinhua; Rivat, Christine; Touzot, Fabien; Mavilio, Fulvio; Lim, Annick; Treluyer, Jean-Marc; Heritier, Sebastien; Lefrere, Francois; Magalon, Jeremy; Pengue-Koyi, Isabelle; Honnet, Geraldine; Blanche, Stephane; Sherman, Eric A.; Male, Frances; Berry, Charles; Malani, Nirav; Bushman, Frederic D.; Fischer, Alain; Thrasher, Adrian J.; Galy, Anne; Cavazzana, Marina			Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; SYNDROME PROTEIN; HEMATOPOIETIC-CELLS; WASP; INTEGRATION; EXPRESSION; ACTIVATION; MUTATIONS	IMPORTANCE Wiskott-Aldrich syndrome is a rare primary immunodeficiency associated with severe microthrombocytopenia. Partially HLA antigen-matched allogeneic hematopoietic stem cell (HSC) transplantation is often curative but is associated with significant comorbidity. OBJECTIVE To assess the outcomes and safety of autologous HSC gene therapy in Wiskott-Aldrich syndrome. DESIGN, SETTING, AND PARTICIPANTS Gene-corrected autologous HSCs were infused in 7 consecutive patients with severe Wiskott-Aldrich syndrome lacking HLA antigen-matched related or unrelated HSC donors (age range, 0.8-15.5 years; mean, 7 years) following myeloablative conditioning. Patients were enrolled in France and England and treated between December 2010 and January 2014. Follow-up of patients in this intermediate analysis ranged from 9 to 42 months. INTERVENTION A single infusion of gene-modified CD34(+) cells with an advanced lentiviral vector. MAIN OUTCOMES AND MEASURES Primary outcomes were improvement at 24 months in eczema, frequency and severity of infections, bleeding tendency, and autoimmunity and reduction in disease-related days of hospitalization. Secondary outcomes were improvement in immunological and hematological characteristics and evidence of safety through vector integration analysis. RESULTS Six of the 7 patients were alive at the time of last follow-up (mean and median follow-up, 28 months and 27 months, respectively) and showed sustained clinical benefit. One patient died 7 months after treatment of preexisting drug-resistant herpes virus infection. Eczema and susceptibility to infections resolved in all 6 patients. Autoimmunity improved in 5 of 5 patients. No severe bleeding episodes were recorded after treatment, and at last follow-up, all 6 surviving patients were free of blood product support and thrombopoietic agonists. Hospitalization days were reduced from a median of 25 days during the 2 years before treatment to a median of 0 days during the 2 years after treatment. All 6 surviving patients exhibited high-level, stable engraftment of functionally corrected lymphoid cells. The degree of myeloid cell engraftment and of platelet reconstitution correlated with the dose of gene-corrected cells administered. No evidence of vector-related toxicity was observed clinically or by molecular analysis. CONCLUSIONS AND RELEVANCE This study demonstrated the feasibility of the use of gene therapy in patients with Wiskott-Aldrich syndrome. Controlled trials with larger numbers of patients are necessary to assess long-term outcomes and safety.	[Abina, Salima Hacein-Bey; Blondeau, Johanna; Caccavelli, Laure; Touzot, Fabien; Lefrere, Francois; Magalon, Jeremy; Pengue-Koyi, Isabelle; Cavazzana, Marina] Necker Childrens Hosp, Assistance Publ Hop Paris, Biotherapy Dept, F-75015 Paris, France; [Abina, Salima Hacein-Bey; Blondeau, Johanna; Caccavelli, Laure; Touzot, Fabien; Magalon, Jeremy; Pengue-Koyi, Isabelle; Cavazzana, Marina] Grp Hosp Univ Quest, Assistance Publ Hop Paris, INSERM, Biotherapy Clin Invest Ctr, Paris, France; [Abina, Salima Hacein-Bey] Univ Paris 05, Fac Sci Pharmaceut & Biol, Unite Technol Chim & Biol Sante, Ctr Natl Rech Sci 8258,INSERM,U1022, Paris, France; [Abina, Salima Hacein-Bey] Grp Hosp Univ Paris Sud, Assistance Publ Hop Paris, Immunol Lab, Paris, France; [Gaspar, H. Bobby; Buckland, Karen; Himoudi, Nourredine; Gilmour, Kimberly; McNicol, Anne-Marie; Hara, Havinder; Rivat, Christine; Thrasher, Adrian J.] UCL, Inst Child Hlth, Sect Mol & Cellular Immunol, London, England; [Gaspar, H. Bobby; Buckland, Karen; Himoudi, Nourredine; Gilmour, Kimberly; McNicol, Anne-Marie; Hara, Havinder; Xu-Bayford, Jinhua; Rivat, Christine; Thrasher, Adrian J.] Hosp Natl Hlth Serv Fdn Trust, Dept Clin Immunol, London, England; [Charrier, Sabine; Galy, Anne] Univ Evry, INSERM, U951, Unite Mixte Rech Mol Immunol & Innovat Biotherapi, Evry, France; [Charrier, Sabine; Mavilio, Fulvio; Honnet, Geraldine; Galy, Anne] Genethon, Evry, France; [Picard, Capucine] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Ctr Ertude Deficits Immunitaires, Paris, France; [Picard, Capucine; Six, Emmanuelle; Touzot, Fabien; Heritier, Sebastien; Pengue-Koyi, Isabelle; Blanche, Stephane; Fischer, Alain; Cavazzana, Marina] Sorbonne Paris Cite Univ, Imagine Inst, Paris Descartes, Paris, France; [Picard, Capucine; Touzot, Fabien; Heritier, Sebastien; Blanche, Stephane; Fischer, Alain] Assistance Publ Hop Paris, Immunol & Pediat Hematol Dept, Paris, France; [Six, Emmanuelle; Fischer, Alain; Cavazzana, Marina] INSERM, Unite Mixte Rech 1163, Lab Human Lymphohematopoiesis, Paris, France; [Lim, Annick] Inst Pasteur, Grp Immunoscope, Dept Immunol, Paris, France; [Treluyer, Jean-Marc] Paris Descartes Univ, Clin Res Ctr Necker Enfants Malad, Paris, France; [Treluyer, Jean-Marc] Paris Descartes Univ, Cochin Hosp, Assistance Publ Hop Paris, Paris, France; [Sherman, Eric A.; Male, Frances; Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Fischer, Alain] Coll France, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; College de France	Cavazzana, M (corresponding author), Necker Childrens Hosp, Biotherapy Dept, 149 Rue Sevres, F-75015 Paris, France.	m.cavazzana@nck.aphp.fr	Touzot, Fabien/T-7797-2018; Héritier, Sébastien/D-8139-2017; treluyer, Jean-Marc/F-8036-2010; Galy, Anne HM/J-4439-2013; Six, Emmanuelle/H-7891-2017; Caccavelli, Laure/H-8880-2017	Touzot, Fabien/0000-0002-0889-4905; Héritier, Sébastien/0000-0003-0384-6370; Galy, Anne HM/0000-0002-0153-4392; Six, Emmanuelle/0000-0001-7806-0968; Thrasher, Adrian/0000-0002-6097-6115; Buckland, Karen/0000-0001-6989-2228; Cavazzana, Marina/0000-0002-0264-0891; CHARRIER, Sabine/0000-0001-9399-7492; Sherman, Erin/0000-0002-1835-8604; Caccavelli, Laure/0000-0001-6324-2304; Mavilio, Fulvio/0000-0003-0459-4320	Genethon, Evry, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082020] Funding Source: NIH RePORTER	Genethon, Evry, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was sponsored by Genethon, Evry, France.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Albert MH, 2011, CURR OPIN HEMATOL, V18, P42, DOI 10.1097/MOH.0b013e32834114bc; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163; Duchamp M, 2014, IMMUN INFLAMM DIS, V2, P131, DOI 10.1002/iid3.26; Friedrich W, 2009, IMMUNOL RES, V44, P18, DOI 10.1007/s12026-008-8063-8; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Kobayashi R, 2006, BRIT J HAEMATOL, V135, P362, DOI 10.1111/j.1365-2141.2006.06297.x; Lim A, 2002, J IMMUNOL METHODS, V261, P177, DOI 10.1016/S0022-1759(02)00004-2; Mahlaoui N, 2013, BLOOD, V121, P1510, DOI 10.1182/blood-2012-08-448118; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Marangoni F, 2009, MOL THER, V17, P1073, DOI 10.1038/mt.2009.31; Merten OW, 2011, HUM GENE THER, V22, P343, DOI 10.1089/hum.2010.060; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Ozsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679; Pai SY, 2010, IMMUNOL ALLERGY CLIN, V30, P179, DOI 10.1016/j.iac.2010.02.001; Poulin JF, 2003, BLOOD, V102, P4600, DOI 10.1182/blood-2003-05-1428; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Wang GP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn125; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Yamaguchi K, 2002, BLOOD, V100, P1208, DOI 10.1182/blood-2002-01-0211; Zanta-Boussif MA, 2009, GENE THER, V16, P605, DOI 10.1038/gt.2009.3; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	43	243	251	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1550	1563		10.1001/jama.2015.3253	http://dx.doi.org/10.1001/jama.2015.3253			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898053	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000353198700020
J	Cole, TB				Cole, Thomas B.			Children's Story (Water Dreaming for Two Children)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1498	1499		10.1001/jama.2014.11709	http://dx.doi.org/10.1001/jama.2014.11709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898031				2022-12-28	WOS:000353198700001
J	Chen, CL; Lin, GA; Bardach, NS; Clay, TH; Boscardin, WJ; Gelb, AW; Maze, M; Cropper, MA; Dudley, RA				Chen, Catherine L.; Lin, Grace A.; Bardach, Naomi S.; Clay, Theodore H.; Boscardin, W. John; Gelb, Adrian W.; Maze, Mervyn; Cropper, Michael A.; Dudley, R. Adams			Preoperative Medical Testing in Medicare Patients Undergoing Cataract Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUIDELINES	BACKGROUND Routine preoperative testing is not recommended for patients undergoing cataract surgery, because testing neither decreases adverse events nor improves outcomes. We sought to assess adherence to this guideline, estimate expenditures from potentially unnecessary testing, and identify patient and health care system characteristics associated with potentially unnecessary testing. METHODS Using an observational cohort of Medicare beneficiaries undergoing cataract surgery in 2011, we determined the prevalence and cost of preoperative testing in the month before surgery. We compared the prevalence of preoperative testing and office visits with the mean percentage of beneficiaries who underwent tests and had office visits during the preceding 11 months. Using multivariate hierarchical analyses, we examined the relationship between preoperative testing and characteristics of patients, health system characteristics, surgical setting, care team, and occurrence of a preoperative office visit. RESULTS Of 440,857 patients, 53% had at least one preoperative test in the month before surgery. Expenditures on testing during that month were $4.8 million higher and expenditures on office visits $12.4 million higher (42% and 78% higher, respectively) than the mean monthly expenditures during the preceding 11 months. Testing varied widely among ophthalmologists; 36% of ophthalmologists ordered preoperative tests for more than 75% of their patients. A patient's probability of undergoing testing was associated mainly with the ophthalmologist who managed the preoperative evaluation. CONCLUSIONS Preoperative testing before cataract surgery occurred frequently and was more strongly associated with provider practice patterns than with patient characteristics.	[Chen, Catherine L.; Gelb, Adrian W.; Maze, Mervyn; Cropper, Michael A.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Bardach, Naomi S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Boscardin, W. John; Dudley, R. Adams] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Boscardin, W. John; Dudley, R. Adams] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chen, Catherine L.; Lin, Grace A.; Bardach, Naomi S.; Dudley, R. Adams] Univ Calif San Francisco, Ctr Healthcare Value, San Francisco, CA 94143 USA; [Lin, Grace A.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Lin, Grace A.; Dudley, R. Adams] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Clay, Theodore H.] Clay Software & Stat, Ashland, OR USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, CL (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Healthcare Value, 513 Parnassus Ave,Rm S436, San Francisco, CA 94143 USA.	chenc1@anesthesia.ucsf.edu			Foundation for Anesthesia Education and Research; Grove Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; Grove Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the Foundation for Anesthesia Education and Research and the Grove Foundation.	Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; American Academy of Ophthalmology, ROUT PREOP LAB TEST; American Academy of Ophthalmology, CAT AD EYE PREF PRAC; Analeyz, 2011, 2011 SURV AM SOC CAT; BASS EB, 1995, ARCH OPHTHALMOL-CHIC, V113, P1248, DOI 10.1001/archopht.1995.01100100036025; Blue Ridge Health, JOINT COMM TOP H P E; Brown SR, 2011, FAM MED, V43, P338; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavallini GM, 2004, EUR J OPHTHALMOL, V14, P369, DOI 10.1177/112067210401400502; Centers for Medicare and Medicaid Services, MED PHYS FEE SCHED 2; Centers for Medicare and Medicaid Services, CLAR AMB SURG CTR AS; Centers for Medicare Medicaid Services, MED CLIN LAB FEE SCH; Cullen Karen A, 2009, Natl Health Stat Report, P1; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fleisher LA, 2014, JAMA INTERN MED, V174, P389, DOI 10.1001/jamainternmed.2013.12298; Keay L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007293.pub3; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lira R P, 2001, Rev Panam Salud Publica, V10, P13, DOI 10.1590/S1020-49892001000700003; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; NHS Institute for Innovation and Improvement, FOC ON CAT; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Schein OD, 2012, OPHTHAL EPIDEMIOL, V19, P257, DOI 10.3109/09286586.2012.698692; STEINBERG EP, 1993, ARCH OPHTHALMOL-CHIC, V111, P1041, DOI 10.1001/archopht.1993.01090080037016; The Joint Commission, 2008, STAND FAQ DET CONT H; The Royal College of Ophthalmologists, 2010, CAT SURG GUID; Thilen SR, 2014, JAMA INTERN MED, V174, P380, DOI 10.1001/jamainternmed.2013.13426; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; WWAMI Rural Health Research Center, RUR URB COMM AR RUCA	29	78	79	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1530	1538		10.1056/NEJMsa1410846	http://dx.doi.org/10.1056/NEJMsa1410846			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875258	Green Published, Green Accepted			2022-12-28	WOS:000352856500008
J	Reddy, U; Mallepaddi, NR; Chevassut, TJ				Reddy, Udaya; Mallepaddi, Nageswara Rao; Chevassut, Timothy J.			10-MINUTE CONSULTATION High INR on warfarin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULATION		[Reddy, Udaya] Worthing Dist Hosp, Dept Gastroenterol, Worthing BN11 2DH, England; [Mallepaddi, Nageswara Rao] Roslyn Rd Surg, Stoke On Trent, Staffs, England; [Chevassut, Timothy J.] Univ Sussex, Sussex Med Sch, Brighton, E Sussex, England; [Chevassut, Timothy J.] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England	University of Brighton; University of Sussex; University of Brighton	Reddy, U (corresponding author), Worthing Dist Hosp, Dept Gastroenterol, Worthing BN11 2DH, England.	udaya.reddy@nhs.net						Baglin T, 2013, BRIT J HAEMATOL, V163, P160, DOI 10.1111/bjh.12502; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Medicines and Healthcare Products Regulatory Agency, 2009, WARF CHNAG PROD SAF, P11; National Institute for Health and Care Excellence, 2007, HEAD INJ CLIN GUID C; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x	6	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1282	10.1136/bmj.h1282	http://dx.doi.org/10.1136/bmj.h1282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858914	Green Accepted			2022-12-28	WOS:000352914700003
J	Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A				Robert, Caroline; Schachter, Jacob; Long, Georgina V.; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S.; McNeil, Catriona; Lotem, Michal; Larkin, James; Lorigan, Paul; Neyns, Bart; Blank, Christian U.; Hamid, Omid; Mateus, Christine; Shapira-Frommer, Ronnie; Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot; Ribas, Antoni		KEYNOTE-006 Investigators	Pembrolizumab versus Ipilimumab in Advanced Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PD-1 BLOCKADE; TUMOR; NIVOLUMAB; SAFETY; IMMUNOTHERAPY; RESPONSES; SURVIVAL; MUTATION; CRITERIA; LIGANDS	BACKGROUND The immune checkpoint inhibitor ipilimumab is the standard-of-care treatment for patients with advanced melanoma. Pembrolizumab inhibits the programmed cell death 1 (PD-1) immune checkpoint and has antitumor activity in patients with advanced melanoma. METHODS In this randomized, controlled, phase 3 study, we assigned 834 patients with advanced melanoma in a 1: 1: 1 ratio to receive pembrolizumab (at a dose of 10 mg per kilogram of body weight) every 2 weeks or every 3 weeks or four doses of ipilimumab (at 3 mg per kilogram) every 3 weeks. Primary end points were progression-free and overall survival. RESULTS The estimated 6-month progression-free-survival rates were 47.3% for pembrolizumab every 2 weeks, 46.4% for pembrolizumab every 3 weeks, and 26.5% for ipilimumab (hazard ratio for disease progression, 0.58; P< 0.001 for both pembrolizumab regimens versus ipilimumab; 95% confidence intervals [CIs], 0.46 to 0.72 and 0.47 to 0.72, respectively). Estimated 12-month survival rates were 74.1%, 68.4%, and 58.2%, respectively (hazard ratio for death for pembrolizumab every 2 weeks, 0.63; 95% CI, 0.47 to 0.83; P = 0.0005; hazard ratio for pembrolizumab every 3 weeks, 0.69; 95% CI, 0.52 to 0.90; P = 0.0036). The response rate was improved with pembrolizumab administered every 2 weeks (33.7%) and every 3 weeks (32.9%), as compared with ipilimumab (11.9%) (P< 0.001 for both comparisons). Responses were ongoing in 89.4%, 96.7%, and 87.9% of patients, respectively, after a median follow-up of 7.9 months. Efficacy was similar in the two pembrolizumab groups. Rates of treatment-related adverse events of grade 3 to 5 severity were lower in the pembrolizumab groups (13.3% and 10.1%) than in the ipilimumab group (19.9%). CONCLUSIONS The anti-PD-1 antibody pembrolizumab prolonged progression-free survival and overall survival and had less high-grade toxicity than did ipilimumab in patients with advanced melanoma.	[Robert, Caroline] Univ Paris Sud, F-94805 Villejuif, France; [Robert, Caroline; Mateus, Christine] Gustave Roussy Dept Med Oncol, Serv Dermatol, F-94805 Villejuif, France; [Robert, Caroline; Mateus, Christine] Univ Paris Sud, Fac Med, F-94270 Le Kremlin Bicetre, France; [Grob, Jean Jacques] Hop Enfants La Timone, Marseille, France; [Schachter, Jacob; Shapira-Frommer, Ronnie] Univ Lille, Ctr Hosp Reg Univ Lille, Lille, France; [Schachter, Jacob; Shapira-Frommer, Ronnie] Sheba Med Ctr, Ella Lemelbaum Inst Melanoma, Tel Hashomer, Israel; [Lotem, Michal] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Mater Hosp, Sydney, NSW 2006, Australia; [Carlino, Matteo S.] Univ Sydney, Melanoma Inst Australia, Westmead & Blacktown Hosp, Sydney, NSW 2006, Australia; [McNeil, Catriona] Royal Prince Alfred Hosp, Chris OBrien Lifehouse, Camperdown, NSW 2050, Australia; [McNeil, Catriona] Melanoma Inst Australia, Camperdown, NSW, Australia; [Arance, Ana] Solid Tumors, Hosp Clin & Translat Genom & Targeted Therapeut, Dept Med Oncol, Barcelona, Spain; [Daud, Adil] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Larkin, James] Royal Marsden Hosp, London SW3 6JJ, England; [Lorigan, Paul] Univ Manchester, Manchester, Lancs, England; [Lorigan, Paul] Christie NHS Fdn Trust, Manchester, Lancs, England; [Neyns, Bart] Univ Ziekenhuis, Brussels, Belgium; [Blank, Christian U.] Netherlands Canc Inst, Amsterdam, Netherlands; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA; [Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA USA; [Kosh, Michele; Zhou, Honghong; Ibrahim, Nageatte; Ebbinghaus, Scot] Merck, Kenilworth, NJ USA	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Chaim Sheba Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Melanoma Institute Australia; University of Sydney; Melanoma Institute Australia; University of Sydney; Blacktown & Mount Druitt Hospital; Melanoma Institute Australia; University of Sydney; University of Sydney; Melanoma Institute Australia; University of California System; University of California San Francisco; Royal Marsden NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; Netherlands Cancer Institute; Angeles Clinic & Research Institute; University of California System; University of California Los Angeles; Merck & Company	Robert, C (corresponding author), Gustave Roussy, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	caroline.robert@gustaveroussy.fr	Neyns, Bart/AAA-8267-2021; Carlino, Matteo/GRS-7198-2022; Daud, Adil/T-3079-2019; Robert, Caroline/G-6157-2018; Lorigan, Paul/J-6898-2015; Neyns, Bart/ABG-3145-2021; Long, Georgina V/C-1771-2013; Straume, Oddbjorn/C-2186-2017	Daud, Adil/0000-0002-6617-8421; Robert, Caroline/0000-0002-9493-0238; Lorigan, Paul/0000-0002-8875-2164; Neyns, Bart/0000-0003-0658-5903; Long, Georgina V/0000-0001-8894-3545; Bar-Sela, Gil/0000-0001-6579-1841; Lutzky, Jose/0000-0002-9503-2130; Grob, Jean-Jacques/0000-0002-0667-153X; Espinosa Arranz, Enrique/0000-0001-6562-7902; Arance, Ana/0000-0003-2896-1957; Straume, Oddbjorn/0000-0001-8867-3645; Carlino, Matteo/0000-0002-7861-4104; Lacour, Jean-Philippe/0000-0001-7663-2053; Larkin, James/0000-0001-5569-9523; Leccia, M.Therese/0000-0003-1222-0396; Cebon, Jonathan/0000-0002-3898-950X; Puzanov, Igor/0000-0002-9803-3497	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	Funded by Merck Sharp & Dohme; KEYNOTE-006 ClinicalTrials.gov number, NCT01866319.	Ascierto PA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-116; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Madore J, 2014, PIGMENT CELL MELANOM; McArthur GA, 2013, J CLIN ONCOL, V31, P499, DOI 10.1200/JCO.2012.45.5568; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A., 2014, SOC MEL RES 2014 INT; Ribas A, 2014, PIGM CELL MELANOMA R, V27, P1223; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu438.42; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	27	3780	3917	10	315	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2521	2532		10.1056/NEJMoa1503093	http://dx.doi.org/10.1056/NEJMoa1503093			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2QD	25891173	Bronze			2022-12-28	WOS:000356788200008
J	Conard, NJ; Bolus, M				Conard, Nicholas J.; Bolus, Michael			Chronicling modern human's arrival in Europe	SCIENCE			English	Editorial Material							NEANDERTHAL EXTINCTION; AURIGNACIAN; C-14; CHRONOLOGY		[Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoenvironm, D-72070 Tubingen, Germany; [Bolus, Michael] Univ Tubingen, Heidelberg Acad Sci & Humanities, Res Ctr Role Culture Early Expans Humans, D-72020 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Eberhard Karls University of Tubingen	Conard, NJ (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany.	nicholas.conard@uni-tuebingen.de; michael.bolus@uni-tuebingen.de		Conard, Nicholas/0000-0002-4633-0385				Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bordes J.-G., 2006, DEFINITION AURIGNTIO, V45, P147; Broglio A., 1998, P 13 UISPP C FORL, V2, P495; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Laplace G., 1966, RECHERCHES LORIGINE; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Peresani M, 2008, J ARCHAEOL SCI, V35, P2986, DOI 10.1016/j.jas.2008.06.013; Sitlivy V., 2012, QUARTAR, V59, P85, DOI DOI 10.7485/QU59_4; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P3320, DOI 10.1016/j.jas.2010.08.001; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P758, DOI 10.1016/j.jas.2009.11.006; Teyssandier N, 2010, J ANTHROPOL RES, V66, P209, DOI 10.3998/jar.0521004.0066.203; Wild EM, 2008, RADIOCARBON, V50, P1, DOI 10.1017/S0033822200043332; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845	15	6	6	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					754	756		10.1126/science.aab0234	http://dx.doi.org/10.1126/science.aab0234			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CI0LN	25908661				2022-12-28	WOS:000354428700019
J	Carmi, Y; Spitzer, MH; Linde, IL; Burt, BM; Prestwood, TR; Perlman, N; Davidson, MG; Kenkel, JA; Segal, E; Pusapati, GV; Bhattacharya, N; Engleman, EG				Carmi, Yaron; Spitzer, Matthew H.; Linde, Ian L.; Burt, Bryan M.; Prestwood, Tyler R.; Perlman, Nicola; Davidson, Matthew G.; Kenkel, Justin A.; Segal, Ehud; Pusapati, Ganesh V.; Bhattacharya, Nupur; Engleman, Edgar G.			Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity	NATURE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; CHRONIC INFLAMMATION; METASTATIC MELANOMA; PANCREATIC-CANCER; TUMOR-REGRESSION; ANTIBODIES; HOST; IMMUNOGLOBULIN; IMMUNOTHERAPY; RECEPTORS	Whereas cancers grow within host tissues and evade host immunity through immune-editing and immunosuppression(1-5), tumours are rarely transmissible between individuals. Much like transplanted allogeneic organs, allogeneic tumours are reliably rejected by host T cells, even when the tumour and host share the same major histocompatibility complex alleles, the most potent determinants of transplant rejection(6-10). How such tumour-eradicating immunity is initiated remains unknown, although elucidating this process could provide the basis for inducing similar responses against naturally arising tumours. Here we find that allogeneic tumour rejection is initiated in mice by naturally occurring tumour-binding IgG antibodies, which enable dendritic cells (DCs) to internalize tumour antigens and subsequently activate tumour-reactive T cells. We exploited this mechanism to treat autologous and autochthonous tumours successfully. Either systemic administration of DCs loaded with allogeneic-IgG-coated tumour cells or intratumoral injection of allogeneic IgG in combination with DC stimuli induced potent T-cell-mediated antitumour immune responses, resulting in tumour eradication in mouse models of melanoma, pancreas, lung and breast cancer. Moreover, this strategy led to eradication of distant tumours and metastases, as well as the injected primary tumours. To assess the clinical relevance of these findings, we studied antibodies and cells from patients with lung cancer. T cells from these patients responded vigorously to autologous tumour antigens after culture with allogeneic-IgG-loaded DCs, recapitulating our findings in mice. These results reveal that tumour-binding allogeneic IgG can induce powerful antitumour immunity that can be exploited for cancer immunotherapy.	[Carmi, Yaron; Spitzer, Matthew H.; Linde, Ian L.; Prestwood, Tyler R.; Perlman, Nicola; Davidson, Matthew G.; Kenkel, Justin A.; Segal, Ehud; Bhattacharya, Nupur; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Spitzer, Matthew H.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Palo Alto, CA 94305 USA; [Burt, Bryan M.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Palo Alto, CA 94305 USA; [Pusapati, Ganesh V.] Stanford Univ, Sch Med, Dept Biochem, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Engleman, EG (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ycarmi76@stanford.edu; edengleman@stanford.edu		Linde, Ian/0000-0002-6077-7466; Spitzer, Matthew/0000-0002-5291-3819; Pusapati, Ganesh/0000-0002-1406-2566	NIH [U01 CA141468, 5T32AI007290-27]; NIH NRSA [F31CA189331]; Smith Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [F31CA189331, U01CA141468, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. C. Grumet and N. E. Reticker-Flynn for helpful discussion. We also thank J. Sonnenburg for providing gnotobiotic mice. This work was supported by NIH grants U01 CA141468 and 5T32AI007290-27. M.H.S. is supported by NIH NRSA F31CA189331. I.L.L. is supported by a Smith Stanford Graduate Fellowship.	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Bishop MR, 2004, J CLIN ONCOL, V22, P3886, DOI 10.1200/JCO.2004.01.127; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; FERRARA J, 1986, J INVEST DERMATOL, V86, P371, DOI 10.1111/1523-1747.ep12285612; Fishman P, 2002, INT J ONCOL, V21, P875; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Goulmy E, 2004, CANCER J, V10, P1, DOI 10.1097/00130404-200401000-00001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gumus E, 2004, INT J UROL, V11, P1070, DOI 10.1111/j.1442-2042.2004.00948.x; Hamanaka Y, 2003, INT J CANCER, V103, P97, DOI 10.1002/ijc.10801; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kurtenkov O, 2007, ACTA ONCOL, V46, P316, DOI 10.1080/02841860601055441; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Manning TC, 1997, J IMMUNOL, V159, P4665; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Schachter J, 2007, ANN NY ACAD SCI, V1110, P305, DOI 10.1196/annals.1423.032; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Soussi T, 2000, CANCER RES, V60, P1777; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016	31	136	146	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					99	U254		10.1038/nature14424	http://dx.doi.org/10.1038/nature14424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924063	Green Accepted			2022-12-28	WOS:000354040900041
J	Sim, F				Sim, Fiona			PERSONAL VIEW Alcoholic drinks contribute to obesity and should come with mandatory calorie counts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Soc Publ Hlth, London E1 8AN, England		Sim, F (corresponding author), Royal Soc Publ Hlth, London E1 8AN, England.	fionasim@nhs.net						Eads L, 2015, DRINKS BUSINESS 0319; Eurocare (European Alcohol Policy Alliance), 2015, COULD IR 1 EUR COUNT; Eurocare (European Alcohol Policy Alliance), POL ISS LAB; Holmes J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1301; NHS Choices, 2014, CAL ALC; Royal Society for Public Health, 2014, INCR AW INV CAL ALC; US Food and Drug Administration, 2014, OV FDA LAB REQ REST	7	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2047	10.1136/bmj.h2047	http://dx.doi.org/10.1136/bmj.h2047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25921691				2022-12-28	WOS:000353955900005
J	Chang, HY; Zhou, MJ; Tang, WZ; Alexander, GC; Singh, S				Chang, Hsien-Yen; Zhou, Meijia; Tang, Wenze; Alexander, G. Caleb; Singh, Sonal			Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; UNITED-STATES; DABIGATRAN; WARFARIN; RIVAROXABAN; ADJUSTMENT; SAFETY	OBJECTIVES To determine the real world safety of dabigatran or rivaroxaban compared with warfarin in terms of gastrointestinal bleeding. DESIGN Retrospective cohort study. SETTING Large administrative database of commercially insured people in United States from 1 October 2010 through 31 March 2012. PARTICIPANTS Enrollees with a prescription of warfarin, dabigatran, or rivaroxaban between 1 October 2010 and 31 March 2012, who were aged 18 years or older, had continuous enrollment and no oral anticoagulant use during the six months before the entry date, with known age and sex, and with no gastrointestinal bleeding for at least six months before the cohort entry date. The final study sample of 46 163 patients included 4907 using dabigatran, 1649 using rivaroxaban, and 39 607 using warfarin. MAIN OUTCOME MEASURE Time to gastrointestinal bleeding. Hazard ratios were derived from Cox proportional hazard models with propensity score weighting and robust estimates of errors. RESULTS Dabigatran users tended to be older (dabigatran v rivaroxaban v warfarin: 62.0 v 57.6 v 57.4 years) and more likely to be male (69% v 49% v 53%). The rate of gastrointestinal bleeding was highest among dabigatran users and lowest among rivaroxaban users (dabigatran v rivaroxaban v warfarin: 9.01 v 3.41 v 7.02 cases per 100 person years). After adjustment for potentially confounding covariates, there was no evidence of a statistically significant difference in the risk of gastrointestinal bleeding between dabigatran and warfarin users (adjusted hazard ratio 1.21, 95% confidence interval 0.96 to 1.53) or between rivaroxaban and warfarin users (0.98, 0.36 to 2.69). CONCLUSIONS Although rates of gastrointestinal bleeding seem to be similar in this commercially insured sample of adults in the United States, we cannot rule out as much as a 50% increase in the risk of gastrointestinal bleeding with dabigatran compared with warfarin or a more than twofold higher risk of bleeding with rivaroxaban compared with warfarin.	[Chang, Hsien-Yen] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Zhou, Meijia; Alexander, G. Caleb; Singh, Sonal] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Dept Epidemiol, Baltimore, MD 21205 USA; [Tang, Wenze] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Epidemiol & Biostat, Washington, DC 20052 USA; [Alexander, G. Caleb; Singh, Sonal] Johns Hopkins Med, Div Gen Internal Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Johns Hopkins University; Johns Hopkins Medicine	Chang, HY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	hchang24@jhmi.edu	Singh, Sonal/A-4614-2008; Chang, Hsien-Yen/E-4627-2014; MIRAJ, A. K. AL/AAA-6449-2021	Singh, Sonal/0000-0003-0912-941X; Chang, Hsien-Yen/0000-0002-7997-4822; 	National Heart, Lung and Blood Institute [R01 HL107345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107345] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	GCA is supported by the National Heart, Lung and Blood Institute (R01 HL107345). The funding source had no role in the design and conduct of the study, the analysis or interpretation of the data, or the preparation or final approval of the manuscript before publication.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Boehringer Ingelheim Pharmaceuticals, 2011, PRAD PACK INS; Bytzer P, 2013, CLIN GASTROENTEROL H, V11, P246, DOI 10.1016/j.cgh.2012.10.021; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Deitelzweig SB, 2013, CLIN THER, V35, P1536, DOI 10.1016/j.clinthera.2013.08.013; Desai J, 2013, THROMB HAEMOSTASIS, V110, P205, DOI 10.1160/TH13-02-0150; Gallagher AM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003839; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Harper P, 2012, NEW ENGL J MED, V366, P864, DOI 10.1056/NEJMc1112874; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Hippisley-Cox J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4606; Ho MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101245; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Hopper Andrew D, 2011, Practitioner, V255, P15; IMS Health Incorporated or its affiliates, 2012, LIFELINK HLTH PLAN C; Janssen Pharmaceuticals, 2011, XAR PACK INS; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Laliberte F, 2014, CURR MED RES OPIN, V30, P1317, DOI 10.1185/03007995.2014.907140; Larsen TB, 2014, AM J MED, V127, P650, DOI 10.1016/j.amjmed.2014.01.031; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; Moore TJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4517; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Sherid M, 2014, DIGESTION, V90, P137, DOI 10.1159/000365967; Sorensen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002758	33	108	111	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h1585	10.1136/bmj.h1585	http://dx.doi.org/10.1136/bmj.h1585			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RC	25911526	hybrid, Green Published			2022-12-28	WOS:000353577000001
J	Brazeau, MD; Friedman, M				Brazeau, Martin D.; Friedman, Matt			The origin and early phylogenetic history of jawed vertebrates	NATURE			English	Review							INTERNAL FERTILIZATION; EVOLUTIONARY NOVELTY; DEVONIAN PERIOD; SHEDS LIGHT; BONY FISHES; PAIRED FINS; CHONDRICHTHYAN; BRAINCASE; ANATOMY; GNATHOSTOMES		[Brazeau, Martin D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Friedman, Matt] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	Imperial College London; University of Oxford	Brazeau, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England.	m.brazeau@imperial.ac.uk; mattf@earth.ox.ac.uk	Brazeau, Martin D/AAU-5390-2020		Philip Leverhulme Prize; John Fell Fund; European Research Council under the European Union [311092]	Philip Leverhulme Prize; John Fell Fund; European Research Council under the European Union(European Research Council (ERC))	This work was supported by the Philip Leverhulme Prize and John Fell Fund, both to M.F., and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement number 311092 to M.D.B. Both authors contributed equally to this Review.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; Balfour FM, 1881, P ZOOL SOC LOND, V1881, P656; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Bernacsek G.M., 1977, PALAEONTOGR ABT A, V158, P1; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Chen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036256; Clack J.A., 2012, GAINING GROUND, VSecond; Coates MI, 2003, THEOR BIOSCI, V122, P266; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Beer G., 1937, DEV VERTEBRATE SKULL; Dean B, 1894, J MORPHOL, V9, P87; Donoghue PCJ, 2000, BIOL REV, V75, P191, DOI 10.1017/S0006323199005472; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Forey P.L., 1984, Journal of Vertebrate Paleontology, V4, P330; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gardiner B. G., 1984, J VERTEBR PALEONTOL, V4, P375; Giles S, 2015, NATURE; Gregory W. K., 1935, Proceedings of the American Philosophical Society, V75, P673; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; HALSTEAD LB, 1979, NATURE, V282, P833, DOI 10.1038/282833a0; Hanke G. F., 2010, MORPHOLOGY PHYLOGENY, P149; Hanke G.F., 2004, RECENT ADV ORIGIN EA, P703; Hanke GF, 2006, J VERTEBR PALEONTOL, V26, P526, DOI 10.1671/0272-4634(2006)26[526:AOTEDA]2.0.CO;2; Hanke GF, 2013, GEODIVERSITAS, V35, P529, DOI 10.5252/g2013n3a2; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; JANVIER P, 1981, Journal of Vertebrate Paleontology, V1, P121; Janvier P., 1984, Journal of Vertebrate Paleontology, V4, P344; JANVIER P, 1979, ZOOL SCR, V8, P287, DOI 10.1111/j.1463-6409.1979.tb00640.x; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 2010, P431; Jarvik E., 1980, BASIC STRUCTURE EVOL; Karatajute-Talimaa Valentina, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P39; KARATAYUTETALIMAA VN, 1990, PALEONTOL ZH, P76; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kuratani S, 2004, J ANAT, V205, P335, DOI 10.1111/j.0021-8782.2004.00345.x; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lankester E. R., 1878, ELEMENTS COMP ANATOM; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Luksevics E., 2010, Palaeoworld, V19, P94, DOI 10.1016/j.palwor.2010.02.001; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2014, J MORPHOL, V275, P586, DOI 10.1002/jmor.20242; Makovicky P. J., 2011, LIVING DINOSAURS EVO, P9, DOI DOI 10.1002/9781119990475.CH1; Marss T., 2007, HDB PALEOICHTHYOLO B, V1B; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; MILES RS, 1964, NATURE, V204, P457, DOI 10.1038/204457a0; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Ota KG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1355; PANCHEN AL, 1987, BIOL REV, V62, P341, DOI 10.1111/j.1469-185X.1987.tb01635.x; REIF WE, 1982, EVOL BIOL, V15, P287; Sansom IJ, 2005, ZOOL J LINN SOC-LOND, V144, P379, DOI 10.1111/j.1096-3642.2005.00171.x; Sansom IJ, 2012, PALAEONTOLOGY, V55, P243, DOI 10.1111/j.1475-4983.2012.01127.x; Sansom RS, 2009, PALAEONTOLOGY, V52, P1257, DOI 10.1111/j.1475-4983.2009.00895.x; Sansom RS, 2009, J SYST PALAEONTOL, V7, P95, DOI 10.1017/S1477201908002551; SCHAEFFER B, 1981, Bulletin of the American Museum of Natural History, V169, P1; Schaeffer B, 1975, PROBLEMES ACTUELS PA, P101; SCHULTZE H-P, 1968, Bulletin of the British Museum (Natural History) Geology, V16, P343; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; Shigetani Y, 2005, BIOESSAYS, V27, P331, DOI 10.1002/bies.20182; Shubin NH, 2002, J MORPHOL, V252, P15, DOI 10.1002/jmor.10017; Smith MM, 1997, PALAEONTOLOGY, V40, P645; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Stensio E. A., 1932, CEPHALASPIDS GREAT B; Trinajstic K., 2014, BIOL REV CAMB PHILOS; Turner S., 2004, RECENT ADV ORIGIN EA, P67; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wang N.-Z., 1991, EARLY VERTEBRATES RE; Watson D. M. S., 1937, Philosophical Transactions London, V228B, P49, DOI 10.1098/rstb.1937.0009; White EI, 1978, NSW T ZOO SOC LOND, V34, P149, DOI 10.1111/j.1096; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; ZANGERL R, 1975, Palaeontology (Oxford), V18, P333; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2001, MAJOR EVENTS EARLY V, P81; Zhu M., 2000, COUR FORSCH I SENCKE, V223, P379; Zhu Min, 2006, Vertebrata Palasiatica, V44, P1; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; [No title captured]	100	105	105	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					490	497		10.1038/nature14438	http://dx.doi.org/10.1038/nature14438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903631	Green Accepted			2022-12-28	WOS:000353334500033
J	Chan, TCY; Jhanji, V				Chan, Tommy C. Y.; Jhanji, Vishal			Amiodarone-Induced Vortex Keratopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chan, Tommy C. Y.] Hong Kong Eye Hosp, Hong Kong, Hong Kong, Peoples R China; [Jhanji, Vishal] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, TCY (corresponding author), Hong Kong Eye Hosp, Hong Kong, Hong Kong, Peoples R China.	vishaljhanji@gmail.com	Chan, Tommy/AAH-7737-2021; Jhanji, Vishal/I-5676-2014; Chan, Tommy/L-3002-2017	Chan, Tommy/0000-0003-4228-9482					0	6	7	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1656	1656		10.1056/NEJMicm1406501	http://dx.doi.org/10.1056/NEJMicm1406501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901429				2022-12-28	WOS:000353294000011
J	Lu, YL; Nakicenovic, N; Visbeck, M; Stevance, AS				Lu, Yonglong; Nakicenovic, Nebojsa; Visbeck, Martin; Stevance, Anne-Sophie			Five priorities for the UN Sustainable Development Goals	NATURE			English	Editorial Material									[Lu, Yonglong] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Nakicenovic, Nebojsa] IIASA, Vienna, Austria; [Visbeck, Martin] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Visbeck, Martin] Univ Kiel, Kiel, Germany; [Stevance, Anne-Sophie] Int Council Sci, Paris, France	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); International Institute for Applied Systems Analysis (IIASA); Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Lu, YL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	yllu@rcees.ac.cn	Visbeck, Martin H/B-6541-2016	Visbeck, Martin H/0000-0002-0844-834X				[Anonymous], 2013, SAINT PETERSBURG DEV; Australian and New Zealand Environment Conservation Council, 2000, AUSTR NZ GUID FRESH, V2; European Environmental Agency, 2011, SHAR ENV INF SYST SE; German Advisory Council on Global Change, 2013, WORLD TRANS GOV MAR; International Council of Science, 2015, REV TARG SUST DEV GO; Organisation for Economic Co-operation and Development, 2013, STRENGTH NAT STAT SY; UN Independent Expert Advisory Group Secretary, 2014, WORLD COUNTS MOB DAT; United Nations Environment Programme, 2013, EMB ENV SUST DEV GOA	8	217	233	14	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					432	433		10.1038/520432a	http://dx.doi.org/10.1038/520432a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5LX	25903612	Bronze			2022-12-28	WOS:000353334500014
J	Brown, NJ; Platt, MPW; Beattie, RM				Brown, Nick J.; Platt, Martin P. Ward; Beattie, R. Mark			Women, children, and global public health: beyond the millennium development goals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-INCOME; MORTALITY; INTERVENTIONS; MALNUTRITION; HIV		[Brown, Nick J.; Platt, Martin P. Ward; Beattie, R. Mark] BMJ Publishing, Arch Dis Childhood, London WC1H 9JR, England	BMJ Publishing Group Ltd	Beattie, RM (corresponding author), BMJ Publishing, Arch Dis Childhood, BMA House, London WC1H 9JR, England.	mark.beattie@uhs.nhs.uk		Beattie, Robert Mark/0000-0003-4721-0577				[Anonymous], 2014, ECONOMIST; [Anonymous], 2008, COMM SOC DET HLTH FI; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bustreo F, 2015, ARCH DIS CHILD, V100, pS34, DOI 10.1136/archdischild-2013-305693; Chopra M, 2015, ARCH DIS CHILD, V100, pS2, DOI 10.1136/archdischild-2013-305437; Darmstadt GL, 2015, ARCH DIS CHILD, V100, pS13, DOI 10.1136/archdischild-2013-305557; Every Newborn, ACT PLAN END PREV DE; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Hoppu K, 2015, ARCH DIS CHILD, V100, pS38, DOI 10.1136/archdischild-2013-305705; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Malqvist M, 2015, ARCH DIS CHILD, V100, pS5, DOI 10.1136/archdischild-2013-305722; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Millennium development goals progress report, 2015, ARCH DIS CHILD, V100, ps1; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Oruamabo RS, 2015, ARCH DIS CHILD, V100, pS19, DOI 10.1136/archdischild-2013-305384; Osrin D, 2010, ARCH DIS CHILD, V95, P1039, DOI 10.1136/adc.2009.179366; Prendergast AJ, 2015, ARCH DIS CHILD, V100, pS48, DOI 10.1136/archdischild-2013-305548; Qazi S, 2015, ARCH DIS CHILD, V100, pS23, DOI 10.1136/archdischild-2013-305429; Requejo JH, 2015, ARCH DIS CHILD, V100, pS76, DOI 10.1136/archdischild-2013-305737; Martin JAR, 2015, ARCH DIS CHILD, V100, pS10, DOI 10.1136/archdischild-2014-306164; Shann F, 2010, J PAEDIATR CHILD H, V46, P217, DOI 10.1111/j.1440-1754.2009.01673.x; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Stevens AJ, 2014, ARCH DIS CHILD, V99, P458, DOI 10.1136/archdischild-2013-305240; Sustainable Development Knowledge Platform, SUST DEV GOALS; Trehan I, 2015, ARCH DIS CHILD, V100, P283, DOI 10.1136/archdischild-2014-306026; Unger A, 2013, ARCH DIS CHILD, V98, P799, DOI 10.1136/archdischild-2011-301621; United Nations, MILL DEV GOALS 2015; United Nations Population Fund Guttmacher Institute, 2014, ADD IT COSTS BEN INV; Vogel JP, 2015, ARCH DIS CHILD, V100, pS43, DOI 10.1136/archdischild-2013-305514; Women4GF, WOM ALL THEIR DIV GL; World Bank, 2014, GLOB FIN FAC SUPP EV; World Health Organization, GLOB TARG 2025; World Health Organization, INT MAN CHILDH ILLN	35	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h1755	10.1136/bmj.h1755	http://dx.doi.org/10.1136/bmj.h1755			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25899935				2022-12-28	WOS:000353576300002
J	Lennon, P; Crotty, M; Fenton, JE				Lennon, Paul; Crotty, Michael; Fenton, John E.			Infectious mononucleosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EPSTEIN-BARR-VIRUS; RISK; DIAGNOSIS; CARE		[Lennon, Paul; Fenton, John E.] Univ Hosp Limerick, Dept Otolaryngol Head & Neck Surg, Limerick, Ireland; [Crotty, Michael] Synergy Med Clin, Gen Practice, Edmonton, AB, Canada	University of Limerick	Lennon, P (corresponding author), Univ Hosp Limerick, Dept Otolaryngol Head & Neck Surg, Limerick, Ireland.	paullennon81@gmail.com	Lennon, P/F-6729-2016	Lennon, P/0000-0001-9297-1485				[Anonymous], 2010, LANCET, V376, P930, DOI 10.1016/S0140-6736(10)61432-8; Becker JA, 2014, SPORTS HEALTH, V6, P232, DOI 10.1177/1941738114521984; Candy B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004402.pub2; Centers for Disease Control and Prevention, 2014, EPST BARR VIR INF MO; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Goldacre MJ, 2009, EPIDEMIOL INFECT, V137, P672, DOI 10.1017/S0950268808001246; Hayward G, 2012, COCHRANE DB SYST REV, V10; Hjalgrim H, 2007, CANCER RES, V67, P2382, DOI 10.1158/0008-5472.CAN-06-3566; Hoagland R J, 1975, Prim Care, V2, P295; Hosey RG, 2008, BRIT J SPORT MED, V42, P974, DOI 10.1136/bjsm.2008.050807; Hurt C, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.12.011; Kofteridis DP, 2011, EUR J INTERN MED, V22, P73, DOI 10.1016/j.ejim.2010.07.016; Lennon P, 2014, CLIN MICROBIOL INFEC, V20, pO450, DOI 10.1111/1469-0691.12437; Lennon P, 2010, CLIN OTOLARYNGOL, V35, P397, DOI 10.1111/j.1749-4486.2010.02187.x; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Petersen I, 2006, QJM-INT J MED, V99, P49, DOI 10.1093/qjmed/hci149; SCHUSTER V, 1992, EUR J PEDIATR, V151, P718, DOI 10.1007/BF01959075; Tattevin P, 2006, J CLIN MICROBIOL, V44, P1873, DOI 10.1128/JCM.44.5.1873-1874.2006; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; Torre D, 1999, SCAND J INFECT DIS, V31, P543, DOI 10.1080/00365549950164409; Vouloumanou EK, 2012, CURR OPIN HEMATOL, V19, P14, DOI 10.1097/MOH.0b013e32834daa08	22	34	40	1	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h1825	10.1136/bmj.h1825	http://dx.doi.org/10.1136/bmj.h1825			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25899165				2022-12-28	WOS:000353576300004
J	Cohen, SP; Hanling, S; Bicket, MC; White, R; Veiz, E; Kurihara, C; Zhao, Z; Hayek, S; Guthmiller, KB; Griffith, SR; Gordin, V; White, MA; Vorobeychik, Y; Pasquina, PF				Cohen, Steven P.; Hanling, Steven; Bicket, Mark C.; White, Ronald; Veiz, Elias; Kurihara, Connie; Zhao, Zirong; Hayek, Salim; Guthmiller, Kevin B.; Griffith, Scott R.; Gordin, Vitaly; White, Mirinda Anderson; Vorobeychik, Yakov; Pasquina, Paul F.			Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; NEUROPATHIC PAIN; CORTICOSTEROID INJECTIONS; POSTHERPETIC NEURALGIA; LEEDS ASSESSMENT; CONTROLLED-TRIAL; CLINICAL-TRIALS; SCIATICA; PLACEBO; MANAGEMENT	OBJECTIVE To evaluate whether an epidural steroid injection or gabapentin is a better treatment for lumbosacral radiculopathy. DESIGN A multicenter randomized study conducted between 2011 and 2014. Computer generated randomization was stratified by site. Patients and evaluating physicians were blinded to treatment outcomes. SETTINGS Eight military, Veterans Administration, and civilian hospitals. PARTICIPANTS 145 people with lumbosacral radicular pain secondary to herniated disc or spinal stenosis for less than four years in duration and in whom leg pain is as severe or more severe than back pain. INTERVENTIONS Participants received either epidural steroid injection plus placebo pills or sham injection plus gabapentin. MAIN OUTCOME MEASURES Average leg pain one and three months after the injection on a 0-10 numerical rating scale. A positive outcome was defined as a >= 2 point decrease in leg pain coupled with a positive global perceived effect. All patients had one month follow-up visits; patients whose condition improved remained blinded for their three month visit. RESULTS There were no significant differences for the primary outcome measure at one month (mean pain score 3.3 (SD 2.6) and mean change from baseline -2.2 (SD 2.4) in epidural steroid injection group versus 3.7 (SD 2.6) and -1.7 (SD 2.6) in gabapentin group; adjusted difference 0.4, 95% confidence interval -0.3 to 1.2; P=0.25) and three months (mean pain score 3.4 (SD 2.7) and mean change from baseline -2.0 (SD 2.6) versus 3.7 (SD 2.8) and -1.6 (SD 2.7), respectively; adjusted difference 0.3, -0.5 to 1.2; P=0.43). Among secondary outcomes, one month after treatment those who received epidural steroid injection had greater reductions in worst leg pain (-3.0, SD 2.8) than those treated with gabapentin (-2.0, SD 2.9; P=0.04) and were more likely to experience a positive successful outcome (66% v 46%; number needed to treat=5.0, 95% confidence interval 2.8 to 27.0; P=0.02). At three months, there were no significant differences between treatments. CONCLUSIONS Although epidural steroid injection might provide greater benefit than gabapentin for some outcome measures, the differences are modest and are transient for most people.	[Cohen, Steven P.] Johns Hopkins Sch Med, Dept Anesthesiol, Blaustein Pain Treatment Ctr, Baltimore, MD 21287 USA; [Cohen, Steven P.; Griffith, Scott R.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Hanling, Steven] Naval Med Ctr, Dept Anesthesiol, Pain Med Div, San Diego, CA USA; [Bicket, Mark C.] Massachusetts Gen Hosp, Dept Anesthesiol, Boston, MA 02114 USA; [White, Ronald] Landstuhl Reg Med Ctr, Dept Surg, Interdisciplinary Pain Med, Landstuhl, Germany; [Veiz, Elias] Case Western Univ, Louis Stokes Cleveland VA Med Ctr, Dept Anesthesiol, Pain Med Serv, Cleveland, OH USA; [Kurihara, Connie] Walter Reed Natl Mil Med Ctr, Dept Surg, Anesthesia Serv, Bethesda, MD USA; [Zhao, Zirong] Dist Columbia VA Hosp, Dept Neurol, Washington, DC USA; [Zhao, Zirong] Dist Columbia VA Hosp, Dept Neurol, Washington, MD USA; [Zhao, Zirong] George Washington Univ, Dept Med, Washington, DC USA; [Zhao, Zirong] George Washington Univ, Dept Med, Washington, MD USA; [Hayek, Salim] Case Western Reserve Sch Med, Dept Anesthesiol, Pain Med Div, Cleveland, OH USA; [Guthmiller, Kevin B.] San Antonio Mil Med Ctr, Dept Anesthesiol, Interdisciplinary Pain Management Clin, San Antonio, TX USA; [Guthmiller, Kevin B.] San Antonio Mil Med Ctr, Dept Anesthesiol, Pain Med Fellowship Program, San Antonio, TX USA; [Gordin, Vitaly] Penn State Hershey Med Ctr, Dept Anesthesiol, Pain Med Div, Hershey, PA USA; [White, Mirinda Anderson] Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Vorobeychik, Yakov] Penn State Hershey Med Ctr, Dept Anesthesiol, Hershey, PA USA; [Vorobeychik, Yakov] Penn State Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Pasquina, Paul F.] Univ Hlth Sci, Walter Reed Natl Mil Med Ctr & Uniformed Serv, Dept Phys Med & Rehabil, Bethesda, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego; Harvard University; Massachusetts General Hospital; Landstuhl Regional Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Walter Reed National Military Medical Center; George Washington University; George Washington University; Case Western Reserve University; San Antonio Military Medical Center; San Antonio Military Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cohen, SP (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol, Blaustein Pain Treatment Ctr, Baltimore, MD 21287 USA.	scohen40@jhmi.edu	Hanling, Steven/AAF-9504-2019; hayek, salim/T-5679-2019	Bicket, Mark/0000-0001-9406-5953	Center for Rehabilitation Sciences Research, Bethesda, MD	Center for Rehabilitation Sciences Research, Bethesda, MD	This study was funded by a congressional grant from the Center for Rehabilitation Sciences Research, Bethesda, MD. The funders paid for personnel, medications, and procedures.	Ackerman WE, 2007, ANESTH ANALG, V104, P1217, DOI 10.1213/01.ane.0000260307.16555.7f; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Baron R, 2015, PAIN PRACT, V15, P455, DOI 10.1111/papr.12200; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bicket MC, 2013, ANESTHESIOLOGY, V119, P907, DOI 10.1097/ALN.0b013e31829c2ddd; Botwin Kenneth, 2004, Pain Physician, V7, P211; Brouwers MC, 2012, J CLIN ONCOL, V30, P4202, DOI 10.1200/JCO.2012.42.1644; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Chaparro LE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008943.pub2; Cohen SP, 2007, ANESTHESIOLOGY, V106, P591, DOI 10.1097/00000542-200703000-00024; Cohen SP, 2014, ANESTHESIOLOGY, V121, P1045, DOI 10.1097/ALN.0000000000000409; Cohen SP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7656; Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Crow WT, 2009, J AM OSTEOPATH ASSOC, V109, P229; Department of Health and Human Services Federal Coordinating Council on Comparative-Effectiveness Research, 2009, REP PRES C; Dincer U, 2007, JOINT BONE SPINE, V74, P467, DOI 10.1016/j.jbspin.2006.09.016; Dunn AS, 2011, J REHABIL RES DEV, V48, P493, DOI 10.1682/JRRD.2010.05.0104; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; El Sissi W, 2010, J INT MED RES, V38, P2135, DOI 10.1177/147323001003800629; Fairbank J C, 1980, Physiotherapy, V66, P271; Forster M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068273; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Furman MB, 2012, PAIN MED, V13, P1265, DOI 10.1111/j.1526-4637.2012.01474.x; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Hassan AE, 2004, SAUDI MED J, V25, P1986; Haugen AJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-183; Hill JC, 2011, SPINE, V36, P2168, DOI 10.1097/BRS.0b013e31820712bb; HOPWOOD MB, 1993, REGION ANESTH, V18, P238; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Iversen T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5278; Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009; James KE, 1996, STAT MED, V15, P1421; Johnson P, 2013, CLIN DRUG INVEST, V33, P35, DOI 10.1007/s40261-012-0030-4; Juniper M, 2009, EXPERT OPIN PHARMACO, V10, P2581, DOI 10.1517/14656560903304063; Kaki AM, 2005, REGION ANESTH PAIN M, V30, P422, DOI 10.1016/j.rapm.2005.05.013; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; Koshi Edvin B, 2007, Pain Pract, V7, P4, DOI 10.1111/j.1533-2500.2007.00104.x; Laiq N, 2009, JCPSP-J COLL PHYSICI, V19, P539, DOI 09.2009/JCPSP.539543; Lane P, 2008, PHARM STAT, V7, P93, DOI 10.1002/pst.267; Liedgens H, 2008, CLIN DRUG INVEST, V28, P583, DOI 10.2165/00044011-200828090-00005; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pE969; McCleane GJ, 2001, PAIN CLINIC, V13, P103, DOI 10.1163/156856901753420945; Moore R Andrew, 2014, Cochrane Database Syst Rev, pCD007938, DOI 10.1002/14651858.CD007938.pub3; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Novak S, 2008, ARCH PHYS MED REHAB, V89, P543, DOI 10.1016/j.apmr.2007.11.008; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; Rice ASC, 2001, PAIN, V94, P215, DOI 10.1016/S0304-3959(01)00407-9; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Romano CL, 2009, J ORTHOP TRAUMATOL, V10, P185, DOI 10.1007/s10195-009-0077-z; Sayegh FE, 2009, SPINE, V34, P1441, DOI 10.1097/BRS.0b013e3181a4804a; Skljarevski V, 2009, EUR J NEUROL, V16, P1041, DOI 10.1111/j.1468-1331.2009.02648.x; Vad VB, 2002, SPINE, V27, P11, DOI 10.1097/00007632-200201010-00005; Yildirim K, 2003, PAIN CLINIC, V15, P213, DOI 10.1163/156856903767650718	61	44	44	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1748	10.1136/bmj.h1748	http://dx.doi.org/10.1136/bmj.h1748			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25883095	hybrid, Green Published			2022-12-28	WOS:000353328700005
J	Hatemi, G; Melikoglu, M; Tunc, R; Korkmaz, C; Ozturk, BT; Mat, C; Merkel, PA; Calamia, KT; Liu, ZQ; Pineda, L; Stevens, RM; Yazici, H; Yazici, Y				Hatemi, Gulen; Melikoglu, Melike; Tunc, Recep; Korkmaz, Cengiz; Ozturk, Banu Turgut; Mat, Cem; Merkel, Peter A.; Calamia, Kenneth T.; Liu, Ziqi; Pineda, Lilia; Stevens, Randall M.; Yazici, Hasan; Yazici, Yusuf			Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; DISEASE; TRIAL; COLCHICINE; MULTICENTER; PSORIASIS; EFFICACY; MODERATE	BACKGROUND Oral ulcers, the hallmark of Behcet's syndrome, can be resistant to conventional treatment; therefore, alternative agents are needed. Apremilast is an oral phosphodiesterase-4 inhibitor that modulates several inflammatory pathways. METHODS We conducted a phase 2, multicenter, placebo-controlled study in which 111 patients with Behcet's syndrome who had two or more oral ulcers were randomly assigned to receive 30 mg of apremilast twice daily or placebo for 12 weeks. This regimen was followed by a 12-week extension phase in which the placebo group was switched to apremilast and a 28-day post-treatment observational follow-up phase. The patients and clinicians were unaware of the study assignments throughout the trial. The primary end point was the number of oral ulcers at week 12. Secondary outcomes included pain from these ulcers (measured on a 100-mm visual-analogue scale, with higher scores indicating worse pain), the number of genital ulcers, overall disease activity, and quality of life. RESULTS The mean (+/- SD) number of oral ulcers per patient at week 12 was significantly lower in the apremilast group than in the placebo group (0.5 +/- 1.0 vs. 2.1 +/- 2.6) (P<0.001). The mean decline in pain from oral ulcers from baseline to week 12 was greater with apremilast than with placebo (-44.7 +/- 24.3 mm vs. -16.0 +/- 32.5 mm) (P<0.001). Nausea, vomiting, and diarrhea were more common in the apremilast group (with 22, 9, and 12 incidents, respectively, among 55 patients) than in the placebo group (with 10, 1, and 2 incidents, respectively, among 56 patients), findings that were similar to those in previous studies of apremilast. There were two serious adverse events in patients receiving apremilast. CONCLUSIONS Apremilast was effective in treating oral ulcers, which are the cardinal manifestation of Behcet's syndrome. This preliminary study was neither large enough nor long enough to assess long-term efficacy, the effect on other manifestations of Behcet's syndrome, or the risk of uncommon serious adverse events.	[Hatemi, Gulen; Melikoglu, Melike; Mat, Cem; Yazici, Hasan] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey; [Tunc, Recep; Ozturk, Banu Turgut] Selcuk Univ, Konya, Turkey; [Korkmaz, Cengiz] Eskisehir Osmangazi Univ, Eskisehir, Turkey; [Merkel, Peter A.] Univ Penn, Philadelphia, PA 19104 USA; [Calamia, Kenneth T.] Mayo Clin, Coll Med, Jacksonville, FL 32224 USA; [Liu, Ziqi; Pineda, Lilia; Stevens, Randall M.] Celgene, Warren, NJ USA; [Yazici, Yusuf] NYU, Hosp Joint Dis, New York, NY 10016 USA	Istanbul University; Istanbul University - Cerrahpasa; Selcuk University; Eskisehir Osmangazi University; University of Pennsylvania; Mayo Clinic; Bristol-Myers Squibb; Celgene Corporation; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Yazici, Y (corresponding author), NYU, Sch Med, Hosp Joint Dis, 333 E 38 St, New York, NY 10016 USA.	yusuf.yazici@nyumc.org	Hatemi, Gulen/AAC-9647-2021	Hatemi, Gulen/0000-0002-1952-1135; Melikoglu, Melike/0000-0003-0253-8368	Celgene; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR057319] Funding Source: NIH RePORTER	Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by Celgene; ClinicalTrials.gov number, NCT00866359.	AKTULGA E, 1980, HAEMATOLOGICA, V65, P399; [Anonymous], SF 36 HLTH SURVEY UP; Bhakta BB, 1999, RHEUMATOLOGY, V38, P728, DOI 10.1093/rheumatology/38.8.728; Davatchi F, 2009, MOD RHEUMATOL, V19, P542, DOI 10.1007/s10165-009-0200-2; Forbess C, 2008, 72 ANN SCI M AM COLL; Gilworth G, 2004, J RHEUMATOL, V31, P931; Hatemi G, 2009, ANN RHEUM DIS, V68, P1528, DOI 10.1136/ard.2008.087957; Kumar N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-96; Kural-Seyahi E, 2003, MEDICINE, V82, P60, DOI 10.1097/00005792-200301000-00006; Melikoglu M, 2005, J RHEUMATOL, V32, P98; Papp KA, 2013, J EUR ACAD DERMATOL, V27, pe376, DOI 10.1111/j.1468-3083.2012.04716.x; Papp K, 2012, LANCET, V380, P738, DOI 10.1016/S0140-6736(12)60642-4; Schett G, 2012, ARTHRITIS RHEUM-US, V64, P3156, DOI 10.1002/art.34627; SILMAN AJ, 1990, LANCET, V335, P1078; Wittmann M, 2013, DERMATOLOGY THER, V3, P1, DOI 10.1007/s13555-013-0023-0; YAZICI H, 1984, ANN RHEUM DIS, V43, P783, DOI 10.1136/ard.43.6.783; Yurdakul S, 2001, ARTHRITIS RHEUM-US, V44, P2686, DOI 10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H; Yurdakul S, 2010, BEHCET'S SYNDROME, P35, DOI 10.1007/978-1-4419-5641-5_3	18	154	160	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1510	1518		10.1056/NEJMoa1408684	http://dx.doi.org/10.1056/NEJMoa1408684			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875256	Bronze			2022-12-28	WOS:000352856500006
J	Landrigan, PJ; Baker, DB				Landrigan, Philip J.; Baker, Dean B.			The National Children's Study - End or New Beginning?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Landrigan, Philip J.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Baker, Dean B.] Univ Calif Irvine, Ctr Occupat & Environm Hlth, Irvine, CA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Irvine	Landrigan, PJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.							Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Duncan GJ, 2014, NAT CHILDR STUD 2014; *NAT AC SCI, 1993, PEST DIETS INF CHILD; Pearson H, 2015, NATURE, V518, P463, DOI 10.1038/518463a	4	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1486	1487		10.1056/NEJMp1500276	http://dx.doi.org/10.1056/NEJMp1500276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9BL	25875255	Green Published			2022-12-28	WOS:000352856500003
J	Low, N; Bavdekar, A; Jeyaseelan, L; Hirve, S; Ramanathan, K; Andrews, NJ; Shaikh, N; Jadi, RS; Rajagopal, A; Brown, KE; Brown, D; Fink, JB; John, O; Scott, P; Riveros-Balta, AX; Greco, M; Dhere, R; Kulkarni, PS; Restrepo, AMH				Low, N.; Bavdekar, A.; Jeyaseelan, L.; Hirve, S.; Ramanathan, K.; Andrews, N. J.; Shaikh, N.; Jadi, R. S.; Rajagopal, A.; Brown, K. E.; Brown, D.; Fink, J. B.; John, O.; Scott, P.; Riveros-Balta, A. X.; Greco, M.; Dhere, R.; Kulkarni, P. S.; Restrepo, A. M. Henao			A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							9-MONTH-OLD MEXICAN CHILDREN; IMMUNOGENICITY; IMMUNIZATION; METAANALYSIS; IMMUNITY; ROUTES; VIRUS	BACKGROUND Aerosolized vaccine can be used as a needle-free method of immunization against measles, a disease that remains a major cause of illness and death. Data on the immunogenicity of aerosolized vaccine against measles in children are inconsistent. METHODS We conducted an open-label noninferiority trial involving children 9.0 to 11.9 months of age in India who were eligible to receive a first dose of measles vaccine. Children were randomly assigned to receive a single dose of vaccine by means of either aerosol inhalation or a subcutaneous injection. The primary end points were seropositivity for antibodies against measles and adverse events 91 days after vaccination. The noninferiority margin was 5 percentage points. RESULTS A total of 1001 children were assigned to receive aerosolized vaccine, and 1003 children were assigned to receive subcutaneous vaccine; 1956 of all the children (97.6%) were followed to day 91, but outcome data were missing for 331 children because of thawed specimens. In the per-protocol population, data on 1560 of 2004 children (77.8%) could be evaluated. At day 91, a total of 662 of 775 children (85.4%; 95% confidence interval [CI], 82.5 to 88.0) in the aerosol group, as compared with 743 of 785 children (94.6%; 95% CI, 92.7 to 96.1) in the subcutaneous group, were seropositive, a difference of -9.2 percentage points (95% CI, -12.2 to -6.3). Findings were similar in the full-analysis set (673 of 788 children in the aerosol group [85.4%] and 754 of 796 children in the subcutaneous group [94.7%] were seropositive at day 91, a difference of -9.3 percentage points [95% CI, -12.3 to -6.4]) and after multiple imputation of missing results. No serious adverse events were attributable to measles vaccination. Adverse-event profiles were similar in the two groups. CONCLUSIONS Aerosolized vaccine against measles was immunogenic, but, at the prespecified margin, the aerosolized vaccine was inferior to the subcutaneous vaccine with respect to the rate of seropositivity.	[Low, N.; Scott, P.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Riveros-Balta, A. X.; Restrepo, A. M. Henao] WHO, CH-1211 Geneva 27, Switzerland; [Bavdekar, A.] King Edward Mem Hosp Res Ctr, Dept Pediat, Pune, Maharashtra, India; [Shaikh, N.; Jadi, R. S.] Natl Inst Virol, Pune, Maharashtra, India; [Dhere, R.; Kulkarni, P. S.] Serum Inst India, Pune, Maharashtra, India; [Hirve, S.] Shirdi Sai Baba Hosp, Pune, Maharashtra, India; [Jeyaseelan, L.; Ramanathan, K.; Rajagopal, A.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [John, O.] WHO Reg Off South East Asia, New Delhi, India; [Andrews, N. J.] Publ Hlth England, Stat Unit, London, England; [Brown, K. E.; Brown, D.] Publ Hlth England, Virus Reference Dept, London, England; [Fink, J. B.] Aerogen, Galway, Ireland	University of Bern; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Serum Institute of India; Christian Medical College & Hospital (CMCH) Vellore; Public Health England; Public Health England	Restrepo, AMH (corresponding author), WHO, Implementat Res & Econ Evaluat, Dept Immunizat Vaccines & Biol, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	henaorestrepoa@who.int	Low, Nicola/H-4718-2019; Jadi, Ramesh/AAV-2059-2020	Low, Nicola/0000-0003-4817-8986; Jadi, Ramesh/0000-0002-5710-4893; Brown, Kevin/0000-0002-1568-683X; Scott, Pippa/0000-0003-0849-1812	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funded by the Bill and Melinda Gates Foundation; Measles Aerosol Vaccine Project Clinical Trials Registry-India number, CTRI/2009/091/000673.	[Anonymous], 2002, WORKB INV; [Anonymous], 2001, HDB GOOD LAB PRACT Q; [Anonymous], 2009, IMM BAS IMM SER; [Anonymous], 2014, MEASL DEATHS REACH R; Beutels P, 2003, EPIDEMIOL INFECT, V130, P273, DOI 10.1017/S0950268802008142; Bonhoeffer J, 2009, VACCINE, V27, P2282, DOI 10.1016/j.vaccine.2008.11.036; Bose AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108786; Cohen BJ, 2008, VACCINE, V26, P6392, DOI 10.1016/j.vaccine.2008.08.074; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; Dilraj A, 2000, LANCET, V355, P798, DOI 10.1016/S0140-6736(99)95140-1; Dilraj A, 2007, VACCINE, V25, P4170, DOI 10.1016/j.vaccine.2007.03.003; Fernandez-de Castro J, 1997, Salud Publica Mex, V39, P53; Garrison LP, 2011, J INFECT DIS, V204, pS124, DOI 10.1093/infdis/jir114; Gay NJ, 2004, J INFECT DIS, V189, pS27, DOI 10.1086/381592; Henao-Restrepo AM, 2010, PROCEDIA VACCINOL, V2, P147, DOI 10.1016/j.provac.2010.07.007; Hiremath GS, 2005, HUM VACCINES, V1, P30, DOI 10.4161/hv.1.1.1423; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; KATZ SL, 1959, AMA J DIS CHILD, V98, P605; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Wong-Chew RM, 2011, J INFECT DIS, V204, P426, DOI 10.1093/infdis/jir278; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Omer SB, 2010, LANCET, V375, P706, DOI 10.1016/S0140-6736(09)62028-6; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Whittle HC, 1999, LANCET, V353, P98, DOI 10.1016/S0140-6736(98)02364-2; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P349; Wong-Chew RM, 2004, J INFECT DIS, V189, P254, DOI 10.1086/380565; Wong-Chew RM, 2006, VACCINE, V24, P683, DOI 10.1016/j.vaccine.2005.08.045; World Health Organization, 2013, GLOB VACC ACT PLAN M	29	47	48	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1519	1529		10.1056/NEJMoa1407417	http://dx.doi.org/10.1056/NEJMoa1407417			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875257	Green Published, Bronze			2022-12-28	WOS:000352856500007
J	Rubin, MA				Rubin, Mark A.			Make precision medicine work for cancer care	NATURE			English	Editorial Material							INHIBITION		[Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Rubin, Mark A.] New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Rubin, MA (corresponding author), Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA.	rubinma@med.cornell.edu		Rubin, Mark/0000-0002-8321-9950				Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Kaushal R, 2014, J AM MED INFORM ASSN, V21, P587, DOI 10.1136/amiajnl-2014-002764; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Massard C, 2015, ANN ONCOL, V26, P4, DOI 10.1093/annonc/mdv081.7; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Ramos P., 2014, ONCOGENE; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769	10	46	54	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					290	291		10.1038/520290a	http://dx.doi.org/10.1038/520290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877189	Bronze			2022-12-28	WOS:000352974200015
J	Stonington, SD				Stonington, Scott D.			The art of medicine On the (f)utility of pain	LANCET			English	Editorial Material									[Stonington, Scott D.] Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA; [Stonington, Scott D.] Harvard Univ, Sch Med, Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Stonington, SD (corresponding author), Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA.	scott.stonington@stanfordalumni.org		Stonington, Scott/0000-0002-0472-3885					0	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1388	1389		10.1016/S0140-6736(15)60708-5	http://dx.doi.org/10.1016/S0140-6736(15)60708-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25890410				2022-12-28	WOS:000352719800015
J	Yusuf, S; Wood, D; Ralston, J; Reddy, KS				Yusuf, Salim; Wood, David; Ralston, Johanna; Reddy, K. Srinath			The World Heart Federation's vision for worldwide cardiovascular disease prevention	LANCET			English	Editorial Material							RISK-FACTORS; GLOBAL BURDEN; INTERVENTIONS; INTERHEART; MORTALITY; COUNTRIES; REGIONS; MIDDLE		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Wood, David] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Ralston, Johanna] World Heart Federat, Geneva, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	McMaster University; Population Health Research Institute; McMaster University; Imperial College London; Public Health Foundation of India	Yusuf, S (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Reddy, K Srinath/0000-0003-3416-3548; Yusuf, Salim/0000-0003-4776-5601				Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Dalen JE, 2014, AM J MED, V127, P807, DOI 10.1016/j.amjmed.2014.04.015; ELLIOTT P, 1988, BRIT MED J, V297, P319; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Huff man MD, GLOBAL HEAR IN PRESS; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Kamath DY, 2014, AM HEART J, V168, P690, DOI 10.1016/j.ahj.2014.07.029; Khatib R., 2014, THESIS MCMASTER U; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; United Nations General Assembly, 2011, A66L1 UN GEN ASS; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; World Bank, 2014, WORLD DEV IND HLTH S; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2014, GLOB PROGR REP IMPL; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2014, EUR HEART J, V35, P353, DOI 10.1093/eurheartj/eht407	28	94	102	2	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					399	402		10.1016/S0140-6736(15)60265-3	http://dx.doi.org/10.1016/S0140-6736(15)60265-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	25892680				2022-12-28	WOS:000358448400029
J	Najm, FJ; Madhavan, M; Zaremba, A; Shick, E; Karl, RT; Factor, DC; Miller, TE; Nevin, ZS; Kantor, C; Sargent, A; Quick, KL; Schlatzer, DM; Tang, H; Papoian, R; Brimacombe, KR; Shen, M; Boxer, MB; Jadhav, A; Robinson, AP; Podojil, JR; Miller, SD; Miller, RH; Tesar, PJ				Najm, Fadi J.; Madhavan, Mayur; Zaremba, Anita; Shick, Elizabeth; Karl, Robert T.; Factor, Daniel C.; Miller, Tyler E.; Nevin, Zachary S.; Kantor, Christopher; Sargent, Alex; Quick, Kevin L.; Schlatzer, Daniela M.; Tang, Hong; Papoian, Ruben; Brimacombe, Kyle R.; Shen, Min; Boxer, Matthew B.; Jadhav, Ajit; Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.; Miller, Robert H.; Tesar, Paul J.			Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo	NATURE			English	Article							OLIGODENDROCYTE PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; SPINAL-CORD; RNA-SEQ; DIFFERENTIATION; GLUCOCORTICOIDS; LYSOLECITHIN; TRANSCRIPTS	Multiple sclerosis involves an aberrant autoimmune response and progressive failure of remyelination in the central nervous system. Prevention of neural degeneration and subsequent disability requires remyelination through the generation of new oligodendrocytes, but current treatments exclusively target the immune system. Oligodendrocyte progenitor cells are stem cells in the central nervous system and the principal source of myelinating oligodendrocytes(1). These cells are abundant in demyelinated regions of patients with multiple sclerosis, yet fail to differentiate, thereby representing a cellular target for pharmacological intervention(2). To discover therapeutic compounds for enhancing myelination from endogenous oligodendrocyte progenitor cells, we screened a library of bioactive small molecules on mouse pluripotent epiblast stem-cell-derived oligodendrocyte progenitor cells(3-5). Here we show seven drugs function at nanomolar doses selectively to enhance the generation of mature oligodendrocytes from progenitor cells in vitro. Two drugs, miconazole and clobetasol, are effective in promoting precocious myelination in organotypic cerebellar slice cultures, and in vivo in early postnatal mouse pups. Systemic delivery of each of the two drugs significantly increases the number of new oligodendrocytes and enhances remyelination in a lysolecithin-induced mouse model of focal demyelination. Administering each of the two drugs at the peak of disease in an experimental autoimmune encephalomyelitis mouse model of chronic progressive multiple sclerosis results in striking reversal of disease severity. Immune response assays show that miconazole functions directly as a remyelinating drug with no effect on the immune system, whereas clobetasol is a potent immunosuppressant as well as a remyelinating agent. Mechanistic studies show that miconazole and clobetasol function in oligodendrocyte progenitor cells through mitogen-activated protein kinase and glucocorticoid receptor signalling, respectively. Furthermore, both drugs enhance the generation of human oligodendrocytes from human oligodendrocyte progenitor cells in vitro. Collectively, our results provide a rationale for testing miconazole and clobetasol, or structurally modified derivatives, to enhance remyelination in patients.	[Najm, Fadi J.; Madhavan, Mayur; Shick, Elizabeth; Karl, Robert T.; Factor, Daniel C.; Miller, Tyler E.; Nevin, Zachary S.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Zaremba, Anita; Kantor, Christopher; Sargent, Alex; Miller, Robert H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Miller, Tyler E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Miller, Tyler E.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Quick, Kevin L.] PerkinElmer, Waltham, MA 02451 USA; [Schlatzer, Daniela M.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Tang, Hong; Papoian, Ruben] Univ Cincinnati, Coll Med, Ctr Drug Discovery, Cincinnati, OH 45237 USA; [Brimacombe, Kyle R.; Shen, Min; Boxer, Matthew B.; Jadhav, Ajit] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA; [Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	rhm3@gwu.edu; paul.tesar@case.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022; Robinson, Andrew/AAA-9162-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155; Robinson, Andrew/0000-0002-1867-5634; Miller, Tyler E/0000-0002-1269-1895; Factor, Daniel/0000-0002-3200-7560; Jadhav, Ajit/0000-0001-7955-1451; Nevin, Zachary/0000-0003-4987-924X	US NIH [NS085246, NS030800, NS026543]; NewYork Stem Cell Foundation; Myelin Repair Foundation; Mt. Sinai Health Care Foundation; NIH [T32GM008056, F30CA183510]; Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center [P30CA043703]; CWRU Council; NATIONAL CANCER INSTITUTE [F30CA183510, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000120, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085246, R01NS030800, R01NS026543] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NewYork Stem Cell Foundation; Myelin Repair Foundation; Mt. Sinai Health Care Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center; CWRU Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the US NIH NS085246 (P.J.T. and R.H.M.), NS030800 (R.H.M.), and NS026543 (S.D.M.); NewYork Stem Cell Foundation (P.J.T.); Myelin Repair Foundation (P.J.T., R.H.M., and S.D.M.); Mt. Sinai Health Care Foundation (P.J.T.); and NIH predoctoral training grants T32GM008056 (R.T.K.) and F30CA183510 (T.E.M). Additional support was provided by the Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center (P30CA043703), the CWRU Council to Advance Human Health, and philanthropic support from the Goodman, Long, and Geller families. P.J.T. is a New York Stem Cell Foundation-Robertson Investigator. We are grateful to M. Hitomi, W. Harte, D. Adams, W. Seibel, M. Haag, P. Scacheri, J. Wanta, C. Fang, H. Olsen, T. LaFramboise, J. Song, F. Van den Akker, and M. Shoham for technical assistance and discussion, A. Lager and M. Elitt for comments on the manuscript, B. Trapp for the PLP1 antibody, and B. Barres and B. Zuchero for RNA from in vivo isolated OPCs.	Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ishii A, 2012, J NEUROSCI, V32, P8855, DOI 10.1523/JNEUROSCI.0137-12.2012; JEFFERY ND, 1995, J NEUROCYTOL, V24, P775, DOI 10.1007/BF01191213; KUMAR S, 1989, P NATL ACAD SCI USA, V86, P6807, DOI 10.1073/pnas.86.17.6807; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Morisaki S, 2010, GLIA, V58, P954, DOI 10.1002/glia.20977; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226	30	266	279	5	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					216	+		10.1038/nature14335	http://dx.doi.org/10.1038/nature14335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25896324	Green Accepted			2022-12-28	WOS:000356016700039
J	Frakt, AB; Bagley, N				Frakt, Austin B.; Bagley, Nicholas			Protection or Harm? Suppressing Substance-Use Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							USE DISORDERS; HEALTH-CARE		[Frakt, Austin B.] Vet Affairs Boston Healthcare Syst, Dept Vet Affairs, Boston, MA 02114 USA; [Frakt, Austin B.] Boston Univ, Boston, MA 02215 USA; [Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Bagley, Nicholas] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Frakt, AB (corresponding author), Vet Affairs Boston Healthcare Syst, Dept Vet Affairs, Boston, MA 02114 USA.			Frakt, Austin/0000-0002-0795-5462				Brennan PL, 2001, MED CARE, V39, P39, DOI 10.1097/00005650-200101000-00006; Frakt AB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-79; Hensley S, 2015, POLL MOST AM WOULD S; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x	4	28	28	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1879	1881		10.1056/NEJMp1501362	http://dx.doi.org/10.1056/NEJMp1501362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25875196				2022-12-28	WOS:000354493300002
J	Dalakas, MC				Dalakas, Marinos C.			Inflammatory Muscle Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INCLUSION-BODY MYOSITIS; CYTOSOLIC 5'-NUCLEOTIDASE 1A; T-CELL-RECEPTOR; JUVENILE DERMATOMYOSITIS; NECROTIZING MYOPATHIES; LASER-MICRODISSECTION; CLONAL EXPANSION; REFRACTORY ADULT; DOUBLE-BLIND; POLYMYOSITIS	INFLAMMATORY MYOPATHIES ARE THE LARGEST GROUP OF POTENTIALLY treatable myopathies in children and adults. They constitute a heterogeneous group of disorders that are best classified, on the basis of distinct clinicopathologic features, in four subtypes: dermatomyositis, polymyositis, necrotizing autoimmune myositis, and inclusion-body myositis (throughout this review, I use this term to refer specifically to sporadic inclusion-body myositis). 1-6 A fifth subtype, termed overlap myositis, is also beginning to be recognized. The identification of the correct subtype and the distinction of these conditions from other diseases that have characteristics that mimic these conditions is fundamental, because each subtype has a different prognosis and response to therapies. This review reflects the current knowledge of these conditions, highlights how best to avoid erroneous diagnoses, describes the main clinicopathologic and immunologic features, and provides practical guidelines regarding therapies.	[Dalakas, Marinos C.] Thomas Jefferson Univ, Dept Neurol, Neuromuscular Div, Philadelphia, PA 19107 USA; [Dalakas, Marinos C.] Univ Athens, Sch Med, Neuroimmunol Unit, GR-10679 Athens, Greece	Jefferson University; Athens Medical School; National & Kapodistrian University of Athens	Dalakas, MC (corresponding author), Thomas Jefferson Univ, Dept Neurol, Neuromuscular Div, 901 Walnut St, Philadelphia, PA 19107 USA.	marinos.dalakas@jefferson.edu			Baxter; Therapath Laboratory; CSL Behring; Genzyme; Octapharma	Baxter; Therapath Laboratory; CSL Behring; Genzyme(Sanofi-AventisGenzyme Corporation); Octapharma	Dr. Dalakas reports having served on a data and safety monitoring board for Baxter, serving on steering committees for Grifols/Talecris, Novartis, and Servier, and receiving consulting fees from Baxter, Therapath Laboratory, CSL Behring, and Genzyme and lecture fees from Baxter and Octapharma. No other potential conflict of interest relevant to this article was reported.	Aggarwal R, 2014, ARTHRITIS RHEUMATOL, V66, P740, DOI 10.1002/art.38270; Alexanderson H, 2012, CURR RHEUMATOL REP, V14, P244, DOI 10.1007/s11926-012-0248-4; Allenbach Y, 2014, MEDICINE, V93, P150, DOI 10.1097/MD.0000000000000028; Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070; Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI [10.1016/j.bbadis.201409.005, 10.1016/j.bbadis.2014.09.005]; Badrising UA, 2000, NEUROLOGY, V55, P1385, DOI 10.1212/WNL.55.9.1385; BENDER A, 1995, J EXP MED, V181, P1863, DOI 10.1084/jem.181.5.1863; Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213; Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547; Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552; Bruder J, 2012, J BIOL CHEM, V287, P20986, DOI 10.1074/jbc.M112.356709; Casciola-Rosen L, 2012, CURR OPIN RHEUMATOL, V24, P602, DOI 10.1097/BOR.0b013e328358bd85; Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe; Chen YJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2987; Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326; Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217; Cupler EJ, 1996, BRAIN, V119, P1887, DOI 10.1093/brain/119.6.1887; Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x; Dalakas MC, 2008, ANN NEUROL, V64, P1, DOI 10.1002/ana.21452; Dalakas MC, 2007, ANN NEUROL, V61, P466, DOI 10.1002/ana.21103; Dalakas MC, 2006, NAT CLIN PRACT NEURO, V2, P437, DOI 10.1038/ncpneuro0261; Dalakas Marinos C, 2011, Presse Med, V40, pe237, DOI 10.1016/j.lpm.2011.01.005; Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2; Dalakas MC, 2009, BRAIN, V132, P1536, DOI 10.1093/brain/awp104; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Dalakas MC, 2006, NAT CLIN PRACT RHEUM, V2, P219, DOI 10.1038/ncprheum0140; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Danieli MG, 2011, AUTOIMMUN REV, V10, P144, DOI 10.1016/j.autrev.2010.09.004; Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7; EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402; ENGEL AG, 1986, HUM PATHOL, V17, P704, DOI 10.1016/S0046-8177(86)80180-0; Engel AG, 2008, MYOLOGY, P1335; Ernste FC, 2013, MAYO CLIN PROC, V88, P83, DOI 10.1016/j.mayocp.2012.10.017; Femia AN, 2013, AM J CLIN DERMATOL, V14, P291, DOI 10.1007/s40257-013-0028-6; Fiorentino DF, 2013, ARTHRITIS RHEUM-US, V65, P2954, DOI 10.1002/art.38093; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; Hofbauer M, 2003, P NATL ACAD SCI USA, V100, P4090, DOI 10.1073/pnas.0236183100; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Ivanidze J, 2011, AM J PATHOL, V179, P1347, DOI 10.1016/j.ajpath.2011.05.055; Kiely PDW, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0359-6; Kosmidis ML, 2013, J NEUROL SCI, V334, P123, DOI 10.1016/j.jns.2013.08.007; Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840; Lloyd TE, 2014, NEUROLOGY, V83, P426, DOI 10.1212/WNL.0000000000000642; Luo YB, 2015, BBA-MOL BASIS DIS, V1852, P622, DOI 10.1016/j.bbadis.2014.05.034; Machado P, 2013, ANN RHEUM DIS, V72, P164; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Mastaglia FL, 2003, J CLIN NEUROSCI, V10, P99, DOI 10.1016/S0967-5868(02)00271-0; Moran EM, 2014, NEUROMUSCULAR DISORD, V24, P943, DOI 10.1016/j.nmd.2014.06.432; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Narazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754; Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3; Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42; Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; Rider LG, 2011, JAMA-J AM MED ASSOC, V305, P183, DOI 10.1001/jama.2010.1977; Rothwell S, 2013, CURR OPIN RHEUMATOL, V25, P735, DOI 10.1097/01.bor.0000434676.70268.66; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Schmidt J, 2012, BRAIN, V135, P1102, DOI 10.1093/brain/aws046; Stenzel W, 2012, NEUROPATH APPL NEURO, V38, P632, DOI 10.1111/j.1365-2990.2012.01302.x; Stenzel W, 2015, NEUROLOGY, V84, P1346, DOI 10.1212/WNL.0000000000001422; Suarez-Calvet X, 2014, J PATHOL, V233, P258, DOI 10.1002/path.4346; Taborda AL, 2014, CLIN EXP RHEUMATOL, V32, P188; Thompson B, 2008, J RHEUMATOL, V35, P2080; Valiyil R, 2010, ARTHRIT CARE RES, V62, P1328, DOI 10.1002/acr.20219; van der Meulen MFG, 2003, NEUROLOGY, V61, P316, DOI 10.1212/WNL.61.3.316; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, BRAIN, V126, P1026, DOI 10.1093/brain/awg114; Wilson FC, 2008, J RHEUMATOL, V35, P445; Zong M, 2014, ANN RHEUM DIS, V73, P913, DOI 10.1136/annrheumdis-2012-202857	79	380	408	3	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1734	1747		10.1056/NEJMra1402225	http://dx.doi.org/10.1056/NEJMra1402225			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923553	Green Published			2022-12-28	WOS:000353655000008
J	Fouda, GG; Cunningham, CK; Permar, SR				Fouda, Genevieve G.; Cunningham, Coleen K.; Permar, Sallie R.			Infant HIV-1 Vaccines Supplementing Strategies to Reduce Maternal-Child Transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VACCINATION; RESPONSES; MOTHERS; TRIAL; BORN		[Fouda, Genevieve G.; Cunningham, Coleen K.; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Fouda, Genevieve G.; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University	Permar, SR (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, POB 103020, Durham, NC 27710 USA.	sallie.permar@duke.edu	Fouda, Genevieve/AAY-8099-2020; Fouda, Genevieve/AAR-9720-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD072796] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, P01AI117915, UM1AI068616, UM1AI068632, P30AI064518] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001115, UL1 TR001117, KL2TR001115] Funding Source: Medline; NIAID NIH HHS [UM1 AI068632, UM1 AI106716, 5P30 AI064518, UM1AI068632, UM1AI106716, P30 AI064518, UM1 AI068616, UM1AI068616, P01 AI117915] Funding Source: Medline; NICHD NIH HHS [R03 HD072796] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215; Fouda GG, 2015, J INFECT DIS, V211, P508, DOI 10.1093/infdis/jiu444; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; Njuguna IN, 2014, VACCINE, V32, P5801, DOI 10.1016/j.vaccine.2014.08.034; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	10	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1513	1514		10.1001/jama.2015.1382	http://dx.doi.org/10.1001/jama.2015.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898044	Green Accepted			2022-12-28	WOS:000353198700011
J	Tran, AP; Silver, J				Tran, Amanda P.; Silver, Jerry			Systemically treating spinal cord injury	SCIENCE			English	Editorial Material							REGENERATION FAILURE; AXON REGENERATION; CELLS; SCAR		[Tran, Amanda P.; Silver, Jerry] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Tran, AP (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	jxs10@case.edu		Tran, Amanda/0000-0002-8393-6124				Bertram JP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000397; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Cajal RS., 1928, DEGENERATION REGENER; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Di Maio A, 2011, J NEUROSCI, V31, P4569, DOI 10.1523/JNEUROSCI.4638-10.2011; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042	15	20	23	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					285	286		10.1126/science.aab1615	http://dx.doi.org/10.1126/science.aab1615			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883342				2022-12-28	WOS:000352999000021
J	Altkorn, D; Cifu, AS				Altkorn, Diane; Cifu, Adam S.			Screening for Osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURES; WOMEN		[Altkorn, Diane] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA; [Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Nelson HD, 2010, AHRQ PUBLICATION, V77; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Vogt TM, 2000, MAYO CLIN PROC, V75, P888, DOI 10.4065/75.9.888; Wade SW, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0182-3; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045	10	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1467	1468		10.1001/jama.2015.1064	http://dx.doi.org/10.1001/jama.2015.1064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871674				2022-12-28	WOS:000352821200024
J	Warman, S				Warman, Sylvia			COMMENTARY How I use health apps	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sylviawarman@hotmail.com							0	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1896	10.1136/bmj.h1896	http://dx.doi.org/10.1136/bmj.h1896			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25873259				2022-12-28	WOS:000353327500007
J	Roehmel, JF; Tintelnot, K; Bernhardt, A; Seibold, M; Staab, D; Schwarz, C				Roehmel, Jobst F.; Tintelnot, Kathrin; Bernhardt, Anne; Seibold, Michael; Staab, Doris; Schwarz, Carsten			Arxula adeninivorans causing invasive pulmonary mycosis and fungaemia in cystic fibrosis	LANCET			English	Editorial Material							YEAST		[Roehmel, Jobst F.; Staab, Doris; Schwarz, Carsten] Charite, Div Cyst Fibrosis Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Tintelnot, Kathrin; Bernhardt, Anne; Seibold, Michael] Robert Koch Inst, Mycot & Parasit Agents & Mycobacteria, FG16, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Schwarz, C (corresponding author), Charite, Div Cyst Fibrosis Pediat Pneumol & Immunol, Augustenburger Pl 1, D-13353 Berlin, Germany.	carsten.schwarz@charite.de	Schwarz, Carsten/AFE-4586-2022; Schwarz, Carsten/AAE-9576-2022	Roehmel, Jobst/0000-0002-1535-8852				Agin H, 2011, MYCOPATHOLOGIA, V172, P237, DOI 10.1007/s11046-011-9418-6; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Blyth CC, 2010, J CLIN MICROBIOL, V48, P314, DOI 10.1128/JCM.01470-09; Kunze G, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-66; Soki Hironobu, 2010, Kansenshogaku Zasshi, V84, P210	5	5	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1476	1476		10.1016/S0140-6736(15)60260-4	http://dx.doi.org/10.1016/S0140-6736(15)60260-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25890423				2022-12-28	WOS:000352719800036
J	Spielman, IB				Spielman, I. B.			Assembling a complex quantum ensemble	SCIENCE			English	Editorial Material									[Spielman, I. B.] Univ Maryland, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Spielman, I. B.] NIST, Gaithersburg, MD 20899 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	Spielman, IB (corresponding author), Univ Maryland, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	spielman@nist.gov			Army Research Office's atomtronics Multidisciplinary University Research Initiative (MURI); Air Force Office of Scientific Research Quantum Matter MURI; NIST; NSF through Physics Frontier Center at the Joint Quantum Institute; Direct For Mathematical & Physical Scien [1430094] Funding Source: National Science Foundation	Army Research Office's atomtronics Multidisciplinary University Research Initiative (MURI); Air Force Office of Scientific Research Quantum Matter MURI; NIST(National Institute of Standards & Technology (NIST) - USA); NSF through Physics Frontier Center at the Joint Quantum Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	I thank M. Rigol for helpful conceptual discussions. Supported by Army Research Office's atomtronics Multidisciplinary University Research Initiative (MURI), Air Force Office of Scientific Research Quantum Matter MURI, NIST, and the NSF through the Physics Frontier Center at the Joint Quantum Institute.	Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Schweikhard V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040404; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401	5	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					185	186		10.1126/science.aaa8070	http://dx.doi.org/10.1126/science.aaa8070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859032				2022-12-28	WOS:000352613700024
J	Kristan, WB				Kristan, William B.			Pinning Down Randomness	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS; DYNAMICS	While some behavioral responses to a stimulus are invariant in animals, most are more likely to be variable or stochastic. In this issue, Gordus et al. illuminate a set of combinatorial neuronal activities that control the variability of a chemotactic behavior in response to an odor, providing a tractable system for understanding how stochastic circuit dynamics affect behavior.	Univ Calif San Diego, Div Biol Sci, Sect Neurobiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kristan, WB (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Neurobiol, La Jolla, CA 92093 USA.	wkristan@ucsd.edu						Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	7	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					189	190		10.1016/j.cell.2015.03.036	http://dx.doi.org/10.1016/j.cell.2015.03.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860598	Bronze			2022-12-28	WOS:000352708300008
J	Lane, R				Lane, Richard			John Meara: helping to make surgery truly global	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					522	522		10.1016/S0140-6736(15)60762-0	http://dx.doi.org/10.1016/S0140-6736(15)60762-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	25924838	Bronze			2022-12-28	WOS:000359431900012
J	Wang, CC				Wang, Chuan-Chao			PERSPECTIVE Give youth a chance	NATURE			English	Editorial Material									[Wang, Chuan-Chao] Fudan Univ, Shanghai 200433, Peoples R China; [Wang, Chuan-Chao] Max Planck Inst Sci Human Hist, Jena, Germany	Fudan University	Wang, CC (corresponding author), Fudan Univ, Shanghai 200433, Peoples R China.	cchao.wang@gmail.com	Wang, Chuan-Chao/AGY-2940-2022; Wang, Chuan-Chao/B-2975-2011	Wang, Chuan-Chao/0000-0003-4630-5232; Wang, Chuan-Chao/0000-0001-9628-0307					0	2	2	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S36	S36		10.1038/520S36a	http://dx.doi.org/10.1038/520S36a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25924199	Bronze			2022-12-28	WOS:000353689700009
J	Gostin, LO; Monahan, JT; DeBartolo, MC; Horton, R				Gostin, Lawrence O.; Monahan, John T.; DeBartolo, Mary C.; Horton, Richard			Law's power to safeguard global health: a Lancet-O'Neill Institute, Georgetown University Commission on Global Health and the Law	LANCET			English	Editorial Material									[Gostin, Lawrence O.; DeBartolo, Mary C.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Monahan, John T.] Georgetown Univ, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, INT HLTH REG; Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3; WHO, 2014, EB RESP ROADM; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; WTO, 2014, WTDS43412	5	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1603	1604		10.1016/S0140-6736(15)60756-5	http://dx.doi.org/10.1016/S0140-6736(15)60756-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25911170	Green Submitted			2022-12-28	WOS:000353418000013
J	Filochowski, J				Filochowski, Jan			The current crisis in the NHS: are we missing the point? An essay by Jan Filochowski	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Filochowski, J (corresponding author), Brunel Univ, Sch Informat Syst Comp & Math, Uxbridge UB8 3PH, Middx, England.	jan@filochowski.net						[Anonymous], 2014, TIMES; Barnes S, 2015, HLTH SERVICES J; Clover B, 2015, HLTH SERVICES J, V20, P4; Davis K, 2014, 2014 UPDATE US HLTH; Filochowski J, 2013, TOO GOOD FAIL MANAGE; Helm T, 2015, OBSERVER; House of Commons Library, 2015, HLTH SERVICES J; House of Commons Public Accounts Committee, 2015, FIN STAB NHS BOD; Mid Staffordshire NHS Foundation Trust, 2013, FIN REP; NHS, 2013, KEOGH MORT REV; NHS England Public Health England Health Education England Monitor Care Quality Commission NHS Trust Development Authority, 2014, NHS ENGLAND PUBLIC E	11	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h2122	10.1136/bmj.h2122	http://dx.doi.org/10.1136/bmj.h2122			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RC	25911221				2022-12-28	WOS:000353577000005
J	Bonifacio, E; Ziegler, AG; Klingensmith, G; Schober, E; Bingley, PJ; Rottenkolber, M; Theil, A; Eugster, A; Puff, R; Peplow, C; Buettner, F; Lange, K; Hasford, J; Achenbach, P				Bonifacio, Ezio; Ziegler, Anette-G.; Klingensmith, Georgeanna; Schober, Edith; Bingley, Polly J.; Rottenkolber, Marietta; Theil, Anke; Eugster, Anne; Puff, Ramona; Peplow, Claudia; Buettner, Florian; Lange, Karin; Hasford, Joerg; Achenbach, Peter		Pre-Point Study Group	Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes The Pre-POINT Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							T-CELLS; AUTOANTIBODIES; TOLERANCE	IMPORTANCE Exposing the oral mucosa to antigen may stimulate immune tolerance. It is unknown whether treatment with oral insulin can induce a tolerogenic immune response in children genetically susceptible to type 1 diabetes. OBJECTIVE To assess the immune responses and adverse events associated with orally administered insulin in autoantibody-negative, genetically at-risk children. DESIGN, SETTING, AND PARTICIPANTS The Pre-POINT study, a double-blind, placebo-controlled, dose-escalation, phase 1/2 clinical pilot study performed between 2009 and 2013 in Germany, Austria, the United States, and the United Kingdom and enrolling 25 islet autoantibody-negative children aged 2 to 7 years with a family history of type 1 diabetes and susceptible human leukocyte antigen class II genotypes. Follow-up was completed in August 2013. INTERVENTIONS Children were randomized to receive oral insulin (n = 15) or placebo (n = 10) once daily for 3 to 18 months. Nine children received insulin with dose escalations from 2.5 to 7.5 mg (n = 3), 2.5 to 22.5mg (n = 3), or 7.5 to 67.5 mg (n = 3) after 6 months; 6 children only received doses of 22.5 mg (n = 3) or 67.5 mg (n = 3). MAIN OUTCOMES AND MEASURES An immune response to insulin, measured as serum IgG and saliva IgA binding to insulin, and CD4(+) T-cell proliferative responses to insulin. RESULTS Increases in IgG binding to insulin, saliva IgA binding to insulin, or CD4(+) T-cell proliferative responses to insulin were observed in 2 of 10 (20%[95% CI, 0.1%-45%]) placebo-treated children and in 1 of 6 (16.7%[95% CI, 0.1%-46%]) children treated with 2.5 mg of insulin, 1 of 6 (16.7%[95% CI, 0.1%-46%]) treated with 7.5mg, 2 of 6 (33.3%[95% CI, 0.1%-71%]) treated with 22.5mg, and 5 of 6 (83.3%[95% CI, 53%-99.9%]) treated with 67.5 mg (P = .02). Insulin-responsive T cells displayed regulatory T-cell features after oral insulin treatment. No hypoglycemia, IgE responses to insulin, autoantibodies to glutamic acid decarboxylase or insulinoma-associated antigen 2, or diabetes were observed. Adverse events were reported in 12 insulin-treated children (67 events) and 10 placebo-treated children (35 events). CONCLUSIONS AND RELEVANCE In this pilot study of children at high risk for type 1 diabetes, daily oral administration of 67.5mg of insulin, compared with placebo, resulted in an immune response without hypoglycemia. These findings support the need for a phase 3 trial to determine whether oral insulin can prevent islet autoimmunity and diabetes in such children.	[Bonifacio, Ezio; Theil, Anke; Eugster, Anne] Tech Univ Dresden, Fac Med, DEG Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Bonifacio, Ezio] Tech Univ Dresden, German Ctr Diabet Res DZD, Paul Langerhans Inst Dresden, D-01062 Dresden, Germany; [Bonifacio, Ezio; Ziegler, Anette-G.; Achenbach, Peter] Forschergrp Diabet eV, Neuherberg, Germany; [Ziegler, Anette-G.; Puff, Ramona; Peplow, Claudia; Achenbach, Peter] Tech Univ Munich, Helmholtz Zentrum Munchen, Diabet Res Inst, D-80290 Munich, Germany; [Ziegler, Anette-G.; Puff, Ramona; Peplow, Claudia; Achenbach, Peter] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, D-80290 Munich, Germany; [Klingensmith, Georgeanna] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Schober, Edith] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Bingley, Polly J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Rottenkolber, Marietta; Hasford, Joerg] Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany; [Buettner, Florian] Helmholtz Zentrurn Munchen, Inst Computat Biol, Munich, Germany; [Lange, Karin] Hannover Med Sch, Dept Med Psychol, Hannover, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of Vienna; University of Bristol; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School	Bonifacio, E (corresponding author), DFG Ctr Regenerat Therapies Dresden, Fetscherstr 105, D-01307 Dresden, Germany.	ezio.bonifacio@crt-dresden.de	Buettner, Florian/ABF-1230-2020; Achenbach, Peter/M-9867-2014; Fuchs, Anke/ABF-9480-2020; Ziegler, Anette-Gabriele/M-4614-2014; Bonifacio, Ezio/E-7700-2010	Buettner, Florian/0000-0001-5587-6761; Achenbach, Peter/0000-0001-6720-2684; Fuchs, Anke/0000-0003-3028-0827; Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713; Puff, Ramona/0000-0001-9752-0122; Rami-Merhar, Birgit/0000-0001-5575-5222; Theis, Fabian/0000-0002-2419-1943	Juvenile Diabetes Research Foundation [8-2006-1091]; Bundesministerium fur Bildung und Forschung in Germany [01 KG 0704]; Deutsche Forschungs Gemeinschaft [FZ-111]; German Federal Ministry of Education and Research (BMBF)	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Bundesministerium fur Bildung und Forschung in Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by grant 8-2006-1091 from the Juvenile Diabetes Research Foundation (Bonifacio), grant 01 KG 0704 from the Bundesministerium fur Bildung und Forschung in Germany (Bonifacio), grant FZ-111 from the Deutsche Forschungs Gemeinschaft, and funding from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). Insulin crystals were provided by Lilly Pharmaceuticals.	Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Barker JM, 2007, DIABETOLOGIA, V50, P1603, DOI 10.1007/s00125-007-0694-0; Bonifacio E, 2004, DIABETES CARE, V27, P2695, DOI 10.2337/diacare.27.11.2695; Bonifacio E, 1999, J IMMUNOL, V163, P525; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; Eugster A, 2013, J IMMUNOL METHODS, V400, P13, DOI 10.1016/j.jim.2013.11.003; Fonte Pedro, 2013, J Diabetes Sci Technol, V7, P520; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Koczwara K, 2007, CLIN IMMUNOL, V124, P77, DOI 10.1016/j.clim.2007.03.545; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Svingos RS, 2013, PHARMACOTHERAPY, V33, pe28, DOI 10.1002/phar.1207; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Takiishi T, 2012, J CLIN INVEST, V122, P1717, DOI 10.1172/JCI60530; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Williams AJK, 1997, J AUTOIMMUN, V10, P473, DOI 10.1006/jaut.1997.0154; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	30	125	128	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1541	1549		10.1001/jama.2015.2928	http://dx.doi.org/10.1001/jama.2015.2928			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898052	Bronze			2022-12-28	WOS:000353198700019
J	Ribic, CM; Clase, CM				Ribic, Christine M.; Clase, Catherine M.			Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DABIGATRAN; WARFARIN		[Ribic, Christine M.; Clase, Catherine M.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Ribic, CM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Jun M, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h246, 10.1136/bmj.h246]; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC3	10.7326/ACPJC-2015-162-8-003	http://dx.doi.org/10.7326/ACPJC-2015-162-8-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894048				2022-12-28	WOS:000353244300002
J	Sen, A				Sen, Ayan			Review: In acute respiratory failure, prehospital CPAP reduces mortality and intubation rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VENTILATION; DISTRESS		Mayo Clin, Dept Crit Care Med, Phoenix, AZ 85054 USA	Mayo Clinic; Mayo Clinic Phoenix	Sen, A (corresponding author), Mayo Clin, Dept Crit Care Med, Phoenix, AZ 85054 USA.							Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Diez A, 2011, DEFENDING LUNG INJUR; Mal S, 2014, ANN EMERG MED, V63, P600, DOI 10.1016/j.annemergmed.2013.11.013; Shahin J, 2015, J CRIT CARE, V30, P649, DOI [10.1016/j.jcrc.2015.03.003, 10.1016/j.jcrc.2014.09.021]	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8							JC5	10.7326/ACPJC-2015-162-8-005	http://dx.doi.org/10.7326/ACPJC-2015-162-8-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894050				2022-12-28	WOS:000353244300004
J	Stockman, MI				Stockman, Mark I.			Nanoplasmonic sensing and detection	SCIENCE			English	Editorial Material									[Stockman, Mark I.] Georgia State Univ, Ctr Nanoopt CeNO, Atlanta, GA 30302 USA; [Stockman, Mark I.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Stockman, MI (corresponding author), Georgia State Univ, Ctr Nanoopt CeNO, 29 Peachtree Ctr Ave, Atlanta, GA 30302 USA.	mstockman@gsu.edu						Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Dantham VR, 2013, NANO LETT, V13, P3347, DOI 10.1021/nl401633y; De Angelis F, 2011, NAT PHOTONICS, V5, P683, DOI [10.1038/NPHOTON.2011.222, 10.1038/nphoton.2011.222]; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Li N, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.107; Ma RM, 2014, NAT NANOTECHNOL, V9, P600, DOI [10.1038/nnano.2014.135, 10.1038/NNANO.2014.135]; Malmqvist Magnus, 1994, Journal of Molecular Recognition, V7, P1, DOI 10.1002/jmr.300070102; Novotny L., 2012, PRINCIPLES NANOOPTIC; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; Stockman MI, 2011, OPT EXPRESS, V19, P22029, DOI 10.1364/OE.19.022029; Stockman MI, 2011, PHYS TODAY, V64, P39, DOI 10.1063/1.3554315; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Wong WR, 2014, ANAL CHEM, V86, P1735, DOI 10.1021/ac403539k; Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u	15	126	130	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					287	288		10.1126/science.aaa6805	http://dx.doi.org/10.1126/science.aaa6805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883343				2022-12-28	WOS:000352999000022
J	Navarese, EP; Andreotti, F; Schulze, V; Kolodziejczak, M; Buffon, A; Brouwer, M; Costa, F; Kowalewski, M; Parati, G; Lip, GYH; Kelm, M; Valgimigli, M				Navarese, Eliano Pio; Andreotti, Felicita; Schulze, Volker; Kolodziejczak, Michalina; Buffon, Antonino; Brouwer, Marc; Costa, Francesco; Kowalewski, Mariusz; Parati, Gianfranco; Lip, Gregory Y. H.; Kelm, Malte; Valgimigli, Marco			Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BARE METAL STENT; CLOPIDOGREL THERAPY; IMPLANTATION; THROMBOSIS; RATIONALE; EFFICACY; DESIGN; SAFETY; SOCIETY; TERM	OBJECTIVE To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents. DESIGN Meta-analysis of randomised controlled trials. DATA SOURCES PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, Scopus, Web of Science, Cochrane Library, and major congress proceedings, searched from 1 January 2002 to 16 February 2015. REVIEW METHODS Trials comparing short term (<12 months) or extended (>12 months) DAPT regimens with standard 12 month duration of therapy. Primary outcomes were cardiovascular mortality, myocardial infarction, stent thrombosis, major bleeding, and all cause mortality. RESULTS 10 randomised controlled trials (n=32 287) were included. Compared to 12 month DAPT, a short term course of therapy was associated with a significant reduction in major bleeding (odds ratio 0.58 (95% confidence interval 0.36 to 0.92); P=0.02) with no significant differences in ischaemic or thrombotic outcomes. Extended versus 12 month DAPT yielded a significant reduction in the odds of myocardial infarction (0.53 (0.42 to 0.66); P<0.001) and stent thrombosis (0.33 (0.21 to 0.51); P<0.001), but more major bleeding (1.62 (1.26 to 2.09); P<0.001). All cause but not cardiovascular death was also significantly increased (1.30 (1.02 to 1.66); P=0.03). CONCLUSIONS Compared with a standard 12 month duration, short term DAPT (<12 months) after drug eluting stent implementation yields reduced bleeding with no apparent increase in ischaemic complications, and could be considered for most patients. In selected patients with low bleeding risk and very high ischaemic risk, extended DAPT (>12 months) could be considered. The increase in all cause but not cardiovascular death with extended DAPT requires further investigation.	[Navarese, Eliano Pio; Schulze, Volker; Kolodziejczak, Michalina; Kelm, Malte] Univ Dusseldorf, Dept Internal Med, Div Cardiol Pulmonol & Vasc Med, D-40225 Dusseldorf, Germany; [Navarese, Eliano Pio; Andreotti, Felicita; Schulze, Volker; Kolodziejczak, Michalina; Buffon, Antonino; Brouwer, Marc; Kowalewski, Mariusz; Lip, Gregory Y. H.; Kelm, Malte] Med Res network, SIRIO, Dusseldorf, Germany; [Andreotti, Felicita; Buffon, Antonino] Catholic Univ, Dept Cardiovasc Sci, Rome, Italy; [Kolodziejczak, Michalina] Nicholas Copernicus Univ, Coll Med Bydgoszcz, Torun, Poland; [Brouwer, Marc] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Costa, Francesco; Valgimigli, Marco] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands; [Kowalewski, Mariusz] 10th Mil Res Hosp & Polyclin, Dept Cardiol, Bydgoszcz, Poland; [Parati, Gianfranco] Univ Milano Bicocca, San Luca Hosp, Dept Cardiovasc Neural & Metab Sci, Milan, Italy; [Lip, Gregory Y. H.] Univ Birmingham, City Hos, Ctr Cardiovasc Sci, Dept Cardiol, Birmingham, W Midlands, England	Heinrich Heine University Dusseldorf; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Nicolaus Copernicus University; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; University of Milano-Bicocca; University of Birmingham	Navarese, EP (corresponding author), Univ Dusseldorf, Dept Internal Med, Div Cardiol Pulmonol & Vasc Med, D-40225 Dusseldorf, Germany.	eliano.navarese@alice.it	Kowalewski, Mariusz/AAA-6845-2020; Kołodziejczak, Michalina/AAL-3968-2020; Brouwer, Marc A/B-1158-2014; Costa, Francesco/O-1304-2019; Valgimigli, Marco/AAE-9103-2019; Parati, Gianfranco/K-7151-2016; Andreotti, Felicita/A-9962-2019	Kołodziejczak, Michalina/0000-0001-5969-6055; Costa, Francesco/0000-0002-3097-2834; Valgimigli, Marco/0000-0002-4353-7110; Parati, Gianfranco/0000-0001-9402-7439; Andreotti, Felicita/0000-0002-1456-6430; Brouwer, Marc/0000-0001-8617-7672; Navarese, Eliano/0000-0002-2355-4589; Kelm, Malte/0000-0003-0060-1052	Collaborative Research Center 1116 Masterswitches in Myocardial Ischemia - German Research Council (Deutsche Forschungsgemeinschaft)	Collaborative Research Center 1116 Masterswitches in Myocardial Ischemia - German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Part of this study was supported by the Collaborative Research Center 1116 Masterswitches in Myocardial Ischemia, funded by the German Research Council (Deutsche Forschungsgemeinschaft).	Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Barone-Rochette G, 2011, AM J CARDIOL, V108, P1401, DOI 10.1016/j.amjcard.2011.07.004; Cassese S, 2012, EUR HEART J, V33, P3078, DOI 10.1093/eurheartj/ehs318; Claessen BE, 2014, JACC-CARDIOVASC INTE, V7, P1081, DOI 10.1016/j.jcin.2014.05.016; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Collet JP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.029; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; El-Hayek G, 2014, AM J CARDIOL, V114, P236, DOI 10.1016/j.amjcard.2014.04.035; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; Faxon DP, 2012, CIRC-CARDIOVASC INTE, V5, P372, DOI 10.1161/CIRCINTERVENTIONS.111.967257; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Feres F, 2012, AM HEART J, V164, P810, DOI 10.1016/j.ahj.2012.09.009; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Kikkert WJ, 2014, J AM COLL CARDIOL, V63, P1866, DOI 10.1016/j.jacc.2014.01.069; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mauri L, 2010, AM HEART J, V160, P1035, DOI 10.1016/j.ahj.2010.07.038; Navarese EP, 2013, MINERVA CARDIOANGIOL, V61, P243; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; Navarese EP, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000064; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Savovic J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-37; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; SEEGER P, 1968, PSYCHOL BULL, V69, P269, DOI 10.1037/h0025667; Siddiqi OK, 2012, CURR OPIN CARDIOL, V27, P634, DOI 10.1097/HCO.0b013e3283587c7e; Steg PG, 2011, EUR HEART J, V32, P1854, DOI 10.1093/eurheartj/ehr204; Tarantini G, 2014, AM HEART J, V167, P401, DOI 10.1016/j.ahj.2013.11.013; Valgimigli M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6427; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Valgimigli M, 2010, AM HEART J, V160, P804, DOI 10.1016/j.ahj.2010.07.034; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	38	182	191	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1618	10.1136/bmj.h1618	http://dx.doi.org/10.1136/bmj.h1618			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25883067	Green Published, hybrid			2022-12-28	WOS:000353328700001
J	O'Connor, RM; Kenny, PJ				O'Connor, Richard M.; Kenny, Paul J.			NEUROSCIENCE Binge drinking and brain stress systems	NATURE			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; AMINOBUTYRIC-ACID RELEASE; ALCOHOL DEPENDENCE; KEY ROLE; AMYGDALA; DEPRESSION; ANXIETY	The discovery that interactions between two stress-associated neuropeptide hormones regulate binge drinking in mice provides insight into the biological mechanisms that underpin the bingeing cycle.	[O'Connor, Richard M.; Kenny, Paul J.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	O'Connor, RM (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	paul.kenny@mssm.edu	O'Connor, Richard/G-2445-2017	O'Connor, Richard/0000-0001-5351-8856				Erb S, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0006.1999; Gilpin NW, 2011, BIOL PSYCHIAT, V69, P1091, DOI 10.1016/j.biopsych.2011.02.004; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Pleil K. E., 2015, NATURE NEUROSCI; POHORECKY LA, 1981, NEUROSCI BIOBEHAV R, V5, P209, DOI 10.1016/0149-7634(81)90003-8; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007	9	2	2	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					168	169		10.1038/520168a	http://dx.doi.org/10.1038/520168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855451				2022-12-28	WOS:000352454600027
J	Sharma, P; Allison, JP				Sharma, Padmanee; Allison, James P.			Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential	CELL			English	Review							COLONY-STIMULATING FACTOR; CTLA-4 BLOCKADE SYNERGIZES; RESISTANT PROSTATE-CANCER; T-CELLS; IMMUNOTHERAPY; MELANOMA; PD-1; ACTIVATION; IPILIMUMAB; SURVIVAL	Research in two fronts has enabled the development of therapies that provide significant benefit to cancer patients. One area stems from a detailed knowledge of mutations that activate or inactivate signaling pathways that drive cancer development. This work triggered the development of targeted therapies that lead to clinical responses in the majority of patients bearing the targeted mutation, although responses are often of limited duration. In the second front are the advances in molecular immunology that unveiled the complexity of the mechanisms regulating cellular immune responses. These developments led to the successful targeting of immune checkpoints to unleash anti-tumor T cell responses, resulting in durable long-lasting responses but only in a fraction of patients. In this Review, we discuss the evolution of research in these two areas and propose that intercrossing them and increasing funding to guide research of combination of agents represent a path forward for the development of curative therapies for the majority of cancer patients.	[Sharma, Padmanee; Allison, James P.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	padsharma@mdanderson.org; jallison@mdanderson.org		Allison, James/0000-0001-8980-5697	PCF Challenge Grant in Immunology; NCI/NIH [1-R01 CA1633793-01]; Cancer Prevention Research in Texas grants; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE [R01CA163793, P30CA016672] Funding Source: NIH RePORTER	PCF Challenge Grant in Immunology; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research in Texas grants; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P.S. and J.P.A. are founders and advisors for Jounce Therapeutics. P.S. also serves as a consultant for Bristol-Myers Squibb, Amgen, and Glaxo SmithKline. J.P.A. is an inventor of intellectual property owned by the University of California, Berkeley, and licensed to Bristol-Myers Squibb and has received royalties from Bristol-Myers Squibb. Our research is supported by a PCF Challenge Grant in Immunology (J.P.A. and P.S.), NCI/NIH 1-R01 CA1633793-01 (P.S.), Cancer Prevention Research in Texas grants (J.P.A. and P.S.), and a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Cancer Research Grant (P.S. and J.P.A.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brignone C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-71; Brignone C, 2009, CLIN CANCER RES, V15, P6225, DOI 10.1158/1078-0432.CCR-09-0068; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen YB, 2014, INTELL SYST SER, P1, DOI 10.1016/B978-0-12-397199-9.00001-X; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao J., 2015, ONCOGENE; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurwitz AA, 1998, P NATL ACAD SCI USA, V95, P10067, DOI 10.1073/pnas.95.17.10067; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Le Mercier I, 2014, CANCER RES, V74, P1933, DOI 10.1158/0008-5472.CAN-13-1506; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; MUELLER DL, 1989, J IMMUNOL, V142, P2617; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramanujam S, 2015, CHIN CLIN ONCOL, V4, DOI 10.3978/j.issn.2304-3865.2015.06.06; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shoushtari AN, 2015, J CLIN ONCOL, V33; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Waitz R, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19442; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	80	1427	1504	15	425	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					205	214		10.1016/j.cell.2015.03.030	http://dx.doi.org/10.1016/j.cell.2015.03.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860605	Bronze, Green Accepted			2022-12-28	WOS:000352708300015
J	Yano, JM; Yu, K; Donaldson, GP; Shastri, GG; Ann, P; Ma, L; Nagler, CR; Ismagilov, RF; Mazmanian, SK; Hsiao, EY				Yano, Jessica M.; Yu, Kristie; Donaldson, Gregory P.; Shastri, Gauri G.; Ann, Phoebe; Ma, Liang; Nagler, Cathryn R.; Ismagilov, Rustem F.; Mazmanian, Sarkis K.; Hsiao, Elaine Y.			Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis	CELL			English	Article							VITAMIN-E; GASTROINTESTINAL MOTILITY; PERIPHERAL SEROTONIN; MAJOR DEPRESSION; SP NOV.; ACID; MICROFLORA; MICE; LIFE; TRANSPORTER	The gastrointestinal (GI) tract contains much of the body's serotonin (5-hydroxytryptamine, 5-HT), but mechanisms controlling the metabolism of gut-derived 5-HT remain unclear. Here, we demonstrate that the microbiota plays a critical role in regulating host 5-HT. Indigenous spore-forming bacteria (Sp) from the mouse and human microbiota promote 5-HT biosynthesis from colonic enterochromaffin cells (ECs), which supply 5-HT to the mucosa, lumen, and circulating platelets. Importantly, microbiota-dependent effects on gut 5-HT significantly impact host physiology, modulating GI motility and platelet function. We identify select fecal metabolites that are increased by Sp and that elevate 5-HT in chromaffin cell cultures, suggesting direct metabolic signaling of gut microbes to ECs. Furthermore, elevating luminal concentrations of particular microbial metabolites increases colonic and blood 5-HT in germ-free mice. Altogether, these findings demonstrate that Sp are important modulators of host 5-HT and further highlight a key role for host-microbiota interactions in regulating fundamental 5-HT-related biological processes.	[Yano, Jessica M.; Yu, Kristie; Donaldson, Gregory P.; Shastri, Gauri G.; Ann, Phoebe; Mazmanian, Sarkis K.; Hsiao, Elaine Y.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ma, Liang; Ismagilov, Rustem F.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	California Institute of Technology; California Institute of Technology; University of Chicago; University of Chicago	Hsiao, EY (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	ehsiao@caltech.edu		Donaldson, Gregory/0000-0002-8551-374X; Yu, Kristie/0000-0001-6735-3968	NIH [5DP5OD017924]; Caltech Center for Environmental Microbial Interactions Award; National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award [EFRI-1137089]; National Human Genome Research Institute (NHGRI) grant [R01HG005826]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant [DK078938]; National Institute of Mental Health (NIMH) grant [MH100556]; National Institute of Allergy and Infectious Diseases (NIAID) grant [AI106302]; Food Allergy Research and Education (FARE); University of Chicago Digestive Diseases Center Core Grant [P30DK42086]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, R56DK078938, P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Center for Environmental Microbial Interactions Award; National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award(National Science Foundation (NSF)); National Human Genome Research Institute (NHGRI) grant; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant; National Institute of Mental Health (NIMH) grant; National Institute of Allergy and Infectious Diseases (NIAID) grant; Food Allergy Research and Education (FARE); University of Chicago Digestive Diseases Center Core Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the assistance of Andrew Stefka and Taylor Feehley (University of Chicago) for contributing pilot serum and fecal samples, Taren Thron, Sara McBride, and Alyssa Maskell for caring for the animals, Drs. Nathan Dalleska and Jesse Allen (Caltech) for conducting pilot LC/MS experiments, Said Bogatyrev (Caltech) for helpful advice, Natasha Shelby (Caltech) for editing the manuscript, and the late Dr. Paul H. Patterson for his valuable support. This work was supported by the NIH Director's Early Independence Award (5DP5OD017924 to E.Y.H.), Caltech Center for Environmental Microbial Interactions Award (to E.Y.H.), National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award (EFRI-1137089 to R.F.I. and S.K.M.), National Human Genome Research Institute (NHGRI) grant (R01HG005826 to R.F.I.), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant (DK078938 to S.K.M.) and National Institute of Mental Health (NIMH) grant (MH100556 to S.K.M.), National Institute of Allergy and Infectious Diseases (NIAID) grant (AI106302 to C.R.N.), and Food Allergy Research and Education (FARE) and University of Chicago Digestive Diseases Center Core Grant (P30DK42086 to C.R.N.).	Abdala-Valencia H, 2012, AM J PHYSIOL-LUNG C, V303, pL642, DOI 10.1152/ajplung.00406.2011; Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HIRANO S, 1981, APPL ENVIRON MICROB, V41, P737, DOI 10.1128/AEM.41.3.737-745.1981; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Kitahara M, 2001, INT J SYST EVOL MICR, V51, P39, DOI 10.1099/00207713-51-1-39; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Lobato KR, 2010, BEHAV BRAIN RES, V209, P249, DOI 10.1016/j.bbr.2010.02.002; Ma L, 2014, P NATL ACAD SCI USA, V111, P9768, DOI 10.1073/pnas.1404753111; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Marcobal A, 2012, CRIT REV FOOD SCI, V52, P448, DOI 10.1080/10408398.2010.500545; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Narushima S, 2006, LIPIDS, V41, P835, DOI 10.1007/s11745-006-5038-1; Neufeld KAM, 2013, NEUROGASTROENT MOTIL, V25, P183, DOI 10.1111/nmo.12049; Nieswandt Bernhard, 2004, Methods Mol Biol, V272, P255; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; ODELL TT, 1961, P SOC EXP BIOL MED, V106, P107; Oleskin A. V., 1998, Mikrobiologiya, V67, P305; Owen AJ, 2005, EUR J CLIN NUTR, V59, P304, DOI 10.1038/sj.ejcn.1602072; Quigley EMM, 2011, J NEUROGASTROENTEROL, V17, P140, DOI 10.5056/jnm.2011.17.2.140; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Roshchina VV, 2010, MICROBIAL ENDOCRINOLOGY: INTERKINGDOM SIGNALING IN INFECTIOUS DISEASE AND HEALTH, P17, DOI 10.1007/978-1-4419-5576-0_2; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Sjogren K, 2012, BONE, V50, pS91, DOI [10.1016/j.bone.2012.02.272, 10.1002/jbmr.1588]; Stasi C, 2014, TECH COLOPROCTOL, V18, P613, DOI 10.1007/s10151-013-1106-8; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Wade PR, 1996, J NEUROSCI, V16, P2352; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WESTPHAL JF, 1994, J ANTIMICROB CHEMOTH, V33, P387, DOI 10.1093/jac/33.3.387; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhao Y, 2010, J AGR FOOD CHEM, V58, P4844, DOI 10.1021/jf904464u; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004	72	1537	1671	57	599	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					264	276		10.1016/j.cell.2015.02.047	http://dx.doi.org/10.1016/j.cell.2015.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860609	Bronze, Green Accepted			2022-12-28	WOS:000352708300020
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Clinical leadership team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1888	10.1136/bmj.h1888	http://dx.doi.org/10.1136/bmj.h1888			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25855671				2022-12-28	WOS:000352907500006
J	Chaillet, N; Dumont, A; Abrahamowicz, M; Pasquier, JC; Audibert, F; Monnier, P; Abenhaim, HA; Dube, E; Dugas, M; Burne, R; Fraser, WD				Chaillet, Nils; Dumont, Alexandre; Abrahamowicz, Michal; Pasquier, Jean-Charles; Audibert, Francois; Monnier, Patricia; Abenhaim, Haim A.; Dube, Eric; Dugas, Marylene; Burne, Rebecca; Fraser, William D.		QUARISMA Trial Res Grp	A Cluster-Randomized Trial to Reduce Cesarean Delivery Rates in Quebec	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRACTICE GUIDELINES; MATERNAL MORTALITY; SECTION; HEALTH; MODE; RISK; LABOR; OUTCOMES; OPINION; AUDIT	BACKGROUND In Canada, cesarean delivery rates have increased substantially over the past decade. Effective, safe strategies are needed to reduce these rates. METHODS We conducted a cluster-randomized, controlled trial of a multifaceted 1.5-year intervention at 32 hospitals in Quebec. The intervention involved audits of indications for cesarean delivery, provision of feedback to health professionals, and implementation of best practices. The primary outcome was the cesarean delivery rate in the 1-year postintervention period. RESULTS Among the 184,952 participants, 53,086 women delivered in the year before the intervention and 52,265 women delivered in the year following the intervention. There was a significant but small reduction in the rate of cesarean delivery from the preintervention period to the postintervention period in the intervention group as compared with the control group (change, 22.5% to 21.8% in the intervention group and 23.2% to 23.5% in the control group; odds ratio for incremental change over time, adjusted for hospital and patient characteristics, 0.90; 95% confidence interval [CI], 0.80 to 0.99; P = 0.04; adjusted risk difference, -1.8%; 95% CI, -3.8 to -0.2). The cesarean delivery rate was significantly reduced among women with low-risk pregnancies (adjusted risk difference, -1.7%; 95% CI, -3.0 to -0.3; P = 0.03) but not among those with high-risk pregnancies (P = 0.35; P = 0.03 for interaction). The intervention group also had a reduction in major neonatal morbidity as compared with the control group (adjusted risk difference, -0.7%; 95% CI, -1.3 to -0.1; P = 0.03) and a smaller increase in minor neonatal morbidity (adjusted risk difference, -1.7%; 95% CI, -2.6 to -0.9; P<0.001). Changes in minor and major maternal morbidity did not differ significantly between the groups. CONCLUSIONS Audits of indications for cesarean delivery, feedback for health professionals, and implementation of best practices, as compared with usual care, resulted in a significant but small reduction in the rate of cesarean delivery, without adverse effects on maternal or neonatal outcomes. The benefit was driven by the effect of the intervention in low-risk pregnancies.	[Chaillet, Nils; Pasquier, Jean-Charles; Dube, Eric; Fraser, William D.] CHU Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ J1H 5N4, Canada; [Abrahamowicz, Michal; Burne, Rebecca] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Audibert, Francois] Univ Montreal, Dept Obstet & Gynecol, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Monnier, Patricia] McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; [Abenhaim, Haim A.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Dugas, Marylene] CHU Quebec, Populat Hlth & Optimal Hlth Practices Res Unit, Res Ctr, Quebec City, PQ, Canada; [Dumont, Alexandre] Univ Paris 05, Sorbonne Paris Cite, Inst Dev Res, UMR 216, Paris, France	University of Sherbrooke; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Royal Victoria Hospital; McGill University; Laval University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Chaillet, N (corresponding author), Univ Sherbrooke, Dept Obstet & Gynecol, Fac Med & Hlth Sci, CHUS,Ctr Rech Clin, 3001,12e Ave Nord,Local 2921, Sherbrooke, PQ J1H 5N4, Canada.	nils.chaillet@usherbrooke.ca	Johri, Mira/D-5104-2013; Audibert, François/AAL-1265-2020	Johri, Mira/0000-0001-5642-787X; Audibert, Francois/0000-0002-2697-3826; Abrahamowicz, Michal/0000-0002-3172-3952	Canadian Institutes of Health Research [200702MCT-171307-RFA-CFCF-153236, MOP 81275]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by grants (200702MCT-171307-RFA-CFCF-153236 and MOP 81275) from the Canadian Institutes of Health Research.	Abrahamowicz Michal, 2013, Pharmacoepidemiol Drug Saf, V22, P1178, DOI 10.1002/pds.3485; Alexander S, 2003, EUR J OBSTET GYN R B, V111, pS78, DOI 10.1016/j.ejogrb.2003.09.008; Allen VM, 2003, OBSTET GYNECOL, V102, P477, DOI 10.1016/S0029-7844(03)00570-2; Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; [Anonymous], 2005, HLTH SYST PERF HLTH, V2005; [Anonymous], 2007, GIV BIRTH CAN COSTS; Bickell NA, 1996, OBSTET GYNECOL, V87, P664, DOI 10.1016/0029-7844(96)00024-5; Blondel B, 2012, J GYNECOL OBST BIO R, V41, P151, DOI 10.1016/j.jgyn.2011.11.008; Canadian Institute for Health Information, 2007, GIV BIRTH CAN REG TR; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Dumont A, 2013, LANCET, V382, P146, DOI 10.1016/S0140-6736(13)60593-0; Hall MH, 1999, LANCET, V354, P776, DOI 10.1016/S0140-6736(05)76016-5; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Khunpradit S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005528.pub2; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lagrew DC, 1996, AM J OBSTET GYNECOL, V174, P184, DOI 10.1016/S0002-9378(96)70392-7; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; Liang Wei-Hsing, 2004, J Chin Med Assoc, V67, P281; Liu SL, 2005, OBSTET GYNECOL, V105, P836, DOI 10.1097/01.AOG.0000154153.31193.2c; LOMAS J, 1991, JAMA-J AM MED ASSOC, V265, P2202, DOI 10.1001/jama.265.17.2202; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Lydon-Rochelle M, 2000, JAMA-J AM MED ASSOC, V283, P2411, DOI 10.1001/jama.283.18.2411; Main E K, 1999, Pediatrics, V103, P374; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; Ministry of Health and Social Ser-vices (Quebec), 2008, ADM DAT MED ECHO QUE; MYERS SA, 1988, NEW ENGL J MED, V319, P1511, DOI 10.1056/NEJM198812083192304; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Pinol APY, 2000, ACLUSTER DESIGN ANAL; Public Health Agency of Canada, 2008, CAN PER HLTH REP 200; Robson MS, 1996, AM J OBSTET GYNECOL, V174, P199, DOI 10.1016/S0002-9378(96)70394-0; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Thomas J, 2001, NATL SENTINEL CAESAR; World Health Organization, 2004, NUMB REV MAT DEATHS; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; 1999, INT J GYNAECOL OBSTE, V66, P197	39	85	86	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1710	1721		10.1056/NEJMoa1407120	http://dx.doi.org/10.1056/NEJMoa1407120			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923551	Bronze			2022-12-28	WOS:000353655000006
J	Ju, L; Shi, ZW; Nair, N; Lv, YC; Jin, CH; Velasco, J; Ojeda-Aristizabal, C; Bechtel, HA; Martin, MC; Zettl, A; Analytis, J; Wang, F				Ju, Long; Shi, Zhiwen; Nair, Nityan; Lv, Yinchuan; Jin, Chenhao; Velasco, Jairo, Jr.; Ojeda-Aristizabal, Claudia; Bechtel, Hans A.; Martin, Michael C.; Zettl, Alex; Analytis, James; Wang, Feng			Topological valley transport at bilayer graphene domain walls	NATURE			English	Article							ELECTRONIC-STRUCTURE; SPECTROSCOPY; PLASMONS; STATES; PHASE	Electron valley, a degree of freedom that is analogous to spin, can lead to novel topological phases in bilayer graphene. A tunable bandgap can be induced in bilayer graphene by an external electric field', and such gapped bilayer graphene is predicted to be a topological insulating phase protected by no-valley mixing symmetry, featuring quantum valley Hall effects and chiral edge states'. Observation of such chiral edge states, however, is challenging because inter-valley scattering is induced by atomic-scale defects at real bilayer graphene edges". Recent theoretical work"' has shown that domain walls between AB- and BA-stacked bilayer graphene can support protected chiral edge states of quantum valley Hall insulators. Here we report an experimental observation of ballistic (that is, with no scattering of electrons) conducting channels at bilayer graphene domain walls. We employ near-field infrared nanometre-scale microscopy (nanoscopy)'" to image in situ bilayer graphene layer-stacking domain walls on device substrates, and we fabricate dual-gated field effect transistors based on the domain walls. Unlike single-domain bilayer graphene, which shows gapped insulating behaviour under a vertical electrical field, bilayer graphene domain walls feature one-dimensional valley-polarized conducting channels with a ballistic length of about 400 nanometres at 4 kelvin. Such topologically protected one-dimensional chiral states at bilayer graphene domain walls open up opportunities for exploring unique topological phases and valley physics in graphene.	[Ju, Long; Shi, Zhiwen; Nair, Nityan; Lv, Yinchuan; Jin, Chenhao; Velasco, Jairo, Jr.; Ojeda-Aristizabal, Claudia; Zettl, Alex; Analytis, James; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bechtel, Hans A.; Martin, Michael C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source Div, Berkeley, CA 94720 USA; [Zettl, Alex; Analytis, James; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Zettl, Alex; Analytis, James; Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Zettl, Alex; Analytis, James; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	JIN, CHENHAO/GYV-5734-2022; analytis, james/ABE-6100-2020; Zettl, Alex K/O-4925-2016; Shi, Zhiwen/C-4945-2013; wang, Feng/I-5727-2015; Martin, Michael C./ABH-9841-2020; Shi, Zhiwen/L-8792-2019	analytis, james/0000-0002-7657-7688; Zettl, Alex K/0000-0001-6330-136X; Shi, Zhiwen/0000-0002-3928-2960; wang, Feng/0000-0001-8369-6194; Martin, Michael C./0000-0002-6611-070X; Shi, Zhiwen/0000-0002-3928-2960; Ojeda-Aristizabal, Claudia/0000-0003-0816-9727	Office of Basic Energy Science, Department of Energy [DE-SC0003949, DE-AC02-05CH11231]; Office of Naval Research [N00014-13-1-0464]; David and Lucile Packard fellowship; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	Office of Basic Energy Science, Department of Energy(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); David and Lucile Packard fellowship(The David & Lucile Packard Foundation); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	We thank Y. Ye and H. Zhu for their help on electron-beam lithography, Y. Zeng and H. Chang for help with device fabrication, and M. Raschke for help with near-field infrared techniques. The optical and electrical measurements were supported by the Office of Basic Energy Science, Department of Energy under contract numbers DE-SC0003949 (Early Career Award), DE-AC02-05CH11231 (Materials Science Division SP2 programme and the Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory). Device fabrication was supported by the Office of Naval Research (award N00014-13-1-0464). F.W. acknowledges support from a David and Lucile Packard fellowship. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231.	Alden JS, 2013, P NATL ACAD SCI USA, V110, P11256, DOI 10.1073/pnas.1309394110; Butz B, 2014, NATURE, V505, P533, DOI 10.1038/nature12780; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; DATTA S, 1995, ELECT TRANSPORT MESO, pCH2; dos Santos JMBL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.256802; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Gorbachev RV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.176805; Jung J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075418; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Keilmann F, 2004, PHILOS T R SOC A, V362, P787, DOI 10.1098/rsta.2003.1347; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lui CH, 2011, NANO LETT, V11, P164, DOI 10.1021/nl1032827; Mak KF, 2010, P NATL ACAD SCI USA, V107, P14999, DOI 10.1073/pnas.1004595107; Martin I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036804; McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403; Min HK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155115; Min HK, 2008, PROG THEOR PHYS SUPP, P227, DOI 10.1143/PTPS.176.227; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Vaezi A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021018; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wen XG, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085103; Yao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096801; Zhang F, 2013, P NATL ACAD SCI USA, V110, P10546, DOI 10.1073/pnas.1308853110; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	32	423	431	40	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					650	U356		10.1038/nature14364	http://dx.doi.org/10.1038/nature14364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901686				2022-12-28	WOS:000353689700044
J	Ohyama, T; Schneider-Mizell, CM; Fetter, RD; Aleman, JV; Franconville, R; Rivera-Alba, M; Mensh, BD; Branson, KM; Simpson, JH; Truman, JW; Cardona, A; Zlatic, M				Ohyama, Tomoko; Schneider-Mizell, Casey M.; Fetter, Richard D.; Aleman, Javier Valdes; Franconville, Romain; Rivera-Alba, Marta; Mensh, Brett D.; Branson, Kristin M.; Simpson, Julie H.; Truman, James W.; Cardona, Albert; Zlatic, Marta			A multilevel multimodal circuit enhances action selection in Drosophila	NATURE			English	Article							MULTISENSORY INTEGRATION; DIRECTION-SELECTIVITY; NOCICEPTIVE NEURONS; WIRING SPECIFICITY; GENE-EXPRESSION; NERVOUS-SYSTEM; UNIT RESPONSES; NOMPC; ORGANIZATION; PROJECTIONS	Natural events present multiple types of sensory cues each detected by a specialized sensory modality. Combining information from several modalities is essential for the selection of appropriate actions. Key to understanding multimodal computations is determining the structural patterns of multimodal convergence and how these patterns contribute to behaviour. Modalities could converge early, late or at multiple levels in the sensory processing hierarchy. Here we show that combining rnechanosensory and nociceptive cues synergistically enhances the selection of the fastest mode of escape locomotion in Drosophila larvae. In an electron microscopy volume that spans the entire insect nervous system, we reconstructed the multisensory circuit supporting the synergy, spanning multiple levels of the sensory processing hierarchy. The wiring diagram revealed a complex multilevel rnultimorlal convergence architecture. Using behavioural and physiological studies, we identified functionally connected circuit nodes that trigger the fastest locomotor mode, and others that facilitate it, and we provide evidence that multiple levels of multimodal integration contribute to escape mode selection. We propose that the multilevel rnultimoclal convergence architecture may be a general feature of multisensory circuits enabling complex input-output functions and selective tuning to ecologically relevant combinations of cues.	[Ohyama, Tomoko; Schneider-Mizell, Casey M.; Fetter, Richard D.; Aleman, Javier Valdes; Franconville, Romain; Rivera-Alba, Marta; Mensh, Brett D.; Branson, Kristin M.; Simpson, Julie H.; Truman, James W.; Cardona, Albert; Zlatic, Marta] Howard Hughes Med Inst Janelia Res Campus, Ashburn, VA 20147 USA		Cardona, A (corresponding author), Howard Hughes Med Inst Janelia Res Campus, 19700 Helix Dr, Ashburn, VA 20147 USA.	cardonaa@hhmi.org; zlaticm@hhmi.org	Franconville, Romain/P-7177-2014	Franconville, Romain/0000-0002-4440-7297; Cardona, Albert/0000-0003-4941-6536; Ohyama, Tomoko/0000-0003-1697-1138; Zlatic, Marta/0000-0002-3149-2250; Simpson, Julie/0000-0002-6793-7100; Valdes-Aleman, Javier/0000-0002-1577-1057; Schneider-Mizell, Casey/0000-0001-9477-3853; Rivera-Alba, Marta/0000-0002-8069-385X	Janelia HHMI; Institute of Neuroinformatics of the University of Zurich; ETH Zurich; SNSF [31003A_132969]; Universitat Zurich Forschungskredit; HHMI Visiting Scientist program at Janelia	Janelia HHMI; Institute of Neuroinformatics of the University of Zurich; ETH Zurich(ETH Zurich); SNSF(Swiss National Science Foundation (SNSF)); Universitat Zurich Forschungskredit; HHMI Visiting Scientist program at Janelia	We thank G. Rubin and the Janelia Fly EM Project for the gift of the comprehensive image dataset of the larval nervous system; S. Lauchie and A. Brothers for assistance with EM imaging; B. Arruda and T. Dang for assistance with behavioural screens; L. Herren, I. Andrade, K. Floria and A. Berthold van der Bourg for assistance with neuronal reconstruction; G. Rubin, H. Dionne and B. Pfeiffer for GAL4 and Split GAL4 lines; A. Nern and G. Rubin for the single cell FLP-out stocks; J.-M. Knapp for Tsh-LexA stock; H.-H. Li and Janelia Fly Light Project Team for images of neuronal lines; K. Hibbard, M. Mercer, T. Laverty and the rest of Janelia Fly Core for stock construction and fly crosses; G. Denisov for the roll and crawl detection LARA software; E. Trautman, R. Svirskas, C. Weaver and D. Olbris for data analysis pipelines; Y. Park, C. Priebe, D. Naiman and J.-B. Masson for advice on statistical analysis; V. Jayaraman for input on calcium imaging; and W. Den k, B. Dickson, S. Druckmann, B. Gerber, K. Svoboda and C. Zuker for helpful comments on the manuscript We thank Janelia HHMI for funding. A.C. and C.M.S.-M. were also funded by the Institute of Neuroinformatics of the University of Zurich and ETH Zurich, the SNSF grant 31003A_132969, the Universitat Zurich Forschungskredit and the HHMI Visiting Scientist program at Janelia. The EM image data is available via the Open Connectome Project (http://www.openconnectomeproject.org).	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Basura GJ, 2012, BRAIN RES, V1485, P95, DOI 10.1016/j.brainres.2012.08.037; BATE M, 1981, J NEUROSCI, V1, P103, DOI 10.1523/JNEUROSCI.01-01-00103.1981; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Dayan P, 2001, COMPUTATIONAL NEUROS; Duda R. O., 2001, PATTERN CLASSIFICATI; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jain R, 2006, NEUROSCI LETT, V395, P71, DOI 10.1016/j.neulet.2005.10.077; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kenshalo DR, 2000, J NEUROPHYSIOL, V84, P719, DOI 10.1152/jn.2000.84.2.719; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MEREDITH MA, 1985, SCIENCE, V227, P657, DOI 10.1126/science.3969558; MILDE JJ, 1990, J COMP NEUROL, V294, P59, DOI 10.1002/cne.902940106; Mu LY, 2014, J EXP BIOL, V217, P2121, DOI 10.1242/jeb.099135; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Olcese U, 2013, NEURON, V79, P579, DOI 10.1016/j.neuron.2013.06.010; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Robertson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078704; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader S, 2000, J COMP NEUROL, V425, P34; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein E. B., 1993, MERGING SENSES; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; van Atteveldt N, 2014, NEURON, V81, P1240, DOI 10.1016/j.neuron.2014.02.044; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	78	240	240	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					633	U107		10.1038/nature14297	http://dx.doi.org/10.1038/nature14297			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25896325				2022-12-28	WOS:000353689700041
J	Huang, MJ; Hsu, CH; Wang, J; Mei, S; Dong, XH; Li, YW; Li, MX; Liu, H; Zhang, W; Aida, TZ; Zhang, WB; Yue, K; Cheng, SZD				Huang, Mingjun; Hsu, Chih-Hao; Wang, Jing; Mei, Shan; Dong, Xuehui; Li, Yiwen; Li, Mingxuan; Liu, Hao; Zhang, Wei; Aida, Takuzo; Zhang, Wen-Bin; Yue, Kan; Cheng, Stephen Z. D.			Selective assemblies of giant tetrahedra via precisely controlled positional interactions	SCIENCE			English	Article							SPHERICAL SUPRAMOLECULAR DENDRIMERS; QUASI-CRYSTALLINE; FRANK-KASPER; SHAPE AMPHIPHILES; JANUS PARTICLES; CLICK SYNTHESIS; SYMMETRY; PHASES; BREAKING; DESIGN	Self-assembly of rigid building blocks with explicit shape and symmetry is substantially influenced by the geometric factors and remains largely unexplored. We report the selective assembly behaviors of a class of precisely defined, nanosized giant tetrahedra constructed by placing different polyhedral oligomeric silsesquioxane (POSS) molecular nanoparticles at the vertices of a rigid tetrahedral framework. Designed symmetry breaking of these giant tetrahedra introduces precise positional interactions and results in diverse selectively assembled, highly ordered supramolecular lattices including a Frank-Kasper A15 phase, which resembles the essential structural features of certain metal alloys but at a larger length scale. These results demonstrate the power of persistent molecular geometry with balanced enthalpy and entropy in creating thermodynamically stable supramolecular lattices with properties distinct from those of other self-assembling soft materials.	[Huang, Mingjun; Hsu, Chih-Hao; Wang, Jing; Mei, Shan; Dong, Xuehui; Li, Yiwen; Li, Mingxuan; Liu, Hao; Zhang, Wei; Yue, Kan; Cheng, Stephen Z. D.] Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Sci, Akron, OH 44325 USA; [Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Zhang, Wen-Bin] Peking Univ, Coll Chem & Mol Engn, Ctr Soft Matter Sci & Engn, Key Lab Polymer Chem & Phys,Minist Educ, Beijing 100871, Peoples R China	University System of Ohio; University of Akron; University of Tokyo; Peking University	Cheng, SZD (corresponding author), Univ Akron, Coll Polymer Sci & Polymer Engn, Dept Polymer Sci, Akron, OH 44325 USA.	wenbin@pku.edu.cn; ky13@zips.uakron.edu; scheng@uakron.edu	Yue, Kan/C-2655-2016; Zhang, Wei/D-3447-2017; Hsu, Chih-Hao/O-6872-2019; Li, Yiwen/D-6865-2015; Zhang, Wen-Bin/B-4514-2014; Hsu, Chih-Hao/P-1996-2015; Aida, Takuzo/I-9117-2012	Zhang, Wei/0000-0002-9321-6411; Hsu, Chih-Hao/0000-0002-0563-7081; Zhang, Wen-Bin/0000-0002-8746-0792; Li, Mingxuan/0000-0001-8243-2250	NSF [DMR-1408872]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Supported by NSF grant DMR-1408872. We thank B. Lotz for helpful discussion. The MALDI-TOF MS analysis was assisted by K. Guo, C. Shi, and C. Wesdemiotis. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357.	Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Bassindale AR, 2003, DALTON T, P2945, DOI 10.1039/b302950f; Cordes DB, 2010, CHEM REV, V110, P2081, DOI 10.1021/cr900201r; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; Dolbecq A, 2010, CHEM REV, V110, P6009, DOI 10.1021/cr1000578; Fischer S, 2011, P NATL ACAD SCI USA, V108, P1810, DOI 10.1073/pnas.1008695108; FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Graef M. D., 2012, STRUCTURE MAT INTRO; Grason GM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058304; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Iacovella CR, 2011, P NATL ACAD SCI USA, V108, P20935, DOI 10.1073/pnas.1019763108; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lee S, 2014, P NATL ACAD SCI USA, V111, P17723, DOI 10.1073/pnas.1408678111; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Li YW, 2011, J AM CHEM SOC, V133, P10712, DOI 10.1021/ja202906m; Liu H, 2014, J AM CHEM SOC, V136, P10691, DOI 10.1021/ja504497h; Percec V, 2008, J AM CHEM SOC, V130, P13079, DOI 10.1021/ja8034703; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Ungar G, 2005, SOFT MATTER, V1, P95, DOI 10.1039/b502443a; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; WEAIRE D, 1994, PHIL MAG LETT, V69, P107, DOI 10.1080/09500839408241577; Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230; Yu XF, 2013, P NATL ACAD SCI USA, V110, P10078, DOI 10.1073/pnas.1302606110; Yu XF, 2012, J AM CHEM SOC, V134, P7780, DOI 10.1021/ja3000529; Yue K, 2012, MACROMOLECULES, V45, P8126, DOI 10.1021/ma3013256; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zhang JW, 2012, J AM CHEM SOC, V134, P7636, DOI 10.1021/ja301770v; Zhang WB, 2014, MACROMOLECULES, V47, P1221, DOI 10.1021/ma401724p; Ziherl P, 2000, PHYS REV LETT, V85, P3528, DOI 10.1103/PhysRevLett.85.3528; Ziherl P, 2001, J PHYS CHEM B, V105, P10147, DOI 10.1021/jp010944q	33	285	288	24	705	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					424	428		10.1126/science.aaa2421	http://dx.doi.org/10.1126/science.aaa2421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908818				2022-12-28	WOS:000353338000031
J	Munk, MR; Ruckert, R				Munk, Marion Ronit; Rueckert, Rene			To work or not shouldn't be a question	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					470	470		10.1126/science.348.6233.470	http://dx.doi.org/10.1126/science.348.6233.470			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5NF	25908825				2022-12-28	WOS:000353338000041
J	Chou, CM; Nelson, C; Tarle, SA; Pribila, JT; Bardakjian, T; Woods, S; Schneider, A; Glaser, T				Chou, Christopher M.; Nelson, Christine; Tarle, Susan A.; Pribila, Jonathan T.; Bardakjian, Tanya; Woods, Sean; Schneider, Adele; Glaser, Tom			Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease	CELL			English	Article							RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; HUMAN PLASMA; HEART-DEFECTS; YOLK-SAC; MUTATIONS; ANOPHTHALMIA; ACID; TRANSTHYRETIN; RECEPTOR	Gestational vitamin A (retinol) deficiency poses a risk for ocular birth defects and blindness. We identified missense mutations in RBP4, encoding serum retinol binding protein, in three families with eye malformations of differing severity, including bilateral anophthalmia. The mutant phenotypes exhibit dominant inheritance, but incomplete penetrance. Maternal transmission significantly increases the probability of phenotypic expression. RBP normally delivers retinol from hepatic stores to peripheral tissues, including the placenta and fetal eye. The disease mutations greatly reduce retinol binding to RBP, yet paradoxically increase the affinity of RBP for its cell surface receptor, STRA6. By occupying STRA6 nonproductively, the dominant-negative proteins disrupt vitamin A delivery from wild-type proteins within the fetus, but also, in the case of maternal transmission, at the placenta. These findings establish a previously uncharacterized mode of maternal inheritance, distinct from imprinting and oocyte-derived mRNA, and define a group of hereditary disorders plausibly modulated by dietary vitamin A.	[Chou, Christopher M.; Tarle, Susan A.; Glaser, Tom] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Chou, Christopher M.; Tarle, Susan A.; Glaser, Tom] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nelson, Christine; Pribila, Jonathan T.] Univ Michigan, Sch Med, Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48109 USA; [Bardakjian, Tanya; Schneider, Adele] Albert Einstein Med Ctr, Div Genet, Philadelphia, PA 19141 USA; [Woods, Sean] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Congenital Eye Dis Study Grp, Davis, CA 95616 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yeshiva University; University of California System; University of California Davis	Glaser, T (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	tmglaser@ucdavis.edu			NIH [EY19497]; Midwest Eye Bank and Transplantation Center; UM Center for Rare Disease; UM Center for Genetics in Health and Medicine; NIH T32 grants [GM07544, HD07505]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Eye Bank and Transplantation Center; UM Center for Rare Disease; UM Center for Genetics in Health and Medicine; NIH T32 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for technical support from Bob Lyons and Susan Dagenais (DNA sequencing), Philip Gafken (MS), Peter Hwang and Andrew Hill (SPR), and Paul Kirchoff (molecular modeling). We thank Catherine Downs and Kari Branham for help with genetic counseling; Ed Pugh for quantitative analysis of binding kinetics; Noor Ghiasvand and Hui Sun for valuable discussions; Friedhelm Hildebrandt and Edgar Otto for advice on library construction; Tony Antonellis for sharing control DNAs; James Doss and Sarah Oelrich for clinical data; Ed Pugh, Ala Moshiri, and Zach Farrow for careful reading of the manuscript; and Dellaney Rudolph and Nathan Vale for technical assistance. We are profoundly grateful to subject families for participating in the study. This research was funded by grants from the NIH (EY19497), Midwest Eye Bank and Transplantation Center, the UM Center for Rare Disease, and the UM Center for Genetics in Health and Medicine. C.M.C. was supported by NIH T32 grants GM07544 and HD07505.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Bellenguez C, 2009, GENET EPIDEMIOL, V33, P207, DOI 10.1002/gepi.20371; BERR F, 1992, J LIPID RES, V33, P915; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Bychkova VE, 1998, FOLD DES, V3, P285, DOI 10.1016/S1359-0278(98)00039-X; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Cukras C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050205; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Drager U. C., 2000, P73; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Flower DR, 1996, BIOCHEM J, V318, P1; Folli C, 2005, BIOCHEM BIOPH RES CO, V336, P1017, DOI 10.1016/j.bbrc.2005.08.227; Folli C, 2010, METHODS MOL BIOL, V652, P189, DOI 10.1007/978-1-60327-325-1_11; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GOODMAN DS, 1965, J LIPID RES, V6, P390; Greene LH, 2006, BIOCHEMISTRY-US, V45, P9475, DOI 10.1021/bi060229c; Hale F, 1933, J HERED, V24, P105, DOI 10.1093/oxfordjournals.jhered.a103720; HELLER J, 1974, J BIOL CHEM, V249, P5933; Hornby Stella J, 2003, Med Sci Monit, V9, pHY23; Johansson S, 1997, ANAT EMBRYOL, V195, P483, DOI 10.1007/s004290050067; Johansson S, 1999, PLACENTA, V20, P459, DOI 10.1053/plac.1999.0397; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lengyel CSE, 2007, J BIOL CHEM, V282, P30658, DOI 10.1074/jbc.M704513200; Malpeli G, 1996, BBA-PROTEIN STRUCT M, V1294, P48, DOI 10.1016/0167-4838(95)00264-2; MELHUS H, 1992, J BIOL CHEM, V267, P12036; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; MUTO Y, 1972, J BIOL CHEM, V247, P2542; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; Onwochei BC, 2000, SURV OPHTHALMOL, V45, P175, DOI 10.1016/S0039-6257(00)00151-X; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Raila J, 2005, J NUTR, V135, P2512, DOI 10.1093/jn/135.11.2512; RAZ A, 1970, J BIOL CHEM, V245, P1903; Sapin V, 1997, DEV DYNAM, V208, P199, DOI 10.1002/(SICI)1097-0177(199702)208:2<199::AID-AJA7>3.0.CO;2-D; See AWM, 2009, DEV BIOL, V325, P94, DOI 10.1016/j.ydbio.2008.09.030; Selvaraj SR, 2008, MOL BIOL CELL, V19, P5579, DOI 10.1091/mbc.E08-01-0026; Soprano Dianne Robert, 1994, P257; SOPRANO DR, 1986, P NATL ACAD SCI USA, V83, P7330, DOI 10.1073/pnas.83.19.7330; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Ward SJ, 1997, BIOL REPROD, V57, P751, DOI 10.1095/biolreprod57.4.751; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Williamson KA, 2014, EUR J MED GENET, V57, P369, DOI 10.1016/j.ejmg.2014.05.002; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173	67	42	44	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					634	646		10.1016/j.cell.2015.03.006	http://dx.doi.org/10.1016/j.cell.2015.03.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910211	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000353553600021
J	Dajani, R				Dajani, Rana			Why I teach evolution to Muslim students	NATURE			English	Editorial Material									[Dajani, Rana] Hashemite Univ, Mol Biol, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Univ Cambridge, Faraday Inst, Cambridge CB2 1TN, England.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					409	409		10.1038/520409a	http://dx.doi.org/10.1038/520409a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903591	Bronze			2022-12-28	WOS:000353334500004
J	Samuel, M; Winston, A; Peters, B				Samuel, Miriam; Winston, Alan; Peters, Barry			Drug treatment for adults with HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL TREATMENT; ASSOCIATION GUIDELINES; TREATMENT-NAIVE; EFAVIRENZ; THERAPY; TRIAL; LIPODYSTROPHY; MANAGEMENT; MORTALITY; IMPACT		[Samuel, Miriam; Peters, Barry] St Thomas Hosp, London SE1 7EH, England; [Winston, Alan] Imperial Coll London, Dept Med, Sect Infect Dis, London, England; [Peters, Barry] Kings Coll London, Dept Infect Dis, London, England	Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; King's College London	Samuel, M (corresponding author), St Thomas Hosp, London SE1 7EH, England.	Miriam.Samuel@nhs.net	Winston, Alan/AGZ-3015-2022	Winston, Alan/0000-0002-5847-8416				Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bolland MJ, 2015, LANCET DIABETES ENDO, V3, P63, DOI 10.1016/S2213-8587(13)70181-5; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Chaponda M, 2011, BRIT J CLIN PHARMACO, V71, P659, DOI 10.1111/j.1365-2125.2010.03784.x; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Department of Health and Human Services, 2014, GUIDELINES USE ANTIR; Gazzard B, 2011, AIDS, V25, P2249, DOI 10.1097/QAD.0b013e32834c4c06; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Guaraldi G, 2013, DRUGS, V73, P1431, DOI 10.1007/s40265-013-0108-1; Keiser O, 2007, ANTIVIR THER, V12, P1157; Levy A, 2010, PHARMACOECONOMICS, V28, P35, DOI 10.2165/11587430-000000000-00000; Maggiolo F, 2009, J ANTIMICROB CHEMOTH, V64, P910, DOI 10.1093/jac/dkp334; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mills AM, 2013, HIV MED, V14, P391, DOI 10.1111/hiv.12012; Mohanna K, 2011, TEACHING MADE EASY M; Mollan KR, 2014, ANN INTERN MED, V161, P1, DOI 10.7326/M14-0293; Peters BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078048; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; Taylor GP, 2012, HIV MED, V13, P87, DOI [10.1111/j.1468-1293.2012.01030.x, 10.1111/j.1468-1293.2012.01030_2.x]; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; WHO, 2013, CONSOLIDATED GUIDELI; WHO, 2010, PRINC REC INF FEED C; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119	28	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2015	350								h1555	10.1136/bmj.h1555	http://dx.doi.org/10.1136/bmj.h1555			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RA	25908648				2022-12-28	WOS:000353576800001
J	Sezgin, E; Davis, SJ; Eggeling, C				Sezgin, Erdinc; Davis, Simon J.; Eggeling, Christian			Membrane Nanoclusters-Tails of the Unexpected	CELL			English	Editorial Material							PLASMA-MEMBRANE; RAFTS	The existence, nature, and role of highly ordered membrane domains, often referred to as lipid rafts, have been highly debated by cell biologists for many years. In this issue, Raghupathy et al. describe molecular mechanisms leading to the formation of ordered lipid-protein clusters.	[Sezgin, Erdinc; Davis, Simon J.; Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Eggeling, C (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	christian.eggeling@rdm.ox.ac.uk	Sezgin, Erdinc/R-1980-2018	Sezgin, Erdinc/0000-0002-4915-388X	Wellcome Trust [107457/Z/15/Z] Funding Source: researchfish; MRC [MR/K01577X/1, MC_UU_12010/4, MC_UU_12010/9] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [MC_UU_12010/4, MC_UU_12010/9, MR/K01577X/1] Funding Source: Medline; Wellcome Trust [098274] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Honigmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6412; Larsen JB, 2015, NAT CHEM BIOL, V11, P192, DOI 10.1038/nchembio.1733; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spillane KM, 2014, NANO LETT, V14, P5390, DOI 10.1021/nl502536u	7	8	8	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					433	434		10.1016/j.cell.2015.04.008	http://dx.doi.org/10.1016/j.cell.2015.04.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910202	Bronze			2022-12-28	WOS:000353553600004
J	Middelburg, JJ				Middelburg, Jack J.			Escape by dilution	SCIENCE			English	Editorial Material							DISSOLVED ORGANIC-MATTER; CARBON; OCEAN		Univ Utrecht, Dept Earth Sci, Fac Geosci, NL-3508 TA Utrecht, Netherlands	Utrecht University	Middelburg, JJ (corresponding author), Univ Utrecht, Dept Earth Sci, Fac Geosci, POB 80021, NL-3508 TA Utrecht, Netherlands.	j.b.m.middelburg@uu.nl	Middelburg, Jack/B-4951-2011	Middelburg, Jack/0000-0003-3601-9072				Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; Benner R, 2015, ANNU REV MAR SCI, V7, P185, DOI 10.1146/annurev-marine-010213-135126; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; JANNASCH HW, 1967, LIMNOL OCEANOGR, V12, P264, DOI 10.4319/lo.1967.12.2.0264; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Middelburg JJ, 2007, SCIENCE, V316, P1294, DOI 10.1126/science.1144001; Ridgwell A, 2011, P NATL ACAD SCI USA, V108, P16485, DOI 10.1073/pnas.1112236108; Thingstad TF, 1997, LIMNOL OCEANOGR, V42, P398, DOI 10.4319/lo.1997.42.2.0398	9	7	7	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					290	290		10.1126/science.aaa9852	http://dx.doi.org/10.1126/science.aaa9852			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883345				2022-12-28	WOS:000352999000024
J	Broderick, C; Nadjm, B; Smith, V; Blaze, M; Checkley, A; Chiodini, PL; Whitty, CJM				Broderick, Claire; Nadjm, Behzad; Smith, Valerie; Blaze, Marie; Checkley, Anna; Chiodini, Peter L.; Whitty, Christopher J. M.			Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMODIUM-FALCIPARUM-MALARIA; TRAVELERS VISITING FRIENDS; SURVEILLANCE DATA; TROPNETEUROP; EPIDEMIOLOGY; HYPNOZOITES; ACTIVATION; PREVENTION; MORTALITY; KNOWLEDGE	OBJECTIVE To examine temporal and geographical trends, risk factors, and seasonality of imported vivax malaria in the United Kingdom to inform clinical advice and policy. DESIGN Observational study. SETTING National surveillance data from the UK Public Health England Malaria Reference Laboratory, data from the International Passenger Survey, and international climactic data. PARTICIPANTS All confirmed and notified cases of malaria in the UK (n=50 187) from 1987 to 2013, focusing on 12 769 cases of vivax malaria. MAIN OUTCOME MEASURES Mortality, sociodemographic details (age, UK region, country of birth and residence, and purpose of travel), destination, and latency (time between arrival in the UK and onset of symptoms). RESULTS Of the malaria cases notified, 25.4% (n=12 769) were due to Plasmodium vivax, of which 78.6% were imported from India and Pakistan. Most affected patients (53.5%) had travelled to visit friends and relatives, and 11.1% occurred in tourists. Imported P vivax is concentrated in areas with large communities of south Asian heritage. Overall mortality was 7/12 725 (0.05%), but with no deaths in 9927 patients aged under 50 years. Restricting the analysis to those aged more than 50 years, mortality was 7/2798 (0.25%), increasing to 4/526 (0.76%) (adjusted odds ratio 32.0, 95% confidence interval 7.1 to 144.0, P<0.001) in those aged 70 years or older. Annual notifications decreased sharply over the period, while traveller numbers between the UK and South Asia increased. The risk of acquiring P vivax from South Asia was year round but was twice as high from June to September (40 per 100 000 trips) compared with the rest of the year. There was strong seasonality in the latency from arrival in the UK to presentation, significantly longer in those arriving in the UK from South Asia from October to March (median 143 days) versus those arriving from April to September (37 days, P<0.001). CONCLUSIONS Travellers visiting friends and family in India and Pakistan are most at risk of acquiring P vivax, and older patients (especially those >70 years) are most at risk of dying; these groups should be targeted for advice before travelling. The risk of acquiring vivax malaria is year round but higher during summer monsoons, masked by latency. The latency of time to clinical presentation of imported vivax malaria in the UK is highly seasonal; seasonal latency has implications for pretravel advice but also for the control of malaria in India and Pakistan. A reduced incidence of vivax malaria in travellers may mean further areas of South Asia can be considered not to need malaria chemoprophylaxis.	[Broderick, Claire; Smith, Valerie; Blaze, Marie; Chiodini, Peter L.; Whitty, Christopher J. M.] Univ London London Sch Hyg & Trop Med, Publ Hlth England Malaria Reference Lab, London WC1E 7HT, England; [Nadjm, Behzad; Checkley, Anna] Hosp Trop Dis, London NW1 0PE, England	University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Whitty, CJM (corresponding author), Univ London London Sch Hyg & Trop Med, Publ Hlth England Malaria Reference Lab, Keppel St, London WC1E 7HT, England.	christopher.whitty@lshtm.ac.uk		Broderick, Claire/0000-0003-2582-4527; Whitty, Christopher/0000-0002-6076-5027; Nadjm, Behzad/0000-0002-7704-3629	Public Health England (UK Health Protection Agency)	Public Health England (UK Health Protection Agency)	Public Health England (UK Health Protection Agency before 2013).	Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013; Angell SY, 2005, INFECT DIS CLIN N AM, V19, P49, DOI 10.1016/j.idc.2004.11.001; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Barnweil JW, 2014, NAT MED, V20, P237, DOI 10.1038/nm.3498; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; Bottieau E, 2006, AM J TROP MED HYG, V75, P133, DOI 10.4269/ajtmh.2006.75.133; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Cathcart SJ, 2010, EPIDEMIOL INFECT, V138, P1052, DOI 10.1017/S0950268809991130; Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116; Chiodini PL, 2014, GUIDELINES MALARIA P; Dembele L, 2014, NAT MED, V20, P307, DOI 10.1038/nm.3461; dos Santos CC, 1999, CAN MED ASSOC J, V160, P195; Garnham PCC, 1988, MALARIA PRINCIPLES P, P69; Gjorup IE, 2002, J TRAVEL MED, V9, P91, DOI 10.2310/7060.2002.21494; Government of India, 2013, TOUR STAT 2013; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Health Protection Agency. Migrant Health, 2006, MIGR HLTH INF DIS NO; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Lover AA, 2013, EMERG INFECT DIS, V19, P1058, DOI 10.3201/eid1907.121674; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Nolder D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002711; Odolini S, 2014, J TRAVEL MED, V21, P314, DOI 10.1111/jtm.12134; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Quispe AM, 2014, AM J TROP MED HYG, V91, P11, DOI 10.4269/ajtmh.12-0610; Schlagenhauf P, 2003, J TRAVEL MED, V10, P106, DOI 10.2310/7060.2003.31764; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; Scolari C, 2002, J TRAVEL MED, V9, P160, DOI 10.2310/7060.2002.23177; Shanks GD, 2013, LANCET INFECT DIS, V13, P900, DOI 10.1016/S1473-3099(13)70095-1; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Stark K, 2012, EUROSURVEILLANCE, V17, P2; Venkatesan P, 2003, T ROY SOC TROP MED H, V97, P550, DOI 10.1016/S0035-9203(03)80023-8; WALKER E, 1983, J INFECTION, V7, P227, DOI 10.1016/S0163-4453(83)97088-3; WARWICK R, 1980, J ROY SOC MED, V73, P333, DOI 10.1177/014107688007300506; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WILLOCKS L, 1992, POSTGRAD MED J, V68, P22, DOI 10.1136/pgmj.68.795.22	40	26	26	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1703	10.1136/bmj.h1703	http://dx.doi.org/10.1136/bmj.h1703			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25882309	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000353328700004
J	Galea, I; Ward-Abel, N; Heesen, C				Galea, Ian; Ward-Abel, Nicki; Heesen, Christoph			Relapse in multiple sclerosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDICALLY UNEXPLAINED SYMPTOMS; DISEASE-MODIFYING THERAPIES; NATURAL-HISTORY; INTERFERON BETA-1A; CONTROLLED PHASE-3; DOUBLE-BLIND; DISABILITY; ADHERENCE; METHYLPREDNISOLONE; PROGRESSION		[Galea, Ian] Univ Southampton, Southampton Gen Hosp, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton SO16 6YD, Hants, England; [Ward-Abel, Nicki] Birmingham City Univ, Birmingham, W Midlands, England; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS, Neurol, Hamburg, Germany; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Neurol, Hamburg, Germany	University of Southampton; Birmingham City University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Galea, I (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton SO16 6YD, Hants, England.	I.Galea@soton.ac.uk	Galea, Ian/B-7997-2011	Galea, Ian/0000-0002-1268-5102				Asano Miho, 2014, Int J MS Care, V16, P99, DOI 10.7224/1537-2073.2013-031; Bennetto L, 2011, MULT SCLER J, V17, P1218, DOI 10.1177/1352458511407368; Berger BA, 2005, J AM PHARM ASSOC, V45, P466, DOI 10.1331/1544345054475469; Bevan CJ, 2014, JAMA NEUROL, V71, P269, DOI 10.1001/jamaneurol.2013.5486; Boster A, 2008, LANCET NEUROL, V7, P173, DOI 10.1016/S1474-4422(08)70020-6; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; CAPLAN LR, 1980, JAMA-J AM MED ASSOC, V243, P2418, DOI 10.1001/jama.243.23.2418; Carbonell CF, 2014, J CHILD NEUROL, V29, P943, DOI 10.1177/0883073813501873; Chataway J, 2006, LANCET NEUROL, V5, P565, DOI 10.1016/S1474-4422(06)70450-1; Cohen JA, 2013, J NEUROL, V260, P2023, DOI 10.1007/s00415-013-6932-0; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Comi G, 2013, NEUROLOGY, P80; D'hooghe MB, 2010, MULT SCLER J, V16, P773, DOI 10.1177/1352458510367721; Dayer L, 2013, J AM PHARM ASSOC, V53, P172, DOI 10.1331/JAPhA.2013.12202; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Dhib-Jalbut Suhayl, 2012, Int J MS Care, V14, P198, DOI 10.7224/1537-2073-14.4.198; Duddy M, 2014, MULT SCLER RELAT DIS, V3, P450, DOI 10.1016/j.msard.2014.02.006; Elovaara I, 2011, CLIN NEUROPHARMACOL, V34, P84, DOI 10.1097/WNF.0b013e31820a17f3; Filippini G, 2000, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001331, DOI 10.1002/14651858.CD001331]; Gal RL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001430.pub3; Galea I, 2004, BRIT MED J, V328, P287, DOI 10.1136/bmj.328.7434.287; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Giovannoni G, 2011, LANCET NEUROL, V10, P329, DOI 10.1016/S1474-4422(11)70023-0; Golan D, 2008, ANN NEUROL, V64, P143, DOI 10.1002/ana.21409; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hartung HP, 2011, EUR NEUROL REV, V6, P106; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Heesen C, 2011, J NEUROL SCI, V306, P192, DOI 10.1016/j.jns.2010.09.012; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Hirst CL, 2012, MULT SCLER J, V18, P1152, DOI 10.1177/1352458511433919; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Imitola J, 2015, JAMA NEUROL, V72, P145, DOI 10.1001/jamaneurol.2014.3860; Inusah S, 2010, MULT SCLER J, V16, P1414, DOI 10.1177/1352458510379246; Iuliano G, 2008, EUR NEUROL, V59, P44, DOI 10.1159/000109260; Jokubaitis VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059694; Kalincik T, 2014, MULT SCLER J, V20, P1511, DOI 10.1177/1352458514528762; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Kopke S, 2009, MULT SCLER J, V15, P96, DOI 10.1177/1352458508095921; Kopke S, 2014, J NEUROL NEUROSUR PS, V85, P411, DOI 10.1136/jnnp-2013-306441; Kopke S, 2004, ACTA NEUROL SCAND, V110, P1, DOI 10.1111/j.1600-0404.2004.00284.x; Leone MA, 2008, MULT SCLER J, V14, P485, DOI 10.1177/1352458507084650; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Loebermann M, 2012, NAT REV NEUROL, V8, P143, DOI 10.1038/nrneurol.2012.8; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin Fred D., 2003, Neurology, V61, P1528; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Merwick A, 2008, Int MS J, V15, P47; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P400, DOI 10.1136/jnnp.2008.157305; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Murta V, 2013, MOL CELL NEUROSCI, V53, P6, DOI 10.1016/j.mcn.2012.06.004; National Institute for Health and Care Excellence, 2014, CLIN GUID CG186; NHS England, 2014, CLIN COMM POL DIS MO; Parkin D, 2004, SOC SCI MED, V59, P351, DOI 10.1016/j.socscimed.2003.10.015; Pasto L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-165; Paulson GW, 1996, SOUTHERN MED J, V89, P301, DOI 10.1097/00007611-199603000-00008; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Quinn D, 2014, MULT SCLER J, V20, P1669, DOI 10.1177/1352458514527865; Rakusa M, 2013, EUR J NEUROL, V20, P448, DOI 10.1111/j.1468-1331.2012.03806.x; Rinon A, 2011, PATIENT PREFER ADHER, V5, P629, DOI 10.2147/PPA.S26479; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Scalfari A, 2013, JAMA NEUROL, V70, P214, DOI 10.1001/jamaneurol.2013.599; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Schmidt J, 2000, BRAIN, V123, P1431, DOI 10.1093/brain/123.7.1431; SIBLEY WA, 1991, J NEUROL NEUROSUR PS, V54, P584, DOI 10.1136/jnnp.54.7.584; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Sorenson PS, 2004, NEUROLOGY, V63, P2028; Steinbrecher N, 2011, PSYCHOSOMATICS, V52, P263, DOI 10.1016/j.psym.2011.01.007; Steinvorth SM, 2013, MULT SCLER J, V19, P1580, DOI 10.1177/1352458513481009; Swanson LM, 2010, FAM PRACT, V27, P487, DOI 10.1093/fampra/cmq051; The King's Fund, 2009, GEN PRACT ENGL OV; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett HL, 1998, J NEUROL NEUROSUR PS, V65, P362, DOI 10.1136/jnnp.65.3.362; Trojano M, 2009, ANN NEUROL, V66, P513, DOI 10.1002/ana.21757; Uitdehaag BMJ, 2011, CURR MED RES OPIN, V27, P1529, DOI 10.1185/03007995.2011.591370; Vercellino M, 2009, ACTA NEUROL SCAND, V119, P126, DOI 10.1111/j.1600-0404.2008.01076.x; Visser LH, 2004, MULT SCLER, V10, P89, DOI 10.1191/1352458504ms978sr; Vollmer T, 2007, J NEUROL SCI, V256, pS5, DOI 10.1016/j.jns.2007.01.065; Warner Richard, 2005, Br J Nurs, V14, P746; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; Willis H, 2014, PATIENT PREFER ADHER, V8, P843, DOI 10.2147/PPA.S54986; Wong J, 2011, CAN J NEUROL SCI, V38, P429, DOI 10.1017/S0317167100011823	89	29	29	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1765	10.1136/bmj.h1765	http://dx.doi.org/10.1136/bmj.h1765			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25872511	Green Accepted			2022-12-28	WOS:000353327500004
J	Fadri-Moskwik, M				Fadri-Moskwik, Maria			Love knows no boundaries	SCIENCE			English	Editorial Material									Washington State Univ, Spokane, WA 99202 USA	Washington State University	Fadri-Moskwik, M (corresponding author), Washington State Univ, Spokane, WA 99202 USA.								0	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					254	254		10.1126/science.348.6231.254	http://dx.doi.org/10.1126/science.348.6231.254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5RD	25859047				2022-12-28	WOS:000352613700049
J	Schwefel, HGL; Tureci, HE				Schwefel, Harald G. L.; Tuereci, Hakan E.			A chaotic approach clears up imaging	SCIENCE			English	Editorial Material							SPATIAL COHERENCE; WAVE CHAOS; LASER; SYSTEMS		[Schwefel, Harald G. L.] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Schwefel, Harald G. L.] Univ Otago, Dept Phys, Dunedin, New Zealand; [Tuereci, Hakan E.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Max Planck Society; University of Otago; Princeton University	Schwefel, HGL (corresponding author), Max Planck Inst Sci Light, D-91058 Erlangen, Germany.	harald.schwefel@mpl.mpg.de; tureci@princeton.edu	Schwefel, Harald G L/D-2710-2009	Schwefel, Harald G L/0000-0002-4304-6469; Tureci, Hakan/0000-0003-4210-3027				BERRY MV, 1977, J PHYS A-MATH GEN, V10, P2083, DOI 10.1088/0305-4470/10/12/016; Cao H, 2015, REV MOD PHYS, V87, P61, DOI 10.1103/RevModPhys.87.61; Chua SL, 2011, OPT EXPRESS, V19, P1539, DOI 10.1364/OE.19.001539; Doya V, 2001, OPT LETT, V26, P872, DOI 10.1364/OL.26.000872; Ge L., 2014, NAT PHOTONICS, V8, P871; HELLER EJ, 1984, PHYS REV LETT, V53, P1515, DOI 10.1103/PhysRevLett.53.1515; Nixon M, 2013, OPT LETT, V38, P3858, DOI 10.1364/OL.38.003858; Nockel JU, 1997, NATURE, V385, P45, DOI 10.1038/385045a0; Redding B, 2015, P NATL ACAD SCI USA, V112, P1304, DOI 10.1073/pnas.1419672112; Redding B, 2012, NAT PHOTONICS, V6, P355, DOI [10.1038/nphoton.2012.90, 10.1038/NPHOTON.2012.90]; Rex NB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.094102; Stano P, 2013, NAT PHOTONICS, V7, P66, DOI [10.1038/nphoton.2012.298, 10.1038/NPHOTON.2012.298]; Tureci HE, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.043822; Tureci HE, 2008, SCIENCE, V320, P643, DOI 10.1126/science.1155311	14	3	3	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					189	190		10.1126/science.aaa7409	http://dx.doi.org/10.1126/science.aaa7409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859035				2022-12-28	WOS:000352613700027
J	Coombes, R				Coombes, Rebecca			UK ELECTIONS What do you think should be the political priorities for the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1808	10.1136/bmj.h1808	http://dx.doi.org/10.1136/bmj.h1808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858910				2022-12-28	WOS:000352914700009
J	Ghosh, J				Ghosh, Jayati			PERSONAL VIEW Deep cuts to India's health spending will delay universal access to healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BUDGET		Jawaharlal Nehru Univ, Sch Social Sci, Ctr Econ Studies & Planning, Econ, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Ghosh, J (corresponding author), Jawaharlal Nehru Univ, Sch Social Sci, Ctr Econ Studies & Planning, Econ, New Delhi 110067, India.	jayatijnu@gmail.com						Bagcchi S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h4; Bharatiya Janata Party, 2014, MANIFESTO; Chatterjee P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2703; Hindu The, 2015, HINDU; Mudur G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1244	5	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1632	10.1136/bmj.h1632	http://dx.doi.org/10.1136/bmj.h1632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858077				2022-12-28	WOS:000352914700005
J	Iacobucci, G				Iacobucci, Gareth			UK GENERAL ELECTION Election watch: access to GP services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						BBC, 2015, BBC             0328; BBC (British Broadcasting Corporation), 2015, BBC             0407; Cowling TE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1513; Department of Health, 2010, REV OP FRAM NHS ENGL; Department of Health, 2010, GUID GP EXT HOURS AC; Health and Social Care Information Centre, 2015, NHS PAYM GEN PRACT E; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5949; Nowottny S, 2011, EXTENDED HOURS FUNDI	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1878	10.1136/bmj.h1878	http://dx.doi.org/10.1136/bmj.h1878			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25857855				2022-12-28	WOS:000352914700017
J	Jin, Y; Strunk, BS; Weisman, LS				Jin, Yui; Strunk, Bethany S.; Weisman, Lois S.			Close Encounters of the Lysosome-Peroxisome Kind	CELL			English	Editorial Material							CONTACT SITES; CHOLESTEROL; MITOCHONDRIA; TRAFFICKING; METABOLISM; VACUOLES; BINDING	Lysosomes provide a major source for cellular cholesterol; however, most of this cholesterol is trafficked to the plasma membrane via unknown mechanisms. Chu et al. identify an unexpected role for peroxisomes in the transport of cholesterol from the lysosome to the plasma membrane via a lysosome-peroxisome membrane contact site.	[Jin, Yui; Strunk, Bethany S.; Weisman, Lois S.] Univ Michigan, Inst Life Sci, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Weisman, LS (corresponding author), Univ Michigan, Inst Life Sci, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	lweisman@umich.edu	JIN, Yui/AGO-9517-2022	Strunk, Bethany/0000-0003-2337-4614	NIDDK NIH HHS [P30 DK020572] Funding Source: Medline; NIGMS NIH HHS [R01-GM050403, R37- GM062261, R01 GM062261, R01 GM050403, R37 GM062261] Funding Source: Medline; NINDS NIH HHS [R01 NS064015, R01-NS064015] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050403, R01GM062261, R37GM062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aubourg P, 2013, HAND CLINIC, V113, P1593, DOI 10.1016/B978-0-444-59565-2.00028-9; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4	10	8	8	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					197	198		10.1016/j.cell.2015.03.046	http://dx.doi.org/10.1016/j.cell.2015.03.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860602	Green Accepted, Bronze			2022-12-28	WOS:000352708300012
J	Johnston, AM; Memon, AA				Johnston, AM; Memon, AA			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; Southport & Formby Dist Gen Hosp, Southport PR8 6PN, Merseyside, England	University of Aberdeen	Johnston, AM (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.		Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					1011	1011		10.1056/NEJM199904013401305	http://dx.doi.org/10.1056/NEJM199904013401305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	25859579				2022-12-28	WOS:000079489800005
J	Towbin, JA; Lorts, A; Jefferies, JL				Towbin, Jeffrey A.; Lorts, Angela; Jefferies, John Lynn			Left ventricular non-compaction cardiomyopathy	LANCET			English	Article							ASSOCIATION TASK-FORCE; CONGENITAL HEART-DISEASE; TERM CLINICAL-COURSE; LONG QT SYNDROME; ISOLATED NONCOMPACTION; BARTH-SYNDROME; PRACTICE GUIDELINES; SPONGY MYOCARDIUM; AMERICAN-COLLEGE; TRANSCRIPTION FACTOR	Left ventricular non-compaction, the most recently classified form of cardiomyopathy, is characterised by abnormal trabeculations in the left ventricle, most frequently at the apex. It can be associated with left ventricular dilation or hypertrophy, systolic or diastolic dysfunction, or both, or various forms of congenital heart disease. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be induced by exercise or be persistent at rest, but many patients are asymptomatic. Patients on chronic treatment for compensated heart failure sometimes present acutely with decompensated heart failure. Other life-threatening risks of left ventricular non-compaction are ventricular arrhythmias or complete atrioventricular block, presenting clinically as syncope, and sudden death. Genetic inheritance arises in at least 30-50% of patients, and several genes that cause left ventricular non-compaction have been identified. These genes seem generally to encode sarcomeric (contractile apparatus) or cytoskeletal proteins, although, in the case of left ventricular non-compaction with congenital heart disease, disturbance of the NOTCH signalling pathway seems part of a final common pathway for this form of the disease. Disrupted mitochondrial function and metabolic abnormalities have a causal role too. Treatments focus on improvement of cardiac efficiency and reduction of mechanical stress in patients with systolic dysfunction. Further, treatment of arrhythmia and implantation of an automatic implantable cardioverter-defibrillator for prevention of sudden death are mainstays of therapy when deemed necessary and appropriate. Patients with left ventricular non-compaction and congenital heart disease often need surgical or catheter-based interventions. Despite progress in diagnosis and treatment in the past 10 years, understanding of the disorder and outcomes need to be improved.	[Towbin, Jeffrey A.; Lorts, Angela; Jefferies, John Lynn] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Towbin, JA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Le Bonheur Childrens Hosptial, Memphis, TN 38103 USA.	jtowbin1@uthsc.edu	Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X				Aras D, 2006, J CARD FAIL, V12, P726, DOI 10.1016/j.cardfail.2006.08.002; Beken S, 2011, GENET COUNSEL, V22, P161; Bhatia NL, 2011, J CARD FAIL, V17, P771, DOI 10.1016/j.cardfail.2011.05.002; Biagini E, 2006, AM J CARDIOL, V98, P821, DOI 10.1016/j.amjcard.2006.04.021; Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.3.CO;2-F; Blinder JJ, 2011, AM J MED GENET A, V155A, P2215, DOI 10.1002/ajmg.a.34129; Brescia ST, 2013, CIRCULATION, V127, P2202, DOI 10.1161/CIRCULATIONAHA.113.002511; Caliskan K, 2012, J CARDIOVASC ELECTR, V23, P938, DOI 10.1111/j.1540-8167.2012.02325.x; Caliskan K, 2011, J CARDIOVASC ELECTR, V22, P898, DOI 10.1111/j.1540-8167.2011.02015.x; Caliskan K, 2009, EUROPACE, V11, P1138, DOI 10.1093/europace/eup228; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Cartoni D, 2007, CIRCULATION, V116, pE81, DOI 10.1161/CIRCULATIONAHA.106.684811; Celiker A, 2005, PACE, V28, P1198, DOI 10.1111/j.1540-8159.2005.09498.x; Chen HY, 2013, DEVELOPMENT, V140, P1946, DOI 10.1242/dev.089920; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Corrado G, 2006, CARDIOLOGY, V105, P142, DOI 10.1159/000091152; Cosson L, 2012, MOL GENET METAB, V106, P115, DOI 10.1016/j.ymgme.2012.01.015; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dellefave LM, 2009, CIRC-CARDIOVASC GENE, V2, P442, DOI 10.1161/CIRCGENETICS.109.861955; Digilio MC, 2013, CLIN GENET, V84, P362, DOI 10.1111/cge.12069; DUSEK J, 1975, ARCH PATHOL, V99, P312; Eidem BW, 2009, PEDIATR CARDIOL, V30, P682, DOI 10.1007/s00246-008-9372-3; Engberding R, 2007, CLIN RES CARDIOL, V96, P481, DOI 10.1007/s00392-007-0528-6; Ergul Y, 2011, ANN NONINVAS ELECTRO, V16, P184, DOI 10.1111/j.1542-474X.2011.00428.x; Fazio G, 2010, PEDIATR CARDIOL, V31, P576, DOI 10.1007/s00246-010-9652-6; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Finsterer J, 2008, SCAND CARDIOVASC J, V42, P9, DOI 10.1080/14017430701854953; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Grant RT, 1926, HEART-J STUD CIRC, V8, P273; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Greutmann M, 2012, AM J CARDIOL, V109, P276, DOI 10.1016/j.amjcard.2011.08.043; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoedemaekers YM, 2010, CIRC-CARDIOVASC GENE, V3, P232, DOI 10.1161/CIRCGENETICS.109.903898; Hollingsworth CL, 2007, AM J ROENTGENOL, V189, P12, DOI 10.2214/AJR.06.1507; Hughes ML, 2007, CARDIOL YOUNG, V17, P56, DOI 10.1017/S1047951106001351; ICARDO JM, 1987, ACTA ANAT, V130, P264; Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9; Ichida F, 2001, CIRCULATION, V103, P1256; Jacquier A, 2010, EUR HEART J, V31, P1098, DOI 10.1093/eurheartj/ehp595; Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Jost CHA, 2004, J AM SOC ECHOCARDIOG, V17, P677, DOI 10.1016/j.echo.2004.02.013; Kobza R, 2010, HEART RHYTHM, V7, P1545, DOI 10.1016/j.hrthm.2010.05.025; Kovacevic-Preradovic T, 2009, CARDIOLOGY, V112, P158, DOI 10.1159/000147899; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Madan S, 2012, PEDIATR CARDIOL, V33, P215, DOI 10.1007/s00246-011-0111-9; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martinez HR, 2011, AM J MED GENET A, V155A, P3030, DOI 10.1002/ajmg.a.33856; Martinez HR, 2011, AM J MED GENET A, V155A, P1115, DOI 10.1002/ajmg.a.33838; Maruyama M, 2011, CIRC RES, V108, P1042, DOI 10.1161/CIRCRESAHA.110.237867; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMahon CJ, 2007, HEART, V93, P676, DOI 10.1136/hrt.2006.093880; Melendez-Ramirez G, 2012, J CARDIOVASC COMPUT, V6, P346, DOI 10.1016/j.jcct.2012.07.001; Murphy RT, 2005, EUR HEART J, V26, P187, DOI 10.1093/eurheartj/ehi025; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Nakashima K, 2013, HEART VESSELS, V28, P126, DOI 10.1007/s00380-012-0235-8; Nascimento BR, 2013, PACE, V36, pe107, DOI 10.1111/j.1540-8159.2011.03054.x; Niemann M, 2012, CIRCULATION, V126, pE240, DOI 10.1161/CIRCULATIONAHA.112.095059; Nihei K, 2004, CIRC J, V68, P82, DOI 10.1253/circj.68.82; Oechslin E, 2011, EUR HEART J, V32, P1446, DOI 10.1093/eurheartj/ehq508; Onay OS, 2013, PEDIATR CARDIOL, V34, P189, DOI 10.1007/s00246-012-0279-7; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Paterick TE, 2012, CIRC J, V76, P1556, DOI 10.1253/circj.CJ-12-0666; Patrianakos AP, 2008, ECHOCARDIOGR-J CARD, V25, P898, DOI 10.1111/j.1540-8175.2008.00708.x; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8; Ping OY, 2011, CLIN CHIM ACTA, V412, P170, DOI 10.1016/j.cca.2010.09.035; Pitta S, 2007, J CLIN ULTRASOUND, V35, P465, DOI 10.1002/jcu.20349; Postma AV, 2011, CIRC-CARDIOVASC GENE, V4, P43, DOI 10.1161/CIRCGENETICS.110.957985; Probst S, 2011, CIRC-CARDIOVASC GENE, V4, P367, DOI 10.1161/CIRCGENETICS.110.959270; Punn R, 2010, J AM SOC ECHOCARDIOG, V23, P46, DOI 10.1016/j.echo.2009.09.003; Ranganathan A, 2012, ECHOCARDIOGR-J CARD, V29, pE169, DOI 10.1111/j.1540-8175.2012.01671.x; Reynen K, 1997, CARDIOLOGY, V88, P601, DOI 10.1159/000177433; Risebro CA, 2006, THESCIENTIFICWORLDJO, V6, P1862, DOI 10.1100/tsw.2006.316; Ritter M, 1997, MAYO CLIN PROC, V72, P26, DOI 10.4065/72.1.26; Ronvelia D, 2012, MOL GENET METAB, V107, P428, DOI 10.1016/j.ymgme.2012.09.013; Sandhu R, 2008, ECHOCARDIOGR-J CARD, V25, P8, DOI 10.1111/j.1540-8175.2007.00560.x; Sarma RJ, 2010, PROG CARDIOVASC DIS, V52, P264, DOI 10.1016/j.pcad.2009.11.001; Sasse-Klaassen S, 2003, AM J MED GENET A, V119A, P162, DOI 10.1002/ajmg.a.20075; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Schreiber S L, 1995, Harvey Lect, V91, P99; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sedmera David, 2008, Heart Fail Clin, V4, P235, DOI 10.1016/j.hfc.2008.02.007; Sellars EA, 2011, AM J MED GENET A, V155A, P1409, DOI 10.1002/ajmg.a.33997; Sen-Chowdhry S, 2008, CURR OPIN CARDIOL, V23, P171, DOI 10.1097/HCO.0b013e3282fdc939; Shan L, 2008, MOL GENET METAB, V93, P468, DOI 10.1016/j.ymgme.2007.10.009; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Stahli BE, 2013, INT J CARDIOL, V167, P2477, DOI 10.1016/j.ijcard.2012.05.095; Steffel J, 2012, ANN MED, V44, P101, DOI 10.3109/07853890.2011.554427; Steffel J, 2009, AM J CARDIOL, V104, P984, DOI 10.1016/j.amjcard.2009.05.042; Stollberger C, 2011, AM J CARDIOL, V108, P1021, DOI 10.1016/j.amjcard.2011.05.039; Stollberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6; Stollberger C, 2004, J AM SOC ECHOCARDIOG, V17, P91, DOI 10.1016/S0894-7317(03)00514-5; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang S, 2010, MITOCHONDRION, V10, P350, DOI 10.1016/j.mito.2010.02.003; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Thuny F, 2010, ARCH CARDIOVASC DIS, V103, P150, DOI 10.1016/j.acvd.2010.01.002; Tigen K, 2008, ECHOCARDIOGR-J CARD, V25, P993, DOI 10.1111/j.1540-8175.2008.00740.x; Towbin Jeffrey A, 2010, Heart Fail Clin, V6, P453, DOI 10.1016/j.hfc.2010.06.005; Ulusoy RE, 2006, EUR J ECHOCARDIOGR, V7, P457, DOI 10.1016/j.euje.2005.07.011; Uribe S, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-9; van Dalen BM, 2008, EUR J HEART FAIL, V10, P1088, DOI 10.1016/j.ejheart.2008.08.006; Wang TW, 2004, FRONT BIOSCI-LANDMRK, V9, P619, DOI 10.2741/1095; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Williams T, 2011, CLIN RES CARDIOL, V100, P1087, DOI 10.1007/s00392-011-0345-9; Wlodarska EK, 2010, INT J CARDIOL, V145, P107, DOI 10.1016/j.ijcard.2009.05.062; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang JW, 2012, CARDIOVASC RES, V96, P276, DOI 10.1093/cvr/cvs250; Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047; Yukifumi M, 2011, PEDIATR CARDIOL, V32, P206, DOI 10.1007/s00246-010-9831-5; Zechner U, 2009, EUR J MED GENET, V52, P306, DOI 10.1016/j.ejmg.2009.06.001; Zhang WJ, 2013, AM J MED GENET C, V163, P144, DOI 10.1002/ajmg.c.31369; Zhang WJ, 2011, J BIOL CHEM, V286, P36820, DOI 10.1074/jbc.M111.279679; Zhao C, 2014, DEVELOPMENT, V141, P281, DOI 10.1242/dev.093690; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zuckerman WA, 2011, PEDIATR CARDIOL, V32, P406, DOI 10.1007/s00246-010-9868-5	126	267	295	10	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					813	825		10.1016/S0140-6736(14)61282-4	http://dx.doi.org/10.1016/S0140-6736(14)61282-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0LR	25865865				2022-12-28	WOS:000360287900027
J	Saver, JL; Goyal, M; Bonafe, A; Diener, HC; Levy, EI; Pereira, VM; Albers, GW; Cognard, C; Cohen, DJ; Hacke, W; Jansen, O; Jovin, TG; Mattle, HP; Nogueira, RG; Siddiqui, AH; Yavagal, DR; Baxter, BW; Devlin, TG; Lopes, DK; Reddy, VK; de Rochemont, RD; Singer, OC; Jahan, R				Saver, Jeffrey L.; Goyal, Mayank; Bonafe, Alain; Diener, Hans-Christoph; Levy, Elad I.; Pereira, Vitor M.; Albers, Gregory W.; Cognard, Christophe; Cohen, David J.; Hacke, Werner; Jansen, Olav; Jovin, Tudor G.; Mattle, Heinrich P.; Nogueira, Raul G.; Siddiqui, Adnan H.; Yavagal, Dileep R.; Baxter, Blaise W.; Devlin, Thomas G.; Lopes, Demetrius K.; Reddy, Vivek K.; de Rochemont, Richard du Mesnil; Singer, Oliver C.; Jahan, Reza		SWIFT PRIME Investigators	Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ENDOVASCULAR TREATMENT; RETROSPECTIVE MULTICENTER; ARTERIAL-OCCLUSION; IMAGING SELECTION; SOLITAIRE FR; TRIAL; THERAPY; REVASCULARIZATION	BACKGROUND Among patients with acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, less than 40% regain functional independence when treated with intravenous tissue plasminogen activator (t-PA) alone. Thrombectomy with the use of a stent retriever, in addition to intravenous t-PA, increases reperfusion rates and may improve long-term functional outcome. METHODS We randomly assigned eligible patients with stroke who were receiving or had received intravenous t-PA to continue with t-PA alone (control group) or to undergo endovascular thrombectomy with the use of a stent retriever within 6 hours after symptom onset (intervention group). Patients had confirmed occlusions in the proximal anterior intracranial circulation and an absence of large ischemic-core lesions. The primary outcome was the severity of global disability at 90 days, as assessed by means of the modified Rankin scale (with scores ranging from 0 [no symptoms] to 6 [death]). RESULTS The study was stopped early because of efficacy. At 39 centers, 196 patients underwent randomization (98 patients in each group). In the intervention group, the median time from qualifying imaging to groin puncture was 57 minutes, and the rate of substantial reperfusion at the end of the procedure was 88%. Thrombectomy with the stent retriever plus intravenous t-PA reduced disability at 90 days over the entire range of scores on the modified Rankin scale (P< 0.001). The rate of functional independence (modified Rankin scale score, 0 to 2) was higher in the intervention group than in the control group (60% vs. 35%, P< 0.001). There were no significant between-group differences in 90-day mortality (9% vs. 12%, P = 0.50) or symptomatic intracranial hemorrhage (0% vs. 3%, P = 0.12). CONCLUSIONS In patients receiving intravenous t-PA for acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, thrombectomy with a stent retriever within 6 hours after onset improved functional outcomes at 90 days.	[Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Stroke Ctr, Los Angeles, CA 90095 USA; [Jahan, Reza] Univ Calif Los Angeles, Div Intervent Neuroradiol, Los Angeles, CA 90095 USA; [Albers, Gregory W.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Goyal, Mayank] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Goyal, Mayank] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Pereira, Vitor M.] Univ Toronto, Div Neuroradiol, Toronto, ON, Canada; [Pereira, Vitor M.] Univ Toronto, Div Neurosurg, Dept Med Imaging, Toronto, ON, Canada; [Pereira, Vitor M.] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Dept Surg, Toronto, ON M5T 2S8, Canada; [Bonafe, Alain] Hop Gui de Chauliac, Dept Neuroradiol, Montpellier, France; [Cognard, Christophe] Univ Hosp Toulouse, Dept Diagnost & Therapeut Neuroradiol, Toulouse, France; [Diener, Hans-Christoph] Univ Duisburg Essen, Univ Hosp, Dept Neurol, Essen, Germany; [Hacke, Werner] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Jansen, Olav] Univ Kiel, Dept Radiol & Neuroradiol, Kiel, Germany; [de Rochemont, Richard du Mesnil] Klinikum Goethe Univ, Inst Neuroradiol, Frankfurt, Germany; [Singer, Oliver C.] Klinikum Goethe Univ, Dept Neurol, Frankfurt, Germany; [Levy, Elad I.; Siddiqui, Adnan H.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA; [Cohen, David J.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64108 USA; [Cohen, David J.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Jovin, Tudor G.; Reddy, Vivek K.] Univ Pittsburgh, Dept Neurol, Med Ctr, Pittsburgh, PA 15260 USA; [Mattle, Heinrich P.] Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Nogueira, Raul G.] Emory Univ, Sch Med, Dept Neurol, Marcus Stroke & Neurosci Ctr,Grady Mem Hosp, Atlanta, GA 30322 USA; [Yavagal, Dileep R.] Univ Miami, Miller Sch Med, Dept Neurol & Neurosurg, Jackson Mem Hosp, Miami, FL 33136 USA; [Baxter, Blaise W.] Univ Tennessee, Dept Radiol, Erlanger Hosp, Chattanooga, TN USA; [Devlin, Thomas G.] Univ Tennessee, Div Neurol, Erlanger Hosp, Chattanooga, TN USA; [Lopes, Demetrius K.] Rush Univ, Dept Neurosurg, Med Ctr, Chicago, IL 60612 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Stanford University; University of Calgary; University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montpellier; CHU de Montpellier; CHU de Toulouse; University of Duisburg Essen; Ruprecht Karls University Heidelberg; University of Kiel; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bern; University Hospital of Bern; Emory University; University of Miami; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Rush University	Saver, JL (corresponding author), Univ Calif Los Angeles, Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu	Horev, Anat/AAB-4919-2021; Schwaiger, Benedikt J/D-7379-2017; Demchuk, Andrew M/E-1103-2012; Hattingen, Elke/D-7880-2015; Goyal, Mayank/AAE-7323-2019; Hacke, Werner/ABE-8661-2020; Lopes, Demetrius/AAD-7334-2020; Siddiqui, Adnan H./AAG-9781-2019; EKER, Omer F/H-1930-2019; Schwaiger, Benedikt J./AAS-6036-2020; Diener, Hans-Christoph/AAF-7275-2019; Jansen, Olav/CAF-4179-2022; Brunner, Freimuth/AAE-9651-2021	Schwaiger, Benedikt J/0000-0003-1803-1510; Demchuk, Andrew M/0000-0002-4930-7789; Lopes, Demetrius/0000-0002-6280-0113; EKER, Omer F/0000-0002-5696-5368; Schwaiger, Benedikt J./0000-0003-1803-1510; Albers, Gregory/0000-0003-0263-4632; Sonig, Ashish/0000-0002-9881-2597; Gutmann, Laurie/0000-0003-3926-4209; cognard, christophe/0000-0003-4287-2627; Killer-Oberpfalzer, Monika/0000-0001-5572-7694; Kondziella, Daniel/0000-0001-5562-9808; Gonzalez, Nestor/0000-0002-8277-6317; Pongratz, Viola/0000-0003-0981-1080; Poppert, Holger/0000-0003-2189-7681; Dehkharghani, Seena/0000-0002-3141-1094; Gascou, Gregory/0000-0002-0817-7324; Andersen, Grethe/0000-0001-6807-2500; Jumaa, Mouhammad/0000-0002-7165-797X; ayrignac, xavier/0000-0003-3834-2981; Brunner, Freimuth/0000-0002-2818-2665; Hattingen, Elke/0000-0002-8392-9004; Seder, David/0000-0002-9717-1038	Covidien; Alberta Innovates [201300690] Funding Source: researchfish	Covidien; Alberta Innovates	Funded by Covidien; SWIFT PRIME ClinicalTrials.gov number, NCT01657461.	Almekhlafi MA, 2013, J NEUROINTERV SURG, V5, P58, DOI 10.1136/neurintsurg-2012-010486; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P1265; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Davalos A, 2012, STROKE, V43, P2699, DOI 10.1161/STROKEAHA.112.663328; De Silva DA, 2010, STROKE, V41, P295, DOI 10.1161/STROKEAHA.109.562827; Demchuk AM, 2012, ANN NY ACAD SCI, V1268, P63, DOI 10.1111/j.1749-6632.2012.06732.x; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2014, STROKE, V45, pE252, DOI 10.1161/STROKEAHA.114.007366; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; JANSEN O, 1995, AM J NEURORADIOL, V16, P1977; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2014, STROKE, V45, P2024, DOI 10.1161/STROKEAHA.114.005050; Mokin M, 2013, NEUROSURGERY, V73, P19, DOI 10.1227/01.neu.0000429859.96652.57; Paciaroni M, 2012, STROKE, V43, P125, DOI 10.1161/STROKEAHA.111.630624; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; Sacks D, 2013, AM J NEURORADIOL, V34, pE0; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2015, INT J STROKE, V10, P439, DOI 10.1111/ijs.12459; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Zaidat OO, 2014, J NEUROINTERV SURG, V6, P584, DOI 10.1136/neurintsurg-2013-010895; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	31	3188	3389	6	139	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2285	2295		10.1056/NEJMoa1415061	http://dx.doi.org/10.1056/NEJMoa1415061			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	25882376	Green Published			2022-12-28	WOS:000356019200004
J	Lal, H; Cunningham, AL; Godeaux, O; Chlibek, R; Diez-Domingo, J; Hwang, SJ; Levin, MJ; McElhaney, JE; Poder, A; Puig-Barbera, J; Vesikari, T; Watanabe, D; Weckx, L; Zahaf, T; Heineman, TC				Lal, Himal; Cunningham, Anthony L.; Godeaux, Olivier; Chlibek, Roman; Diez-Domingo, Javier; Hwang, Shinn-Jang; Levin, Myron J.; McElhaney, Janet E.; Poder, Airi; Puig-Barbera, Joan; Vesikari, Timo; Watanabe, Daisuke; Weckx, Lily; Zahaf, Toufik; Heineman, Thomas C.		ZOE-50 Study Grp	Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL RESPONSES; CANDIDATE VACCINE; IMMUNE-RESPONSE; VIRUS; IMMUNOGENICITY; SAFETY; ANTIGENS; QS21	Background In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01(B) adjuvant system (called HZ/su) had a clinically acceptable safety profile and elicited a robust immune response. Methods We conducted a randomized, placebo-controlled, phase 3 study in 18 countries to evaluate the efficacy and safety of HZ/su in older adults (>= 50 years of age), stratified according to age group (50 to 59, 60 to 69, and >= 70 years). Participants received two intramuscular doses of the vaccine or placebo 2 months apart. The primary objective was to assess the efficacy of the vaccine, as compared with placebo, in reducing the risk of herpes zoster in older adults. Results A total of 15,411 participants who could be evaluated received either the vaccine (7698 participants) or placebo (7713 participants). During a mean follow-up of 3.2 years, herpes zoster was confirmed in 6 participants in the vaccine group and in 210 participants in the placebo group (incidence rate, 0.3 vs. 9.1 per 1000 person-years) in the modified vaccinated cohort. Overall vaccine efficacy against herpes zoster was 97.2% (95% confidence interval [CI], 93.7 to 99.0; P<0.001). Vaccine efficacy was between 96.6% and 97.9% for all age groups. Solicited reports of injection-site and systemic reactions within 7 days after vaccination were more frequent in the vaccine group. There were solicited or unsolicited reports of grade 3 symptoms in 17.0% of vaccine recipients and 3.2% of placebo recipients. The proportions of participants who had serious adverse events or potential immune-mediated diseases or who died were similar in the two groups. Conclusions The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older. Vaccine efficacy in adults who were 70 years of age or older was similar to that in the other two age groups. (Funded by GlaxoSmithKline Biologicals; ZOE-50 ClinicalTrials.govnumber, NCT01165177.)	[Lal, Himal; Heineman, Thomas C.] GSK Vaccines, King Of Prussia, PA 19406 USA; [Cunningham, Anthony L.] Westmead Millennium Inst Med Res, Westmead, NSW, Australia; [Cunningham, Anthony L.] Univ Sydney, Sydney, NSW 2006, Australia; [Godeaux, Olivier; Zahaf, Toufik] GSK Vaccines, Wavre, Belgium; [Chlibek, Roman] Univ Def, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic; [Diez-Domingo, Javier; Puig-Barbera, Joan] Fdn Fomento Invest Sanitaria & Biomed, Vaccine Res Unit, Valencia, Spain; [Hwang, Shinn-Jang] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hwang, Shinn-Jang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Levin, Myron J.] Univ Colorado, Aurora, CO USA; [McElhaney, Janet E.] Adv Med Res Inst Canada, Sudbury, ON, Canada; [Poder, Airi] Tartu Univ Hosp, Tartu, Estonia; [Vesikari, Timo] Univ Tampere, Vaccine Res Ctr, FIN-33101 Tampere, Finland; [Watanabe, Daisuke] Aichi Med Univ, Dept Dermatol, Nagakute, Aichi 48011, Japan; [Weckx, Lily] Univ Fed Sao Paulo, Ctr Referencia Imunobiol Especiais, Sao Paulo, Brazil	GlaxoSmithKline; University of Sydney; GlaxoSmithKline; University of Defence - Czech Republic; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Colorado System; University of Colorado Anschutz Medical Campus; Tampere University; Aichi Medical University; Universidade Federal de Sao Paulo (UNIFESP)	Heineman, TC (corresponding author), GSK Vaccines, Global Clin Res & Dev, 2301 Renaissance Blvd, King Of Prussia, PA 19406 USA.	thomas.c.heineman@gsk.com	Domingo, Javier Diez/B-7293-2015; Sanmartin Berglund, Johan/HGB-0471-2022; Chlibek, Roman/P-9084-2016; Puig-Barberà, Joan/F-1563-2015; Watanabe, Daisuke/AAG-2962-2021	Domingo, Javier Diez/0000-0003-1008-3922; Puig-Barberà, Joan/0000-0001-5783-0409; VOLPI, Antonio/0000-0001-9709-4186; Cunningham, Anthony/0000-0002-6744-5667; Watanabe, Daisuke/0000-0001-6817-3993; Smetana, Jan/0000-0002-4566-3356; WECKX, LILY/0000-0003-4949-3582; McNeil, Shelly/0000-0001-5444-4166				Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123; Berkowitz EM, 2015, J INFECT DIS, V211, P1279, DOI 10.1093/infdis/jiu606; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Chlibek R, 2014, VACCINE, V32, P1745, DOI 10.1016/j.vaccine.2014.01.019; Chlibek R, 2013, J INFECT DIS, V208, P1953, DOI 10.1093/infdis/jit365; Clark TG, 2005, DEV BIOLOGICALS, V121, P153; Da Silva FT, 2013, VACCINE, V31, P1870, DOI 10.1016/j.vaccine.2013.01.042; Dendouga N, 2012, VACCINE, V30, P3126, DOI 10.1016/j.vaccine.2012.01.088; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gershon AA, 2010, J CLIN VIROL, V48, pS2, DOI 10.1016/S1386-6532(10)70002-0; Gilbert PB, 2014, J INFECT DIS, V210, P1573, DOI 10.1093/infdis/jiu279; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Gowrishankar K, 2010, J VIROL, V84, P8861, DOI 10.1128/JVI.01020-10; Hales CM, 2014, MMWR-MORBID MORTAL W, V63; Haumont M, 1996, VIRUS RES, V40, P199, DOI 10.1016/0168-1702(95)01270-2; Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724; Johnson RW, 2010, EXPERT REV VACCINES, V9, P21, DOI 10.1586/ERV.10.30; Leroux-Roels I, 2012, J INFECT DIS, V206, P1280, DOI 10.1093/infdis/jis497; Leroux-Roels I, 2010, VACCINE, V28, P7016, DOI 10.1016/j.vaccine.2010.08.035; Levin MJ, 2012, CURR OPIN IMMUNOL, V24, P494, DOI 10.1016/j.coi.2012.06.002; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Mols JF, 2013, J VIROL METHODS, V188, P145, DOI 10.1016/j.jviromet.2012.12.013; Oxman MN, 2010, CLIN INFECT DIS, V51, P197, DOI 10.1086/653605; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Stadtmauer EA, 2014, BLOOD, V124, P2921, DOI 10.1182/blood-2014-04-573048; Steain M, 2014, J VIROL, V88, P2704, DOI 10.1128/JVI.03445-13; VAFAI A, 1993, VACCINE, V11, P937, DOI 10.1016/0264-410X(93)90382-8; VAFAI A, 1995, VACCINE, V13, P1336, DOI 10.1016/0264-410X(94)00073-V; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038	35	690	727	10	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2087	2096		10.1056/NEJMoa1501184	http://dx.doi.org/10.1056/NEJMoa1501184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	25916341	Green Published, Green Submitted			2022-12-28	WOS:000355146800004
J	Rosenblatt, M; Kuhlik, B				Rosenblatt, Michael; Kuhlik, Bruce			Principles and Challenges in Access to Experimental Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rosenblatt, Michael; Kuhlik, Bruce] Merck & Co Inc, Kenilworth, NJ 07033 USA	Merck & Company	Rosenblatt, M (corresponding author), Merck & Co Inc, 2000 Galloping Hill Rd,K1-4118B, Kenilworth, NJ 07033 USA.	michael.rosenblatt@merck.com						Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465; Leonard Kimberley, 2014, US NEWS; Lieu CH, J CLIN ONCOL, DOI [10.1200/JCO.2014.60.6004, DOI 10.1200/JC0.2014.60.6004]; Sanghavi D, 2014, HLTH POLICY ISSUE BR; Turkewitzjan J., 2015, NY TIMES	5	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2023	2024		10.1001/jama.2015.4135	http://dx.doi.org/10.1001/jama.2015.4135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	25906392				2022-12-28	WOS:000355142400012
J	Thi, EP; Mire, CE; Lee, ACH; Geisbert, JB; Zhou, JZ; Agans, KN; Snead, NM; Deer, DJ; Barnard, TR; Fenton, KA; MacLachlan, I; Geisbert, TW				Thi, Emily P.; Mire, Chad E.; Lee, Amy C. H.; Geisbert, Joan B.; Zhou, Joy Z.; Agans, Krystle N.; Snead, Nicholas M.; Deer, Daniel J.; Barnard, Trisha R.; Fenton, Karla A.; MacLachlan, Ian; Geisbert, Thomas W.			Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates	NATURE			English	Article							HEPATITIS-C VIRUS; HAIRPIN RNAS; DISEASE; MICE	The current outbreak of Ebola virus in West Africa is unprecedented, causing more cases and fatalities than all previous outbreaks combined, and has yet to be controlled(1). Several post-exposure interventions have been employed under compassionate use to treat patients repatriated to Europe and the United States(2). However, the in vivo efficacy of these interventions against the new outbreak strain of Ebola virus is unknown. Here we show that lipid-nanoparticle-encapsulated short interfering RNAs (siRNAs) rapidly adapted to target the Makona outbreak strain of Ebola virus are able to protect 100% of rhesus monkeys against lethal challenge when treatment was initiated at 3 days after exposure while animals were viraemic and clinically ill. Although all infected animals showed evidence of advanced disease including abnormal haematology, blood chemistry and coagulopathy, siRNA-treated animals had milder clinical features and fully recovered, while the untreated control animals succumbed to the disease. These results represent the first, to our knowledge, successful demonstration of therapeutic anti-Ebola virus efficacy against the new outbreak strain in nonhuman primates and highlight the rapid development of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.	[Thi, Emily P.; Lee, Amy C. H.; Zhou, Joy Z.; Snead, Nicholas M.; Barnard, Trisha R.; MacLachlan, Ian] Tekmira Pharmaceut, Burnaby, BC V5J 5J8, Canada; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA.	twgeisbe@utmb.edu	Mire, Chad/Z-6338-2019	Mire, Chad/0000-0001-7596-1808	Department of Health and Human Services, National Institutes of Health [U19AI109711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109711] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Borisevich for assistance with clinical pathology assays performed in the GNL BSL-4 laboratory. We also thank S. Klassen for his assistance with siRNA-LNP preparation. This study was supported by the Department of Health and Human Services, National Institutes of Health grant U19AI109711 to T.W.G. and I.M.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227; Dallas A, 2014, J VIROL, V88, P4647, DOI 10.1128/JVI.00105-14; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Ma H, 2014, GASTROENTEROLOGY, V146, P63, DOI 10.1053/j.gastro.2013.09.049; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Trefry C., 2015, ASM BIOD EM DIS RES; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; World Health Organization, 2015, EB DAT STAT	21	185	192	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					362	+		10.1038/nature14442	http://dx.doi.org/10.1038/nature14442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25901685	Green Accepted			2022-12-28	WOS:000354816500058
J	Huang, HH; Lin, FC; Schmandt, B; Farrell, J; Smith, RB; Tsai, VC				Huang, Hsin-Hua; Lin, Fan-Chi; Schmandt, Brandon; Farrell, Jamie; Smith, Robert B.; Tsai, Victor C.			The Yellowstone magmatic system from the mantle plume to the upper crust	SCIENCE			English	Article							SILL COMPLEX BENEATH; STORAGE BENEATH; HYDROTHERMAL SYSTEM; JOINT INVERSION; UNITED-STATES; TOMOGRAPHY; CALDERA; VOLCANO; WESTERN; DYNAMICS	The Yellowstone supervolcano is one of the largest active continental silicic volcanic fields in the world. An understanding of its properties is key to enhancing our knowledge of volcanic mechanisms and corresponding risk. Using a joint local and teleseismic earthquake P-wave seismic inversion, we revealed a basaltic lower-crustal magma body that provides a magmatic link between the Yellowstone mantle plume and the previously imaged upper-crustal magma reservoir. This lower-crustal magma body has a volume of 46,000 cubic kilometers, similar to 4.5 times that of the upper-crustal magma reservoir, and contains a melt fraction of similar to 2%. These estimates are critical to understanding the evolution of bimodal basaltic-rhyolitic volcanism, explaining the magnitude of CO2 discharge, and constraining dynamic models of the magmatic system for volcanic hazard assessment.	[Huang, Hsin-Hua; Lin, Fan-Chi; Farrell, Jamie; Smith, Robert B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Huang, Hsin-Hua; Tsai, Victor C.] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [Schmandt, Brandon] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	Utah System of Higher Education; University of Utah; California Institute of Technology; University of New Mexico	Huang, HH (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	hsinhua.huang@utah.edu	Tsai, Victor C/J-8405-2012; Huang, Hsin-Hua/E-5677-2013; Lin, Fan-Chi/E-8170-2012	Tsai, Victor C/0000-0003-1809-6672; Huang, Hsin-Hua/0000-0002-1115-2427; Lin, Fan-Chi/0000-0003-0394-6830	NSF [CyberSEES-1442665, EAR-1252191, EAR-03233309]; University of Utah; University of Utah Seismograph Stations; Brinson Foundation; Carrico funds; Division of Computing and Communication Foundations [1442665] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Utah; University of Utah Seismograph Stations; Brinson Foundation; Carrico funds; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Data were collected from the Yellowstone seismograph network operated by the University of Utah, the NSF-funded EarthScope project, and a temporary seismic array operated by Stanford University. All waveform data used in this project can be obtained through the IRIS Data Management Center. Supported by the University of Utah, the University of Utah Seismograph Stations, NSF grants CyberSEES-1442665, EAR-1252191, and EAR-03233309 (in support of the EarthScope Transportable Array), and the Brinson Foundation and Carrico funds.	Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Chang WL, 2007, SCIENCE, V318, P952, DOI 10.1126/science.1146842; Christiansen R.L., 2001, 729G US GEOL SURV, P145; Chu RS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041656; DeNosaquo KR, 2009, J VOLCANOL GEOTH RES, V188, P108, DOI 10.1016/j.jvolgeores.2009.08.006; Farrell J, 2014, GEOPHYS RES LETT, V41, P3068, DOI 10.1002/2014GL059588; FOURNIER RO, 1989, ANNU REV EARTH PL SC, V17, P13, DOI 10.1146/annurev.ea.17.050189.000305; Gudmundsson A, 2011, TECTONOPHYSICS, V500, P50, DOI 10.1016/j.tecto.2009.10.015; Huang HH, 2014, GEOPHYS RES LETT, V41, P6350, DOI 10.1002/2014GL061115; Hurwitz S, 2014, REV GEOPHYS, V52, P375, DOI 10.1002/2014RG000452; Husen S, 2004, J VOLCANOL GEOTH RES, V131, P397, DOI 10.1016/S0377-0273(03)00416-5; Jaxybulatov K, 2014, SCIENCE, V346, P617, DOI 10.1126/science.1258582; Koulakov I, 2013, J VOLCANOL GEOTH RES, V263, P75, DOI 10.1016/j.jvolgeores.2012.10.014; Lowenstern JB, 2008, ELEMENTS, V4, P35, DOI 10.2113/GSELEMENTS.4.1.35; Mitchell MA, 2013, GEOPHYS RES LETT, V40, P5040, DOI 10.1002/grl.50899; Obrebski M, 2011, GEOPHYS J INT, V185, P1003, DOI 10.1111/j.1365-246X.2011.04990.x; Paulatto M, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003892; ROECKER SW, 1993, J GEOPHYS RES-SOL EA, V98, P15779, DOI 10.1029/93JB01560; Schmandt B, 2014, GEOPHYS RES LETT, V41, P6342, DOI 10.1002/2014GL061231; Schmandt B, 2012, EARTH PLANET SC LETT, V331, P224, DOI 10.1016/j.epsl.2012.03.025; Seats KJ, 2014, GEOPHYS RES LETT, V41, P8277, DOI 10.1002/2014GL061913; Shen WS, 2013, J GEOPHYS RES-SOL EA, V118, P262, DOI 10.1029/2012JB009602; Shervais JW, 2006, GEOLOGY, V34, P365, DOI 10.1130/G22226.1; Smith RB, 2009, J VOLCANOL GEOTH RES, V188, P26, DOI 10.1016/j.jvolgeores.2009.08.020; Syracuse EM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007554; Waite GP, 2009, J VOLCANOL GEOTH RES, V182, P113, DOI 10.1016/j.jvolgeores.2009.02.009; Werner C, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000473; West M, 2001, NATURE, V413, P833, DOI 10.1038/35101581; White SM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001002; Xue M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006079; Yuan HY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022056; ZHAO DP, 1994, J GEOPHYS RES-SOL EA, V99, P22313, DOI 10.1029/94JB01149	32	169	174	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					773	776		10.1126/science.aaa5648	http://dx.doi.org/10.1126/science.aaa5648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25908659				2022-12-28	WOS:000354428700036
J	Gutsche, I; Desfosses, A; Effantin, G; Ling, WL; Haupt, M; Ruigrok, RWH; Sachse, C; Schoehn, G				Gutsche, Irina; Desfosses, Ambroise; Effantin, Gregory; Ling, Wai Li; Haupt, Melina; Ruigrok, Rob W. H.; Sachse, Carsten; Schoehn, Guy			Near-atomic cryo-EM structure of the helical measles virus nucleocapsid	SCIENCE			English	Article							NUCLEOPROTEIN-RNA COMPLEX; RESPIRATORY SYNCYTIAL VIRUS; VESICULAR STOMATITIS-VIRUS; CRYSTAL-STRUCTURE; RECONSTRUCTION; PHOSPHOPROTEIN; BINDING; DOMAIN	Measles is a highly contagious human disease. We used cryo-electron microscopy and single particle-based helical image analysis to determine the structure of the helical nucleocapsid formed by the folded domain of the measles virus nucleoprotein encapsidating an RNA at a resolution of 4.3 angstroms. The resulting pseudoatomic model of the measles virus nucleocapsid offers important insights into the mechanism of the helical polymerization of nucleocapsids of negative-strand RNA viruses, in particular via the exchange subdomains of the nucleoprotein. The structure reveals the mode of the nucleoprotein-RNA interaction and explains why each nucleoprotein of measles virus binds six nucleotides, whereas the respiratory syncytial virus nucleoprotein binds seven. It provides a rational basis for further analysis of measles virus replication and transcription, and reveals potential targets for drug design.	[Gutsche, Irina; Effantin, Gregory; Ruigrok, Rob W. H.; Schoehn, Guy] CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Gutsche, Irina; Effantin, Gregory; Ruigrok, Rob W. H.; Schoehn, Guy] Univ Grenoble Alpes, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Desfosses, Ambroise; Sachse, Carsten] European Mol Biol Lab, Struct & Computat Biol Unit, D-69917 Heidelberg, Germany; [Ling, Wai Li; Schoehn, Guy] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Ling, Wai Li; Schoehn, Guy] CNRS, IBS, F-38044 Grenoble, France; [Ling, Wai Li; Schoehn, Guy] CEA, IBS, F-38044 Grenoble, France; [Haupt, Melina] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL)	Gutsche, I (corresponding author), CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France.	gutsche@embl.fr	Sachse, Carsten/AAY-9384-2020; Ling, Wai Li W/F-9823-2012; Sachse, Carsten/H-2727-2012	Sachse, Carsten/0000-0002-1168-5143; Ling, Wai Li W/0000-0002-4264-5750; Sachse, Carsten/0000-0002-1168-5143; Schoehn, Guy/0000-0002-1459-3201; Desfosses, Ambroise/0000-0002-6525-5042	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions [PCOFUND-GA-2008-229597]	FRISBI; GRAL; EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions	We thank A. Jakobi for assistance in real-space coordinate refinement using PHENIX, and M. Jamin for discussions and comments on the manuscript. This work used the platforms of the Grenoble Instruct Center (ISBG: UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB); the electron microscope facility is supported by the Rhone-Alpes Region and by the Fondation pour la Recherche Medicale. A.D. received support from EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions (PCOFUND-GA-2008-229597). The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. The cryo-EM map of the helical MeV Ncore-RNA nucleocapsid and the atomic model are deposited in the Electron Microscopy Data Bank and in the Protein Data Bank with accession codes EMDB-2867 and 4uft. The authors declare no competing financial interests. I.G., R.W.H.R., and G.S. designed the study; M.H. purified biological material; I.G., A.D., W.L.L., C.S., and G.S. performed research and analyzed data; R.W.H.R. and G.E. contributed to data interpretation; and I.G. wrote the paper with input from G.E.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; BUCKLAND R, 1989, J GEN VIROL, V70, P435, DOI 10.1099/0022-1317-70-2-435; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cox R, 2014, P NATL ACAD SCI USA, V111, P15208, DOI 10.1073/pnas.1413268111; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; EGELMAN EH, 1989, J VIROL, V63, P2233, DOI 10.1128/JVI.63.5.2233-2243.1989; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Green TJ, 2014, J VIROL, V88, P3766, DOI 10.1128/JVI.03483-13; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Krumm SA, 2013, J BIOL CHEM, V288, P29943, DOI 10.1074/jbc.M113.503862; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868	21	96	99	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					704	707		10.1126/science.aaa5137	http://dx.doi.org/10.1126/science.aaa5137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25883315				2022-12-28	WOS:000354045700048
J	Kahn, JM				Kahn, Jeremy M.			Virtual Visits - Confronting the Challenges of Telemedicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kahn, Jeremy M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.			Kahn, Jeremy/0000-0001-9688-5576				Adler-Milstein J, 2014, HEALTH AFFAIR, V33, P207, DOI 10.1377/hlthaff.2013.1054; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; McLean S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071238; Nesbitt T.S., 2012, ROLE TELEHEALTH EVOL; Wilcox ME, 2012, CRIT CARE, V16, DOI 10.1186/cc11429	5	83	84	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1684	1685		10.1056/NEJMp1500533	http://dx.doi.org/10.1056/NEJMp1500533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG9RF	25923547				2022-12-28	WOS:000353655000002
J	Boyle, A; Viccellio, P; Whale, C				Boyle, Adrian; Viccellio, Peter; Whale, Chris			Is "boarding" appropriate to help reduce crowding in emergency departments?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Boyle, Adrian] Cambridge Univ Hosp Fdn Trust, Cambridge, England; [Viccellio, Peter] Stony Brook Univ Hosp, New York, NY USA; [Whale, Chris] Derby Teaching Hosp NHS Fdn Trust, Acute Med Business Unit, Derby, England	University of Cambridge; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Boyle, A (corresponding author), Cambridge Univ Hosp Fdn Trust, Cambridge, England.	boylea@doctors.org.uk; chris.whale1@nhs.net		Boyle, Adrian/0000-0002-9009-5423				Adams S, 2015, DAILY MAIL; Ahyow LC, 2013, INFECT CONT HOSP EP, V34, P1062, DOI 10.1086/673156; Boyle A, 2014, CROWDING EMERGENCY D; Carter EJ, 2014, J NURS SCHOLARSHIP, V46, P106, DOI 10.1111/jnu.12055; GUTTMANN A, 2011, BMJ-BRIT MED J, V342, P2983, DOI [10.1136/bmj.d2983, DOI 10.1136/BMJ.D2983]; Henderson K, 2014, BRIT J HOSP MED, V75, P623, DOI 10.12968/hmed.2014.75.11.623; Madsen F, 2014, HEALTH AFFAIR, V33, P1236, DOI 10.1377/hlthaff.2013.1303; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; Plunkett PK, 2011, EUR J EMERG MED, V18, P192, DOI 10.1097/MEJ.0b013e328344917e; Reid E, 2015, CLIN MED, V15, P117, DOI 10.7861/clinmedicine.15-2-117; Society for Academic Emergency Medicine, 2011, POL DRIV IMPR CROWD; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Viccellio A, 2009, ANN EMERG MED, V54, P487, DOI 10.1016/j.annemergmed.2009.03.005; Viccellio P, 2013, J EMERG MED, V45, P942, DOI 10.1016/j.jemermed.2013.07.018; Watase T, 2012, AM J EMERG MED, V30, P1329, DOI 10.1016/j.ajem.2011.09.017	15	8	8	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2249	10.1136/bmj.h2249	http://dx.doi.org/10.1136/bmj.h2249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25921206				2022-12-28	WOS:000353955900017
J	Coombes, R				Coombes, Rebecca			ROUND TABLE What the politicians aren't saying about health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2248	10.1136/bmj.h2248	http://dx.doi.org/10.1136/bmj.h2248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25921647				2022-12-28	WOS:000353955900016
J	Stettler, N; McKiernan, CM; Melin, CQ; Adejoro, OO; Walczak, NB				Stettler, Nicolas; McKiernan, Colleen M.; Melin, Court Q.; Adejoro, Oluwakayode O.; Walczak, Nancy B.			Proportion of Adults With Sickle Cell Anemia and Pain Crises Receiving Hydroxyurea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Stettler, Nicolas; McKiernan, Colleen M.; Melin, Court Q.; Adejoro, Oluwakayode O.; Walczak, Nancy B.] Lewin Grp, Falls Church, VA 22042 USA		Stettler, N (corresponding author), Lewin Grp, 3130 Fairview Pk Dr, Falls Church, VA 22042 USA.	nicolas.stettler@lewin.com						Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	5	42	43	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1671	1672		10.1001/jama.2015.3075	http://dx.doi.org/10.1001/jama.2015.3075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919532	Bronze			2022-12-28	WOS:000353595200019
J	Alexander, HM				Alexander, Helen M.			ECOLOGY Shared ancestry predicts disease levels	NATURE			English	Editorial Material							PHYLOGENETIC SIGNAL; HOST-RANGE; DIVERSITY; PATHOGENS; RISK	Ecological factors such as host density are important predictors of disease incidence. But another key determinant may be the evolutionary history and relatedness of the host community.	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas	Alexander, HM (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	halexander@ku.edu						Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert GS, 2012, EVOL APPL, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Parker IM, 2015, NATURE, V520, P542, DOI 10.1038/nature14372; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	10	2	2	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					446	447		10.1038/520446a	http://dx.doi.org/10.1038/520446a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903624				2022-12-28	WOS:000353334500027
J	Chistol, G; Walter, JC				Chistol, Gheorghe; Walter, Johannes C.			Single-Molecule Visualization of MCM2-7 DNA Loading: Seeing Is Believing	CELL			English	Editorial Material							COMPLEX	The first event in the initiation of eukaryotic DNA replication is the recruitment of the MCM2-7 ATPase, the core of the replicative DNA helicase, to origins. Ticau et al. use single-molecule imaging to reveal how ORC, Cdc6, and Cdt1 cooperate to load MCM2-7 onto DNA, enabling bidirectional replication.	[Chistol, Gheorghe; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Walter, Johannes C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Chistol, Gheorghe/0000-0003-4868-3667; Walter, Johannes/0000-0002-4186-7570				Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Duzdevich D., 2015, MOL CELL, V58; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285	8	4	4	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					429	430		10.1016/j.cell.2015.04.006	http://dx.doi.org/10.1016/j.cell.2015.04.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910200	Bronze			2022-12-28	WOS:000353553600002
J	Raghupathy, R; Anilkumar, AA; Polley, A; Singh, PP; Yadav, M; Johnson, C; Suryawanshi, S; Saikam, V; Sawant, SD; Panda, A; Guo, Z; Vishwakarma, RA; Rao, M; Mayor, S				Raghupathy, Riya; Anilkumar, Anupama Ambika; Polley, Anirban; Singh, Parvinder Pal; Yadav, Mahipal; Johnson, Charles; Suryawanshi, Sharad; Saikam, Varma; Sawant, Sanghapal D.; Panda, Aniruddha; Guo, Zhongwu; Vishwakarma, Ram A.; Rao, Madan; Mayor, Satyajit			Transbilayer Lipid Interactions Mediate Nanoclustering of Lipid-Anchored Proteins	CELL			English	Article							CELL-SURFACE MOLECULES; PLASMA-MEMBRANE; NANOSCALE ORGANIZATION; INDEPENDENT ENDOCYTOSIS; PHOSPHOLIPASE-C; PHOSPHATIDYLSERINE; RECEPTOR; DOMAINS; BIOSYNTHESIS; VESICLES	Understanding how functional lipid domains in live cell membranes are generated has posed a challenge. Here, we show that transbilayer interactions are necessary for the generation of cholesterol-dependent nanoclusters of GPI-anchored proteins mediated by membrane-adjacent dynamic actin filaments. We find that long saturated acyl-chains are required for forming GPI-anchor nanoclusters. Simultaneously, at the inner leaflet, long acyl-chain-containing phosphatidylserine (PS) is necessary for transbilayer coupling. All-atom molecular dynamics simulations of asymmetric multicomponent-membrane bilayers in a mixed phase provide evidence that immobilization of long saturated acyl-chain lipids at either leaflet stabilizes cholesterol-dependent transbilayer interactions forming local domains with characteristics similar to a liquid-ordered (lo) phase. This is verified by experiments wherein immobilization of long acyl-chain lipids at one leaflet effects transbilayer interactions of corresponding lipids at the opposite leaflet. This suggests a general mechanism for the generation and stabilization of nanoscale cholesterol-dependent and actin-mediated lipid clusters in live cell membranes.	[Raghupathy, Riya; Anilkumar, Anupama Ambika; Panda, Aniruddha; Rao, Madan; Mayor, Satyajit] Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Polley, Anirban; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India; [Raghupathy, Riya; Anilkumar, Anupama Ambika] Shanmugha Arts Sci Technol & Res Acad, Thanjavur 613401, India; [Mayor, Satyajit] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Johnson, Charles; Suryawanshi, Sharad; Guo, Zhongwu] Wayne State Univ, Detroit, MI 48202 USA; [Singh, Parvinder Pal; Yadav, Mahipal; Saikam, Varma; Sawant, Sanghapal D.; Vishwakarma, Ram A.] Indian Inst Integrat Med CSIR, Jammu 180001, India; [Panda, Aniruddha] Manipal Univ, Manipal 576104, Karnataka, India; [Polley, Anirban] Tampere Univ Technol, Tampere 33720, Finland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Wayne State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Manipal Academy of Higher Education (MAHE); Tampere University	Rao, M (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	madan@ncbs.res.in; mayor@ncbs.res.in	Saikam, Varma/AAW-9765-2020; Yadav, Mahipal/AAD-1896-2021; Sawant, Sanghapal/GOE-6804-2022; Rao, Madan/E-2927-2012; Polley, Anirban/X-8050-2018	Saikam, Varma/0000-0003-2500-9717; Yadav, Mahipal/0000-0003-4394-9737; Sawant, Sanghapal/0000-0002-6224-3214; Polley, Anirban/0000-0001-9425-8835; Panda, Aniruddha/0000-0002-9447-9547	DST (Government of India); HFSP [RGP0027/2012]; CSIR; Simons Foundation; NSF [CHE-1053848]; NIH [GM090270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090270] Funding Source: NIH RePORTER; Division Of Chemistry [1053848] Funding Source: National Science Foundation	DST (Government of India)(Department of Science & Technology (India)); HFSP(Human Frontier Science Program); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Simons Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Suvrajit Saha for help with FCS measurements and MEM analysis; Balaji for Matlab codes to analyze the anisotropy data; Kabir Husain for help with the correlation analysis; Joseph Jose Thottacherry and Darius Koester for FRAP measurement and analysis; Taroh Kinoshita, Tomohiko Taguchi, Tobias Meyer, and Antonio S. Sechi for their generous gifts of various reagents (as indicated in the Supplemental Information); Max Planck-NCBS lipid centre; Dominik Schwudke and Sudarkodi Sukumar for mass spectrometry; and H. Krishnamurthy and Manoj Mathew at the Central Imaging and Flow Facility (NCBS). R.R. acknowledges Vytas A. Bankaitis for suggestions with lipid incorporation methods. We thank Tampere University of Technology for help with the longer run simulations and all SM lab members for their critical comments on the manuscript. S.M. acknowledges JC Bose Fellowship from DST (Government of India) and a grant from HFSP RGP0027/2012. A. A. A. acknowledges pre-doctoral fellowship from CSIR. M.R. acknowledges a grant from Simons Foundation. Z.G. acknowledges NSF CHE-1053848 and NIH GM090270 for providing financial support.	An XL, 2004, BLOOD CELL MOL DIS, V32, P430, DOI 10.1016/j.bcmd.2004.02.001; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; ITO S, 1983, J BIOL CHEM, V258, P4626; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kobayashi T, 1996, JPN J MED SCI BIOL, V49, P103, DOI 10.7883/yoken1952.49.103; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Makuch R, 1997, BIOPHYS J, V73, P1607, DOI 10.1016/S0006-3495(97)78192-X; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mazerik JN, 2012, J BIOL CHEM, V287, P13104, DOI 10.1074/jbc.M111.336313; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MUGURUMA M, 1995, J BIOCHEM-TOKYO, V117, P1036, DOI 10.1093/oxfordjournals.jbchem.a124803; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; Pick H, 2005, J AM CHEM SOC, V127, P2908, DOI 10.1021/ja044605x; Polley A, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892087; Polley A, 2012, J PHYS CHEM B, V116, P13403, DOI 10.1021/jp3032868; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Raucher D, 2001, J CELL SCI, V114, P3759; Saha S, 2015, METHODS MOL BIOL, V1251, P151, DOI 10.1007/978-1-4939-2080-8_9; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	52	215	215	2	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					581	594		10.1016/j.cell.2015.03.048	http://dx.doi.org/10.1016/j.cell.2015.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910209	Bronze, Green Accepted			2022-12-28	WOS:000353553600017
J	Comstock, MJ; Whitley, KD; Jia, HF; Sokoloski, J; Lohman, TM; Ha, T; Chemla, YR				Comstock, Matthew J.; Whitley, Kevin D.; Jia, Haifeng; Sokoloski, Joshua; Lohman, Timothy M.; Ha, Taekjip; Chemla, Yann R.			Direct observation of structure-function relationship in a nucleic acid-processing enzyme	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI UVRD; HELICASE-II; CRYSTAL-STRUCTURES; MECHANISM; TRANSLOCATION; MONOMER; ATP; COMPLEXES	The relationship between protein three-dimensional structure and function is essential for mechanism determination. Unfortunately, most techniques do not provide a direct measurement of this relationship. Structural data are typically limited to static pictures, and function must be inferred. Conversely, functional assays usually provide little information on structural conformation. We developed a single-molecule technique combining optical tweezers and fluorescence microscopy that allows for both measurements simultaneously. Here we present measurements of UvrD, a DNA repair helicase, that directly and unambiguously reveal the connection between its structure and function. Our data reveal that UvrD exhibits two distinct types of unwinding activity regulated by its stoichiometry. Furthermore, two UvrD conformational states, termed "closed" and "open," correlate with movement toward or away from the DNA fork.	[Comstock, Matthew J.; Whitley, Kevin D.; Ha, Taekjip; Chemla, Yann R.] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Comstock, Matthew J.; Whitley, Kevin D.; Ha, Taekjip; Chemla, Yann R.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jia, Haifeng; Sokoloski, Joshua; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Chemla, YR (corresponding author), Univ Illinois, Dept Phys, Ctr Phys Living Cells, 1110 W Green St, Urbana, IL 61801 USA.	ychemla@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Chemla, Yann/0000-0001-9167-0234; Whitley, Kevin/0000-0001-9719-6916	NSF [MCB-0952442, PHY-1430124]; NIH [R21 RR025341, R01 GM065367, R01 GM045948]; Alfred P. Sloan Research Fellowship; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM045948] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0952442] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank members of the Chemla (including Z. Qi), Ha (including K.-S. Lee), and Lohman (including E. Tomko) laboratories for scientific discussion and assistance in the experimental design. Funding was provided by NSF grants MCB-0952442 (CAREER to Y.R.C.) and PHY-1430124 (Center for the Physics of Living Cells to Y.R.C. and T.H.); NIH grants R21 RR025341 (to Y.R.C. and T.H.), R01 GM065367 (to T.H.), and R01 GM045948 (to T.M.L.); and the Alfred P. Sloan Research Fellowship (to Y.R.C.). T.H. is an investigator with the Howard Hughes Medical Institute.	Arslan S, 2015, SCIENCE, V348, P344, DOI 10.1126/science.aaa0445; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kisker C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012591; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2882; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qi Z, 2013, ELIFE, V2, DOI 10.7554/eLife.00334; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Tomko EJ, 2012, J MOL BIOL, V418, P32, DOI 10.1016/j.jmb.2012.02.013; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yokota H, 2013, BIOPHYS J, V104, P924, DOI 10.1016/j.bpj.2013.01.014	29	126	126	6	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					352	354		10.1126/science.aaa0130	http://dx.doi.org/10.1126/science.aaa0130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883359	Green Accepted			2022-12-28	WOS:000352999000049
J	Husain, I; Spence, D				Husain, Iltifat; Spence, Des			HEAD TO HEAD Can healthy people benefit from health apps?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEIGHT-LOSS; TECHNOLOGY		[Husain, Iltifat] Wake Forest Sch Med, Emergency Med, Winston Salem, NC 27157 USA	Wake Forest University	Husain, I (corresponding author), Wake Forest Sch Med, Emergency Med, Winston Salem, NC 27157 USA.	ihusain@wakehealth.edu; destwo@yahoo.co.uk						[Anonymous], 2010, SEV ANX OV BLOOD PRE; Brookings Institution, 2013, MOD HLTH CAR MOB TEC; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; DiFilippo KN, 2015, J TELEMED TELECARE, V21, P243, DOI 10.1177/1357633X15572203; Dolan B, 2014, MOBI HLTH NEWS  0107; Gates A, 2014, PROFILES MED OUTREAC; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Medicines and Healthcare Products Regulatory Agency, 2014, MED DEV SOFTW APPL A; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NHS Choices, HLTH APPS LIB; Nielsen, 2014, HACKING HLTH CONSUME; Odosoft, FET DOPPL UNB IT PRE; RAVEN R J, 1988, American Museum Novitates, P1; Spring B, 2013, JAMA INTERN MED, V173, P105, DOI 10.1001/jamainternmed.2013.1221; US Food and Drug Administration, MOB MED APPL	16	38	39	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1887	10.1136/bmj.h1887	http://dx.doi.org/10.1136/bmj.h1887			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25873345				2022-12-28	WOS:000353327500006
J	Berkovits, BD; Mayr, C				Berkovits, Binyamin D.; Mayr, Christine			Alternative 3 ' UTRs act as scaffolds to regulate membrane protein localization	NATURE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; IN-VIVO; GTP-BINDING; SET PROTEIN; CELL; HUR; CD47; SITES; IMMUNOPRECIPITATION	About half of human genes use alternative cleavage and polyadenylation (ApA) to generate messenger RNA transcripts that differ in the length of their 3' untranslated regions (3' UTRs) while producing the same protein(1-3). Here we show in human cell lines that alternative 3' UTRs differentially regulate the localization of membrane proteins. The long 3' UTR of CD47 enables efficient cell surface expression of CD47 protein, whereas the short 3' UTR primarily localizes CD47 protein to the endoplasmic reticulum. CD47 protein localization occurs post-translationally and independently of RNA localization. In our model of 3' UTR-dependent protein localization, the long 3' UTR of CD47 acts as a scaffold to recruit a protein complex containing the RNA-binding protein HuR (also known as ELAVL1) and SET4 to the site of translation. This facilitates interaction of SET with the newly translated cytoplasmic domains of CD47 and results in subsequent translocation of CD47 to the plasma membrane via activated RAC1 (ref. 5). We also show that CD47 protein has different functions depending on whether it was generated by the short or long 3' UTR isoforms. Thus, ApA contributes to the functional diversity of the proteome without changing the amino acid sequence. 3' UTR-dependent protein localization has the potential to be a widespread trafficking mechanism for membrane proteins because HuR binds to thousands of mRNAs(6-9), and we show that the long 3' UTRs of CD44, ITGA1 and TNFRSF13C, which are bound by HuR, increase surface protein expression compared to their corresponding short 3' UTRs. We propose that during translation the scaffold function of 3' UTRs facilitates binding of proteins to nascent proteins to direct their transport or function-and this role of 3' UTRs can be regulated by ApA.	[Berkovits, Binyamin D.; Mayr, Christine] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Mayr, C (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA.	mayrc@mskcc.org			Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation [DRR-24-13]; National Institutes of Health [U01-CA164190];  [P30 CA008748]; NATIONAL CANCER INSTITUTE [U01CA164190, P30CA008748] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Innovator Award of the Damon Runyon-Rachleff Cancer Foundation and the Island Outreach Foundation (DRR-24-13) and National Institutes of Health grant U01-CA164190. We thank N. Patel for help with cloning of the constructs and the members of the Mayr laboratory, specifically S.-H. Lee and E. Kallin, as well as N. Rajewsky and A. Ventura, for helpful discussions. We also thank J. Joyce, C. Haynes, A. Hall and R. Benezra for critical reading of the manuscript. The N17RAC1 construct was provided by A. Hall and the JinB8 cells by W.A. Frazier and D. D. Roberts. We thank the Molecular Cytology Core Facility (Memorial Sloan Kettering Cancer Center) for help with the confocal microscopy (funded by P30 CA008748).	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Avet C, 2013, J BIOL CHEM, V288, P2641, DOI 10.1074/jbc.M112.388876; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Frazier W. A., 2010, UCSD NATURE MOL PAGE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; REINHOLD MI, 1995, J CELL SCI, V108, P3419; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Soto-Pantoja D., 2011, J GENET SYNDR GENE T, V2, DOI 10.4172/2157-7412.1000105; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	40	256	267	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					363	+		10.1038/nature14321	http://dx.doi.org/10.1038/nature14321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25896326	Green Accepted			2022-12-28	WOS:000356425400058
J	Raine, NE; Gill, RJ				Raine, Nigel E.; Gill, Richard J.			ECOLOGY Tasteless pesticides affect bees in the field	NATURE			English	Editorial Material							SEED-TREATED CANOLA; EXPOSURE; POLLINATORS; NEONICOTINOIDS; IMPACT		[Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Gill, Richard J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	University of Guelph; Imperial College London	Raine, NE (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	nraine@uoguelph.ca; r.gill@imperial.ac.uk	Raine, Nigel/AAK-6425-2020	Raine, Nigel/0000-0001-6343-2829; Gill, Richard/0000-0001-9389-1284	BBSRC [BB/I000178/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000178/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, ECOTOXICOLOGY, V23, P1755, DOI 10.1007/s10646-014-1340-5; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; FERA (The Food and Environment Research Agency), 2013, EFF NEON SEED TREATM; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Nieto A., 2014, EUROPEAN RED LIST BE; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	20	28	31	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					38	40		10.1038/nature14391	http://dx.doi.org/10.1038/nature14391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901679				2022-12-28	WOS:000354040900025
J	Gerdts, J; Brace, EJ; Sasaki, Y; DiAntonio, A; Milbrandt, J				Gerdts, Josiah; Brace, E. J.; Sasaki, Yo; DiAntonio, Aaron; Milbrandt, Jeffrey			SARM1 activation triggers axon degeneration locally via NAD(+) destruction	SCIENCE			English	Article							CELL-DEATH; WALLERIAN DEGENERATION; PROTEIN; BIOSYNTHESIS; MITOCHONDRIA; PROTECTION; REQUIRES; NEURONS; PATHWAY; DISEASE	Axon degeneration is an intrinsic self-destruction program that underlies axon loss during injury and disease. Sterile alpha and TIR motif-containing 1 (SARM1) protein is an essential mediator of axon degeneration. We report that SARM1 initiates a local destruction program involving rapid breakdown of nicotinamide adenine dinucleotide (NAD(+)) after injury. We used an engineered protease-sensitized SARM1 to demonstrate that SARM1 activity is required after axon injury to induce axon degeneration. Dimerization of the Toll-interleukin receptor (TIR) domain of SARM1 alone was sufficient to induce locally mediated axon degeneration. Formation of the SARM1 TIR dimer triggered rapid breakdown of NAD(+), whereas SARM1-induced axon destruction could be counteracted by increased NAD(+) synthesis. SARM1-induced depletion of NAD(+) may explain the potent axon protection in Wallerian degeneration slow (Wld(s)) mutant mice.	[Gerdts, Josiah; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brace, E. J.; DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [DiAntonio, Aaron; Milbrandt, Jeffrey] Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [RO1DA020812, RO1AG013730, RO1NS065053, RO1NS087632, RO1NS078007, F31NS074517]; Vertex Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065053, R01NS087632, R01NS078007, F31NS074517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vertex Pharmaceuticals(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institutes of Health grants RO1DA020812 (A.D.), RO1AG013730 (J.M.), RO1NS065053, RO1NS087632, and RO1NS078007 (J.M. and A.D.), and F31NS074517 (J.G.); and a grant from Vertex Pharmaceuticals. We thank ChromaDex (Irvine, California) for providing nicotinamide riboside; A. Strickland, T. Farhner, and N. Panchenko for technical assistance; and members of the Milbrandt and DiAntonio labs for fruitful discussions.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; ELIA MC, 1991, ANAL BIOCHEM, V192, P329, DOI 10.1016/0003-2697(91)90544-4; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967	23	304	310	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					453	457		10.1126/science.1258366	http://dx.doi.org/10.1126/science.1258366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908823	Green Accepted			2022-12-28	WOS:000353338000039
J	Penn, RB				Penn, Raymond B.			Calcilytics for asthma relief	SCIENCE			English	Editorial Material							AIRWAY SMOOTH-MUSCLE; AGONISTS		Thomas Jefferson Univ, Dept Med, Div Pulm & Crit Care Med, Jane & Leonard Korman Lung Ctr,Ctr Translat Med, Philadelphia, PA 19107 USA	Jefferson University	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Div Pulm & Crit Care Med, Jane & Leonard Korman Lung Ctr,Ctr Translat Med, Philadelphia, PA 19107 USA.	raymond.penn@jeferson.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058506, P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110007] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL114471, R01 HL058506] Funding Source: Medline; NIAID NIH HHS [R01 AI110007] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Danielsson J, 2014, AM J PHYSIOL-LUNG C, V307, pL273, DOI 10.1152/ajplung.00351.2013; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Ortega VE, 2010, CURR OPIN PHARMACOL, V10, P246, DOI 10.1016/j.coph.2010.04.009; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Townsend E. A., 2012, J ALLERGY, V2012; Yarova P.L., 2015, SCI TRANSL MED, V284, pra60	7	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					398	399		10.1126/science.aab2173	http://dx.doi.org/10.1126/science.aab2173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908810	Green Accepted			2022-12-28	WOS:000353338000019
J	Lee, DC; Sohn, HA; Park, ZY; Oh, SH; Kang, YK; Lee, KM; Kang, MH; Jang, YJ; Yang, SJ; Hong, YK; Noh, H; Kim, JA; Kim, DJ; Bae, KH; Kim, DM; Chung, SJ; Yoo, HS; Yu, DY; Park, KC; Yeom, YI				Lee, Dong Chul; Sohn, Hyun Ahm; Park, Zee-Yong; Oh, Sangho; Kang, Yun Kyung; Lee, Kyoung-min; Kang, Minho; Jang, Ye Jin; Yang, Suk-Jin; Hong, Young Ki; Noh, Hanmi; Kim, Jung-Ae; Kim, Dong Joon; Bae, Kwang-Hee; Kim, Dong Min; Chung, Sang J.; Yoo, Hyang Sook; Yu, Dae-Yeul; Park, Kyung Chan; Yeom, Young Il			A Lactate-Induced Response to Hypoxia	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; CANCER; HIF-1; HIF-1-ALPHA; INHIBITION; EXPRESSION; PATHWAYS; THERAPY; FAMILY	Organisms must be able to respond to low oxygen in a number of homeostatic and pathological contexts. Regulation of hypoxic responses via the hypoxia-inducible factor (HIF) is well established, but evidence indicates that other, HIF-independent mechanisms are also involved. Here, we report a hypoxic response that depends on the accumulation of lactate, a metabolite whose production increases in hypoxic conditions. We find that the NDRG3 protein is degraded in a PHD2/VHL-dependent manner in normoxia but is protected from destruction by binding to lactate that accumulates under hypoxia. The stabilized NDRG3 protein binds c-Raf to mediate hypoxia-induced activation of Raf-ERK pathway, promoting angiogenesis and cell growth. Inhibiting cellular lactate production abolishes the NDRG3-mediated hypoxia responses. Our study, therefore, elucidates the molecular basis for lactate-induced hypoxia signaling, which can be exploited for the development of therapies targeting hypoxia-induced diseases.	[Lee, Dong Chul; Sohn, Hyun Ahm; Kang, Minho; Jang, Ye Jin; Yang, Suk-Jin; Hong, Young Ki; Noh, Hanmi; Kim, Jung-Ae; Kim, Dong Joon; Kim, Dong Min; Chung, Sang J.; Yoo, Hyang Sook; Yu, Dae-Yeul; Park, Kyung Chan; Yeom, Young Il] Korea Res Inst Biosci & Biotechnol KRIBB, Med Genom Res Ctr, Taejon 305806, South Korea; [Yeom, Young Il] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang Branch Inst, Taejon 305806, South Korea; [Oh, Sangho] Korea Res Inst Biosci & Biotechnol KRIBB, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol KRIBB, Res Ctr Integrat Cellul, Taejon 305806, South Korea; [Park, Zee-Yong; Lee, Kyoung-min] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kang, Yun Kyung] Inje Univ, Seoul Paik Hosp, Dept Pathol, Seoul 100032, South Korea; [Noh, Hanmi; Kim, Jung-Ae; Bae, Kwang-Hee; Yeom, Young Il] Korea Univ Sci & Technol, Dept Funct Genom, Taejon 305350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gwangju Institute of Science & Technology (GIST); Inje University	Park, KC (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Med Genom Res Ctr, Taejon 305806, South Korea.	kpark@kribb.re.kr; yeomyi@kribb.re.kr	Kim, Dong Joon/AAL-8967-2020	Bae, Kwang-Hee/0000-0002-5868-2556	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2010-0030020, NRF-2011-0028171, NRF-2013M3A9B5076422, NRF-2006-2006799]; KRIBB Research Initiative Program	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; KRIBB Research Initiative Program	We thank Chul-Ho Lee (KRIBB) and MoonKyung Kang (Inje University) for the helps with animal studies and viral particles preparation, respectively. This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2010-0030020, NRF-2011-0028171, NRF-2013M3A9B5076422, NRF-2006-2006799) and by KRIBB Research Initiative Program.	Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hopfl G, 2002, CANCER RES, V62, P2962; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Maher ER, 2011, EUR J HUM GENET, V19, P617, DOI 10.1038/ejhg.2010.175; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rapisarda A, 2009, CELL CYCLE, V8, P4040, DOI 10.4161/cc.8.24.10145; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SETA KA, 2002, SCI STKE, pRE11	22	247	258	9	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					595	609		10.1016/j.cell.2015.03.011	http://dx.doi.org/10.1016/j.cell.2015.03.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892225	Bronze			2022-12-28	WOS:000353553600018
J	Bailey, DB; Gehtland, L				Bailey, Donald B., Jr.; Gehtland, Lisa			Newborn Screening Evolving Challenges in an Era of Rapid Discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Bailey, Donald B., Jr.; Gehtland, Lisa] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Bailey, DB (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	dbailey@rti.org		Bailey, Donald/0000-0002-0513-9330	NCATS NIH HHS [1UL1TR001111, UL1 TR002489, UL1 TR001111] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Duffner PK, 2009, PEDIATR NEUROL, V40, P245, DOI 10.1016/j.pediatrneurol.2008.11.010; Goldenberg AJ, 2012, JAMA-J AM MED ASSOC, V307, P461, DOI 10.1001/jama.2012.68; Grosse SD, 2006, PEDIATRICS, V117, P923, DOI 10.1542/peds.2005-0553; Kemper AR, 2014, GENET MED, V16, P183, DOI 10.1038/gim.2013.98; *PRES COUNC BIOETH, CHANG MOR FOC NEWB S; Ross LF, 2010, KENNEDY INST ETHIC J, V20, P299; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	7	26	26	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1511	1512		10.1001/jama.2014.17488	http://dx.doi.org/10.1001/jama.2014.17488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898043	Green Accepted			2022-12-28	WOS:000353198700010
J	Boat, TF				Boat, Thomas F.			Improving Lifetime Health by Promoting Behavioral Health in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE CHILDHOOD EXPERIENCES		[Boat, Thomas F.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Boat, Thomas F.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Boat, TF (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MCL 2021, Cincinnati, OH 45229 USA.	thomas.boat@uc.edu						Bethell CD, 2014, HEALTH AFFAIR, V33, P2106, DOI 10.1377/hlthaff.2014.0914; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Field MJ, 2012, SAFE EFFECTIVE MED C, P296; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Perrin EC, 2014, JAMA PEDIATR, V168, P16, DOI 10.1001/jamapediatrics.2013.2919; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185	8	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1509	1510		10.1001/jama.2015.2977	http://dx.doi.org/10.1001/jama.2015.2977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898042				2022-12-28	WOS:000353198700009
J	Arslan, S; Khafizov, R; Thomas, CD; Chemla, YR; Ha, T				Arslan, Sinan; Khafizov, Rustem; Thomas, Christopher D.; Chemla, Yann R.; Ha, Taekjip			Engineering of a superhelicase through conformational control	SCIENCE			English	Article							ESCHERICHIA-COLI UVRD; INITIATOR PROTEIN REPD; SINGLE-STRANDED-DNA; HELICASE IN-VITRO; PCRA HELICASE; CRYSTAL-STRUCTURES; PROCESSIVITY; COMPLEXES; MECHANISM; MONOMER	Conformational control of biomolecular activities can reveal functional insights and enable the engineering of novel activities. Here we show that conformational control through intramolecular cross-linking of a helicase monomer with undetectable unwinding activity converts it into a superhelicase that can unwind thousands of base pairs processively, even against a large opposing force. A natural partner that enhances the helicase activity is shown to achieve its stimulating role also by selectively stabilizing the active conformation. Our work provides insight into the regulation of nucleic acid unwinding activity and introduces a monomeric superhelicase without nuclease activities, which may be useful for biotechnological applications.	[Arslan, Sinan; Khafizov, Rustem; Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Arslan, Sinan; Khafizov, Rustem; Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Thomas, Christopher D.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Leeds; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Thomas, Christopher D./E-1236-2015; Ha, Taekjip/B-9506-2009	Thomas, Christopher D./0000-0003-0316-6391; Ha, Taekjip/0000-0003-2195-6258; Chemla, Yann/0000-0001-9167-0234	NIH [GM065367]; NSF (Physics Frontier Center) [0822613, MCB 09-52442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Division Of Physics [1430124] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0952442] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (Physics Frontier Center)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Park and M. Schlierf for experimental help and R. Zhou, H. Balci, K. Lee, J. Yodh, T. Ngo, B. Leslie, M. Comstock, P. Jena, and A. Jain for helpful discussions. This work was supported by the NIH (grant GM065367) and the NSF (Physics Frontier Center grant PHY 0822613 and CAREER award MCB 09-52442 to Y. R. C.). T. H. and S. A. have filed a patent application (62/079,183) that relates to superhelicases.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Comstock MJ, 2015, SCIENCE, V348, P352, DOI 10.1126/science.aaa0130; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee G, 2012, SCIENCE, V336, P1726, DOI 10.1126/science.1216848; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Machon C, 2010, NUCLEIC ACIDS RES, V38, P1874, DOI 10.1093/nar/gkp1153; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Zhang WK, 2007, J MOL BIOL, V371, P336, DOI 10.1016/j.jmb.2007.05.050	27	65	72	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					344	347		10.1126/science.aaa0445	http://dx.doi.org/10.1126/science.aaa0445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883358	Green Accepted			2022-12-28	WOS:000352999000047
J	Webster, R				Webster, Rob			It's time to be honest about NHS funding for the next five years	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									NHS Confederat, London, England		Webster, R (corresponding author), NHS Confederat, London, England.	Rob.Webster@nhsconfed.org						Department of Health NHS England, 2013, BETT PROC BETT VAL B; Health Foundation, 2015, NHS FIN CHALL ALL PO; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2009; Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1362; NHS Confederation, 2014, DEC OF VAL; NHS Confederation, THE 2015 CHALL; NHS England, 2014, 5 YEARS FORW VIEW; O'Dowd A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1440; Webster R, 2015, COMMUNICATION	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2015	350								h1978	10.1136/bmj.h1978	http://dx.doi.org/10.1136/bmj.h1978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JV	25882314				2022-12-28	WOS:000353328700011
J	Agius, S; Gatt, D; Rogers, M; Borg, A				Agius, Shawn; Gatt, Daphne; Rogers, Marilyn; Borg, Andrew			CASE REVIEW Back pain in a young adult	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL EPIDURAL ABSCESS; HIV PREVALENCE; INFECTIONS; MANAGEMENT; CANCER; RISK		[Agius, Shawn] Mater Dei Hosp, Dept Neurosci, Neurosurg, Msida 2090, MSD, Malta; [Gatt, Daphne] Mater Dei Hosp, Dept Med, Msida 2090, MSD, Malta; [Rogers, Marilyn; Borg, Andrew] Mater Dei Hosp, Dept Rheumatol, Rheumatol, Msida 2090, MSD, Malta		Agius, S (corresponding author), Mater Dei Hosp, Dept Neurosci, Neurosurg, Msida 2090, MSD, Malta.	shawnagius@outlook.com						Bhangle SD, 2009, CLEV CLIN J MED, V76, P393, DOI 10.3949/ccjm.76a.08099; Bostrom A, 2008, MINIM INVAS NEUROSUR, V51, P36, DOI 10.1055/s-2007-1004547; Briggs AM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-77; Connor DE, 2013, J NEUROSURG-SPINE, V19, P119, DOI 10.3171/2013.3.SPINE12762; Gerszten PC, 2000, ONCOLOGY-NY, V14, P1013; Health Protection Agency Health Protection Scotland Public Health Wales CDSC Northern Ireland and the CRDHB, 2010, SHOOT INF DRUG US UK; Hwang LY, 2000, CLIN INFECT DIS, V31, P920, DOI 10.1086/318131; Karikari IO, 2009, NEUROSURGERY, V65, P919, DOI 10.1227/01.NEU.0000356972.97356.C5; Kourbeti IS, 2008, CURR OPIN RHEUMATOL, V20, P471, DOI 10.1097/BOR.0b013e3282ff5e66; Mantadakis E, 2011, EUR J PEDIATR, V170, P945, DOI 10.1007/s00431-011-1437-2; Patel AR, 2014, SPINE J, V14, P326, DOI 10.1016/j.spinee.2013.10.046; Pathak Ashish, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-009285; Rahimi-Movaghar A, 2012, INT J DRUG POLICY, V23, P271, DOI 10.1016/j.drugpo.2011.09.002; Reepalu A, 2012, ACTA ONCOL, V51, P51, DOI 10.3109/0284186X.2011.626445; Sendi P, 2008, QJM-INT J MED, V101, P1, DOI 10.1093/qjmed/hcm100; Siddiq DM, 2014, EUR J CLIN MICROBIOL, V33, P517, DOI 10.1007/s10096-013-1997-3; Siemionow K, 2008, CLEV CLIN J MED, V75, P557, DOI 10.3949/ccjm.75.8.557; Westphal N, 2009, DTSCH ARZTEBL INT, V106, P481, DOI 10.3238/arztebl.2009.0481; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7	19	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1752	10.1136/bmj.h1752	http://dx.doi.org/10.1136/bmj.h1752			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25877766				2022-12-28	WOS:000353328000002
J	Benanti, EL; Nguyen, CM; Welch, MD				Benanti, Erin L.; Nguyen, Catherine M.; Welch, Matthew D.			Virulent Burkholderia Species Mimic Host Actin Polymerases to Drive Actin-Based Motility	CELL			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; TRIMERIC AUTOTRANSPORTER ADHESINS; BARBED-END ASSOCIATION; III SECRETION SYSTEM; FILAMENT NUCLEATION; ENA/VASP PROTEINS; ARP2/3 COMPLEX; VI SECRETION; MOLECULAR-MECHANISM; CAPPING PROTEIN	Burkholderia pseudomallei and B. mallei are bacterial pathogens that cause melioidosis and glanders, whereas their close relative B. thailandensis is nonpathogenic. All use the trimeric autotransporter BimA to facilitate actin-based motility, host cell fusion, and dissemination. Here, we show that BimA orthologs mimic different host actin-polymerizing proteins. B. thailandensis BimA activates the host Arp2/3 complex. In contrast, B. pseudomallei and B. mallei BimA mimic host Ena/VASP actin polymerases in their ability to nucleate, elongate, and bundle filaments by associating with barbed ends, as well as in their use of WH2 motifs and oligomerization for activity. Mechanistic differences among BimA orthologs resulted in distinct actin filament organization and motility parameters, which affected the efficiency of cell fusion during infection. Our results identify bacterial Ena/VASP mimics and reveal that pathogens imitate the full spectrum of host actin-polymerizing pathways, suggesting that mimicry of different polymerization mechanisms influences key parameters of infection.	[Benanti, Erin L.; Nguyen, Catherine M.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Benanti, EL (corresponding author), Aduro Biotech, 626 Bancroft Way 3C, Berkeley, CA 94710 USA.	ebenanti@aduro.com; welch@berkeley.edu			NIH/NIGMS NRSA [F32 GM093652]; NIH/NIGMS [R01 GM059609]; NIH/NIAID [R01 AI109044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109044, R21AI109270, R21AI119743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609, F32GM093652] Funding Source: NIH RePORTER	NIH/NIGMS NRSA; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Peggy Cotter, Jeffrey Iwig, and Rebecca Lamason for comments on the manuscript and Tiago Barros for expertise in model design. We are grateful to Melissa Anderson, Erin Garcia, Peggy Cotter, Todd French, and Jeff F. Miller for reagents and technical advice and to Taro Ohkawa for imaging assistance. E.L.B. was supported by NIH/NIGMS NRSA F32 GM093652. M.D.W. is supported by NIH/NIGMS R01 GM059609 and NIH/NIAID R01 AI109044.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MACK D, 1994, MED MICROBIOL IMMUN, V183, P217; Madasu Y, 2013, P NATL ACAD SCI USA, V110, pE2677, DOI 10.1073/pnas.1307235110; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Sitthidet C, 2010, J BACTERIOL, V192, P5249, DOI 10.1128/JB.00608-10; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Truong D, 2014, BIOESSAYS, V36, P687, DOI 10.1002/bies.201400038; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; WILKINSON L, 1981, MED HIST, V25, P363, DOI 10.1017/S0025727300034876; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110	55	71	73	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					348	360		10.1016/j.cell.2015.02.044	http://dx.doi.org/10.1016/j.cell.2015.02.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860613	Green Accepted, Bronze			2022-12-28	WOS:000352708300026
J	Maclntyre, CR; Chughtai, AA				Maclntyre, C. Raina; Chughtai, Abrar Ahmad			Facemasks for the prevention of infection in healthcare and community settings	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE RESPIRATORY SYNDROME; SURGICAL FACE MASKS; MULTIDRUG-RESISTANT TUBERCULOSIS; PERSONAL PROTECTIVE EQUIPMENT; RANDOMIZED CLINICAL-TRIAL; HAND HYGIENE; INFLUENZA TRANSMISSION; SARS TRANSMISSION; NONPHARMACEUTICAL INTERVENTIONS; NOSOCOMIAL TRANSMISSION	Facemasks are recommended for diseases transmitted through droplets and respirators for respiratory aerosols, yet recommendations and terminology vary between guidelines. The concepts of droplet and airborne transmission that are entrenched in clinical practice have recently been shown to be more complex than previously thought. Several randomised clinical trials of facemasks have been conducted in community and healthcare settings, using widely varying interventions, including mixed interventions (such as masks and handwashing), and diverse outcomes. Of the nine trials of facemasks identified in community settings, in all but one, facemasks were used for respiratory protection of well people. They found that facemasks and facemasks plus hand hygiene may prevent infection in community settings, subject to early use and compliance. Two trials in healthcare workers favoured respirators for clinical respiratory illness. The use of reusable cloth masks is widespread globally, particularly in Asia, which is an important region for emerging infections, but there is no clinical research to inform their use and most policies offer no guidance on them. Health economic analyses of facemasks are scarce and the few published cost effectiveness models do not use clinical efficacy data. The lack of research on facemasks and respirators is reflected in varied and sometimes conflicting policies and guidelines. Further research should focus on examining the efficacy of facemasks against specific infectious threats such as influenza and tuberculosis, assessing the efficacy of cloth masks, investigating common practices such as reuse of masks, assessing compliance, filling in policy gaps, and obtaining cost effectiveness data using clinical efficacy estimates.	[Maclntyre, C. Raina; Chughtai, Abrar Ahmad] Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Maclntyre, CR (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Fac Med, Sydney, NSW 2052, Australia.	r.macintyre@unsw.edu.au		Chughtai, Abrar/0000-0003-4203-7891; MacIntyre, C Raina/0000-0002-3060-0555	3M; GSK; Merck; BioCSL; Pfizer; 3M Australia	3M(3M); GSK(GlaxoSmithKline); Merck(Merck & Company); BioCSL; Pfizer(Pfizer); 3M Australia(3M)	We have read and understood BMJ policy on declaration of interests and declare the following interests: CRM has received funding for investigator driven research on facemasks from 3M in the form of an Australian Research Council Industry Linkage grant (where 3M was the industry partner) and supply of masks for clinical research. She also has received funding or in-kind support from GSK, Merck, BioCSL, and Pfizer for investigator driven research on infectious diseases. 3M Australia provided support to AAC for facemask testing as part of his PhD thesis.	A-Asmary S, 2007, INT J INFECT DIS, V11, P268, DOI 10.1016/j.ijid.2006.04.008; Aiello AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029744; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Albano L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-208; Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; [Anonymous], 2013, INF PREV CONTR HLTH; [Anonymous], 2013, WHOCDSCSRGAR2003; [Anonymous], HLTH WORKERS NEED OP; APIC, 2009, APIC POS PAP EXT US APIC POS PAP EXT US; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Beckman S, 2013, AM J INFECT CONTROL, V41, P1024, DOI 10.1016/j.ajic.2013.05.006; Belkin NL, 2002, J HOSP INFECT, V50, P233, DOI 10.1053/jhin.2001.1166; Belkin NL, 1997, INFECT CONT HOSP EP, V18, P49, DOI 10.2307/30141964; Bell D, 2006, EMERG INFECT DIS, V12, P88; bin-Reza F, 2012, INFLUENZA OTHER RESP, V6, P257, DOI 10.1111/j.1750-2659.2011.00307.x; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brienen NCJ, 2010, RISK ANAL, V30, P1210, DOI 10.1111/j.1539-6924.2010.01428.x; Bryce E, 2008, J HOSP INFECT, V68, P241, DOI 10.1016/j.jhin.2007.12.007; Canini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013998; Caplan A, 2013, JAMA-J AM MED ASSOC, V310, P1797, DOI 10.1001/jama.2013.280633; Capps JA, 1918, J AMER MED ASSOC, V71, P448, DOI 10.1001/jama.1918.26020320008010a; Centers for Disease Control and Prevention, 2014, PREV STRAT SEAS INFL; Centers for Disease Control and Prevention, 2010, INT GUID INF CONTR M; Centers for Disease Control and Prevention, 2014, INT INF PREV CONTR R; Centers for Disease Control and Prevention, 2009, INT REC FAC RESP US; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P433; Centers for Disease Control and Prevention (CDC), 2014, GUID PERS PROT EQ US; CHAMBERLAIN GV, 1984, ANN ROY COLL SURG, V66, P432; Chen MIC, 2006, ANN ACAD MED SINGAP, V35, P317; CHEN SK, 1994, AM J INFECT CONTROL, V22, P65, DOI 10.1016/0196-6553(94)90116-3; Chen WQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-81; Chen YC, 2004, EMERG INFECT DIS, V10, P895, DOI 10.3201/eid1005.030777; CHRISTIE CDC, 1995, INFECT CONT HOSP EP, V16, P556; Chughtai AA, 2013, INT J INFECT CONTROL, V9, DOI [DOI 10.3396/IJIC.V9I3.020.13, 10.3396/IJIC.v9i3.020.13]; Chughtai Abrar Ahmad, 2015, J Infect Prev, V16, P68, DOI 10.1177/1757177414560251; Chughtai AA, 2015, AM J INFECT CONTROL, V43, P72, DOI 10.1016/j.ajic.2014.10.009; Chughtai Abrar Ahmad, 2013, BMC Res Notes, V6, P216, DOI 10.1186/1756-0500-6-216; Cohen J, 2014, SCIENCE, V346, P17, DOI 10.1126/science.346.6205.17; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Danyluk Q, 2011, J OCCUP ENVIRON HYG, V8, P267, DOI 10.1080/15459624.2011.566016; DAVIES KJ, 1994, BRIT DENT J, V176, P262, DOI 10.1038/sj.bdj.4808430; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Derrick JL, 2005, J HOSP INFECT, V59, P365, DOI 10.1016/j.jhin.2004.10.013; Dharmadhikari AS, 2012, AM J RESP CRIT CARE, V185, P1104, DOI 10.1164/rccm.201107-1190OC; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; European Centre for Disease Prevention and Control, 2014, Q A SEAS INFL; Fella P, 1995, AM J INFECT CONTROL, V23, P352, DOI 10.1016/0196-6553(95)90265-1; Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002; Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x; Gershon Robyn R M, 2010, Am J Disaster Med, V5, P15; GERSHON RRM, 1995, AM J INFECT CONTROL, V23, P225, DOI 10.1016/0196-6553(95)90067-5; Gralton J, 2010, CRIT CARE MED, V38, P657, DOI 10.1097/CCM.0b013e3181b9e8b3; HALL CB, 1981, AM J DIS CHILD, V135, P512, DOI 10.1001/archpedi.1981.02130300012006; Institute of Medicine, 2006, REUC FAC INFL PAND F; Institute of Medicine (IOM) National Academy of Sciences, 2010, PREV TRANSM PAND INF; Jacobs JL, 2009, AM J INFECT CONTROL, V37, P417, DOI 10.1016/j.ajic.2008.11.002; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; KISER JC, 1958, SURGERY, V44, P936; La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lau JTF, 2004, EMERG INFECT DIS, V10, P280, DOI 10.3201/eid1002.030534; Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169; Lee KM, 2011, PHYS INTERVENTIONS I; Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Liu JW, 2006, INFECT CONT HOSP EP, V27, P466, DOI 10.1086/504501; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; MacIntyre CR, 2014, EPIDEMIOL INFECT, V142, P1802, DOI 10.1017/S095026881300304X; MacIntyre CR, 2014, INT J NURS STUD, V51, P1421, DOI 10.1016/j.ijnurstu.2014.09.002; MacIntyre CR, 2014, PREV MED, V62, P1, DOI 10.1016/j.ypmed.2014.01.015; MacIntyre CR, 2013, AM J RESP CRIT CARE, V187, P960, DOI 10.1164/rccm.201207-1164OC; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; MacIntyre CR, 2014, ANZCTR; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; MADSEN PO, 1967, AM J SURG, V114, P431, DOI 10.1016/0002-9610(67)90168-7; Makison Booth C, 2013, J HOSP INFECT, V84, P22, DOI 10.1016/j.jhin.2013.02.007; MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002; Manangan LP, 1999, INFECT CONT HOSP EP, V20, P337, DOI 10.1086/501627; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; McKinney KR, 2006, J ENVIRON HEALTH, V68, P26; McNett EH, 1949, AM J NURS, V49, P32, DOI 10.2307/3458307; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; MITCHELL NJ, 1991, J HOSP INFECT, V18, P239, DOI 10.1016/0195-6701(91)90148-2; Moore D, 2005, AM J INFECT CONTROL, V33, P88, DOI 10.1016/j.ajic.2004.11.003; MURPHY D, 1981, J PEDIATR-US, V99, P746, DOI 10.1016/S0022-3476(81)80401-5; National Institute for Occupational Safety and Health (NIOSH), 1995, NIOSH GUID SEL US PA; New South Wales Department of Public Health, REP INFL EP NEW S 1; Ng TC, 2009, INFECT CONT HOSP EP, V30, P292, DOI 10.1086/595690; Nichol K, 2013, AM J INFECT CONTROL, V41, P8, DOI 10.1016/j.ajic.2011.12.018; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Nishiura H, 2005, AM J TROP MED HYG, V73, P17, DOI 10.4269/ajtmh.2005.73.17; Nishiyama A, 2008, JPN J INFECT DIS, V61, P388; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Occupational Safety and Health Administration (OSHA) U.S. Department of Labor, 2002, 3079 OSHA; Occupational Safety and Health Administration (OSHA). US Department of Labor, 1994, RESP FIT TEST; Occupational Safety and Health Administration (OSHA). US Department of Labor, PROP GUID WORKPL STO; ORR N, 1982, ANN ROY COLL SURG, V64, P205; Park BJ, 2004, EMERG INFECT DIS, V10, P244; Perl TM, 2014, INCIDENCE RESPITATOR; Phin NF, 2009, J HOSP INFECT, V71, P15, DOI 10.1016/j.jhin.2008.09.005; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; QUESNEL LB, 1975, BRIT J SURG, V62, P936, DOI 10.1002/bjs.1800621203; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rashid H., 2013, CLUSTER RANDOMISED C; Rebmann T, 2009, AM J INFECT CONTROL, V37, pE5, DOI 10.1016/j.ajic.2009.09.003; Rengasamy S, 2008, J OCCUP ENVIRON HYG, V5, P556, DOI 10.1080/15459620802275387; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Salgado CD, 2002, LANCET INFECT DIS, V2, P145, DOI 10.1016/S1473-3099(02)00221-9; Seale H, 2009, INFECT CONT HOSP EP, V30, P710, DOI 10.1086/599254; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003; Society for Healthcare Epidemiology of America (SHEA), 2009, SHEA POS STAT INT GU; Standards Australia Limited/Standards New Zealand, 2012, 1716 ASNZS; Suess T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-26; Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; TUNEVALL TG, 1991, WORLD J SURG, V15, P383, DOI 10.1007/BF01658736; Ulmer B. C., 2008, AORN J, V87, P721, DOI DOI 10.1016/j.aorn.2007.10.012; van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618; Weaver GH, 1918, J AMER MED ASSOC, V70, P76, DOI 10.1001/jama.1918.02600020010005; Weaver GH, 1919, J INFECT DIS, V24, P218, DOI 10.1093/infdis/24.3.218; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5; Whitelaw TH, 1919, CAN MED ASSOC J, V9, P1070; WHO, 2014, INF PREV CONTR GUID; WHO, 2003, PRACT GUID INF CONTR; Wilder-Smith A, 2005, EMERG INFECT DIS, V11, P1142, DOI 10.3201/eid1107.041165; Winter S, 2010, CRIT CARE RESUSC, V12, P24; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730; Wu L.-T., 1926, TREATISE PNEUMONIC P; Yin Wen-wu, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P18; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	153	155	155	0	76	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h694	10.1136/bmj.h694	http://dx.doi.org/10.1136/bmj.h694			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9VG	25858901				2022-12-28	WOS:000352914700001
J	Ridaura, V; Belkaid, Y				Ridaura, Vanessa; Belkaid, Yasmine			Gut Microbiota: The Link to Your Second Brain	CELL			English	Editorial Material							TRANSIT	Serotonin is a highly ubiquitous signaling molecule that plays a role in the regulation of various physiological functions. Several lines of evidence, including the present work from Hsiao and colleagues, demonstrate that, in the gut, microbial-derived metabolites affect the production of serotonin that in turn impacts host physiological functions.	[Ridaura, Vanessa; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, NIH, Bethesda, MD 20892 USA; [Ridaura, Vanessa; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Program Barrier Immun & Repair, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Reigstad CS, 2014, FASEB J; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047	8	78	90	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					193	194		10.1016/j.cell.2015.03.033	http://dx.doi.org/10.1016/j.cell.2015.03.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860600	Bronze			2022-12-28	WOS:000352708300010
J	Barone, MA; Widmer, M; Arrowsmith, S; Ruminjo, J; Seuc, A; Landry, E; Barry, TH; Danladi, D; Djangnikpo, L; Gbawuru-Mansaray, T; Harou, I; Lewis, A; Muleta, M; Nembunzu, D; Olupot, R; Sunday-Adeoye, I; Wakasiaka, WK; Landoulsi, S; Delamou, A; Were, L; Frajzyngier, V; Beattie, K; Gulmezoglu, AM				Barone, Mark A.; Widmer, Mariana; Arrowsmith, Steven; Ruminjo, Joseph; Seuc, Armando; Landry, Evelyn; Barry, Thierno Hamidou; Danladi, Dantani; Djangnikpo, Lucien; Gbawuru-Mansaray, Tagie; Harou, Issoufa; Lewis, Alyona; Muleta, Mulu; Nembunzu, Dolores; Olupot, Robert; Sunday-Adeoye, Ileogben; Wakasiaka, Weston Khisa; Landoulsi, Sihem; Delamou, Alexandre; Were, Lilian; Frajzyngier, Vera; Beattie, Karen; Guelmezoglu, A. Metin			Breakdown of simple female genital fistula repair after 7 day versus 14 day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial	LANCET			English	Article							LONG-TERM CATHETERIZATION; COMPARING SHORT; SURGERY; MANAGEMENT	Background Duration of bladder catheterisation after female genital fistula repair varies widely. We aimed to establish whether 7 day bladder catheterisation was non-inferior to 14 days in terms of incidence of fistula repair breakdown in women with simple fistula. Methods In this randomised, controlled, open-label, non-inferiority trial, we enrolled patients at eight hospitals in the Democratic Republic of the Congo, Ethiopia, Guinea, Kenya, Niger, Nigeria, Sierra Leone, and Uganda. Consenting patients were eligible if they had a simple fistula that was closed after surgery and remained closed 7 days after surgery, understood study procedures and requirements, and agreed to return for follow-up 3 months after surgery. We excluded women if their fistula was not simple or was radiation-induced, associated with cancer, or due to lymphogranuloma venereum; if they were pregnant; or if they had multiple fistula. A research assistant at each site randomly allocated participants 1:1 (randomly varying block sizes of 4-6; stratified by country) to 7 day or 14 day bladder catheterisation (via a random allocation sequence computer generated centrally by WHO). Outcome assessors were not masked to treatment assignment. The primary outcome was fistula repair breakdown, on the basis of dye test results, any time between 8 days after catheter removal and 3 months after surgery. The non-inferiority margin was 10%, assessed in the per-protocol population. This trial is registered with ClinicalTrials.gov, number NCT01428830. Findings We randomly allocated 524 participants between March 7, 2012, and May 6, 2013; 261 in the 7 day group and 263 in the 14 day group. In the per-protocol analysis, ten (4%) of 250 patients had repair breakdown in the 7 day group (95% CI 2-8) compared with eight (3%) of 251 (2-6) in the 14 day group (risk difference 0.% [95% CI -2.8 to 4.5]), meeting the criteria for non-inferiority. Interpretation 7 day bladder catheterisation after repair of simple fistula is non-inferior to 14 day catheterisation and could be used for management of women after repair of simple fistula with no evidence of a significantly increased risk of repair breakdown, urinary retention, or residual incontinence up to 3 months after surgery.	[Barone, Mark A.; Arrowsmith, Steven; Ruminjo, Joseph; Landry, Evelyn; Delamou, Alexandre; Were, Lilian; Frajzyngier, Vera; Beattie, Karen] EngenderHealth, Fistula Care, New York, NY 10001 USA; [Widmer, Mariana; Seuc, Armando; Landoulsi, Sihem; Guelmezoglu, A. Metin] WHO, World Bank Special Programme Res Dev & Res Traini, UN Dev Programme, UN Populat Fund, CH-1211 Geneva, Switzerland; [Arrowsmith, Steven] Fistula Consulting, Grand Rapids, MI USA; [Barry, Thierno Hamidou] Hop Prefectoral Kissidougou, Kissidougou, Guinea; [Danladi, Dantani; Sunday-Adeoye, Ileogben] Natl Obstet Fistula Ctr Abakaliki, Abakaliki, Ebonyi State, Nigeria; [Djangnikpo, Lucien; Harou, Issoufa] Matern Cent Zinder, Zinder, Niger; [Gbawuru-Mansaray, Tagie; Lewis, Alyona] Aberdeen Womens Ctr, Freetown, Sierra Leone; [Muleta, Mulu] Gondar Univ Hosp, Fistula Unit, Gondar, Ethiopia; [Nembunzu, Dolores] Hop St Joseph, Limete Residentiel, Kinshasa, DEM REP CONGO; [Olupot, Robert] Kagando Hosp, Kasese Dist, Uganda; [Wakasiaka, Weston Khisa] Kenyatta Natl Hosp, Nairobi, Kenya	The World Bank; United Nations Population Fund; World Health Organization; Kenyatta National Hospital	Barone, MA (corresponding author), EngenderHealth, New York, NY 10001 USA.	mbarone@engenderhealth.org			US Agency for International Development	US Agency for International Development(United States Agency for International Development (USAID))	US Agency for International Development.	Arrowsmith SD, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-73; Barone MA, 2012, OBSTET GYNECOL, V120, P524, DOI 10.1097/AOG.0b013e31826579e8; Barone MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-5; Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014; Crosby EC, 2013, INT UROGYNECOL J, V24, P1543, DOI 10.1007/s00192-013-2054-6; de Moya MA, 2009, J SURG RES, V156, P274, DOI 10.1016/j.jss.2009.03.094; Hakvoort RA, 2004, BJOG-INT J OBSTET GY, V111, P828, DOI 10.1111/j.1471-0528.2004.00181.x; Hong B, 2003, J UROLOGY, V170, P852, DOI 10.1097/01.ju.0000081095.85420.ab; Inaba K, 2006, J TRAUMA, V60, P23, DOI 10.1097/01.ta.0000200096.44452.8a; Kamilya G, 2010, J OBSTET GYNAECOL RE, V36, P154, DOI 10.1111/j.1447-0756.2009.01096.x; Miller OF, 2002, J UROLOGY, V167, P2556, DOI 10.1016/S0022-5347(05)65036-7; Nardos R, 2008, INT J GYNECOL OBSTET, V103, P30, DOI 10.1016/j.ijgo.2008.05.021; Nardos R, 2012, INT J GYNECOL OBSTET, V118, P21, DOI 10.1016/j.ijgo.2012.01.024; Niel-Weise BS, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004203.pub2, 10.1002/14651828.CD004201.pub2]; Phipps S, 2006, COCHRANE DB SYST REV, V2; Ruminjo JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-220; Sekhavat L, 2008, AUST NZ J OBSTET GYN, V48, P348, DOI 10.1111/j.1479-828X.2008.00842.x; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; Vierhout ME, 1998, ACTA OBSTET GYN SCAN, V77, P997, DOI 10.1034/j.1600-0412.1998.771009.x; Wall L L, 2005, Obstet Gynecol Surv, V60, pS3, DOI 10.1097/00006254-200507001-00002; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2	21	22	22	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					56	62		10.1016/S0140-6736(14)62337-0	http://dx.doi.org/10.1016/S0140-6736(14)62337-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25911172				2022-12-28	WOS:000357519400028
J	Moorthy, VS; Okwo-Bele, JM				Moorthy, Vasee S.; Okwo-Bele, Jean-Marie			Final results from a pivotal phase 3 malaria vaccine trial	LANCET			English	Editorial Material									[Moorthy, Vasee S.; Okwo-Bele, Jean-Marie] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland	World Health Organization	Moorthy, VS (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.	moorthyv@who.int		Moorthy, Vasee/0000-0002-6535-2854	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; RTS S Clinical Trials Partnership, 2015, LANCET; WHO, 2013, WORLD MALARIA REPORT 2013, P1	5	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					5	7		10.1016/S0140-6736(15)60767-X	http://dx.doi.org/10.1016/S0140-6736(15)60767-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25913271				2022-12-28	WOS:000357519400005
J	Grow, EJ; Flynn, RA; Chavez, SL; Bayless, NL; Wossidlo, M; Wesche, DJ; Martin, L; Ware, CB; Blish, CA; Chang, HY; Pera, RAR; Wysocka, J				Grow, Edward J.; Flynn, Ryan A.; Chavez, Shawn L.; Bayless, Nicholas L.; Wossidlo, Mark; Wesche, Daniel J.; Martin, Lance; Ware, Carol B.; Blish, Catherine A.; Chang, Howard Y.; Pera, Renee A. Reijo; Wysocka, Joanna			Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells	NATURE			English	Article							HERV-K; REGULATORY CIRCUITRY; IDENTIFICATION; ELEMENTS; PROTEIN; FAMILY; HERV-K(HML-2); EXPRESSION; INDUCTION; DYNAMICS	Endogenous retroviruses (ERVs) are remnants of ancient retroviral infections, and comprise nearly 8% of the human genome(1). The most recently acquired human ERV is HERVK(HML-2), which repeatedly infected the primate lineage both before and after the divergence of the human and chimpanzee common ancestor(2,3). Unlike most other human ERVs, HERVK retained multiple copies of intact open reading frames encoding retroviral proteins(4). However, HERVK is transcriptionally silenced by the host, with the exception of in certain pathological contexts such as germ-cell tumours, melanoma or human immunodeficiency virus (HIV) infection(5-7). Here we demonstrate that DNA hypomethylation at long terminal repeat elements representing the most recent genomic integrations, together with transactivation by OCT4 (also known as POU5F1), synergistically facilitate HERVK expression. Consequently, HERVK is transcribed during normal human embryogenesis, beginning with embryonic genome activation at the eight-cell stage, continuing through the emergence of epiblast cells in preimplantation blastocysts, and ceasing during human embryonic stem cell derivation from blastocyst outgrowths. Remarkably, we detected HERVK viral-like particles and Gag proteins in human blastocysts, indicating that early human development proceeds in the presence of retroviral products. We further show that overexpression of one such product, the HERVK accessory protein Rec, in a pluripotent cell line is sufficient to increase IFITM1 levels on the cell surface and inhibit viral infection, suggesting at least one mechanism through which HERVK can induce viral restriction pathways in early embryonic cells. Moreover, Rec directly binds a subset of cellular RNAs and modulates their ribosome occupancy, indicating that complex interactions between retroviral proteins and host factors can fine-tune pathways of early human development.	[Grow, Edward J.; Wossidlo, Mark; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chavez, Shawn L.; Wossidlo, Mark; Wesche, Daniel J.; Pera, Renee A. Reijo; Wysocka, Joanna] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chavez, Shawn L.; Wossidlo, Mark; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Chavez, Shawn L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Bayless, Nicholas L.] Stanford Univ, Sch Med, Stanford Immunol, Stanford, CA 94305 USA; [Ware, Carol B.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Blish, Catherine A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pera, Renee A. Reijo] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Oregon Health & Science University; Oregon National Primate Research Center; Stanford University; University of Washington; University of Washington Seattle; Stanford University; Montana State University System; Montana State University Bozeman; Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wysocka@stanford.edu	Wossidlo, Mark/M-9690-2019; Chavez, Shawn L./ABF-6125-2021	Wossidlo, Mark/0000-0002-3184-0753; Chavez, Shawn L./0000-0002-8285-0222; Blish, Catherine/0000-0001-6946-7627; Reijo Pera, Renee/0000-0002-6487-1329; Flynn, Ryan/0000-0001-5013-0442	National Institutes of Health (NIH) [P01GM099130, R01 GM112720]; Stanford Genome Sciences Training Program; National Science Foundation Graduate Research Fellowship Program; NIH [1F30CA189514-01, DP2AI11219301, P50-HG007735, 1S10RR02933801, 1S10RR02678001]; Smith Family Stanford Graduate Fellowship; CIRM [RB4-05763, RB3-02209]; March of Dimes [6-FY10-351, U01 HL100397]; NATIONAL CANCER INSTITUTE [F30CA189514, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112720, P01GM099130] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Genome Sciences Training Program; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Stanford Graduate Fellowship; CIRM(California Institute for Regenerative Medicine); March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Bieniasz for the HERVK-con plasmid, P. Lovelace for assistance with FACS, M. Teruel for recombinant Giardia DICER, J. Perrino for TEM assistance, T. Swigut for ideas and input on data analysis, B. Gu for assistance with bisulfite sequencing, A. Moore for assistance with influenza experiments, J. Skowronski and members of the Wysocka laboratory for invaluable comments on the manuscript. This work was supported by the National Institutes of Health (NIH) P01GM099130 and R01 GM112720 (J.W.); Stanford Genome Sciences Training Program and National Science Foundation Graduate Research Fellowship Program (E.J.G.); NIH F30 (1F30CA189514-01) (R.A.F.); NIH DP2AI11219301 (C.A.B.); Smith Family Stanford Graduate Fellowship (N.L.B.); CIRM RB4-05763 and NIH P50-HG007735 (H.Y.C.); CIRM RB3-02209, March of Dimes 6-FY10-351 and U01 HL100397 (R.A.R.P.) grants and NIH equipment grants 1S10RR02933801 (Institute for Stem Cell Biology and Regenerative Medicine FACS core) and 1S10RR02678001 (electronmicroscopy core facility).	Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Bieda K, 2001, J GEN VIROL, V82, P591, DOI 10.1099/0022-1317-82-3-591; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chavez SL, 2008, STEM CELLS DEV, V17, P535, DOI 10.1089/scd.2007.0216; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Hanke K, 2013, J VIROL, V87, P11019, DOI 10.1128/JVI.03031-12; Herbst H, 1996, AM J PATHOL, V149, P1727; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; LOWER R, 1995, J VIROL, V69, P141; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Magin-Lachmann C, 2001, J VIROL, V75, P10359, DOI 10.1128/JVI.75.21.10359-10371.2001; Muster T, 2003, CANCER RES, V63, P8735; Myers JW, 2005, METH MOL B, V309, P93; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Shin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060605; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wong C, 2013, REPROD BIOMED ONLINE, V26, P120, DOI 10.1016/j.rbmo.2012.11.003; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	41	340	351	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					221	+		10.1038/nature14308	http://dx.doi.org/10.1038/nature14308			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25896322	Green Accepted			2022-12-28	WOS:000356016700040
J	Betley, JN; Xu, SJ; Cao, ZFH; Gong, R; Magnus, CJ; Yu, Y; Sternson, SM				Betley, J. Nicholas; Xu, Shengjin; Cao, Zhen Fang Huang; Gong, Rong; Magnus, Christopher J.; Yu, Yang; Sternson, Scott M.			Neurons for hunger and thirst transmit a negative-valence teaching signal	NATURE			English	Article							LATERAL HYPOTHALAMUS; CIRCUIT; FOOD; AGRP; ACTIVATION; DEPRESSION; NUCLEUS; SWITCH; WATER	Homeostasis is a biological principle for regulation of essential physiological parameters within a set range. Behavioural responses due to deviation from homeostasis are critical for survival, but motivational processes engaged by physiological need states are incompletely understood. We examined motivational characteristics of two separate neuron populations that regulate energy and fluid homeostasis by using cell-type-specific activity manipulations in mice. We found that starvation-sensitive AGRP neurons exhibit properties consistent with a negative-valence teaching signal. Mice avoided activation of AGRP neurons, indicating that AGRP neuron activity has negative valence. AGRP neuron inhibition conditioned preference for flavours and places. Correspondingly, deep-brain calcium imaging revealed that AGRP neuron activity rapidly reduced in response to food-related cues. Complementary experiments activating thirst-promoting neurons also conditioned avoidance. Therefore, these need-sensing neurons condition preference for environmental cues associated with nutrient or water ingestion, which is learned through reduction of negative-valence signals during restoration of homeostasis.	[Betley, J. Nicholas; Xu, Shengjin; Cao, Zhen Fang Huang; Gong, Rong; Magnus, Christopher J.; Yu, Yang; Sternson, Scott M.] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Janelia Res Campus, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Core, Vector/CAF-4832-2022; Xu, Shengjin/G-2594-2016; Gong, Rong/A-6358-2017; Yu, Yang/D-4071-2015	Gong, Rong/0000-0002-9775-118X; Yu, Yang/0000-0002-4340-430X; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute; HHMI Janelia Farm Graduate Scholar program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Farm Graduate Scholar program	This research was funded by the Howard Hughes Medical Institute. Z.F.H.C. was funded by the HHMI Janelia Farm Graduate Scholar program. We thank B. Balleine, M. Schnitzer, N. Ji, A. Lee, Z. Guo for suggestions on experimental design; H. Su for molecular biology; J. Rouchard, S. Lindo, K. Morris, M. McManus for mouse breeding and procedures; M. Copeland for histology; J. Osborne and C. Werner for apparatus design; K. Branson for automated mouse tracking software (Ctrax); J. Dudman, S. Eddy, H. Grill, N. Geary, U. Heberlein for comments on the manuscript.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; CRAVENS RW, 1969, J EXP PSYCHOL, V81, P312, DOI 10.1037/h0027777; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47, DOI 10.1152/ajpregu.2000.279.1.R47; Hull C., 1943, PRINCIPLES BEHAV; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Johnson RF, 2003, AM J PHYSIOL-REG I, V285, pR394, DOI 10.1152/ajpregu.00130.2003; Keys A, 1950, BIOL HUMAN STARVATIO, V2, DOI DOI 10.1017/S1352465801003010; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Navratilova E, 2012, P NATL ACAD SCI USA, V109, P20709, DOI 10.1073/pnas.1214605109; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; Olds J., 1973, BRAIN STIMULATION MO, P81; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; ROLLS BJ, 1980, AM J PHYSIOL, V239, pR476, DOI 10.1152/ajpregu.1980.239.5.R476; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SIDMAN M, 1953, SCIENCE, V118, P157, DOI 10.1126/science.118.3058.157; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; STUNKARD AJ, 1974, ANN INTERN MED, V81, P526, DOI 10.7326/0003-4819-81-4-526; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; WADDEN TA, 1986, J CONSULT CLIN PSYCH, V54, P869, DOI 10.1037/0022-006X.54.6.869; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yiin YM, 2005, PHYSIOL BEHAV, V84, P217, DOI 10.1016/j.physbeh.2004.11.008	47	366	372	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					180	+		10.1038/nature14416	http://dx.doi.org/10.1038/nature14416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25915020	Green Accepted			2022-12-28	WOS:000354377800050
J	Simkens, LHJ; van Tinteren, H; May, A; ten Tije, AJ; Creemers, GJM; Loosveld, OJL; de Jongh, FE; Erdkamp, FLG; Erjavec, Z; van der Torren, AME; Tol, J; Braun, HJJ; Nieboer, P; van der Hoeven, JJM; Haasjes, JG; Jansen, RLH; Wals, J; Cats, A; Derleyn, VA; Honkoop, AEH; Mol, L; Punt, CJA; Koopman, M				Simkens, Lieke H. J.; van Tinteren, Harm; May, Anne; ten Tije, Albert J.; Creemers, Geert-Jan M.; Loosveld, Olaf J. L.; de Jongh, Felix E.; Erdkamp, Frans L. G.; Erjavec, Zoran; van der Torren, Adelheid M. E.; Tol, Jolien; Braun, Hans J. J.; Nieboer, Peter; van der Hoeven, Jacobus J. M.; Haasjes, Janny G.; Jansen, Rob L. H.; Wals, Jaap; Cats, Annemieke; Derleyn, Veerle A.; Honkoop, Aafk E. H.; Mol, Linda; Punt, Cornelis J. A.; Koopman, Miriam			Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group	LANCET			English	Article							COMBINATION CHEMOTHERAPY; 1ST-LINE TREATMENT; HEPATIC RESECTION; PLUS BEVACIZUMAB; III TRIAL; OXALIPLATIN; SURVIVAL; FLUOROURACIL; INTERMITTENT; IRINOTECAN	Background The optimum duration of first-line treatment with chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer is unknown. The CAIRO3 study was designed to determine the efficacy of maintenance treatment with capecitabine plus bevacizumab versus observation. Methods In this open-label, phase 3, randomised controlled trial, we recruited patients in 64 hospitals in the Netherlands. We included patients older than 18 years with previously untreated metastatic colorectal cancer, with stable disease or better after induction treatment with six 3-weekly cycles of capecitabine, oxaliplatin, and bevacizumab (CAPOX-B), WHO performance status of 0 or 1, and adequate bone marrow, liver, and renal function. Patients were randomly assigned (1: 1) to either maintenance treatment with capecitabine and bevacizumab (maintenance group) or observation (observation group). Randomisation was done centrally by minimisation, with stratification according to previous adjuvant chemotherapy, response to induction treatment, WHO performance status, serum lactate dehydrogenase concentration, and treatment centre. Both patients and investigators were aware of treatment assignment. We assessed disease status every 9 weeks. On first progression (defined as PFS1), patients in both groups were to receive the induction regimen of CAPOX-B until second progression (PFS2), which was the study's primary endpoint. All endpoints were calculated from the time of randomisation. Analyses were done by intention to treat. This trial is registered with ClinicalTrials.gov,number NCT00442637. Findings Between May 30, 2007, and Oct 15, 2012, we randomly assigned 558 patients to either the maintenance group (n=279) or the observation group (n=279). Median follow-up was 48 months (IQR 36-57). The primary endpoint of median PFS2 was significantly improved in patients on maintenance treatment, and was 8.5 months in the observation group and 11.7 months in the maintenance group (HR 0.67, 95% CI 0.56-0.81, p<0.0001). This difference remained signifi cant when any treatment after PFS1 was considered. Maintenance treatment was well tolerated, although the incidence of hand-foot syndrome was increased (64 [23%] patients with hand-foot skin reaction during maintenance). The global quality of life did not deteriorate during maintenance treatment and was clinically not different between treatment groups. Interpretation Maintenance treatment with capecitabine plus bevacizumab after six cycles of CAPOX-B in patients with metastatic colorectal cancer is effective and does not compromise quality of life.	[Simkens, Lieke H. J.; Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Tinteren, Harm] Netherlands Canc Inst, Dept Biostat, Amsterdam, Netherlands; [May, Anne] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [ten Tije, Albert J.] Amphia Hosp, Dept Med Oncol, Breda, Netherlands; [ten Tije, Albert J.; Loosveld, Olaf J. L.] Tergooi Hosp, Dept Med Oncol, Blaricum, Netherlands; [Creemers, Geert-Jan M.] Catharina Hosp, Dept Med Oncol, Eindhoven, Netherlands; [de Jongh, Felix E.] Ikazia Hosp, Dept Med Oncol, Rotterdam, Netherlands; [Erdkamp, Frans L. G.] Orbis Med Ctr, Dept Med Oncol, Sittard, Netherlands; [Erjavec, Zoran] Ommelander Hosp Grp, Dept Med Oncol, Delfzijl, Netherlands; [van der Torren, Adelheid M. E.] Groene Hart Hosp, Dept Med Oncol, Gouda, Netherlands; [Tol, Jolien] Radboud Univ Nijmegen, Dept Med Oncol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Braun, Hans J. J.] Vlietland Hosp, Dept Med Oncol, Schiedam, Netherlands; [Nieboer, Peter] Wilhemina Hosp, Dept Med Oncol, Assen, Netherlands; [van der Hoeven, Jacobus J. M.] Med Ctr Alkmaar, Dept Med Oncol, Alkmaar, Netherlands; [Haasjes, Janny G.] Bethesda Hosp, Dept Med Oncol, Hoogeveen, Netherlands; [Jansen, Rob L. H.] Maastricht Univ, Dept Med Oncol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Wals, Jaap] Atrium Med Ctr, Dept Med Oncol, Heerlen, Netherlands; [Cats, Annemieke] Antoni van Leeuwenhoek Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Derleyn, Veerle A.] Elkerliek Hosp, Dept Med Oncol, Helmond, Netherlands; [Honkoop, Aafk E. H.] Isala Klin, Dept Med Oncol, Zwolle, Netherlands; [Mol, Linda] Netherlands Comprehens Canc Org, Nijmegen, Netherlands; [Koopman, Miriam] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Amphia Hospital; Tergooi Blaricum; Catharina Hospital; Ikazia Hospital; Orbis Medical Center; Radboud University Nijmegen; Medical Center Of Alkmaar; Maastricht University; Atrium Medical Center; Isala Clinics; Utrecht University; Utrecht University Medical Center	Koopman, M (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, POB 85500, NL-3508 GA Utrecht, Netherlands.	m.koopman-6@umcutrecht.nl	May, Anne M/G-9183-2011; van der Hoeven, Koos JM/S-3281-2017; Tol, J./L-4695-2015	van Tinteren, Harm/0000-0002-4626-8702	Dutch Colorectal Cancer Group (DCCG); Commissie Klinische Studies (CKS) of the Dutch Cancer Foundation (KWF); Roche; Sanofi-Aventis; Commissie Klinische Studies of the Dutch Cancer Foundation	Dutch Colorectal Cancer Group (DCCG); Commissie Klinische Studies (CKS) of the Dutch Cancer Foundation (KWF); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Commissie Klinische Studies of the Dutch Cancer Foundation	Dutch Colorectal Cancer Group (DCCG). The DCCG received financial support for the study from the Commissie Klinische Studies (CKS) of the Dutch Cancer Foundation (KWF), Roche, and Sanofi-Aventis.; We thank the participating patients and staff at each of the study centres, and Frans A Timmer for performing the independent radiology review. We highly appreciated the valuable input of the members of the independent data monitoring committee, Elizabeth G E de Vries, Kit C Roes, Marc Buyse, Johan W Nortier, and Elsken E van der Wall. The study was supported by the Dutch Colorectal Cancer Group (DCCG). The DCCG received grants for data management and statistical analysis from the Commissie Klinische Studies of the Dutch Cancer Foundation, and unrestricted scientific grants from Roche and Sanofi-Aventis.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adams RA, 2011, LANCET ONCOL, V12, P642, DOI 10.1016/S1470-2045(11)70102-4; Arnold D, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3503; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Budman DR, 1998, J CLIN ONCOL, V16, P1795, DOI 10.1200/JCO.1998.16.5.1795; Chibaudel B, 2014, ANN ONCOL          S, V25, P4; Chibaudel B, 2009, J CLIN ONCOL, V27, P5727, DOI 10.1200/JCO.2009.23.4344; Cummings LC, 2007, CANCER, V109, P718, DOI 10.1002/cncr.22448; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Diaz-Rubio E, 2012, ONCOLOGIST, V17, P15, DOI 10.1634/theoncologist.2011-0249; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Grothey A, 2005, J CLIN ONCOL, V23, P9441, DOI 10.1200/JCO.2005.04.4792; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Johnsson A, 2013, ANN ONCOL, V24, P2335, DOI 10.1093/annonc/mdt236; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Labianca R, 2011, ANN ONCOL, V22, P1236, DOI 10.1093/annonc/mdq580; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Maughan TS, 2003, LANCET, V361, P457, DOI 10.1016/S0140-6736(03)12461-0; Mekenkamp LJM, 2010, BRIT J CANCER, V103, P159, DOI 10.1038/sj.bjc.6605737; Mol L, 2010, ANN ONCOL, V21, P415, DOI 10.1093/annonc/mdp330; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5	32	335	346	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1843	1852		10.1016/S0140-6736(14)62004-3	http://dx.doi.org/10.1016/S0140-6736(14)62004-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6ZE	25862517				2022-12-28	WOS:000354184500028
J	Kun, H				Kun, Huang			EVALUATION Moving away from metrics	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					S18	S20		10.1038/520S18a	http://dx.doi.org/10.1038/520S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH0DQ	25924194	Bronze			2022-12-28	WOS:000353689700004
J	Torjesen, I				Torjesen, Ingrid			MEDICINE AND THE MEDIA Does the UK civil service code stifle reporting on health and science?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2015, NATURE, V520, P5, DOI 10.1038/520005a; Fox F, 2015, COMMUNICATION   0327; HM Government, 2015, STAT GUID CIV SERV C; McGinty L, 2015, COMMUNICATION	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2015	350								h2290	10.1136/bmj.h2290	http://dx.doi.org/10.1136/bmj.h2290			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UR	25925081				2022-12-28	WOS:000353956400006
J	Horne, RSC; Hauck, FR; Moon, RY				Horne, Rosemary S. C.; Hauck, Fern R.; Moon, Rachel Y.			Sudden infant death syndrome and advice for safe sleeping	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK-FACTORS; CONFIDENTIAL INQUIRY; PASSIVE SMOKING; UNITED-STATES; NEW-ZEALAND; COT DEATH; POSITION; PRONE; SIDS; ENVIRONMENT		[Horne, Rosemary S. C.] Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Horne, Rosemary S. C.] Prince Henrys Inst, Melbourne, Vic, Australia; [Horne, Rosemary S. C.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Hauck, Fern R.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Moon, Rachel Y.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	Monash University; Prince Henry's Institute of Medical Research; Monash University; University of Virginia; George Washington University	Horne, RSC (corresponding author), Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.	rosemary.horne@monash.edu		Horne, Rosemary/0000-0003-3575-0461				Alexander RT, 2005, J FORENSIC SCI, V50, P147; Anderson HR, 1997, THORAX, V52, P1003, DOI 10.1136/thx.52.11.1003; Anderson HR, 1999, THORAX, V54, P365; Ateah CA, 2008, JOGNN-J OBST GYN NEO, V37, P274, DOI 10.1111/j.1552-6909.2008.00242.x; Australian Bureau of Statistics, 2012, INF DEATHS AUSTR; Balaguer A, 2006, COCHRANE DB SYST REV, V4; Ball HL, 2003, BIRTH-ISS PERINAT C, V30, P181, DOI 10.1046/j.1523-536X.2003.00243.x; Blair PS, 2008, ARCH DIS CHILD, V93, P778, DOI 10.1136/adc.2007.136366; Blair PS, 2006, INT J EPIDEMIOL, V35, P1563, DOI 10.1093/ije/dyl212; Blair PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107799; Blair PS, 2010, PEDIATRICS, V126, pE1119, DOI 10.1542/peds.2010-1277; Blair PS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3666; Blair PS, 2004, ARCH DIS CHILD, V89, P1106, DOI 10.1136/adc.2003.038067; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Byard RW, 2000, J PAEDIATR CHILD H, V36, P403, DOI 10.1046/j.1440-1754.2000.00503.x; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Carpenter RJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002775; Carroll-Pankhurst C, 2001, PEDIATRICS, V107, P530, DOI 10.1542/peds.107.3.530; Colson ER, 2013, JAMA PEDIATR, V167, P1032, DOI 10.1001/jamapediatrics.2013.2560; DEJONGE GA, 1989, BRIT MED J, V298, P722, DOI 10.1136/bmj.298.6675.722; Dietz PM, 2010, AM J PREV MED, V39, P45, DOI 10.1016/j.amepre.2010.03.009; Dwyer T, 1999, AM J EPIDEMIOL, V149, P593; DWYER T, 1991, LANCET, V337, P1244, DOI 10.1016/0140-6736(91)92917-Q; Escott A, 2009, NEW ZEAL MED J, V122, P59; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Fleming PJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h563; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Franco P, 2010, SLEEP MED, V11, P603, DOI 10.1016/j.sleep.2009.12.014; Fu LY, 2010, ACAD PEDIATR, V10, P376, DOI 10.1016/j.acap.2010.09.001; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; GUNTHEROTH WG, 1992, JAMA-J AM MED ASSOC, V267, P2359, DOI 10.1001/jama.267.17.2359; HAGLUND B, 1993, ACTA PAEDIATR, V82, P37, DOI 10.1111/j.1651-2227.1993.tb12872.x; Harper RM, 2000, PEDIATR RES, V48, P140, DOI 10.1203/00006450-200008000-00004; Harper RM, 2010, CURR PEDIATR REV, V6, P39, DOI 10.2174/157339610791317214; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; Hauck FR, 2003, PEDIATRICS, V111, P1207; Horne RSC, 2014, PAEDIATR RESPIR REV, V15, P312, DOI 10.1016/j.prrv.2014.09.007; Horne RSC, 2014, J PAEDIATR CHILD H, V50, P170, DOI 10.1111/jpc.12402; Horne RSC, 2010, SLEEP MED, V11, P615, DOI 10.1016/j.sleep.2009.10.008; Huang Y, 2013, JAMA PEDIATR, V167, P1038, DOI 10.1001/jamapediatrics.2013.2632; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Hutchison BL, 2011, ACTA PAEDIATR, V100, P1108, DOI 10.1111/j.1651-2227.2011.02221.x; Ip S, 2009, BREASTFEED MED, V4, pS17, DOI 10.1089/bfm.2009.0050; IRGENS LM, 1995, ARCH DIS CHILD, V72, P478, DOI 10.1136/adc.72.6.478; Jeffery HE, 1999, PEDIATRICS, V104, P263, DOI 10.1542/peds.104.2.263; Joyner BL, 2010, J NATL MED ASSOC, V102, P881, DOI 10.1016/S0027-9684(15)30706-9; Kanetake J, 2003, PEDIATR INT, V45, P284, DOI 10.1046/j.1442-200X.2003.01708.x; Kemp JS, 1998, J PEDIATR-US, V132, P234, DOI 10.1016/S0022-3476(98)70437-8; Kemp JS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e41; KLONOFFCOHEN HS, 1995, JAMA-J AM MED ASSOC, V273, P795, DOI 10.1001/jama.273.10.795; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; L'Hoir MP, 1998, EUR J PEDIATR, V157, P681, DOI 10.1007/s004310050911; Li DK, 2003, AM J EPIDEMIOL, V157, P446, DOI 10.1093/aje/kwf226; MACKAY M, 1984, ARCH DIS CHILD, V59, P136, DOI 10.1136/adc.59.2.136; Malloy MH, 2013, J PERINATOL, V33, P470, DOI 10.1038/jp.2012.158; MALLOY MH, 1995, PEDIATRICS, V96, P464; Malloy MH, 2002, PEDIATRICS, V109, P661, DOI 10.1542/peds.109.4.661; McGarvey C, 2006, ARCH DIS CHILD, V91, P318, DOI 10.1136/adc.2005.074674; McGarvey C, 2003, ARCH DIS CHILD, V88, P1058, DOI 10.1136/adc.88.12.1058; McKenna James J, 2005, Paediatr Respir Rev, V6, P134, DOI 10.1016/j.prrv.2005.03.006; Mitchell E. A., 2006, Reviews on Environmental Health, V21, P81; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; MITCHELL EA, 1993, PEDIATRICS, V91, P893; Mitchell EA, 1997, PEDIATRICS, V100, P835, DOI 10.1542/peds.100.5.835; Mitchell EA, 1995, SUDDEN INFANT DEATH; Mitchell EA, 2012, J PAEDIATR CHILD H, V48, P626, DOI 10.1111/j.1440-1754.2011.02215.x; Mitchell EA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3466; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Moon RY, 2011, PEDIATRICS, V128, P1030, DOI 10.1542/peds.2011-2284; Nelson EAS, 2001, EARLY HUM DEV, V62, P43, DOI 10.1016/S0378-3782(01)00116-5; Office for National Statistics, 2013, CHILD MORT STAT MET; Okami P, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200208000-00009; Oyen N, 1997, PEDIATRICS, V100, P613, DOI 10.1542/peds.100.4.613; Patel AL, 2001, J APPL PHYSIOL, V91, P2537, DOI 10.1152/jappl.2001.91.6.2537; Platt MJ, 1996, ARCH DIS CHILD, V75, P527, DOI 10.1136/adc.75.6.527; PONSONBY AL, 1993, NEW ENGL J MED, V329, P377, DOI 10.1056/NEJM199308053290601; Rechtman LR, 2014, PEDIATRICS, V134, pE1293, DOI 10.1542/peds.2014-1543; Ruys JH, 2007, ACTA PAEDIATR, V96, P1399, DOI 10.1111/j.1651-2227.2007.00413.x; Scheers NJ, 1998, ARCH PEDIAT ADOL MED, V152, P540; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; Scragg RKR, 1996, LANCET, V347, P7, DOI 10.1016/S0140-6736(96)91554-8; Sowter B, 1999, MED J AUSTRALIA, V171, P411, DOI 10.5694/j.1326-5377.1999.tb123719.x; Stark AR, 2008, PEDIATRICS, V122, P1119, DOI 10.1542/peds.2008-2174; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; Tablizo MA, 2007, ARCH PEDIAT ADOL MED, V161, P507, DOI 10.1001/archpedi.161.5.507; Tappin D, 2005, J PEDIATR-US, V147, P32, DOI 10.1016/j.jpeds.2005.01.035; Taylor JA, 1996, J PEDIATR-US, V128, P626, DOI 10.1016/S0022-3476(96)80126-0; Thach BT, 2007, J PEDIATR-US, V151, P271, DOI 10.1016/j.jpeds.2007.04.028; US Centers for Disease Control and Prevention, 2015, CDC WOND INF DEATHS; Vennemann MM, 2009, PEDIATRICS, V123, pe406, DOI 10.1542/peds.2008-2145; Vennemann MM, 2012, J PEDIATR-US, V160, P44, DOI 10.1016/j.jpeds.2011.06.052; Vennemann MM, 2009, PEDIATRICS, V123, P1162, DOI 10.1542/peds.2008-0505; Vogel A, 1999, ACTA PAEDIATR, V88, P1320, DOI 10.1080/080352599750030013; WARD SLD, 1986, PEDIATRICS, V77, P451; Weber MA, 2012, J PAEDIATR CHILD H, V48, P335, DOI 10.1111/j.1440-1754.2011.02228.x; Willinger M, 2003, ARCH PEDIAT ADOL MED, V157, P43, DOI 10.1001/archpedi.157.1.43	98	27	27	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h1989	10.1136/bmj.h1989	http://dx.doi.org/10.1136/bmj.h1989			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25921604				2022-12-28	WOS:000353955900004
J	Wilson, KD; Wu, JC				Wilson, Kitchener D.; Wu, Joseph C.			Induced Pluripotent Stem Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Kitchener D.; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wu, JC (corresponding author), Stanford Univ, Lorry Lokey Stem Cell Bldg,265 Campus Dr, Stanford, CA 94305 USA.	joewu@stanford.edu	Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113006, U01HL107393, R24HL117756] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000044] Funding Source: Medline; NHLBI NIH HHS [R01 HL113006, R24 HL117756, U01 HL107393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Marx V, 2015, NAT METHODS, V12, P111, DOI 10.1038/nmeth.3263; McKernan R, 2013, NAT BIOTECHNOL, V31, P875, DOI 10.1038/nbt.2710; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	8	35	35	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1613	1614		10.1001/jama.2015.1846	http://dx.doi.org/10.1001/jama.2015.1846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919522				2022-12-28	WOS:000353595200006
J	Gantz, VM; Bier, E				Gantz, Valentino M.; Bier, Ethan			The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations	SCIENCE			English	Article							DROSOPHILA	An organism with a single recessive loss-of-function allele will typically have a wild-type phenotype, whereas individuals homozygous for two copies of the allele will display a mutant phenotype. We have developed a method called the mutagenic chain reaction (MCR), which is based on the CRISPR/Cas9 genome-editing system for generating autocatalytic mutations, to produce homozygous loss-of-function mutations. In Drosophila, we found that MCR mutations efficiently spread from their chromosome of origin to the homologous chromosome, thereby converting heterozygous mutations to homozygosity in the vast majority of somatic and germline cells. MCR technology should have broad applications in diverse organisms.	[Gantz, Valentino M.; Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA	University of California System; University of California San Diego	Gantz, VM (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA.	vgantz@ucsd.edu; ebier@ucsd.edu		Gantz, Valentino/0000-0003-2453-0711	NIH [R01 GM067247, R56 NS029870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070654, R01AI110713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Yanofsky, W. McGinnis, S. Wasserman, R. Kolodner, H. Bellen, and members of the Bier lab for helpful discussions and comments on the manuscript; M. Harrison, K. O'Connor-Giles, J. Wildonger, and S. Bullock for providing CRISPR/Cas9 reagents and information; and J. Vinetz and A. Lubar for granting us access to their BSL2 Insectary. Supported by NIH grants R01 GM067247 and R56 NS029870 and by a generous gift from S. Sandell and M. Marshall. E.B. and V.M.G. are authors on a patent applied for by the University of California, San Diego (provisional patent application number 62075534) that relates to the mutagenic chain reaction. MCR fly stocks and DNA constructs are available from E.B. under a material transfer agreement from UCSD. This protocol for use and containment of our MCR stocks in a BSL2 barrier insectary also used for containment of malaria-infected mosquitos was reviewed and approved by the UCSD Institutional Biosafety Committee (BUA R461).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	7	352	369	3	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					442	444		10.1126/science.aaa5945	http://dx.doi.org/10.1126/science.aaa5945			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908821	Green Accepted			2022-12-28	WOS:000353338000036
J	Holland, ND; Holland, LZ; Holland, PWH				Holland, Nicholas D.; Holland, Linda Z.; Holland, Peter W. H.			Scenarios for the making of vertebrates	NATURE			English	Review							DEVELOPING HEMICHORDATE; NERVOUS-SYSTEM; COMMON ORIGIN; EVOLUTION; EXPRESSION; INSIGHTS; HYPOTHESIS; AMPHIOXUS; ANCESTRY; INSECTS	Over the past 200 years, almost every invertebrate phylum has been proposed as a starting point for evolving vertebrates. Most of these scenarios are outdated, but several are still seriously considered. The short-range transition from ancestral invertebrate chordates (similar to amphioxus and tunicates) to vertebrates is well accepted. However, longer-range transitions leading up to the invertebrate chordates themselves are more controversial. Opinion is divided between the annelid and the enteropneust scenarios, predicting, respectively, a complex or a simple ancestor for bilaterian animals. Deciding between these ideas will be facilitated by further comparative studies of multicellular animals, including enigmatic taxa such as xenacoelomorphs.	[Holland, Nicholas D.; Holland, Linda Z.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford	Holland, ND (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	nholland@ucsd.edu		Holland, Peter/0000-0003-1533-9376	Division Of Integrative Organismal Systems [1353688] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Achatz JG, 2013, ORG DIVERS EVOL, V13, P267, DOI 10.1007/s13127-012-0112-4; Anderson D. T., 1982, P LINN SOC N S W, V106, P151; ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0; Arendt D, 1999, DEVELOPMENT, V126, P2309; Ayers H., 1890, Journal of Morphology, Viv, P221; Balavoine G, 2003, INTEGR COMP BIOL, V43, P137, DOI 10.1093/icb/43.1.137; Bateson W., 1886, Q J MICROSC SCI, V26, P535; Beard J., 1889, Nature, Vxxxix, P259; Beaster-Jones L, 2008, DEV GENES EVOL, V218, P599, DOI 10.1007/s00427-008-0257-5; Beraneck M. E., 1892, THEORIES RECENTES DE; Berg LeoS., 1926, NOMOGENESIS EVOLUTIO; BERGSTROM J, 1989, LETHAIA, V22, P259, DOI 10.1111/j.1502-3931.1989.tb01340.x; Bernard H. M., 1898, Natural Science, Vxiii, P17; Berrill N.J., 1955, ORIGIN VERTEBRATES; Bjerring H.C., 1984, Journal of Vertebrate Paleontology, V4, P17; BROOKS WK, 1893, MEM BIOL LAB J HOPKI, V2, P1; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Christoffersen Martin L., 1994, Revista Nordestina de Biologia, V9, P173; Clark A. H., 1930, NEW EVOLUTION ZOOGEN; Cunningham D, 2014, DEV BIOL, V386, P252, DOI 10.1016/j.ydbio.2013.12.001; De Robertis EM, 2008, P NATL ACAD SCI USA, V105, P16411, DOI 10.1073/pnas.0808774105; Delage Y., 1898, TRAITE ZOOLOGIE CONC, VVII; Delsman H. C., 1922, ANCESTRY VERTEBRATES; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dewel RA, 2000, J MORPHOL, V243, P35; DILLON LS, 1965, EVOLUTION, V19, P436, DOI 10.2307/2406453; Dohrn A., 1875, URSPRUNG WIRBELTHIER; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Dzik J, 2000, EVOL BIOL, V31, P105; EATON T H, 1970, Journal of Paleontology, V44, P969; Eisig H., 1878, Zoologischer Anzeiger, Vi, P148; Furlong RF, 2002, ZOOL SCI, V19, P593, DOI 10.2108/zsj.19.593; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Garstang W, 1929, Q J MICROSC SCI, V72, P51; Garstang W., 1894, Zoologischer Anzeiger, Vxvii, P122; Gaskell W.H., 1908, ORIGIN VERTEBRATES; Gaskell W. H., 1910, P LINN SOC LONDON, V122, P9; Gaudry A., 1883, ENCHAINMENTS MONDE A; Geoffroy St., 1822, MEM MUS HIST NAT, V9, P89; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Gislen T, 1930, ZOOL BIDR UPPS, V12, P199; Goette A., 1895, VERH DTSCH ZOOL GESE, V5, P12; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Gregory WK, 1936, BIOL REV CAMB PHILOS, V11, P311, DOI 10.1111/j.1469-185X.1936.tb00909.x; GUTMANN WF, 1981, AM ZOOL, V21, P63; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hatschek B., 1878, ARB ZOOL I WIEN, V11, P1; Hesse R., 1910, TIERBAU TIERIEBEN IH, V1; HOFFHAUS CE, 1963, J PALEONTOL, V37, P458; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Hubrecht A. A. W., 1887, Quarterly Journal of Microscopical Science, Vxxvii, P605; INGLIS WG, 1985, AUST J ZOOL, V33, P153, DOI 10.1071/ZO9850153; Ivanova-Kazas O. M., 1997, RUSS J MAR BIOL, V23, P219; Jaeckel O., 1896, SITZUNGSBER GES NATU, V1896, P107; Jefferies R.P.S., 1986, ANCESTRY VERTEBRATES; JENSEN DD, 1960, NATURE, V188, P649, DOI 10.1038/188649a0; JOLLIE M, 1973, ACTA ZOOLOGICA, V54, P81; JONES CM, 1992, DEVELOPMENT, V115, P639; Kemna A., 1904, ANN SOC ROY ZOOL MAL, V39, plxxxv; Kennel J., 1892, SITZUNGSBER NATURFOR, V9, P408; KLEINENBERG N., 1886, Z WISS ZOOL, V44, P1; Koehler R., 1886, Zoologischer Anzeiger, Vix, P507; Kulakova M, 2007, DEV GENES EVOL, V217, P39, DOI 10.1007/s00427-006-0119-y; Kupffer C. v., 1870, ARCH MIKROSK ANAT, V6, P115; Kuznetsov AN, 2012, THEOR BIOL FORUM, V105, P21; Lamarck JB, 1809, PHILOS ZOOLOGIQUE, V2; Lameere A., 1891, B SEANC SOC BELGE MI, V17, P91; Lauri A, 2014, SCIENCE, V345, P1365, DOI 10.1126/science.1253396; Leydig F., 1864, HDB VERGLEICHENDEN A, V1; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Lowe CJ, 2008, PHILOS T R SOC B, V363, P1569, DOI 10.1098/rstb.2007.2247; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Macbride E. W., 1894, Quarterly Journal of Microscopical Science, Vxxxvi, P385; Macfarlane J. M., 1918, CAUSES COURSE ORGANI; Manzanares M, 2003, NEURON, V37, P895, DOI 10.1016/S0896-6273(03)00161-2; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Masterman A. T., 1897, Q J MICROSC SCI, V40, P281; Minot C. S., 1897, AM NAT, V31, P927, DOI DOI 10.1086/276733); Miyamoto N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3713; NAEF ADOLF, 1926, BIOL ZENTRALBL, V46, P39; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; Northcutt RG, 2012, P NATL ACAD SCI USA, V109, P10626, DOI 10.1073/pnas.1201889109; Northcutt RG, 2005, J EXP ZOOL PART B, V304B, P274, DOI 10.1002/jez.b.21063; NublerJung K, 1996, CURR BIOL, V6, P352, DOI 10.1016/S0960-9822(02)00491-8; NURSALL JR, 1962, EVOLUTION, V16, P118, DOI 10.2307/2406271; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Ota KG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1355; Patten W., 1912, EVOLUTION VERTEBRATE; Perrier E., 1898, Compte Rendu de l'Academie des Sciences, Vcxxvi, P1479; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Plate L., 1924, Anatomischer Anzeiger, V58, P39; Puelles L, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00047; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RAW F, 1960, J PALEONTOL, V34, P497; Rottinger E, 2010, INTEGR COMP BIOL, V50, pE144; Rottinger E, 2012, DEVELOPMENT, V139, P2463, DOI 10.1242/dev.066712; Romer A.S., 1962, VERTEBRATE BODY; Roule Louis, 1909, Archives de Zoologie Paris (Ser 4), V10; Satoh N, 2008, GENESIS, V46, P614, DOI 10.1002/dvg.20416; Sedgwick A, 1884, Q J MICROSC SCI, V24, P43; Semper C., 1875, ARBEITE ZOOLOGISCH-Z, V2, P25; Sepp E. K., 1959, DEV HIST NERVOUS SYS; SEWERTZOFF A. N., 1929, ACTA ZOOLOGICA [STOCKHOLM], V10, P59; SILLMAN LR, 1960, J PALEONTOL, V34, P540; Theophiloff S., 1892, PHYLOGENIE TUNICATEN; Todaro F., 1888, ARCH ITAL BIOL, V9, P55; TOKIOKA T, 1971, Publications of the Seto Marine Biological Laboratory, V19, P43; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Tretjakoff D., 1929, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V134, P558; Van Beneden E., 1886, ARCH BIOL, V6, P237; van der Horst C. J., 1939, HG BRONNS KLASSEN 4, V4; van Wijhe J. W., 1884, ZOOL ANZ, V7, P683; van Z Engelbrecht D., 1969, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V7, P18; von Salvini-Plawen L, 1998, J ZOOL SYST EVOL RES, V36, P129; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; WHITEAR MART, 1957, ANN AND MAG NAT HIST, V10, P338; Willey A., 1894, AMPHIOXUS ANCESTRY V; WILLMER EN, 1974, BIOL REV, V49, P321, DOI 10.1111/j.1469-185X.1974.tb01083.x; Wlizla M., 2011, THESIS U CHICAGO; Ziegler Heinrich Ernst, 1908, Jenaische Zeitschrift fuer Naturwissenschaft, V43	125	30	31	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					450	455		10.1038/nature14433	http://dx.doi.org/10.1038/nature14433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903626				2022-12-28	WOS:000353334500028
J	Szanton, SL; Leff, B; Gitlin, LN				Szanton, Sarah L.; Leff, Bruce; Gitlin, Laura N.			Improvement Interventions	ANNALS OF INTERNAL MEDICINE			English	Letter									[Szanton, Sarah L.; Leff, Bruce; Gitlin, Laura N.] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Szanton, SL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.							Davidoff F, 2014, ANN INTERN MED, V161, P526, DOI 10.7326/M14-1789; Szanton SL, 2011, J AM GERIATR SOC, V59, P2314, DOI 10.1111/j.1532-5415.2011.03698.x	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					596	597		10.7326/L15-5071-2	http://dx.doi.org/10.7326/L15-5071-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894033				2022-12-28	WOS:000353244300026
J	Lin, TY; Ebb, DH; Boepple, PA; Thiele, EA; Rincon, SP; Mordes, DA				Lin, Ting-Yi; Ebb, David H.; Boepple, Paul A.; Thiele, Elizabeth A.; Rincon, Sandra P.; Mordes, Daniel A.			Case 12-2015: A Newborn Boy with Respiratory Distress, Lethargy, and Hypernatremia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MECONIUM ASPIRATION SYNDROME; BECKWITH-WIEDEMANN-SYNDROME; CONGENITAL BRAIN-TUMORS; CLINICAL-COURSE; RHABDOID TUMOR; RISK-FACTORS; INFANTS; INTRAPARTUM; MANAGEMENT; CHILDREN		[Lin, Ting-Yi; Ebb, David H.; Boepple, Paul A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Thiele, Elizabeth A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mordes, Daniel A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lin, Ting-Yi; Ebb, David H.; Boepple, Paul A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Thiele, Elizabeth A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rincon, Sandra P.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mordes, Daniel A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lin, TY (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							Athale UH, 2009, J PEDIAT HEMATOL ONC, V31, P651, DOI 10.1097/MPH.0b013e3181b258a9; Basu S, 2007, J TROP PEDIATRICS, V53, P331, DOI 10.1093/tropej/fmm035; Bourdeaut F, 2011, CLIN CANCER RES, V17, P31, DOI 10.1158/1078-0432.CCR-10-1795; Chua BA, 2000, AM J OBSTET GYNECOL, V183, P235, DOI 10.1067/mob.2000.105821; Dani C, 1999, EUR RESPIR J, V14, P155, DOI 10.1034/j.1399-3003.1999.14a26.x; Dargaville PA, 2006, PEDIATRICS, V117, P1712, DOI 10.1542/peds.2005-2215; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; El Shahed A. I., 2007, COCHRANE DB SYST REV, V3; Gadzinowski J, 2008, J PERINATOL, V28, pS56, DOI 10.1038/jp.2008.163; Haberler C, 2006, AM J SURG PATHOL, V30, P1462, DOI 10.1097/01.pas.0000213329.71745.ef; Hwang SW, 2012, SEMIN FETAL NEONAT M, V17, P202, DOI 10.1016/j.siny.2012.03.001; Isaacs H, 2002, PEDIATR NEUROL, V27, P249, DOI 10.1016/S0887-8994(02)00472-1; Ivanov VA, 2010, PEDIATR RES, V68, P221, DOI 10.1203/00006450-201011001-00431; Kaapa P, 2008, J PERINATOL, V28, pS120, DOI 10.1038/jp.2008.147; Kaapa PO, 2009, EARLY HUM DEV, V85, P627, DOI 10.1016/j.earlhumdev.2009.09.014; Manoranjan B, 2011, J CHILD NEUROL, V26, P599, DOI 10.1177/0883073810394848; McLendon RE, 2007, WHO CLASSIFICATION T, P141; Muszynska-Roslan K, 2007, PEDIATR BLOOD CANCER, V49, P107, DOI 10.1002/pbc.20991; Okazaki K, 2008, PEDIATRICS, V121, pE748, DOI 10.1542/peds.2007-1697; Parmar HA, 2011, SEMIN ULTRASOUND CT, V32, P578, DOI 10.1053/j.sult.2011.07.001; Pillai S, 2012, CHILD NERV SYST, V28, P547, DOI 10.1007/s00381-012-1707-y; Poggi SH, 2009, EARLY HUM DEV, V85, P607, DOI 10.1016/j.earlhumdev.2009.09.011; Qaddoumi I, 2011, J CHILD NEUROL, V26, P988, DOI 10.1177/0883073811401398; Qian LI, 2008, PEDIATRICS, V121, pE1115, DOI 10.1542/peds.2006-2426; Ross MG, 2005, NEW ENGL J MED, V353, P946, DOI 10.1056/NEJMe058149; Severino M, 2010, NEURORADIOLOGY, V52, P531, DOI 10.1007/s00234-010-0699-0; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tripathi S, 2007, J TROP PEDIATRICS, V53, P8, DOI 10.1093/tropej/fml018; van Ierland Y, 2009, EARLY HUM DEV, V85, P617, DOI 10.1016/j.earlhumdev.2009.09.009; Van Poppel M, 2011, J NEUROSURG-PEDIATR, V8, P251, DOI 10.3171/2011.6.PEDS11158; Vasilatou-Kosmidis H, 2003, MED PEDIATR ONCOL, V41, P7, DOI 10.1002/mpo.10153; Velaphi S, 2006, CLIN PERINATOL, V33, P29, DOI 10.1016/j.clp.2005.11.014; Yoder BA, 2002, OBSTET GYNECOL, V99, P731, DOI 10.1016/S0029-7844(02)01942-7	34	1	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1550	1562		10.1056/NEJMcpc1400837	http://dx.doi.org/10.1056/NEJMcpc1400837			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875261				2022-12-28	WOS:000352856500012
J	Gilbert, D				Gilbert, David			WHAT YOUR PATIENT IS THINKING Car parking is a clinical quality issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1312	10.1136/bmj.h1312	http://dx.doi.org/10.1136/bmj.h1312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25873102	Green Published, Bronze			2022-12-28	WOS:000353327500001
J	Langen, T; Erne, S; Geiger, R; Rauer, B; Schweigler, T; Kuhnert, M; Rohringer, W; Mazets, IE; Gasenzer, T; Schmiedmayer, J				Langen, Tim; Erne, Sebastian; Geiger, Remi; Rauer, Bernhard; Schweigler, Thomas; Kuhnert, Maximilian; Rohringer, Wolfgang; Mazets, Igor E.; Gasenzer, Thomas; Schmiedmayer, Joerg			Experimental observation of a generalized Gibbs ensemble	SCIENCE			English	Article							STATISTICAL MECHANICS; INFORMATION THEORY; QUANTUM-SYSTEMS	The description of the non-equilibrium dynamics of isolated quantum many-body systems within the framework of statistical mechanics is a fundamental open question. Conventional thermodynamical ensembles fail to describe the large class of systems that exhibit nontrivial conserved quantities, and generalized ensembles have been predicted to maximize entropy in these systems. We show experimentally that a degenerate one-dimensional Bose gas relaxes to a state that can be described by such a generalized ensemble. This is verified through a detailed study of correlation functions up to 10th order. The applicability of the generalized ensemble description for isolated quantum many-body systems points to a natural emergence of classical statistical properties from the microscopic unitary quantum evolution.	[Langen, Tim; Erne, Sebastian; Geiger, Remi; Rauer, Bernhard; Schweigler, Thomas; Kuhnert, Maximilian; Rohringer, Wolfgang; Mazets, Igor E.; Schmiedmayer, Joerg] TU Wien, Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria; [Erne, Sebastian; Gasenzer, Thomas] Heidelberg Univ, Inst Theoret Phys, D-69120 Heidelberg, Germany; [Erne, Sebastian; Gasenzer, Thomas] GSI Helmholtzzentrum Schwerionenforsch GmbH, ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany; [Mazets, Igor E.] Wolfgang Pauli Inst, A-1090 Vienna, Austria; [Mazets, Igor E.] Ioffe Physicotech Inst, St Petersburg 194021, Russia	Technische Universitat Wien; Ruprecht Karls University Heidelberg; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute	Schmiedmayer, J (corresponding author), TU Wien, Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria.	schmiedmayer@atomchip.org	Rauer, Bernhard/U-8788-2019; Langen, Tim/I-6357-2012; Schmiedmayer, Jörg/B-4717-2008; Mazets, Igor/T-6610-2019; Geiger, Remi/M-4231-2016; Schmiedmayer, Jörg/M-9669-2019; Mazets, Igor E./D-4862-2011	Rauer, Bernhard/0000-0001-5180-3100; Langen, Tim/0000-0003-2561-0326; Schmiedmayer, Jörg/0000-0001-7799-5614; Mazets, Igor/0000-0002-3769-8313; Geiger, Remi/0000-0003-4678-7139; Schmiedmayer, Jörg/0000-0001-7799-5614; Mazets, Igor E./0000-0002-3769-8313; Schweigler, Thomas/0000-0002-8447-2683; LANGEN, TIM/0000-0002-2012-2895; Erne, Sebastian/0000-0003-2836-8993	European Union (SIQS); European Union (ERC); Austrian Science Fund (FWF) through the Doctoral Programme CoQuS [W1210]; Lise Meitner Programme [M1423]; Deutsche Forschungsgemeinschaft [GA677/7,8]; University of Heidelberg Center for Quantum Dynamics; Helmholtz Association [HA216/EMMI]; NSF [PHY11-25915];  [P22590-N16]	European Union (SIQS); European Union (ERC)(European Research Council (ERC)European Commission); Austrian Science Fund (FWF) through the Doctoral Programme CoQuS(Austrian Science Fund (FWF)); Lise Meitner Programme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg Center for Quantum Dynamics; Helmholtz Association(Helmholtz Association); NSF(National Science Foundation (NSF)); 	We acknowledge discussions with E. Demler, E. Dalla Torre, K. Agarwal, J. Berges, M. Karl, V. Kasper, I. Bouchoule, M. Cheneau, and P. Grisins. Supported by the European Union (SIQS and ERC advanced grant QuantumRelax), the Austrian Science Fund (FWF) through the Doctoral Programme CoQuS (W1210) (B.R. and T.S.), the Lise Meitner Programme M1423 (R.G.) and project P22590-N16 (I. E. M.), Deutsche Forschungsgemeinschaft grant GA677/7,8 (T.G.), the University of Heidelberg Center for Quantum Dynamics, Helmholtz Association grant HA216/EMMI, and NSF grant PHY11-25915. T.L., T.G., and J.S. thank the Kavli Institute for Theoretical Physics, Santa Barbara, for its hospitality.	[Anonymous], 1987, STAT MECH; Berges J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.142002; Berges J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033604; Berrada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3077; Betz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020407; Calabrese P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.227203; Caux JS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257203; Caux JS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.175301; Cazalilla MA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.156403; Eckstein M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.056403; Gasenzer T, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063604; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Hubener R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.040401; Hughes I., 2010, MEASUREMENTS THEIR U; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kitagawa T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073018; Kitagawa T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.255302; Kollar M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054304; Korepin V. E., 1993, QUANTUM INVERSE SCAT; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Reichel J., 2011, ATOM CHIPS; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Rigol M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.100403; Ronzheimer JP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.205301; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; Shannon C. E., 1949, MATH THEORY COMMUNIC; Vosk R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067204	35	365	365	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					207	211		10.1126/science.1257026	http://dx.doi.org/10.1126/science.1257026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859041	Green Submitted			2022-12-28	WOS:000352613700038
J	Zitvogel, L; Kroemer, G				Zitvogel, Laurence; Kroemer, Guido			CANCER Antibodies regulate antitumour immunity	NATURE			English	Editorial Material							DEATH		[Zitvogel, Laurence] Gustave Roussy Comprehens Canc Ctr, F-94805 Villejuif, France; [Kroemer, Guido] Univ Paris 05, Cordeliers Res Ctr, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, Paris, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Gustave Roussy Comprehens Canc Ctr, F-94805 Villejuif, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998				Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Galluzzi L, 2014, ONCOTARGET, V5, P12472, DOI 10.18632/oncotarget.2998; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Hannani D, 2014, CELL DEATH DIFFER, V21, P50, DOI 10.1038/cdd.2013.60; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	10	27	28	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					35	37		10.1038/nature14388	http://dx.doi.org/10.1038/nature14388			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924066				2022-12-28	WOS:000354040900023
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Rigging the NHS for votes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTINUITY; CARE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Freeman G, 2010, CONTINUITY CARE PATI; Hansen AH, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0629-7; Rhodes P, 2014, BRIT J GEN PRACT, V64, pE758, DOI 10.3399/bjgp14X682825	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2015	350								h2269	10.1136/bmj.h2269	http://dx.doi.org/10.1136/bmj.h2269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UM	25920977	Bronze			2022-12-28	WOS:000353955900018
J	Chen, KH; Boettiger, AN; Moffitt, JR; Wang, SY; Zhuang, XW				Chen, Kok Hao; Boettiger, Alistair N.; Moffitt, Jeffrey R.; Wang, Siyuan; Zhuang, Xiaowei			Spatially resolved, highly multiplexed RNA profiling in single cells	SCIENCE			English	Article							GENE-EXPRESSION; MOLECULE FLUORESCENCE; MESSENGER-RNAS; DESIGN; VISUALIZATION; TRANSLOCATION; LOCALIZATION; MECHANISMS; REVEALS; TOOL	Knowledge of the expression profile and spatial landscape of the transcriptome in individual cells is essential for understanding the rich repertoire of cellular behaviors. Here, we report multiplexed error-robust fluorescence in situ hybridization (MERFISH), a single-molecule imaging approach that allows the copy numbers and spatial localizations of thousands of RNA species to be determined in single cells. Using error-robust encoding schemes to combat single-molecule labeling and detection errors, we demonstrated the imaging of 100 to 1000 distinct RNA species in hundreds of individual cells. Correlation analysis of the similar to 10(4) to 10(6) pairs of genes allowed us to constrain gene regulatory networks, predict novel functions for many unannotated genes, and identify distinct spatial distribution patterns of RNAs that correlate with properties of the encoded proteins.	[Chen, Kok Hao; Boettiger, Alistair N.; Moffitt, Jeffrey R.; Wang, Siyuan; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	, 周一珉/AAQ-9453-2020	Boettiger, Alistair/0000-0002-3554-5196; Wang, Siyuan (Steven)/0000-0001-6550-4064	National Institutes of Health; Agency for Science, Technology and Research of Singapore; Damon Runyon Foundation; Helen Hay Whitney Foundation; Jane Coffins Child Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450, R01GM105637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Damon Runyon Foundation; Helen Hay Whitney Foundation; Jane Coffins Child Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Babcock for technical advice and help with instrumentation and B. Bintu for aid in error analysis. This work was in part supported by the National Institutes of Health. K.H.C. acknowledges a National Science Scholarship from the Agency for Science, Technology and Research of Singapore. A.N.B. acknowledges support by the Damon Runyon Foundation postdoctoral fellowship. J.R.M. acknowledges support from the Helen Hay Whitney Foundation postdoctoral fellowship. S.W. acknowledges support from Jane Coffins Child Foundation postdoctoral fellowship. X.Z. is a Howard Hughes Medical Institute investigator. RNA-seq data were deposited under the accession number GSE67685. MERFISH data are available at http://zhuang.harvard.edu/merfish. X.Z., K.H.C., A.N.B., J.R.M., and S.W. are inventors on a patent applied for by Harvard University that covers the MERFISH method described here; X.Z., J.R.M., and A.N.B. are inventors on a patent applied for by Harvard University that covers the probe synthesis method described here.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babcock Hazen, 2012, Opt Nanoscopy, V1, DOI 10.1186/2192-2853-1-6; Babcock HP, 2013, OPT EXPRESS, V21, P28583, DOI 10.1364/OE.21.028583; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Dolinski K, 2005, GENOME RES, V15, P1611, DOI 10.1101/gr.3727505; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gregor T, 2014, TRENDS GENET, V30, P364, DOI 10.1016/j.tig.2014.06.002; Ha T, 2014, NAT METHODS, V11, P1015, DOI 10.1038/nmeth.3107; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moon TK, 2005, ERROR CORRECTION CODING: MATHEMATICAL METHODS AND ALGORITHMS, P1, DOI 10.1002/0471739219; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murgha YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094752; Padovan-Merhar O, 2013, WIRES SYST BIOL MED, V5, P751, DOI 10.1002/wsbm.1243; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rodriguez AJ, 2008, CURR OPIN CELL BIOL, V20, P144, DOI 10.1016/j.ceb.2008.02.004; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	51	914	951	39	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233							aaa6090	10.1126/science.aaa6090	http://dx.doi.org/10.1126/science.aaa6090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25858977	Green Published, Green Accepted			2022-12-28	WOS:000353338000027
J	Zimmerman, K; Yoder, BK				Zimmerman, Kurt; Yoder, Bradley K.			SnapShot: Sensing and Signaling by Cilia	CELL			English	Editorial Material									[Zimmerman, Kurt; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zimmerman, K (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, R01DK065655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007051] Funding Source: Medline; NIDDK NIH HHS [P30 DK074038, DK065655, R01 DK065655] Funding Source: Medline; NIGMS NIH HHS [2K12GM088010-06, K12 GM088010] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Ibraghimov-Beskrovnaya O, 2011, TRENDS MOL MED, V17, P625, DOI 10.1016/j.molmed.2011.06.003; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Welmbs T., 2013, JAK STAT, V2; Yildiz O, 2012, VISION RES, V75, P112, DOI 10.1016/j.visres.2012.08.007; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	9	26	30	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					692	692		10.1016/j.cell.2015.04.015	http://dx.doi.org/10.1016/j.cell.2015.04.015			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910215	Green Accepted, Bronze			2022-12-28	WOS:000353553600026
J	Hussey, HH				Hussey, Hugh H.			Immunity Against Contagious Diseases: Inadequacies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		SCHIFF GM, 1973, JAMA-J AM MED ASSOC, V226, P554, DOI 10.1001/jama.226.5.554	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1577	1577		10.1001/jama.2014.11702	http://dx.doi.org/10.1001/jama.2014.11702			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898065				2022-12-28	WOS:000353198700031
J	Psaty, BM; Platt, R; Altman, RB				Psaty, Bruce M.; Platt, Richard; Altman, Russ B.			Neurotoxicity of Generic Anesthesia Agents in Infants and Children An Orphan Research Question in Search of a Sponsor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEURODEGENERATION; EXPOSURE		[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Platt, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Platt, Richard] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Genet & Med, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Stanford University; Stanford University	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu		Altman, Russ/0000-0003-3859-2905	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078888, R01HL103612, R01HL105756] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL078888, HL103612, R01 HL103612, HL105756] Funding Source: Medline; NIGMS NIH HHS [GM61374] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andropoulos DB, FDA PUBLIC SESSION R; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Hays SR, 2013, J UROLOGY, V189, P1222, DOI 10.1016/j.juro.2012.11.090; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; US Food and Drug Administration, SIGN EX NONCL CLIN D; US Food and Drug Administration, CLIN INV POT EFF AN; Yu CK, 2013, F1000RESEARCH, V2, P166, DOI [DOI 10.12688/F1000RESEARCH.2-166.V1, 10.12688/f1000research.2-166.v2]	10	39	39	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1515	1516		10.1001/jama.2015.1149	http://dx.doi.org/10.1001/jama.2015.1149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898045				2022-12-28	WOS:000353198700012
J	Lu, Y; Lee, BH; King, RW; Finley, D; Kirschner, MW				Lu, Ying; Lee, Byung-hoon; King, Randall W.; Finley, Daniel; Kirschner, Marc W.			Substrate degradation by the proteasome: A single-molecule kinetic analysis	SCIENCE			English	Article							UBIQUITINATED PROTEINS ACTIVATE; 26S PROTEASOME; CYCLIN B1; RECOGNITION; DEUBIQUITINATION; INITIATION; RECEPTORS; BINDING; SIGNAL; MULTIUBIQUITINATION	To address how the configuration of conjugated ubiquitins determines the recognition of substrates by the proteasome, we analyzed the degradation kinetics of substrates with chemically defined ubiquitin configurations. Contrary to the view that a tetraubiquitin chain is the minimal signal for efficient degradation, we find that distributing the ubiquitins as diubiquitin chains provides a more efficient signal. To understand how the proteasome actually discriminates among ubiquitin configurations, we developed single-molecule assays that distinguished intermediate steps of degradation kinetically. The level of ubiquitin on a substrate drives proteasome-substrate interaction, whereas the chain structure of ubiquitin affects translocation into the axial channel on the proteasome. Together these two features largely determine the susceptibility of substrates for proteasomal degradation.	[Lu, Ying; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lee, Byung-hoon; King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu		Lee, Byung-Hoon/0000-0002-7101-0471	Damon Runyon Research Fellowship; NIH [GM43601, GM66492]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R56GM066492, R37GM043601, R01GM066492, R01GM039023] Funding Source: NIH RePORTER	Damon Runyon Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bai and W. Ma for commenting on the manuscript. We thank the Nikon Imaging Center at Harvard Medical School for providing instruments. Y.L. is supported by a Damon Runyon Research Fellowship and is a Lallage Feazel Wall Fellow. This work was supported in part by NIH grants GM43601 (to D.F.) and GM66492 (to R.W.K.)	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Imamura S, 2012, J BIOL CHEM, V287, P23047, DOI 10.1074/jbc.M111.332882; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722	54	132	133	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231							1250834	10.1126/science.1250834	http://dx.doi.org/10.1126/science.1250834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859050	Green Accepted			2022-12-28	WOS:000352613700036
J	Weiss, RA; Fassati, A				Weiss, Robin A.; Fassati, Ariberto			The Clammy Grip of Parasitic Tumors	CELL			English	Editorial Material							TRANSMISSIBLE CANCER; DEVIL; ORIGIN; DOG	An epidemic of leukemia among bivalve molluscs is spreading along the Atlantic coast of North America, with a serious population decline of soft-shelled clams. In this issue of Cell, Metzger et al. use forensic DNA markers to demonstrate that the leukemia cells have a clonal origin and appear to be transmitted through sea water.	[Weiss, Robin A.; Fassati, Ariberto] UCL, Div Infect & Immun, Wohl Vir Ctr, London WC1E 6BT, England	University of London; University College London	Weiss, RA (corresponding author), UCL, Div Infect & Immun, Wohl Vir Ctr, Gower St, London WC1E 6BT, England.	r.weiss@ucl.ac.uk		Fassati, Ariberto/0000-0003-1934-5327				Arriagada G, 2014, P NATL ACAD SCI USA, V111, P14175, DOI 10.1073/pnas.1409945111; BANFIELD WG, 1965, SCIENCE, V148, P1239, DOI 10.1126/science.148.3674.1239; Belov K, 2012, BIOESSAYS, V34, P285, DOI 10.1002/bies.201100161; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Siddle HV, 2015, IMMUNOLOGY, V144, P11, DOI 10.1111/imm.12377	9	3	3	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					191	192		10.1016/j.cell.2015.03.034	http://dx.doi.org/10.1016/j.cell.2015.03.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860599	Bronze			2022-12-28	WOS:000352708300009
J	Leon, DA				Leon, David A.			Imagining a better place: trust, care, and progress in medicine	LANCET			English	Editorial Material							MORTALITY; TRENDS		[Leon, David A.] London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London WC1E 7HT, England; [Leon, David A.] Arctic Univ Norway, Tromso, Norway	University of London; London School of Hygiene & Tropical Medicine; UiT The Arctic University of Tromso	Leon, DA (corresponding author), London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London WC1E 7HT, England.	david.leon@lshtm.ac.uk	Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762				Berger J., 2015, FORTUNATE MAN STORY; Brock A, 2003, HLTH STAT Q, V18, P5; Ezzati M, 2015, NAT REV CAR IN PRESS; Gawande A., 2014, BIENG MORTALPENGUIN; Hosking, 2014, TRUST A HIST; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Levi F, 2002, HEART, V88, P119, DOI 10.1136/heart.88.2.119; Malvezzi M, 2013, LUNG CANCER, V80, P138, DOI 10.1016/j.lungcan.2013.01.020; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Purushotham A, 2013, EUR J CANCER, V49, P1669, DOI 10.1016/j.ejca.2013.01.004; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; University of California Berkeley USA, 2015, HUM MORT DAT	12	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1263	1264		10.1016/S0140-6736(15)60606-7	http://dx.doi.org/10.1016/S0140-6736(15)60606-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25890895				2022-12-28	WOS:000352272400010
J	Stewart, EA				Stewart, Elizabeth A.			Uterine Fibroids	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AFRICAN-AMERICAN WOMEN; VOLUMETRIC THERMAL ABLATION; REPRODUCTIVE FACTORS; ARTERY EMBOLIZATION; ULIPRISTAL ACETATE; LEIOMYOMATA; RISK; TUMORS; PREDISPOSITION; INFERTILITY	A 47-year-old black woman has heavy menstrual bleeding and iron-deficiency anemia. She reports nocturia and urinary frequency. A colonoscopy is negative. Ultrasonography shows a modestly enlarged uterus with three uterine fibroids. She is not planning to become pregnant. How should this case be evaluated and managed?	[Stewart, Elizabeth A.] Mayo Clin, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Stewart, Elizabeth A.] Mayo Clin, Div Reprod Endocrinol & Infertil, Dept Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Stewart, EA (corresponding author), Mayo Clin, Div Reprod Endocrinol & Infertil, 200 First St SW, Rochester, MN 55905 USA.	stewart.elizabeth@mayo.edu		Stewart, Elizabeth/0000-0003-1110-2400	Gynesonics; Abbot; Bayer; GlaxoSmithKline; Astellas Pharma; Welltwigs; InSightec	Gynesonics; Abbot; Bayer(Bayer AG); GlaxoSmithKline(GlaxoSmithKline); Astellas Pharma(Astellas Pharmaceuticals); Welltwigs; InSightec	Dr. Stewart reports receiving fees for serving on an advisory board from Gynesonics, consulting fees from Abbott, Bayer, GlaxoSmithKline, Astellas Pharma, and Welltwigs, and fees from InSightec, paid to her institution, to cover costs of focused ultrasound surgery in a clinical trial, holding a patent (US 6440445) related to methods and compounds for the treatment of abnormal uterine bleeding, and planned consulting with Viteava Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Amer Soc Reprod Med Collaboration, 2008, FERTIL STERIL, V90, pS125, DOI 10.1016/j.fertnstert.2008.09.012; American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P387, DOI 10.1097/AOG.0b013e318183fbab; [Anonymous], 2013, HEAV MENSTR BLEED; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2011, FERTIL STERIL, V95, P242, DOI 10.1016/j.fertnstert.2010.05.011; Berman JM, 2014, J MINIM INVAS GYN, V21, P767, DOI 10.1016/j.jmig.2014.02.015; Brucker SY, 2014, INT J GYNECOL OBSTET, V125, P261, DOI 10.1016/j.ijgo.2013.11.012; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Eggert SL, 2012, AM J HUM GENET, V91, P621, DOI 10.1016/j.ajhg.2012.08.009; Eltoukhi HM, 2014, AM J OBSTET GYNECOL, V210, P194, DOI 10.1016/j.ajog.2013.08.008; Food and Drug Administration, 2014, UPD LAP UT POW MOR H; Gizzo S, 2014, REPROD SCI, V21, P465, DOI 10.1177/1933719113497289; Gliklich RE, 2011, 31 AG HEALTHC RES QU; Goodwin SC, 2009, NEW ENGL J MED, V361, P690, DOI 10.1056/NEJMct0806942; Gupta JK, 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005073; Hehenkamp WJK, 2007, HUM REPROD, V22, P1996, DOI 10.1093/humrep/dem105; Hodge JC, 2009, HUM GENET, V125, P257, DOI 10.1007/s00439-008-0621-6; Kaump GR, 2013, J VASC INTERV RADIOL, V24, P459, DOI 10.1016/j.jvir.2012.12.002; Lethaby A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000400.pub3; Lukes AS, 2010, OBSTET GYNECOL, V116, P865, DOI 10.1097/AOG.0b013e3181f20177; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Marret H, 2012, EUR J OBSTET GYN R B, V165, P156, DOI 10.1016/j.ejogrb.2012.07.030; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Marshall LM, 1998, FERTIL STERIL, V70, P432, DOI 10.1016/S0015-0282(98)00208-8; Mercorio F, 2003, CONTRACEPTION, V67, P277, DOI 10.1016/S0010-7824(02)00522-X; Metwally M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003857.pub3; Munro MG, 2011, FERTIL STERIL, V95, P2204, DOI 10.1016/j.fertnstert.2011.03.079; Nieboer TE, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003677.pub4, 10.1002/14651858.CD003677.pub5]; Parker WH, 2013, OBSTET GYNECOL, V121, P709, DOI 10.1097/AOG.0b013e3182864350; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Perez-Lopez FR, 2014, MATURITAS, V79, P106, DOI 10.1016/j.maturitas.2014.06.002; Pritts EA, 2001, OBSTET GYNECOL SURV, V56, P483, DOI 10.1097/00006254-200108000-00022; Pritts EA, 2009, FERTIL STERIL, V91, P1215, DOI 10.1016/j.fertnstert.2008.01.051; Quinn SD, 2014, EUR J OBSTET GYN R B, V182, P243, DOI 10.1016/j.ejogrb.2014.09.039; Rabinovici J, 2010, FERTIL STERIL, V93, P199, DOI 10.1016/j.fertnstert.2008.10.001; Sangkomkamhang US, 2013, COCHRANE DB SYST REV, V2; Song H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009505.pub2; Stewart EA, 2013, J WOMENS HEALTH, V22, P807, DOI 10.1089/jwh.2013.4334; Stewart Elizabeth A, 2012, Minn Med, V95, P36; Tanaka YO, 2004, J MAGN RESON IMAGING, V20, P998, DOI 10.1002/jmri.20207; Tristan M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007687.pub2; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016; Wise LA, 2011, AM J CLIN NUTR, V94, P1620, DOI 10.3945/ajcn.111.016600; Wright JD, 2014, JAMA-J AM MED ASSOC, V312, P1253, DOI 10.1001/jama.2014.9005	50	360	383	7	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1646	1655		10.1056/NEJMcp1411029	http://dx.doi.org/10.1056/NEJMcp1411029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25901428				2022-12-28	WOS:000353294000010
J	Meara, JG; Leather, AJM; Hagander, L; Alkire, BC; Alonso, N; Ameh, EA; Bickler, SW; Conteh, L; Dare, AJ; Davies, J; Merisier, ED; El-Halabi, S; Farmer, PE; Gawande, A; Gullies, R; Greenberg, SLM; Grimes, CE; Gruen, RL; Ismail, EA; Kamara, TB; Lavy, C; Ganbold, L; Mkandawire, NC; Raykar, NP; Riesel, JN; Rodas, E; Rose, J; Roy, N; Shrime, MG; Sullivan, R; Verguet, S; Watters, D; Weiser, TG; Wilson, IH; Yamey, G; Yip, W				Meara, John G.; Leather, Andrew J. M.; Hagander, Lars; Alkire, Blake C.; Alonso, Nivaldo; Ameh, Emmanuel A.; Bickler, Stephen W.; Conteh, Lesong; Dare, Anna J.; Davies, Justine; Merisier, Eunice Derivois; El-Halabi, Shenaaz; Farmer, Paul E.; Gawande, Atul; Gullies, Rowan; Greenberg, Sarah L. M.; Grimes, Canis E.; Gruen, Russell L.; Ismail, Edna Adan; Kamara, Thaim Buya; Lavy, Chris; Ganbold, Lundeg; Mkandawire, Nyengo C.; Raykar, Nakul P.; Riesel, Johanna N.; Rodas, Edgar; Rose, John; Roy, Nobhojit; Shrime, Mark G.; Sullivan, Richard; Verguet, Stephane; Watters, David; Weiser, Thomas G.; Wilson, Iain H.; Yamey, Gavin; Yip, Winnie			Global Surgery 2030: Evidence and solutions for achieving health, welfare, and economic development	SURGERY			English	Article									[Meara, John G.; Greenberg, Sarah L. M.; Raykar, Nakul P.; Riesel, Johanna N.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Shrime, Mark G.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Meara, John G.; Hagander, Lars; Raykar, Nakul P.; Riesel, Johanna N.] Boston Childrens Hosp, Boston, MA USA; [Leather, Andrew J. M.; Dare, Anna J.; Grimes, Canis E.] Kings Hlth Partners, Kings Ctr Global Hlth, London, England; [Leather, Andrew J. M.; Dare, Anna J.; Grimes, Canis E.] Kings Coll London, London, England; [Hagander, Lars] Lund Univ, Clin Sci Lund, Dept Pediat, Pediat Surg & Global Pediat, Lund, Sweden; [Alkire, Blake C.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, Boston, MA 02114 USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Off Global Surg, Boston, MA 02114 USA; [Alonso, Nivaldo] Univ Sao Paulo, Dept Plast Surg, Sao Paulo, Brazil; [Ameh, Emmanuel A.] Natl Hosp, Dept Surg, Div Peadiat Surg, Abuja, Nigeria; [Bickler, Stephen W.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92103 USA; [Rose, John] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Davies, Justine] Lancet, London, England; [Merisier, Eunice Derivois] Dept Minist Hlth, Grassier, Ouest, Haiti; [El-Halabi, Shenaaz] Minist Hlth, Gaborone, Botswana; [Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Div Global Hlth Equ, Boston, MA 02115 USA; [Farmer, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Gawande, Atul; Rose, John] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Gawande, Atul] Ariadne Labs, Boston, MA USA; [Gullies, Rowan] Royal N Shore Hosp, St Leonards, NSW 2065, Australia; [Greenberg, Sarah L. M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Gruen, Russell L.] Alfred Hosp, Melbourne, Vic, Australia; [Gruen, Russell L.] Monash Univ, Melbourne, Vic 3004, Australia; Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Ismail, Edna Adan] Edna Adan Univ Hosp, Hargeisa, Somalia; [Kamara, Thaim Buya] Connaught Hosp, Freetown, Sierra Leone; [Kamara, Thaim Buya] Univ Sierra Leone, Dept Surg, Freetown, Sierra Leone; [Lavy, Chris] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England; [Ganbold, Lundeg] Mongolian Natl Univ Med Sci, Ulaanbaatar, Mongolia; [Mkandawire, Nyengo C.] Univ Malawi, Coll Med, Dept Surg, Blantyre, Malawi; [Mkandawire, Nyengo C.] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [Raykar, Nakul P.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Riesel, Johanna N.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Rodas, Edgar] Univ Cuenca, Cinterandes Fdn, Cuenca, Ecuador; [Rodas, Edgar] Univ Azuay, Cuenca, Ecuador; [Rodas, Edgar] Univ Azuay, Cuenca, Ecuador; [Roy, Nobhojit] BARC Hosp, Mumbai, Maharashtra, India; [Shrime, Mark G.] Harvard Interfac Initiat Hlth Policy, Cambridge, MA USA; [Sullivan, Richard] Kings Coll London, Kings Ctr Global Hlth, Li Kings Hlth Partners Integrated Canc Ctr, Inst Canc Policy, London, England; [Verguet, Stephane] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Watters, David] Royal Australasian Coll Surg, East Melbourne, Vic, Australia; [Watters, David] Deakin Univ, Melbourne, Vic, Australia; [Weiser, Thomas G.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA USA; [Wilson, Iain H.] Royal Devon & Exeter NHS Fdn Trust, Dept Anaesthesia, Exeter, Devon, England; [Yamey, Gavin] Univ Calif San Francisco, Global Hlth Grp, Evidence Policy Initiat, San Francisco, CA USA; [Yip, Winnie] Univ Oxford, Blavatnik Sch Govt, Oxford, England	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of London; King's College London; University of London; King's College London; Lund University; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Universidade de Sao Paulo; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Royal North Shore Hospital; Medical College of Wisconsin; Florey Institute of Neuroscience & Mental Health; Monash University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Connaught Hospital; University of Oxford; Mongolian National University of Medical Sciences; University of Malawi; Flinders University South Australia; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Universidad de Cuenca; Universidad del Azuay; Universidad del Azuay; Bhabha Atomic Research Center (BARC); University of London; King's College London; Harvard University; Harvard T.H. Chan School of Public Health; Deakin University; Stanford University; University of Exeter; University of California System; University of California San Francisco; University of Oxford	Meara, JG (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	john.meara@childrens.harvard.edu	Alonso, Nivaldo/D-2711-2012; Weiser, Thomas G/AAC-4609-2022; GANBOLD, Lundeg/AAL-4966-2021; Alkire, Blake/AAY-6463-2020; Alonso, Nivaldo/AAB-4570-2021; Watters, David Allan/AAI-1022-2020; Grimes, Caris/C-8252-2018	Alonso, Nivaldo/0000-0003-1532-9610; Weiser, Thomas G/0000-0002-3118-3888; GANBOLD, Lundeg/0000-0001-8470-7342; Alonso, Nivaldo/0000-0003-1532-9610; Watters, David Allan/0000-0002-5742-8417; Roy, Nobhojit/0000-0003-2022-7416; Meara, John G./0000-0003-4369-3209; Leather, Andy/0000-0003-0500-5962; Sullivan, Richard/0000-0002-6435-1825; Davies, Justine/0000-0001-6834-1838; Grimes, Caris/0000-0002-1662-5799	Medical Research Council [MR/K010174/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Kim J., 2014, LANCET BOSTON MA US	1	390	408	5	20	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	JUL	2015	158	1					3	6		10.1016/j.surg.2015.04.011	http://dx.doi.org/10.1016/j.surg.2015.04.011			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CK6ED	25987187				2022-12-28	WOS:000356320400002
J	Stewart, EA; Laughlin-Tommaso, SK; Catherino, WH; Lalitkumar, S; Gupta, D; Vollenhoven, B				Stewart, Elizabeth A.; Laughlin-Tommaso, Shannon K.; Catherino, William H.; Lalitkumar, Sujata; Gupta, Devashana; Vollenhoven, Beverley			Uterine fibroids	NATURE REVIEWS DISEASE PRIMERS			English	Article							REPRODUCTIVE-TRACT LEIOMYOMATA; AFRICAN-AMERICAN WOMEN; ORAL-CONTRACEPTIVE USE; OF-LIFE QUESTIONNAIRE; SMOOTH-MUSCLE; TRANSVAGINAL SONOGRAPHY; ULIPRISTAL ACETATE; HYSTEROSCOPIC RESECTION; PREMENOPAUSAL WOMEN; VITAMIN-D	Uterine fibroids (also known as leiomyomas or myomas) are common clonal neoplasms of the uterus. Fibroids have both smooth muscle and fibroblast components, in addition to a substantial amount of fibrous extracellular matrix, which all contribute to the pathogenetic process. Fibroids are extremely heterogeneous in their pathophysiology, size, location and clinical symptomatology. They are also a part of a range of disease in which some variants have facets of malignant behaviour but overall are benign. Risk for fibroids is associated with race; black women have a higher risk of developing fibroids earlier in life than their white counterparts and also develop more-severe forms of the disease. Clinically, fibroids account for one-third to half of all hysterectomies and are associated with substantial morbidity and health care costs for women of reproductive age. Indeed, current treatments are primarily surgical and interventional; approximately three-quarters of all fibroid treatments are hysterectomies. However, clinical innovations are emerging in the use of progesterone receptor modulators as a medical therapy. New information is rapidly accumulating about the genetic subgroups that lead to fibroid formation, which might aid further understanding of the clinical heterogeneity of this disease and lead to individualized treatments. This information is a crucial development given the current lack of high-quality evidence on which to base therapeutic decisions.	[Stewart, Elizabeth A.; Laughlin-Tommaso, Shannon K.] Mayo Clin, Dept Obstet & Gynecol, 200 First St SW, Rochester, MN 55905 USA; [Stewart, Elizabeth A.; Laughlin-Tommaso, Shannon K.] Mayo Clin, Dept Surg, 200 First St SW, Rochester, MN 55905 USA; [Catherino, William H.] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA; [Lalitkumar, Sujata] Karolinska Inst, Dept Obstet & Gynecol, Stockholm, Sweden; [Gupta, Devashana; Vollenhoven, Beverley] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia; [Gupta, Devashana; Vollenhoven, Beverley] Monash Hlth, Womens Program, Melbourne, Vic, Australia; [Gupta, Devashana; Vollenhoven, Beverley] Monash IVF, Clayton, Vic, Australia	Mayo Clinic; Mayo Clinic; Uniformed Services University of the Health Sciences - USA; Karolinska Institutet; Monash University	Stewart, EA (corresponding author), Mayo Clin, Dept Obstet & Gynecol, 200 First St SW, Rochester, MN 55905 USA.; Stewart, EA (corresponding author), Mayo Clin, Dept Surg, 200 First St SW, Rochester, MN 55905 USA.	stewart.elizabeth@mayo.edu		Stewart, Elizabeth/0000-0003-1110-2400	US NIH [R01HD060503, P50HS023418, R01HD074711]; Insightec Inc.	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Insightec Inc.	E.A.S. has received research support from the US NIH (R01HD060503, P50HS023418 and R01HD074711) and from Insightec Inc. The authors acknowledge the technical assistance of D. Littlefield.	American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V112, P387, DOI 10.1097/AOG.0b013e318183fbab; Dinh A, 2015, CONTRACEPTION, V91, P360, DOI 10.1016/j.contraception.2015.01.008; Baird DD, 2005, REPROD TOXICOL, V20, P81, DOI 10.1016/j.reprotox.2005.01.002; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2013, EPIDEMIOLOGY, V24, P447, DOI 10.1097/EDE.0b013e31828acca0; Becker E, 2002, J ULTRAS MED, V21, P237, DOI 10.7863/jum.2002.21.3.237; Benassayag C, 1999, AM J PHYSIOL-ENDOC M, V276, pE1112, DOI 10.1152/ajpendo.1999.276.6.E1112; Bergamini V, 2005, AM J OBSTET GYNECOL, V192, P768, DOI 10.1016/j.ajog.2004.10.591; Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Borah BJ, 2016, OBSTET GYNECOL, V127, P67, DOI 10.1097/AOG.0000000000001160; Borah BJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.017; Borgfeldt C, 2000, ACTA OBSTET GYN SCAN, V79, P202, DOI 10.1034/j.1600-0412.2000.079003202.x; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Bosteels J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009461.pub2; Bower JK, 2009, AM J PUBLIC HEALTH, V99, P300, DOI 10.2105/AJPH.2008.133702; Brakta S, 2015, FERTIL STERIL, V104, P698, DOI 10.1016/j.fertnstert.2015.05.031; BROSENS JJ, 1995, LANCET, V346, P558, DOI 10.1016/S0140-6736(95)91387-4; Brucker SY, 2014, INT J GYNECOL OBSTET, V125, P261, DOI 10.1016/j.ijgo.2013.11.012; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Butt JL, 2012, INT J GYNECOL OBSTET, V116, P112, DOI 10.1016/j.ijgo.2011.09.026; Cantuaria GHC, 1998, OBSTET GYNECOL, V92, P109, DOI 10.1016/S0029-7844(98)00131-8; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; CARR BR, 1993, J CLIN ENDOCR METAB, V76, P1217, DOI 10.1210/jc.76.5.1217; Catherino WH, 2007, FERTIL STERIL, V87, P1388, DOI 10.1016/j.fertnstert.2006.11.093; Ciavattini A, 2015, J MATERN-FETAL NEO M, V28, P484, DOI 10.3109/14767058.2014.921675; CICINELLI E, 1995, OBSTET GYNECOL, V85, P42, DOI 10.1016/0029-7844(94)00298-R; Clement P.B., 2014, ATLAS GYNECOLOGIC SU; Coronado GD, 2000, OBSTET GYNECOL, V95, P764, DOI 10.1016/S0029-7844(99)00605-5; COUTINHO EM, 1989, ACTA OBSTET GYN SCAN, P39; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; DUDIAK CM, 1988, RADIOLOGY, V167, P627, DOI 10.1148/radiology.167.3.3283833; Dueholm M, 2002, HUM REPROD, V17, P195, DOI 10.1093/humrep/17.1.195; Dueholm M, 2001, FERTIL STERIL, V76, P350, DOI 10.1016/S0015-0282(01)01900-8; Eder S, 2013, WOMENS HEALTH, V9, P397, DOI [10.2217/whe.13.28, 10.2217/WHE.13.28]; Eggemoen AR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0796-0; Engman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080114; Eskenazi B, 2007, AM J EPIDEMIOL, V166, P79, DOI 10.1093/aje/kwm048; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Faerstein E, 2001, AM J EPIDEMIOL, V153, P11, DOI 10.1093/aje/153.1.11; Ferreira JCP, 2015, ACTA OBSTET GYN SCAN, V94, P660, DOI 10.1111/aogs.12626; Fisher B, 1999, EUR J CANCER, V35, P1963, DOI 10.1016/S0959-8049(99)00217-8; Flake G. P., 2013, OBSTET GYNECOL INT, V2013; Fleischer R, 2008, BEST PRACT RES CL OB, V22, P603, DOI 10.1016/j.bpobgyn.2008.01.005; Flierman PA, 2005, BJOG-INT J OBSTET GY, V112, P638, DOI 10.1111/j.1471-0528.2004.00504.x; Fonseca-Moutinho JA, 2013, INT J WOMENS HEALTH, V5, P689, DOI 10.2147/IJWH.S50786; Gattas GJF, 1999, GENE CHROMOSOME CANC, V25, P316, DOI 10.1002/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0; Ghant MS, 2015, J PSYCHOSOM RES, V78, P499, DOI 10.1016/j.jpsychores.2014.12.016; Gliklich R. E., 2011, IDENTIFICATION FUTUR; Gorny KR, 2014, J VASC INTERV RADIOL, V25, P1506, DOI 10.1016/j.jvir.2014.05.012; Gupta JK, 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005073; Halder SK, 2015, MOL GENET GENOMICS, V290, P505, DOI 10.1007/s00438-014-0938-x; Halder SK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098145; Halder SK, 2011, J CLIN ENDOCR METAB, V96, pE754, DOI 10.1210/jc.2010-2131; Harding G, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-99; Hassan MH, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.010; Hehenkamp WJK, 2007, HUM REPROD, V22, P1996, DOI 10.1093/humrep/dem105; Hilario SG, 2009, FERTIL STERIL, V91, P240, DOI 10.1016/j.fertnstert.2007.11.006; Hodge JC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.011; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Hodge JC, 2009, HUM GENET, V125, P257, DOI 10.1007/s00439-008-0621-6; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Holdsworth-Carson SJ, 2014, REPRODUCTION, V147, P683, DOI 10.1530/REP-13-0580; Holdsworth-Carson SJ, 2014, MOL HUM REPROD, V20, P250, DOI 10.1093/molehr/gat083; HOWE SR, 1995, AM J PATHOL, V146, P1568; Hsieh YY, 2003, FERTIL STERIL, V79, P96, DOI 10.1016/S0015-0282(02)04563-6; Huyck KL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.038; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Johnson G, 2012, HUM REPROD, V27, P2991, DOI 10.1093/humrep/des263; Kamath MS, 2014, EUR J OBSTET GYN R B, V177, P11, DOI 10.1016/j.ejogrb.2014.03.009; Kim CH, 2006, INT J GYNECOL CANCER, V16, P843, DOI 10.1111/j.1525-1438.2006.00524.x; Kim DC, 2008, REPROD SCI, V15, P552, DOI 10.1177/1933719107312681; Klatsky PC, 2008, AM J OBSTET GYNECOL, V198, P357, DOI 10.1016/j.ajog.2007.12.039; Koumas L, 2001, AM J PATHOL, V159, P925, DOI 10.1016/S0002-9440(10)61768-3; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Kriplani A, 2012, INT J GYNECOL OBSTET, V116, P35, DOI 10.1016/j.ijgo.2011.07.031; Kurman R. J., 2002, BLAUSTEINS PATHOLOGY; Lan M, 2016, REPROD SCI, V23, P264, DOI 10.1177/1933719115602771; Laughlin SK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.018; Laughlin SK, 2010, FERTIL STERIL, V94, P2421, DOI 10.1016/j.fertnstert.2010.03.035; Laughlin SK, 2010, SEMIN REPROD MED, V28, P203, DOI 10.1055/s-0030-1251477; Laughlin SK, 2009, OBSTET GYNECOL, V113, P630, DOI 10.1097/AOG.0b013e318197bbaf; Laughlin-Tommaso SK, 2015, FERTIL STERIL, V104, P435, DOI 10.1016/j.fertnstert.2015.04.029; Lee BS, 2001, J CLIN ENDOCR METAB, V86, P913, DOI 10.1210/jc.86.2.913; Lee TK, 2004, INT IMMUNOPHARMACOL, V4, P447, DOI 10.1016/j.intimp.2003.12.012; Leppert PC, 2004, FERTIL STERIL, V82, P1182, DOI 10.1016/j.fertnstert.2004.04.030; Lethaby AE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002126.pub2; Lethaby A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000400.pub3; Lethaby AE, 2008, BEST PRACT RES CL OB, V22, P307, DOI 10.1016/j.bpobgyn.2007.07.010; Levy G, 2013, FERTIL STERIL, V99, P1146, DOI 10.1016/j.fertnstert.2012.10.048; Lukacz ES, 2004, AM J OBSTET GYNECOL, V191, P165, DOI 10.1016/j.ajog.2004.04.047; Lukes AS, 2010, OBSTET GYNECOL, V116, P865, DOI 10.1097/AOG.0b013e3181f20177; Lumbiganon P, 1996, BRIT J OBSTET GYNAEC, V103, P909, DOI 10.1111/j.1471-0528.1996.tb09911.x; Luyckx M, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1253; Machado SA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101188; Maekawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066632; Makinen N, 2013, EUR J HUM GENET, V21, P1300, DOI 10.1038/ejhg.2013.33; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik M, 2008, CLIN ENDOCRINOL, V69, P462, DOI 10.1111/j.1365-2265.2008.03207.x; Malik M, 2009, FERTIL STERIL, V91, P2177, DOI 10.1016/j.fertnstert.2008.03.045; Mara M, 2008, CARDIOVASC INTER RAD, V31, P73, DOI 10.1007/s00270-007-9195-2; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; Markowski DN, 2011, ANTICANCER RES, V31, P753; Marret H, 2012, EUR J OBSTET GYN R B, V165, P156, DOI 10.1016/j.ejogrb.2012.07.030; Marsh EE, 2014, INT J GYNECOL OBSTET, V125, P56, DOI 10.1016/j.ijgo.2013.09.027; Marsh EE, 2013, FERTIL STERIL, V99, P1951, DOI 10.1016/j.fertnstert.2013.02.017; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Marshall LM, 1998, FERTIL STERIL, V70, P432, DOI 10.1016/S0015-0282(98)00208-8; Matsuda M., 2014, Sarcoma, V2014, P498682, DOI 10.1155/2014/498682; Mehine M, 2014, FERTIL STERIL, V102, P621, DOI 10.1016/j.fertnstert.2014.06.050; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mercorio F, 2003, CONTRACEPTION, V67, P277, DOI 10.1016/S0010-7824(02)00522-X; Merrill RM, 2008, MED SCI MONITOR, V14, pCR24; Metwally M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003857.pub3; Moore KR, 2014, FERTIL STERIL, V101, P208, DOI 10.1016/j.fertnstert.2013.09.021; MOOS RH, 1968, PSYCHOSOM MED, V30, P853, DOI 10.1097/00006842-196811000-00006; Moravek MB, 2015, CURR OPIN OBSTET GYN, V27, P276, DOI 10.1097/GCO.0000000000000185; Munro MG, 2011, INT J GYNECOL OBSTET, V113, P3, DOI 10.1016/j.ijgo.2010.11.011; Mutter GL, 2008, MODERN PATHOL, V21, P591, DOI 10.1038/modpathol.2008.19; Muzii L, 2010, FERTIL STERIL, V94, P1496, DOI 10.1016/j.fertnstert.2009.05.070; Myers E., 2001, MANAGEMENT UTERINE F; Myers SL, 2012, J WOMENS HEALTH, V21, P285, DOI 10.1089/jwh.2011.3008; Nanda S, 2002, AUST NZ J OBSTET GYN, V42, P530, DOI 10.1111/j.0004-8666.2002.00530.x; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Nowak RA, 1999, GYNECOL OBSTET INVES, V48, P127, DOI 10.1159/000010154; Ono M, 2013, P NATL ACAD SCI USA, V110, P17053, DOI 10.1073/pnas.1313650110; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Palomba S, 2002, HUM REPROD, V17, P3213, DOI 10.1093/humrep/17.12.3213; Palomba S, 2002, J CLIN ENDOCR METAB, V87, P3603, DOI 10.1210/jc.87.8.3603; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Perez-Lopez FR, 2015, CLIMACTERIC, V18, P177, DOI 10.3109/13697137.2014.981133; Perez-Lopez FR, 2014, MATURITAS, V79, P106, DOI 10.1016/j.maturitas.2014.06.002; Perez-Lopez FR, 2014, CLIMACTERIC, V17, P308, DOI 10.3109/13697137.2014.908578; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015; Pisco JM, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.08.032; Pritts EA, 2009, FERTIL STERIL, V91, P1215, DOI 10.1016/j.fertnstert.2008.01.051; Puri K, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.038; Qi LH, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.027; Qin JB, 2013, ARCH GYNECOL OBSTET, V288, P139, DOI 10.1007/s00404-013-2797-9; Quinn SD, 2014, EUR J OBSTET GYN R B, V182, P243, DOI 10.1016/j.ejogrb.2014.09.039; Rabinovici J, 2010, FERTIL STERIL, V93, P199, DOI 10.1016/j.fertnstert.2008.10.001; Rocca WA, 2012, NEURODEGENER DIS, V10, P175, DOI 10.1159/000334764; Rocca WA, 2012, MATURITAS, V71, P1, DOI 10.1016/j.maturitas.2011.10.006; Rogers R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.057; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Roshdy E, 2013, INT J WOMENS HEALTH, V5, P477, DOI 10.2147/IJWH.S41021; RUTA DA, 1995, QUAL LIFE RES, V4, P33, DOI 10.1007/BF00434381; Sangkomkamhang US, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008994.pub2; Santos P, 2015, DIAGN INTERV RADIOL, V21, DOI 10.5152/dir.2014.14053; Sanz-Ortega J, 2013, AM J SURG PATHOL, V37, P74, DOI 10.1097/PAS.0b013e31825ec16f; Selo-Ojeme D, 2008, J OBSTET GYNAECOL, V28, P421, DOI 10.1080/01443610802149863; Sinclair DC, 2011, J CLIN ENDOCR METAB, V96, P412, DOI 10.1210/jc.2010-1450; Socolov D, 2011, EUR J CONTRACEP REPR, V16, P480, DOI 10.3109/13625187.2011.614028; Spielmann AL, 2006, AM J ROENTGENOL, V187, P1499, DOI 10.2214/AJR.05.1476; Spies JB, 2002, OBSTET GYNECOL, V99, P290, DOI 10.1016/S0029-7844(01)01702-1; Steinauer J, 2004, OBSTET GYNECOL, V103, P1331, DOI 10.1097/01.AOG.0000127622.63269.8b; Stewart EA, 1996, HUM REPROD UPDATE, V2, P295, DOI 10.1093/humupd/2.4.295; Stewart EA, 2007, UTERINE FIBROIDS COM; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Stewart EA, 2013, J WOMENS HEALTH, V22, P807, DOI 10.1089/jwh.2013.4334; Stout MJ, 2010, OBSTET GYNECOL, V116, P1056, DOI 10.1097/AOG.0b013e3181f7496d; Taran FA, 2010, FERTIL STERIL, V94, P1223, DOI 10.1016/j.fertnstert.2009.06.049; Toledo G, 2008, ARCH PATHOL LAB MED, V132, P595, DOI 10.1043/1543-2165(2008)132[595:SMTOTU]2.0.CO;2; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; U.S. Food and Drug Administration, 2014, UPD LAP UT POW MORC; van der Kooij SM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.016; Varelas FK, 2007, OBSTET GYNECOL, V110, P643, DOI 10.1097/01.AOG.0000279151.20878.60; Varghese BV, 2013, P NATL ACAD SCI USA, V110, P2187, DOI 10.1073/pnas.1215759110; VOLLENHOVEN BJ, 1993, J CLIN ENDOCR METAB, V76, P1106, DOI 10.1210/jc.76.5.1106; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; WAMSTEKER K, 1993, OBSTET GYNECOL, V82, P736; Wang GW, 2014, FERTIL STERIL, V101, P1485, DOI 10.1016/j.fertnstert.2014.01.054; Wechter ME, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.008; Wei JJ, 2006, HUM REPROD, V21, P57, DOI 10.1093/humrep/dei309; Weston G, 2003, MOL HUM REPROD, V9, P541, DOI 10.1093/molehr/gag066; Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016; Wise LA, 2012, AM J EPIDEMIOL, V176, P1159, DOI 10.1093/aje/kws276; Wise LA, 2011, AM J CLIN NUTR, V94, P1620, DOI 10.3945/ajcn.111.016600; Wise LA, 2010, AM J EPIDEMIOL, V171, P221, DOI 10.1093/aje/kwp355; Wong JYY, 2016, J CLIN ENDOCR METAB, V101, P122, DOI 10.1210/jc.2015-2935; Wright JD, 2014, JAMA-J AM MED ASSOC, V312, P1253, DOI 10.1001/jama.2014.9005; Yin HW, 2013, MOL ENDOCRINOL, V27, P726, DOI 10.1210/me.2012-1305; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Yin P, 2010, CANCER RES, V70, P1722, DOI 10.1158/0008-5472.CAN-09-2612; Youm J, 2014, INT J GYNECOL OBSTET, V126, P165, DOI 10.1016/j.ijgo.2014.02.017; Zaitseva M, 2008, HUM REPROD, V23, P1076, DOI 10.1093/humrep/den083; Zaitseva M, 2007, MOL HUM REPROD, V13, P577, DOI 10.1093/molehr/gam040; Zaitseva M, 2013, REPRODUCTION, V146, P91, DOI 10.1530/REP-13-0087; Zakherah MS, 2011, GYNECOL OBSTET INVES, V71, P281, DOI 10.1159/000320336; Zhou ST, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017988	197	360	383	7	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2056-676X			NAT REV DIS PRIMERS	Nat. Rev. Dis. Primers	JUN 23	2016	2								16043	10.1038/nrdp.2016.43	http://dx.doi.org/10.1038/nrdp.2016.43			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT3HK	25901428				2022-12-28	WOS:000381371500001
